data_1tum_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1tum _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.485 ' HE2' ' NE2' ' A' ' 5' ' ' GLN . 20.3 tttt . . . . . 0 N--CA 1.478 0.931 0 CA-C-O 121.51 0.672 . . . . 0.0 109.868 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.575 HD13 HG13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -158.25 150.87 22.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.565 ' N ' ' CD2' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -121.38 161.59 21.86 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.093 -1.005 . . . . 0.0 109.231 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -124.4 114.94 43.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.253 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -84.07 64.46 8.2 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.535 ' CB ' ' O ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -79.21 -79.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.206 -179.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.599 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 73.97 85.76 0.26 Allowed Glycine 0 C--N 1.298 -1.571 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.556 HD12 ' CE1' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -49.43 169.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.03 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.557 HG23 ' CG2' ' A' ' 87' ' ' VAL . 7.1 pt -137.92 78.1 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.271 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.56 ' NH1' ' HG ' ' A' ' 129' ' ' LEU . 5.7 ptm180 -82.19 137.87 34.82 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.62 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -158.58 0.23 0.09 Allowed 'General case' 0 C--O 1.187 -2.22 0 C-N-CA 116.748 -1.981 . . . . 0.0 114.805 -177.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.511 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 22.0 tt0 -92.85 -32.52 14.59 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 118.246 -2.784 . . . . 0.0 106.923 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.402 ' C ' ' OD1' ' A' ' 15' ' ' ASN . 16.4 t-20 -163.79 -48.49 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 101.844 -3.391 . . . . 0.0 101.844 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.534 ' OD1' ' NH2' ' A' ' 12' ' ' ARG . 56.1 t30 -161.74 37.4 0.13 Allowed 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 175.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.511 ' CG ' ' HB3' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -90.17 101.45 14.17 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.013 -177.166 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.547 HG21 ' CB ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -89.34 149.78 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 122.003 0.906 . . . . 0.0 110.518 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.602 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 44.7 t80 -82.98 41.94 0.77 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.501 HG13 ' N ' ' A' ' 21' ' ' THR . 6.3 tp -81.07 156.23 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 122.193 0.996 . . . . 0.0 111.58 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.501 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -64.39 95.05 0.12 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.545 ' O ' ' C ' ' A' ' 23' ' ' ARG . 32.4 tpt180 -104.82 78.95 1.47 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.211 -0.931 . . . . 0.0 111.055 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.545 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 25.33 76.44 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 120.97 0.415 . . . . 0.0 110.706 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.69 -48.53 5.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.43 -0.794 . . . . 0.0 109.07 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.65 154.15 27.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.409 -0.807 . . . . 0.0 108.858 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.71 110.93 1.89 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.047 -1.033 . . . . 0.0 109.16 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.458 ' CB ' ' HD2' ' A' ' 23' ' ' ARG . . . -100.0 149.96 22.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 110.003 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.09 -20.54 52.07 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.424 ' SD ' ' N ' ' A' ' 29' ' ' MET . 2.7 mpp? -97.53 -166.78 1.43 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -156.78 18.65 0.32 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.014 -1.054 . . . . 0.0 110.217 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.0 m-20 -99.67 17.28 20.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.072 -1.017 . . . . 0.0 108.879 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.495 ' HD2' ' CA ' ' A' ' 23' ' ' ARG . 1.1 tttp -81.52 39.5 0.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.386 -0.821 . . . . 0.0 111.124 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 115' ' ' PHE . 19.9 mt -107.33 91.91 3.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.826 -1.171 . . . . 0.0 109.351 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.568 ' O ' ' CD1' ' A' ' 35' ' ' PHE . 37.9 tt0 -91.16 -128.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.314 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 17.9 m-85 -157.11 131.91 5.31 Favored Pre-proline 0 N--CA 1.485 1.324 0 O-C-N 120.81 -1.181 . . . . 0.0 109.758 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.535 ' O ' ' CB ' ' A' ' 8' ' ' VAL . 1.4 Cg_endo -61.01 88.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.51 2.14 . . . . 0.0 110.435 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -54.65 -160.16 0.01 OUTLIER Glycine 0 N--CA 1.494 2.518 0 O-C-N 121.314 -0.866 . . . . 0.0 111.061 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 163.87 -28.85 0.23 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.541 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 69.91 102.32 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.973 -0.722 . . . . 0.0 111.058 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.564 HG22 ' CD1' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -81.54 132.32 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.199 -0.938 . . . . 0.0 108.928 178.452 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -171.64 -32.55 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 109.739 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.403 ' HB2' ' HA ' ' A' ' 49' ' ' ALA . 8.7 mmt -53.02 161.61 0.78 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 109.744 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.04 -121.13 12.52 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.412 ' OE2' ' HA ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -168.99 25.03 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.496 -1.002 . . . . 0.0 108.925 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.565 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 63.4 m -154.24 144.37 15.64 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.595 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 10.8 Cg_exo -48.37 -16.43 0.68 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.894 1.73 . . . . 0.0 111.443 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.489 ' O ' HG11 ' A' ' 51' ' ' VAL . 2.5 mt-10 -78.6 -72.71 0.36 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.744 -1.222 . . . . 0.0 109.124 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.55 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 3.8 mt-30 -56.48 -30.87 63.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.399 -1.438 . . . . 0.0 109.321 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.631 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -67.14 -63.24 1.1 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.475 -0.766 . . . . 0.0 109.816 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.574 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 2.3 p -67.91 -48.19 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.051 -1.031 . . . . 0.0 110.463 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.574 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 1.6 p -55.73 -42.57 70.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 121.188 0.518 . . . . 0.0 110.334 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 2.4 mmm180 -77.65 -29.79 51.81 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.631 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 21.1 mm-40 -75.75 -11.88 60.08 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.6 ' HB3' ' CH2' ' A' ' 95' ' ' TRP . 0.7 OUTLIER -80.17 -57.19 3.74 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.755 0.788 . . . . 0.0 108.989 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.484 ' N ' ' CZ3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -65.38 -42.0 93.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.896 -0.502 . . . . 0.0 110.946 -179.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.592 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -57.57 -24.43 56.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.094 -1.004 . . . . 0.0 111.556 -177.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.57 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -80.21 -83.03 0.11 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.409 -1.432 . . . . 0.0 110.572 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.561 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 74.6 t -80.27 -80.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.037 -1.039 . . . . 0.0 110.007 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.21 32.8 0.1 OUTLIER Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.325 -1.417 . . . . 0.0 110.837 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.642 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.8 pp -94.27 -159.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.809 -1.407 . . . . 0.0 108.419 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.588 ' CB ' ' CD ' ' A' ' 62' ' ' PRO . 1.8 m -135.45 -70.87 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.773 -1.205 . . . . 0.0 110.637 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.598 ' HD2' ' HB3' ' A' ' 91' ' ' GLU . 2.6 Cg_endo -59.3 -171.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.084 0 C-N-CA 121.487 1.458 . . . . 0.0 110.402 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.577 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 2.6 pt20 144.03 -22.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.531 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.3 OUTLIER 43.82 72.12 0.21 Allowed 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -69.54 149.17 48.49 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.836 0.826 . . . . 0.0 110.898 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -143.66 144.91 32.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.605 HD21 ' CE2' ' A' ' 85' ' ' TRP . 1.9 tm? -66.29 -68.72 0.35 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.774 -1.204 . . . . 0.0 110.25 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.582 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 81.35 -51.72 0.28 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 -178.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.495 ' N ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER 167.74 179.12 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 109.242 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -159.72 158.01 30.53 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.045 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.533 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 1.1 pp -117.93 -177.26 3.22 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.026 -1.047 . . . . 0.0 110.192 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -154.84 89.69 1.25 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.524 ' CE2' ' O ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -79.55 127.12 31.76 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.157 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -100.98 133.84 44.87 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.06 -1.025 . . . . 0.0 109.482 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.541 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -116.9 171.09 5.16 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 108.843 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.9 Cg_exo -48.23 -47.24 20.28 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.992 1.794 . . . . 0.0 110.196 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.431 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 5.4 p-10 -141.26 33.05 1.7 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.468 ' O ' HD11 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -140.15 93.14 2.6 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.554 -0.716 . . . . 0.0 110.32 -179.048 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -82.7 92.94 7.28 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.602 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -97.68 163.42 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -0.963 . . . . 0.0 111.26 -177.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.568 ' N ' ' CG2' ' A' ' 80' ' ' ILE . 1.3 m -140.46 168.71 19.17 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.451 HD22 ' CG1' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -157.31 85.23 0.93 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.539 -1.351 . . . . 0.0 110.595 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.564 ' CD1' HG22 ' A' ' 40' ' ' ILE . 70.6 m95 -58.49 126.56 28.1 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.303 -0.873 . . . . 0.0 109.418 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.575 ' CD2' HG12 ' A' ' 122' ' ' VAL . 19.1 m-85 -101.57 70.73 1.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 0.0 109.878 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.605 ' CE2' HD21 ' A' ' 67' ' ' LEU . 93.6 m95 -74.26 91.25 2.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.943 -1.098 . . . . 0.0 108.983 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.546 HD22 ' CD2' ' A' ' 68' ' ' PHE . 3.5 mm? -73.48 126.58 30.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.208 -0.932 . . . . 0.0 110.489 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.557 ' CG2' HG23 ' A' ' 11' ' ' ILE . 1.5 m -112.02 169.18 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 78.0 mt-10 -149.55 17.37 0.91 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.487 -1.383 . . . . 0.0 112.954 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.605 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.26 67.51 0.36 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.089 -1.632 . . . . 0.0 110.56 178.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.62 ' CH2' ' ND2' ' A' ' 13' ' ' ASN . 1.8 p90 -80.74 164.79 22.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.329 -1.482 . . . . 0.0 109.656 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.667 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.9 OUTLIER -80.86 141.97 34.09 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.105 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.477 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 27.92 -80.33 0.0 OUTLIER Glycine 0 N--CA 1.502 3.046 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' A' ' 91' ' ' GLU . 0.8 OUTLIER -100.55 151.7 37.64 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.335 -1.097 . . . . 0.0 109.63 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.607 ' HB3' ' CE3' ' A' ' 90' ' ' TRP . 9.9 Cg_endo -73.94 -158.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.724 2.282 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.644 ' CD1' ' O ' ' A' ' 95' ' ' TRP . 0.2 OUTLIER 177.53 112.53 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.644 -0.66 . . . . 0.0 109.784 179.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . 174.47 -40.83 0.13 Allowed Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.405 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.542 ' HB2' ' CG ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -44.4 124.24 3.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.101 -1.235 . . . . 0.0 109.489 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.493 ' OE1' ' HA2' ' A' ' 38' ' ' GLY . 8.2 tp10 -74.7 -111.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.713 -1.242 . . . . 0.0 107.687 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.76 12.25 64.14 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.542 ' CG ' ' HB2' ' A' ' 97' ' ' LYS . 6.4 pt20 -92.97 170.13 9.33 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.696 -0.885 . . . . 0.0 109.495 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -68.69 -48.67 0.95 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.022 1.814 . . . . 0.0 110.281 -179.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.594 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.62 118.52 0.01 OUTLIER Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.587 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 4.5 pt-20 -157.18 145.19 19.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.932 -1.334 . . . . 0.0 110.44 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.4 ' CD1' ' HD1' ' A' ' 19' ' ' PHE . 1.3 m0 -48.58 135.16 14.87 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -129.88 112.95 14.05 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.081 -1.012 . . . . 0.0 109.492 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.9 t -78.22 73.33 4.78 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.614 ' O ' ' CB ' ' A' ' 108' ' ' VAL . 8.0 tt -80.7 -66.51 0.87 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.433 -0.792 . . . . 0.0 109.792 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.614 ' CB ' ' O ' ' A' ' 107' ' ' LEU . 99.3 t 103.75 98.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 41.98 82.57 0.02 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.591 HD23 ' CZ ' ' A' ' 115' ' ' PHE . 2.1 mp -29.96 153.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.962 0.887 . . . . 0.0 111.612 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -132.38 -6.26 3.35 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.692 -0.63 . . . . 0.0 110.618 -178.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.589 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . . . 73.88 -3.26 2.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.217 -0.927 . . . . 0.0 108.806 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.82 -22.31 40.11 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.572 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 14.9 m-20 -104.92 -10.42 17.3 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 33' ' ' LEU . 27.7 m-85 -102.7 144.99 29.72 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.395 -0.815 . . . . 0.0 109.557 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 2.3 Cg_endo -65.6 151.19 85.41 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.547 2.165 . . . . 0.0 110.94 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.448 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . 1.6 Cg_endo -65.33 -23.75 58.54 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.239 1.959 . . . . 0.0 109.824 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.524 ' O ' ' CE2' ' A' ' 73' ' ' TYR . . . -46.14 -58.49 3.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.384 -0.822 . . . . 0.0 109.686 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.494 ' O ' HD13 ' A' ' 123' ' ' ILE . 12.7 m120 -85.82 45.3 1.19 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 108.892 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.621 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 2.6 mt-10 -59.56 -43.66 96.19 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 121.378 -0.826 . . . . 0.0 112.137 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 7.7 Cg_exo -53.18 -36.44 77.3 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.058 1.839 . . . . 0.0 112.537 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.575 HG12 ' CD2' ' A' ' 84' ' ' PHE . 2.0 t -100.42 -38.0 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.611 -1.305 . . . . 0.0 109.707 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.589 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 6.8 mt -56.94 -27.54 26.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.478 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -60.7 -39.0 86.9 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.426 ' HG3' ' OE1' ' A' ' 69' ' ' GLU . 13.7 mmtp -76.11 -40.13 53.59 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.212 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.526 ' HB3' ' CB ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -55.45 -43.23 75.26 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.541 ' CD ' ' HB1' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -39.58 -41.81 1.08 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.997 0.903 . . . . 0.0 108.652 178.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 129' ' ' LEU . 1.0 OUTLIER -79.21 -50.99 10.09 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.56 ' HG ' ' NH1' ' A' ' 12' ' ' ARG . 1.8 tp . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.608 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.541 ' CG ' ' O ' ' A' ' 79' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 121.7 0.762 . . . . 0.0 110.339 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.512 ' CD2' HD11 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -136.1 -171.92 3.0 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.087 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.5 ' O ' HD13 ' A' ' 4' ' ' LEU . 7.8 mp0 -144.05 177.96 8.2 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -145.65 109.87 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.72 -178.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.56 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -83.0 67.26 9.01 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.605 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 0.8 OUTLIER -78.83 -73.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.177 -0.952 . . . . 0.0 109.385 -179.514 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.636 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 62.61 81.7 0.09 OUTLIER Glycine 0 C--N 1.295 -1.747 0 N-CA-C 107.958 -2.057 . . . . 0.0 107.958 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.48 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -48.04 172.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.318 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -136.73 81.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.121 -178.551 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.543 ' CA ' HG21 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -91.61 134.96 34.23 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.059 -1.026 . . . . 0.0 108.344 179.345 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 13' ' ' ASN . 5.2 p-10 -161.66 62.2 0.26 Allowed 'General case' 0 C--O 1.189 -2.119 0 C-N-CA 117.596 -1.641 . . . . 0.0 113.158 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.566 ' CB ' ' HG3' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -148.7 -49.55 0.15 Allowed 'General case' 0 C--N 1.269 -2.92 0 CA-C-O 124.499 2.095 . . . . 0.0 105.616 176.18 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -161.17 -48.54 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 100.885 -3.746 . . . . 0.0 100.885 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.484 ' ND2' ' HD2' ' A' ' 12' ' ' ARG . 1.7 t-20 -162.34 42.52 0.13 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.31 -1.768 . . . . 0.0 106.684 175.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.566 ' HG3' ' CB ' ' A' ' 14' ' ' GLU . 9.4 mm-40 -93.46 95.93 9.58 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.962 -1.495 . . . . 0.0 110.901 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.543 HG21 ' CA ' ' A' ' 12' ' ' ARG . 2.7 pt -89.01 153.83 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.637 -0.664 . . . . 0.0 110.362 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.656 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 3.7 t80 -83.15 47.73 1.28 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.668 ' CD1' ' CE2' ' A' ' 115' ' ' PHE . 5.2 tt -82.36 155.42 3.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.986 0.898 . . . . 0.0 111.299 -177.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.461 HG23 ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -70.07 98.14 1.27 Allowed 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.528 ' O ' ' C ' ' A' ' 23' ' ' ARG . 28.9 tpt180 -104.46 97.3 7.25 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 110.662 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.528 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 24.49 76.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.211 0.529 . . . . 0.0 110.93 179.186 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -44.61 -52.62 7.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.111 -0.993 . . . . 0.0 109.555 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.27 -178.18 6.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.167 -0.958 . . . . 0.0 109.412 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.71 107.06 8.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.24 -0.913 . . . . 0.0 108.934 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.491 ' HB1' ' HD2' ' A' ' 23' ' ' ARG . . . -101.02 171.96 7.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 110.119 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -127.73 16.08 6.94 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.621 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 4.3 mtm -121.29 -106.33 0.37 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.442 -0.786 . . . . 0.0 109.69 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.621 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 148.85 -4.32 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.696 -0.627 . . . . 0.0 110.503 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.461 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 50.3 t-20 -76.27 6.65 5.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.616 -1.302 . . . . 0.0 109.425 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 23' ' ' ARG . 4.1 tmtm? -81.29 62.85 5.38 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.535 -0.728 . . . . 0.0 110.857 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.638 ' CD1' ' CE1' ' A' ' 115' ' ' PHE . 10.6 mt -124.22 90.29 3.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.052 -1.03 . . . . 0.0 109.045 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.23 -144.97 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.903 -1.123 . . . . 0.0 108.794 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.58 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 66.7 m-85 -145.93 124.27 6.41 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 120.901 -1.124 . . . . 0.0 110.019 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.496 ' HB3' ' HA ' ' A' ' 97' ' ' LYS . 9.5 Cg_endo -65.79 90.48 0.24 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.194 1.929 . . . . 0.0 110.219 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -131.0 127.65 5.22 Favored Glycine 0 N--CA 1.494 2.562 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.368 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.542 ' CA ' ' HB2' ' A' ' 98' ' ' GLU . . . -106.65 38.26 3.41 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 120.05 -1.072 . . . . 0.0 111.163 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.503 ' HE3' ' HB2' ' A' ' 4' ' ' LEU . 10.5 tptm 60.24 120.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.777 -0.837 . . . . 0.0 111.433 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.56 ' HB ' ' CB ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -82.59 133.51 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 42' ' ' MET . 1.8 pt-20 -171.83 -25.64 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.548 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.458 ' HE2' ' HG2' ' A' ' 56' ' ' GLU . 3.3 tpp -54.57 129.65 37.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.856 -1.153 . . . . 0.0 109.27 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.12 -120.78 12.54 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -168.27 22.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.402 -1.058 . . . . 0.0 109.716 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.505 HG21 ' HD2' ' A' ' 46' ' ' PRO . 20.6 m -140.9 138.91 18.65 Favored Pre-proline 0 C--O 1.201 -1.486 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.509 ' CB ' ' CZ2' ' A' ' 85' ' ' TRP . 8.6 Cg_exo -48.57 -16.52 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.829 1.686 . . . . 0.0 111.344 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.453 ' O ' HG13 ' A' ' 51' ' ' VAL . 2.7 mt-10 -80.42 -78.7 0.16 Allowed 'General case' 0 C--O 1.201 -1.491 0 O-C-N 120.587 -1.321 . . . . 0.0 108.61 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.558 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 24.7 mt-30 -50.14 -30.75 11.87 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.389 -1.444 . . . . 0.0 109.364 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.643 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -68.6 -60.36 2.47 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.113 -0.992 . . . . 0.0 110.504 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.556 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 4.3 p -70.09 -45.83 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.718 -1.239 . . . . 0.0 110.227 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.583 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 1.4 p -58.12 -47.77 86.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.302 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.583 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -73.48 -36.13 65.78 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.643 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 21.7 mm-40 -65.22 -19.83 66.15 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.655 ' CD1' ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -78.31 -63.39 1.41 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.885 -178.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.546 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -58.94 -44.5 91.4 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.356 -0.84 . . . . 0.0 110.092 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.551 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -54.92 -20.71 9.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.108 -0.995 . . . . 0.0 110.193 -179.239 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.429 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mt-10 -80.26 -92.82 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.065 -1.022 . . . . 0.0 109.837 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.586 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 47.9 t -80.21 -78.98 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.346 -0.846 . . . . 0.0 110.045 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.88 27.51 0.13 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 118.599 -1.762 . . . . 0.0 112.723 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.642 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.3 pp -81.49 -144.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 120.181 -1.776 . . . . 0.0 107.582 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.576 ' CB ' ' CD ' ' A' ' 62' ' ' PRO . 1.3 m -143.07 -71.26 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.206 -1.559 . . . . 0.0 110.24 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.592 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 9.4 Cg_endo -67.01 -170.01 0.21 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.249 1.3 . . . . 0.0 110.127 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.592 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 136.28 -26.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.499 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.2 OUTLIER 56.64 -163.31 0.17 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.444 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 7.2 p90 177.11 143.75 0.09 Allowed 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.533 -1.267 . . . . 0.0 110.585 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -144.13 157.06 44.53 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.613 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -74.29 -69.92 0.42 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.251 -0.906 . . . . 0.0 110.856 -178.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.613 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 83.99 -51.85 0.13 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.2 mt-10 157.3 175.05 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.42 -168.6 2.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.953 -1.092 . . . . 0.0 110.115 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.537 ' HG ' ' CG2' ' A' ' 122' ' ' VAL . 0.3 OUTLIER -147.36 161.41 41.07 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.49 -0.756 . . . . 0.0 109.947 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 80' ' ' ILE . 2.6 tt0 -137.42 90.09 2.48 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.03 119.88 25.47 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.439 -0.788 . . . . 0.0 109.119 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.501 ' HG3' ' HA ' ' A' ' 79' ' ' HIS . 11.1 tt0 -112.2 155.78 23.41 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.318 -0.864 . . . . 0.0 109.824 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.751 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 67.4 m-85 -136.76 -115.22 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.641 0 CA-C-O 117.341 -1.314 . . . . 0.0 109.3 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.751 ' CD ' ' CB ' ' A' ' 75' ' ' PHE . 1.9 Cg_endo -62.44 -43.81 20.9 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 CA-C-N 122.077 1.777 . . . . 0.0 109.895 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -171.4 29.9 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.91 88.73 2.81 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.488 -0.757 . . . . 0.0 109.933 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.541 ' O ' ' CG ' ' A' ' 3' ' ' LYS . 0.3 OUTLIER -79.66 79.84 6.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 108.797 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.512 HD11 ' CD2' ' A' ' 4' ' ' LEU . 2.7 mm -85.0 145.3 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.036 -1.04 . . . . 0.0 110.725 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -120.98 139.43 53.29 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.556 HD21 ' CE1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -124.44 74.07 1.29 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.949 -1.094 . . . . 0.0 109.658 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.405 ' HB3' ' NE1' ' A' ' 85' ' ' TRP . 80.1 m95 -53.53 114.02 1.37 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.033 -1.042 . . . . 0.0 109.48 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.556 ' CE1' HD21 ' A' ' 82' ' ' LEU . 32.4 m-85 -89.53 78.11 7.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.138 -0.976 . . . . 0.0 108.379 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.636 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 97.7 m95 -74.37 85.77 1.98 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.014 -1.054 . . . . 0.0 109.228 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.527 ' O ' ' OG ' ' A' ' 66' ' ' SER . 2.5 mm? -68.88 124.91 24.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.397 -1.439 . . . . 0.0 110.061 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.537 ' O ' ' CG ' ' A' ' 88' ' ' GLU . 0.6 OUTLIER -113.01 178.87 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.537 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 13.8 mt-10 -160.16 33.46 0.17 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 118.103 -1.439 . . . . 0.0 112.881 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.565 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -161.02 47.08 0.21 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 119.803 -1.811 . . . . 0.0 112.404 179.117 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.609 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 1.4 p90 -70.57 160.69 32.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 119.863 -1.773 . . . . 0.0 108.991 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -90.29 146.5 24.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.189 -0.944 . . . . 0.0 108.614 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.44 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . 35.94 -82.33 0.0 OUTLIER Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.664 ' N ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -112.25 157.77 39.0 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.334 -1.097 . . . . 0.0 110.009 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.607 ' HG2' ' CE2' ' A' ' 19' ' ' PHE . 9.0 Cg_endo -76.21 -159.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.993 2.462 . . . . 0.0 110.614 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.655 ' CD1' ' CD1' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -177.87 39.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.862 -1.149 . . . . 0.0 111.189 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -124.81 -7.57 6.05 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.021 -1.562 . . . . 0.0 111.497 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.542 ' HD2' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -63.44 103.72 0.55 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.717 -1.461 . . . . 0.0 110.998 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.542 ' HB2' ' CA ' ' A' ' 38' ' ' GLY . 9.6 tp10 -70.14 92.43 0.75 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -0.99 . . . . 0.0 108.509 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.22 14.99 42.67 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.479 ' HG2' ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -96.69 146.56 31.52 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.6 -0.941 . . . . 0.0 109.027 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.567 ' O ' ' O ' ' A' ' 102' ' ' GLY . 4.9 Cg_exo -58.63 -21.38 55.12 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 N-CA-C 108.385 -1.429 . . . . 0.0 108.385 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.656 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 37.13 105.03 0.01 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -141.43 131.39 24.52 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.382 -1.658 . . . . 0.0 110.483 179.309 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.434 ' C ' ' O ' ' A' ' 103' ' ' GLU . 1.6 m0 -46.17 129.26 10.05 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -123.4 117.07 24.35 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.623 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.33 63.31 5.6 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.654 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 6.9 tt -69.06 -54.06 17.09 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.59 -0.693 . . . . 0.0 110.118 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.654 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 66.6 t 85.32 108.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 46.87 82.51 0.03 OUTLIER Glycine 0 N--CA 1.486 1.968 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 -178.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.586 HD23 ' CZ ' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -34.48 160.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.981 0.896 . . . . 0.0 111.738 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -156.59 141.42 17.04 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.528 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . . . -65.93 -22.34 66.49 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.92 -25.19 4.29 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.574 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -108.17 -18.77 13.69 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.668 ' CE2' ' CD1' ' A' ' 20' ' ' ILE . 44.5 m-85 -100.54 149.64 36.29 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.881 . . . . 0.0 110.605 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.439 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -66.95 144.77 71.67 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.518 2.145 . . . . 0.0 109.941 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 118' ' ' ALA . 1.6 Cg_endo -64.35 -28.22 63.27 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.997 1.798 . . . . 0.0 110.15 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -43.05 -41.08 3.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 109.892 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -108.71 55.72 0.63 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.246 -0.909 . . . . 0.0 109.357 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.681 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -71.76 -35.96 4.05 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.555 -0.715 . . . . 0.0 112.585 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.9 Cg_exo -59.07 -31.37 95.45 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.653 1.569 . . . . 0.0 113.174 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.537 ' CG2' ' HG ' ' A' ' 71' ' ' LEU . 1.8 t -99.97 -38.58 6.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.376 -1.452 . . . . 0.0 109.342 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.589 HD13 ' CD2' ' A' ' 115' ' ' PHE . 2.0 mm -58.86 -37.31 66.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.494 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -39.74 -37.3 0.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.144 0.973 . . . . 0.0 108.946 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.484 ' HE2' ' OE2' ' A' ' 69' ' ' GLU . 7.2 mmtm -81.65 -47.33 13.14 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.802 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.56 ' HB3' ' CB ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -64.62 -10.33 25.77 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.378 -1.451 . . . . 0.0 109.093 179.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.554 ' CG ' ' O ' ' A' ' 123' ' ' ILE . 0.3 OUTLIER -68.75 -37.71 79.58 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -12.29 59.81 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.333 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.526 HD22 ' CZ ' ' A' ' 12' ' ' ARG . 3.0 tp . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.79 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.507 ' HG2' ' N ' ' A' ' 4' ' ' LEU . 6.1 ttpt . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 121.509 0.671 . . . . 0.0 109.991 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.572 ' CD1' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -154.11 156.06 36.54 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.069 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.532 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 14.1 mp0 -124.94 173.66 8.49 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.027 -1.046 . . . . 0.0 108.531 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.498 HD11 HG22 ' A' ' 6' ' ' ILE . 1.1 mm -136.47 110.14 9.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.704 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -84.63 62.17 7.17 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 36' ' ' PRO . 1.1 p -78.29 -70.0 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.363 -0.835 . . . . 0.0 109.902 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.648 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 59.82 80.82 0.09 OUTLIER Glycine 0 C--N 1.297 -1.615 0 N-CA-C 107.055 -2.418 . . . . 0.0 107.055 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -48.4 170.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -178.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.562 HG23 ' CG2' ' A' ' 87' ' ' VAL . 7.7 pt -137.67 99.84 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 C-N-CA 119.406 -0.918 . . . . 0.0 108.768 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.527 ' HG2' ' CG2' ' A' ' 18' ' ' ILE . 13.3 mtm180 -76.68 -176.54 3.85 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.593 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -157.17 -61.42 0.09 Allowed 'General case' 0 C--O 1.191 -2.01 0 C-N-CA 116.957 -1.897 . . . . 0.0 114.527 -177.457 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.569 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 1.9 tt0 -93.3 -30.12 15.31 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 119.038 -2.289 . . . . 0.0 111.435 -175.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -160.85 -43.52 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.804 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.484 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 14.1 t30 -158.32 34.99 0.24 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 177.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 105' ' ' MET . 2.4 mt-10 -78.74 83.77 4.87 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 117.965 -1.494 . . . . 0.0 108.764 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.575 HD11 ' HB ' ' A' ' 20' ' ' ILE . 4.7 pt -80.08 142.54 13.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 119.684 -0.807 . . . . 0.0 109.425 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.671 ' CZ ' ' HG2' ' A' ' 94' ' ' PRO . 10.2 t80 -80.19 42.9 0.59 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.699 -0.626 . . . . 0.0 109.544 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.575 ' HB ' HD11 ' A' ' 18' ' ' ILE . 6.8 tp -82.11 155.62 4.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 122.012 0.91 . . . . 0.0 111.579 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.516 ' N ' HG13 ' A' ' 20' ' ' ILE . 7.6 t -64.92 96.48 0.19 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.47 ' O ' ' C ' ' A' ' 23' ' ' ARG . 27.1 tpt180 -98.16 87.44 3.93 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.423 -0.798 . . . . 0.0 110.257 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.501 ' CB ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 36.79 84.43 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.896 -0.503 . . . . 0.0 109.969 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.59 -51.78 5.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.377 -0.827 . . . . 0.0 109.092 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.89 -160.48 0.16 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -76.17 -43.66 41.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.019 -1.051 . . . . 0.0 109.307 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.501 ' HB1' ' CB ' ' A' ' 23' ' ' ARG . . . 52.89 110.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.35 -0.844 . . . . 0.0 110.24 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -78.96 -6.13 55.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.981 -1.074 . . . . 0.0 108.981 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.555 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 3.1 mpp? -86.81 -124.64 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.188 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 161.49 -2.33 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.833 -1.167 . . . . 0.0 111.647 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 3.8 p-10 -81.96 13.11 3.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.239 -1.538 . . . . 0.0 109.115 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.47 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -81.41 58.99 3.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.599 -0.688 . . . . 0.0 110.322 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.598 ' O ' ' CD2' ' A' ' 115' ' ' PHE . 14.4 mt -130.61 85.46 2.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.945 -1.097 . . . . 0.0 109.097 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.579 ' O ' ' CE2' ' A' ' 115' ' ' PHE . 3.2 tt0 -92.94 -127.63 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -0.975 . . . . 0.0 108.879 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.572 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -151.9 134.54 8.81 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.942 -1.099 . . . . 0.0 108.46 178.521 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 97' ' ' LYS . 4.5 Cg_endo -62.09 92.91 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.924 1.749 . . . . 0.0 109.541 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.513 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -54.56 -152.86 0.01 OUTLIER Glycine 0 N--CA 1.493 2.455 0 CA-C-O 122.051 0.806 . . . . 0.0 111.378 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.593 ' N ' ' CG ' ' A' ' 98' ' ' GLU . . . 162.07 -26.35 0.25 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.518 ' HE3' ' HB2' ' A' ' 4' ' ' LEU . 15.7 tptm 64.09 96.94 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.933 -0.745 . . . . 0.0 110.183 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.568 HG22 ' CD1' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -80.4 133.17 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.206 -0.933 . . . . 0.0 108.574 178.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.483 ' HG2' ' N ' ' A' ' 42' ' ' MET . 2.9 pt-20 -170.6 -32.88 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.464 -0.773 . . . . 0.0 109.721 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.483 ' N ' ' HG2' ' A' ' 41' ' ' GLU . 8.0 mtt -59.17 166.43 2.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.203 -0.936 . . . . 0.0 109.696 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 51.66 -125.77 27.12 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -169.38 26.66 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.448 -1.03 . . . . 0.0 109.2 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.496 HG21 ' HD2' ' A' ' 46' ' ' PRO . 18.5 m -155.32 141.63 13.11 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.577 ' HG3' ' CH2' ' A' ' 83' ' ' TRP . 15.0 Cg_exo -45.66 -18.44 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.072 1.848 . . . . 0.0 111.176 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.48 ' O ' HG11 ' A' ' 51' ' ' VAL . 3.4 mt-10 -77.49 -80.64 0.1 Allowed 'General case' 0 C--O 1.2 -1.541 0 O-C-N 120.827 -1.171 . . . . 0.0 108.773 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 38.0 mt-30 -48.65 -32.84 8.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.307 -1.496 . . . . 0.0 109.287 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.59 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -65.81 -62.75 1.33 Allowed 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.367 -0.833 . . . . 0.0 110.437 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.508 HG11 ' O ' ' A' ' 46' ' ' PRO . 4.3 p -70.23 -44.24 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.724 -1.235 . . . . 0.0 110.641 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.526 ' CG1' ' HA ' ' A' ' 48' ' ' GLN . 2.4 p -59.4 -43.49 90.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 121.769 -0.582 . . . . 0.0 110.326 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.1 OUTLIER -73.58 -48.19 34.69 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.59 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 7.7 mm-40 -59.95 -18.63 46.82 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.688 ' HB3' ' CE3' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -78.8 -65.36 1.0 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.582 0.706 . . . . 0.0 109.479 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -52.45 -55.53 21.25 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.48 -0.762 . . . . 0.0 109.052 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.587 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -43.44 -32.8 0.94 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 109.325 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -76.32 -90.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.452 -0.78 . . . . 0.0 109.656 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.577 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 4.9 t -80.03 -78.17 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 121.016 -1.053 . . . . 0.0 109.372 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.65 56.1 0.14 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.205 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.638 ' CD1' ' OE1' ' A' ' 63' ' ' GLN . 2.5 pp -107.73 -140.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 120.757 -1.437 . . . . 0.0 109.024 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.566 ' HB ' ' CD ' ' A' ' 62' ' ' PRO . 2.5 m -159.84 -67.19 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.276 0 O-C-N 119.754 -1.841 . . . . 0.0 112.535 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.628 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 11.5 Cg_exo -43.17 -67.12 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 122.265 1.977 . . . . 0.0 110.704 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.721 ' HB2' ' CE2' ' A' ' 95' ' ' TRP . 0.8 OUTLIER 29.65 27.71 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 114.603 -1.181 . . . . 0.0 113.638 178.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.631 ' C ' ' O ' ' A' ' 63' ' ' GLN . 20.2 t-160 -14.03 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.738 0 CA-C-N 120.181 1.355 . . . . 0.0 110.119 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.611 ' N ' ' O ' ' A' ' 63' ' ' GLN . 3.3 p90 -75.71 146.97 39.74 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.92 0.867 . . . . 0.0 112.377 -175.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 86' ' ' LEU . 4.6 m -148.59 151.47 35.1 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.677 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -80.24 -66.96 0.81 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.769 -1.207 . . . . 0.0 109.836 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.677 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 86.32 -56.81 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.565 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER 159.71 142.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.578 ' HE3' ' CD2' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -124.45 172.43 9.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.549 -0.719 . . . . 0.0 110.833 -178.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.556 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -121.11 176.72 5.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.819 . . . . 0.0 109.428 178.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.418 ' HG3' HG21 ' A' ' 81' ' ' THR . 7.3 tt0 -152.88 85.89 1.24 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.89 148.33 31.34 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -114.58 171.76 7.44 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.766 -1.174 . . . . 0.0 110.277 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.638 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -142.44 -177.14 0.62 Allowed Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.638 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.0 Cg_exo -57.12 -27.83 76.09 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.469 1.446 . . . . 0.0 109.75 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.459 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 56.5 p30 -169.98 36.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.468 ' O ' HD11 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -136.61 96.52 3.36 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.663 -0.648 . . . . 0.0 109.564 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.496 ' C ' ' CD1' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -82.13 116.43 21.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.391 -0.818 . . . . 0.0 109.501 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.601 HG21 ' N ' ' A' ' 81' ' ' THR . 0.4 OUTLIER -115.65 144.78 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.001 -1.062 . . . . 0.0 110.586 -179.282 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.601 ' N ' HG21 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -129.99 142.3 50.65 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.475 ' HG ' ' CG2' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -127.43 80.8 1.98 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.634 -1.291 . . . . 0.0 110.671 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.578 ' CD2' ' HE3' ' A' ' 70' ' ' LYS . 82.0 m95 -51.62 108.93 0.3 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.172 -0.955 . . . . 0.0 109.161 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.565 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 12.1 m-85 -87.46 70.88 9.91 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.215 -0.928 . . . . 0.0 109.684 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.648 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 13.6 m95 -70.51 83.63 0.59 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.91 -1.119 . . . . 0.0 108.791 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.577 HD22 ' CD2' ' A' ' 68' ' ' PHE . 2.9 mm? -71.87 124.91 25.88 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.41 -1.431 . . . . 0.0 110.242 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.562 ' CG2' HG23 ' A' ' 11' ' ' ILE . 1.5 m -112.31 -178.4 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.539 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 54.4 mt-10 -155.99 6.24 0.2 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 117.869 -1.533 . . . . 0.0 112.361 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.589 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -153.23 64.51 0.76 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.209 -1.557 . . . . 0.0 110.51 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.593 ' CH2' ' HB2' ' A' ' 13' ' ' ASN . 8.3 p90 -73.93 159.36 32.88 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.796 -1.19 . . . . 0.0 110.039 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.622 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.8 OUTLIER -78.02 138.11 38.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.407 -0.808 . . . . 0.0 109.347 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 30.42 -82.0 0.0 OUTLIER Glycine 0 N--CA 1.5 2.939 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.622 ' N ' ' O ' ' A' ' 91' ' ' GLU . 0.7 OUTLIER -88.37 158.33 49.1 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.188 -1.184 . . . . 0.0 109.874 -179.393 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.671 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 15.5 Cg_endo -71.41 -156.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.864 2.376 . . . . 0.0 110.332 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.722 ' CD1' ' O ' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -178.67 120.11 0.08 Allowed 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.324 -0.86 . . . . 0.0 110.167 179.508 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.473 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . 145.25 -48.02 0.72 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.431 -1.842 . . . . 0.0 111.487 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.58 ' HG2' ' CE2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -39.36 118.18 0.79 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -1.177 . . . . 0.0 110.466 -178.356 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.593 ' CG ' ' N ' ' A' ' 38' ' ' GLY . 3.4 mm-40 -73.31 -143.54 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.04 -18.57 6.28 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.96 165.62 12.5 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.38 -1.071 . . . . 0.0 110.749 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HG2' ' OG1' ' A' ' 21' ' ' THR . 2.1 Cg_endo -69.05 -60.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.666 2.244 . . . . 0.0 110.006 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.603 ' O ' ' CE1' ' A' ' 19' ' ' PHE . . . 76.22 121.61 0.16 Allowed Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.587 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 5.9 pt-20 -156.29 134.18 11.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.391 -1.064 . . . . 0.0 110.048 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.532 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 1.1 m0 -46.53 133.83 9.81 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.605 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 4.9 tpt -117.98 114.35 23.04 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.031 -1.043 . . . . 0.0 109.432 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.6 t -80.39 61.07 4.03 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.614 HD23 ' HA ' ' A' ' 110' ' ' LEU . 4.7 tt -77.61 -49.1 15.27 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.57 ' CB ' ' O ' ' A' ' 107' ' ' LEU . 21.2 t 89.91 101.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-O 121.568 0.699 . . . . 0.0 109.267 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 46.77 84.57 0.02 OUTLIER Glycine 0 N--CA 1.484 1.85 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.62 ' CD2' ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -37.58 162.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.918 -0.754 . . . . 0.0 110.475 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.545 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 6.0 t-20 -138.73 -8.13 1.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 111.339 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.568 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . . . 81.74 -18.06 0.51 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.183 -0.948 . . . . 0.0 108.614 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.0 -21.17 66.81 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.552 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 13.0 m-20 -104.96 -15.47 15.12 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.62 ' CD1' ' CD2' ' A' ' 110' ' ' LEU . 3.2 m-85 -91.42 133.44 31.37 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.151 -0.968 . . . . 0.0 109.121 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.1 131.56 43.5 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 121.398 1.399 . . . . 0.0 108.617 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.457 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 3.3 Cg_exo -52.99 -22.04 17.46 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.365 2.043 . . . . 0.0 112.181 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.08 -39.07 68.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.723 -1.235 . . . . 0.0 109.552 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.528 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 25.8 p30 -96.26 45.12 1.07 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.444 -0.785 . . . . 0.0 109.69 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.66 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.2 mt-10 -70.25 -33.15 3.15 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 113.191 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.2 Cg_exo -55.96 -47.83 22.9 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.218 1.279 . . . . 0.0 112.801 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.475 HG21 ' HB3' ' A' ' 71' ' ' LEU . 1.9 t -92.91 -33.93 5.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 120.531 -1.355 . . . . 0.0 109.489 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.594 HG12 ' CD2' ' A' ' 115' ' ' PHE . 1.7 mp -66.56 -20.84 27.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.52 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -58.55 -29.47 66.38 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 0.4 OUTLIER -80.38 -37.96 31.29 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.915 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.589 ' CD1' ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -65.83 -24.78 66.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.461 -1.399 . . . . 0.0 107.336 178.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.526 ' CD ' ' HB1' ' A' ' 112' ' ' ALA . 1.5 mtmp? -55.17 -35.73 65.09 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.459 ' O ' ' C ' ' A' ' 129' ' ' LEU . 1.9 mtp180 -83.93 -24.6 30.65 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.524 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 2.1 tp . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.069 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HG3' ' HB3' ' A' ' 79' ' ' HIS . 4.9 ttpt . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.506 HD13 ' O ' ' A' ' 5' ' ' GLN . 0.5 OUTLIER -140.95 177.26 8.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.244 -0.91 . . . . 0.0 109.535 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.559 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -141.55 174.27 10.72 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.462 HG21 HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -141.81 124.69 14.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 O-C-N 121.019 -1.051 . . . . 0.0 109.821 -178.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.561 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -87.0 60.12 6.03 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.541 ' HB ' ' CA ' ' A' ' 37' ' ' GLY . 0.8 OUTLIER -78.63 -87.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.79 -178.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.622 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 75.63 88.85 0.25 Allowed Glycine 0 C--N 1.297 -1.625 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.547 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -49.33 175.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.031 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -143.9 92.09 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.577 -1.249 . . . . 0.0 110.349 -178.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.603 ' NH1' ' CD2' ' A' ' 129' ' ' LEU . 8.8 mtm180 -75.62 174.09 10.19 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.534 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -161.14 -46.19 0.04 OUTLIER 'General case' 0 C--O 1.191 -2.017 0 C-N-CA 115.744 -2.382 . . . . 0.0 115.142 -177.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.494 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 1.5 tp10 -92.4 -27.97 17.17 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 118.64 -2.537 . . . . 0.0 110.369 -176.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -163.22 -45.21 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.569 ' ND2' ' HD2' ' A' ' 12' ' ' ARG . 0.7 OUTLIER -160.04 35.42 0.18 Allowed 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 177.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 105' ' ' MET . 17.4 mt-10 -84.54 94.08 8.49 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.098 -1.441 . . . . 0.0 110.046 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.572 ' CG2' ' HG2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -83.03 142.75 13.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.579 -0.701 . . . . 0.0 109.374 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.639 ' CD1' ' CG ' ' A' ' 94' ' ' PRO . 70.1 t80 -82.2 46.36 1.02 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.482 ' O ' ' HG2' ' A' ' 103' ' ' GLU . 6.7 tp -81.9 151.83 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-O 122.256 1.027 . . . . 0.0 112.016 -177.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.497 ' OG1' ' HG2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -63.88 90.45 0.06 Allowed 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.6 ' O ' ' C ' ' A' ' 23' ' ' ARG . 28.7 tpt180 -89.49 106.04 18.19 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.135 -0.978 . . . . 0.0 109.73 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.6 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 3.22 76.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 121.317 0.58 . . . . 0.0 110.865 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -39.35 -53.85 1.93 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.25 0.547 . . . . 0.0 109.965 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.54 -177.1 5.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.015 -1.053 . . . . 0.0 109.243 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -80.05 77.35 6.75 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.222 -0.924 . . . . 0.0 109.668 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.476 ' HB1' ' CD ' ' A' ' 23' ' ' ARG . . . -56.79 -31.23 64.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.92 . . . . 0.0 109.357 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.412 ' C ' ' SD ' ' A' ' 29' ' ' MET . 3.5 t60 67.97 8.12 6.26 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.343 -0.848 . . . . 0.0 109.104 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.601 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -120.03 -101.0 0.43 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.276 -0.89 . . . . 0.0 109.096 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.601 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 152.31 -10.49 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.703 -0.623 . . . . 0.0 110.329 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 12.2 m120 -78.35 6.03 9.25 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.893 -1.129 . . . . 0.0 109.646 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.497 ' HD2' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -81.91 47.21 1.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.393 -0.817 . . . . 0.0 110.415 -179.578 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.679 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 13.2 mt -117.84 91.03 3.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.851 -1.156 . . . . 0.0 109.125 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.533 ' C ' ' CG ' ' A' ' 35' ' ' PHE . 11.9 tt0 -90.31 -127.56 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.496 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.533 ' CG ' ' C ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -155.75 128.89 4.34 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.882 -1.136 . . . . 0.0 109.382 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.611 ' CB ' ' HA ' ' A' ' 97' ' ' LYS . 9.6 Cg_endo -69.79 97.85 0.66 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.055 1.837 . . . . 0.0 109.462 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' CA ' ' HB ' ' A' ' 8' ' ' VAL . . . -109.28 -173.55 21.03 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.308 -1.425 . . . . 0.0 111.455 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.519 ' HA2' ' OE1' ' A' ' 98' ' ' GLU . . . -163.74 20.35 0.15 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.475 ' O ' ' OE2' ' A' ' 53' ' ' GLU . 1.9 tptm 58.83 108.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.528 -0.984 . . . . 0.0 110.106 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.561 ' HB ' ' CB ' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -82.02 130.63 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.825 -1.172 . . . . 0.0 109.227 178.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -173.66 -26.07 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.088 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.67 153.48 0.8 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.977 -1.077 . . . . 0.0 109.272 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 46.87 -117.04 2.76 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -170.95 23.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.471 -1.017 . . . . 0.0 109.621 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.52 HG21 ' HD2' ' A' ' 46' ' ' PRO . 84.5 m -140.41 139.67 21.15 Favored Pre-proline 0 C--O 1.203 -1.385 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 6.3 Cg_exo -50.26 -19.07 4.01 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 121.1 1.2 . . . . 0.0 110.128 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.49 ' HG2' ' CZ ' ' A' ' 65' ' ' PHE . 1.6 mt-10 -79.71 -86.83 0.07 Allowed 'General case' 0 C--O 1.201 -1.481 0 O-C-N 121.108 -0.995 . . . . 0.0 108.536 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.594 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 15.7 mt-30 -43.09 -29.48 0.36 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.704 -1.247 . . . . 0.0 110.081 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.599 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -72.04 -60.99 1.95 Allowed 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.418 -0.801 . . . . 0.0 109.83 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 3.8 p -66.84 -45.94 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.008 -1.058 . . . . 0.0 110.184 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.574 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 2.2 p -60.15 -46.89 93.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-O 121.239 0.542 . . . . 0.0 109.662 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.594 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 8.0 mmm180 -74.1 -21.61 59.83 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.599 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 26.5 mm-40 -78.3 -19.7 53.03 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.649 ' CD1' ' CD1' ' A' ' 95' ' ' TRP . 2.1 mm? -79.87 -42.03 25.06 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.166 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.637 ' HG2' ' CZ3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -79.91 -42.78 23.43 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.599 -0.688 . . . . 0.0 109.467 -179.399 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.549 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 1.1 pp20? -57.68 -23.27 50.68 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.545 -0.722 . . . . 0.0 110.01 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.472 ' OE2' ' HA3' ' A' ' 38' ' ' GLY . 9.1 mt-10 -80.24 -92.08 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.982 -1.074 . . . . 0.0 110.456 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.617 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 22.2 t -80.07 -78.93 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.486 -0.759 . . . . 0.0 110.745 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.36 35.57 0.14 Allowed Glycine 0 N--CA 1.496 2.698 0 C-N-CA 118.572 -1.775 . . . . 0.0 112.783 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.675 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.1 pp -91.13 -145.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 120.276 -1.72 . . . . 0.0 107.127 177.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.59 ' CB ' ' CD ' ' A' ' 62' ' ' PRO . 1.5 m -141.26 -73.45 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.256 -1.528 . . . . 0.0 110.496 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 61' ' ' THR . 6.2 Cg_endo -64.54 -171.5 0.16 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.105 1.203 . . . . 0.0 110.781 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.555 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 149.41 -23.14 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.508 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 13.5 t-160 43.91 80.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.49 ' CZ ' ' HG2' ' A' ' 47' ' ' GLU . 49.6 p90 -76.32 145.02 39.85 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.621 0.724 . . . . 0.0 110.373 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -141.58 142.54 33.48 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.634 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -67.18 -69.73 0.29 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.812 -1.18 . . . . 0.0 110.475 -179.146 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.634 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 83.99 -51.66 0.13 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.2 mt-10 170.31 177.27 0.05 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.581 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -161.16 173.18 15.5 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 109.675 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.545 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -141.15 178.41 7.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.145 -0.972 . . . . 0.0 110.596 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -151.41 93.94 1.95 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -79.5 129.68 34.7 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.524 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 4.8 tt0 -101.25 106.05 17.21 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.146 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.529 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -81.22 171.07 13.11 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.219 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 9.5 Cg_exo -47.33 -29.62 9.97 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.972 1.781 . . . . 0.0 109.999 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.454 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -162.53 28.28 0.1 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -134.36 90.95 2.73 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.791 -0.568 . . . . 0.0 109.961 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.524 ' CD2' ' HG3' ' A' ' 74' ' ' GLU . 1.9 t-160 -86.3 110.17 19.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.101 -1.0 . . . . 0.0 108.513 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.595 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -112.56 152.31 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.137 -0.977 . . . . 0.0 110.426 -178.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.559 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 4.1 m -125.98 137.23 53.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.526 ' CD2' HG12 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -128.62 79.64 1.92 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.594 -1.317 . . . . 0.0 110.775 -179.287 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.581 ' CE3' ' HD2' ' A' ' 70' ' ' LYS . 94.3 m95 -51.16 108.82 0.28 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.994 -1.066 . . . . 0.0 108.838 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.58 ' CD2' HG12 ' A' ' 122' ' ' VAL . 12.4 m-85 -82.36 69.32 9.08 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.053 -1.03 . . . . 0.0 109.947 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.622 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 97.5 m95 -71.95 82.8 0.94 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.06 -1.025 . . . . 0.0 109.692 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 66' ' ' SER . 3.0 mm? -67.05 124.17 22.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.459 -1.4 . . . . 0.0 109.631 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.539 ' CG2' ' CG2' ' A' ' 11' ' ' ILE . 0.7 OUTLIER -109.14 177.32 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 70.0 mt-10 -154.59 18.85 0.47 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 117.69 -1.604 . . . . 0.0 113.504 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.557 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -161.08 62.11 0.29 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 119.618 -1.926 . . . . 0.0 112.155 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.534 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 6.6 p90 -81.09 158.52 25.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.331 -1.481 . . . . 0.0 108.79 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -91.63 145.39 24.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.953 -1.092 . . . . 0.0 110.235 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 45.64 -87.44 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.57 ' O ' ' CG2' ' A' ' 60' ' ' ILE . 8.1 pt-20 -111.37 161.44 25.26 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.316 -1.108 . . . . 0.0 109.647 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.639 ' CG ' ' CD1' ' A' ' 19' ' ' PHE . 7.0 Cg_endo -74.68 -161.06 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.554 2.169 . . . . 0.0 109.594 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.675 ' CD2' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER 179.02 33.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.111 -0.993 . . . . 0.0 110.793 178.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.558 ' CA ' HD12 ' A' ' 54' ' ' LEU . . . -117.65 6.14 16.31 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.269 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.611 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 8.0 pttt -79.99 147.59 31.49 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.113 -1.227 . . . . 0.0 110.046 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.519 ' OE1' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -82.18 37.26 0.49 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.53 -0.731 . . . . 0.0 109.658 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.81 -10.54 73.4 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.594 ' CB ' ' CD ' ' A' ' 101' ' ' PRO . 11.8 pt20 -64.49 -172.14 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.451 -1.029 . . . . 0.0 108.677 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 100' ' ' GLN . 4.2 Cg_exo -65.65 -55.88 0.39 Allowed 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.122 1.215 . . . . 0.0 109.351 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.61 ' O ' ' CE1' ' A' ' 19' ' ' PHE . . . 57.26 115.38 0.01 OUTLIER Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 2.9 pt-20 -153.26 133.47 13.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.836 -1.391 . . . . 0.0 110.303 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.455 ' C ' ' O ' ' A' ' 103' ' ' GLU . 3.7 m0 -44.43 136.54 4.11 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.578 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -130.26 113.88 14.96 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.267 -179.378 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.65 51.11 1.62 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.486 0.66 . . . . 0.0 109.507 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.588 ' CD2' ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -65.42 -41.56 93.43 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.583 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 48.9 t 79.61 116.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.984 -0.447 . . . . 0.0 110.332 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . 39.3 83.55 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.653 ' CD2' ' CE1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -38.65 160.57 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.766 -0.843 . . . . 0.0 110.755 -178.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 112' ' ' ALA . 11.4 t30 -136.34 -4.81 2.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.483 -0.761 . . . . 0.0 110.932 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.598 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . . . 74.91 -4.09 2.45 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.09 -1.006 . . . . 0.0 108.768 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.54 -32.93 36.6 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.537 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -93.19 -11.21 33.27 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.679 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 5.0 m-85 -98.41 152.62 38.03 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.488 -0.758 . . . . 0.0 109.937 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.508 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 2.8 Cg_endo -68.79 135.44 32.85 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.198 1.932 . . . . 0.0 109.348 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 118' ' ' ALA . 6.3 Cg_exo -59.85 -27.7 85.53 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 121.89 1.727 . . . . 0.0 110.852 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -43.1 -51.18 5.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.107 -0.996 . . . . 0.0 109.572 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.468 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 0.4 OUTLIER -88.25 48.46 1.64 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.457 -0.777 . . . . 0.0 109.23 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.644 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -63.33 -41.85 70.82 Favored Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.787 -0.571 . . . . 0.0 112.013 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 8.0 Cg_exo -51.86 -39.18 68.72 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 121.889 1.726 . . . . 0.0 113.088 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.58 HG12 ' CD2' ' A' ' 84' ' ' PHE . 2.7 t -100.51 -37.91 6.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 120.446 -1.409 . . . . 0.0 110.037 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.598 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -60.94 -21.96 25.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.481 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -62.75 -34.52 77.39 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 9.4 mmtm -79.71 -38.51 33.27 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.982 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.613 ' CD1' ' CZ ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -59.24 -40.51 86.13 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.542 ' CD ' ' HB1' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -38.84 -37.16 0.32 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.09 0.947 . . . . 0.0 108.767 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.514 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -80.03 -51.81 8.58 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.287 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.603 ' CD2' ' NH1' ' A' ' 12' ' ' ARG . 2.5 tp . . . . . 0 N--CA 1.505 2.294 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.66 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.513 ' HG3' ' N ' ' A' ' 4' ' ' LEU . 2.7 tttt . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.513 ' N ' ' HG3' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -149.56 168.4 23.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.112 178.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.56 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 1.6 mp0 -142.52 171.35 14.17 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.463 HG21 HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -138.36 115.62 11.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 C-N-CA 118.969 -1.092 . . . . 0.0 109.624 -179.414 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.551 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -84.39 63.68 7.94 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.649 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -79.06 -77.44 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.381 -0.825 . . . . 0.0 110.345 -178.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.626 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 67.59 88.26 0.07 OUTLIER Glycine 0 C--N 1.296 -1.68 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 -177.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.55 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -50.19 176.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.544 HG21 ' CG1' ' A' ' 87' ' ' VAL . 2.5 pt -142.54 77.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 C-N-CA 117.856 -1.537 . . . . 0.0 111.087 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 88' ' ' GLU . 0.4 OUTLIER -78.89 158.68 28.03 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 177.17 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.514 ' CG ' ' CZ3' ' A' ' 90' ' ' TRP . 12.1 p-10 -160.61 -24.33 0.06 Allowed 'General case' 0 C--O 1.188 -2.143 0 C-N-CA 115.608 -2.437 . . . . 0.0 115.5 -177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.517 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 20.6 tt0 -93.51 -27.0 16.91 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 118.05 -2.906 . . . . 0.0 108.911 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.44 -48.74 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.482 ' ND2' HD21 ' A' ' 107' ' ' LEU . 60.9 t-20 -162.95 38.09 0.1 Allowed 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 105' ' ' MET . 19.8 mt-10 -84.06 88.5 7.18 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 117.92 -1.512 . . . . 0.0 109.973 -177.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.541 HD12 ' CD1' ' A' ' 110' ' ' LEU . 1.5 pt -82.5 147.24 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.964 0.888 . . . . 0.0 111.167 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.589 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 12.7 t80 -82.58 45.28 0.96 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.508 HD12 ' O ' ' A' ' 34' ' ' GLU . 4.3 tp -80.42 151.35 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.85 0.833 . . . . 0.0 110.645 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.503 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -71.11 88.43 0.8 Allowed 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.591 ' O ' ' C ' ' A' ' 23' ' ' ARG . 28.2 tpt180 -86.2 94.56 9.33 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.53 -0.731 . . . . 0.0 110.373 -178.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.591 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 17.89 75.97 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.142 0.496 . . . . 0.0 110.346 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -39.36 -55.72 1.69 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.608 -0.683 . . . . 0.0 110.168 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.46 -147.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.158 -0.964 . . . . 0.0 108.988 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 77.4 m-20 -79.88 -60.77 2.21 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.026 -1.046 . . . . 0.0 109.128 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 26' ' ' ASP . . . 81.78 -28.33 0.12 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.435 -0.791 . . . . 0.0 110.715 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER 49.15 25.3 1.13 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.413 ' N ' ' C ' ' A' ' 27' ' ' ALA . 5.6 mtt -145.08 -164.16 1.87 Allowed 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.463 ' O ' ' OD1' ' A' ' 114' ' ' ASP . . . -164.25 23.13 0.07 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.804 -1.185 . . . . 0.0 110.326 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 114' ' ' ASP . 1.3 m-20 -101.9 15.94 27.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.058 -1.026 . . . . 0.0 108.259 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -81.81 50.72 1.57 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.767 -0.583 . . . . 0.0 111.006 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.616 ' O ' ' CE1' ' A' ' 115' ' ' PHE . 17.0 mt -109.57 86.77 2.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.763 -1.211 . . . . 0.0 108.875 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.576 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -91.5 -135.87 0.14 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.123 -0.986 . . . . 0.0 110.191 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.576 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -150.45 119.44 3.64 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 120.758 -1.214 . . . . 0.0 109.626 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.553 ' CB ' ' HA ' ' A' ' 97' ' ' LYS . 11.5 Cg_endo -71.29 94.39 0.66 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.323 2.015 . . . . 0.0 110.772 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.649 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -127.2 -135.73 4.19 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 118.767 -1.682 . . . . 0.0 111.04 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.537 ' CA ' ' OE1' ' A' ' 98' ' ' GLU . . . 167.65 35.53 0.02 OUTLIER Glycine 0 N--CA 1.487 2.071 0 O-C-N 121.383 -1.069 . . . . 0.0 110.53 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.506 ' HE2' ' O ' ' A' ' 40' ' ' ILE . 14.1 tptm 56.5 110.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.979 -0.718 . . . . 0.0 111.891 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.56 ' CG1' ' HB2' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -81.9 142.13 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.217 -0.927 . . . . 0.0 108.662 177.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.414 ' N ' HG12 ' A' ' 40' ' ' ILE . 10.9 pt-20 -172.21 -30.45 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.417 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.3 mmm -55.33 149.0 13.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.148 -0.97 . . . . 0.0 110.011 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.48 -127.44 33.66 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -164.66 18.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.493 -1.004 . . . . 0.0 109.842 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.499 ' O ' ' HB1' ' A' ' 49' ' ' ALA . 45.4 m -133.39 137.23 28.64 Favored Pre-proline 0 C--O 1.204 -1.332 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.594 ' HG3' ' CH2' ' A' ' 83' ' ' TRP . 3.0 Cg_exo -48.98 -16.37 0.83 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 121.57 1.513 . . . . 0.0 110.281 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.473 ' O ' HG11 ' A' ' 51' ' ' VAL . 2.8 mt-10 -75.5 -85.47 0.05 OUTLIER 'General case' 0 C--O 1.203 -1.386 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.552 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 18.6 mt-30 -45.22 -34.75 2.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.66 -1.275 . . . . 0.0 109.778 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.594 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -63.77 -64.03 1.01 Allowed 'General case' 0 C--N 1.292 -1.927 0 O-C-N 121.339 -0.85 . . . . 0.0 109.666 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.581 ' O ' ' CD2' ' A' ' 54' ' ' LEU . 2.0 p -66.69 -51.89 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.049 -1.032 . . . . 0.0 110.55 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.57 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 3.7 p -51.97 -44.76 39.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.352 -0.843 . . . . 0.0 110.731 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.55 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 5.8 mmt180 -74.76 -37.79 62.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 108.875 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.594 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 6.5 mm-40 -70.37 -13.08 61.99 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.665 ' CD1' ' CD1' ' A' ' 95' ' ' TRP . 1.6 mm? -80.06 -63.82 1.33 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.622 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.41 -52.71 64.28 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.833 -0.542 . . . . 0.0 110.176 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.558 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -47.28 -22.35 0.4 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.017 -1.052 . . . . 0.0 109.875 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.441 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 3.4 mt-10 -80.03 -96.79 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.046 -1.034 . . . . 0.0 109.31 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.645 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 57.4 t -80.01 -79.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.215 -0.928 . . . . 0.0 109.322 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 133.66 46.33 0.11 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.247 -1.454 . . . . 0.0 111.777 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.638 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -87.59 -127.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.604 -1.527 . . . . 0.0 108.44 178.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.585 ' CB ' ' CD ' ' A' ' 62' ' ' PRO . 1.3 m -159.64 -68.6 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.006 -1.684 . . . . 0.0 112.146 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 61' ' ' THR . 2.2 Cg_endo -54.19 -80.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.028 1.819 . . . . 0.0 112.061 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.591 ' NE2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER 39.81 61.62 1.41 Allowed 'General case' 0 C--N 1.289 -2.039 0 CA-C-O 121.781 0.8 . . . . 0.0 109.608 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.654 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -53.24 102.22 0.05 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -95.46 144.28 26.09 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 122.177 0.989 . . . . 0.0 111.362 -177.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -143.25 145.0 32.37 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.149 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.599 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 1.4 tm? -67.95 -64.45 0.86 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.068 -1.02 . . . . 0.0 110.808 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.599 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 83.6 -54.2 0.15 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.357 -0.84 . . . . 0.0 108.796 -179.359 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.596 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 6.0 tp10 164.86 128.9 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -118.97 -171.71 2.15 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.443 -0.786 . . . . 0.0 109.868 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.527 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.6 OUTLIER -142.06 -172.04 3.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 110.315 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -159.75 94.26 1.13 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.45 151.3 22.08 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.275 -0.891 . . . . 0.0 108.87 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.437 ' OE2' ' CE1' ' A' ' 79' ' ' HIS . 2.0 tt0 -119.71 137.5 53.88 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.144 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.558 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 1.1 m-30 -106.55 172.92 3.48 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.5 Cg_exo -46.24 -39.95 21.48 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.706 1.604 . . . . 0.0 110.31 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.431 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 3.1 m-20 -156.24 40.1 0.36 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.57 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -147.33 101.75 3.41 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.477 ' C ' ' CD1' ' A' ' 80' ' ' ILE . 5.5 m170 -77.81 137.26 38.32 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.57 ' CD1' ' O ' ' A' ' 78' ' ' ARG . 1.9 mp -132.82 153.74 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.767 -1.208 . . . . 0.0 110.653 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.56 ' HB ' ' CB ' ' A' ' 5' ' ' GLN . 1.6 m -141.67 150.45 41.92 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.482 ' HG ' HG13 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -138.94 77.73 1.64 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.812 -1.18 . . . . 0.0 109.985 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.594 ' CH2' ' HG3' ' A' ' 46' ' ' PRO . 93.4 m95 -50.68 113.65 0.95 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 108.993 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.599 ' O ' ' O ' ' A' ' 67' ' ' LEU . 13.6 m-85 -90.76 70.56 6.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.254 -0.904 . . . . 0.0 110.208 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.626 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 61.5 m95 -77.46 87.6 3.82 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.705 -1.247 . . . . 0.0 109.751 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.55 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 3.0 mm? -68.2 129.55 40.25 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.524 -1.36 . . . . 0.0 109.974 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.591 ' CG1' ' NE2' ' A' ' 63' ' ' GLN . 0.8 OUTLIER -116.42 154.74 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.284 -0.885 . . . . 0.0 108.729 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 1.2 mt-10 -143.02 35.38 1.37 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.738 -1.226 . . . . 0.0 113.219 -178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.654 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -161.32 40.49 0.15 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 119.79 -1.819 . . . . 0.0 111.729 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.635 ' CH2' ' CD1' ' A' ' 104' ' ' TRP . 1.3 p90 -67.19 157.09 34.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.02 -1.675 . . . . 0.0 109.37 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.574 ' O ' ' CD1' ' A' ' 90' ' ' TRP . 10.4 pt-20 -77.8 -125.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.234 -0.916 . . . . 0.0 110.439 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.504 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -53.09 -55.22 25.14 Favored Glycine 0 N--CA 1.494 2.51 0 O-C-N 120.658 -1.277 . . . . 0.0 110.735 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.588 ' O ' ' CG2' ' A' ' 60' ' ' ILE . 6.9 pt-20 -132.94 166.91 25.79 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.161 -1.199 . . . . 0.0 109.577 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.588 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 9.9 Cg_endo -77.28 -168.14 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.36 2.04 . . . . 0.0 110.123 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.665 ' CD1' ' CD1' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -171.0 28.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 0.0 110.086 178.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.544 ' CA ' HD12 ' A' ' 54' ' ' LEU . . . -116.1 3.38 20.72 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.983 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.553 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 11.5 pttt -76.57 136.46 39.26 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.922 -1.34 . . . . 0.0 109.212 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.537 ' OE1' ' CA ' ' A' ' 38' ' ' GLY . 2.6 tp10 -75.61 -117.63 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.64 22.33 36.2 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 107.47 -2.252 . . . . 0.0 107.47 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.471 ' OE1' ' HB3' ' A' ' 36' ' ' PRO . 1.5 pt20 -94.97 165.11 17.71 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.731 -0.864 . . . . 0.0 110.136 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 102' ' ' GLY . 1.4 Cg_endo -66.99 -42.55 8.0 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.994 1.796 . . . . 0.0 109.851 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.589 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 57.69 110.38 0.01 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 7.1 pt-20 -142.96 134.07 25.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.768 -1.43 . . . . 0.0 110.672 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.635 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 1.6 m0 -50.19 127.59 17.34 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.603 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -118.88 116.37 26.36 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.77 45.59 0.71 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.262 -0.899 . . . . 0.0 110.161 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.581 ' HG ' ' N ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -81.41 158.09 24.74 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.051 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.581 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 33.4 t -114.66 134.07 58.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.061 -1.024 . . . . 0.0 109.541 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 39.52 79.87 0.04 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.556 ' CA ' HD22 ' A' ' 107' ' ' LEU . 0.3 OUTLIER -41.62 166.13 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.573 -0.957 . . . . 0.0 110.694 -178.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 4.5 t30 -159.71 151.17 19.92 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.449 ' CB ' HG23 ' A' ' 123' ' ' ILE . . . -55.98 -22.07 24.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 108.563 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -42.72 -36.9 1.57 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.522 -0.736 . . . . 0.0 109.082 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.536 ' CB ' ' CD1' ' A' ' 33' ' ' LEU . 73.8 m-20 -115.29 -8.5 12.29 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.685 -0.634 . . . . 0.0 109.556 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.667 ' CG ' HG12 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -100.93 123.53 45.01 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.339 -0.851 . . . . 0.0 109.709 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.547 ' O ' ' CD1' ' A' ' 123' ' ' ILE . 7.2 Cg_exo -52.62 148.2 28.3 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.415 2.077 . . . . 0.0 111.373 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 118' ' ' ALA . 2.1 Cg_endo -62.61 -26.18 75.69 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.309 2.006 . . . . 0.0 110.699 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.6 -48.57 5.43 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.123 -0.986 . . . . 0.0 109.656 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.545 ' O ' ' CD1' ' A' ' 123' ' ' ILE . 0.8 OUTLIER -100.15 55.65 0.92 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.625 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 4.6 mt-10 -67.32 -43.19 42.64 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.602 -0.686 . . . . 0.0 112.366 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.3 Cg_exo -55.52 -31.78 79.93 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.764 1.643 . . . . 0.0 112.125 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.466 ' O ' HD12 ' A' ' 126' ' ' LEU . 2.4 t -101.05 -38.93 6.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.76 -1.212 . . . . 0.0 109.569 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.667 HG12 ' CG ' ' A' ' 115' ' ' PHE . 15.2 mt -55.77 -34.55 36.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.27 -38.5 58.45 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.949 0.881 . . . . 0.0 109.137 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -79.81 -37.37 35.31 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.242 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.582 ' CD1' ' N ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -59.3 -39.67 83.76 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.179 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -39.8 -37.66 0.57 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.949 0.88 . . . . 0.0 108.927 178.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.481 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -87.57 -49.9 6.87 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.502 ' HG ' ' NH2' ' A' ' 12' ' ' ARG . 1.9 tp . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.322 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 17.0 tttt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.57 ' CD1' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -146.67 131.98 18.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.388 -0.82 . . . . 0.0 109.385 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.531 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 2.1 mp0 -98.51 162.06 13.35 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.504 ' HB ' HD13 ' A' ' 82' ' ' LEU . 0.9 OUTLIER -126.0 112.83 31.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.564 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -84.56 65.78 9.17 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.621 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 1.1 p -78.94 -70.37 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.023 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.659 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 57.5 83.43 0.05 OUTLIER Glycine 0 C--N 1.292 -1.915 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 -178.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.565 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -47.7 168.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -179.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.584 HG13 ' CB ' ' A' ' 19' ' ' PHE . 2.7 pt -133.24 95.14 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.344 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.533 ' HG2' ' CG2' ' A' ' 18' ' ' ILE . 15.8 mtm180 -76.78 179.83 5.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.596 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -158.69 -60.81 0.08 Allowed 'General case' 0 C--O 1.194 -1.856 0 C-N-CA 116.458 -2.097 . . . . 0.0 115.068 -177.119 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.551 ' CB ' ' HG3' ' A' ' 17' ' ' GLU . 6.9 tp10 -92.72 -26.04 17.94 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 119.254 -2.154 . . . . 0.0 111.745 -175.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -161.96 -45.17 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.479 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 14.7 t30 -160.41 35.81 0.17 Allowed 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 177.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 105' ' ' MET . 4.9 mm-40 -78.36 85.86 4.46 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 118.007 -1.477 . . . . 0.0 109.105 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.533 ' CG2' ' HG2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -79.15 142.49 13.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.615 ' CZ ' ' HG2' ' A' ' 94' ' ' PRO . 11.9 t80 -81.94 46.0 0.96 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.661 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 12.9 tt -79.1 153.0 4.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-O 121.858 0.837 . . . . 0.0 110.463 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.517 ' HB ' ' HD2' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -66.5 89.91 0.15 Allowed 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.255 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.509 ' O ' ' C ' ' A' ' 23' ' ' ARG . 28.5 tpt180 -87.37 81.77 7.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.184 -0.948 . . . . 0.0 110.416 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HB3' ' CB ' ' A' ' 27' ' ' ALA . 1.1 ptt180 32.53 72.79 0.07 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.917 -0.489 . . . . 0.0 110.269 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.23 -53.31 4.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -0.853 . . . . 0.0 109.302 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.28 -171.54 3.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.232 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -79.92 80.68 6.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.473 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . . . -61.31 -31.77 71.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.819 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 55.41 21.13 4.05 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.553 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 6.1 mmm -127.36 -112.53 0.28 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 160.01 -14.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.064 -1.022 . . . . 0.0 111.065 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -81.53 12.53 3.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.906 -1.122 . . . . 0.0 109.779 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.502 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -81.99 54.79 2.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.476 -0.765 . . . . 0.0 110.642 -179.479 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.594 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 6.4 mt -120.83 83.75 2.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.644 -1.285 . . . . 0.0 109.75 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.46 -146.98 0.19 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.389 -0.82 . . . . 0.0 109.358 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.65 ' CZ ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -140.16 125.61 11.5 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.864 -1.147 . . . . 0.0 110.157 -178.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.584 ' CB ' ' HA ' ' A' ' 97' ' ' LYS . 13.8 Cg_endo -73.78 100.11 1.23 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.364 2.043 . . . . 0.0 110.118 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -136.36 135.08 7.53 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.175 -1.488 . . . . 0.0 110.961 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.533 ' CA ' ' OE1' ' A' ' 98' ' ' GLU . . . -108.14 36.53 4.32 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.523 ' HD2' HD21 ' A' ' 4' ' ' LEU . 7.0 tptm 59.26 119.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.54 -0.976 . . . . 0.0 112.083 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.564 HG23 ' N ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -83.24 135.96 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.132 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -171.31 -31.51 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.906 -1.121 . . . . 0.0 110.266 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.55 142.98 25.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.133 -0.979 . . . . 0.0 109.316 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.22 -115.96 8.71 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -169.23 -15.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.775 -0.838 . . . . 0.0 110.737 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.508 HG21 ' HD2' ' A' ' 46' ' ' PRO . 24.9 m -103.82 141.09 21.78 Favored Pre-proline 0 C--O 1.205 -1.28 0 O-C-N 120.876 -1.14 . . . . 0.0 108.353 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HD2' HG21 ' A' ' 45' ' ' THR . 7.9 Cg_exo -47.32 -18.06 0.68 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.082 1.855 . . . . 0.0 110.938 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.477 ' O ' HG11 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -77.87 -81.89 0.09 Allowed 'General case' 0 C--O 1.202 -1.424 0 O-C-N 120.857 -1.152 . . . . 0.0 108.594 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.544 ' O ' ' CG ' ' A' ' 52' ' ' ARG . 53.0 mt-30 -48.73 -25.56 1.88 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.384 -1.448 . . . . 0.0 109.948 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.612 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -73.51 -59.65 2.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.875 -1.14 . . . . 0.0 109.874 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 2.5 p -70.01 -48.94 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.053 -1.029 . . . . 0.0 109.843 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.571 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 2.1 p -56.33 -42.91 75.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 O-C-N 121.797 -0.564 . . . . 0.0 110.4 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 48' ' ' GLN . 21.2 mmt180 -74.86 -35.7 62.33 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.612 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 15.7 mm-40 -68.07 -15.47 63.61 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.614 HD11 ' CG ' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -79.09 -62.79 1.59 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.473 ' NE2' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -57.37 -53.84 53.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.345 -0.847 . . . . 0.0 109.828 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.554 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -50.13 -21.7 1.4 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.334 -0.854 . . . . 0.0 110.496 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.4 mt-10 -80.04 -91.02 0.05 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.059 -1.026 . . . . 0.0 109.967 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.587 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 47.3 t -80.06 -78.98 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.448 -0.782 . . . . 0.0 110.302 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.18 22.21 0.1 OUTLIER Glycine 0 N--CA 1.494 2.563 0 C-N-CA 118.77 -1.681 . . . . 0.0 112.472 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.63 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.2 pt -81.19 -136.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.187 -1.772 . . . . 0.0 108.102 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.594 ' CB ' ' CD ' ' A' ' 62' ' ' PRO . 1.2 m -159.08 -68.6 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.465 -1.397 . . . . 0.0 109.967 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 61' ' ' THR . 5.7 Cg_endo -62.51 -173.74 0.15 Allowed 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.686 1.591 . . . . 0.0 110.741 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.56 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 1.1 pt20 145.19 -24.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.547 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.2 OUTLIER 43.32 48.96 5.92 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -42.84 160.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.745 0.783 . . . . 0.0 110.584 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -156.89 136.91 12.63 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.167 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.629 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -59.64 -71.92 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.824 -1.172 . . . . 0.0 110.321 -178.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.629 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 85.08 -56.55 0.09 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.026 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 30.9 tp10 165.97 123.38 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.604 0.716 . . . . 0.0 109.753 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HD2' ' CD2' ' A' ' 83' ' ' TRP . 5.7 ptmt -110.11 170.54 8.01 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.706 -0.621 . . . . 0.0 109.615 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.554 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -122.8 169.8 10.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.097 -1.002 . . . . 0.0 110.14 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -147.07 85.78 1.62 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.21 123.77 28.74 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.429 ' CG ' ' NE2' ' A' ' 79' ' ' HIS . 2.6 tt0 -91.85 108.43 19.92 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.281 -0.968 . . . . 0.0 109.017 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.522 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 1.9 m-85 -78.32 170.35 16.65 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.398 -0.814 . . . . 0.0 109.468 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 7.5 Cg_exo -49.65 -38.15 45.13 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.112 1.874 . . . . 0.0 109.714 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.63 43.46 0.44 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.502 ' O ' HD12 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -148.07 97.54 2.8 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.091 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.449 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -79.82 94.91 5.89 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.585 ' CG2' ' N ' ' A' ' 81' ' ' THR . 0.4 OUTLIER -102.17 164.52 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.183 -0.948 . . . . 0.0 110.559 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.585 ' N ' ' CG2' ' A' ' 80' ' ' ILE . 1.2 m -148.3 151.62 35.7 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.504 HD13 ' HB ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -142.63 79.56 1.66 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.696 -1.253 . . . . 0.0 110.682 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.551 ' CD2' ' HD2' ' A' ' 70' ' ' LYS . 87.5 m95 -53.96 111.37 0.74 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 109.296 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.601 ' CG ' HG12 ' A' ' 122' ' ' VAL . 8.7 m-85 -87.01 71.31 10.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.157 -0.964 . . . . 0.0 109.546 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.659 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 67.5 m95 -75.44 86.6 2.58 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.94 -1.1 . . . . 0.0 109.554 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.565 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 1.7 mm? -67.89 130.75 43.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.626 -1.296 . . . . 0.0 109.711 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.533 HG21 ' N ' ' A' ' 88' ' ' GLU . 0.6 OUTLIER -111.37 179.45 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.19 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.533 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -160.93 17.6 0.12 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.341 -1.475 . . . . 0.0 112.57 -179.349 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.575 ' O ' ' CD ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.52 50.63 0.28 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.048 -1.657 . . . . 0.0 111.139 179.439 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.596 ' CH2' ' HB2' ' A' ' 13' ' ' ASN . 4.0 p90 -67.4 164.61 18.27 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.687 -1.258 . . . . 0.0 109.351 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.606 ' O ' ' N ' ' A' ' 93' ' ' GLU . 6.6 tt0 -87.95 140.18 29.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.152 -0.967 . . . . 0.0 109.363 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 36.29 -85.17 0.01 OUTLIER Glycine 0 N--CA 1.497 2.731 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 91' ' ' GLU . 10.4 pt-20 -101.61 159.61 28.93 Favored Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.242 -1.152 . . . . 0.0 109.706 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.615 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 15.0 Cg_endo -75.52 -159.94 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.364 2.043 . . . . 0.0 109.669 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.63 ' CD2' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER 175.18 27.21 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.72 -0.612 . . . . 0.0 110.667 178.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.519 ' HA2' HD12 ' A' ' 54' ' ' LEU . . . -103.28 -6.15 45.3 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.584 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -81.15 128.54 33.87 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.347 -1.09 . . . . 0.0 110.854 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.533 ' OE1' ' CA ' ' A' ' 38' ' ' GLY . 22.7 tp10 -81.69 -96.14 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.529 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . -89.7 -19.5 47.88 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 107.634 -2.187 . . . . 0.0 107.634 177.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.514 ' HG3' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -61.55 149.29 84.53 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.865 -0.786 . . . . 0.0 109.219 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.517 ' HD2' ' HB ' ' A' ' 21' ' ' THR . 1.2 Cg_endo -67.6 -37.35 16.93 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.737 1.625 . . . . 0.0 108.79 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.61 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.12 123.2 0.01 OUTLIER Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.555 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 1.4 pp20? -151.79 125.65 9.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.957 -1.319 . . . . 0.0 109.795 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.592 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 1.2 m-90 -45.08 132.62 7.0 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.62 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 7.7 tpt -124.31 120.73 33.02 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.288 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.31 47.51 1.16 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.608 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 6.8 tt -59.47 -48.0 83.32 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.74 -0.6 . . . . 0.0 109.427 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.608 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 49.3 t 82.79 112.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 40.89 82.79 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.577 ' CB ' ' HB3' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -42.08 164.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.377 -1.073 . . . . 0.0 109.869 -179.211 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 3.6 t-20 -138.43 -6.97 1.53 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.001 -1.062 . . . . 0.0 111.924 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.595 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . . . 82.34 -26.43 0.14 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.219 -0.926 . . . . 0.0 108.87 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER -58.27 -24.42 59.35 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.003 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.553 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 4.4 m-20 -103.07 -13.64 16.75 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.661 ' CZ ' ' CD1' ' A' ' 20' ' ' ILE . 2.0 m-85 -95.3 143.25 25.79 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.287 -0.883 . . . . 0.0 109.945 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -60.15 132.97 47.14 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.032 1.822 . . . . 0.0 109.575 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.55 -16.29 23.42 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.144 1.896 . . . . 0.0 110.988 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.05 -57.28 9.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.939 -1.1 . . . . 0.0 109.104 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.65 ' ND2' ' CZ ' ' A' ' 35' ' ' PHE . 9.8 m-20 -86.67 48.55 1.65 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.806 0.812 . . . . 0.0 109.043 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -56.61 -44.12 99.62 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.778 -0.576 . . . . 0.0 112.427 -179.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 11.5 Cg_exo -53.3 -57.55 1.93 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.048 1.832 . . . . 0.0 112.962 -177.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.601 HG12 ' CG ' ' A' ' 84' ' ' PHE . 2.0 t -78.93 -32.99 15.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 120.788 -1.195 . . . . 0.0 109.532 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.595 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 5.7 mt -64.16 -23.97 34.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.544 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -61.49 -28.45 69.31 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.899 0.857 . . . . 0.0 108.92 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -80.35 -40.09 27.3 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.752 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.577 ' HB3' ' CB ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -66.3 -22.02 66.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.623 -1.298 . . . . 0.0 107.845 179.148 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.565 ' CD ' ' HB1' ' A' ' 112' ' ' ALA . 12.6 mtmt -58.35 -33.54 69.66 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -87.19 -21.42 25.9 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.602 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 1.6 tp . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.736 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 79' ' ' HIS . 26.8 tttt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.51 0.671 . . . . 0.0 109.89 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.597 ' CD1' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -157.24 144.33 18.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.979 179.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.525 ' HG3' ' CB ' ' A' ' 81' ' ' THR . 9.7 mp0 -108.71 166.08 11.06 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.465 HG21 HG13 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -128.81 114.73 34.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 O-C-N 120.992 -1.067 . . . . 0.0 109.334 -178.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.454 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -85.2 62.61 7.6 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 36' ' ' PRO . 1.2 p -79.01 -70.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.353 -0.842 . . . . 0.0 109.972 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.629 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 59.08 84.48 0.04 OUTLIER Glycine 0 N--CA 1.481 1.649 0 N-CA-C 107.569 -2.212 . . . . 0.0 107.569 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.478 HG13 ' CD1' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -48.63 166.76 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.533 HG23 ' CG2' ' A' ' 87' ' ' VAL . 1.8 pt -130.65 78.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.687 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.585 ' HB3' ' CG2' ' A' ' 18' ' ' ILE . 2.9 ptm180 -83.25 144.92 29.42 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.598 ' OD1' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -161.3 -5.6 0.05 OUTLIER 'General case' 0 C--O 1.185 -2.291 0 C-N-CA 116.769 -1.972 . . . . 0.0 114.203 -179.072 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.588 ' HB2' ' CG ' ' A' ' 17' ' ' GLU . 19.7 mm-40 -94.02 -32.2 13.92 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 118.182 -2.824 . . . . 0.0 107.471 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -162.82 -48.62 0.04 OUTLIER 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 102.382 -3.192 . . . . 0.0 102.382 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -161.74 35.78 0.13 Allowed 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 175.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 105' ' ' MET . 0.3 OUTLIER -86.1 92.86 8.85 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.069 -1.452 . . . . 0.0 110.8 -176.449 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.585 ' CG2' ' HB3' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -84.95 156.66 3.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.536 0.684 . . . . 0.0 109.872 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.605 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 6.4 t80 -82.97 44.1 0.9 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.556 ' CG2' HG13 ' A' ' 18' ' ' ILE . 7.0 tp -82.05 155.69 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.148 -0.97 . . . . 0.0 110.55 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' A' ' 101' ' ' PRO . 5.0 t -73.08 89.23 1.46 Allowed 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.465 ' O ' ' C ' ' A' ' 23' ' ' ARG . 29.1 tpt180 -90.21 76.06 6.9 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.501 -0.75 . . . . 0.0 110.555 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.523 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 35.26 76.97 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.762 -0.586 . . . . 0.0 110.093 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.55 -52.98 9.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.928 . . . . 0.0 109.875 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.28 -170.23 2.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.119 -0.988 . . . . 0.0 109.489 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -79.5 128.51 33.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.194 -0.941 . . . . 0.0 109.141 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.523 ' CB ' ' HD2' ' A' ' 23' ' ' ARG . . . -124.46 -44.85 1.97 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.132 -0.98 . . . . 0.0 110.184 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.6 t60 56.41 20.44 4.75 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.49 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 6.3 mtp -115.28 -40.99 3.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.654 -0.654 . . . . 0.0 109.372 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' A' ' 31' ' ' ASN . . . 76.18 -177.49 0.13 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.304 -0.872 . . . . 0.0 109.003 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 1.3 t30 78.1 -5.95 2.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 109.403 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.49 ' O ' ' O ' ' A' ' 21' ' ' THR . 3.8 tmtm? -82.59 48.29 1.29 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.433 -0.792 . . . . 0.0 109.871 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.629 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 9.5 mt -117.91 79.93 1.44 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.846 -1.158 . . . . 0.0 109.304 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.589 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 13.2 tt0 -81.3 -134.18 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.345 -0.847 . . . . 0.0 109.132 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.589 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -149.37 124.75 4.94 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.544 -1.348 . . . . 0.0 110.261 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.549 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 1.7 Cg_endo -57.99 94.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.14 1.893 . . . . 0.0 109.515 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -55.34 -148.14 0.01 OUTLIER Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.287 -0.883 . . . . 0.0 111.757 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.602 ' N ' ' CG ' ' A' ' 98' ' ' GLU . . . 157.41 -31.96 0.53 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 107.538 -2.225 . . . . 0.0 107.538 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HE3' HD21 ' A' ' 4' ' ' LEU . 2.5 tptm 67.18 100.43 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 122.237 -0.567 . . . . 0.0 110.744 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.553 HG22 ' CD1' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -80.74 134.5 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.721 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' A' ' 42' ' ' MET . 4.0 pt-20 -171.39 -31.94 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.784 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.443 ' O ' ' C ' ' A' ' 43' ' ' GLY . 4.4 mmt -54.69 162.92 1.05 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.113 -0.992 . . . . 0.0 109.252 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 42' ' ' MET . . . 43.93 -125.81 5.68 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -164.6 23.21 0.06 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.474 -1.015 . . . . 0.0 108.948 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.505 ' O ' ' HB1' ' A' ' 49' ' ' ALA . 24.1 m -138.24 140.04 27.34 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.5 ' O ' HG11 ' A' ' 50' ' ' VAL . 10.0 Cg_exo -51.05 -17.84 3.95 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 121.748 1.632 . . . . 0.0 110.136 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.479 ' O ' HG11 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -77.95 -85.14 0.07 Allowed 'General case' 0 C--O 1.202 -1.401 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.519 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.553 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 14.3 mt-30 -43.83 -33.17 1.24 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.569 -1.332 . . . . 0.0 109.715 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.616 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -65.76 -62.63 1.4 Allowed 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.511 -0.743 . . . . 0.0 110.021 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.561 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 2.6 p -68.99 -49.58 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.216 -0.928 . . . . 0.0 110.316 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.561 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 3.4 p -54.95 -45.48 76.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 121.684 -0.635 . . . . 0.0 110.186 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 5.4 mmt180 -71.06 -37.35 72.49 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.616 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 17.6 mm-40 -68.9 -14.59 63.13 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.606 ' HB3' ' CH2' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -80.0 -59.94 2.53 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -54.04 46.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.447 -0.783 . . . . 0.0 110.007 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.565 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 1.1 pp20? -47.57 -21.74 0.39 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.039 -1.038 . . . . 0.0 110.075 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.433 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 3.3 mt-10 -80.04 -92.92 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.075 -1.016 . . . . 0.0 109.632 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.634 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 36.2 t -79.97 -78.34 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 110.117 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.94 18.89 0.1 OUTLIER Glycine 0 N--CA 1.493 2.496 0 C-N-CA 118.43 -1.843 . . . . 0.0 112.643 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.621 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.6 pp -80.05 -156.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.123 -1.81 . . . . 0.0 107.628 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.572 ' CB ' ' CD ' ' A' ' 62' ' ' PRO . 1.5 m -137.36 -72.25 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.421 -1.424 . . . . 0.0 110.947 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.584 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 1.6 Cg_endo -61.43 -169.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 121.029 1.153 . . . . 0.0 110.712 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.584 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER 143.27 -23.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -179.436 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.554 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 1.6 t-80 44.84 53.21 7.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.455 -0.778 . . . . 0.0 109.484 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -45.97 156.05 0.16 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.036 0.922 . . . . 0.0 110.372 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -149.36 140.62 23.14 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.604 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -63.49 -68.1 0.37 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.731 -1.23 . . . . 0.0 109.78 -179.112 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.604 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 83.73 -50.53 0.14 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.599 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.5 mt-10 162.16 174.02 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.36 -172.38 3.36 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.824 -1.172 . . . . 0.0 109.891 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.548 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -140.18 -177.7 5.13 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.795 0.807 . . . . 0.0 109.891 179.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.407 ' HG3' HG21 ' A' ' 81' ' ' THR . 11.3 tt0 -160.18 88.7 0.82 Allowed 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.03 105.48 9.27 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.497 ' HG3' ' NE2' ' A' ' 79' ' ' HIS . 2.8 tt0 -96.72 118.29 32.86 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.119 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -105.69 174.3 2.72 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 2.9 Cg_exo -49.03 -60.51 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 121.418 1.412 . . . . 0.0 109.558 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.5 50.39 1.71 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.473 ' CD ' HD12 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -150.36 87.97 1.48 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.457 -0.777 . . . . 0.0 109.743 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.497 ' NE2' ' HG3' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -90.28 98.72 11.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.89 . . . . 0.0 109.386 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.575 ' CG2' ' N ' ' A' ' 81' ' ' THR . 0.5 OUTLIER -113.14 163.55 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.0 110.253 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.575 ' N ' ' CG2' ' A' ' 80' ' ' ILE . 0.7 OUTLIER -151.34 147.1 26.52 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.336 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.517 ' O ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -134.49 73.83 1.51 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.918 -1.114 . . . . 0.0 110.816 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.553 ' CD1' HG22 ' A' ' 40' ' ' ILE . 78.8 m95 -46.35 117.15 1.47 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.06 -1.025 . . . . 0.0 108.563 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.576 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 33.9 m-85 -94.03 76.78 4.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.966 -1.084 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.629 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 24.6 m95 -76.89 84.21 3.45 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.902 -1.124 . . . . 0.0 109.372 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.589 HD22 ' CD1' ' A' ' 68' ' ' PHE . 2.4 mm? -69.24 128.04 35.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.671 -1.268 . . . . 0.0 109.212 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.533 ' CG2' HG23 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -112.0 175.78 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 87.2 mt-10 -157.14 19.41 0.3 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.48 -1.388 . . . . 0.0 112.786 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.578 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.67 64.16 0.31 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.105 -1.622 . . . . 0.0 111.087 178.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.61 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 1.5 p90 -80.74 164.6 22.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.747 -1.22 . . . . 0.0 109.156 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.6 OUTLIER -88.27 142.94 27.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.854 -1.154 . . . . 0.0 109.386 178.314 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 38.25 -83.37 0.0 OUTLIER Glycine 0 N--CA 1.498 2.814 0 O-C-N 121.585 -0.697 . . . . 0.0 112.073 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' A' ' 91' ' ' GLU . 10.6 pt-20 -106.98 164.86 13.93 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.149 -1.206 . . . . 0.0 111.254 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.583 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 11.2 Cg_endo -75.86 -160.91 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 122.717 2.278 . . . . 0.0 109.934 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.634 ' HA ' ' CG2' ' A' ' 58' ' ' VAL . 0.2 OUTLIER 176.51 54.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.196 -0.94 . . . . 0.0 110.865 178.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . -139.98 0.6 2.12 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 118.334 -1.888 . . . . 0.0 111.814 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.541 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -78.03 106.94 10.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.403 -1.646 . . . . 0.0 110.772 -179.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.602 ' CG ' ' N ' ' A' ' 38' ' ' GLY . 1.2 mm-40 -60.27 -91.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.735 -1.228 . . . . 0.0 107.73 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.74 22.17 34.55 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 106.692 -2.563 . . . . 0.0 106.692 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.506 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -100.11 143.38 26.39 Favored Pre-proline 0 N--CA 1.485 1.289 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.498 ' HD2' ' HB ' ' A' ' 21' ' ' THR . 4.4 Cg_exo -57.31 -30.67 88.5 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 N-CA-C 108.127 -1.528 . . . . 0.0 108.127 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.605 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 53.63 110.97 0.01 OUTLIER Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 4.6 pt-20 -147.8 133.73 19.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.758 -1.437 . . . . 0.0 110.557 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.53 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 7.8 m0 -46.06 123.62 4.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 108.495 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.619 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -115.55 111.07 20.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.08 -1.012 . . . . 0.0 109.764 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.507 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 19.3 t -79.58 63.07 4.06 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.368 -0.832 . . . . 0.0 110.634 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.536 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 4.2 pp -82.37 -40.38 21.41 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.3 -0.875 . . . . 0.0 109.883 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.536 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 2.0 t 70.64 118.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 42.53 84.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.621 -1.791 . . . . 0.0 108.621 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.623 HD23 ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -45.74 174.34 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.587 -0.949 . . . . 0.0 110.147 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 112' ' ' ALA . 4.4 t-20 -152.77 0.54 0.28 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.979 -1.075 . . . . 0.0 112.069 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.558 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . . . 79.78 -32.3 0.13 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.889 -1.132 . . . . 0.0 109.008 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 111' ' ' ASN . 3.1 t0 -49.8 -26.51 3.99 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.55 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 9.2 m-20 -108.3 -17.62 13.96 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.809 -0.557 . . . . 0.0 109.872 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.629 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -91.77 144.32 29.21 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.134 -0.979 . . . . 0.0 109.853 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.531 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.8 Cg_endo -65.2 134.13 38.05 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.269 1.979 . . . . 0.0 109.962 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 118' ' ' ALA . 5.5 Cg_exo -60.65 -25.52 81.04 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.083 1.856 . . . . 0.0 110.731 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.91 -46.58 5.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.215 -0.928 . . . . 0.0 109.231 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.485 ' HB2' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -95.33 51.78 1.35 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.326 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.627 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -59.97 -44.15 96.1 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.621 -0.674 . . . . 0.0 112.358 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.2 Cg_exo -54.34 -32.89 74.13 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.013 1.809 . . . . 0.0 112.872 -177.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.56 HG22 ' CE1' ' A' ' 84' ' ' PHE . 2.4 t -101.41 -36.8 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.522 -1.361 . . . . 0.0 110.153 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.558 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 1.1 mp -61.93 -27.85 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.519 ' HA ' ' CE ' ' A' ' 127' ' ' LYS . . . -55.06 -35.08 64.14 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 125' ' ' LYS . 26.0 mmtp -80.11 -41.62 25.16 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.946 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.602 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -60.3 -22.0 62.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.335 -1.478 . . . . 0.0 107.448 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.535 ' HD3' ' CB ' ' A' ' 112' ' ' ALA . 6.3 mttt -57.36 -42.02 81.23 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -79.07 -18.98 52.45 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 2.5 tp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.984 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HE2' ' CD ' ' A' ' 5' ' ' GLN . 3.6 ttpm? . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 121.36 0.6 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.56 ' CD1' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -148.22 122.11 9.37 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.539 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 2.9 mp0 -110.65 154.65 23.52 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.114 -0.991 . . . . 0.0 108.339 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.52 ' CG2' ' HA2' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -122.5 118.21 54.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.396 -178.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HB3' ' CB ' ' A' ' 50' ' ' VAL . . . -85.52 60.76 6.44 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.529 ' HB ' ' HA2' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -79.16 -71.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.096 -179.203 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.645 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 59.84 82.23 0.07 OUTLIER Glycine 0 C--N 1.298 -1.57 0 N-CA-C 106.304 -2.719 . . . . 0.0 106.304 -177.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.534 HG23 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -48.15 154.69 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -178.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 4.0 pt -116.48 102.27 13.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.886 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.529 ' NH1' ' OD1' ' A' ' 16' ' ' ASN . 8.6 mtm180 -76.65 -173.12 2.46 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.595 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -155.43 -66.32 0.12 Allowed 'General case' 0 C--O 1.188 -2.161 0 C-N-CA 116.826 -1.95 . . . . 0.0 114.267 -177.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.596 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 29.1 tp10 -91.51 -33.82 15.03 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 118.953 -2.342 . . . . 0.0 111.496 -175.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.483 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 41.8 t-20 -161.73 -42.08 0.04 OUTLIER 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.529 ' OD1' ' NH1' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -155.96 32.8 0.35 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 177.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.596 ' CG ' ' HB3' ' A' ' 14' ' ' GLU . 1.9 mm-40 -90.1 109.45 20.5 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 118.038 -1.465 . . . . 0.0 108.49 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.557 ' CD1' ' HB3' ' A' ' 105' ' ' MET . 0.2 OUTLIER -102.92 148.44 8.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.793 -177.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.622 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 20.4 t80 -81.54 38.34 0.49 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.513 ' O ' ' HG2' ' A' ' 103' ' ' GLU . 6.1 tp -78.47 152.55 5.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.259 -0.901 . . . . 0.0 110.442 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.477 HG23 ' NE2' ' A' ' 100' ' ' GLN . 1.4 t -65.49 85.5 0.07 Allowed 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.511 ' O ' ' C ' ' A' ' 23' ' ' ARG . 21.2 tpt180 -87.38 93.59 9.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.688 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.559 ' CB ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 28.55 76.63 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 120.986 0.422 . . . . 0.0 110.385 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.25 -47.52 4.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.363 -0.836 . . . . 0.0 109.105 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.25 155.1 26.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.869 . . . . 0.0 108.992 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -59.6 92.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.07 -1.018 . . . . 0.0 109.649 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.559 ' HB1' ' CB ' ' A' ' 23' ' ' ARG . . . -97.54 96.84 8.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -0.947 . . . . 0.0 109.947 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -48.95 -25.61 2.04 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.41 ' N ' ' C ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -72.06 -167.29 0.29 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.54 0.686 . . . . 0.0 109.477 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.528 ' O ' ' CB ' ' A' ' 31' ' ' ASN . . . -154.58 -157.98 0.81 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 0.7 OUTLIER 75.26 -2.7 2.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.059 -1.025 . . . . 0.0 109.074 -179.164 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.39 59.66 4.69 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.563 -0.71 . . . . 0.0 110.279 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.594 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 12.0 mt -122.41 85.09 2.36 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.556 ' O ' ' CD1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -80.8 -138.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.15 -1.593 . . . . 0.0 109.443 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 23.6 m-85 -154.22 123.98 3.26 Favored Pre-proline 0 N--CA 1.485 1.317 0 O-C-N 121.066 -1.021 . . . . 0.0 109.464 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 37' ' ' GLY . 2.1 Cg_endo -58.63 88.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.889 1.726 . . . . 0.0 109.464 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.529 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -57.12 -141.41 0.01 OUTLIER Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.569 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . 162.48 -55.35 0.3 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.569 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 99.04 69.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 123.11 0.564 . . . . 0.0 110.352 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.572 HG12 ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -53.79 123.45 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.963 -1.086 . . . . 0.0 108.684 179.353 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 42' ' ' MET . 8.1 pt-20 -173.16 -22.52 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.647 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.438 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -38.82 -81.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.133 -0.979 . . . . 0.0 110.153 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.41 -122.95 2.25 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.69 9.07 1.97 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.531 -0.982 . . . . 0.0 109.124 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.547 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 60.4 m -126.01 142.41 42.38 Favored Pre-proline 0 N--CA 1.486 1.335 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.585 ' HG3' ' CZ3' ' A' ' 83' ' ' TRP . 3.6 Cg_exo -52.41 -15.7 4.25 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.545 1.497 . . . . 0.0 110.317 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.485 ' O ' HG11 ' A' ' 51' ' ' VAL . 2.4 tt0 -75.97 -81.25 0.08 Allowed 'General case' 0 C--O 1.201 -1.486 0 O-C-N 120.983 -1.073 . . . . 0.0 108.638 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 1.3 mt-30 -47.75 -36.02 10.8 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.265 -1.522 . . . . 0.0 109.455 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.594 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -62.17 -64.17 1.01 Allowed 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.198 -0.939 . . . . 0.0 110.136 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.578 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 1.3 p -69.47 -49.81 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.305 -0.872 . . . . 0.0 110.657 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.578 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 3.1 p -55.89 -37.12 46.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.745 -0.597 . . . . 0.0 110.421 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.557 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -78.96 -37.16 40.22 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.594 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 2.2 mm-40 -69.83 -14.23 62.65 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.614 HD11 ' CG ' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -80.08 -65.5 1.0 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.498 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.06 -49.8 74.74 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.697 -0.627 . . . . 0.0 110.479 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.577 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -46.64 -24.76 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.881 -1.137 . . . . 0.0 109.915 -178.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 8.0 mm-40 -80.13 -95.04 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.091 -1.005 . . . . 0.0 109.563 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.622 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 66.3 t -79.96 -79.36 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.098 -1.001 . . . . 0.0 109.911 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.99 37.58 0.09 OUTLIER Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.241 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.643 HG13 ' CD2' ' A' ' 95' ' ' TRP . 2.9 pp -93.36 -152.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 120.793 -1.416 . . . . 0.0 108.542 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.588 ' N ' ' CD1' ' A' ' 60' ' ' ILE . 1.3 m -161.7 -64.96 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 120.327 -1.483 . . . . 0.0 112.511 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 64' ' ' HIS . 3.8 Cg_exo -51.59 -2.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.827 2.351 . . . . 0.0 114.267 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.504 ' C ' ' O ' ' A' ' 62' ' ' PRO . 1.3 pt20 -34.89 -29.15 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 119.575 1.079 . . . . 0.0 110.791 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.578 ' N ' ' O ' ' A' ' 62' ' ' PRO . 2.2 t60 55.32 73.37 0.42 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.676 -1.265 . . . . 0.0 108.053 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 15.5 p90 -72.99 146.4 46.01 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.791 0.805 . . . . 0.0 111.179 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -144.4 135.37 25.13 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.62 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -61.46 -70.16 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.752 -1.217 . . . . 0.0 109.985 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.62 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 84.1 -52.51 0.13 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -178.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.9 mm-40 172.69 177.54 0.09 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.262 -0.899 . . . . 0.0 108.885 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.422 ' HE2' HG21 ' A' ' 81' ' ' THR . 0.0 OUTLIER -161.37 -174.59 4.36 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.195 -0.941 . . . . 0.0 109.38 -179.389 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.569 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -149.02 175.79 11.0 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.135 -0.978 . . . . 0.0 109.986 179.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -144.06 89.16 2.01 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.15 123.16 27.11 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.24 156.3 17.3 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.294 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.569 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -133.22 174.13 5.07 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.569 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 5.4 Cg_exo -47.68 -33.35 18.44 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.696 1.597 . . . . 0.0 109.74 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -164.18 51.59 0.14 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.152 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.487 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -155.64 94.0 1.53 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.652 -0.655 . . . . 0.0 109.778 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.46 ' O ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -78.72 120.7 23.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.047 -1.033 . . . . 0.0 108.707 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.598 ' CG2' ' N ' ' A' ' 81' ' ' THR . 1.3 mp -117.89 165.25 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 122.135 0.969 . . . . 0.0 110.592 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.598 ' N ' ' CG2' ' A' ' 80' ' ' ILE . 1.5 m -153.6 155.98 37.13 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.466 HD21 ' CE1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -148.49 77.04 1.38 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.912 -1.118 . . . . 0.0 110.301 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.585 ' CZ3' ' HG3' ' A' ' 46' ' ' PRO . 75.9 m95 -49.0 108.59 0.19 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.809 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.551 ' CG ' HG12 ' A' ' 122' ' ' VAL . 19.1 m-85 -85.06 69.81 10.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.134 -0.979 . . . . 0.0 109.593 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.645 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 71.0 m95 -74.23 87.53 1.96 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.905 -1.122 . . . . 0.0 109.361 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.565 HD22 ' CD2' ' A' ' 68' ' ' PHE . 3.3 mm? -70.07 126.98 31.26 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 120.67 -1.269 . . . . 0.0 109.573 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.523 ' CG2' HG23 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -101.52 179.98 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.01 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.523 ' N ' HG21 ' A' ' 87' ' ' VAL . 42.8 mt-10 -153.28 1.69 0.27 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 117.735 -1.586 . . . . 0.0 113.219 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.593 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.32 71.27 0.44 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.002 -1.686 . . . . 0.0 110.95 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.611 ' CH2' ' CD1' ' A' ' 104' ' ' TRP . 2.8 p90 -78.87 165.64 23.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.418 -1.426 . . . . 0.0 110.036 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.542 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 1.5 pt-20 -86.98 137.6 32.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.206 -0.934 . . . . 0.0 109.824 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 41.1 -89.49 0.01 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.561 ' O ' ' CG2' ' A' ' 60' ' ' ILE . 12.6 pt-20 -103.9 162.54 19.64 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.199 -1.177 . . . . 0.0 109.745 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.615 ' HG2' ' CE2' ' A' ' 19' ' ' PHE . 10.1 Cg_endo -76.64 -155.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.58 2.187 . . . . 0.0 110.067 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.643 ' CD2' HG13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER 179.48 49.64 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.336 -0.852 . . . . 0.0 110.56 179.115 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 36' ' ' PRO . . . -130.63 -2.92 4.75 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.078 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.499 ' N ' ' CD ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -56.92 99.47 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.242 -1.152 . . . . 0.0 110.29 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.479 ' OE2' ' HA2' ' A' ' 38' ' ' GLY . 5.7 tp10 -82.1 84.43 7.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.114 -0.991 . . . . 0.0 108.821 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.07 16.95 65.05 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.485 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 2.8 pt20 -121.54 164.62 23.5 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.556 -0.967 . . . . 0.0 109.003 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 3.2 Cg_exo -65.65 -49.35 2.4 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 121.742 1.628 . . . . 0.0 109.79 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.622 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.94 119.27 0.01 OUTLIER Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.543 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 2.4 pt-20 -151.96 134.7 15.52 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.037 -1.273 . . . . 0.0 110.846 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.611 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 2.1 m0 -48.85 127.88 14.7 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.595 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -108.23 133.41 52.51 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -178.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.503 ' HA ' ' OE2' ' A' ' 17' ' ' GLU . 1.6 t -84.65 41.12 0.83 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.411 -1.431 . . . . 0.0 109.531 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.53 ' CD1' ' HG ' ' A' ' 110' ' ' LEU . 1.6 tt -82.54 150.96 26.64 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.481 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 48.4 t -119.52 132.32 69.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 109.293 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 129' ' ' LEU . . . 39.96 80.8 0.03 OUTLIER Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.647 ' CD2' ' CD2' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -41.87 163.71 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.479 -1.013 . . . . 0.0 110.072 -178.177 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.547 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 3.8 t30 -138.79 0.4 2.0 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 111.322 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.574 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . . . 82.59 -33.62 0.09 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.221 -0.924 . . . . 0.0 108.632 -178.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 111' ' ' ASN . 1.2 t0 -50.87 -28.91 10.55 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.512 -0.742 . . . . 0.0 109.044 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.544 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 8.5 m-20 -101.33 -19.41 15.64 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.538 -0.726 . . . . 0.0 109.406 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.647 ' CD2' ' CD2' ' A' ' 110' ' ' LEU . 1.3 m-85 -86.26 142.46 35.72 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.332 -0.855 . . . . 0.0 108.723 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.57 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.2 Cg_endo -62.94 146.28 94.78 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.276 1.984 . . . . 0.0 110.249 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.485 ' HA ' ' CD ' ' A' ' 120' ' ' GLU . 1.3 Cg_endo -64.4 -18.9 64.68 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.182 1.921 . . . . 0.0 110.994 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.66 -56.48 20.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.094 . . . . 0.0 110.09 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.558 ' CB ' HD13 ' A' ' 123' ' ' ILE . 9.0 m-80 -91.62 44.96 1.2 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.094 -1.004 . . . . 0.0 109.852 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.673 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 1.3 tp10 -60.71 -47.07 96.94 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.442 -0.786 . . . . 0.0 112.156 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 24.6 Cg_exo -43.85 -48.14 9.33 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.115 1.877 . . . . 0.0 112.452 -177.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.551 HG12 ' CG ' ' A' ' 84' ' ' PHE . 2.5 t -91.67 -25.75 5.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 O-C-N 120.619 -1.301 . . . . 0.0 107.874 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.631 HG12 ' CD2' ' A' ' 115' ' ' PHE . 1.5 mt -69.42 -11.55 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.536 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -71.36 -27.68 63.53 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -80.24 -38.83 30.24 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.752 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.602 ' CD1' ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -67.03 -22.87 65.86 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.525 -1.359 . . . . 0.0 107.719 179.299 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.563 ' CD ' ' HB1' ' A' ' 112' ' ' ALA . 2.7 mtmm -56.77 -31.46 64.65 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -89.82 -21.78 22.42 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.327 -0.852 . . . . 0.0 108.711 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 1.4 tp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.77 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.446 ' CG ' ' N ' ' A' ' 4' ' ' LEU . 2.1 ttpt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 121.45 0.643 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -160.48 160.0 31.5 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.133 -0.979 . . . . 0.0 109.161 178.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.538 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 15.3 mp0 -131.09 173.22 11.24 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.179 -0.951 . . . . 0.0 108.657 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.439 ' C ' HG23 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -140.85 116.75 7.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 121.131 -0.98 . . . . 0.0 109.084 -179.388 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.471 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -82.29 67.63 8.39 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.513 ' HB ' ' HA2' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -79.15 -76.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.273 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.662 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 65.3 78.48 0.22 Allowed Glycine 0 C--N 1.295 -1.697 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 -178.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.501 HD13 ' NH2' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -47.15 168.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -178.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.565 HG21 ' CG1' ' A' ' 87' ' ' VAL . 3.7 pt -140.38 93.85 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 120.859 -1.15 . . . . 0.0 110.083 -177.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -95.56 152.08 18.75 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.621 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -161.08 -10.39 0.04 OUTLIER 'General case' 0 C--O 1.188 -2.182 0 C-N-CA 116.663 -2.015 . . . . 0.0 115.444 -177.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -94.47 -31.16 14.07 Favored 'General case' 0 N--CA 1.51 2.548 0 O-C-N 118.047 -2.908 . . . . 0.0 108.458 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.8 -48.75 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 102.174 -3.269 . . . . 0.0 102.174 177.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.43 ' C ' ' OE1' ' A' ' 17' ' ' GLU . 16.9 t30 -162.03 38.31 0.12 Allowed 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 175.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -85.35 93.14 8.65 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.432 -1.307 . . . . 0.0 110.697 -177.056 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 2.0 pt -79.12 146.83 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.63 0.729 . . . . 0.0 111.063 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.604 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 6.3 t80 -82.75 43.68 0.86 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.582 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -80.67 151.11 4.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.07 0.938 . . . . 0.0 110.49 -178.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.509 ' N ' HG13 ' A' ' 20' ' ' ILE . 5.3 t -66.56 91.34 0.18 Allowed 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.585 ' O ' ' N ' ' A' ' 24' ' ' ALA . 21.4 tpt180 -94.47 140.5 29.75 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.281 -0.887 . . . . 0.0 108.712 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.539 ' CZ ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -32.21 91.19 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . -42.82 -54.44 4.13 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.493 -0.754 . . . . 0.0 109.149 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.69 -163.09 0.53 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 73.2 m-20 -70.09 -49.96 45.72 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.908 -1.12 . . . . 0.0 109.805 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 26' ' ' ASP . . . 81.98 -24.16 0.19 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.346 -0.846 . . . . 0.0 110.212 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.506 ' O ' ' HG2' ' A' ' 29' ' ' MET . 0.1 OUTLIER 47.77 25.43 0.71 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.79 -1.193 . . . . 0.0 108.047 -178.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 28' ' ' HIS . 20.7 mmt -154.94 -167.68 2.65 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 31' ' ' ASN . . . -153.09 -162.47 1.49 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 108.929 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 1.0 OUTLIER 77.18 -2.71 2.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.443 -0.786 . . . . 0.0 109.327 -179.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.523 ' HD2' ' N ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -82.09 55.34 2.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.47 -0.769 . . . . 0.0 110.097 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.653 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 6.6 mt -124.06 86.53 2.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.805 -1.184 . . . . 0.0 108.544 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.582 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 4.6 tt0 -82.38 -123.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.078 -1.014 . . . . 0.0 110.32 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -161.38 123.68 1.75 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 120.646 -1.284 . . . . 0.0 109.277 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.672 ' CB ' ' HA ' ' A' ' 97' ' ' LYS . 6.9 Cg_endo -65.03 99.09 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.884 1.723 . . . . 0.0 109.725 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.513 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -95.02 -130.77 6.19 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.994 -1.098 . . . . 0.0 111.663 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 150.06 -8.65 0.81 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 15.2 tptm 72.78 106.13 0.07 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.39 0.614 . . . . 0.0 111.056 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.531 HG12 ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -81.63 134.7 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.414 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 42' ' ' MET . 2.4 pt-20 -172.33 -29.37 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.216 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.428 ' O ' ' C ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -55.17 160.63 2.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.923 -1.111 . . . . 0.0 108.914 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.442 ' C ' ' HG2' ' A' ' 44' ' ' GLU . . . 46.35 -127.14 9.69 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.442 ' HG2' ' C ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -166.57 23.46 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.35 -1.088 . . . . 0.0 109.046 179.061 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.553 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 87.4 m -142.73 142.67 23.3 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 9.0 Cg_exo -48.94 -16.8 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.899 1.732 . . . . 0.0 111.107 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.484 ' O ' HG11 ' A' ' 51' ' ' VAL . 4.8 mt-10 -78.5 -80.4 0.11 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.747 -1.221 . . . . 0.0 108.63 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 30.6 mt-30 -51.69 -23.94 5.07 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.396 -1.44 . . . . 0.0 109.164 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.604 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -72.1 -64.08 1.01 Allowed 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.484 -0.76 . . . . 0.0 109.737 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.566 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 2.6 p -70.06 -49.14 58.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.251 -0.906 . . . . 0.0 110.192 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.566 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 1.4 p -52.96 -44.62 50.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 O-C-N 121.749 -0.594 . . . . 0.0 110.292 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.597 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 7.8 mmt180 -73.57 -39.66 64.51 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.604 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 6.3 mm-40 -66.67 -15.12 63.27 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.608 ' HB3' ' CH2' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -80.19 -61.08 2.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -54.55 43.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.799 . . . . 0.0 109.906 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.566 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -46.0 -24.22 0.39 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -0.963 . . . . 0.0 109.658 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.44 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.2 mt-10 -79.99 -95.67 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.169 -0.957 . . . . 0.0 109.525 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.597 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 46.9 t -80.0 -78.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 110.109 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.12 24.19 0.12 Allowed Glycine 0 N--CA 1.494 2.507 0 C-N-CA 118.922 -1.609 . . . . 0.0 112.361 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.701 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.1 pp -84.38 -146.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.325 -1.691 . . . . 0.0 107.827 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.57 ' CB ' ' CD ' ' A' ' 62' ' ' PRO . 1.2 m -161.03 -66.92 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 120.174 -1.579 . . . . 0.0 112.329 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.599 ' O ' ' CG ' ' A' ' 63' ' ' GLN . 10.2 Cg_exo -43.54 -94.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.169 1.912 . . . . 0.0 112.426 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.667 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 3.2 pt20 54.05 6.21 0.09 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.197 -0.939 . . . . 0.0 111.382 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.598 ' C ' ' O ' ' A' ' 63' ' ' GLN . 5.3 t-160 22.32 50.69 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.58 0 O-C-N 120.962 -1.086 . . . . 0.0 110.444 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 63' ' ' GLN . 1.7 p90 -35.52 141.34 0.08 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.091 0.948 . . . . 0.0 112.127 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -145.2 147.58 32.59 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.596 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -77.85 -65.28 0.99 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.79 -1.194 . . . . 0.0 110.13 -179.004 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.596 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 82.71 -51.33 0.18 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.302 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER 163.42 178.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 0.0 109.496 179.144 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.586 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 15.1 ptmt -160.96 170.3 20.86 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.301 -0.874 . . . . 0.0 109.727 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.541 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -136.16 171.58 14.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.098 179.582 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -150.09 94.15 2.11 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.01 122.23 26.48 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.478 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 15.0 tt0 -96.67 127.64 42.85 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.108 -0.995 . . . . 0.0 109.468 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.57 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 7.1 m-85 -106.7 168.34 8.24 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.362 -0.836 . . . . 0.0 109.17 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 7.5 Cg_exo -48.7 -28.48 12.68 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.943 1.762 . . . . 0.0 109.77 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.47 ' O ' ' HD2' ' A' ' 78' ' ' ARG . 8.0 m-20 -162.25 31.08 0.11 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.519 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.66 89.98 2.36 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.71 -0.619 . . . . 0.0 109.961 -178.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.478 ' CD2' ' HG3' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -89.86 113.3 24.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.911 -1.118 . . . . 0.0 109.126 179.58 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.589 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.6 mp -118.54 155.71 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.974 -1.079 . . . . 0.0 110.446 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.538 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 1.9 m -136.14 137.84 41.39 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.483 ' HG ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -127.22 75.89 1.62 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.815 -1.178 . . . . 0.0 110.101 -179.206 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.586 ' CE3' ' HD2' ' A' ' 70' ' ' LYS . 92.2 m95 -51.79 111.24 0.57 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.265 -0.897 . . . . 0.0 109.45 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.548 ' O ' ' O ' ' A' ' 67' ' ' LEU . 45.5 m-85 -86.92 73.04 10.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.9 . . . . 0.0 110.178 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.662 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 12.7 m95 -71.94 85.76 0.99 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.819 -1.176 . . . . 0.0 108.328 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 66' ' ' SER . 2.8 mm? -67.78 125.78 27.33 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.478 -1.389 . . . . 0.0 110.024 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.667 ' HB ' ' O ' ' A' ' 63' ' ' GLN . 0.9 OUTLIER -112.29 169.81 4.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 38.8 mt-10 -160.54 29.59 0.16 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 117.972 -1.491 . . . . 0.0 112.552 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.581 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.85 30.19 0.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.329 -1.482 . . . . 0.0 109.943 179.235 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.622 ' CH2' ' CD1' ' A' ' 104' ' ' TRP . 1.6 p90 -48.96 148.78 2.12 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.951 -1.093 . . . . 0.0 109.967 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 93' ' ' GLU . 1.6 tt0 -81.26 133.11 35.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.387 -0.821 . . . . 0.0 109.722 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 45.75 -86.89 0.01 OUTLIER Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.578 ' O ' ' CG2' ' A' ' 60' ' ' ILE . 17.1 pt-20 -100.6 161.89 22.51 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.301 -1.117 . . . . 0.0 110.051 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.595 ' HG2' ' CE2' ' A' ' 19' ' ' PHE . 13.9 Cg_endo -79.05 -162.6 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.772 2.315 . . . . 0.0 109.908 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.701 ' CD2' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER 177.8 26.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.218 -0.927 . . . . 0.0 111.011 178.574 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.467 ' HA2' HD12 ' A' ' 54' ' ' LEU . . . -93.88 -48.67 2.64 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.521 -1.323 . . . . 0.0 110.24 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.672 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -42.47 146.07 0.37 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -1.117 . . . . 0.0 111.243 -179.291 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.484 ' OE1' ' HA2' ' A' ' 38' ' ' GLY . 6.2 tp10 -81.08 -97.32 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.459 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . -108.64 3.95 32.51 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.504 ' HG2' ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -74.85 174.85 4.62 Favored Pre-proline 0 N--CA 1.482 1.166 0 O-C-N 121.826 -0.808 . . . . 0.0 109.199 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 102' ' ' GLY . 2.1 Cg_endo -69.63 -50.86 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.95 1.767 . . . . 0.0 109.591 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.604 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 61.78 114.38 0.01 OUTLIER Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.064 -2.015 . . . . 0.0 108.064 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.553 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 7.1 pt-20 -148.61 135.85 20.23 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.113 -1.228 . . . . 0.0 110.441 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.622 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 5.0 m0 -48.18 129.29 15.1 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.555 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -119.79 119.2 32.92 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.85 -1.157 . . . . 0.0 110.032 -178.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.35 68.12 5.26 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.613 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 7.4 tt -81.86 -54.36 5.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 109.188 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 48.6 t 86.29 112.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 40.3 83.79 0.01 OUTLIER Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.603 HD22 ' CD1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -40.22 165.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.725 -0.868 . . . . 0.0 110.596 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 14.6 t30 -144.15 1.75 1.12 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.126 -0.984 . . . . 0.0 111.234 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.593 ' CB ' ' CD ' ' A' ' 127' ' ' LYS . . . 70.24 -3.42 1.82 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.914 -1.116 . . . . 0.0 109.282 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 111' ' ' ASN . 1.1 t0 -80.95 -24.68 37.95 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.474 ' HB3' HD13 ' A' ' 33' ' ' LEU . 3.3 m-20 -102.11 -13.11 17.62 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.653 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 4.0 m-85 -95.08 150.98 38.49 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.293 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.54 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.3 Cg_endo -66.63 139.75 54.21 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.498 2.132 . . . . 0.0 109.63 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 118' ' ' ALA . 2.4 Cg_endo -61.93 -31.15 84.46 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.224 1.949 . . . . 0.0 111.179 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.64 -44.83 4.42 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.004 -1.06 . . . . 0.0 110.187 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.477 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 3.5 m-80 -99.16 51.61 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 109.273 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.672 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.4 mt-10 -69.36 -36.57 7.31 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.558 -0.714 . . . . 0.0 112.437 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.3 Cg_exo -56.35 -34.89 95.3 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.511 1.474 . . . . 0.0 112.047 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.512 HG12 ' CD1' ' A' ' 84' ' ' PHE . 1.7 t -99.77 -36.48 5.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.583 -1.323 . . . . 0.0 108.829 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.59 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -66.64 -15.56 19.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.565 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.513 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -62.83 -29.9 71.09 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.474 ' HE2' ' OE2' ' A' ' 69' ' ' GLU . 12.8 mmtm -81.53 -39.43 24.69 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.094 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.601 ' HB3' ' CB ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -66.62 -22.05 66.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.733 -1.229 . . . . 0.0 108.195 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.593 ' CD ' ' CB ' ' A' ' 112' ' ' ALA . 1.7 mtmt -53.23 -31.13 41.75 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.03 -27.85 22.95 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.361 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.521 HD23 ' NH1' ' A' ' 12' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.681 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 79' ' ' HIS . 9.1 tttt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 121.428 0.632 . . . . 0.0 109.804 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.554 ' CD1' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -158.67 147.36 18.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.478 -0.764 . . . . 0.0 109.007 178.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.529 ' HG3' ' CB ' ' A' ' 81' ' ' THR . 1.6 mp0 -111.7 170.13 8.35 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 109.094 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.554 ' CG2' ' HA3' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -135.04 108.15 9.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.202 -179.501 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.556 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -82.81 72.68 9.88 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.541 -0.725 . . . . 0.0 109.327 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.544 ' HB ' ' CA ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -83.81 -84.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.415 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.61 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 81.33 78.37 0.97 Allowed Glycine 0 C--N 1.299 -1.475 0 N-CA-C 106.947 -2.461 . . . . 0.0 106.947 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.536 ' CG2' HG23 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -48.21 150.5 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -178.731 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.526 HG23 ' CG2' ' A' ' 87' ' ' VAL . 10.0 pt -120.48 75.87 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.394 -177.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.626 ' HB3' HG22 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -79.69 153.95 28.94 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.46 ' OD1' ' CH2' ' A' ' 90' ' ' TRP . 2.6 p-10 -154.14 -20.98 0.13 Allowed 'General case' 0 C--O 1.187 -2.225 0 C-N-CA 117.218 -1.793 . . . . 0.0 114.901 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.554 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 3.4 tt0 -93.41 -32.31 14.29 Favored 'General case' 0 N--CA 1.511 2.605 0 O-C-N 118.076 -2.89 . . . . 0.0 109.486 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -161.68 -47.44 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 102.971 -2.974 . . . . 0.0 102.971 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.465 ' HB2' ' HA ' ' A' ' 108' ' ' VAL . 1.5 m120 -161.87 38.07 0.13 Allowed 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.626 ' HA ' ' O ' ' A' ' 105' ' ' MET . 84.0 mt-10 -85.1 84.51 7.68 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.143 -1.423 . . . . 0.0 110.43 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.626 HG22 ' HB3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -78.97 153.85 4.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.434 0.635 . . . . 0.0 109.942 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.614 ' CZ ' ' HG2' ' A' ' 94' ' ' PRO . 6.8 t80 -83.16 42.77 0.83 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 34' ' ' GLU . 5.5 tp -80.69 148.81 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-O 122.585 1.183 . . . . 0.0 111.734 -176.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.476 ' OG1' ' HG2' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -58.43 89.41 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.593 ' O ' ' C ' ' A' ' 23' ' ' ARG . 32.0 tpt180 -97.24 91.89 5.75 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.724 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.593 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 13.68 79.4 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.356 0.598 . . . . 0.0 110.971 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -41.56 -56.05 2.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.424 -0.798 . . . . 0.0 110.287 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.75 -179.04 3.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.069 -1.019 . . . . 0.0 109.476 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.96 84.44 4.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.214 -0.929 . . . . 0.0 109.534 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.53 ' HB1' ' CB ' ' A' ' 23' ' ' ARG . . . -72.54 -36.92 68.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.243 -0.911 . . . . 0.0 109.324 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 49.92 23.57 1.1 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.404 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -117.12 -33.96 4.53 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.563 -0.711 . . . . 0.0 109.1 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.531 ' O ' ' CB ' ' A' ' 31' ' ' ASN . . . 69.19 -177.65 0.21 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.437 -0.789 . . . . 0.0 109.822 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 1.1 t30 78.96 -8.63 1.62 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.523 -0.736 . . . . 0.0 109.523 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.543 ' HD2' ' CA ' ' A' ' 23' ' ' ARG . 4.8 tttp -83.29 51.47 1.98 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.385 -0.822 . . . . 0.0 110.227 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.576 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 17.4 mt -107.73 85.84 2.19 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' O ' HD12 ' A' ' 20' ' ' ILE . 1.5 tt0 -87.4 -137.28 0.09 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.388 -1.445 . . . . 0.0 109.614 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.679 ' CE2' ' CE1' ' A' ' 115' ' ' PHE . 10.9 m-85 -153.31 126.61 4.2 Favored Pre-proline 0 N--CA 1.486 1.364 0 O-C-N 121.048 -1.032 . . . . 0.0 109.586 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.543 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 5.4 Cg_endo -65.64 89.17 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.011 1.807 . . . . 0.0 108.483 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.554 ' HA3' ' CG2' ' A' ' 6' ' ' ILE . . . -115.34 107.18 1.7 Allowed Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.714 -1.231 . . . . 0.0 111.525 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.499 ' HA2' ' CD ' ' A' ' 98' ' ' GLU . . . -82.14 16.81 20.61 Favored Glycine 0 N--CA 1.489 2.181 0 O-C-N 121.576 -0.955 . . . . 0.0 111.168 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 3.1 tptm 63.9 108.25 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 118.244 1.022 . . . . 0.0 110.984 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.561 ' CG1' ' HB2' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.37 138.67 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.924 -1.11 . . . . 0.0 109.017 178.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.4 ' N ' HG12 ' A' ' 40' ' ' ILE . 3.5 pt-20 -172.28 -32.81 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.89 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.407 ' SD ' ' HB3' ' A' ' 52' ' ' ARG . 38.5 mtt -55.74 159.34 3.1 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.128 -0.982 . . . . 0.0 109.511 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.56 -130.5 9.39 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.16 24.44 0.11 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.435 -1.038 . . . . 0.0 108.749 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.535 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 27.4 m -136.82 140.86 33.03 Favored Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.561 ' HG3' ' CH2' ' A' ' 83' ' ' TRP . 7.1 Cg_exo -50.09 -20.35 5.2 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.815 1.677 . . . . 0.0 109.897 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.454 ' O ' ' C ' ' A' ' 48' ' ' GLN . 3.2 mt-10 -75.72 -87.35 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.346 -0.846 . . . . 0.0 108.763 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.536 ' O ' ' CG ' ' A' ' 52' ' ' ARG . 42.3 mt-30 -41.72 -33.01 0.43 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.845 -1.159 . . . . 0.0 110.147 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.616 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -67.19 -63.26 1.1 Allowed 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.024 -1.047 . . . . 0.0 109.674 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.573 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 2.2 p -66.72 -49.38 75.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.645 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.573 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 4.1 p -57.31 -44.65 84.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.547 -0.721 . . . . 0.0 110.34 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.536 ' CG ' ' O ' ' A' ' 48' ' ' GLN . 14.9 mmt180 -72.05 -32.25 66.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.009 -1.057 . . . . 0.0 108.665 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.616 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 12.4 mm-40 -75.22 -15.96 60.51 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.585 HD11 ' CD2' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -79.97 -62.62 1.63 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.749 0.785 . . . . 0.0 108.997 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.49 ' N ' ' CZ3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.45 -51.74 68.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.784 -0.572 . . . . 0.0 109.691 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.57 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -47.15 -26.22 1.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.888 -1.133 . . . . 0.0 108.868 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 54' ' ' LEU . 3.6 mt-10 -80.05 -95.3 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.355 -0.841 . . . . 0.0 109.377 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.618 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 28.2 t -80.21 -78.91 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.304 -0.873 . . . . 0.0 110.321 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 138.2 32.5 0.21 Allowed Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.374 -1.394 . . . . 0.0 111.275 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.645 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.1 pp -90.75 -152.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.589 -1.536 . . . . 0.0 108.278 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.577 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.6 m -162.23 -63.16 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.349 -1.469 . . . . 0.0 112.73 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.577 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 6.3 Cg_exo -55.9 0.62 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.537 2.158 . . . . 0.0 114.373 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.542 ' NE2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -39.18 -27.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.623 -1.298 . . . . 0.0 110.289 -179.07 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 62' ' ' PRO . 1.9 t60 51.84 88.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.505 ' HB3' ' NE2' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -88.87 159.31 17.76 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.377 1.084 . . . . 0.0 111.901 -177.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -153.64 141.15 19.81 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.242 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.61 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -63.31 -67.22 0.44 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.878 -1.139 . . . . 0.0 110.272 -178.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.61 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 84.05 -51.75 0.13 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.264 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.574 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 4.9 tp10 159.54 135.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.564 ' HE3' ' CD2' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -125.6 -177.76 4.02 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.467 -0.771 . . . . 0.0 109.515 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.533 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -136.51 -177.41 4.71 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.341 -0.85 . . . . 0.0 109.938 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -151.71 86.16 1.32 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.15 104.01 9.48 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -95.18 154.41 17.2 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.416 -0.914 . . . . 0.0 108.587 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.562 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -141.73 173.09 5.1 Favored Pre-proline 0 C--N 1.297 -1.677 0 O-C-N 121.214 -0.929 . . . . 0.0 109.104 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 7.3 Cg_exo -48.23 -39.39 34.54 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 121.776 1.651 . . . . 0.0 109.703 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.438 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 4.7 p-10 -148.21 35.14 0.81 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.481 ' O ' HD11 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -142.73 78.95 1.63 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.549 -0.719 . . . . 0.0 110.077 -178.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.419 ' C ' ' CD1' ' A' ' 80' ' ' ILE . 24.5 m170 -82.35 119.58 24.33 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.581 ' CG2' ' N ' ' A' ' 81' ' ' THR . 2.3 mp -129.69 162.75 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 118.793 -1.163 . . . . 0.0 111.433 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.581 ' N ' ' CG2' ' A' ' 80' ' ' ILE . 2.0 m -147.32 148.84 31.8 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.512 HD22 ' CG1' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -141.32 82.96 1.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.716 -1.24 . . . . 0.0 110.348 -179.395 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.564 ' CD2' ' HE3' ' A' ' 70' ' ' LYS . 89.8 m95 -54.05 111.76 0.82 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.267 -0.896 . . . . 0.0 109.034 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.565 ' O ' ' O ' ' A' ' 67' ' ' LEU . 11.6 m-85 -88.6 68.05 8.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.247 -0.908 . . . . 0.0 109.793 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.61 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 75.3 m95 -72.36 84.29 1.08 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.794 -1.191 . . . . 0.0 109.747 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.596 HD21 ' CD2' ' A' ' 68' ' ' PHE . 3.2 mm? -68.07 129.44 39.91 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.566 -1.334 . . . . 0.0 109.942 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.547 HG22 ' N ' ' A' ' 88' ' ' GLU . 0.8 OUTLIER -111.2 -175.08 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.547 ' N ' HG22 ' A' ' 87' ' ' VAL . 1.2 mt-10 -159.89 8.13 0.1 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 117.612 -1.635 . . . . 0.0 113.54 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.572 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.73 71.96 0.44 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 119.855 -1.778 . . . . 0.0 110.651 178.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.498 ' HB2' HD12 ' A' ' 60' ' ' ILE . 17.4 p90 -80.69 163.0 23.9 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.718 -1.239 . . . . 0.0 110.191 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.648 ' O ' ' N ' ' A' ' 93' ' ' GLU . 5.0 pt-20 -81.81 135.53 35.45 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.179 -0.951 . . . . 0.0 109.762 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 35.02 -80.34 0.0 OUTLIER Glycine 0 N--CA 1.502 3.088 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.648 ' N ' ' O ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -98.82 153.32 37.92 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.333 -1.098 . . . . 0.0 109.219 -179.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.614 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 20.2 Cg_endo -80.85 -159.07 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.787 2.325 . . . . 0.0 110.025 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.645 ' CD2' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER 178.58 132.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.771 0.796 . . . . 0.0 110.017 178.184 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . 152.93 -40.04 0.72 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.509 ' N ' ' CD ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -41.09 107.51 0.07 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.517 -0.99 . . . . 0.0 109.526 -179.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 5.5 tp10 -77.38 87.28 3.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.273 -0.892 . . . . 0.0 108.712 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.35 30.71 65.04 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.477 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 7.4 pt20 -125.96 168.08 15.05 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.475 -1.015 . . . . 0.0 109.299 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 9.8 Cg_endo -78.21 42.6 1.24 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.562 2.175 . . . . 0.0 110.842 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.57 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . -44.78 123.82 5.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.606 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -146.79 144.38 29.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -1.118 . . . . 0.0 109.8 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.495 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 1.2 m-90 -52.35 139.84 23.47 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.968 -1.083 . . . . 0.0 108.225 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.626 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -139.06 108.85 6.26 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.286 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.482 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -81.33 46.79 0.97 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.597 -0.689 . . . . 0.0 109.351 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.567 ' HG ' ' HG ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -64.72 -12.7 49.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 108.859 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.501 ' O ' ' C ' ' A' ' 109' ' ' GLY . 1.4 t 59.63 121.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.452 -0.78 . . . . 0.0 110.189 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.585 ' HA2' ' HB3' ' A' ' 129' ' ' LEU . . . 38.12 74.06 0.13 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.678 ' CD2' ' CD2' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -38.19 158.24 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.914 -0.756 . . . . 0.0 109.905 -178.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.56 ' ND2' ' HE3' ' A' ' 127' ' ' LYS . 0.8 OUTLIER -154.76 143.77 20.98 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.139 -0.976 . . . . 0.0 110.182 -178.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.508 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . . . -44.07 -27.84 0.42 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -42.07 -53.93 3.76 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.317 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.492 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 14.3 m-20 -97.94 -9.75 25.7 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.679 ' CE1' ' CE2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -91.96 136.92 25.55 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.543 -0.723 . . . . 0.0 109.754 -179.26 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' A' ' 123' ' ' ILE . 2.5 Cg_endo -68.24 153.6 74.14 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.373 2.049 . . . . 0.0 110.22 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 118' ' ' ALA . 1.7 Cg_endo -65.12 -36.37 37.53 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.212 1.941 . . . . 0.0 110.817 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -39.37 -47.79 1.81 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.408 -0.807 . . . . 0.0 110.123 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.481 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 0.7 OUTLIER -98.64 55.83 1.09 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.372 -0.83 . . . . 0.0 109.034 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.614 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -69.13 -47.17 29.53 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.722 -0.611 . . . . 0.0 111.688 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 8.2 Cg_exo -52.25 -40.12 70.55 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.194 1.929 . . . . 0.0 112.846 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.495 HG12 ' CE2' ' A' ' 84' ' ' PHE . 2.2 t -98.21 -34.05 4.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 O-C-N 120.642 -1.286 . . . . 0.0 109.5 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.653 HG12 ' CG ' ' A' ' 115' ' ' PHE . 31.4 mt -59.0 -29.18 40.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.53 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -59.44 -35.08 73.35 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.928 0.871 . . . . 0.0 109.129 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.0 mmmt -77.68 -35.58 52.11 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.567 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.597 ' CD1' ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -66.71 -34.62 78.26 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.158 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.56 ' HE3' ' ND2' ' A' ' 111' ' ' ASN . 7.1 mtpt -45.4 -29.01 0.97 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.568 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -91.2 -34.65 14.91 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.297 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.585 ' HB3' ' HA2' ' A' ' 109' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.508 2.426 0 CA-C-O 118.035 -0.983 . . . . 0.0 111.635 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.422 ' CG ' ' N ' ' A' ' 4' ' ' LEU . 15.1 tttt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.333 0.587 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.61 ' CD1' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -158.38 143.84 16.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.808 . . . . 0.0 109.278 179.105 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.537 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 0.3 OUTLIER -113.53 166.74 11.21 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.86 -1.15 . . . . 0.0 108.394 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.518 ' CG2' ' HA2' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -127.23 110.95 23.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.451 ' HB3' ' HB ' ' A' ' 40' ' ' ILE . . . -81.85 68.55 8.27 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.526 ' CB ' ' O ' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -79.47 -83.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.465 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.659 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 75.61 82.3 0.48 Allowed Glycine 0 N--CA 1.479 1.517 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 -178.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -49.13 157.2 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 1.6 pt -124.54 85.27 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.866 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.547 ' HG2' ' CG2' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -77.51 167.75 21.12 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.2 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 17' ' ' GLU . 2.0 p-10 -161.94 -26.11 0.05 OUTLIER 'General case' 0 C--O 1.185 -2.31 0 C-N-CA 115.966 -2.294 . . . . 0.0 114.889 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HB3' ' OE2' ' A' ' 17' ' ' GLU . 4.9 tt0 -95.01 -34.22 12.43 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 118.36 -2.712 . . . . 0.0 109.132 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -162.35 -45.95 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 103.211 -2.885 . . . . 0.0 103.211 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.527 ' ND2' ' HD2' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -160.37 36.2 0.17 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 176.511 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -88.14 98.95 11.84 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.088 -1.445 . . . . 0.0 109.234 -178.474 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -92.34 150.09 3.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.927 0.87 . . . . 0.0 111.265 -178.414 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.631 ' CE1' ' HA ' ' A' ' 103' ' ' GLU . 14.3 t80 -82.2 43.71 0.81 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.51 HD11 ' HD3' ' A' ' 36' ' ' PRO . 5.1 tp -81.02 154.96 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-O 122.053 0.93 . . . . 0.0 111.269 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.509 ' N ' HG13 ' A' ' 20' ' ' ILE . 1.4 t -66.14 93.72 0.22 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.575 ' O ' ' N ' ' A' ' 24' ' ' ALA . 23.7 tpt180 -102.05 149.01 24.69 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.668 -0.645 . . . . 0.0 109.601 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.577 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -34.34 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . -46.55 -54.34 9.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.382 -0.823 . . . . 0.0 110.393 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.49 -151.1 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.006 -1.058 . . . . 0.0 109.204 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.35 -51.39 10.92 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.292 -0.88 . . . . 0.0 109.066 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.577 ' CB ' ' HD2' ' A' ' 23' ' ' ARG . . . 57.7 -168.45 0.12 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.639 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -162.34 -35.07 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.473 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 1.5 mpt? -49.61 -46.44 49.31 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.337 -0.852 . . . . 0.0 109.398 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.487 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . . . 72.34 5.63 5.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.288 -0.883 . . . . 0.0 109.456 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -98.65 11.64 37.85 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.24 -0.912 . . . . 0.0 108.853 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -81.8 54.78 2.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.602 -0.686 . . . . 0.0 110.402 -179.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.715 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 15.0 mt -122.49 84.55 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.64 -1.287 . . . . 0.0 109.666 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.491 ' O ' HD12 ' A' ' 20' ' ' ILE . 1.4 tt0 -82.84 -136.86 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.987 -1.071 . . . . 0.0 109.983 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.648 ' CZ ' ' CD2' ' A' ' 115' ' ' PHE . 77.7 m-85 -152.0 125.37 4.22 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.124 -0.985 . . . . 0.0 109.338 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.526 ' O ' ' CB ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -58.09 90.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.616 1.544 . . . . 0.0 109.127 178.663 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.518 ' HA2' ' CG2' ' A' ' 6' ' ' ILE . . . -56.27 -142.46 0.01 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 154.56 -33.3 0.69 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 69.89 97.02 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 122.185 -0.597 . . . . 0.0 109.397 -179.519 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.537 HG12 ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.23 132.62 31.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.794 179.346 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.482 ' HB3' ' NZ ' ' A' ' 39' ' ' LYS . 6.6 pt-20 -170.67 -34.14 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.47 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -47.85 147.16 2.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.337 -0.852 . . . . 0.0 109.54 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 53.03 -120.92 13.76 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.06 23.07 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.647 -0.914 . . . . 0.0 109.125 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.489 ' O ' ' HB1' ' A' ' 49' ' ' ALA . 56.1 m -138.68 139.13 23.34 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.584 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 14.2 Cg_exo -49.3 -17.25 1.45 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.004 1.803 . . . . 0.0 110.606 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.47 ' O ' HG11 ' A' ' 51' ' ' VAL . 2.4 mt-10 -77.89 -83.14 0.08 Allowed 'General case' 0 C--O 1.203 -1.352 0 O-C-N 120.934 -1.104 . . . . 0.0 108.557 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 36.9 mt-30 -45.67 -33.62 3.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.502 -1.374 . . . . 0.0 109.54 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.642 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -65.2 -63.34 1.13 Allowed 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.452 -0.78 . . . . 0.0 110.24 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.575 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 2.4 p -68.82 -48.99 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.912 -1.118 . . . . 0.0 110.607 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.575 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 2.3 p -54.63 -44.06 68.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 121.371 0.605 . . . . 0.0 110.295 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.551 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 18.7 mmt180 -74.87 -34.49 62.26 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.642 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 20.8 mm-40 -71.21 -13.39 61.9 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.601 ' HB3' ' CZ2' ' A' ' 95' ' ' TRP . 1.1 mm? -79.34 -64.31 1.22 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.499 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.12 -51.49 69.1 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.54 -0.725 . . . . 0.0 110.187 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.576 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 1.3 pp20? -50.18 -21.08 1.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.052 -1.03 . . . . 0.0 110.479 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -80.14 -92.22 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.918 -1.114 . . . . 0.0 110.038 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.625 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 21.0 t -79.98 -79.17 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.426 -0.796 . . . . 0.0 109.678 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.54 22.72 0.1 Allowed Glycine 0 N--CA 1.495 2.605 0 C-N-CA 118.485 -1.817 . . . . 0.0 112.554 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.642 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.6 pp -82.93 -166.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.283 -1.716 . . . . 0.0 108.031 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.593 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 2.0 m -123.36 -71.73 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.434 -1.416 . . . . 0.0 110.844 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 91' ' ' GLU . 5.7 Cg_endo -64.19 -170.82 0.13 Allowed 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.078 1.185 . . . . 0.0 109.707 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.6 ' HG2' ' CZ2' ' A' ' 95' ' ' TRP . 0.7 OUTLIER 139.54 -23.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -179.204 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.494 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 1.9 t60 57.23 -167.41 0.13 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 64' ' ' HIS . 28.3 p90 -179.38 150.83 0.45 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.414 -1.314 . . . . 0.0 110.676 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -159.35 141.89 13.9 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.609 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -65.95 -66.71 0.52 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.04 -1.037 . . . . 0.0 109.313 -179.507 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.609 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 85.38 -55.07 0.09 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.576 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 9.5 tp10 169.62 151.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.502 ' CG ' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.67 -164.53 1.89 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.847 -1.158 . . . . 0.0 109.295 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.552 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -150.96 -177.13 5.83 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.208 -0.933 . . . . 0.0 110.419 -179.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -149.51 90.78 1.75 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -78.21 108.35 11.46 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.426 ' HG3' ' NE2' ' A' ' 79' ' ' HIS . 25.0 tt0 -92.62 99.57 12.25 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.488 -0.758 . . . . 0.0 110.158 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.506 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -79.26 170.97 13.75 Favored Pre-proline 0 C--N 1.301 -1.503 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.338 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 5.5 Cg_exo -51.89 -55.02 4.31 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.872 1.715 . . . . 0.0 109.606 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.04 35.88 4.08 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -144.31 91.52 2.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.521 -0.737 . . . . 0.0 109.682 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.426 ' NE2' ' HG3' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -82.15 90.99 6.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.752 -1.218 . . . . 0.0 109.087 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.616 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.0 OUTLIER -98.84 157.28 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.005 -1.059 . . . . 0.0 110.272 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.537 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 2.2 m -136.34 170.6 15.77 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.588 ' O ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -159.5 85.8 0.79 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.601 -1.312 . . . . 0.0 110.035 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.477 ' O ' HG11 ' A' ' 8' ' ' VAL . 97.3 m95 -65.43 115.12 5.35 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.786 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.588 ' CD1' ' O ' ' A' ' 82' ' ' LEU . 10.1 m-85 -89.56 71.32 7.91 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.938 -1.101 . . . . 0.0 109.606 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.659 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 88.4 m95 -72.28 87.81 1.14 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.015 -1.053 . . . . 0.0 109.149 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 66' ' ' SER . 3.0 mm? -68.39 130.16 42.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.755 -1.216 . . . . 0.0 110.121 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.551 ' O ' ' CG ' ' A' ' 88' ' ' GLU . 0.8 OUTLIER -117.61 176.89 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.551 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 23.4 mt-10 -159.76 28.88 0.19 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.386 -1.446 . . . . 0.0 112.944 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.595 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -159.62 57.98 0.38 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 119.878 -1.764 . . . . 0.0 111.721 178.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.588 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 2.4 p90 -79.15 162.37 25.83 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.222 -1.549 . . . . 0.0 109.267 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.608 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -92.94 145.86 24.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.999 -1.063 . . . . 0.0 109.583 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 39.29 -87.51 0.01 OUTLIER Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 91' ' ' GLU . 2.8 pt-20 -105.34 157.04 35.3 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.235 -1.156 . . . . 0.0 109.868 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.594 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 10.6 Cg_endo -75.59 -159.07 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.93 2.42 . . . . 0.0 110.263 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.642 ' CD2' HG13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -179.56 66.16 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.291 -0.881 . . . . 0.0 110.36 178.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . -139.07 -33.71 0.17 Allowed Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.367 -1.397 . . . . 0.0 110.688 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.569 ' HG3' ' CE2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -39.62 106.79 0.06 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.129 -1.218 . . . . 0.0 110.496 -179.063 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.489 ' OE1' ' HA2' ' A' ' 38' ' ' GLY . 8.0 tp10 -80.43 100.59 8.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.265 -0.897 . . . . 0.0 109.139 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 54.12 21.96 19.66 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.556 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 7.8 pt20 -122.75 170.82 7.41 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.497 -1.002 . . . . 0.0 108.868 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.556 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 4.2 Cg_exo -63.14 -46.14 10.87 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.0 1.8 . . . . 0.0 110.785 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.58 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 59.69 112.81 0.01 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.631 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 5.2 pt-20 -152.76 137.25 16.76 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.136 -1.214 . . . . 0.0 110.493 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.499 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 1.7 m-90 -48.64 135.7 14.32 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.581 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -125.85 115.65 20.32 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.197 -0.939 . . . . 0.0 109.521 -179.055 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.466 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -82.54 57.81 3.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 110.015 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.587 ' CD2' ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -80.69 -41.28 23.95 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.168 -0.958 . . . . 0.0 108.417 179.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.546 ' N ' HD21 ' A' ' 107' ' ' LEU . 86.4 t 70.13 126.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.854 -0.529 . . . . 0.0 109.938 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 41.18 81.43 0.03 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.662 HD23 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -42.79 166.7 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.487 -1.008 . . . . 0.0 110.545 -178.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.538 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -143.9 -7.34 0.74 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.325 -0.859 . . . . 0.0 111.846 -178.463 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.585 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . . . 81.02 -31.53 0.11 Allowed 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.91 -1.119 . . . . 0.0 109.024 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -58.3 -16.83 15.74 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.453 -0.779 . . . . 0.0 109.099 179.311 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 33' ' ' LEU . 2.0 m-20 -111.67 -12.86 13.84 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.599 -0.688 . . . . 0.0 109.919 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.715 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 7.5 m-85 -100.7 148.77 35.47 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.905 . . . . 0.0 109.808 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.58 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 3.5 Cg_exo -64.04 142.1 79.73 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.642 2.228 . . . . 0.0 110.547 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.9 -19.97 70.2 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.04 1.826 . . . . 0.0 110.08 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -45.92 -51.02 13.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 109.25 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.52 ' CB ' HD13 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -94.85 54.68 1.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.618 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.4 mt-10 -64.8 -45.71 75.2 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 2.8 Cg_exo -54.84 -35.38 88.46 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.907 1.738 . . . . 0.0 112.92 -177.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.519 HG13 ' CE2' ' A' ' 84' ' ' PHE . 2.1 t -100.34 -31.94 3.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.579 -1.325 . . . . 0.0 109.243 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.585 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -61.7 -26.99 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.514 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -55.77 -37.63 68.8 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 125' ' ' LYS . 29.1 mmtm -78.09 -35.86 48.79 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.861 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.599 HD13 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -66.6 -21.71 66.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.45 -1.406 . . . . 0.0 107.334 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.539 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 7.2 mtmt -57.69 -35.21 70.3 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 177.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 125' ' ' LYS . 4.2 mtp180 -82.34 -22.97 35.32 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.429 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 1.3 tp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.473 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.551 ' HG2' ' N ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.695 0.76 . . . . 0.0 109.938 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.566 ' CD1' ' C ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -138.25 125.94 22.25 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.54 ' N ' HD21 ' A' ' 4' ' ' LEU . 0.9 OUTLIER -96.25 164.52 12.63 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.313 -1.492 . . . . 0.0 110.091 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.524 ' CG2' ' HG ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -131.2 117.82 38.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.495 -0.753 . . . . 0.0 109.046 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -86.61 63.17 7.83 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.533 ' HB ' ' HA2' ' A' ' 37' ' ' GLY . 1.3 p -78.42 -72.43 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 109.735 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.63 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 57.38 87.65 0.02 OUTLIER Glycine 0 N--CA 1.479 1.528 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.531 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -47.77 168.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.238 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.557 ' CG2' ' CG2' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -131.04 94.62 2.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 O-C-N 121.181 -0.949 . . . . 0.0 109.33 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.575 ' HG2' ' CG2' ' A' ' 18' ' ' ILE . 13.9 mtm180 -75.82 177.36 6.99 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.577 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -151.44 -60.98 0.17 Allowed 'General case' 0 C--O 1.191 -1.977 0 C-N-CA 116.783 -1.967 . . . . 0.0 114.367 -176.296 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.485 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -92.32 -29.65 16.25 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 119.204 -2.185 . . . . 0.0 111.091 -176.124 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -162.16 -43.04 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.528 ' ND2' ' HD2' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -157.43 34.02 0.28 Allowed 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.359 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 105' ' ' MET . 17.1 mt-10 -82.01 87.36 6.45 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 118.005 -1.478 . . . . 0.0 108.88 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.575 ' CG2' ' HG2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -80.0 147.96 6.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.395 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.639 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 7.8 t80 -81.68 45.05 0.86 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.524 HG13 ' N ' ' A' ' 21' ' ' THR . 6.6 tp -79.0 151.78 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-O 122.437 1.113 . . . . 0.0 111.575 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.565 ' CG2' ' NE2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -68.86 84.47 0.31 Allowed 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.438 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.492 ' O ' ' C ' ' A' ' 23' ' ' ARG . 18.2 tpt180 -79.24 84.98 5.13 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.016 -1.053 . . . . 0.0 109.822 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.492 ' C ' ' O ' ' A' ' 22' ' ' ARG . 1.5 ptt180 31.94 62.9 0.27 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.275 0.56 . . . . 0.0 110.319 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -41.92 -41.8 2.57 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.691 -0.631 . . . . 0.0 109.354 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' A' ' 23' ' ' ARG . . . -80.57 -179.96 7.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 109.195 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 26' ' ' ASP . 3.6 p30 -78.79 112.86 16.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 109.328 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 23' ' ' ARG . . . -112.27 -30.18 7.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 109.841 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 49.65 28.38 2.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.011 -1.055 . . . . 0.0 108.448 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.587 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 30.8 mmm -140.03 -100.01 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.392 -0.818 . . . . 0.0 109.976 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.587 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 152.13 -169.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER 78.84 -8.78 1.6 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.158 -0.964 . . . . 0.0 109.03 -179.312 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.488 ' HG2' ' HA ' ' A' ' 23' ' ' ARG . 5.2 tptt -83.4 55.93 3.37 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.671 -0.643 . . . . 0.0 109.857 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.652 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 7.1 mt -120.04 93.09 3.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.288 -0.882 . . . . 0.0 108.779 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.551 ' O ' ' CG ' ' A' ' 35' ' ' PHE . 3.0 tt0 -88.56 -126.76 0.06 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.876 -1.14 . . . . 0.0 110.786 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.551 ' CG ' ' O ' ' A' ' 34' ' ' GLU . 98.9 m-85 -160.07 128.72 3.01 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.756 -1.215 . . . . 0.0 110.247 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.528 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 3.7 Cg_endo -64.79 97.28 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.113 1.875 . . . . 0.0 109.727 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.543 ' CA ' ' HB2' ' A' ' 98' ' ' GLU . . . -55.51 -153.15 0.01 OUTLIER Glycine 0 N--CA 1.492 2.405 0 O-C-N 121.298 -0.876 . . . . 0.0 111.013 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 163.86 -33.67 0.28 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.521 ' CD ' HD23 ' A' ' 4' ' ' LEU . 10.4 tptm 65.85 101.28 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.95 -0.735 . . . . 0.0 110.253 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.585 HG22 ' CD1' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -80.42 135.44 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.039 -1.038 . . . . 0.0 108.693 178.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.525 ' HG3' ' N ' ' A' ' 42' ' ' MET . 6.9 pt-20 -171.12 -31.99 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.422 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.525 ' N ' ' HG3' ' A' ' 41' ' ' GLU . 1.7 mtt -62.08 151.89 34.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.065 -1.022 . . . . 0.0 109.842 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.98 -127.54 43.14 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.35 21.05 0.1 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.443 -1.034 . . . . 0.0 109.209 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.519 HG21 ' HD2' ' A' ' 46' ' ' PRO . 1.8 m -147.01 140.78 15.27 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.593 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 11.0 Cg_exo -45.24 -18.6 0.28 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.067 1.845 . . . . 0.0 111.268 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.488 ' HB2' HG23 ' A' ' 45' ' ' THR . 0.5 OUTLIER -76.87 -80.18 0.1 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.507 -1.37 . . . . 0.0 108.879 178.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.58 ' O ' ' CG ' ' A' ' 52' ' ' ARG . 60.0 mt-30 -48.58 -33.45 9.75 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.087 -1.633 . . . . 0.0 109.207 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.597 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -64.31 -63.6 1.1 Allowed 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.193 -0.942 . . . . 0.0 110.29 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 1.7 p -68.7 -48.87 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.142 -0.974 . . . . 0.0 110.57 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.572 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 2.9 p -56.03 -39.0 55.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-O 121.189 0.519 . . . . 0.0 110.357 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.58 ' CG ' ' O ' ' A' ' 48' ' ' GLN . 18.3 mmt180 -78.65 -32.99 47.47 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.597 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 24.3 mm-40 -71.89 -12.84 61.46 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.581 HD11 ' CD2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -80.09 -55.34 5.01 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.645 0.736 . . . . 0.0 109.331 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.432 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -69.38 -33.92 73.76 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.691 -0.631 . . . . 0.0 111.173 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.586 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -64.26 -25.8 68.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.821 -1.175 . . . . 0.0 111.385 -177.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.539 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -80.34 -80.8 0.13 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.499 -1.375 . . . . 0.0 109.887 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.553 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 69.9 t -80.17 -82.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.145 -0.972 . . . . 0.0 109.463 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.95 21.66 0.12 Allowed Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.632 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.645 ' CG1' ' CD2' ' A' ' 95' ' ' TRP . 1.1 pt -80.17 -144.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.496 -1.591 . . . . 0.0 108.395 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.588 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 2.1 m -151.36 -71.46 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 120.474 -1.392 . . . . 0.0 110.965 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.588 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 1.0 OUTLIER -60.4 -173.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.934 0 C-N-CA 121.082 1.188 . . . . 0.0 109.918 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 1.5 pt20 152.04 -23.55 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.596 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER 47.35 61.64 2.8 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.336 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.43 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 5.1 p90 -60.78 155.43 19.4 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.886 0.851 . . . . 0.0 110.735 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -152.51 139.24 18.85 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.169 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.585 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -66.31 -67.15 0.47 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.854 -1.154 . . . . 0.0 109.814 -179.048 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.603 ' CZ ' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER 81.75 -48.94 0.23 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.281 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER 164.42 176.54 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.093 -1.004 . . . . 0.0 108.412 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.542 ' HE3' ' CE3' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -161.58 175.04 12.51 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.948 -1.095 . . . . 0.0 110.161 -179.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.55 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -136.73 -179.12 5.5 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.387 -0.821 . . . . 0.0 109.758 179.402 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -154.75 90.23 1.29 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.09 162.77 22.41 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.447 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 4.0 mt-10 -118.0 161.08 20.39 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.551 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.608 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -128.98 179.48 1.28 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.608 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 6.9 Cg_exo -52.69 -24.05 21.97 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.522 1.481 . . . . 0.0 109.787 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.426 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 2.2 p30 -171.13 32.55 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.489 ' NH2' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -141.28 93.74 2.61 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.705 -0.622 . . . . 0.0 110.151 -178.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.447 ' CD2' ' HG3' ' A' ' 74' ' ' GLU . 8.9 t-160 -79.1 93.08 5.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.037 -1.039 . . . . 0.0 108.384 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.496 ' CG2' HD11 ' A' ' 4' ' ' LEU . 13.3 mm -83.95 157.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.263 1.03 . . . . 0.0 111.486 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.479 HG23 ' NZ ' ' A' ' 70' ' ' LYS . 2.4 m -131.0 155.27 47.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.524 ' HG ' ' CG2' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -141.83 83.92 1.87 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.495 -1.378 . . . . 0.0 110.72 -179.106 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.585 ' CD1' HG22 ' A' ' 40' ' ' ILE . 72.5 m95 -55.74 109.54 0.58 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.939 -1.101 . . . . 0.0 109.162 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.617 ' CD1' HG23 ' A' ' 122' ' ' VAL . 35.7 m-85 -86.79 75.04 9.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.02 -1.05 . . . . 0.0 109.72 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.63 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 83.9 m95 -79.41 89.39 5.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.051 -1.031 . . . . 0.0 109.456 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.56 HD21 ' CD2' ' A' ' 68' ' ' PHE . 3.3 mm? -68.78 132.38 46.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.843 -1.161 . . . . 0.0 109.831 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.557 ' CG2' ' CG2' ' A' ' 11' ' ' ILE . 0.7 OUTLIER -120.54 170.4 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.603 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.478 ' HG2' ' HB2' ' A' ' 12' ' ' ARG . 37.4 mt-10 -154.33 23.11 0.48 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.201 -1.562 . . . . 0.0 113.453 -178.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.596 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -160.24 55.76 0.34 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 119.832 -1.793 . . . . 0.0 111.138 178.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.629 ' CZ2' ' CD1' ' A' ' 104' ' ' TRP . 4.8 p90 -73.99 157.89 35.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.929 -1.107 . . . . 0.0 109.456 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.618 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -79.88 142.54 35.11 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.136 -0.977 . . . . 0.0 109.559 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 29.89 -82.38 0.0 OUTLIER Glycine 0 N--CA 1.5 2.907 0 O-C-N 121.985 -0.447 . . . . 0.0 112.1 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.618 ' N ' ' O ' ' A' ' 91' ' ' GLU . 2.9 mm-40 -93.74 157.12 38.75 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.216 -1.167 . . . . 0.0 110.74 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.627 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 29.4 Cg_endo -82.52 -157.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.622 2.215 . . . . 0.0 109.805 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.645 ' CD2' ' CG1' ' A' ' 60' ' ' ILE . 0.3 OUTLIER 172.63 114.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.454 0.645 . . . . 0.0 109.881 178.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . 165.2 -36.37 0.27 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.543 ' N ' ' HD3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -39.5 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.667 -0.902 . . . . 0.0 110.789 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.543 ' HB2' ' CA ' ' A' ' 37' ' ' GLY . 3.1 tp10 -68.22 96.3 0.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.014 -1.054 . . . . 0.0 108.423 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.26 46.39 57.14 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.565 ' NE2' ' CG2' ' A' ' 21' ' ' THR . 0.0 OUTLIER -144.5 163.58 33.3 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.552 ' HD2' ' HG3' ' A' ' 100' ' ' GLN . 1.2 Cg_endo -64.1 -51.91 1.92 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 121.402 1.402 . . . . 0.0 109.796 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.639 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 59.25 113.35 0.01 OUTLIER Glycine 0 N--CA 1.479 1.519 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.586 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 12.4 pt-20 -150.33 131.78 14.73 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.211 -1.17 . . . . 0.0 109.858 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.629 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -47.25 133.69 11.89 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.555 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -124.75 121.84 35.75 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 109.614 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.2 t -81.13 63.2 5.39 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.607 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -80.24 -47.75 14.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.346 -0.847 . . . . 0.0 108.971 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 40.7 t 82.2 119.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.841 -0.537 . . . . 0.0 110.081 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 108' ' ' VAL . . . 36.51 82.67 0.01 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.671 HD22 ' CD1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -40.98 164.84 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.625 -0.927 . . . . 0.0 110.67 -178.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.526 ' O ' ' HB2' ' A' ' 112' ' ' ALA . 1.7 t-20 -142.88 -5.19 0.91 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 111.621 -178.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.609 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . . . 77.37 -6.38 2.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.998 -1.064 . . . . 0.0 108.51 -177.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 -18.18 50.94 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.532 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -109.61 -11.15 14.8 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.329 0.585 . . . . 0.0 109.562 -179.454 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.671 ' CD1' HD22 ' A' ' 110' ' ' LEU . 15.7 m-85 -103.76 149.77 37.48 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.905 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.565 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 2.1 Cg_endo -63.8 145.48 90.76 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.718 2.278 . . . . 0.0 110.651 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.481 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 1.3 Cg_endo -66.14 -27.5 49.14 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.27 1.98 . . . . 0.0 110.399 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -43.21 -54.25 4.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.049 -1.032 . . . . 0.0 109.621 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.473 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 7.5 m-80 -90.08 50.46 1.87 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.655 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 5.4 mt-10 -67.54 -37.85 13.71 Favored Pre-proline 0 C--N 1.3 -1.576 0 O-C-N 121.682 -0.636 . . . . 0.0 112.268 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.655 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.2 Cg_exo -55.36 -37.22 94.82 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.392 1.395 . . . . 0.0 112.035 -178.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.617 HG23 ' CD1' ' A' ' 84' ' ' PHE . 2.2 t -99.76 -34.41 4.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.69 -1.257 . . . . 0.0 109.046 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.609 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -60.68 -22.7 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.556 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.555 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -60.7 -36.85 79.82 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.079 0.943 . . . . 0.0 108.501 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.55 -38.92 47.59 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.737 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.603 HD13 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -64.17 -23.07 67.18 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.564 ' CD ' ' HB1' ' A' ' 112' ' ' ALA . 12.7 mtmt -54.96 -38.65 68.02 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.438 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -80.24 -24.43 40.16 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.686 179.233 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.595 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 2.0 tp . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.936 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.459 ' C ' ' HD2' ' A' ' 3' ' ' LYS . 4.0 tmmm? . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.579 HD12 ' CG2' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -148.66 132.74 17.26 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.163 -0.961 . . . . 0.0 108.901 178.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.526 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 5.8 mp0 -99.44 155.88 17.32 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.379 -1.451 . . . . 0.0 109.069 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.536 ' CG2' ' HA2' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -116.97 117.16 54.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.348 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.415 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -84.41 66.19 9.3 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.569 ' CB ' ' O ' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -79.44 -77.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.168 -0.958 . . . . 0.0 110.123 -179.375 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.595 ' CA ' ' N ' ' A' ' 85' ' ' TRP . . . 63.15 93.24 0.02 OUTLIER Glycine 0 N--CA 1.484 1.852 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.547 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -52.95 162.32 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.563 HG21 ' CG1' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -128.79 92.42 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.328 -179.177 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.535 ' HG2' ' CG2' ' A' ' 18' ' ' ILE . 8.9 mtm180 -75.71 177.23 7.01 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.646 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -156.76 -61.5 0.1 Allowed 'General case' 0 C--O 1.191 -2.005 0 C-N-CA 116.069 -2.252 . . . . 0.0 114.716 -176.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.524 ' CB ' ' OE2' ' A' ' 17' ' ' GLU . 5.9 tp10 -91.7 -25.94 18.86 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 119.335 -2.103 . . . . 0.0 111.594 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -161.75 -45.53 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -160.92 35.6 0.15 Allowed 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.524 ' OE2' ' CB ' ' A' ' 14' ' ' GLU . 12.6 mt-10 -79.83 83.82 5.71 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 118.403 -1.319 . . . . 0.0 109.161 -178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.535 ' CG2' ' HG2' ' A' ' 12' ' ' ARG . 18.1 pt -79.19 141.36 15.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.22 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.587 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 13.5 t80 -81.71 45.09 0.86 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.663 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 4.4 tt -80.13 152.29 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-O 121.93 0.872 . . . . 0.0 110.863 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 101' ' ' PRO . 0.6 OUTLIER -69.88 95.34 0.91 Allowed 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.507 ' O ' ' C ' ' A' ' 23' ' ' ARG . 13.2 tpt180 -99.09 90.37 4.58 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.641 -0.662 . . . . 0.0 111.072 -178.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.508 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 32.41 83.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.898 -0.501 . . . . 0.0 110.177 178.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.44 -46.53 4.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.224 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.84 176.43 9.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.432 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -77.47 105.28 8.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.121 -0.987 . . . . 0.0 109.427 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.508 ' CB ' ' HD2' ' A' ' 23' ' ' ARG . . . -104.14 133.8 48.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.12 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -82.25 4.23 24.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 0.0 109.059 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.528 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -102.55 -126.69 0.21 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.603 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 163.62 -4.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.978 -1.076 . . . . 0.0 111.729 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 114' ' ' ASP . 2.9 p-10 -79.24 8.68 5.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.27 -1.519 . . . . 0.0 109.136 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.472 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -81.5 61.34 4.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.588 -0.695 . . . . 0.0 110.105 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.607 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 7.6 mt -123.66 93.11 3.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.868 -1.145 . . . . 0.0 109.291 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.533 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.72 -145.97 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.465 -0.772 . . . . 0.0 109.003 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.497 ' CZ ' ' CG ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -142.53 128.35 10.52 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.745 -1.222 . . . . 0.0 109.49 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.569 ' O ' ' CB ' ' A' ' 8' ' ' VAL . 3.0 Cg_endo -60.05 97.09 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.004 1.803 . . . . 0.0 109.53 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.536 ' HA2' ' CG2' ' A' ' 6' ' ' ILE . . . -54.13 -141.95 0.0 OUTLIER Glycine 0 N--CA 1.496 2.677 0 O-C-N 121.531 -0.73 . . . . 0.0 111.589 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 153.59 -34.78 0.75 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 5.0 tptm 69.15 95.53 0.07 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.039 -0.683 . . . . 0.0 110.465 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.601 HG12 ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.66 135.71 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.204 -0.935 . . . . 0.0 108.833 178.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -170.28 -34.23 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.353 -0.842 . . . . 0.0 109.756 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.415 ' O ' ' C ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -49.35 156.47 0.6 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.243 -0.911 . . . . 0.0 109.514 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' MET . . . 44.23 -122.44 4.46 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.78 21.27 0.09 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.406 -1.055 . . . . 0.0 109.484 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.533 HG21 ' HD2' ' A' ' 46' ' ' PRO . 98.0 m -135.18 141.9 39.72 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.22 -0.925 . . . . 0.0 108.907 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.533 ' HD2' HG21 ' A' ' 45' ' ' THR . 11.2 Cg_exo -50.37 -16.9 2.29 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.573 1.516 . . . . 0.0 110.205 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.493 ' O ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -76.99 -84.08 0.07 Allowed 'General case' 0 C--O 1.202 -1.43 0 O-C-N 121.181 -0.949 . . . . 0.0 108.768 178.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.572 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -45.14 -35.91 3.43 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.484 -1.385 . . . . 0.0 109.747 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.635 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -64.23 -60.67 2.92 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.299 -0.875 . . . . 0.0 110.387 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.565 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 1.8 p -70.32 -48.82 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.897 -1.127 . . . . 0.0 110.548 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.565 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 4.1 p -56.7 -37.41 52.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.823 -0.548 . . . . 0.0 110.575 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 2.9 mmt180 -79.17 -39.73 32.69 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.635 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 19.9 mm-40 -65.98 -15.66 63.2 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.674 ' HB3' ' CZ2' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -80.26 -39.29 29.23 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.752 0.787 . . . . 0.0 109.961 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.61 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 1.8 mt-30 -79.2 -52.55 8.0 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.624 0.726 . . . . 0.0 109.192 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.602 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -44.65 -23.9 0.16 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.644 -0.66 . . . . 0.0 110.097 -179.58 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 3.9 mm-40 -80.16 -95.84 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.864 -1.148 . . . . 0.0 109.516 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.656 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 57.6 t -80.38 -78.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.07 -1.019 . . . . 0.0 109.809 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.64 37.54 0.11 Allowed Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.434 -1.365 . . . . 0.0 111.653 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.677 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -91.56 -147.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.506 -1.585 . . . . 0.0 108.689 178.64 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.5 m -162.73 -64.03 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 120.439 -1.413 . . . . 0.0 112.985 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.55 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 1.8 Cg_endo -56.66 -2.63 0.47 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 122.53 2.153 . . . . 0.0 113.963 -177.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.603 ' HG2' ' CZ2' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -40.24 -26.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.789 -1.194 . . . . 0.0 109.917 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.57 ' N ' ' HG3' ' A' ' 63' ' ' GLN . 0.4 OUTLIER 57.4 -170.16 0.1 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -178.255 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -179.34 158.85 0.89 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.521 -1.362 . . . . 0.0 111.683 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -156.84 147.84 21.91 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.749 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.597 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -70.07 -67.44 0.49 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.888 -1.133 . . . . 0.0 109.655 -179.202 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.597 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 82.31 -52.4 0.22 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.586 ' CB ' ' O ' ' A' ' 68' ' ' PHE . 2.2 mm-40 150.56 133.36 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.798 -0.564 . . . . 0.0 109.819 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.511 ' HG3' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -122.64 -162.74 1.03 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.148 -0.97 . . . . 0.0 109.336 179.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.529 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -145.62 175.79 10.1 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.372 -0.83 . . . . 0.0 109.871 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -148.27 83.26 1.49 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.32 126.23 34.18 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.61 160.69 14.67 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.544 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 3.1 m-85 -128.75 170.02 11.62 Favored Pre-proline 0 C--N 1.296 -1.747 0 O-C-N 121.182 -0.948 . . . . 0.0 109.29 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.2 Cg_exo -48.83 -23.23 5.54 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.083 1.855 . . . . 0.0 109.694 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.0 42.29 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.472 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -153.39 90.0 1.39 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.787 -0.571 . . . . 0.0 109.563 -178.37 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.482 ' C ' ' CD1' ' A' ' 80' ' ' ILE . 7.0 t-160 -80.31 100.28 8.31 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.579 ' CG2' HD12 ' A' ' 4' ' ' LEU . 1.2 mm -115.89 144.41 23.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 118.809 -1.156 . . . . 0.0 112.138 -178.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.526 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 1.6 m -119.3 166.24 13.26 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.434 ' HG ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -151.73 76.24 1.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.761 -1.212 . . . . 0.0 110.069 179.81 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.593 ' CD1' HG22 ' A' ' 40' ' ' ILE . 75.6 m95 -51.68 128.37 23.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.123 -0.986 . . . . 0.0 109.142 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.599 ' CD2' HG12 ' A' ' 122' ' ' VAL . 23.5 m-85 -103.62 76.35 1.39 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.039 -1.038 . . . . 0.0 109.782 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.595 ' N ' ' CA ' ' A' ' 9' ' ' GLY . 40.8 m95 -78.39 91.66 4.5 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.997 -1.064 . . . . 0.0 109.209 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.547 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 1.6 mm? -71.8 131.76 43.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.955 -1.091 . . . . 0.0 109.882 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.563 ' CG1' HG21 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -117.67 -178.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 87' ' ' VAL . 43.5 mt-10 -158.07 2.45 0.11 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.139 -1.601 . . . . 0.0 113.397 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.596 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -151.45 68.61 0.92 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 119.623 -1.923 . . . . 0.0 111.723 -179.62 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.692 ' CZ2' ' CD1' ' A' ' 104' ' ' TRP . 9.6 p90 -80.57 167.91 19.53 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.467 -1.395 . . . . 0.0 109.38 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.546 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -92.41 144.15 25.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.137 -0.977 . . . . 0.0 109.435 179.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 40.08 -91.03 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.577 ' O ' ' CG2' ' A' ' 60' ' ' ILE . 13.6 pt-20 -107.07 161.65 22.23 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.214 -1.168 . . . . 0.0 109.77 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.583 ' HG3' ' CD1' ' A' ' 19' ' ' PHE . 9.8 Cg_endo -75.77 -155.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.563 2.175 . . . . 0.0 109.93 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.677 ' CD2' HG13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER 178.96 46.59 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.425 -0.797 . . . . 0.0 109.83 179.277 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -128.1 -20.86 1.58 Allowed Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.751 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.581 ' O ' ' HG2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -49.92 104.04 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.871 -1.37 . . . . 0.0 109.618 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.479 ' HB2' ' C ' ' A' ' 37' ' ' GLY . 9.0 tp10 -82.81 94.29 7.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.9 -1.125 . . . . 0.0 109.244 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.98 13.54 34.38 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.491 ' CG ' ' HB2' ' A' ' 97' ' ' LYS . 1.8 pt20 -114.92 162.74 22.32 Favored Pre-proline 0 N--CA 1.487 1.383 0 O-C-N 121.345 -1.091 . . . . 0.0 108.683 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 102' ' ' GLY . 6.0 Cg_exo -60.32 -44.11 30.27 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.815 1.677 . . . . 0.0 109.728 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.587 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 56.27 112.75 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 3.7 pt-20 -147.24 132.31 18.26 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.8 -1.412 . . . . 0.0 111.068 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.692 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 2.4 m0 -47.8 126.02 9.66 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.5 ' HE1' ' HB2' ' A' ' 22' ' ' ARG . 7.7 tpp -123.31 105.57 9.96 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.347 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.29 81.39 0.74 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.647 ' O ' ' CB ' ' A' ' 108' ' ' VAL . 6.2 tt -80.99 -80.04 0.15 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.471 -0.768 . . . . 0.0 110.614 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.647 ' CB ' ' O ' ' A' ' 107' ' ' LEU . 54.5 t 115.49 103.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.504 ' CA ' ' OXT' ' A' ' 129' ' ' LEU . . . 41.94 78.77 0.06 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.594 -1.803 . . . . 0.0 108.594 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.598 HD22 ' CD1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -39.54 163.66 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.617 -0.931 . . . . 0.0 110.989 -178.639 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 1.5 t-20 -139.68 -8.28 1.25 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.406 -0.809 . . . . 0.0 111.412 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.583 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . . . 83.66 -25.38 0.14 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.301 -0.875 . . . . 0.0 108.713 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.12 -29.69 61.05 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.541 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 9.7 m-20 -94.22 -19.22 20.94 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.663 ' CZ ' ' CD1' ' A' ' 20' ' ' ILE . 6.5 m-85 -95.82 148.05 33.95 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.325 -0.859 . . . . 0.0 109.908 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.488 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.4 Cg_endo -68.0 142.52 56.9 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.409 2.073 . . . . 0.0 110.061 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 118' ' ' ALA . 2.4 Cg_endo -63.04 -27.97 74.25 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.157 1.905 . . . . 0.0 110.476 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -41.43 -48.56 3.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.414 -0.804 . . . . 0.0 109.383 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.497 ' CG ' ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -96.33 55.17 1.46 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.632 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -62.75 -42.33 77.8 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.764 -0.585 . . . . 0.0 112.027 -179.59 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 11.6 Cg_exo -54.02 -47.94 24.33 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 121.846 1.698 . . . . 0.0 112.615 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.599 HG12 ' CD2' ' A' ' 84' ' ' PHE . 1.5 t -88.64 -38.02 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.704 -1.248 . . . . 0.0 109.62 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.583 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 1.1 mp -63.1 -21.0 27.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.535 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -63.64 -31.06 72.12 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -80.32 -40.34 26.92 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.519 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.584 ' CD1' ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -65.09 -21.09 66.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.682 -1.261 . . . . 0.0 107.755 179.366 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.549 ' CD ' ' HB1' ' A' ' 112' ' ' ALA . 1.9 mtmt -58.1 -36.5 72.98 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -83.23 -20.53 34.4 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.503 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 1.2 tp . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.627 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.474 ' CG ' ' N ' ' A' ' 4' ' ' LEU . 8.6 ttpt . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 121.632 0.73 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.49 ' CD1' ' C ' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -159.0 110.0 2.07 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.526 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 2.5 mp0 -104.7 169.53 8.4 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.015 -1.053 . . . . 0.0 109.427 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.458 HG21 HG13 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -135.23 122.87 37.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.437 -0.79 . . . . 0.0 108.984 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . . . -86.2 62.16 7.27 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -79.15 -77.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.717 -179.514 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.627 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 62.99 89.07 0.03 OUTLIER Glycine 0 N--CA 1.48 1.567 0 N-CA-C 106.956 -2.458 . . . . 0.0 106.956 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.616 ' CG2' ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -55.13 163.93 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.556 ' CG2' ' CG2' ' A' ' 87' ' ' VAL . 2.0 pt -127.42 71.46 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.301 -177.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.592 ' NH1' ' CD2' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -77.99 159.78 28.58 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.266 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.07 -18.61 0.04 OUTLIER 'General case' 0 C--O 1.187 -2.19 0 C-N-CA 115.81 -2.356 . . . . 0.0 115.479 -177.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.513 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 1.4 tm-20 -93.48 -31.67 14.49 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 118.165 -2.834 . . . . 0.0 108.646 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -163.13 -46.51 0.03 OUTLIER 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.485 ' ND2' ' HD2' ' A' ' 12' ' ' ARG . 1.1 t-20 -162.05 37.87 0.12 Allowed 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 176.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 105' ' ' MET . 92.3 mt-10 -91.6 94.29 9.34 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 118.003 -1.479 . . . . 0.0 110.831 -177.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.616 ' CD1' ' CG2' ' A' ' 10' ' ' ILE . 0.6 OUTLIER -96.99 152.36 3.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.544 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.608 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 13.6 t80 -80.39 45.38 0.76 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.548 ' N ' HD13 ' A' ' 18' ' ' ILE . 5.7 tp -81.09 154.78 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.231 -0.918 . . . . 0.0 111.382 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.535 ' O ' ' O ' ' A' ' 32' ' ' LYS . 1.4 t -67.67 92.98 0.35 Allowed 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 23' ' ' ARG . 30.3 tpt180 -100.78 83.92 2.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.46 -0.775 . . . . 0.0 110.534 -178.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.503 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 31.69 86.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.826 -0.546 . . . . 0.0 110.129 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -44.7 -52.32 8.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.089 -1.007 . . . . 0.0 109.532 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.62 -161.04 0.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 0.0 109.11 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.76 -27.56 40.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.205 -0.934 . . . . 0.0 109.231 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.466 ' HB2' ' HD2' ' A' ' 23' ' ' ARG . . . 50.76 -175.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 109.787 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.53 25.78 0.23 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.535 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 0.7 OUTLIER -126.45 -41.69 1.86 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.367 -0.833 . . . . 0.0 110.318 -179.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 78.93 0.86 2.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 110.124 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 25.4 p-10 -92.98 9.86 33.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.829 -1.169 . . . . 0.0 108.565 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.535 ' O ' ' O ' ' A' ' 21' ' ' THR . 0.9 OUTLIER -81.22 36.43 0.41 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.565 -0.709 . . . . 0.0 110.653 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.672 ' CD1' ' CE1' ' A' ' 115' ' ' PHE . 22.3 mt -110.82 88.05 2.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.553 -1.342 . . . . 0.0 109.564 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.455 ' O ' HD12 ' A' ' 20' ' ' ILE . 1.1 tt0 -91.79 -137.38 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.457 -0.777 . . . . 0.0 109.534 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.46 ' HA ' HD12 ' A' ' 20' ' ' ILE . 90.6 m-85 -149.66 130.8 7.23 Favored Pre-proline 0 C--N 1.306 -1.299 0 O-C-N 121.072 -1.017 . . . . 0.0 109.745 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.551 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 2.1 Cg_endo -56.6 95.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.303 2.002 . . . . 0.0 109.894 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -55.69 -147.04 0.01 OUTLIER Glycine 0 N--CA 1.494 2.528 0 O-C-N 121.319 -0.863 . . . . 0.0 111.205 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 158.97 -40.29 0.5 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.554 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 13.4 tptp 73.75 94.49 0.07 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.146 -0.62 . . . . 0.0 110.596 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.594 HG12 ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.92 131.8 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 108.805 178.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 42' ' ' MET . 4.6 pt-20 -171.76 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.963 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.401 ' N ' ' HG2' ' A' ' 41' ' ' GLU . 4.9 mmt -58.7 163.84 3.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -0.913 . . . . 0.0 109.857 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 47.61 -121.73 6.99 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -167.07 24.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.528 -0.984 . . . . 0.0 108.739 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.552 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 30.4 m -146.71 142.87 17.72 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.588 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 11.1 Cg_exo -50.58 -17.22 2.75 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 121.412 1.408 . . . . 0.0 109.957 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.482 ' O ' HG11 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -75.33 -83.36 0.06 Allowed 'General case' 0 C--O 1.201 -1.483 0 O-C-N 121.081 -1.012 . . . . 0.0 108.938 178.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.519 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 32.9 mt-30 -45.52 -36.66 4.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.37 -1.456 . . . . 0.0 109.776 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.594 ' CB ' HG12 ' A' ' 40' ' ' ILE . . . -62.84 -64.99 0.75 Allowed 'General case' 0 C--N 1.289 -2.056 0 O-C-N 120.964 -1.085 . . . . 0.0 110.26 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 1.9 p -65.05 -48.93 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.048 -1.033 . . . . 0.0 111.018 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.577 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 2.9 p -55.66 -46.48 79.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-O 121.384 0.612 . . . . 0.0 110.109 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.565 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 8.0 mmt180 -72.46 -27.61 62.41 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.591 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 29.9 mm-40 -77.81 -14.18 59.66 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.544 ' HB3' ' CH2' ' A' ' 95' ' ' TRP . 0.8 OUTLIER -80.18 -58.52 3.11 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.482 ' CA ' ' CZ3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -63.16 -50.14 71.56 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.738 -0.601 . . . . 0.0 109.722 179.428 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.587 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 1.4 pp20? -53.25 -20.12 3.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.994 -1.066 . . . . 0.0 109.746 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.482 ' OE1' ' HA2' ' A' ' 96' ' ' GLY . 1.6 mt-10 -80.2 -91.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 109.861 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.588 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 41.7 t -79.96 -79.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.436 -0.79 . . . . 0.0 110.016 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.02 27.04 0.17 Allowed Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.212 -1.47 . . . . 0.0 111.448 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.592 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -81.75 -145.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.607 -1.525 . . . . 0.0 107.948 178.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.578 ' CB ' ' CD ' ' A' ' 62' ' ' PRO . 1.3 m -145.23 -70.43 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 120.512 -1.367 . . . . 0.0 109.943 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.599 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 8.8 Cg_endo -66.71 -169.42 0.18 Allowed 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 121.137 1.225 . . . . 0.0 109.636 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.599 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER 134.09 -20.27 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 -179.112 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.515 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.1 OUTLIER 52.12 -164.59 0.07 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -179.485 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -177.22 144.63 0.43 Allowed 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 117.636 -1.626 . . . . 0.0 111.046 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -145.07 143.48 30.46 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.615 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -74.61 -65.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.856 -1.152 . . . . 0.0 110.216 -178.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.615 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 81.89 -50.74 0.24 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.538 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER 164.15 179.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.135 -0.978 . . . . 0.0 109.595 179.306 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.18 142.82 13.37 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.313 -0.867 . . . . 0.0 109.109 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.541 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -96.93 -171.71 2.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.997 -1.064 . . . . 0.0 109.789 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.407 ' HG3' HG22 ' A' ' 81' ' ' THR . 5.3 tt0 -160.24 95.48 1.14 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.5 123.15 27.29 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.412 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 2.1 tt0 -96.87 143.23 27.96 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.537 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.558 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 5.5 m-85 -119.39 169.76 7.74 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 7.6 Cg_exo -49.26 -31.86 23.58 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.441 1.427 . . . . 0.0 109.307 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -160.72 41.04 0.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.212 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.521 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -146.16 95.76 2.67 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.597 -0.689 . . . . 0.0 109.956 -178.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.436 ' C ' HD13 ' A' ' 80' ' ' ILE . 14.6 m80 -82.64 113.02 20.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.015 -1.053 . . . . 0.0 108.781 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.3 mp -110.87 165.09 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -0.987 . . . . 0.0 110.161 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.559 ' N ' ' CG2' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -153.52 149.37 27.62 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.511 ' O ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -137.0 77.47 1.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.903 -1.123 . . . . 0.0 109.909 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.579 ' CD1' HG22 ' A' ' 40' ' ' ILE . 81.8 m95 -46.71 116.34 1.3 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.183 -0.948 . . . . 0.0 109.658 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.582 ' CE2' HG12 ' A' ' 122' ' ' VAL . 26.0 m-85 -92.37 71.21 5.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.155 -0.966 . . . . 0.0 109.931 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.627 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 30.9 m95 -75.14 91.8 2.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.843 -1.161 . . . . 0.0 109.06 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 66' ' ' SER . 3.3 mm? -73.02 127.29 32.14 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.774 -1.204 . . . . 0.0 110.281 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.556 ' CG2' ' CG2' ' A' ' 11' ' ' ILE . 0.8 OUTLIER -115.7 172.79 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 43.8 mt-10 -157.48 32.68 0.27 Allowed 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 117.835 -1.546 . . . . 0.0 113.392 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.593 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.21 55.94 0.35 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 119.872 -1.767 . . . . 0.0 111.154 178.251 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.539 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 5.1 p90 -78.94 159.09 27.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.19 -1.569 . . . . 0.0 109.488 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -88.43 138.21 31.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 32.79 -79.72 0.0 OUTLIER Glycine 0 N--CA 1.501 3.025 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.664 ' N ' ' O ' ' A' ' 91' ' ' GLU . 2.8 mm-40 -94.49 144.79 28.53 Favored Pre-proline 0 C--N 1.303 -1.424 0 O-C-N 121.164 -1.198 . . . . 0.0 109.645 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.573 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 14.0 Cg_endo -79.58 -161.62 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.18 1.92 . . . . 0.0 109.651 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.657 ' CD1' ' O ' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -176.21 116.72 0.13 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.016 0.912 . . . . 0.0 109.946 177.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.482 ' HA2' ' OE1' ' A' ' 57' ' ' GLU . . . 167.61 -34.59 0.21 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.562 ' CA ' ' HG2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -39.57 100.51 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.539 -0.977 . . . . 0.0 109.849 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.486 ' OE1' ' HA2' ' A' ' 38' ' ' GLY . 18.2 tp10 -80.15 105.48 11.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.311 -0.868 . . . . 0.0 108.822 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 50.53 30.77 20.46 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.562 ' HG2' ' CA ' ' A' ' 97' ' ' LYS . 1.7 pt20 -134.26 165.26 38.05 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.544 -0.974 . . . . 0.0 109.337 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 3.5 Cg_exo -63.47 -45.61 11.28 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.206 1.938 . . . . 0.0 110.484 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.608 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.59 114.42 0.01 OUTLIER Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.607 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 1.8 pt-20 -152.25 134.16 14.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.086 -1.243 . . . . 0.0 110.079 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.522 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 1.7 m-90 -46.15 134.45 8.45 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.609 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -125.97 116.15 21.03 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.135 -0.978 . . . . 0.0 109.031 -179.04 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.528 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -79.52 43.69 0.57 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.428 -0.795 . . . . 0.0 110.858 -178.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.584 ' CD2' ' HA ' ' A' ' 110' ' ' LEU . 9.4 tt -67.01 161.9 23.29 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.511 ' N ' HD21 ' A' ' 107' ' ' LEU . 24.5 t -118.78 114.69 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.048 -1.033 . . . . 0.0 108.935 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 43.18 84.45 0.01 OUTLIER Glycine 0 N--CA 1.493 2.436 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.646 HD23 ' CZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -35.55 157.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.764 0.793 . . . . 0.0 111.33 -178.137 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 3.2 t-20 -138.45 -5.04 1.61 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.687 -0.633 . . . . 0.0 111.346 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.6 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . . . 81.99 -34.93 0.1 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -49.99 -26.59 4.42 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.452 -0.78 . . . . 0.0 109.266 179.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.559 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 62.9 m-20 -104.25 -20.01 13.92 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.753 -0.592 . . . . 0.0 109.503 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.672 ' CE1' ' CD1' ' A' ' 33' ' ' LEU . 9.4 m-85 -98.8 148.36 34.46 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.226 -0.921 . . . . 0.0 109.101 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.526 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 6.1 Cg_exo -62.03 132.27 38.59 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.459 2.106 . . . . 0.0 110.448 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.93 -18.5 42.84 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.948 1.765 . . . . 0.0 110.201 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -46.52 -52.48 13.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.235 -0.916 . . . . 0.0 108.879 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.509 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 10.9 m120 -86.56 46.68 1.38 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.615 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 2.2 mt-10 -57.66 -44.31 99.4 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.667 -0.646 . . . . 0.0 112.485 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 7.1 Cg_exo -53.35 -42.7 63.39 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.877 1.718 . . . . 0.0 113.15 -177.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.582 HG12 ' CE2' ' A' ' 84' ' ' PHE . 1.8 t -96.98 -32.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.458 -1.401 . . . . 0.0 110.06 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.6 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -62.92 -25.85 39.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.555 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -57.59 -33.36 68.12 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.165 0.983 . . . . 0.0 108.419 178.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 68.1 mmtt -80.18 -40.55 27.03 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.704 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.594 ' CD1' ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -66.95 -16.31 64.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.647 -1.283 . . . . 0.0 107.884 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.559 ' CG ' ' O ' ' A' ' 123' ' ' ILE . 12.0 mtmt -61.68 -35.08 76.96 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 177.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 125' ' ' LYS . 1.2 mtp180 -81.91 -19.92 39.82 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.281 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.592 ' CD2' ' NH1' ' A' ' 12' ' ' ARG . 1.2 tp . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.111 -0.947 . . . . 0.0 109.447 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.506 ' HG2' ' N ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.641 ' CD1' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -142.88 119.42 11.02 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.043 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.492 ' HG3' ' OG1' ' A' ' 81' ' ' THR . 8.4 mp0 -101.57 160.92 14.03 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.727 -1.233 . . . . 0.0 107.844 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.478 ' CG2' HG13 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -123.1 117.76 52.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 C-N-CA 119.351 -0.939 . . . . 0.0 109.288 -179.136 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.56 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -87.44 58.56 5.03 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -78.02 -73.72 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.506 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.629 ' CA ' ' N ' ' A' ' 85' ' ' TRP . . . 60.01 82.24 0.07 OUTLIER Glycine 0 N--CA 1.48 1.603 0 N-CA-C 107.584 -2.207 . . . . 0.0 107.584 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.535 HG13 HD12 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -45.97 160.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.052 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.6 OUTLIER -120.26 95.32 3.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 C-N-CA 119.57 -0.852 . . . . 0.0 108.915 -179.234 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.594 ' HG2' ' CG2' ' A' ' 18' ' ' ILE . 20.3 mtm180 -74.35 173.19 10.59 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.596 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -150.98 -64.41 0.19 Allowed 'General case' 0 C--O 1.188 -2.142 0 C-N-CA 117.18 -1.808 . . . . 0.0 114.222 -176.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 7.7 tp10 -91.81 -32.73 15.25 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 118.957 -2.34 . . . . 0.0 112.014 -175.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.476 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 5.7 t-20 -161.15 -43.96 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.555 ' HB3' ' CD2' ' A' ' 107' ' ' LEU . 7.5 m120 -157.07 35.35 0.29 Allowed 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.545 ' HG2' ' CB ' ' A' ' 106' ' ' SER . 31.5 mt-10 -88.52 83.92 6.79 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 117.778 -1.569 . . . . 0.0 109.629 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.594 ' CG2' ' HG2' ' A' ' 12' ' ' ARG . 3.0 pt -79.82 149.09 5.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.632 ' CE2' ' HG2' ' A' ' 94' ' ' PRO . 7.0 t80 -81.57 43.68 0.76 Allowed 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.534 ' CD1' ' HD3' ' A' ' 36' ' ' PRO . 6.7 tp -83.33 159.9 3.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.93 0.871 . . . . 0.0 110.806 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.525 ' N ' HG13 ' A' ' 20' ' ' ILE . 7.4 t -70.32 98.6 1.42 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 176.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.51 ' O ' ' C ' ' A' ' 23' ' ' ARG . 31.6 tpt180 -99.61 80.39 2.36 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 110.976 -177.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.536 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 32.68 83.63 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.304 0.573 . . . . 0.0 110.137 178.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -43.51 -49.46 7.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -0.942 . . . . 0.0 110.087 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.35 178.65 8.15 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.179 -0.951 . . . . 0.0 108.763 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.444 ' O ' ' O ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -57.96 -30.81 66.3 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.171 -1.012 . . . . 0.0 108.894 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.536 ' CB ' ' HD2' ' A' ' 23' ' ' ARG . . . 58.07 159.12 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.325 -0.86 . . . . 0.0 109.537 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -131.57 25.73 4.75 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.67 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 11.2 mtm -129.08 -95.2 0.41 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.497 -0.752 . . . . 0.0 109.242 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.67 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 137.71 -4.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.61 14.41 5.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.125 -0.984 . . . . 0.0 108.834 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.9 tmtt? -80.98 28.77 0.35 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.468 -0.77 . . . . 0.0 110.708 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.638 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 16.6 mt -107.02 83.36 1.82 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.453 -1.405 . . . . 0.0 110.057 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.491 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 1.7 tt0 -85.46 -143.04 0.09 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.615 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 22.2 m-85 -142.66 127.55 10.05 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.693 -1.255 . . . . 0.0 109.701 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.54 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 5.0 Cg_endo -60.81 95.47 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.813 1.676 . . . . 0.0 109.225 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -54.26 -149.28 0.01 OUTLIER Glycine 0 N--CA 1.493 2.5 0 CA-C-O 122.039 0.799 . . . . 0.0 111.548 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.533 ' N ' ' CG ' ' A' ' 98' ' ' GLU . . . 159.9 -37.1 0.46 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 20.9 tptp 72.52 98.3 0.07 Allowed 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.172 0.51 . . . . 0.0 110.875 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.576 HG22 ' CD1' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -81.59 130.21 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.306 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -170.51 -32.3 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.428 -0.795 . . . . 0.0 109.76 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.409 ' O ' ' C ' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -53.73 164.26 0.58 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.907 . . . . 0.0 109.378 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' MET . . . 45.08 -122.05 4.9 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -165.89 24.05 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.43 -1.041 . . . . 0.0 108.997 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.529 HG21 ' HD2' ' A' ' 46' ' ' PRO . 88.4 m -144.19 141.93 19.07 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.356 -0.84 . . . . 0.0 108.845 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.529 ' HD2' HG21 ' A' ' 45' ' ' THR . 7.5 Cg_exo -48.89 -18.58 1.74 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.705 1.603 . . . . 0.0 109.804 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 48' ' ' GLN . 0.1 OUTLIER -76.0 -87.57 0.04 OUTLIER 'General case' 0 C--O 1.201 -1.449 0 O-C-N 121.214 -0.929 . . . . 0.0 108.799 178.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.558 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 22.7 mt-30 -42.72 -34.81 0.97 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.744 -1.223 . . . . 0.0 109.977 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.599 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -65.06 -63.87 1.0 Allowed 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.299 -0.875 . . . . 0.0 109.83 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 1.9 p -65.59 -49.37 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.962 -1.086 . . . . 0.0 110.864 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.568 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 3.8 p -56.55 -43.9 79.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.641 -0.662 . . . . 0.0 110.283 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.558 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 27.4 mmm180 -73.83 -28.46 61.62 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.599 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 25.0 mm-40 -76.69 -15.2 59.86 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.608 HD11 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -79.85 -55.51 4.93 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.68 0.752 . . . . 0.0 109.297 -179.732 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.612 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -68.71 -41.21 79.39 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.819 -0.551 . . . . 0.0 110.657 -179.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.564 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 0.9 OUTLIER -59.12 -20.81 56.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.006 -1.059 . . . . 0.0 110.73 -178.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 9.9 mm-40 -80.1 -91.07 0.05 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.812 -1.18 . . . . 0.0 110.445 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.599 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 94.7 t -77.49 -80.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.37 -0.832 . . . . 0.0 110.203 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.76 32.76 0.1 Allowed Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.178 -1.487 . . . . 0.0 111.678 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.644 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.3 pt -89.44 -137.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.552 -1.558 . . . . 0.0 108.305 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.589 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.8 m -154.32 -71.57 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.333 -1.479 . . . . 0.0 111.166 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.589 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 3.6 Cg_endo -64.09 -175.34 0.3 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 120.965 1.11 . . . . 0.0 110.315 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.575 ' NE2' ' HB3' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 151.79 -22.04 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.748 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.571 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 1.0 OUTLIER 48.61 50.53 16.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.479 -0.763 . . . . 0.0 109.748 179.026 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.575 ' HB3' ' NE2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -48.64 149.56 1.67 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.808 0.813 . . . . 0.0 110.68 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 86' ' ' LEU . 3.1 m -153.63 133.58 13.19 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.618 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -56.76 -71.4 0.1 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.856 -1.152 . . . . 0.0 110.482 -179.044 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.618 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 84.78 -52.19 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.58 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 0.8 OUTLIER 154.88 138.77 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.151 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.497 ' N ' ' HG3' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -128.76 -175.17 3.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.972 . . . . 0.0 109.893 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.554 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -125.16 -169.53 2.01 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.669 0.747 . . . . 0.0 109.647 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.502 ' N ' HD11 ' A' ' 71' ' ' LEU . 4.9 tt0 -156.37 83.12 0.98 Allowed 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.78 106.56 10.87 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.51 -170.17 2.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.348 -0.845 . . . . 0.0 109.471 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.569 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 5.6 m-85 -160.33 169.46 10.13 Favored Pre-proline 0 C--N 1.297 -1.681 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.351 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.4 Cg_exo -50.73 -28.85 24.04 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.974 1.783 . . . . 0.0 109.607 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.64 42.07 0.14 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.558 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -151.52 92.88 1.81 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.841 -0.537 . . . . 0.0 109.725 -178.383 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.476 ' C ' ' CD1' ' A' ' 80' ' ' ILE . 24.2 m170 -82.95 104.82 13.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.966 -1.084 . . . . 0.0 109.067 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.588 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -115.04 138.08 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.005 -1.059 . . . . 0.0 110.284 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.544 ' N ' HG21 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -112.9 179.54 3.94 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.34 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.58 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -160.32 72.53 0.48 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.658 -1.276 . . . . 0.0 110.394 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.576 ' CD1' HG22 ' A' ' 40' ' ' ILE . 79.3 m95 -51.74 131.12 30.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 108.956 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.585 ' CG ' HG13 ' A' ' 122' ' ' VAL . 16.0 m-85 -110.12 71.92 0.77 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.054 -1.029 . . . . 0.0 109.132 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.629 ' N ' ' CA ' ' A' ' 9' ' ' GLY . 38.2 m95 -70.75 85.11 0.65 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.315 -0.865 . . . . 0.0 109.588 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.535 HD12 HG13 ' A' ' 10' ' ' ILE . 3.6 mm? -70.77 124.22 23.79 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.749 -1.181 . . . . 0.0 109.059 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.561 ' CG2' ' CG2' ' A' ' 11' ' ' ILE . 1.1 m -113.72 159.86 13.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 87' ' ' VAL . 17.1 mp0 -148.44 36.56 0.81 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.095 -1.442 . . . . 0.0 112.924 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.591 ' O ' ' CD ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -161.06 31.98 0.14 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 119.881 -1.762 . . . . 0.0 111.532 178.7 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.596 ' CH2' ' HB2' ' A' ' 13' ' ' ASN . 2.8 p90 -54.79 165.5 0.61 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.16 -1.587 . . . . 0.0 108.274 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.539 ' HB3' ' CG ' ' A' ' 62' ' ' PRO . 8.1 pt-20 -77.35 -123.85 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.994 -1.066 . . . . 0.0 110.408 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.46 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -64.83 -50.46 58.24 Favored Glycine 0 N--CA 1.489 2.217 0 O-C-N 120.738 -1.226 . . . . 0.0 110.075 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.584 ' O ' ' CG2' ' A' ' 60' ' ' ILE . 3.1 mt-10 -123.29 156.56 63.35 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.018 -1.283 . . . . 0.0 110.278 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.632 ' HG2' ' CE2' ' A' ' 19' ' ' PHE . 8.4 Cg_endo -73.86 -160.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.731 2.288 . . . . 0.0 110.086 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.644 ' CD2' HG13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER 176.7 48.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 111.049 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . -132.69 2.89 4.95 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.169 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.556 ' HD3' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -80.08 94.91 6.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.383 -1.069 . . . . 0.0 111.239 -179.251 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.533 ' CG ' ' N ' ' A' ' 38' ' ' GLY . 2.8 mm-40 -42.02 -88.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.913 . . . . 0.0 108.729 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.97 1.68 27.15 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.515 ' HG3' ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -73.89 146.98 85.92 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.725 -0.868 . . . . 0.0 109.366 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.515 ' HD2' ' HG3' ' A' ' 100' ' ' GLN . 3.0 Cg_exo -56.39 -29.46 77.46 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 N-CA-C 107.897 -1.616 . . . . 0.0 107.897 178.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.627 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 54.76 110.73 0.01 OUTLIER Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.589 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 2.9 pt-20 -151.83 127.95 10.45 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.07 -1.253 . . . . 0.0 109.19 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.449 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -41.65 141.34 0.8 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.494 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.492 ' HG3' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -139.15 96.05 3.04 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.363 -0.836 . . . . 0.0 108.961 -179.455 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.545 ' CB ' ' HG2' ' A' ' 17' ' ' GLU . 10.4 t -78.51 72.17 5.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.46 -0.775 . . . . 0.0 109.399 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.614 ' CD2' ' N ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -80.03 -10.92 59.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.916 -1.115 . . . . 0.0 109.903 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.614 ' N ' ' CD2' ' A' ' 107' ' ' LEU . 2.5 t 64.93 122.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 108' ' ' VAL . . . 33.26 83.03 0.01 OUTLIER Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.64 ' CD2' ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -41.09 165.07 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.772 -0.84 . . . . 0.0 109.866 -178.068 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 2.0 t-20 -144.3 -4.94 0.78 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.804 -1.185 . . . . 0.0 111.87 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.593 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . . . 81.23 -26.29 0.15 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.961 -1.087 . . . . 0.0 108.56 -177.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -57.24 -40.47 77.64 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.571 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 59.8 m-20 -86.67 -13.12 46.44 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.64 ' CD1' ' CD2' ' A' ' 110' ' ' LEU . 5.1 m-85 -101.3 146.26 31.87 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 110.317 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.521 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 5.9 Cg_exo -60.92 141.66 95.24 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.44 2.094 . . . . 0.0 110.31 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.478 ' O ' ' OE1' ' A' ' 120' ' ' GLU . 1.6 Cg_endo -64.36 -8.1 15.94 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.098 1.866 . . . . 0.0 110.626 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.27 -53.45 52.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.09 -1.006 . . . . 0.0 110.174 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.541 ' CB ' HD11 ' A' ' 123' ' ' ILE . 6.7 m-80 -87.85 42.87 1.08 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 109.764 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.656 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -57.66 -44.3 99.39 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 120.981 -1.074 . . . . 0.0 111.734 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 20.8 Cg_exo -47.15 -44.92 22.84 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.825 1.683 . . . . 0.0 113.043 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.585 HG13 ' CG ' ' A' ' 84' ' ' PHE . 1.7 t -96.37 -35.94 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.306 -1.496 . . . . 0.0 109.215 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.593 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 2.1 mt -62.54 -17.95 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.589 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -63.27 -35.87 81.79 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.0 mmtm -74.21 -42.21 60.14 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.668 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.603 ' CD1' ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -65.46 -20.61 66.43 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.783 -1.198 . . . . 0.0 108.224 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.589 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 11.3 mtmt -57.98 -36.75 73.05 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -23.66 41.35 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.533 HD21 ' ND2' ' A' ' 16' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.539 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.556 ' HG3' ' N ' ' A' ' 4' ' ' LEU . 1.7 tttt . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.623 ' CD2' ' HD2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -139.54 110.0 6.62 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.493 ' O ' HD23 ' A' ' 4' ' ' LEU . 4.2 mp0 -96.93 162.47 13.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.109 -0.994 . . . . 0.0 109.804 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.467 ' CG2' ' HG ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -128.92 108.99 18.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.581 ' N ' HG21 ' A' ' 40' ' ' ILE . . . -84.74 64.71 8.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.471 -0.768 . . . . 0.0 109.113 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.572 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . 1.3 p -79.52 -71.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 110.405 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.64 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 60.04 74.04 0.41 Allowed Glycine 0 C--N 1.298 -1.554 0 N-CA-C 106.788 -2.525 . . . . 0.0 106.788 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.568 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -42.27 142.75 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -178.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 2.7 pt -98.14 97.59 6.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.169 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.556 ' CG ' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -77.44 171.47 14.83 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.581 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 6.1 t30 -148.92 -64.5 0.23 Allowed 'General case' 0 C--O 1.188 -2.134 0 C-N-CA 116.86 -1.936 . . . . 0.0 114.74 -177.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.53 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 3.0 tp10 -91.86 -28.91 17.01 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 118.775 -2.453 . . . . 0.0 111.592 -175.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -162.79 -43.03 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.735 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -160.06 31.31 0.18 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 177.582 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 105' ' ' MET . 36.4 mt-10 -83.01 89.31 6.88 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 117.517 -1.673 . . . . 0.0 108.025 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.0 OUTLIER -85.01 150.13 4.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-O 121.644 0.735 . . . . 0.0 110.812 -178.235 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.634 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 14.0 t80 -82.66 43.72 0.85 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.543 HD13 ' N ' ' A' ' 34' ' ' GLU . 6.6 tp -80.78 157.39 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 121.37 -0.831 . . . . 0.0 110.386 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.515 ' N ' HG13 ' A' ' 20' ' ' ILE . 2.0 t -74.01 86.0 1.8 Allowed 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.517 ' NH2' ' OD2' ' A' ' 114' ' ' ASP . 15.6 tpt180 -82.55 84.28 7.29 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.205 -0.934 . . . . 0.0 109.922 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.497 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 30.21 64.69 0.15 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.37 0.605 . . . . 0.0 110.359 -179.625 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -45.81 -54.32 8.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.359 -0.838 . . . . 0.0 109.233 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.73 -177.33 3.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -0.892 . . . . 0.0 108.872 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -76.15 86.58 3.01 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.013 -1.054 . . . . 0.0 109.337 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.451 ' C ' ' N ' ' A' ' 29' ' ' MET . . . -68.19 -27.97 66.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.861 . . . . 0.0 109.805 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.592 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 72.7 t60 49.02 24.71 0.93 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -177.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -152.19 -166.65 2.54 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.821 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.523 ' O ' ' OD1' ' A' ' 31' ' ' ASN . . . -137.44 -153.09 0.47 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.523 ' OD1' ' O ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER 63.8 2.79 1.41 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.218 -0.926 . . . . 0.0 109.504 -179.033 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.462 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -83.47 50.43 1.78 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.196 -0.94 . . . . 0.0 110.316 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.66 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 12.7 mt -128.74 85.77 2.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.975 -1.078 . . . . 0.0 108.197 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.582 ' O ' ' CE1' ' A' ' 115' ' ' PHE . 21.8 mt-10 -91.2 -123.52 0.07 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.176 -0.952 . . . . 0.0 110.842 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.634 ' CE2' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -160.49 124.0 1.95 Allowed Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 120.579 -1.325 . . . . 0.0 109.832 -178.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.604 ' CB ' ' HA ' ' A' ' 97' ' ' LYS . 19.7 Cg_endo -76.7 95.81 1.07 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.415 2.077 . . . . 0.0 110.575 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.572 ' CA ' ' HA ' ' A' ' 8' ' ' VAL . . . -145.62 123.4 1.87 Allowed Glycine 0 N--CA 1.499 2.843 0 O-C-N 120.654 -1.279 . . . . 0.0 110.166 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.571 ' CA ' ' HG3' ' A' ' 98' ' ' GLU . . . -103.77 74.22 0.27 Allowed Glycine 0 N--CA 1.491 2.339 0 O-C-N 121.172 -1.193 . . . . 0.0 111.942 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.623 ' HD2' ' CD2' ' A' ' 4' ' ' LEU . 5.4 tptt 42.07 121.02 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 176.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.583 HG23 ' CD1' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -81.65 129.96 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.475 ' OE1' ' HG2' ' A' ' 39' ' ' LYS . 3.1 pt-20 -171.71 -20.9 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 118.534 -1.267 . . . . 0.0 111.43 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.5 mmt -39.42 -74.28 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.096 -1.003 . . . . 0.0 109.655 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.57 -132.71 7.38 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -134.34 3.1 3.33 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.625 -0.926 . . . . 0.0 109.101 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.538 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 22.5 m -118.64 142.53 31.78 Favored Pre-proline 0 N--CA 1.486 1.338 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 8.2 Cg_exo -52.76 -17.49 7.35 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.395 1.397 . . . . 0.0 109.653 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.457 ' O ' ' C ' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -79.48 -87.97 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.209 -0.932 . . . . 0.0 108.821 178.556 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.563 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 10.6 mt-30 -42.66 -34.29 0.86 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.815 -1.178 . . . . 0.0 109.327 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.594 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -63.88 -62.46 1.63 Allowed 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.069 -1.019 . . . . 0.0 110.119 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 2.1 p -69.3 -49.17 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.186 -0.946 . . . . 0.0 110.763 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.558 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 4.2 p -55.32 -44.22 74.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.551 -0.718 . . . . 0.0 110.264 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -72.35 -36.88 68.9 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 179.375 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.594 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 11.6 mm-40 -69.0 -13.74 62.63 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.594 HD11 ' CD1' ' A' ' 95' ' ' TRP . 0.8 OUTLIER -80.37 -61.39 1.99 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.616 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.536 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -58.13 -50.26 74.1 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.747 -0.596 . . . . 0.0 109.891 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -49.45 -21.57 0.96 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.062 -1.024 . . . . 0.0 110.04 -178.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.461 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mt-10 -79.98 -95.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.928 -1.107 . . . . 0.0 109.622 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.607 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 45.4 t -80.12 -78.48 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 110.184 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.06 31.84 0.13 Allowed Glycine 0 N--CA 1.493 2.434 0 C-N-CA 118.626 -1.75 . . . . 0.0 112.476 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.648 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.2 pp -87.13 -153.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 120.372 -1.664 . . . . 0.0 107.639 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.58 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.8 m -135.95 -70.93 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.389 -1.444 . . . . 0.0 110.584 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 91' ' ' GLU . 5.8 Cg_endo -63.04 -170.61 0.1 Allowed 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 121.433 1.422 . . . . 0.0 110.719 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.574 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 143.0 -24.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.504 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.3 OUTLIER 44.54 71.03 0.28 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.423 -0.798 . . . . 0.0 109.312 178.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.456 ' HB3' ' NE2' ' A' ' 63' ' ' GLN . 8.0 p90 -67.26 141.98 57.06 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.342 -0.849 . . . . 0.0 109.833 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -132.42 135.85 46.36 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.583 HD21 ' CE2' ' A' ' 85' ' ' TRP . 1.3 tm? -57.53 -64.94 0.72 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.977 -1.077 . . . . 0.0 109.36 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.589 ' O ' ' CB ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER 80.66 -50.01 0.31 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.589 ' CB ' ' O ' ' A' ' 68' ' ' PHE . 27.1 tt0 150.16 142.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.35 178.07 7.0 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 110.541 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.526 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -127.47 166.34 18.13 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.725 0.774 . . . . 0.0 109.887 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -141.0 91.4 2.4 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.83 113.4 16.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.426 ' CG ' ' CD2' ' A' ' 79' ' ' HIS . 2.8 tt0 -91.72 146.79 23.49 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.562 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -133.51 173.02 6.35 Favored Pre-proline 0 C--N 1.296 -1.722 0 O-C-N 121.272 -0.893 . . . . 0.0 108.731 -179.585 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 7.3 Cg_exo -47.93 -40.5 32.84 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.818 1.678 . . . . 0.0 109.742 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -151.63 45.75 0.78 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.44 ' HB2' ' CB ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -148.77 93.06 2.07 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.714 -0.616 . . . . 0.0 109.565 -178.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.426 ' CD2' ' CG ' ' A' ' 74' ' ' GLU . 22.7 m80 -91.87 73.36 5.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.137 -0.977 . . . . 0.0 108.74 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.581 ' CG2' ' CD1' ' A' ' 4' ' ' LEU . 3.1 mm -84.52 154.32 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.995 -1.066 . . . . 0.0 110.486 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.459 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 3.2 m -136.51 154.45 50.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.617 ' O ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -139.77 75.53 1.52 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.74 -1.225 . . . . 0.0 110.021 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.583 ' CD1' HG23 ' A' ' 40' ' ' ILE . 89.4 m95 -48.46 124.1 7.6 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 118.6 -1.24 . . . . 0.0 108.611 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.617 ' CD1' ' O ' ' A' ' 82' ' ' LEU . 40.3 m-85 -102.28 71.77 1.25 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.996 -1.065 . . . . 0.0 110.32 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.64 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 76.7 m95 -75.88 85.52 2.83 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.757 -1.214 . . . . 0.0 108.994 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.568 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 2.1 mm? -72.58 123.11 22.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.509 -1.369 . . . . 0.0 108.779 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.542 ' O ' ' CG ' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -102.76 176.7 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.542 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 41.3 mt-10 -157.1 16.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.654 -1.218 . . . . 0.0 112.113 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.612 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -159.75 64.39 0.36 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.146 -1.596 . . . . 0.0 111.451 179.131 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.656 ' CH2' ' CD1' ' A' ' 104' ' ' TRP . 2.0 p90 -80.25 168.56 18.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 119.951 -1.718 . . . . 0.0 108.382 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.611 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -89.7 113.95 25.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.077 -1.014 . . . . 0.0 109.05 179.188 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 44.21 -80.87 0.0 OUTLIER Glycine 0 N--CA 1.501 2.984 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.611 ' N ' ' O ' ' A' ' 91' ' ' GLU . 4.8 mt-10 -82.52 145.7 51.91 Favored Pre-proline 0 C--N 1.298 -1.638 0 O-C-N 120.881 -1.364 . . . . 0.0 109.941 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.61 ' CG ' ' CE1' ' A' ' 19' ' ' PHE . 11.7 Cg_endo -79.17 -167.25 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.451 2.101 . . . . 0.0 108.511 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.648 ' CD2' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -179.12 34.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.728 -1.233 . . . . 0.0 112.009 178.235 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.51 ' HA2' HD12 ' A' ' 54' ' ' LEU . . . -121.36 1.7 11.41 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 178.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.604 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -80.83 127.22 32.28 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.446 -1.032 . . . . 0.0 111.863 -179.014 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.571 ' HG3' ' CA ' ' A' ' 38' ' ' GLY . 32.8 mm-40 -81.84 -135.29 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.13 -19.85 47.38 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.414 ' HG2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -55.21 148.96 28.23 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.866 -0.785 . . . . 0.0 109.84 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 21' ' ' THR . 2.2 Cg_endo -65.28 -37.73 30.05 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.89 1.727 . . . . 0.0 108.418 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.634 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 58.09 115.91 0.01 OUTLIER Glycine 0 N--CA 1.481 1.653 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 18.9 pt-20 -150.4 130.0 13.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.038 -1.272 . . . . 0.0 110.174 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.656 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -46.65 131.96 11.18 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.95 123.42 42.42 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.14 -0.975 . . . . 0.0 109.338 -178.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.99 46.87 1.15 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.334 -0.854 . . . . 0.0 108.873 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.561 ' HG ' ' HG ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -75.07 -28.95 60.54 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.506 ' HA ' ' HB3' ' A' ' 16' ' ' ASN . 49.0 t 55.91 123.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.713 -0.617 . . . . 0.0 110.495 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.54 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 42.83 82.77 0.02 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.561 ' HG ' ' HG ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -45.45 175.01 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.562 -0.964 . . . . 0.0 109.433 -177.338 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 1.5 t30 -143.8 -5.64 0.8 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.266 -1.521 . . . . 0.0 112.762 -177.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 111' ' ' ASN . . . 82.35 -35.75 0.09 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.039 -1.038 . . . . 0.0 108.405 -177.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -54.76 -24.9 24.56 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.557 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -105.38 -17.41 14.45 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.439 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.66 ' CD1' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -91.61 122.43 65.73 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.397 -0.814 . . . . 0.0 109.14 179.09 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.475 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 14.1 Cg_exo -48.49 147.52 9.08 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.836 1.69 . . . . 0.0 110.446 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 118' ' ' ALA . 3.5 Cg_exo -60.27 -30.58 91.46 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.496 2.13 . . . . 0.0 110.99 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.89 -61.59 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 109.57 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.634 ' ND2' ' CE2' ' A' ' 35' ' ' PHE . 4.6 m-20 -88.71 51.6 2.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.353 -0.842 . . . . 0.0 109.134 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.62 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -70.29 -40.68 12.34 Favored Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -179.079 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 5.7 Cg_exo -54.36 -47.21 28.12 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 121.928 1.752 . . . . 0.0 113.12 -177.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 71' ' ' LEU . 2.1 t -87.62 -28.19 5.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 120.581 -1.325 . . . . 0.0 109.118 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.642 ' CG1' ' CG ' ' A' ' 115' ' ' PHE . 1.1 mp -67.48 -23.16 29.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.507 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -58.61 -28.14 65.33 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -81.01 -41.1 23.24 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.265 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.592 ' CD1' ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -64.59 -26.45 68.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.507 -1.371 . . . . 0.0 107.476 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.552 ' CD ' ' HB1' ' A' ' 112' ' ' ALA . 14.8 mtmt -50.75 -37.37 41.53 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -83.53 -27.54 29.28 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.869 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.514 ' HB2' ' HA ' ' A' ' 126' ' ' LEU . 1.1 tp . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.838 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.101 0.477 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.557 ' HG2' ' N ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -150.94 171.4 17.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.04 -1.038 . . . . 0.0 109.471 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.557 ' N ' ' HG2' ' A' ' 2' ' ' LYS . 20.3 tttt -145.17 152.67 40.38 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.868 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.58 ' HG ' " O4'" ' A' ' 130' ' ' APC . 0.0 OUTLIER -158.25 150.87 22.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.565 ' N ' ' CD2' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -121.38 161.59 21.86 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.093 -1.005 . . . . 0.0 109.231 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.602 ' CD1' ' N7 ' ' A' ' 130' ' ' APC . 0.3 OUTLIER -124.4 114.94 43.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.253 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -84.07 64.46 8.2 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.535 ' CB ' ' O ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -79.21 -79.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.206 -179.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.599 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 73.97 85.76 0.26 Allowed Glycine 0 C--N 1.298 -1.571 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.556 HD12 ' CE1' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -49.43 169.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.03 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.557 HG23 ' CG2' ' A' ' 87' ' ' VAL . 7.1 pt -137.92 78.1 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.271 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.56 ' NH1' ' HG ' ' A' ' 129' ' ' LEU . 5.7 ptm180 -82.19 137.87 34.82 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.62 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -158.58 0.23 0.09 Allowed 'General case' 0 C--O 1.187 -2.22 0 C-N-CA 116.748 -1.981 . . . . 0.0 114.805 -177.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.511 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 22.0 tt0 -92.85 -32.52 14.59 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 118.246 -2.784 . . . . 0.0 106.923 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.402 ' C ' ' OD1' ' A' ' 15' ' ' ASN . 16.4 t-20 -163.79 -48.49 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 101.844 -3.391 . . . . 0.0 101.844 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.534 ' OD1' ' NH2' ' A' ' 12' ' ' ARG . 56.1 t30 -161.74 37.4 0.13 Allowed 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 175.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.511 ' CG ' ' HB3' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -90.17 101.45 14.17 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.013 -177.166 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.547 HG21 ' CB ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -89.34 149.78 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 122.003 0.906 . . . . 0.0 110.518 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.602 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 44.7 t80 -82.98 41.94 0.77 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.501 HG13 ' N ' ' A' ' 21' ' ' THR . 6.3 tp -81.07 156.23 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 122.193 0.996 . . . . 0.0 111.58 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.501 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -64.39 95.05 0.12 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.545 ' O ' ' C ' ' A' ' 23' ' ' ARG . 32.4 tpt180 -104.82 78.95 1.47 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.211 -0.931 . . . . 0.0 111.055 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.545 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 25.33 76.44 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 120.97 0.415 . . . . 0.0 110.706 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.69 -48.53 5.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.43 -0.794 . . . . 0.0 109.07 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.65 154.15 27.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.409 -0.807 . . . . 0.0 108.858 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.71 110.93 1.89 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.047 -1.033 . . . . 0.0 109.16 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.458 ' CB ' ' HD2' ' A' ' 23' ' ' ARG . . . -100.0 149.96 22.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 110.003 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.09 -20.54 52.07 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.424 ' SD ' ' N ' ' A' ' 29' ' ' MET . 2.7 mpp? -97.53 -166.78 1.43 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -156.78 18.65 0.32 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.014 -1.054 . . . . 0.0 110.217 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.0 m-20 -99.67 17.28 20.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.072 -1.017 . . . . 0.0 108.879 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.495 ' HD2' ' CA ' ' A' ' 23' ' ' ARG . 1.1 tttp -81.52 39.5 0.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.386 -0.821 . . . . 0.0 111.124 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 115' ' ' PHE . 19.9 mt -107.33 91.91 3.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.826 -1.171 . . . . 0.0 109.351 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.568 ' O ' ' CD1' ' A' ' 35' ' ' PHE . 37.9 tt0 -91.16 -128.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.314 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 17.9 m-85 -157.11 131.91 5.31 Favored Pre-proline 0 N--CA 1.485 1.324 0 O-C-N 120.81 -1.181 . . . . 0.0 109.758 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.535 ' O ' ' CB ' ' A' ' 8' ' ' VAL . 1.4 Cg_endo -61.01 88.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.51 2.14 . . . . 0.0 110.435 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -54.65 -160.16 0.01 OUTLIER Glycine 0 N--CA 1.494 2.518 0 O-C-N 121.314 -0.866 . . . . 0.0 111.061 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 163.87 -28.85 0.23 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.554 ' CG ' H3A1 ' A' ' 130' ' ' APC . 0.1 OUTLIER 69.91 102.32 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.973 -0.722 . . . . 0.0 111.058 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.564 HG22 ' CD1' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -81.54 132.32 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.199 -0.938 . . . . 0.0 108.928 178.452 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -171.64 -32.55 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 109.739 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.403 ' HB2' ' HA ' ' A' ' 49' ' ' ALA . 8.7 mmt -53.02 161.61 0.78 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 109.744 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.04 -121.13 12.52 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.412 ' OE2' ' HA ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -168.99 25.03 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.496 -1.002 . . . . 0.0 108.925 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.565 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 63.4 m -154.24 144.37 15.64 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.595 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 10.8 Cg_exo -48.37 -16.43 0.68 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.894 1.73 . . . . 0.0 111.443 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.489 ' O ' HG11 ' A' ' 51' ' ' VAL . 2.5 mt-10 -78.6 -72.71 0.36 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.744 -1.222 . . . . 0.0 109.124 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.55 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 3.8 mt-30 -56.48 -30.87 63.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.399 -1.438 . . . . 0.0 109.321 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.631 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -67.14 -63.24 1.1 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.475 -0.766 . . . . 0.0 109.816 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.574 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 2.3 p -67.91 -48.19 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.051 -1.031 . . . . 0.0 110.463 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.574 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 1.6 p -55.73 -42.57 70.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 121.188 0.518 . . . . 0.0 110.334 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 2.4 mmm180 -77.65 -29.79 51.81 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.631 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 21.1 mm-40 -75.75 -11.88 60.08 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.6 ' HB3' ' CH2' ' A' ' 95' ' ' TRP . 0.7 OUTLIER -80.17 -57.19 3.74 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.755 0.788 . . . . 0.0 108.989 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.484 ' N ' ' CZ3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -65.38 -42.0 93.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.896 -0.502 . . . . 0.0 110.946 -179.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.592 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -57.57 -24.43 56.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.094 -1.004 . . . . 0.0 111.556 -177.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.57 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -80.21 -83.03 0.11 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.409 -1.432 . . . . 0.0 110.572 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.561 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 74.6 t -80.27 -80.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.037 -1.039 . . . . 0.0 110.007 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.21 32.8 0.1 OUTLIER Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.325 -1.417 . . . . 0.0 110.837 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.642 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.8 pp -94.27 -159.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.809 -1.407 . . . . 0.0 108.419 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.588 ' CB ' ' CD ' ' A' ' 62' ' ' PRO . 1.8 m -135.45 -70.87 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.773 -1.205 . . . . 0.0 110.637 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.598 ' HD2' ' HB3' ' A' ' 91' ' ' GLU . 2.6 Cg_endo -59.3 -171.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.084 0 C-N-CA 121.487 1.458 . . . . 0.0 110.402 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.577 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 2.6 pt20 144.03 -22.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.531 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.3 OUTLIER 43.82 72.12 0.21 Allowed 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -69.54 149.17 48.49 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.836 0.826 . . . . 0.0 110.898 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -143.66 144.91 32.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.605 HD21 ' CE2' ' A' ' 85' ' ' TRP . 1.9 tm? -66.29 -68.72 0.35 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.774 -1.204 . . . . 0.0 110.25 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.582 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 81.35 -51.72 0.28 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 -178.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.495 ' N ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER 167.74 179.12 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 109.242 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -159.72 158.01 30.53 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.045 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.533 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 1.1 pp -117.93 -177.26 3.22 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.026 -1.047 . . . . 0.0 110.192 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -154.84 89.69 1.25 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.524 ' CE2' ' O ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -79.55 127.12 31.76 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.157 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -100.98 133.84 44.87 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.06 -1.025 . . . . 0.0 109.482 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.541 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -116.9 171.09 5.16 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 108.843 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.9 Cg_exo -48.23 -47.24 20.28 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.992 1.794 . . . . 0.0 110.196 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.431 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 5.4 p-10 -141.26 33.05 1.7 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.468 ' O ' HD11 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -140.15 93.14 2.6 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.554 -0.716 . . . . 0.0 110.32 -179.048 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -82.7 92.94 7.28 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.618 HG22 ' C6 ' ' A' ' 130' ' ' APC . 0.3 OUTLIER -97.68 163.42 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -0.963 . . . . 0.0 111.26 -177.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.568 ' N ' ' CG2' ' A' ' 80' ' ' ILE . 1.3 m -140.46 168.71 19.17 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.488 ' CD1' HN61 ' A' ' 130' ' ' APC . 0.2 OUTLIER -157.31 85.23 0.93 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.539 -1.351 . . . . 0.0 110.595 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.564 ' CD1' HG22 ' A' ' 40' ' ' ILE . 70.6 m95 -58.49 126.56 28.1 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.303 -0.873 . . . . 0.0 109.418 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.575 ' CD2' HG12 ' A' ' 122' ' ' VAL . 19.1 m-85 -101.57 70.73 1.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 0.0 109.878 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.605 ' CE2' HD21 ' A' ' 67' ' ' LEU . 93.6 m95 -74.26 91.25 2.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.943 -1.098 . . . . 0.0 108.983 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.546 HD22 ' CD2' ' A' ' 68' ' ' PHE . 3.5 mm? -73.48 126.58 30.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.208 -0.932 . . . . 0.0 110.489 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.557 ' CG2' HG23 ' A' ' 11' ' ' ILE . 1.5 m -112.02 169.18 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 78.0 mt-10 -149.55 17.37 0.91 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.487 -1.383 . . . . 0.0 112.954 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.605 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.26 67.51 0.36 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.089 -1.632 . . . . 0.0 110.56 178.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.62 ' CH2' ' ND2' ' A' ' 13' ' ' ASN . 1.8 p90 -80.74 164.79 22.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.329 -1.482 . . . . 0.0 109.656 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.667 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.9 OUTLIER -80.86 141.97 34.09 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.105 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.477 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 27.92 -80.33 0.0 OUTLIER Glycine 0 N--CA 1.502 3.046 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' A' ' 91' ' ' GLU . 0.8 OUTLIER -100.55 151.7 37.64 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.335 -1.097 . . . . 0.0 109.63 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.607 ' HB3' ' CE3' ' A' ' 90' ' ' TRP . 9.9 Cg_endo -73.94 -158.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.724 2.282 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.644 ' CD1' ' O ' ' A' ' 95' ' ' TRP . 0.2 OUTLIER 177.53 112.53 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.644 -0.66 . . . . 0.0 109.784 179.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . 174.47 -40.83 0.13 Allowed Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.405 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.542 ' HB2' ' CG ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -44.4 124.24 3.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.101 -1.235 . . . . 0.0 109.489 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.51 ' OE1' ' O2G' ' A' ' 130' ' ' APC . 8.2 tp10 -74.7 -111.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.713 -1.242 . . . . 0.0 107.687 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.76 12.25 64.14 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.542 ' CG ' ' HB2' ' A' ' 97' ' ' LYS . 6.4 pt20 -92.97 170.13 9.33 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.696 -0.885 . . . . 0.0 109.495 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -68.69 -48.67 0.95 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.022 1.814 . . . . 0.0 110.281 -179.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.594 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.62 118.52 0.01 OUTLIER Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.587 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 4.5 pt-20 -157.18 145.19 19.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.932 -1.334 . . . . 0.0 110.44 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.4 ' CD1' ' HD1' ' A' ' 19' ' ' PHE . 1.3 m0 -48.58 135.16 14.87 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -129.88 112.95 14.05 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.081 -1.012 . . . . 0.0 109.492 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.9 t -78.22 73.33 4.78 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.614 ' O ' ' CB ' ' A' ' 108' ' ' VAL . 8.0 tt -80.7 -66.51 0.87 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.433 -0.792 . . . . 0.0 109.792 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.614 ' CB ' ' O ' ' A' ' 107' ' ' LEU . 99.3 t 103.75 98.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 41.98 82.57 0.02 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.591 HD23 ' CZ ' ' A' ' 115' ' ' PHE . 2.1 mp -29.96 153.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.962 0.887 . . . . 0.0 111.612 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -132.38 -6.26 3.35 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.692 -0.63 . . . . 0.0 110.618 -178.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.589 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . . . 73.88 -3.26 2.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.217 -0.927 . . . . 0.0 108.806 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.82 -22.31 40.11 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.572 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 14.9 m-20 -104.92 -10.42 17.3 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 33' ' ' LEU . 27.7 m-85 -102.7 144.99 29.72 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.395 -0.815 . . . . 0.0 109.557 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 2.3 Cg_endo -65.6 151.19 85.41 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.547 2.165 . . . . 0.0 110.94 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.448 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . 1.6 Cg_endo -65.33 -23.75 58.54 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.239 1.959 . . . . 0.0 109.824 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.524 ' O ' ' CE2' ' A' ' 73' ' ' TYR . . . -46.14 -58.49 3.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.384 -0.822 . . . . 0.0 109.686 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.494 ' O ' HD13 ' A' ' 123' ' ' ILE . 12.7 m120 -85.82 45.3 1.19 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 108.892 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.621 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 2.6 mt-10 -59.56 -43.66 96.19 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 121.378 -0.826 . . . . 0.0 112.137 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 7.7 Cg_exo -53.18 -36.44 77.3 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.058 1.839 . . . . 0.0 112.537 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.575 HG12 ' CD2' ' A' ' 84' ' ' PHE . 2.0 t -100.42 -38.0 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.611 -1.305 . . . . 0.0 109.707 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.589 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 6.8 mt -56.94 -27.54 26.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.478 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -60.7 -39.0 86.9 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.426 ' HG3' ' OE1' ' A' ' 69' ' ' GLU . 13.7 mmtp -76.11 -40.13 53.59 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.212 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.526 ' HB3' ' CB ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -55.45 -43.23 75.26 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.541 ' CD ' ' HB1' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -39.58 -41.81 1.08 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.997 0.903 . . . . 0.0 108.652 178.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 129' ' ' LEU . 1.0 OUTLIER -79.21 -50.99 10.09 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.56 ' HG ' ' NH1' ' A' ' 12' ' ' ARG . 1.8 tp . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.608 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' APC . . . . . 0.618 ' C6 ' HG22 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HOH . . . . . 0.433 ' O ' ' O ' ' A' ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.501 ' CD ' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -159.05 -131.05 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.175 -0.953 . . . . 0.0 109.033 179.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.541 ' CG ' ' O ' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -148.99 158.69 44.38 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.234 -1.541 . . . . 0.0 110.339 -178.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.652 ' CD2' " O4'" ' A' ' 130' ' ' APC . 0.7 OUTLIER -136.1 -171.92 3.0 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.087 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.5 ' O ' HD13 ' A' ' 4' ' ' LEU . 7.8 mp0 -144.05 177.96 8.2 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.575 HG13 ' N7 ' ' A' ' 130' ' ' APC . 0.2 OUTLIER -145.65 109.87 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.72 -178.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.56 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -83.0 67.26 9.01 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.605 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 0.8 OUTLIER -78.83 -73.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.177 -0.952 . . . . 0.0 109.385 -179.514 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.636 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 62.61 81.7 0.09 OUTLIER Glycine 0 C--N 1.295 -1.747 0 N-CA-C 107.958 -2.057 . . . . 0.0 107.958 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.48 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -48.04 172.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.318 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -136.73 81.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.121 -178.551 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.543 ' CA ' HG21 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -91.61 134.96 34.23 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.059 -1.026 . . . . 0.0 108.344 179.345 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 13' ' ' ASN . 5.2 p-10 -161.66 62.2 0.26 Allowed 'General case' 0 C--O 1.189 -2.119 0 C-N-CA 117.596 -1.641 . . . . 0.0 113.158 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.566 ' CB ' ' HG3' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -148.7 -49.55 0.15 Allowed 'General case' 0 C--N 1.269 -2.92 0 CA-C-O 124.499 2.095 . . . . 0.0 105.616 176.18 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -161.17 -48.54 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 100.885 -3.746 . . . . 0.0 100.885 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.484 ' ND2' ' HD2' ' A' ' 12' ' ' ARG . 1.7 t-20 -162.34 42.52 0.13 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.31 -1.768 . . . . 0.0 106.684 175.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.566 ' HG3' ' CB ' ' A' ' 14' ' ' GLU . 9.4 mm-40 -93.46 95.93 9.58 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.962 -1.495 . . . . 0.0 110.901 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.543 HG21 ' CA ' ' A' ' 12' ' ' ARG . 2.7 pt -89.01 153.83 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.637 -0.664 . . . . 0.0 110.362 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.656 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 3.7 t80 -83.15 47.73 1.28 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.668 ' CD1' ' CE2' ' A' ' 115' ' ' PHE . 5.2 tt -82.36 155.42 3.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.986 0.898 . . . . 0.0 111.299 -177.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.461 HG23 ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -70.07 98.14 1.27 Allowed 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.528 ' O ' ' C ' ' A' ' 23' ' ' ARG . 28.9 tpt180 -104.46 97.3 7.25 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 110.662 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.528 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 24.49 76.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.211 0.529 . . . . 0.0 110.93 179.186 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -44.61 -52.62 7.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.111 -0.993 . . . . 0.0 109.555 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.27 -178.18 6.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.167 -0.958 . . . . 0.0 109.412 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.71 107.06 8.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.24 -0.913 . . . . 0.0 108.934 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.491 ' HB1' ' HD2' ' A' ' 23' ' ' ARG . . . -101.02 171.96 7.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 110.119 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -127.73 16.08 6.94 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.621 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 4.3 mtm -121.29 -106.33 0.37 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.442 -0.786 . . . . 0.0 109.69 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.621 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 148.85 -4.32 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.696 -0.627 . . . . 0.0 110.503 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.461 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 50.3 t-20 -76.27 6.65 5.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.616 -1.302 . . . . 0.0 109.425 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 23' ' ' ARG . 4.1 tmtm? -81.29 62.85 5.38 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.535 -0.728 . . . . 0.0 110.857 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.638 ' CD1' ' CE1' ' A' ' 115' ' ' PHE . 10.6 mt -124.22 90.29 3.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.052 -1.03 . . . . 0.0 109.045 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.23 -144.97 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.903 -1.123 . . . . 0.0 108.794 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.58 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 66.7 m-85 -145.93 124.27 6.41 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 120.901 -1.124 . . . . 0.0 110.019 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.496 ' HB3' ' HA ' ' A' ' 97' ' ' LYS . 9.5 Cg_endo -65.79 90.48 0.24 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.194 1.929 . . . . 0.0 110.219 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -131.0 127.65 5.22 Favored Glycine 0 N--CA 1.494 2.562 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.368 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.542 ' CA ' ' HB2' ' A' ' 98' ' ' GLU . . . -106.65 38.26 3.41 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 120.05 -1.072 . . . . 0.0 111.163 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.568 ' HB2' H3A1 ' A' ' 130' ' ' APC . 10.5 tptm 60.24 120.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.777 -0.837 . . . . 0.0 111.433 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.56 ' HB ' ' CB ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -82.59 133.51 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 42' ' ' MET . 1.8 pt-20 -171.83 -25.64 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.548 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.458 ' HE2' ' HG2' ' A' ' 56' ' ' GLU . 3.3 tpp -54.57 129.65 37.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.856 -1.153 . . . . 0.0 109.27 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.12 -120.78 12.54 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -168.27 22.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.402 -1.058 . . . . 0.0 109.716 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.505 HG21 ' HD2' ' A' ' 46' ' ' PRO . 20.6 m -140.9 138.91 18.65 Favored Pre-proline 0 C--O 1.201 -1.486 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.509 ' CB ' ' CZ2' ' A' ' 85' ' ' TRP . 8.6 Cg_exo -48.57 -16.52 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.829 1.686 . . . . 0.0 111.344 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.453 ' O ' HG13 ' A' ' 51' ' ' VAL . 2.7 mt-10 -80.42 -78.7 0.16 Allowed 'General case' 0 C--O 1.201 -1.491 0 O-C-N 120.587 -1.321 . . . . 0.0 108.61 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.558 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 24.7 mt-30 -50.14 -30.75 11.87 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.389 -1.444 . . . . 0.0 109.364 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.643 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -68.6 -60.36 2.47 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.113 -0.992 . . . . 0.0 110.504 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.556 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 4.3 p -70.09 -45.83 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.718 -1.239 . . . . 0.0 110.227 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.583 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 1.4 p -58.12 -47.77 86.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.302 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.583 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -73.48 -36.13 65.78 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.643 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 21.7 mm-40 -65.22 -19.83 66.15 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.655 ' CD1' ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -78.31 -63.39 1.41 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.885 -178.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.546 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -58.94 -44.5 91.4 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.356 -0.84 . . . . 0.0 110.092 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.551 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -54.92 -20.71 9.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.108 -0.995 . . . . 0.0 110.193 -179.239 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.429 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mt-10 -80.26 -92.82 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.065 -1.022 . . . . 0.0 109.837 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.586 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 47.9 t -80.21 -78.98 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.346 -0.846 . . . . 0.0 110.045 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.88 27.51 0.13 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 118.599 -1.762 . . . . 0.0 112.723 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.642 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.3 pp -81.49 -144.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 120.181 -1.776 . . . . 0.0 107.582 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.576 ' CB ' ' CD ' ' A' ' 62' ' ' PRO . 1.3 m -143.07 -71.26 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.206 -1.559 . . . . 0.0 110.24 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.592 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 9.4 Cg_endo -67.01 -170.01 0.21 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.249 1.3 . . . . 0.0 110.127 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.592 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 136.28 -26.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.499 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.2 OUTLIER 56.64 -163.31 0.17 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.444 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 7.2 p90 177.11 143.75 0.09 Allowed 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.533 -1.267 . . . . 0.0 110.585 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -144.13 157.06 44.53 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.613 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -74.29 -69.92 0.42 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.251 -0.906 . . . . 0.0 110.856 -178.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.613 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 83.99 -51.85 0.13 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.2 mt-10 157.3 175.05 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.42 -168.6 2.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.953 -1.092 . . . . 0.0 110.115 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.537 ' HG ' ' CG2' ' A' ' 122' ' ' VAL . 0.3 OUTLIER -147.36 161.41 41.07 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.49 -0.756 . . . . 0.0 109.947 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 80' ' ' ILE . 2.6 tt0 -137.42 90.09 2.48 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.03 119.88 25.47 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.439 -0.788 . . . . 0.0 109.119 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.501 ' HG3' ' HA ' ' A' ' 79' ' ' HIS . 11.1 tt0 -112.2 155.78 23.41 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.318 -0.864 . . . . 0.0 109.824 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.751 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 67.4 m-85 -136.76 -115.22 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.641 0 CA-C-O 117.341 -1.314 . . . . 0.0 109.3 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.751 ' CD ' ' CB ' ' A' ' 75' ' ' PHE . 1.9 Cg_endo -62.44 -43.81 20.9 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 CA-C-N 122.077 1.777 . . . . 0.0 109.895 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -171.4 29.9 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.91 88.73 2.81 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.488 -0.757 . . . . 0.0 109.933 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.541 ' O ' ' CG ' ' A' ' 3' ' ' LYS . 0.3 OUTLIER -79.66 79.84 6.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 108.797 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.597 ' CG2' ' C5 ' ' A' ' 130' ' ' APC . 2.7 mm -85.0 145.3 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.036 -1.04 . . . . 0.0 110.725 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -120.98 139.43 53.29 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.568 HD12 HN61 ' A' ' 130' ' ' APC . 0.2 OUTLIER -124.44 74.07 1.29 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.949 -1.094 . . . . 0.0 109.658 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.405 ' HB3' ' NE1' ' A' ' 85' ' ' TRP . 80.1 m95 -53.53 114.02 1.37 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.033 -1.042 . . . . 0.0 109.48 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.556 ' CE1' HD21 ' A' ' 82' ' ' LEU . 32.4 m-85 -89.53 78.11 7.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.138 -0.976 . . . . 0.0 108.379 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.636 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 97.7 m95 -74.37 85.77 1.98 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.014 -1.054 . . . . 0.0 109.228 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.527 ' O ' ' OG ' ' A' ' 66' ' ' SER . 2.5 mm? -68.88 124.91 24.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.397 -1.439 . . . . 0.0 110.061 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.537 ' O ' ' CG ' ' A' ' 88' ' ' GLU . 0.6 OUTLIER -113.01 178.87 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.537 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 13.8 mt-10 -160.16 33.46 0.17 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 118.103 -1.439 . . . . 0.0 112.881 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.565 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -161.02 47.08 0.21 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 119.803 -1.811 . . . . 0.0 112.404 179.117 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.609 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 1.4 p90 -70.57 160.69 32.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 119.863 -1.773 . . . . 0.0 108.991 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -90.29 146.5 24.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.189 -0.944 . . . . 0.0 108.614 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.44 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . 35.94 -82.33 0.0 OUTLIER Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.664 ' N ' ' O ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -112.25 157.77 39.0 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.334 -1.097 . . . . 0.0 110.009 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.607 ' HG2' ' CE2' ' A' ' 19' ' ' PHE . 9.0 Cg_endo -76.21 -159.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.993 2.462 . . . . 0.0 110.614 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.655 ' CD1' ' CD1' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -177.87 39.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.862 -1.149 . . . . 0.0 111.189 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -124.81 -7.57 6.05 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.021 -1.562 . . . . 0.0 111.497 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.542 ' HD2' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -63.44 103.72 0.55 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.717 -1.461 . . . . 0.0 110.998 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.542 ' HB2' ' CA ' ' A' ' 38' ' ' GLY . 9.6 tp10 -70.14 92.43 0.75 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -0.99 . . . . 0.0 108.509 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.22 14.99 42.67 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.479 ' HG2' ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -96.69 146.56 31.52 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.6 -0.941 . . . . 0.0 109.027 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.567 ' O ' ' O ' ' A' ' 102' ' ' GLY . 4.9 Cg_exo -58.63 -21.38 55.12 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 N-CA-C 108.385 -1.429 . . . . 0.0 108.385 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.656 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 37.13 105.03 0.01 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -141.43 131.39 24.52 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.382 -1.658 . . . . 0.0 110.483 179.309 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.434 ' C ' ' O ' ' A' ' 103' ' ' GLU . 1.6 m0 -46.17 129.26 10.05 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -123.4 117.07 24.35 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.623 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.33 63.31 5.6 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.654 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 6.9 tt -69.06 -54.06 17.09 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.59 -0.693 . . . . 0.0 110.118 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.654 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 66.6 t 85.32 108.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 46.87 82.51 0.03 OUTLIER Glycine 0 N--CA 1.486 1.968 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 -178.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.586 HD23 ' CZ ' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -34.48 160.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.981 0.896 . . . . 0.0 111.738 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -156.59 141.42 17.04 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.528 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . . . -65.93 -22.34 66.49 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.92 -25.19 4.29 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.574 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -108.17 -18.77 13.69 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.668 ' CE2' ' CD1' ' A' ' 20' ' ' ILE . 44.5 m-85 -100.54 149.64 36.29 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.881 . . . . 0.0 110.605 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.439 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -66.95 144.77 71.67 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.518 2.145 . . . . 0.0 109.941 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 118' ' ' ALA . 1.6 Cg_endo -64.35 -28.22 63.27 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.997 1.798 . . . . 0.0 110.15 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -43.05 -41.08 3.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 109.892 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -108.71 55.72 0.63 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.246 -0.909 . . . . 0.0 109.357 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.681 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -71.76 -35.96 4.05 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.555 -0.715 . . . . 0.0 112.585 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.9 Cg_exo -59.07 -31.37 95.45 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.653 1.569 . . . . 0.0 113.174 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.537 ' CG2' ' HG ' ' A' ' 71' ' ' LEU . 1.8 t -99.97 -38.58 6.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.376 -1.452 . . . . 0.0 109.342 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.589 HD13 ' CD2' ' A' ' 115' ' ' PHE . 2.0 mm -58.86 -37.31 66.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.494 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -39.74 -37.3 0.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.144 0.973 . . . . 0.0 108.946 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.484 ' HE2' ' OE2' ' A' ' 69' ' ' GLU . 7.2 mmtm -81.65 -47.33 13.14 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.802 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.56 ' HB3' ' CB ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -64.62 -10.33 25.77 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.378 -1.451 . . . . 0.0 109.093 179.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.554 ' CG ' ' O ' ' A' ' 123' ' ' ILE . 0.3 OUTLIER -68.75 -37.71 79.58 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -12.29 59.81 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.333 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.526 HD22 ' CZ ' ' A' ' 12' ' ' ARG . 3.0 tp . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.79 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' APC . . . . . 0.652 " O4'" ' CD2' ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' CON . . . . . 0.621 ' N3 ' ' O2A' ' A' ' 130' ' ' APC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.426 ' C ' ' HG3' ' A' ' 2' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.515 0.674 . . . . 0.0 109.386 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.467 ' HD3' ' C ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -178.19 -165.2 0.09 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.363 -0.835 . . . . 0.0 109.019 -179.802 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.507 ' HG2' ' N ' ' A' ' 4' ' ' LEU . 6.1 ttpt -143.63 153.24 42.31 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.061 -1.025 . . . . 0.0 109.991 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.612 ' HG ' " O4'" ' A' ' 130' ' ' APC . 0.0 OUTLIER -154.11 156.06 36.54 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.069 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.532 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 14.1 mp0 -124.94 173.66 8.49 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.027 -1.046 . . . . 0.0 108.531 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.595 HG13 ' N7 ' ' A' ' 130' ' ' APC . 1.1 mm -136.47 110.14 9.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.704 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -84.63 62.17 7.17 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 36' ' ' PRO . 1.1 p -78.29 -70.0 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.363 -0.835 . . . . 0.0 109.902 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.648 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 59.82 80.82 0.09 OUTLIER Glycine 0 C--N 1.297 -1.615 0 N-CA-C 107.055 -2.418 . . . . 0.0 107.055 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -48.4 170.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -178.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.562 HG23 ' CG2' ' A' ' 87' ' ' VAL . 7.7 pt -137.67 99.84 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 C-N-CA 119.406 -0.918 . . . . 0.0 108.768 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.527 ' HG2' ' CG2' ' A' ' 18' ' ' ILE . 13.3 mtm180 -76.68 -176.54 3.85 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.593 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -157.17 -61.42 0.09 Allowed 'General case' 0 C--O 1.191 -2.01 0 C-N-CA 116.957 -1.897 . . . . 0.0 114.527 -177.457 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.569 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 1.9 tt0 -93.3 -30.12 15.31 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 119.038 -2.289 . . . . 0.0 111.435 -175.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -160.85 -43.52 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.804 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.484 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 14.1 t30 -158.32 34.99 0.24 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 177.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 105' ' ' MET . 2.4 mt-10 -78.74 83.77 4.87 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 117.965 -1.494 . . . . 0.0 108.764 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.575 HD11 ' HB ' ' A' ' 20' ' ' ILE . 4.7 pt -80.08 142.54 13.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 119.684 -0.807 . . . . 0.0 109.425 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.671 ' CZ ' ' HG2' ' A' ' 94' ' ' PRO . 10.2 t80 -80.19 42.9 0.59 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.699 -0.626 . . . . 0.0 109.544 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.575 ' HB ' HD11 ' A' ' 18' ' ' ILE . 6.8 tp -82.11 155.62 4.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 122.012 0.91 . . . . 0.0 111.579 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.516 ' N ' HG13 ' A' ' 20' ' ' ILE . 7.6 t -64.92 96.48 0.19 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.47 ' O ' ' C ' ' A' ' 23' ' ' ARG . 27.1 tpt180 -98.16 87.44 3.93 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.423 -0.798 . . . . 0.0 110.257 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.501 ' CB ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 36.79 84.43 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.896 -0.503 . . . . 0.0 109.969 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.59 -51.78 5.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.377 -0.827 . . . . 0.0 109.092 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.89 -160.48 0.16 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -76.17 -43.66 41.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.019 -1.051 . . . . 0.0 109.307 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.501 ' HB1' ' CB ' ' A' ' 23' ' ' ARG . . . 52.89 110.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.35 -0.844 . . . . 0.0 110.24 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -78.96 -6.13 55.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.981 -1.074 . . . . 0.0 108.981 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.555 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 3.1 mpp? -86.81 -124.64 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.188 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 161.49 -2.33 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.833 -1.167 . . . . 0.0 111.647 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 3.8 p-10 -81.96 13.11 3.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.239 -1.538 . . . . 0.0 109.115 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.47 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -81.41 58.99 3.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.599 -0.688 . . . . 0.0 110.322 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.598 ' O ' ' CD2' ' A' ' 115' ' ' PHE . 14.4 mt -130.61 85.46 2.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.945 -1.097 . . . . 0.0 109.097 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.579 ' O ' ' CE2' ' A' ' 115' ' ' PHE . 3.2 tt0 -92.94 -127.63 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -0.975 . . . . 0.0 108.879 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.572 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -151.9 134.54 8.81 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.942 -1.099 . . . . 0.0 108.46 178.521 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 97' ' ' LYS . 4.5 Cg_endo -62.09 92.91 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.924 1.749 . . . . 0.0 109.541 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.513 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -54.56 -152.86 0.01 OUTLIER Glycine 0 N--CA 1.493 2.455 0 CA-C-O 122.051 0.806 . . . . 0.0 111.378 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.593 ' N ' ' CG ' ' A' ' 98' ' ' GLU . . . 162.07 -26.35 0.25 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.585 ' HB3' ' H1 ' ' A' ' 133' ' ' HOH . 15.7 tptm 64.09 96.94 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.933 -0.745 . . . . 0.0 110.183 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.568 HG22 ' CD1' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -80.4 133.17 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.206 -0.933 . . . . 0.0 108.574 178.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.483 ' HG2' ' N ' ' A' ' 42' ' ' MET . 2.9 pt-20 -170.6 -32.88 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.464 -0.773 . . . . 0.0 109.721 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.483 ' N ' ' HG2' ' A' ' 41' ' ' GLU . 8.0 mtt -59.17 166.43 2.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.203 -0.936 . . . . 0.0 109.696 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 51.66 -125.77 27.12 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -169.38 26.66 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.448 -1.03 . . . . 0.0 109.2 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.496 HG21 ' HD2' ' A' ' 46' ' ' PRO . 18.5 m -155.32 141.63 13.11 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.577 ' HG3' ' CH2' ' A' ' 83' ' ' TRP . 15.0 Cg_exo -45.66 -18.44 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.072 1.848 . . . . 0.0 111.176 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.48 ' O ' HG11 ' A' ' 51' ' ' VAL . 3.4 mt-10 -77.49 -80.64 0.1 Allowed 'General case' 0 C--O 1.2 -1.541 0 O-C-N 120.827 -1.171 . . . . 0.0 108.773 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 38.0 mt-30 -48.65 -32.84 8.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.307 -1.496 . . . . 0.0 109.287 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.59 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -65.81 -62.75 1.33 Allowed 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.367 -0.833 . . . . 0.0 110.437 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.508 HG11 ' O ' ' A' ' 46' ' ' PRO . 4.3 p -70.23 -44.24 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.724 -1.235 . . . . 0.0 110.641 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.526 ' CG1' ' HA ' ' A' ' 48' ' ' GLN . 2.4 p -59.4 -43.49 90.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 121.769 -0.582 . . . . 0.0 110.326 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.1 OUTLIER -73.58 -48.19 34.69 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.59 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 7.7 mm-40 -59.95 -18.63 46.82 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.688 ' HB3' ' CE3' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -78.8 -65.36 1.0 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.582 0.706 . . . . 0.0 109.479 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -52.45 -55.53 21.25 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.48 -0.762 . . . . 0.0 109.052 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.587 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -43.44 -32.8 0.94 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 109.325 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -76.32 -90.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.452 -0.78 . . . . 0.0 109.656 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.577 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 4.9 t -80.03 -78.17 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 121.016 -1.053 . . . . 0.0 109.372 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.65 56.1 0.14 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.205 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.638 ' CD1' ' OE1' ' A' ' 63' ' ' GLN . 2.5 pp -107.73 -140.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 120.757 -1.437 . . . . 0.0 109.024 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.566 ' HB ' ' CD ' ' A' ' 62' ' ' PRO . 2.5 m -159.84 -67.19 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.276 0 O-C-N 119.754 -1.841 . . . . 0.0 112.535 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.628 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 11.5 Cg_exo -43.17 -67.12 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 122.265 1.977 . . . . 0.0 110.704 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.721 ' HB2' ' CE2' ' A' ' 95' ' ' TRP . 0.8 OUTLIER 29.65 27.71 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 114.603 -1.181 . . . . 0.0 113.638 178.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.631 ' C ' ' O ' ' A' ' 63' ' ' GLN . 20.2 t-160 -14.03 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.738 0 CA-C-N 120.181 1.355 . . . . 0.0 110.119 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.611 ' N ' ' O ' ' A' ' 63' ' ' GLN . 3.3 p90 -75.71 146.97 39.74 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.92 0.867 . . . . 0.0 112.377 -175.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 86' ' ' LEU . 4.6 m -148.59 151.47 35.1 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.677 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -80.24 -66.96 0.81 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.769 -1.207 . . . . 0.0 109.836 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.677 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 86.32 -56.81 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.565 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER 159.71 142.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.578 ' HE3' ' CD2' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -124.45 172.43 9.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.549 -0.719 . . . . 0.0 110.833 -178.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.556 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -121.11 176.72 5.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.819 . . . . 0.0 109.428 178.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.418 ' HG3' HG21 ' A' ' 81' ' ' THR . 7.3 tt0 -152.88 85.89 1.24 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.89 148.33 31.34 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -114.58 171.76 7.44 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.766 -1.174 . . . . 0.0 110.277 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.638 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -142.44 -177.14 0.62 Allowed Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.638 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.0 Cg_exo -57.12 -27.83 76.09 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.469 1.446 . . . . 0.0 109.75 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.459 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 56.5 p30 -169.98 36.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.468 ' O ' HD11 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -136.61 96.52 3.36 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.663 -0.648 . . . . 0.0 109.564 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.496 ' C ' ' CD1' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -82.13 116.43 21.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.391 -0.818 . . . . 0.0 109.501 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.617 HG22 ' C5 ' ' A' ' 130' ' ' APC . 0.4 OUTLIER -115.65 144.78 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.001 -1.062 . . . . 0.0 110.586 -179.282 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.601 ' N ' HG21 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -129.99 142.3 50.65 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.475 ' HG ' ' CG2' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -127.43 80.8 1.98 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.634 -1.291 . . . . 0.0 110.671 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.578 ' CD2' ' HE3' ' A' ' 70' ' ' LYS . 82.0 m95 -51.62 108.93 0.3 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.172 -0.955 . . . . 0.0 109.161 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.565 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 12.1 m-85 -87.46 70.88 9.91 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.215 -0.928 . . . . 0.0 109.684 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.648 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 13.6 m95 -70.51 83.63 0.59 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.91 -1.119 . . . . 0.0 108.791 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.577 HD22 ' CD2' ' A' ' 68' ' ' PHE . 2.9 mm? -71.87 124.91 25.88 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.41 -1.431 . . . . 0.0 110.242 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.562 ' CG2' HG23 ' A' ' 11' ' ' ILE . 1.5 m -112.31 -178.4 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.539 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 54.4 mt-10 -155.99 6.24 0.2 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 117.869 -1.533 . . . . 0.0 112.361 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.589 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -153.23 64.51 0.76 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.209 -1.557 . . . . 0.0 110.51 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.593 ' CH2' ' HB2' ' A' ' 13' ' ' ASN . 8.3 p90 -73.93 159.36 32.88 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.796 -1.19 . . . . 0.0 110.039 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.622 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.8 OUTLIER -78.02 138.11 38.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.407 -0.808 . . . . 0.0 109.347 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 30.42 -82.0 0.0 OUTLIER Glycine 0 N--CA 1.5 2.939 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.622 ' N ' ' O ' ' A' ' 91' ' ' GLU . 0.7 OUTLIER -88.37 158.33 49.1 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.188 -1.184 . . . . 0.0 109.874 -179.393 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.671 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 15.5 Cg_endo -71.41 -156.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.864 2.376 . . . . 0.0 110.332 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.722 ' CD1' ' O ' ' A' ' 95' ' ' TRP . 0.4 OUTLIER -178.67 120.11 0.08 Allowed 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.324 -0.86 . . . . 0.0 110.167 179.508 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.473 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . 145.25 -48.02 0.72 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.431 -1.842 . . . . 0.0 111.487 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.58 ' HG2' ' CE2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -39.36 118.18 0.79 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -1.177 . . . . 0.0 110.466 -178.356 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.593 ' CG ' ' N ' ' A' ' 38' ' ' GLY . 3.4 mm-40 -73.31 -143.54 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.04 -18.57 6.28 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.96 165.62 12.5 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.38 -1.071 . . . . 0.0 110.749 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HG2' ' OG1' ' A' ' 21' ' ' THR . 2.1 Cg_endo -69.05 -60.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.666 2.244 . . . . 0.0 110.006 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.603 ' O ' ' CE1' ' A' ' 19' ' ' PHE . . . 76.22 121.61 0.16 Allowed Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.587 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 5.9 pt-20 -156.29 134.18 11.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.391 -1.064 . . . . 0.0 110.048 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.532 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 1.1 m0 -46.53 133.83 9.81 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.605 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 4.9 tpt -117.98 114.35 23.04 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.031 -1.043 . . . . 0.0 109.432 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.6 t -80.39 61.07 4.03 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.614 HD23 ' HA ' ' A' ' 110' ' ' LEU . 4.7 tt -77.61 -49.1 15.27 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.57 ' CB ' ' O ' ' A' ' 107' ' ' LEU . 21.2 t 89.91 101.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-O 121.568 0.699 . . . . 0.0 109.267 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 46.77 84.57 0.02 OUTLIER Glycine 0 N--CA 1.484 1.85 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.62 ' CD2' ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -37.58 162.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.918 -0.754 . . . . 0.0 110.475 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.545 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 6.0 t-20 -138.73 -8.13 1.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 111.339 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.568 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . . . 81.74 -18.06 0.51 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.183 -0.948 . . . . 0.0 108.614 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.0 -21.17 66.81 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.552 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 13.0 m-20 -104.96 -15.47 15.12 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.62 ' CD1' ' CD2' ' A' ' 110' ' ' LEU . 3.2 m-85 -91.42 133.44 31.37 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.151 -0.968 . . . . 0.0 109.121 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.1 131.56 43.5 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 121.398 1.399 . . . . 0.0 108.617 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.457 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 3.3 Cg_exo -52.99 -22.04 17.46 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.365 2.043 . . . . 0.0 112.181 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.08 -39.07 68.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.723 -1.235 . . . . 0.0 109.552 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.528 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 25.8 p30 -96.26 45.12 1.07 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.444 -0.785 . . . . 0.0 109.69 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.66 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.2 mt-10 -70.25 -33.15 3.15 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 113.191 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.2 Cg_exo -55.96 -47.83 22.9 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.218 1.279 . . . . 0.0 112.801 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.475 HG21 ' HB3' ' A' ' 71' ' ' LEU . 1.9 t -92.91 -33.93 5.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 120.531 -1.355 . . . . 0.0 109.489 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.594 HG12 ' CD2' ' A' ' 115' ' ' PHE . 1.7 mp -66.56 -20.84 27.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.52 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -58.55 -29.47 66.38 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 0.4 OUTLIER -80.38 -37.96 31.29 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.915 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.589 ' CD1' ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -65.83 -24.78 66.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.461 -1.399 . . . . 0.0 107.336 178.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.526 ' CD ' ' HB1' ' A' ' 112' ' ' ALA . 1.5 mtmp? -55.17 -35.73 65.09 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.459 ' O ' ' C ' ' A' ' 129' ' ' LEU . 1.9 mtp180 -83.93 -24.6 30.65 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.524 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 2.1 tp . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.069 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' APC . . . . . 0.617 ' C5 ' HG22 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HOH . . . . . 0.585 ' H1 ' ' HB3' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.404 ' HB2' ' OD1' ' A' ' 77' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.453 ' HD3' ' C ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -159.82 179.07 9.14 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.366 -0.834 . . . . 0.0 109.292 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HG3' ' HB3' ' A' ' 79' ' ' HIS . 4.9 ttpt -156.02 145.14 20.6 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.195 -0.941 . . . . 0.0 109.312 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.637 ' CD2' " O4'" ' A' ' 130' ' ' APC . 0.5 OUTLIER -140.95 177.26 8.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.244 -0.91 . . . . 0.0 109.535 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.559 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -141.55 174.27 10.72 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.536 ' CD1' ' N7 ' ' A' ' 130' ' ' APC . 0.2 OUTLIER -141.81 124.69 14.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 O-C-N 121.019 -1.051 . . . . 0.0 109.821 -178.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.561 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -87.0 60.12 6.03 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.541 ' HB ' ' CA ' ' A' ' 37' ' ' GLY . 0.8 OUTLIER -78.63 -87.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.79 -178.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.622 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 75.63 88.85 0.25 Allowed Glycine 0 C--N 1.297 -1.625 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.547 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -49.33 175.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.031 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -143.9 92.09 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.577 -1.249 . . . . 0.0 110.349 -178.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.603 ' NH1' ' CD2' ' A' ' 129' ' ' LEU . 8.8 mtm180 -75.62 174.09 10.19 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.534 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -161.14 -46.19 0.04 OUTLIER 'General case' 0 C--O 1.191 -2.017 0 C-N-CA 115.744 -2.382 . . . . 0.0 115.142 -177.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.494 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 1.5 tp10 -92.4 -27.97 17.17 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 118.64 -2.537 . . . . 0.0 110.369 -176.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -163.22 -45.21 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.569 ' ND2' ' HD2' ' A' ' 12' ' ' ARG . 0.7 OUTLIER -160.04 35.42 0.18 Allowed 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 177.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 105' ' ' MET . 17.4 mt-10 -84.54 94.08 8.49 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.098 -1.441 . . . . 0.0 110.046 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.572 ' CG2' ' HG2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -83.03 142.75 13.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.579 -0.701 . . . . 0.0 109.374 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.639 ' CD1' ' CG ' ' A' ' 94' ' ' PRO . 70.1 t80 -82.2 46.36 1.02 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.482 ' O ' ' HG2' ' A' ' 103' ' ' GLU . 6.7 tp -81.9 151.83 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-O 122.256 1.027 . . . . 0.0 112.016 -177.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.497 ' OG1' ' HG2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -63.88 90.45 0.06 Allowed 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.6 ' O ' ' C ' ' A' ' 23' ' ' ARG . 28.7 tpt180 -89.49 106.04 18.19 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.135 -0.978 . . . . 0.0 109.73 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.6 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 3.22 76.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 121.317 0.58 . . . . 0.0 110.865 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -39.35 -53.85 1.93 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.25 0.547 . . . . 0.0 109.965 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.54 -177.1 5.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.015 -1.053 . . . . 0.0 109.243 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -80.05 77.35 6.75 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.222 -0.924 . . . . 0.0 109.668 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.476 ' HB1' ' CD ' ' A' ' 23' ' ' ARG . . . -56.79 -31.23 64.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.92 . . . . 0.0 109.357 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.412 ' C ' ' SD ' ' A' ' 29' ' ' MET . 3.5 t60 67.97 8.12 6.26 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.343 -0.848 . . . . 0.0 109.104 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.601 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -120.03 -101.0 0.43 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.276 -0.89 . . . . 0.0 109.096 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.601 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 152.31 -10.49 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.703 -0.623 . . . . 0.0 110.329 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 12.2 m120 -78.35 6.03 9.25 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.893 -1.129 . . . . 0.0 109.646 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.497 ' HD2' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -81.91 47.21 1.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.393 -0.817 . . . . 0.0 110.415 -179.578 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.679 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 13.2 mt -117.84 91.03 3.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.851 -1.156 . . . . 0.0 109.125 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.533 ' C ' ' CG ' ' A' ' 35' ' ' PHE . 11.9 tt0 -90.31 -127.56 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.496 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.533 ' CG ' ' C ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -155.75 128.89 4.34 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.882 -1.136 . . . . 0.0 109.382 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.611 ' CB ' ' HA ' ' A' ' 97' ' ' LYS . 9.6 Cg_endo -69.79 97.85 0.66 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.055 1.837 . . . . 0.0 109.462 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' CA ' ' HB ' ' A' ' 8' ' ' VAL . . . -109.28 -173.55 21.03 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.308 -1.425 . . . . 0.0 111.455 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.519 ' HA2' ' OE1' ' A' ' 98' ' ' GLU . . . -163.74 20.35 0.15 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.581 ' HD3' " C5'" ' A' ' 130' ' ' APC . 1.9 tptm 58.83 108.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.528 -0.984 . . . . 0.0 110.106 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.561 ' HB ' ' CB ' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -82.02 130.63 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.825 -1.172 . . . . 0.0 109.227 178.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -173.66 -26.07 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.088 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.67 153.48 0.8 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.977 -1.077 . . . . 0.0 109.272 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 46.87 -117.04 2.76 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -170.95 23.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.471 -1.017 . . . . 0.0 109.621 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.52 HG21 ' HD2' ' A' ' 46' ' ' PRO . 84.5 m -140.41 139.67 21.15 Favored Pre-proline 0 C--O 1.203 -1.385 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 6.3 Cg_exo -50.26 -19.07 4.01 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 121.1 1.2 . . . . 0.0 110.128 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.49 ' HG2' ' CZ ' ' A' ' 65' ' ' PHE . 1.6 mt-10 -79.71 -86.83 0.07 Allowed 'General case' 0 C--O 1.201 -1.481 0 O-C-N 121.108 -0.995 . . . . 0.0 108.536 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.594 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 15.7 mt-30 -43.09 -29.48 0.36 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.704 -1.247 . . . . 0.0 110.081 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.599 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -72.04 -60.99 1.95 Allowed 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.418 -0.801 . . . . 0.0 109.83 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 3.8 p -66.84 -45.94 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.008 -1.058 . . . . 0.0 110.184 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.574 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 2.2 p -60.15 -46.89 93.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-O 121.239 0.542 . . . . 0.0 109.662 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.594 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 8.0 mmm180 -74.1 -21.61 59.83 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.599 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 26.5 mm-40 -78.3 -19.7 53.03 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.649 ' CD1' ' CD1' ' A' ' 95' ' ' TRP . 2.1 mm? -79.87 -42.03 25.06 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.166 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.637 ' HG2' ' CZ3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -79.91 -42.78 23.43 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.599 -0.688 . . . . 0.0 109.467 -179.399 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.549 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 1.1 pp20? -57.68 -23.27 50.68 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.545 -0.722 . . . . 0.0 110.01 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.472 ' OE2' ' HA3' ' A' ' 38' ' ' GLY . 9.1 mt-10 -80.24 -92.08 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.982 -1.074 . . . . 0.0 110.456 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.617 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 22.2 t -80.07 -78.93 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.486 -0.759 . . . . 0.0 110.745 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.36 35.57 0.14 Allowed Glycine 0 N--CA 1.496 2.698 0 C-N-CA 118.572 -1.775 . . . . 0.0 112.783 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.675 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.1 pp -91.13 -145.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 120.276 -1.72 . . . . 0.0 107.127 177.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.59 ' CB ' ' CD ' ' A' ' 62' ' ' PRO . 1.5 m -141.26 -73.45 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.256 -1.528 . . . . 0.0 110.496 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 61' ' ' THR . 6.2 Cg_endo -64.54 -171.5 0.16 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.105 1.203 . . . . 0.0 110.781 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.555 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 149.41 -23.14 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.508 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 13.5 t-160 43.91 80.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.49 ' CZ ' ' HG2' ' A' ' 47' ' ' GLU . 49.6 p90 -76.32 145.02 39.85 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.621 0.724 . . . . 0.0 110.373 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -141.58 142.54 33.48 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.634 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -67.18 -69.73 0.29 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.812 -1.18 . . . . 0.0 110.475 -179.146 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.634 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 83.99 -51.66 0.13 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.2 mt-10 170.31 177.27 0.05 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.581 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -161.16 173.18 15.5 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 109.675 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.545 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -141.15 178.41 7.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.145 -0.972 . . . . 0.0 110.596 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -151.41 93.94 1.95 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -79.5 129.68 34.7 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.524 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 4.8 tt0 -101.25 106.05 17.21 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.146 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.529 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -81.22 171.07 13.11 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.219 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 9.5 Cg_exo -47.33 -29.62 9.97 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.972 1.781 . . . . 0.0 109.999 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.454 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -162.53 28.28 0.1 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -134.36 90.95 2.73 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.791 -0.568 . . . . 0.0 109.961 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.524 ' CD2' ' HG3' ' A' ' 74' ' ' GLU . 1.9 t-160 -86.3 110.17 19.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.101 -1.0 . . . . 0.0 108.513 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.595 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -112.56 152.31 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.137 -0.977 . . . . 0.0 110.426 -178.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.559 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 4.1 m -125.98 137.23 53.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.647 ' CD1' HN61 ' A' ' 130' ' ' APC . 0.2 OUTLIER -128.62 79.64 1.92 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.594 -1.317 . . . . 0.0 110.775 -179.287 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.581 ' CE3' ' HD2' ' A' ' 70' ' ' LYS . 94.3 m95 -51.16 108.82 0.28 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.994 -1.066 . . . . 0.0 108.838 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.58 ' CD2' HG12 ' A' ' 122' ' ' VAL . 12.4 m-85 -82.36 69.32 9.08 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.053 -1.03 . . . . 0.0 109.947 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.622 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 97.5 m95 -71.95 82.8 0.94 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.06 -1.025 . . . . 0.0 109.692 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 66' ' ' SER . 3.0 mm? -67.05 124.17 22.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.459 -1.4 . . . . 0.0 109.631 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.539 ' CG2' ' CG2' ' A' ' 11' ' ' ILE . 0.7 OUTLIER -109.14 177.32 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 70.0 mt-10 -154.59 18.85 0.47 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 117.69 -1.604 . . . . 0.0 113.504 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.557 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -161.08 62.11 0.29 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 119.618 -1.926 . . . . 0.0 112.155 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.534 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 6.6 p90 -81.09 158.52 25.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.331 -1.481 . . . . 0.0 108.79 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -91.63 145.39 24.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.953 -1.092 . . . . 0.0 110.235 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 45.64 -87.44 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.57 ' O ' ' CG2' ' A' ' 60' ' ' ILE . 8.1 pt-20 -111.37 161.44 25.26 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.316 -1.108 . . . . 0.0 109.647 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.639 ' CG ' ' CD1' ' A' ' 19' ' ' PHE . 7.0 Cg_endo -74.68 -161.06 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.554 2.169 . . . . 0.0 109.594 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.675 ' CD2' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER 179.02 33.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.111 -0.993 . . . . 0.0 110.793 178.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.558 ' CA ' HD12 ' A' ' 54' ' ' LEU . . . -117.65 6.14 16.31 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.269 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.611 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 8.0 pttt -79.99 147.59 31.49 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.113 -1.227 . . . . 0.0 110.046 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.519 ' OE1' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -82.18 37.26 0.49 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.53 -0.731 . . . . 0.0 109.658 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.81 -10.54 73.4 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.594 ' CB ' ' CD ' ' A' ' 101' ' ' PRO . 11.8 pt20 -64.49 -172.14 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.451 -1.029 . . . . 0.0 108.677 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 100' ' ' GLN . 4.2 Cg_exo -65.65 -55.88 0.39 Allowed 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.122 1.215 . . . . 0.0 109.351 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.61 ' O ' ' CE1' ' A' ' 19' ' ' PHE . . . 57.26 115.38 0.01 OUTLIER Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 2.9 pt-20 -153.26 133.47 13.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.836 -1.391 . . . . 0.0 110.303 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.455 ' C ' ' O ' ' A' ' 103' ' ' GLU . 3.7 m0 -44.43 136.54 4.11 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.578 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -130.26 113.88 14.96 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.267 -179.378 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.65 51.11 1.62 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.486 0.66 . . . . 0.0 109.507 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.588 ' CD2' ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -65.42 -41.56 93.43 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.583 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 48.9 t 79.61 116.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.984 -0.447 . . . . 0.0 110.332 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . 39.3 83.55 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.653 ' CD2' ' CE1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -38.65 160.57 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.766 -0.843 . . . . 0.0 110.755 -178.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 112' ' ' ALA . 11.4 t30 -136.34 -4.81 2.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.483 -0.761 . . . . 0.0 110.932 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.598 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . . . 74.91 -4.09 2.45 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.09 -1.006 . . . . 0.0 108.768 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.54 -32.93 36.6 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.537 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -93.19 -11.21 33.27 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.679 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 5.0 m-85 -98.41 152.62 38.03 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.488 -0.758 . . . . 0.0 109.937 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.508 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 2.8 Cg_endo -68.79 135.44 32.85 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.198 1.932 . . . . 0.0 109.348 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 118' ' ' ALA . 6.3 Cg_exo -59.85 -27.7 85.53 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 121.89 1.727 . . . . 0.0 110.852 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -43.1 -51.18 5.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.107 -0.996 . . . . 0.0 109.572 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.468 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 0.4 OUTLIER -88.25 48.46 1.64 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.457 -0.777 . . . . 0.0 109.23 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.644 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -63.33 -41.85 70.82 Favored Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.787 -0.571 . . . . 0.0 112.013 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 8.0 Cg_exo -51.86 -39.18 68.72 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 121.889 1.726 . . . . 0.0 113.088 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.58 HG12 ' CD2' ' A' ' 84' ' ' PHE . 2.7 t -100.51 -37.91 6.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 120.446 -1.409 . . . . 0.0 110.037 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.598 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -60.94 -21.96 25.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.481 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -62.75 -34.52 77.39 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 9.4 mmtm -79.71 -38.51 33.27 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.982 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.613 ' CD1' ' CZ ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -59.24 -40.51 86.13 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.542 ' CD ' ' HB1' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -38.84 -37.16 0.32 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.09 0.947 . . . . 0.0 108.767 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.514 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -80.03 -51.81 8.58 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.287 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.603 ' CD2' ' NH1' ' A' ' 12' ' ' ARG . 2.5 tp . . . . . 0 N--CA 1.505 2.294 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.66 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' APC . . . . . 0.647 HN61 ' CD1' ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' HOH . . . . . 0.46 ' O ' ' O ' ' A' ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.481 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 1.1 tpp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.568 ' N ' ' HD3' ' A' ' 2' ' ' LYS . 0.2 OUTLIER 176.76 -152.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.474 -0.766 . . . . 0.0 109.243 -179.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.567 ' N ' ' HG2' ' A' ' 2' ' ' LYS . 2.7 tttt -102.1 151.82 21.72 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.628 ' CD2' " O4'" ' A' ' 130' ' ' APC . 0.2 OUTLIER -149.56 168.4 23.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.112 178.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.56 ' CB ' ' HB ' ' A' ' 81' ' ' THR . 1.6 mp0 -142.52 171.35 14.17 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.556 HG13 ' N7 ' ' A' ' 130' ' ' APC . 0.2 OUTLIER -138.36 115.62 11.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 C-N-CA 118.969 -1.092 . . . . 0.0 109.624 -179.414 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.551 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -84.39 63.68 7.94 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.649 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -79.06 -77.44 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.381 -0.825 . . . . 0.0 110.345 -178.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.626 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 67.59 88.26 0.07 OUTLIER Glycine 0 C--N 1.296 -1.68 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 -177.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.55 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -50.19 176.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.544 HG21 ' CG1' ' A' ' 87' ' ' VAL . 2.5 pt -142.54 77.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 C-N-CA 117.856 -1.537 . . . . 0.0 111.087 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 88' ' ' GLU . 0.4 OUTLIER -78.89 158.68 28.03 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 177.17 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.514 ' CG ' ' CZ3' ' A' ' 90' ' ' TRP . 12.1 p-10 -160.61 -24.33 0.06 Allowed 'General case' 0 C--O 1.188 -2.143 0 C-N-CA 115.608 -2.437 . . . . 0.0 115.5 -177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.517 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 20.6 tt0 -93.51 -27.0 16.91 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 118.05 -2.906 . . . . 0.0 108.911 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.44 -48.74 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.482 ' ND2' HD21 ' A' ' 107' ' ' LEU . 60.9 t-20 -162.95 38.09 0.1 Allowed 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 105' ' ' MET . 19.8 mt-10 -84.06 88.5 7.18 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 117.92 -1.512 . . . . 0.0 109.973 -177.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.541 HD12 ' CD1' ' A' ' 110' ' ' LEU . 1.5 pt -82.5 147.24 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.964 0.888 . . . . 0.0 111.167 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.589 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 12.7 t80 -82.58 45.28 0.96 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.508 HD12 ' O ' ' A' ' 34' ' ' GLU . 4.3 tp -80.42 151.35 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.85 0.833 . . . . 0.0 110.645 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.503 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -71.11 88.43 0.8 Allowed 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.591 ' O ' ' C ' ' A' ' 23' ' ' ARG . 28.2 tpt180 -86.2 94.56 9.33 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.53 -0.731 . . . . 0.0 110.373 -178.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.591 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 17.89 75.97 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.142 0.496 . . . . 0.0 110.346 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -39.36 -55.72 1.69 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.608 -0.683 . . . . 0.0 110.168 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.46 -147.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.158 -0.964 . . . . 0.0 108.988 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 77.4 m-20 -79.88 -60.77 2.21 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.026 -1.046 . . . . 0.0 109.128 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 26' ' ' ASP . . . 81.78 -28.33 0.12 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.435 -0.791 . . . . 0.0 110.715 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER 49.15 25.3 1.13 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.413 ' N ' ' C ' ' A' ' 27' ' ' ALA . 5.6 mtt -145.08 -164.16 1.87 Allowed 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.463 ' O ' ' OD1' ' A' ' 114' ' ' ASP . . . -164.25 23.13 0.07 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.804 -1.185 . . . . 0.0 110.326 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 114' ' ' ASP . 1.3 m-20 -101.9 15.94 27.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.058 -1.026 . . . . 0.0 108.259 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -81.81 50.72 1.57 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.767 -0.583 . . . . 0.0 111.006 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.616 ' O ' ' CE1' ' A' ' 115' ' ' PHE . 17.0 mt -109.57 86.77 2.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.763 -1.211 . . . . 0.0 108.875 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.576 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -91.5 -135.87 0.14 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.123 -0.986 . . . . 0.0 110.191 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.576 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -150.45 119.44 3.64 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 120.758 -1.214 . . . . 0.0 109.626 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.553 ' CB ' ' HA ' ' A' ' 97' ' ' LYS . 11.5 Cg_endo -71.29 94.39 0.66 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.323 2.015 . . . . 0.0 110.772 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.649 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -127.2 -135.73 4.19 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 118.767 -1.682 . . . . 0.0 111.04 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.537 ' CA ' ' OE1' ' A' ' 98' ' ' GLU . . . 167.65 35.53 0.02 OUTLIER Glycine 0 N--CA 1.487 2.071 0 O-C-N 121.383 -1.069 . . . . 0.0 110.53 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.577 ' HD3' H5'1 ' A' ' 130' ' ' APC . 14.1 tptm 56.5 110.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.979 -0.718 . . . . 0.0 111.891 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.56 ' CG1' ' HB2' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -81.9 142.13 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.217 -0.927 . . . . 0.0 108.662 177.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.414 ' N ' HG12 ' A' ' 40' ' ' ILE . 10.9 pt-20 -172.21 -30.45 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.417 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.3 mmm -55.33 149.0 13.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.148 -0.97 . . . . 0.0 110.011 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.48 -127.44 33.66 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -164.66 18.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.493 -1.004 . . . . 0.0 109.842 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.499 ' O ' ' HB1' ' A' ' 49' ' ' ALA . 45.4 m -133.39 137.23 28.64 Favored Pre-proline 0 C--O 1.204 -1.332 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.594 ' HG3' ' CH2' ' A' ' 83' ' ' TRP . 3.0 Cg_exo -48.98 -16.37 0.83 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 121.57 1.513 . . . . 0.0 110.281 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.473 ' O ' HG11 ' A' ' 51' ' ' VAL . 2.8 mt-10 -75.5 -85.47 0.05 OUTLIER 'General case' 0 C--O 1.203 -1.386 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.552 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 18.6 mt-30 -45.22 -34.75 2.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.66 -1.275 . . . . 0.0 109.778 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.594 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -63.77 -64.03 1.01 Allowed 'General case' 0 C--N 1.292 -1.927 0 O-C-N 121.339 -0.85 . . . . 0.0 109.666 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.581 ' O ' ' CD2' ' A' ' 54' ' ' LEU . 2.0 p -66.69 -51.89 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.049 -1.032 . . . . 0.0 110.55 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.57 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 3.7 p -51.97 -44.76 39.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.352 -0.843 . . . . 0.0 110.731 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.55 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 5.8 mmt180 -74.76 -37.79 62.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 108.875 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.594 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 6.5 mm-40 -70.37 -13.08 61.99 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.665 ' CD1' ' CD1' ' A' ' 95' ' ' TRP . 1.6 mm? -80.06 -63.82 1.33 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.622 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.41 -52.71 64.28 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.833 -0.542 . . . . 0.0 110.176 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.558 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -47.28 -22.35 0.4 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.017 -1.052 . . . . 0.0 109.875 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.441 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 3.4 mt-10 -80.03 -96.79 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.046 -1.034 . . . . 0.0 109.31 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.645 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 57.4 t -80.01 -79.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.215 -0.928 . . . . 0.0 109.322 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 133.66 46.33 0.11 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.247 -1.454 . . . . 0.0 111.777 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.638 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -87.59 -127.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.604 -1.527 . . . . 0.0 108.44 178.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.585 ' CB ' ' CD ' ' A' ' 62' ' ' PRO . 1.3 m -159.64 -68.6 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.006 -1.684 . . . . 0.0 112.146 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 61' ' ' THR . 2.2 Cg_endo -54.19 -80.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.028 1.819 . . . . 0.0 112.061 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.591 ' NE2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER 39.81 61.62 1.41 Allowed 'General case' 0 C--N 1.289 -2.039 0 CA-C-O 121.781 0.8 . . . . 0.0 109.608 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.654 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -53.24 102.22 0.05 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -95.46 144.28 26.09 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 122.177 0.989 . . . . 0.0 111.362 -177.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -143.25 145.0 32.37 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.149 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.599 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 1.4 tm? -67.95 -64.45 0.86 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.068 -1.02 . . . . 0.0 110.808 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.599 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 83.6 -54.2 0.15 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.357 -0.84 . . . . 0.0 108.796 -179.359 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.596 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 6.0 tp10 164.86 128.9 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -118.97 -171.71 2.15 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.443 -0.786 . . . . 0.0 109.868 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.527 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.6 OUTLIER -142.06 -172.04 3.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 110.315 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -159.75 94.26 1.13 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.45 151.3 22.08 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.275 -0.891 . . . . 0.0 108.87 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.437 ' OE2' ' CE1' ' A' ' 79' ' ' HIS . 2.0 tt0 -119.71 137.5 53.88 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.144 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.558 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 1.1 m-30 -106.55 172.92 3.48 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.5 Cg_exo -46.24 -39.95 21.48 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.706 1.604 . . . . 0.0 110.31 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.431 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 3.1 m-20 -156.24 40.1 0.36 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.57 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -147.33 101.75 3.41 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.477 ' C ' ' CD1' ' A' ' 80' ' ' ILE . 5.5 m170 -77.81 137.26 38.32 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.57 ' CD1' ' O ' ' A' ' 78' ' ' ARG . 1.9 mp -132.82 153.74 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.767 -1.208 . . . . 0.0 110.653 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.56 ' HB ' ' CB ' ' A' ' 5' ' ' GLN . 1.6 m -141.67 150.45 41.92 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.605 ' CD1' HN61 ' A' ' 130' ' ' APC . 0.3 OUTLIER -138.94 77.73 1.64 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.812 -1.18 . . . . 0.0 109.985 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.594 ' CH2' ' HG3' ' A' ' 46' ' ' PRO . 93.4 m95 -50.68 113.65 0.95 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 108.993 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.599 ' O ' ' O ' ' A' ' 67' ' ' LEU . 13.6 m-85 -90.76 70.56 6.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.254 -0.904 . . . . 0.0 110.208 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.626 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 61.5 m95 -77.46 87.6 3.82 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.705 -1.247 . . . . 0.0 109.751 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.55 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 3.0 mm? -68.2 129.55 40.25 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.524 -1.36 . . . . 0.0 109.974 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.591 ' CG1' ' NE2' ' A' ' 63' ' ' GLN . 0.8 OUTLIER -116.42 154.74 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.284 -0.885 . . . . 0.0 108.729 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 1.2 mt-10 -143.02 35.38 1.37 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.738 -1.226 . . . . 0.0 113.219 -178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.654 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -161.32 40.49 0.15 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 119.79 -1.819 . . . . 0.0 111.729 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.635 ' CH2' ' CD1' ' A' ' 104' ' ' TRP . 1.3 p90 -67.19 157.09 34.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.02 -1.675 . . . . 0.0 109.37 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.574 ' O ' ' CD1' ' A' ' 90' ' ' TRP . 10.4 pt-20 -77.8 -125.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.234 -0.916 . . . . 0.0 110.439 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.504 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -53.09 -55.22 25.14 Favored Glycine 0 N--CA 1.494 2.51 0 O-C-N 120.658 -1.277 . . . . 0.0 110.735 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.588 ' O ' ' CG2' ' A' ' 60' ' ' ILE . 6.9 pt-20 -132.94 166.91 25.79 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.161 -1.199 . . . . 0.0 109.577 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.588 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 9.9 Cg_endo -77.28 -168.14 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.36 2.04 . . . . 0.0 110.123 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.665 ' CD1' ' CD1' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -171.0 28.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 0.0 110.086 178.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.544 ' CA ' HD12 ' A' ' 54' ' ' LEU . . . -116.1 3.38 20.72 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.983 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.553 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 11.5 pttt -76.57 136.46 39.26 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.922 -1.34 . . . . 0.0 109.212 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.585 ' HG3' ' PG ' ' A' ' 130' ' ' APC . 2.6 tp10 -75.61 -117.63 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.64 22.33 36.2 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 107.47 -2.252 . . . . 0.0 107.47 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.471 ' OE1' ' HB3' ' A' ' 36' ' ' PRO . 1.5 pt20 -94.97 165.11 17.71 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.731 -0.864 . . . . 0.0 110.136 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 102' ' ' GLY . 1.4 Cg_endo -66.99 -42.55 8.0 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.994 1.796 . . . . 0.0 109.851 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.589 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 57.69 110.38 0.01 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 7.1 pt-20 -142.96 134.07 25.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.768 -1.43 . . . . 0.0 110.672 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.635 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 1.6 m0 -50.19 127.59 17.34 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.603 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -118.88 116.37 26.36 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.77 45.59 0.71 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.262 -0.899 . . . . 0.0 110.161 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.581 ' HG ' ' N ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -81.41 158.09 24.74 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.051 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.581 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 33.4 t -114.66 134.07 58.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.061 -1.024 . . . . 0.0 109.541 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 39.52 79.87 0.04 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.556 ' CA ' HD22 ' A' ' 107' ' ' LEU . 0.3 OUTLIER -41.62 166.13 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.573 -0.957 . . . . 0.0 110.694 -178.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 4.5 t30 -159.71 151.17 19.92 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.449 ' CB ' HG23 ' A' ' 123' ' ' ILE . . . -55.98 -22.07 24.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 108.563 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -42.72 -36.9 1.57 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.522 -0.736 . . . . 0.0 109.082 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.536 ' CB ' ' CD1' ' A' ' 33' ' ' LEU . 73.8 m-20 -115.29 -8.5 12.29 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.685 -0.634 . . . . 0.0 109.556 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.667 ' CG ' HG12 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -100.93 123.53 45.01 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.339 -0.851 . . . . 0.0 109.709 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.547 ' O ' ' CD1' ' A' ' 123' ' ' ILE . 7.2 Cg_exo -52.62 148.2 28.3 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.415 2.077 . . . . 0.0 111.373 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 118' ' ' ALA . 2.1 Cg_endo -62.61 -26.18 75.69 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.309 2.006 . . . . 0.0 110.699 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.6 -48.57 5.43 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.123 -0.986 . . . . 0.0 109.656 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.545 ' O ' ' CD1' ' A' ' 123' ' ' ILE . 0.8 OUTLIER -100.15 55.65 0.92 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.625 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 4.6 mt-10 -67.32 -43.19 42.64 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.602 -0.686 . . . . 0.0 112.366 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.3 Cg_exo -55.52 -31.78 79.93 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.764 1.643 . . . . 0.0 112.125 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.466 ' O ' HD12 ' A' ' 126' ' ' LEU . 2.4 t -101.05 -38.93 6.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.76 -1.212 . . . . 0.0 109.569 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.667 HG12 ' CG ' ' A' ' 115' ' ' PHE . 15.2 mt -55.77 -34.55 36.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.27 -38.5 58.45 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.949 0.881 . . . . 0.0 109.137 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -79.81 -37.37 35.31 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.242 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.582 ' CD1' ' N ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -59.3 -39.67 83.76 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.179 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -39.8 -37.66 0.57 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.949 0.88 . . . . 0.0 108.927 178.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.481 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -87.57 -49.9 6.87 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.502 ' HG ' ' NH2' ' A' ' 12' ' ' ARG . 1.9 tp . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.322 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' APC . . . . . 0.628 " O4'" ' CD2' ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' CON . . . . . 0.575 ' N3 ' ' O2A' ' A' ' 130' ' ' APC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' HOH . . . . . 0.441 ' O ' ' O ' ' A' ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.416 ' C ' ' HG3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.523 ' HE3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 178.79 -166.77 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.224 -0.923 . . . . 0.0 109.359 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.523 ' N ' ' HE3' ' A' ' 2' ' ' LYS . 17.0 tttt -140.83 140.28 34.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.084 -1.01 . . . . 0.0 109.343 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.66 ' HG ' " O4'" ' A' ' 130' ' ' APC . 0.0 OUTLIER -146.67 131.98 18.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.388 -0.82 . . . . 0.0 109.385 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.531 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 2.1 mp0 -98.51 162.06 13.35 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.549 HG13 ' N7 ' ' A' ' 130' ' ' APC . 0.9 OUTLIER -126.0 112.83 31.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.564 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -84.56 65.78 9.17 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.621 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 1.1 p -78.94 -70.37 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.023 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.659 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 57.5 83.43 0.05 OUTLIER Glycine 0 C--N 1.292 -1.915 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 -178.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.565 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -47.7 168.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -179.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.584 HG13 ' CB ' ' A' ' 19' ' ' PHE . 2.7 pt -133.24 95.14 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.344 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.533 ' HG2' ' CG2' ' A' ' 18' ' ' ILE . 15.8 mtm180 -76.78 179.83 5.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.596 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -158.69 -60.81 0.08 Allowed 'General case' 0 C--O 1.194 -1.856 0 C-N-CA 116.458 -2.097 . . . . 0.0 115.068 -177.119 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.551 ' CB ' ' HG3' ' A' ' 17' ' ' GLU . 6.9 tp10 -92.72 -26.04 17.94 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 119.254 -2.154 . . . . 0.0 111.745 -175.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -161.96 -45.17 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.479 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 14.7 t30 -160.41 35.81 0.17 Allowed 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 177.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 105' ' ' MET . 4.9 mm-40 -78.36 85.86 4.46 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 118.007 -1.477 . . . . 0.0 109.105 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.533 ' CG2' ' HG2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -79.15 142.49 13.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.615 ' CZ ' ' HG2' ' A' ' 94' ' ' PRO . 11.9 t80 -81.94 46.0 0.96 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.661 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 12.9 tt -79.1 153.0 4.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-O 121.858 0.837 . . . . 0.0 110.463 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.517 ' HB ' ' HD2' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -66.5 89.91 0.15 Allowed 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.255 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.509 ' O ' ' C ' ' A' ' 23' ' ' ARG . 28.5 tpt180 -87.37 81.77 7.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.184 -0.948 . . . . 0.0 110.416 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HB3' ' CB ' ' A' ' 27' ' ' ALA . 1.1 ptt180 32.53 72.79 0.07 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.917 -0.489 . . . . 0.0 110.269 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.23 -53.31 4.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -0.853 . . . . 0.0 109.302 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.28 -171.54 3.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.232 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -79.92 80.68 6.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.473 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 23' ' ' ARG . . . -61.31 -31.77 71.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.819 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 55.41 21.13 4.05 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.553 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 6.1 mmm -127.36 -112.53 0.28 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 160.01 -14.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.064 -1.022 . . . . 0.0 111.065 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -81.53 12.53 3.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.906 -1.122 . . . . 0.0 109.779 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.502 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -81.99 54.79 2.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.476 -0.765 . . . . 0.0 110.642 -179.479 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.594 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 6.4 mt -120.83 83.75 2.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.644 -1.285 . . . . 0.0 109.75 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.46 -146.98 0.19 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.389 -0.82 . . . . 0.0 109.358 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.65 ' CZ ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -140.16 125.61 11.5 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.864 -1.147 . . . . 0.0 110.157 -178.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.584 ' CB ' ' HA ' ' A' ' 97' ' ' LYS . 13.8 Cg_endo -73.78 100.11 1.23 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.364 2.043 . . . . 0.0 110.118 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -136.36 135.08 7.53 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.175 -1.488 . . . . 0.0 110.961 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.533 ' CA ' ' OE1' ' A' ' 98' ' ' GLU . . . -108.14 36.53 4.32 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.584 ' HB2' H3A1 ' A' ' 130' ' ' APC . 7.0 tptm 59.26 119.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.54 -0.976 . . . . 0.0 112.083 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.564 HG23 ' N ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -83.24 135.96 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.132 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -171.31 -31.51 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.906 -1.121 . . . . 0.0 110.266 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.55 142.98 25.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.133 -0.979 . . . . 0.0 109.316 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.22 -115.96 8.71 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -169.23 -15.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.775 -0.838 . . . . 0.0 110.737 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.508 HG21 ' HD2' ' A' ' 46' ' ' PRO . 24.9 m -103.82 141.09 21.78 Favored Pre-proline 0 C--O 1.205 -1.28 0 O-C-N 120.876 -1.14 . . . . 0.0 108.353 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HD2' HG21 ' A' ' 45' ' ' THR . 7.9 Cg_exo -47.32 -18.06 0.68 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.082 1.855 . . . . 0.0 110.938 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.477 ' O ' HG11 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -77.87 -81.89 0.09 Allowed 'General case' 0 C--O 1.202 -1.424 0 O-C-N 120.857 -1.152 . . . . 0.0 108.594 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.544 ' O ' ' CG ' ' A' ' 52' ' ' ARG . 53.0 mt-30 -48.73 -25.56 1.88 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.384 -1.448 . . . . 0.0 109.948 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.612 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -73.51 -59.65 2.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.875 -1.14 . . . . 0.0 109.874 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 2.5 p -70.01 -48.94 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.053 -1.029 . . . . 0.0 109.843 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.571 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 2.1 p -56.33 -42.91 75.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 O-C-N 121.797 -0.564 . . . . 0.0 110.4 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 48' ' ' GLN . 21.2 mmt180 -74.86 -35.7 62.33 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.612 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 15.7 mm-40 -68.07 -15.47 63.61 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.614 HD11 ' CG ' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -79.09 -62.79 1.59 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.473 ' NE2' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -57.37 -53.84 53.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.345 -0.847 . . . . 0.0 109.828 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.554 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -50.13 -21.7 1.4 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.334 -0.854 . . . . 0.0 110.496 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.4 mt-10 -80.04 -91.02 0.05 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.059 -1.026 . . . . 0.0 109.967 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.587 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 47.3 t -80.06 -78.98 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.448 -0.782 . . . . 0.0 110.302 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.18 22.21 0.1 OUTLIER Glycine 0 N--CA 1.494 2.563 0 C-N-CA 118.77 -1.681 . . . . 0.0 112.472 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.63 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.2 pt -81.19 -136.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.187 -1.772 . . . . 0.0 108.102 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.594 ' CB ' ' CD ' ' A' ' 62' ' ' PRO . 1.2 m -159.08 -68.6 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.465 -1.397 . . . . 0.0 109.967 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 61' ' ' THR . 5.7 Cg_endo -62.51 -173.74 0.15 Allowed 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.686 1.591 . . . . 0.0 110.741 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.56 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 1.1 pt20 145.19 -24.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.547 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.2 OUTLIER 43.32 48.96 5.92 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -42.84 160.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.745 0.783 . . . . 0.0 110.584 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -156.89 136.91 12.63 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.167 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.629 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -59.64 -71.92 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.824 -1.172 . . . . 0.0 110.321 -178.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.629 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 85.08 -56.55 0.09 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.026 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 30.9 tp10 165.97 123.38 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.604 0.716 . . . . 0.0 109.753 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HD2' ' CD2' ' A' ' 83' ' ' TRP . 5.7 ptmt -110.11 170.54 8.01 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.706 -0.621 . . . . 0.0 109.615 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.554 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -122.8 169.8 10.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.097 -1.002 . . . . 0.0 110.14 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -147.07 85.78 1.62 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.21 123.77 28.74 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.429 ' CG ' ' NE2' ' A' ' 79' ' ' HIS . 2.6 tt0 -91.85 108.43 19.92 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.281 -0.968 . . . . 0.0 109.017 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.522 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 1.9 m-85 -78.32 170.35 16.65 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.398 -0.814 . . . . 0.0 109.468 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 7.5 Cg_exo -49.65 -38.15 45.13 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.112 1.874 . . . . 0.0 109.714 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.63 43.46 0.44 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.502 ' O ' HD12 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -148.07 97.54 2.8 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.091 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.449 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -79.82 94.91 5.89 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.585 ' CG2' ' N ' ' A' ' 81' ' ' THR . 0.4 OUTLIER -102.17 164.52 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.183 -0.948 . . . . 0.0 110.559 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.585 ' N ' ' CG2' ' A' ' 80' ' ' ILE . 1.2 m -148.3 151.62 35.7 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.637 ' CD1' HN61 ' A' ' 130' ' ' APC . 0.2 OUTLIER -142.63 79.56 1.66 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.696 -1.253 . . . . 0.0 110.682 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.551 ' CD2' ' HD2' ' A' ' 70' ' ' LYS . 87.5 m95 -53.96 111.37 0.74 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 109.296 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.601 ' CG ' HG12 ' A' ' 122' ' ' VAL . 8.7 m-85 -87.01 71.31 10.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.157 -0.964 . . . . 0.0 109.546 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.659 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 67.5 m95 -75.44 86.6 2.58 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.94 -1.1 . . . . 0.0 109.554 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.565 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 1.7 mm? -67.89 130.75 43.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.626 -1.296 . . . . 0.0 109.711 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.533 HG21 ' N ' ' A' ' 88' ' ' GLU . 0.6 OUTLIER -111.37 179.45 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.19 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.533 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -160.93 17.6 0.12 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.341 -1.475 . . . . 0.0 112.57 -179.349 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.575 ' O ' ' CD ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.52 50.63 0.28 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.048 -1.657 . . . . 0.0 111.139 179.439 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.596 ' CH2' ' HB2' ' A' ' 13' ' ' ASN . 4.0 p90 -67.4 164.61 18.27 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.687 -1.258 . . . . 0.0 109.351 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.606 ' O ' ' N ' ' A' ' 93' ' ' GLU . 6.6 tt0 -87.95 140.18 29.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.152 -0.967 . . . . 0.0 109.363 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 36.29 -85.17 0.01 OUTLIER Glycine 0 N--CA 1.497 2.731 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 91' ' ' GLU . 10.4 pt-20 -101.61 159.61 28.93 Favored Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.242 -1.152 . . . . 0.0 109.706 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.615 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 15.0 Cg_endo -75.52 -159.94 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.364 2.043 . . . . 0.0 109.669 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.63 ' CD2' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER 175.18 27.21 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.72 -0.612 . . . . 0.0 110.667 178.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.519 ' HA2' HD12 ' A' ' 54' ' ' LEU . . . -103.28 -6.15 45.3 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.584 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -81.15 128.54 33.87 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.347 -1.09 . . . . 0.0 110.854 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.533 ' OE1' ' CA ' ' A' ' 38' ' ' GLY . 22.7 tp10 -81.69 -96.14 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.529 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . -89.7 -19.5 47.88 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 107.634 -2.187 . . . . 0.0 107.634 177.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.514 ' HG3' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -61.55 149.29 84.53 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.865 -0.786 . . . . 0.0 109.219 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.517 ' HD2' ' HB ' ' A' ' 21' ' ' THR . 1.2 Cg_endo -67.6 -37.35 16.93 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.737 1.625 . . . . 0.0 108.79 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.61 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.12 123.2 0.01 OUTLIER Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.555 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 1.4 pp20? -151.79 125.65 9.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.957 -1.319 . . . . 0.0 109.795 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.592 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 1.2 m-90 -45.08 132.62 7.0 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.62 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 7.7 tpt -124.31 120.73 33.02 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.288 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.31 47.51 1.16 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.608 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 6.8 tt -59.47 -48.0 83.32 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.74 -0.6 . . . . 0.0 109.427 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.608 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 49.3 t 82.79 112.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 40.89 82.79 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.577 ' CB ' ' HB3' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -42.08 164.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.377 -1.073 . . . . 0.0 109.869 -179.211 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 3.6 t-20 -138.43 -6.97 1.53 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.001 -1.062 . . . . 0.0 111.924 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.595 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . . . 82.34 -26.43 0.14 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.219 -0.926 . . . . 0.0 108.87 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER -58.27 -24.42 59.35 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.003 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.553 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 4.4 m-20 -103.07 -13.64 16.75 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.661 ' CZ ' ' CD1' ' A' ' 20' ' ' ILE . 2.0 m-85 -95.3 143.25 25.79 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.287 -0.883 . . . . 0.0 109.945 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -60.15 132.97 47.14 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.032 1.822 . . . . 0.0 109.575 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.55 -16.29 23.42 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.144 1.896 . . . . 0.0 110.988 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.05 -57.28 9.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.939 -1.1 . . . . 0.0 109.104 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.65 ' ND2' ' CZ ' ' A' ' 35' ' ' PHE . 9.8 m-20 -86.67 48.55 1.65 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.806 0.812 . . . . 0.0 109.043 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -56.61 -44.12 99.62 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.778 -0.576 . . . . 0.0 112.427 -179.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 11.5 Cg_exo -53.3 -57.55 1.93 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.048 1.832 . . . . 0.0 112.962 -177.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.601 HG12 ' CG ' ' A' ' 84' ' ' PHE . 2.0 t -78.93 -32.99 15.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 120.788 -1.195 . . . . 0.0 109.532 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.595 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 5.7 mt -64.16 -23.97 34.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.544 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -61.49 -28.45 69.31 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.899 0.857 . . . . 0.0 108.92 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -80.35 -40.09 27.3 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.752 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.577 ' HB3' ' CB ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -66.3 -22.02 66.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.623 -1.298 . . . . 0.0 107.845 179.148 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.565 ' CD ' ' HB1' ' A' ' 112' ' ' ALA . 12.6 mtmt -58.35 -33.54 69.66 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -87.19 -21.42 25.9 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.602 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 1.6 tp . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.736 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' APC . . . . . 0.66 " O4'" ' HG ' ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' HOH . . . . . 0.472 ' O ' ' O ' ' A' ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 2' ' ' LYS . 2.9 ptt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.5 ' HE2' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -47.43 176.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 0.0 109.467 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.5 ' N ' ' HE2' ' A' ' 2' ' ' LYS . 26.8 tttt -158.72 149.15 19.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.976 . . . . 0.0 109.89 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.599 ' HG ' " O4'" ' A' ' 130' ' ' APC . 0.0 OUTLIER -157.24 144.33 18.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.979 179.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.525 ' HG3' ' CB ' ' A' ' 81' ' ' THR . 9.7 mp0 -108.71 166.08 11.06 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.617 HG13 ' N7 ' ' A' ' 130' ' ' APC . 0.8 OUTLIER -128.81 114.73 34.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 O-C-N 120.992 -1.067 . . . . 0.0 109.334 -178.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.454 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -85.2 62.61 7.6 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 36' ' ' PRO . 1.2 p -79.01 -70.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.353 -0.842 . . . . 0.0 109.972 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.629 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 59.08 84.48 0.04 OUTLIER Glycine 0 N--CA 1.481 1.649 0 N-CA-C 107.569 -2.212 . . . . 0.0 107.569 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.478 HG13 ' CD1' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -48.63 166.76 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.533 HG23 ' CG2' ' A' ' 87' ' ' VAL . 1.8 pt -130.65 78.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.687 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.585 ' HB3' ' CG2' ' A' ' 18' ' ' ILE . 2.9 ptm180 -83.25 144.92 29.42 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.598 ' OD1' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -161.3 -5.6 0.05 OUTLIER 'General case' 0 C--O 1.185 -2.291 0 C-N-CA 116.769 -1.972 . . . . 0.0 114.203 -179.072 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.588 ' HB2' ' CG ' ' A' ' 17' ' ' GLU . 19.7 mm-40 -94.02 -32.2 13.92 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 118.182 -2.824 . . . . 0.0 107.471 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -162.82 -48.62 0.04 OUTLIER 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 102.382 -3.192 . . . . 0.0 102.382 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -161.74 35.78 0.13 Allowed 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 175.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 105' ' ' MET . 0.3 OUTLIER -86.1 92.86 8.85 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.069 -1.452 . . . . 0.0 110.8 -176.449 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.585 ' CG2' ' HB3' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -84.95 156.66 3.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.536 0.684 . . . . 0.0 109.872 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.605 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 6.4 t80 -82.97 44.1 0.9 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.556 ' CG2' HG13 ' A' ' 18' ' ' ILE . 7.0 tp -82.05 155.69 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.148 -0.97 . . . . 0.0 110.55 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' A' ' 101' ' ' PRO . 5.0 t -73.08 89.23 1.46 Allowed 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.465 ' O ' ' C ' ' A' ' 23' ' ' ARG . 29.1 tpt180 -90.21 76.06 6.9 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.501 -0.75 . . . . 0.0 110.555 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.523 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 35.26 76.97 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.762 -0.586 . . . . 0.0 110.093 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.55 -52.98 9.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.928 . . . . 0.0 109.875 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.28 -170.23 2.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.119 -0.988 . . . . 0.0 109.489 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -79.5 128.51 33.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.194 -0.941 . . . . 0.0 109.141 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.523 ' CB ' ' HD2' ' A' ' 23' ' ' ARG . . . -124.46 -44.85 1.97 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.132 -0.98 . . . . 0.0 110.184 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.6 t60 56.41 20.44 4.75 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.49 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 6.3 mtp -115.28 -40.99 3.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.654 -0.654 . . . . 0.0 109.372 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' A' ' 31' ' ' ASN . . . 76.18 -177.49 0.13 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.304 -0.872 . . . . 0.0 109.003 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 1.3 t30 78.1 -5.95 2.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 109.403 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.49 ' O ' ' O ' ' A' ' 21' ' ' THR . 3.8 tmtm? -82.59 48.29 1.29 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.433 -0.792 . . . . 0.0 109.871 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.629 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 9.5 mt -117.91 79.93 1.44 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.846 -1.158 . . . . 0.0 109.304 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.589 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 13.2 tt0 -81.3 -134.18 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.345 -0.847 . . . . 0.0 109.132 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.589 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -149.37 124.75 4.94 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.544 -1.348 . . . . 0.0 110.261 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.549 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 1.7 Cg_endo -57.99 94.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.14 1.893 . . . . 0.0 109.515 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -55.34 -148.14 0.01 OUTLIER Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.287 -0.883 . . . . 0.0 111.757 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.602 ' N ' ' CG ' ' A' ' 98' ' ' GLU . . . 157.41 -31.96 0.53 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 107.538 -2.225 . . . . 0.0 107.538 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HE3' HD21 ' A' ' 4' ' ' LEU . 2.5 tptm 67.18 100.43 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 122.237 -0.567 . . . . 0.0 110.744 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.553 HG22 ' CD1' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -80.74 134.5 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.721 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' A' ' 42' ' ' MET . 4.0 pt-20 -171.39 -31.94 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.784 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.443 ' O ' ' C ' ' A' ' 43' ' ' GLY . 4.4 mmt -54.69 162.92 1.05 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.113 -0.992 . . . . 0.0 109.252 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 42' ' ' MET . . . 43.93 -125.81 5.68 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -164.6 23.21 0.06 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.474 -1.015 . . . . 0.0 108.948 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.505 ' O ' ' HB1' ' A' ' 49' ' ' ALA . 24.1 m -138.24 140.04 27.34 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.5 ' O ' HG11 ' A' ' 50' ' ' VAL . 10.0 Cg_exo -51.05 -17.84 3.95 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 121.748 1.632 . . . . 0.0 110.136 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' O ' HG11 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -77.95 -85.14 0.07 Allowed 'General case' 0 C--O 1.202 -1.401 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.519 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.553 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 14.3 mt-30 -43.83 -33.17 1.24 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.569 -1.332 . . . . 0.0 109.715 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.616 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -65.76 -62.63 1.4 Allowed 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.511 -0.743 . . . . 0.0 110.021 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.561 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 2.6 p -68.99 -49.58 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.216 -0.928 . . . . 0.0 110.316 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.561 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 3.4 p -54.95 -45.48 76.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 121.684 -0.635 . . . . 0.0 110.186 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 5.4 mmt180 -71.06 -37.35 72.49 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.616 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 17.6 mm-40 -68.9 -14.59 63.13 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.606 ' HB3' ' CH2' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -80.0 -59.94 2.53 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -54.04 46.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.447 -0.783 . . . . 0.0 110.007 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.565 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 1.1 pp20? -47.57 -21.74 0.39 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.039 -1.038 . . . . 0.0 110.075 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.433 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 3.3 mt-10 -80.04 -92.92 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.075 -1.016 . . . . 0.0 109.632 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.634 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 36.2 t -79.97 -78.34 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 110.117 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.94 18.89 0.1 OUTLIER Glycine 0 N--CA 1.493 2.496 0 C-N-CA 118.43 -1.843 . . . . 0.0 112.643 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.621 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.6 pp -80.05 -156.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.123 -1.81 . . . . 0.0 107.628 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.572 ' CB ' ' CD ' ' A' ' 62' ' ' PRO . 1.5 m -137.36 -72.25 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.421 -1.424 . . . . 0.0 110.947 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.584 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 1.6 Cg_endo -61.43 -169.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 121.029 1.153 . . . . 0.0 110.712 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.584 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER 143.27 -23.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -179.436 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.554 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 1.6 t-80 44.84 53.21 7.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.455 -0.778 . . . . 0.0 109.484 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -45.97 156.05 0.16 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.036 0.922 . . . . 0.0 110.372 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -149.36 140.62 23.14 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.604 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -63.49 -68.1 0.37 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.731 -1.23 . . . . 0.0 109.78 -179.112 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.604 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 83.73 -50.53 0.14 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.599 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.5 mt-10 162.16 174.02 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.36 -172.38 3.36 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.824 -1.172 . . . . 0.0 109.891 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.548 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -140.18 -177.7 5.13 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.795 0.807 . . . . 0.0 109.891 179.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.407 ' HG3' HG21 ' A' ' 81' ' ' THR . 11.3 tt0 -160.18 88.7 0.82 Allowed 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.03 105.48 9.27 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.497 ' HG3' ' NE2' ' A' ' 79' ' ' HIS . 2.8 tt0 -96.72 118.29 32.86 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.119 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -105.69 174.3 2.72 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 2.9 Cg_exo -49.03 -60.51 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 121.418 1.412 . . . . 0.0 109.558 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.5 50.39 1.71 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.473 ' CD ' HD12 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -150.36 87.97 1.48 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.457 -0.777 . . . . 0.0 109.743 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.497 ' NE2' ' HG3' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -90.28 98.72 11.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.89 . . . . 0.0 109.386 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.627 HG22 ' C6 ' ' A' ' 130' ' ' APC . 0.5 OUTLIER -113.14 163.55 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.0 110.253 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.575 ' N ' ' CG2' ' A' ' 80' ' ' ILE . 0.7 OUTLIER -151.34 147.1 26.52 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.336 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.517 ' O ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -134.49 73.83 1.51 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.918 -1.114 . . . . 0.0 110.816 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.553 ' CD1' HG22 ' A' ' 40' ' ' ILE . 78.8 m95 -46.35 117.15 1.47 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.06 -1.025 . . . . 0.0 108.563 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.576 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 33.9 m-85 -94.03 76.78 4.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.966 -1.084 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.629 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 24.6 m95 -76.89 84.21 3.45 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.902 -1.124 . . . . 0.0 109.372 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.589 HD22 ' CD1' ' A' ' 68' ' ' PHE . 2.4 mm? -69.24 128.04 35.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.671 -1.268 . . . . 0.0 109.212 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.533 ' CG2' HG23 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -112.0 175.78 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 87.2 mt-10 -157.14 19.41 0.3 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.48 -1.388 . . . . 0.0 112.786 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.578 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.67 64.16 0.31 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.105 -1.622 . . . . 0.0 111.087 178.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.61 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 1.5 p90 -80.74 164.6 22.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.747 -1.22 . . . . 0.0 109.156 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.6 OUTLIER -88.27 142.94 27.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.854 -1.154 . . . . 0.0 109.386 178.314 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 38.25 -83.37 0.0 OUTLIER Glycine 0 N--CA 1.498 2.814 0 O-C-N 121.585 -0.697 . . . . 0.0 112.073 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' A' ' 91' ' ' GLU . 10.6 pt-20 -106.98 164.86 13.93 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.149 -1.206 . . . . 0.0 111.254 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.583 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 11.2 Cg_endo -75.86 -160.91 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 122.717 2.278 . . . . 0.0 109.934 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.634 ' HA ' ' CG2' ' A' ' 58' ' ' VAL . 0.2 OUTLIER 176.51 54.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.196 -0.94 . . . . 0.0 110.865 178.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . -139.98 0.6 2.12 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 118.334 -1.888 . . . . 0.0 111.814 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.541 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -78.03 106.94 10.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.403 -1.646 . . . . 0.0 110.772 -179.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.602 ' CG ' ' N ' ' A' ' 38' ' ' GLY . 1.2 mm-40 -60.27 -91.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.735 -1.228 . . . . 0.0 107.73 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.74 22.17 34.55 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 106.692 -2.563 . . . . 0.0 106.692 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.506 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -100.11 143.38 26.39 Favored Pre-proline 0 N--CA 1.485 1.289 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.498 ' HD2' ' HB ' ' A' ' 21' ' ' THR . 4.4 Cg_exo -57.31 -30.67 88.5 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 N-CA-C 108.127 -1.528 . . . . 0.0 108.127 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.605 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 53.63 110.97 0.01 OUTLIER Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 4.6 pt-20 -147.8 133.73 19.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.758 -1.437 . . . . 0.0 110.557 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.53 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 7.8 m0 -46.06 123.62 4.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 108.495 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.619 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -115.55 111.07 20.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.08 -1.012 . . . . 0.0 109.764 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.507 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 19.3 t -79.58 63.07 4.06 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.368 -0.832 . . . . 0.0 110.634 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.536 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 4.2 pp -82.37 -40.38 21.41 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.3 -0.875 . . . . 0.0 109.883 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.536 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 2.0 t 70.64 118.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 42.53 84.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.621 -1.791 . . . . 0.0 108.621 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.623 HD23 ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -45.74 174.34 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.587 -0.949 . . . . 0.0 110.147 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 112' ' ' ALA . 4.4 t-20 -152.77 0.54 0.28 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.979 -1.075 . . . . 0.0 112.069 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.558 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . . . 79.78 -32.3 0.13 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.889 -1.132 . . . . 0.0 109.008 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 111' ' ' ASN . 3.1 t0 -49.8 -26.51 3.99 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.55 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 9.2 m-20 -108.3 -17.62 13.96 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.809 -0.557 . . . . 0.0 109.872 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.629 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -91.77 144.32 29.21 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.134 -0.979 . . . . 0.0 109.853 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.531 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.8 Cg_endo -65.2 134.13 38.05 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.269 1.979 . . . . 0.0 109.962 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 118' ' ' ALA . 5.5 Cg_exo -60.65 -25.52 81.04 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.083 1.856 . . . . 0.0 110.731 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.91 -46.58 5.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.215 -0.928 . . . . 0.0 109.231 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.485 ' HB2' ' CE2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -95.33 51.78 1.35 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.326 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.627 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -59.97 -44.15 96.1 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.621 -0.674 . . . . 0.0 112.358 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.2 Cg_exo -54.34 -32.89 74.13 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.013 1.809 . . . . 0.0 112.872 -177.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.56 HG22 ' CE1' ' A' ' 84' ' ' PHE . 2.4 t -101.41 -36.8 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.522 -1.361 . . . . 0.0 110.153 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.558 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 1.1 mp -61.93 -27.85 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.519 ' HA ' ' CE ' ' A' ' 127' ' ' LYS . . . -55.06 -35.08 64.14 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 125' ' ' LYS . 26.0 mmtp -80.11 -41.62 25.16 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.946 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.602 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -60.3 -22.0 62.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.335 -1.478 . . . . 0.0 107.448 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.535 ' HD3' ' CB ' ' A' ' 112' ' ' ALA . 6.3 mttt -57.36 -42.02 81.23 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -79.07 -18.98 52.45 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 2.5 tp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.984 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' APC . . . . . 0.627 ' C6 ' HG22 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' HOH . . . . . 0.401 ' O ' ' O ' ' A' ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.412 0.625 . . . . 0.0 109.452 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.522 ' HE3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -156.49 -173.91 4.7 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.408 -0.808 . . . . 0.0 109.2 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.522 ' N ' ' HE3' ' A' ' 2' ' ' LYS . 3.6 ttpm? -121.88 153.81 37.92 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.194 -0.941 . . . . 0.0 109.443 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.568 ' HG ' " O4'" ' A' ' 130' ' ' APC . 0.0 OUTLIER -148.22 122.11 9.37 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.539 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 2.9 mp0 -110.65 154.65 23.52 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.114 -0.991 . . . . 0.0 108.339 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.541 HG13 ' N7 ' ' A' ' 130' ' ' APC . 1.0 OUTLIER -122.5 118.21 54.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.396 -178.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HB3' ' CB ' ' A' ' 50' ' ' VAL . . . -85.52 60.76 6.44 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.529 ' HB ' ' HA2' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -79.16 -71.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.096 -179.203 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.645 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 59.84 82.23 0.07 OUTLIER Glycine 0 C--N 1.298 -1.57 0 N-CA-C 106.304 -2.719 . . . . 0.0 106.304 -177.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.534 HG23 ' CG2' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -48.15 154.69 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -178.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 4.0 pt -116.48 102.27 13.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.886 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.529 ' NH1' ' OD1' ' A' ' 16' ' ' ASN . 8.6 mtm180 -76.65 -173.12 2.46 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.595 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -155.43 -66.32 0.12 Allowed 'General case' 0 C--O 1.188 -2.161 0 C-N-CA 116.826 -1.95 . . . . 0.0 114.267 -177.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.596 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 29.1 tp10 -91.51 -33.82 15.03 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 118.953 -2.342 . . . . 0.0 111.496 -175.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.483 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 41.8 t-20 -161.73 -42.08 0.04 OUTLIER 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.529 ' OD1' ' NH1' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -155.96 32.8 0.35 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 177.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.596 ' CG ' ' HB3' ' A' ' 14' ' ' GLU . 1.9 mm-40 -90.1 109.45 20.5 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 118.038 -1.465 . . . . 0.0 108.49 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.557 ' CD1' ' HB3' ' A' ' 105' ' ' MET . 0.2 OUTLIER -102.92 148.44 8.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.793 -177.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.622 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 20.4 t80 -81.54 38.34 0.49 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.513 ' O ' ' HG2' ' A' ' 103' ' ' GLU . 6.1 tp -78.47 152.55 5.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.259 -0.901 . . . . 0.0 110.442 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.477 HG23 ' NE2' ' A' ' 100' ' ' GLN . 1.4 t -65.49 85.5 0.07 Allowed 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.511 ' O ' ' C ' ' A' ' 23' ' ' ARG . 21.2 tpt180 -87.38 93.59 9.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.688 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.559 ' CB ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 28.55 76.63 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 120.986 0.422 . . . . 0.0 110.385 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.25 -47.52 4.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.363 -0.836 . . . . 0.0 109.105 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.25 155.1 26.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.869 . . . . 0.0 108.992 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -59.6 92.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.07 -1.018 . . . . 0.0 109.649 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.559 ' HB1' ' CB ' ' A' ' 23' ' ' ARG . . . -97.54 96.84 8.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -0.947 . . . . 0.0 109.947 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -48.95 -25.61 2.04 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.41 ' N ' ' C ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -72.06 -167.29 0.29 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.54 0.686 . . . . 0.0 109.477 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.528 ' O ' ' CB ' ' A' ' 31' ' ' ASN . . . -154.58 -157.98 0.81 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 0.7 OUTLIER 75.26 -2.7 2.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.059 -1.025 . . . . 0.0 109.074 -179.164 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.39 59.66 4.69 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.563 -0.71 . . . . 0.0 110.279 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.594 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 12.0 mt -122.41 85.09 2.36 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.556 ' O ' ' CD1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -80.8 -138.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.15 -1.593 . . . . 0.0 109.443 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 23.6 m-85 -154.22 123.98 3.26 Favored Pre-proline 0 N--CA 1.485 1.317 0 O-C-N 121.066 -1.021 . . . . 0.0 109.464 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 37' ' ' GLY . 2.1 Cg_endo -58.63 88.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.889 1.726 . . . . 0.0 109.464 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.529 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -57.12 -141.41 0.01 OUTLIER Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.569 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . 162.48 -55.35 0.3 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.574 ' HB2' ' PB ' ' A' ' 130' ' ' APC . 0.0 OUTLIER 99.04 69.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 123.11 0.564 . . . . 0.0 110.352 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.572 HG12 ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -53.79 123.45 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.963 -1.086 . . . . 0.0 108.684 179.353 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 42' ' ' MET . 8.1 pt-20 -173.16 -22.52 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.647 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.438 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -38.82 -81.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.133 -0.979 . . . . 0.0 110.153 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.41 -122.95 2.25 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.69 9.07 1.97 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.531 -0.982 . . . . 0.0 109.124 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.547 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 60.4 m -126.01 142.41 42.38 Favored Pre-proline 0 N--CA 1.486 1.335 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.585 ' HG3' ' CZ3' ' A' ' 83' ' ' TRP . 3.6 Cg_exo -52.41 -15.7 4.25 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.545 1.497 . . . . 0.0 110.317 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.485 ' O ' HG11 ' A' ' 51' ' ' VAL . 2.4 tt0 -75.97 -81.25 0.08 Allowed 'General case' 0 C--O 1.201 -1.486 0 O-C-N 120.983 -1.073 . . . . 0.0 108.638 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 1.3 mt-30 -47.75 -36.02 10.8 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.265 -1.522 . . . . 0.0 109.455 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.594 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -62.17 -64.17 1.01 Allowed 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.198 -0.939 . . . . 0.0 110.136 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.578 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 1.3 p -69.47 -49.81 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.305 -0.872 . . . . 0.0 110.657 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.578 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 3.1 p -55.89 -37.12 46.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.745 -0.597 . . . . 0.0 110.421 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.557 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -78.96 -37.16 40.22 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.594 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 2.2 mm-40 -69.83 -14.23 62.65 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.614 HD11 ' CG ' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -80.08 -65.5 1.0 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.498 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.06 -49.8 74.74 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.697 -0.627 . . . . 0.0 110.479 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.577 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -46.64 -24.76 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.881 -1.137 . . . . 0.0 109.915 -178.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 8.0 mm-40 -80.13 -95.04 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.091 -1.005 . . . . 0.0 109.563 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.622 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 66.3 t -79.96 -79.36 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.098 -1.001 . . . . 0.0 109.911 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.99 37.58 0.09 OUTLIER Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.241 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.643 HG13 ' CD2' ' A' ' 95' ' ' TRP . 2.9 pp -93.36 -152.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 120.793 -1.416 . . . . 0.0 108.542 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.588 ' N ' ' CD1' ' A' ' 60' ' ' ILE . 1.3 m -161.7 -64.96 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 120.327 -1.483 . . . . 0.0 112.511 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 64' ' ' HIS . 3.8 Cg_exo -51.59 -2.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.827 2.351 . . . . 0.0 114.267 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.504 ' C ' ' O ' ' A' ' 62' ' ' PRO . 1.3 pt20 -34.89 -29.15 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 119.575 1.079 . . . . 0.0 110.791 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.578 ' N ' ' O ' ' A' ' 62' ' ' PRO . 2.2 t60 55.32 73.37 0.42 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.676 -1.265 . . . . 0.0 108.053 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 15.5 p90 -72.99 146.4 46.01 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.791 0.805 . . . . 0.0 111.179 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -144.4 135.37 25.13 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.62 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -61.46 -70.16 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.752 -1.217 . . . . 0.0 109.985 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.62 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 84.1 -52.51 0.13 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -178.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.9 mm-40 172.69 177.54 0.09 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.262 -0.899 . . . . 0.0 108.885 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.422 ' HE2' HG21 ' A' ' 81' ' ' THR . 0.0 OUTLIER -161.37 -174.59 4.36 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.195 -0.941 . . . . 0.0 109.38 -179.389 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.569 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -149.02 175.79 11.0 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.135 -0.978 . . . . 0.0 109.986 179.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -144.06 89.16 2.01 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.15 123.16 27.11 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.24 156.3 17.3 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.294 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.569 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -133.22 174.13 5.07 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.569 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 5.4 Cg_exo -47.68 -33.35 18.44 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.696 1.597 . . . . 0.0 109.74 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 1' ' ' MET . 0.5 OUTLIER -164.18 51.59 0.14 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.152 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.487 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -155.64 94.0 1.53 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.652 -0.655 . . . . 0.0 109.778 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.46 ' O ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -78.72 120.7 23.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.047 -1.033 . . . . 0.0 108.707 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.61 HG23 ' C6 ' ' A' ' 130' ' ' APC . 1.3 mp -117.89 165.25 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 122.135 0.969 . . . . 0.0 110.592 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.598 ' N ' ' CG2' ' A' ' 80' ' ' ILE . 1.5 m -153.6 155.98 37.13 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.466 HD21 ' CE1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -148.49 77.04 1.38 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.912 -1.118 . . . . 0.0 110.301 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.585 ' CZ3' ' HG3' ' A' ' 46' ' ' PRO . 75.9 m95 -49.0 108.59 0.19 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.809 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.551 ' CG ' HG12 ' A' ' 122' ' ' VAL . 19.1 m-85 -85.06 69.81 10.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.134 -0.979 . . . . 0.0 109.593 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.645 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 71.0 m95 -74.23 87.53 1.96 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.905 -1.122 . . . . 0.0 109.361 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.565 HD22 ' CD2' ' A' ' 68' ' ' PHE . 3.3 mm? -70.07 126.98 31.26 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 120.67 -1.269 . . . . 0.0 109.573 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.523 ' CG2' HG23 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -101.52 179.98 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.01 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.523 ' N ' HG21 ' A' ' 87' ' ' VAL . 42.8 mt-10 -153.28 1.69 0.27 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 117.735 -1.586 . . . . 0.0 113.219 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.593 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.32 71.27 0.44 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.002 -1.686 . . . . 0.0 110.95 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.611 ' CH2' ' CD1' ' A' ' 104' ' ' TRP . 2.8 p90 -78.87 165.64 23.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.418 -1.426 . . . . 0.0 110.036 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.542 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 1.5 pt-20 -86.98 137.6 32.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.206 -0.934 . . . . 0.0 109.824 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 41.1 -89.49 0.01 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.561 ' O ' ' CG2' ' A' ' 60' ' ' ILE . 12.6 pt-20 -103.9 162.54 19.64 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.199 -1.177 . . . . 0.0 109.745 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.615 ' HG2' ' CE2' ' A' ' 19' ' ' PHE . 10.1 Cg_endo -76.64 -155.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.58 2.187 . . . . 0.0 110.067 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.643 ' CD2' HG13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER 179.48 49.64 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.336 -0.852 . . . . 0.0 110.56 179.115 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 36' ' ' PRO . . . -130.63 -2.92 4.75 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.078 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.499 ' N ' ' CD ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -56.92 99.47 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.242 -1.152 . . . . 0.0 110.29 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.479 ' OE2' ' HA2' ' A' ' 38' ' ' GLY . 5.7 tp10 -82.1 84.43 7.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.114 -0.991 . . . . 0.0 108.821 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.07 16.95 65.05 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.485 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 2.8 pt20 -121.54 164.62 23.5 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.556 -0.967 . . . . 0.0 109.003 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 3.2 Cg_exo -65.65 -49.35 2.4 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 121.742 1.628 . . . . 0.0 109.79 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.622 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.94 119.27 0.01 OUTLIER Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.543 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 2.4 pt-20 -151.96 134.7 15.52 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.037 -1.273 . . . . 0.0 110.846 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.611 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 2.1 m0 -48.85 127.88 14.7 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.595 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -108.23 133.41 52.51 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -178.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.503 ' HA ' ' OE2' ' A' ' 17' ' ' GLU . 1.6 t -84.65 41.12 0.83 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.411 -1.431 . . . . 0.0 109.531 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.53 ' CD1' ' HG ' ' A' ' 110' ' ' LEU . 1.6 tt -82.54 150.96 26.64 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.481 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 48.4 t -119.52 132.32 69.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 109.293 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 129' ' ' LEU . . . 39.96 80.8 0.03 OUTLIER Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.647 ' CD2' ' CD2' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -41.87 163.71 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.479 -1.013 . . . . 0.0 110.072 -178.177 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.547 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 3.8 t30 -138.79 0.4 2.0 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 111.322 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.574 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . . . 82.59 -33.62 0.09 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.221 -0.924 . . . . 0.0 108.632 -178.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 111' ' ' ASN . 1.2 t0 -50.87 -28.91 10.55 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.512 -0.742 . . . . 0.0 109.044 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.544 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 8.5 m-20 -101.33 -19.41 15.64 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.538 -0.726 . . . . 0.0 109.406 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.647 ' CD2' ' CD2' ' A' ' 110' ' ' LEU . 1.3 m-85 -86.26 142.46 35.72 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.332 -0.855 . . . . 0.0 108.723 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.57 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.2 Cg_endo -62.94 146.28 94.78 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.276 1.984 . . . . 0.0 110.249 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.485 ' HA ' ' CD ' ' A' ' 120' ' ' GLU . 1.3 Cg_endo -64.4 -18.9 64.68 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.182 1.921 . . . . 0.0 110.994 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.66 -56.48 20.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.094 . . . . 0.0 110.09 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.558 ' CB ' HD13 ' A' ' 123' ' ' ILE . 9.0 m-80 -91.62 44.96 1.2 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.094 -1.004 . . . . 0.0 109.852 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.673 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 1.3 tp10 -60.71 -47.07 96.94 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.442 -0.786 . . . . 0.0 112.156 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 24.6 Cg_exo -43.85 -48.14 9.33 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.115 1.877 . . . . 0.0 112.452 -177.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.551 HG12 ' CG ' ' A' ' 84' ' ' PHE . 2.5 t -91.67 -25.75 5.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 O-C-N 120.619 -1.301 . . . . 0.0 107.874 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.631 HG12 ' CD2' ' A' ' 115' ' ' PHE . 1.5 mt -69.42 -11.55 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.536 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -71.36 -27.68 63.53 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -80.24 -38.83 30.24 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.752 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.602 ' CD1' ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -67.03 -22.87 65.86 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.525 -1.359 . . . . 0.0 107.719 179.299 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.563 ' CD ' ' HB1' ' A' ' 112' ' ' ALA . 2.7 mtmm -56.77 -31.46 64.65 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -89.82 -21.78 22.42 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.327 -0.852 . . . . 0.0 108.711 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 1.4 tp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.77 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' APC . . . . . 0.77 ' PA ' HN31 ' A' ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' CON . . . . . 0.77 HN31 ' PA ' ' A' ' 130' ' ' APC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' HOH . . . . . 0.411 ' O ' ' O ' ' A' ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.558 ' O ' ' O ' ' A' ' 2' ' ' LYS . 1.8 tpt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.558 ' O ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 45.04 167.36 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 122.065 0.936 . . . . 0.0 111.962 179.574 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.446 ' CG ' ' N ' ' A' ' 4' ' ' LEU . 2.1 ttpt -162.5 159.07 24.49 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.058 -1.026 . . . . 0.0 109.77 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.631 ' CD2' " O4'" ' A' ' 130' ' ' APC . 0.2 OUTLIER -160.48 160.0 31.5 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.133 -0.979 . . . . 0.0 109.161 178.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.538 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 15.3 mp0 -131.09 173.22 11.24 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.179 -0.951 . . . . 0.0 108.657 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.624 HG13 ' N7 ' ' A' ' 130' ' ' APC . 0.1 OUTLIER -140.85 116.75 7.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 121.131 -0.98 . . . . 0.0 109.084 -179.388 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.471 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -82.29 67.63 8.39 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.513 ' HB ' ' HA2' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -79.15 -76.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.273 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.662 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 65.3 78.48 0.22 Allowed Glycine 0 C--N 1.295 -1.697 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 -178.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.501 HD13 ' NH2' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -47.15 168.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -178.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.565 HG21 ' CG1' ' A' ' 87' ' ' VAL . 3.7 pt -140.38 93.85 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 120.859 -1.15 . . . . 0.0 110.083 -177.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -95.56 152.08 18.75 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.621 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -161.08 -10.39 0.04 OUTLIER 'General case' 0 C--O 1.188 -2.182 0 C-N-CA 116.663 -2.015 . . . . 0.0 115.444 -177.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -94.47 -31.16 14.07 Favored 'General case' 0 N--CA 1.51 2.548 0 O-C-N 118.047 -2.908 . . . . 0.0 108.458 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.8 -48.75 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 102.174 -3.269 . . . . 0.0 102.174 177.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.43 ' C ' ' OE1' ' A' ' 17' ' ' GLU . 16.9 t30 -162.03 38.31 0.12 Allowed 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 175.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -85.35 93.14 8.65 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.432 -1.307 . . . . 0.0 110.697 -177.056 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 2.0 pt -79.12 146.83 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.63 0.729 . . . . 0.0 111.063 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.604 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 6.3 t80 -82.75 43.68 0.86 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.582 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -80.67 151.11 4.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.07 0.938 . . . . 0.0 110.49 -178.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.509 ' N ' HG13 ' A' ' 20' ' ' ILE . 5.3 t -66.56 91.34 0.18 Allowed 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.585 ' O ' ' N ' ' A' ' 24' ' ' ALA . 21.4 tpt180 -94.47 140.5 29.75 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.281 -0.887 . . . . 0.0 108.712 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.539 ' CZ ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -32.21 91.19 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . -42.82 -54.44 4.13 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.493 -0.754 . . . . 0.0 109.149 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.69 -163.09 0.53 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 73.2 m-20 -70.09 -49.96 45.72 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.908 -1.12 . . . . 0.0 109.805 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 26' ' ' ASP . . . 81.98 -24.16 0.19 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.346 -0.846 . . . . 0.0 110.212 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.506 ' O ' ' HG2' ' A' ' 29' ' ' MET . 0.1 OUTLIER 47.77 25.43 0.71 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.79 -1.193 . . . . 0.0 108.047 -178.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 28' ' ' HIS . 20.7 mmt -154.94 -167.68 2.65 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 31' ' ' ASN . . . -153.09 -162.47 1.49 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 108.929 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 1.0 OUTLIER 77.18 -2.71 2.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.443 -0.786 . . . . 0.0 109.327 -179.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.523 ' HD2' ' N ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -82.09 55.34 2.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.47 -0.769 . . . . 0.0 110.097 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.653 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 6.6 mt -124.06 86.53 2.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.805 -1.184 . . . . 0.0 108.544 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.582 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 4.6 tt0 -82.38 -123.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.078 -1.014 . . . . 0.0 110.32 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -161.38 123.68 1.75 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 120.646 -1.284 . . . . 0.0 109.277 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.672 ' CB ' ' HA ' ' A' ' 97' ' ' LYS . 6.9 Cg_endo -65.03 99.09 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.884 1.723 . . . . 0.0 109.725 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.513 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -95.02 -130.77 6.19 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.994 -1.098 . . . . 0.0 111.663 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 150.06 -8.65 0.81 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.6 ' HD3' " C5'" ' A' ' 130' ' ' APC . 15.2 tptm 72.78 106.13 0.07 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.39 0.614 . . . . 0.0 111.056 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.531 HG12 ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -81.63 134.7 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.414 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 42' ' ' MET . 2.4 pt-20 -172.33 -29.37 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.216 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.428 ' O ' ' C ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -55.17 160.63 2.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.923 -1.111 . . . . 0.0 108.914 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.442 ' C ' ' HG2' ' A' ' 44' ' ' GLU . . . 46.35 -127.14 9.69 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.442 ' HG2' ' C ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -166.57 23.46 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.35 -1.088 . . . . 0.0 109.046 179.061 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.553 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 87.4 m -142.73 142.67 23.3 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 9.0 Cg_exo -48.94 -16.8 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.899 1.732 . . . . 0.0 111.107 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.484 ' O ' HG11 ' A' ' 51' ' ' VAL . 4.8 mt-10 -78.5 -80.4 0.11 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.747 -1.221 . . . . 0.0 108.63 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 30.6 mt-30 -51.69 -23.94 5.07 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.396 -1.44 . . . . 0.0 109.164 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.604 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -72.1 -64.08 1.01 Allowed 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.484 -0.76 . . . . 0.0 109.737 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.566 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 2.6 p -70.06 -49.14 58.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.251 -0.906 . . . . 0.0 110.192 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.566 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 1.4 p -52.96 -44.62 50.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 O-C-N 121.749 -0.594 . . . . 0.0 110.292 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.597 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 7.8 mmt180 -73.57 -39.66 64.51 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.604 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 6.3 mm-40 -66.67 -15.12 63.27 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.608 ' HB3' ' CH2' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -80.19 -61.08 2.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -54.55 43.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.799 . . . . 0.0 109.906 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.566 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -46.0 -24.22 0.39 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -0.963 . . . . 0.0 109.658 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.44 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.2 mt-10 -79.99 -95.67 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.169 -0.957 . . . . 0.0 109.525 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.597 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 46.9 t -80.0 -78.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 110.109 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.12 24.19 0.12 Allowed Glycine 0 N--CA 1.494 2.507 0 C-N-CA 118.922 -1.609 . . . . 0.0 112.361 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.701 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.1 pp -84.38 -146.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.325 -1.691 . . . . 0.0 107.827 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.57 ' CB ' ' CD ' ' A' ' 62' ' ' PRO . 1.2 m -161.03 -66.92 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 120.174 -1.579 . . . . 0.0 112.329 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.599 ' O ' ' CG ' ' A' ' 63' ' ' GLN . 10.2 Cg_exo -43.54 -94.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.169 1.912 . . . . 0.0 112.426 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.667 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 3.2 pt20 54.05 6.21 0.09 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.197 -0.939 . . . . 0.0 111.382 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.598 ' C ' ' O ' ' A' ' 63' ' ' GLN . 5.3 t-160 22.32 50.69 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.58 0 O-C-N 120.962 -1.086 . . . . 0.0 110.444 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 63' ' ' GLN . 1.7 p90 -35.52 141.34 0.08 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.091 0.948 . . . . 0.0 112.127 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -145.2 147.58 32.59 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.596 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -77.85 -65.28 0.99 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.79 -1.194 . . . . 0.0 110.13 -179.004 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.596 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 82.71 -51.33 0.18 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.302 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER 163.42 178.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 0.0 109.496 179.144 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.586 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 15.1 ptmt -160.96 170.3 20.86 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.301 -0.874 . . . . 0.0 109.727 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.541 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -136.16 171.58 14.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.098 179.582 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -150.09 94.15 2.11 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.01 122.23 26.48 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.478 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 15.0 tt0 -96.67 127.64 42.85 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.108 -0.995 . . . . 0.0 109.468 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.57 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 7.1 m-85 -106.7 168.34 8.24 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.362 -0.836 . . . . 0.0 109.17 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 7.5 Cg_exo -48.7 -28.48 12.68 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.943 1.762 . . . . 0.0 109.77 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.47 ' O ' ' HD2' ' A' ' 78' ' ' ARG . 8.0 m-20 -162.25 31.08 0.11 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.519 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.66 89.98 2.36 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.71 -0.619 . . . . 0.0 109.961 -178.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.478 ' CD2' ' HG3' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -89.86 113.3 24.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.911 -1.118 . . . . 0.0 109.126 179.58 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.589 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.6 mp -118.54 155.71 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.974 -1.079 . . . . 0.0 110.446 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.538 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 1.9 m -136.14 137.84 41.39 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.56 ' CD1' HN61 ' A' ' 130' ' ' APC . 0.2 OUTLIER -127.22 75.89 1.62 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.815 -1.178 . . . . 0.0 110.101 -179.206 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.586 ' CE3' ' HD2' ' A' ' 70' ' ' LYS . 92.2 m95 -51.79 111.24 0.57 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.265 -0.897 . . . . 0.0 109.45 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.548 ' O ' ' O ' ' A' ' 67' ' ' LEU . 45.5 m-85 -86.92 73.04 10.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.9 . . . . 0.0 110.178 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.662 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 12.7 m95 -71.94 85.76 0.99 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.819 -1.176 . . . . 0.0 108.328 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 66' ' ' SER . 2.8 mm? -67.78 125.78 27.33 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.478 -1.389 . . . . 0.0 110.024 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.667 ' HB ' ' O ' ' A' ' 63' ' ' GLN . 0.9 OUTLIER -112.29 169.81 4.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 38.8 mt-10 -160.54 29.59 0.16 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 117.972 -1.491 . . . . 0.0 112.552 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.581 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.85 30.19 0.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.329 -1.482 . . . . 0.0 109.943 179.235 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.622 ' CH2' ' CD1' ' A' ' 104' ' ' TRP . 1.6 p90 -48.96 148.78 2.12 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.951 -1.093 . . . . 0.0 109.967 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 93' ' ' GLU . 1.6 tt0 -81.26 133.11 35.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.387 -0.821 . . . . 0.0 109.722 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 45.75 -86.89 0.01 OUTLIER Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.578 ' O ' ' CG2' ' A' ' 60' ' ' ILE . 17.1 pt-20 -100.6 161.89 22.51 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.301 -1.117 . . . . 0.0 110.051 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.595 ' HG2' ' CE2' ' A' ' 19' ' ' PHE . 13.9 Cg_endo -79.05 -162.6 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.772 2.315 . . . . 0.0 109.908 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.701 ' CD2' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER 177.8 26.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.218 -0.927 . . . . 0.0 111.011 178.574 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.467 ' HA2' HD12 ' A' ' 54' ' ' LEU . . . -93.88 -48.67 2.64 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.521 -1.323 . . . . 0.0 110.24 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.672 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -42.47 146.07 0.37 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -1.117 . . . . 0.0 111.243 -179.291 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.488 ' HG2' ' O3G' ' A' ' 130' ' ' APC . 6.2 tp10 -81.08 -97.32 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.459 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . -108.64 3.95 32.51 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.504 ' HG2' ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -74.85 174.85 4.62 Favored Pre-proline 0 N--CA 1.482 1.166 0 O-C-N 121.826 -0.808 . . . . 0.0 109.199 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 102' ' ' GLY . 2.1 Cg_endo -69.63 -50.86 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.95 1.767 . . . . 0.0 109.591 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.604 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 61.78 114.38 0.01 OUTLIER Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.064 -2.015 . . . . 0.0 108.064 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.553 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 7.1 pt-20 -148.61 135.85 20.23 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.113 -1.228 . . . . 0.0 110.441 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.622 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 5.0 m0 -48.18 129.29 15.1 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.555 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -119.79 119.2 32.92 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.85 -1.157 . . . . 0.0 110.032 -178.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.35 68.12 5.26 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.613 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 7.4 tt -81.86 -54.36 5.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 109.188 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 48.6 t 86.29 112.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 40.3 83.79 0.01 OUTLIER Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.603 HD22 ' CD1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -40.22 165.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.725 -0.868 . . . . 0.0 110.596 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 14.6 t30 -144.15 1.75 1.12 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.126 -0.984 . . . . 0.0 111.234 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.593 ' CB ' ' CD ' ' A' ' 127' ' ' LYS . . . 70.24 -3.42 1.82 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.914 -1.116 . . . . 0.0 109.282 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 111' ' ' ASN . 1.1 t0 -80.95 -24.68 37.95 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.474 ' HB3' HD13 ' A' ' 33' ' ' LEU . 3.3 m-20 -102.11 -13.11 17.62 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.653 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 4.0 m-85 -95.08 150.98 38.49 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.293 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.54 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.3 Cg_endo -66.63 139.75 54.21 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.498 2.132 . . . . 0.0 109.63 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 118' ' ' ALA . 2.4 Cg_endo -61.93 -31.15 84.46 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.224 1.949 . . . . 0.0 111.179 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.64 -44.83 4.42 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.004 -1.06 . . . . 0.0 110.187 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.477 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 3.5 m-80 -99.16 51.61 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 109.273 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.672 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.4 mt-10 -69.36 -36.57 7.31 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.558 -0.714 . . . . 0.0 112.437 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.3 Cg_exo -56.35 -34.89 95.3 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.511 1.474 . . . . 0.0 112.047 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.512 HG12 ' CD1' ' A' ' 84' ' ' PHE . 1.7 t -99.77 -36.48 5.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.583 -1.323 . . . . 0.0 108.829 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.59 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -66.64 -15.56 19.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.565 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.513 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -62.83 -29.9 71.09 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.474 ' HE2' ' OE2' ' A' ' 69' ' ' GLU . 12.8 mmtm -81.53 -39.43 24.69 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.094 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.601 ' HB3' ' CB ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -66.62 -22.05 66.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.733 -1.229 . . . . 0.0 108.195 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.593 ' CD ' ' CB ' ' A' ' 112' ' ' ALA . 1.7 mtmt -53.23 -31.13 41.75 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.03 -27.85 22.95 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.361 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.521 HD23 ' NH1' ' A' ' 12' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.681 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' APC . . . . . 0.631 " O4'" ' CD2' ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' HOH . . . . . 0.446 ' O ' ' O ' ' A' ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.484 ' HG2' ' HA ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -111.94 165.88 11.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.107 -0.996 . . . . 0.0 109.373 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 79' ' ' HIS . 9.1 tttt -162.1 150.96 15.33 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.804 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.669 ' HG ' " O4'" ' A' ' 130' ' ' APC . 0.0 OUTLIER -158.67 147.36 18.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.478 -0.764 . . . . 0.0 109.007 178.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.529 ' HG3' ' CB ' ' A' ' 81' ' ' THR . 1.6 mp0 -111.7 170.13 8.35 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 109.094 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.569 HG13 ' N7 ' ' A' ' 130' ' ' APC . 0.2 OUTLIER -135.04 108.15 9.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.202 -179.501 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.556 ' CB ' ' HB ' ' A' ' 40' ' ' ILE . . . -82.81 72.68 9.88 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.541 -0.725 . . . . 0.0 109.327 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.544 ' HB ' ' CA ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -83.81 -84.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.415 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.61 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 81.33 78.37 0.97 Allowed Glycine 0 C--N 1.299 -1.475 0 N-CA-C 106.947 -2.461 . . . . 0.0 106.947 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.536 ' CG2' HG23 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -48.21 150.5 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -178.731 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.526 HG23 ' CG2' ' A' ' 87' ' ' VAL . 10.0 pt -120.48 75.87 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.394 -177.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.626 ' HB3' HG22 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -79.69 153.95 28.94 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.46 ' OD1' ' CH2' ' A' ' 90' ' ' TRP . 2.6 p-10 -154.14 -20.98 0.13 Allowed 'General case' 0 C--O 1.187 -2.225 0 C-N-CA 117.218 -1.793 . . . . 0.0 114.901 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.554 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 3.4 tt0 -93.41 -32.31 14.29 Favored 'General case' 0 N--CA 1.511 2.605 0 O-C-N 118.076 -2.89 . . . . 0.0 109.486 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -161.68 -47.44 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 102.971 -2.974 . . . . 0.0 102.971 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.465 ' HB2' ' HA ' ' A' ' 108' ' ' VAL . 1.5 m120 -161.87 38.07 0.13 Allowed 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.626 ' HA ' ' O ' ' A' ' 105' ' ' MET . 84.0 mt-10 -85.1 84.51 7.68 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.143 -1.423 . . . . 0.0 110.43 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.626 HG22 ' HB3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -78.97 153.85 4.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.434 0.635 . . . . 0.0 109.942 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.614 ' CZ ' ' HG2' ' A' ' 94' ' ' PRO . 6.8 t80 -83.16 42.77 0.83 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 34' ' ' GLU . 5.5 tp -80.69 148.81 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-O 122.585 1.183 . . . . 0.0 111.734 -176.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.476 ' OG1' ' HG2' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -58.43 89.41 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.593 ' O ' ' C ' ' A' ' 23' ' ' ARG . 32.0 tpt180 -97.24 91.89 5.75 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.724 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.593 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 13.68 79.4 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.356 0.598 . . . . 0.0 110.971 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -41.56 -56.05 2.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.424 -0.798 . . . . 0.0 110.287 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.75 -179.04 3.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.069 -1.019 . . . . 0.0 109.476 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.96 84.44 4.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.214 -0.929 . . . . 0.0 109.534 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.53 ' HB1' ' CB ' ' A' ' 23' ' ' ARG . . . -72.54 -36.92 68.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.243 -0.911 . . . . 0.0 109.324 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 49.92 23.57 1.1 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.404 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -117.12 -33.96 4.53 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.563 -0.711 . . . . 0.0 109.1 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.531 ' O ' ' CB ' ' A' ' 31' ' ' ASN . . . 69.19 -177.65 0.21 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.437 -0.789 . . . . 0.0 109.822 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 1.1 t30 78.96 -8.63 1.62 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.523 -0.736 . . . . 0.0 109.523 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.543 ' HD2' ' CA ' ' A' ' 23' ' ' ARG . 4.8 tttp -83.29 51.47 1.98 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.385 -0.822 . . . . 0.0 110.227 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.576 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 17.4 mt -107.73 85.84 2.19 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' O ' HD12 ' A' ' 20' ' ' ILE . 1.5 tt0 -87.4 -137.28 0.09 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.388 -1.445 . . . . 0.0 109.614 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.679 ' CE2' ' CE1' ' A' ' 115' ' ' PHE . 10.9 m-85 -153.31 126.61 4.2 Favored Pre-proline 0 N--CA 1.486 1.364 0 O-C-N 121.048 -1.032 . . . . 0.0 109.586 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.543 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 5.4 Cg_endo -65.64 89.17 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.011 1.807 . . . . 0.0 108.483 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.554 ' HA3' ' CG2' ' A' ' 6' ' ' ILE . . . -115.34 107.18 1.7 Allowed Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.714 -1.231 . . . . 0.0 111.525 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.499 ' HA2' ' CD ' ' A' ' 98' ' ' GLU . . . -82.14 16.81 20.61 Favored Glycine 0 N--CA 1.489 2.181 0 O-C-N 121.576 -0.955 . . . . 0.0 111.168 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.56 ' HD3' " C5'" ' A' ' 130' ' ' APC . 3.1 tptm 63.9 108.25 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 118.244 1.022 . . . . 0.0 110.984 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.561 ' CG1' ' HB2' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.37 138.67 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.924 -1.11 . . . . 0.0 109.017 178.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.4 ' N ' HG12 ' A' ' 40' ' ' ILE . 3.5 pt-20 -172.28 -32.81 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.89 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.407 ' SD ' ' HB3' ' A' ' 52' ' ' ARG . 38.5 mtt -55.74 159.34 3.1 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.128 -0.982 . . . . 0.0 109.511 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.56 -130.5 9.39 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.16 24.44 0.11 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.435 -1.038 . . . . 0.0 108.749 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.535 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 27.4 m -136.82 140.86 33.03 Favored Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.561 ' HG3' ' CH2' ' A' ' 83' ' ' TRP . 7.1 Cg_exo -50.09 -20.35 5.2 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.815 1.677 . . . . 0.0 109.897 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.454 ' O ' ' C ' ' A' ' 48' ' ' GLN . 3.2 mt-10 -75.72 -87.35 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.346 -0.846 . . . . 0.0 108.763 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.536 ' O ' ' CG ' ' A' ' 52' ' ' ARG . 42.3 mt-30 -41.72 -33.01 0.43 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.845 -1.159 . . . . 0.0 110.147 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.616 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -67.19 -63.26 1.1 Allowed 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.024 -1.047 . . . . 0.0 109.674 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.573 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 2.2 p -66.72 -49.38 75.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.645 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.573 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 4.1 p -57.31 -44.65 84.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.547 -0.721 . . . . 0.0 110.34 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.536 ' CG ' ' O ' ' A' ' 48' ' ' GLN . 14.9 mmt180 -72.05 -32.25 66.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.009 -1.057 . . . . 0.0 108.665 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.616 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 12.4 mm-40 -75.22 -15.96 60.51 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.585 HD11 ' CD2' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -79.97 -62.62 1.63 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.749 0.785 . . . . 0.0 108.997 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.49 ' N ' ' CZ3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.45 -51.74 68.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.784 -0.572 . . . . 0.0 109.691 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.57 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -47.15 -26.22 1.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.888 -1.133 . . . . 0.0 108.868 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 54' ' ' LEU . 3.6 mt-10 -80.05 -95.3 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.355 -0.841 . . . . 0.0 109.377 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.618 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 28.2 t -80.21 -78.91 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.304 -0.873 . . . . 0.0 110.321 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 138.2 32.5 0.21 Allowed Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.374 -1.394 . . . . 0.0 111.275 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.645 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.1 pp -90.75 -152.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.589 -1.536 . . . . 0.0 108.278 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.577 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.6 m -162.23 -63.16 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.349 -1.469 . . . . 0.0 112.73 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.577 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 6.3 Cg_exo -55.9 0.62 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.537 2.158 . . . . 0.0 114.373 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.542 ' NE2' ' CG1' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -39.18 -27.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.623 -1.298 . . . . 0.0 110.289 -179.07 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 62' ' ' PRO . 1.9 t60 51.84 88.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.505 ' HB3' ' NE2' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -88.87 159.31 17.76 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.377 1.084 . . . . 0.0 111.901 -177.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -153.64 141.15 19.81 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.242 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.61 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -63.31 -67.22 0.44 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.878 -1.139 . . . . 0.0 110.272 -178.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.61 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 84.05 -51.75 0.13 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.264 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.574 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 4.9 tp10 159.54 135.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.564 ' HE3' ' CD2' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -125.6 -177.76 4.02 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.467 -0.771 . . . . 0.0 109.515 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.533 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -136.51 -177.41 4.71 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.341 -0.85 . . . . 0.0 109.938 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -151.71 86.16 1.32 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.15 104.01 9.48 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -95.18 154.41 17.2 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.416 -0.914 . . . . 0.0 108.587 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.562 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -141.73 173.09 5.1 Favored Pre-proline 0 C--N 1.297 -1.677 0 O-C-N 121.214 -0.929 . . . . 0.0 109.104 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 7.3 Cg_exo -48.23 -39.39 34.54 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 121.776 1.651 . . . . 0.0 109.703 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.484 ' HA ' ' HG2' ' A' ' 1' ' ' MET . 4.7 p-10 -148.21 35.14 0.81 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.481 ' O ' HD11 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -142.73 78.95 1.63 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.549 -0.719 . . . . 0.0 110.077 -178.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 2' ' ' LYS . 24.5 m170 -82.35 119.58 24.33 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.628 HG22 ' C6 ' ' A' ' 130' ' ' APC . 2.3 mp -129.69 162.75 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 118.793 -1.163 . . . . 0.0 111.433 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.581 ' N ' ' CG2' ' A' ' 80' ' ' ILE . 2.0 m -147.32 148.84 31.8 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.512 HD22 ' CG1' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -141.32 82.96 1.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.716 -1.24 . . . . 0.0 110.348 -179.395 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.564 ' CD2' ' HE3' ' A' ' 70' ' ' LYS . 89.8 m95 -54.05 111.76 0.82 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.267 -0.896 . . . . 0.0 109.034 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.565 ' O ' ' O ' ' A' ' 67' ' ' LEU . 11.6 m-85 -88.6 68.05 8.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.247 -0.908 . . . . 0.0 109.793 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.61 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 75.3 m95 -72.36 84.29 1.08 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.794 -1.191 . . . . 0.0 109.747 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.596 HD21 ' CD2' ' A' ' 68' ' ' PHE . 3.2 mm? -68.07 129.44 39.91 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.566 -1.334 . . . . 0.0 109.942 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.547 HG22 ' N ' ' A' ' 88' ' ' GLU . 0.8 OUTLIER -111.2 -175.08 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.547 ' N ' HG22 ' A' ' 87' ' ' VAL . 1.2 mt-10 -159.89 8.13 0.1 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 117.612 -1.635 . . . . 0.0 113.54 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.572 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.73 71.96 0.44 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 119.855 -1.778 . . . . 0.0 110.651 178.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.498 ' HB2' HD12 ' A' ' 60' ' ' ILE . 17.4 p90 -80.69 163.0 23.9 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.718 -1.239 . . . . 0.0 110.191 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.648 ' O ' ' N ' ' A' ' 93' ' ' GLU . 5.0 pt-20 -81.81 135.53 35.45 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.179 -0.951 . . . . 0.0 109.762 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 35.02 -80.34 0.0 OUTLIER Glycine 0 N--CA 1.502 3.088 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.648 ' N ' ' O ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER -98.82 153.32 37.92 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.333 -1.098 . . . . 0.0 109.219 -179.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.614 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 20.2 Cg_endo -80.85 -159.07 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.787 2.325 . . . . 0.0 110.025 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.645 ' CD2' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER 178.58 132.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.771 0.796 . . . . 0.0 110.017 178.184 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . 152.93 -40.04 0.72 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.509 ' N ' ' CD ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -41.09 107.51 0.07 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.517 -0.99 . . . . 0.0 109.526 -179.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 5.5 tp10 -77.38 87.28 3.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.273 -0.892 . . . . 0.0 108.712 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.35 30.71 65.04 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.477 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 7.4 pt20 -125.96 168.08 15.05 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.475 -1.015 . . . . 0.0 109.299 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 9.8 Cg_endo -78.21 42.6 1.24 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.562 2.175 . . . . 0.0 110.842 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.57 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . -44.78 123.82 5.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.606 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -146.79 144.38 29.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -1.118 . . . . 0.0 109.8 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.495 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 1.2 m-90 -52.35 139.84 23.47 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.968 -1.083 . . . . 0.0 108.225 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.626 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -139.06 108.85 6.26 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.286 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.482 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -81.33 46.79 0.97 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.597 -0.689 . . . . 0.0 109.351 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.567 ' HG ' ' HG ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -64.72 -12.7 49.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 108.859 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.501 ' O ' ' C ' ' A' ' 109' ' ' GLY . 1.4 t 59.63 121.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.452 -0.78 . . . . 0.0 110.189 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.585 ' HA2' ' HB3' ' A' ' 129' ' ' LEU . . . 38.12 74.06 0.13 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.678 ' CD2' ' CD2' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -38.19 158.24 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.914 -0.756 . . . . 0.0 109.905 -178.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.56 ' ND2' ' HE3' ' A' ' 127' ' ' LYS . 0.8 OUTLIER -154.76 143.77 20.98 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.139 -0.976 . . . . 0.0 110.182 -178.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.508 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . . . -44.07 -27.84 0.42 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -42.07 -53.93 3.76 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.317 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.492 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 14.3 m-20 -97.94 -9.75 25.7 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.679 ' CE1' ' CE2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -91.96 136.92 25.55 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.543 -0.723 . . . . 0.0 109.754 -179.26 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' A' ' 123' ' ' ILE . 2.5 Cg_endo -68.24 153.6 74.14 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.373 2.049 . . . . 0.0 110.22 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 118' ' ' ALA . 1.7 Cg_endo -65.12 -36.37 37.53 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.212 1.941 . . . . 0.0 110.817 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -39.37 -47.79 1.81 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.408 -0.807 . . . . 0.0 110.123 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.481 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 0.7 OUTLIER -98.64 55.83 1.09 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.372 -0.83 . . . . 0.0 109.034 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.614 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -69.13 -47.17 29.53 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.722 -0.611 . . . . 0.0 111.688 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 8.2 Cg_exo -52.25 -40.12 70.55 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.194 1.929 . . . . 0.0 112.846 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.495 HG12 ' CE2' ' A' ' 84' ' ' PHE . 2.2 t -98.21 -34.05 4.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 O-C-N 120.642 -1.286 . . . . 0.0 109.5 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.653 HG12 ' CG ' ' A' ' 115' ' ' PHE . 31.4 mt -59.0 -29.18 40.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.53 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -59.44 -35.08 73.35 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.928 0.871 . . . . 0.0 109.129 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.0 mmmt -77.68 -35.58 52.11 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.567 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.597 ' CD1' ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -66.71 -34.62 78.26 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.158 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.56 ' HE3' ' ND2' ' A' ' 111' ' ' ASN . 7.1 mtpt -45.4 -29.01 0.97 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.568 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -91.2 -34.65 14.91 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.297 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.585 ' HB3' ' HA2' ' A' ' 109' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.508 2.426 0 CA-C-O 118.035 -0.983 . . . . 0.0 111.635 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' APC . . . . . 0.669 " O4'" ' HG ' ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' CON . . . . . 0.443 ' N3 ' ' O2A' ' A' ' 130' ' ' APC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' HOH . . . . . 0.454 ' O ' ' O ' ' A' ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.488 ' HD3' ' O ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -51.95 164.14 0.29 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.021 -1.049 . . . . 0.0 109.552 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.455 ' N ' ' HE3' ' A' ' 2' ' ' LYS . 15.1 tttt -160.57 157.31 27.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 0.0 109.542 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.61 ' CD1' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -158.38 143.84 16.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.808 . . . . 0.0 109.278 179.105 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.537 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 0.3 OUTLIER -113.53 166.74 11.21 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.86 -1.15 . . . . 0.0 108.394 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.518 ' CG2' ' HA2' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -127.23 110.95 23.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.451 ' HB3' ' HB ' ' A' ' 40' ' ' ILE . . . -81.85 68.55 8.27 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.526 ' CB ' ' O ' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -79.47 -83.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.465 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.659 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 75.61 82.3 0.48 Allowed Glycine 0 N--CA 1.479 1.517 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 -178.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -49.13 157.2 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 1.6 pt -124.54 85.27 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.866 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.547 ' HG2' ' CG2' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -77.51 167.75 21.12 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.2 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 17' ' ' GLU . 2.0 p-10 -161.94 -26.11 0.05 OUTLIER 'General case' 0 C--O 1.185 -2.31 0 C-N-CA 115.966 -2.294 . . . . 0.0 114.889 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HB3' ' OE2' ' A' ' 17' ' ' GLU . 4.9 tt0 -95.01 -34.22 12.43 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 118.36 -2.712 . . . . 0.0 109.132 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -162.35 -45.95 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 103.211 -2.885 . . . . 0.0 103.211 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.527 ' ND2' ' HD2' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -160.37 36.2 0.17 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 176.511 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -88.14 98.95 11.84 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.088 -1.445 . . . . 0.0 109.234 -178.474 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -92.34 150.09 3.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.927 0.87 . . . . 0.0 111.265 -178.414 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.631 ' CE1' ' HA ' ' A' ' 103' ' ' GLU . 14.3 t80 -82.2 43.71 0.81 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.51 HD11 ' HD3' ' A' ' 36' ' ' PRO . 5.1 tp -81.02 154.96 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-O 122.053 0.93 . . . . 0.0 111.269 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.509 ' N ' HG13 ' A' ' 20' ' ' ILE . 1.4 t -66.14 93.72 0.22 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.575 ' O ' ' N ' ' A' ' 24' ' ' ALA . 23.7 tpt180 -102.05 149.01 24.69 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.668 -0.645 . . . . 0.0 109.601 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.577 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -34.34 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . -46.55 -54.34 9.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.382 -0.823 . . . . 0.0 110.393 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.49 -151.1 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.006 -1.058 . . . . 0.0 109.204 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.35 -51.39 10.92 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.292 -0.88 . . . . 0.0 109.066 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.577 ' CB ' ' HD2' ' A' ' 23' ' ' ARG . . . 57.7 -168.45 0.12 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.639 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -162.34 -35.07 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.473 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 1.5 mpt? -49.61 -46.44 49.31 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.337 -0.852 . . . . 0.0 109.398 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.487 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . . . 72.34 5.63 5.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.288 -0.883 . . . . 0.0 109.456 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -98.65 11.64 37.85 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.24 -0.912 . . . . 0.0 108.853 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -81.8 54.78 2.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.602 -0.686 . . . . 0.0 110.402 -179.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.715 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 15.0 mt -122.49 84.55 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.64 -1.287 . . . . 0.0 109.666 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.491 ' O ' HD12 ' A' ' 20' ' ' ILE . 1.4 tt0 -82.84 -136.86 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.987 -1.071 . . . . 0.0 109.983 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.648 ' CZ ' ' CD2' ' A' ' 115' ' ' PHE . 77.7 m-85 -152.0 125.37 4.22 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.124 -0.985 . . . . 0.0 109.338 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.526 ' O ' ' CB ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -58.09 90.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.616 1.544 . . . . 0.0 109.127 178.663 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.518 ' HA2' ' CG2' ' A' ' 6' ' ' ILE . . . -56.27 -142.46 0.01 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 154.56 -33.3 0.69 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.586 ' HD3' " C5'" ' A' ' 130' ' ' APC . 0.0 OUTLIER 69.89 97.02 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 122.185 -0.597 . . . . 0.0 109.397 -179.519 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.537 HG12 ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.23 132.62 31.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.794 179.346 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.482 ' HB3' ' NZ ' ' A' ' 39' ' ' LYS . 6.6 pt-20 -170.67 -34.14 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.47 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -47.85 147.16 2.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.337 -0.852 . . . . 0.0 109.54 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 53.03 -120.92 13.76 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.06 23.07 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.647 -0.914 . . . . 0.0 109.125 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.489 ' O ' ' HB1' ' A' ' 49' ' ' ALA . 56.1 m -138.68 139.13 23.34 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.584 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 14.2 Cg_exo -49.3 -17.25 1.45 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.004 1.803 . . . . 0.0 110.606 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.47 ' O ' HG11 ' A' ' 51' ' ' VAL . 2.4 mt-10 -77.89 -83.14 0.08 Allowed 'General case' 0 C--O 1.203 -1.352 0 O-C-N 120.934 -1.104 . . . . 0.0 108.557 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 36.9 mt-30 -45.67 -33.62 3.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.502 -1.374 . . . . 0.0 109.54 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.642 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -65.2 -63.34 1.13 Allowed 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.452 -0.78 . . . . 0.0 110.24 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.575 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 2.4 p -68.82 -48.99 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.912 -1.118 . . . . 0.0 110.607 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.575 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 2.3 p -54.63 -44.06 68.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 121.371 0.605 . . . . 0.0 110.295 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.551 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 18.7 mmt180 -74.87 -34.49 62.26 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.642 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 20.8 mm-40 -71.21 -13.39 61.9 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.601 ' HB3' ' CZ2' ' A' ' 95' ' ' TRP . 1.1 mm? -79.34 -64.31 1.22 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.499 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.12 -51.49 69.1 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.54 -0.725 . . . . 0.0 110.187 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.576 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 1.3 pp20? -50.18 -21.08 1.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.052 -1.03 . . . . 0.0 110.479 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -80.14 -92.22 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.918 -1.114 . . . . 0.0 110.038 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.625 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 21.0 t -79.98 -79.17 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.426 -0.796 . . . . 0.0 109.678 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.54 22.72 0.1 Allowed Glycine 0 N--CA 1.495 2.605 0 C-N-CA 118.485 -1.817 . . . . 0.0 112.554 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.642 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.6 pp -82.93 -166.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.283 -1.716 . . . . 0.0 108.031 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.593 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 2.0 m -123.36 -71.73 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.434 -1.416 . . . . 0.0 110.844 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 91' ' ' GLU . 5.7 Cg_endo -64.19 -170.82 0.13 Allowed 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.078 1.185 . . . . 0.0 109.707 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.6 ' HG2' ' CZ2' ' A' ' 95' ' ' TRP . 0.7 OUTLIER 139.54 -23.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -179.204 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.494 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 1.9 t60 57.23 -167.41 0.13 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 64' ' ' HIS . 28.3 p90 -179.38 150.83 0.45 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.414 -1.314 . . . . 0.0 110.676 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -159.35 141.89 13.9 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.609 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -65.95 -66.71 0.52 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.04 -1.037 . . . . 0.0 109.313 -179.507 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.609 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 85.38 -55.07 0.09 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.576 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 9.5 tp10 169.62 151.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.502 ' CG ' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.67 -164.53 1.89 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.847 -1.158 . . . . 0.0 109.295 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.552 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -150.96 -177.13 5.83 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.208 -0.933 . . . . 0.0 110.419 -179.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -149.51 90.78 1.75 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -78.21 108.35 11.46 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.426 ' HG3' ' NE2' ' A' ' 79' ' ' HIS . 25.0 tt0 -92.62 99.57 12.25 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.488 -0.758 . . . . 0.0 110.158 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.506 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -79.26 170.97 13.75 Favored Pre-proline 0 C--N 1.301 -1.503 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.338 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 5.5 Cg_exo -51.89 -55.02 4.31 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.872 1.715 . . . . 0.0 109.606 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.04 35.88 4.08 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -144.31 91.52 2.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.521 -0.737 . . . . 0.0 109.682 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.426 ' NE2' ' HG3' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -82.15 90.99 6.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.752 -1.218 . . . . 0.0 109.087 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.624 HG22 ' C6 ' ' A' ' 130' ' ' APC . 1.0 OUTLIER -98.84 157.28 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.005 -1.059 . . . . 0.0 110.272 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.537 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 2.2 m -136.34 170.6 15.77 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.588 ' O ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -159.5 85.8 0.79 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.601 -1.312 . . . . 0.0 110.035 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.477 ' O ' HG11 ' A' ' 8' ' ' VAL . 97.3 m95 -65.43 115.12 5.35 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.786 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.588 ' CD1' ' O ' ' A' ' 82' ' ' LEU . 10.1 m-85 -89.56 71.32 7.91 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.938 -1.101 . . . . 0.0 109.606 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.659 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 88.4 m95 -72.28 87.81 1.14 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.015 -1.053 . . . . 0.0 109.149 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 66' ' ' SER . 3.0 mm? -68.39 130.16 42.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.755 -1.216 . . . . 0.0 110.121 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.551 ' O ' ' CG ' ' A' ' 88' ' ' GLU . 0.8 OUTLIER -117.61 176.89 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.551 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 23.4 mt-10 -159.76 28.88 0.19 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.386 -1.446 . . . . 0.0 112.944 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.595 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -159.62 57.98 0.38 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 119.878 -1.764 . . . . 0.0 111.721 178.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.588 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 2.4 p90 -79.15 162.37 25.83 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.222 -1.549 . . . . 0.0 109.267 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.608 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -92.94 145.86 24.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.999 -1.063 . . . . 0.0 109.583 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 39.29 -87.51 0.01 OUTLIER Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 91' ' ' GLU . 2.8 pt-20 -105.34 157.04 35.3 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.235 -1.156 . . . . 0.0 109.868 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.594 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 10.6 Cg_endo -75.59 -159.07 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.93 2.42 . . . . 0.0 110.263 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.642 ' CD2' HG13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -179.56 66.16 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.291 -0.881 . . . . 0.0 110.36 178.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . -139.07 -33.71 0.17 Allowed Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.367 -1.397 . . . . 0.0 110.688 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.569 ' HG3' ' CE2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -39.62 106.79 0.06 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.129 -1.218 . . . . 0.0 110.496 -179.063 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.489 ' OE1' ' HA2' ' A' ' 38' ' ' GLY . 8.0 tp10 -80.43 100.59 8.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.265 -0.897 . . . . 0.0 109.139 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 54.12 21.96 19.66 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.556 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 7.8 pt20 -122.75 170.82 7.41 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.497 -1.002 . . . . 0.0 108.868 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.556 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 4.2 Cg_exo -63.14 -46.14 10.87 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.0 1.8 . . . . 0.0 110.785 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.58 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 59.69 112.81 0.01 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.631 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 5.2 pt-20 -152.76 137.25 16.76 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.136 -1.214 . . . . 0.0 110.493 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.499 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 1.7 m-90 -48.64 135.7 14.32 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.581 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -125.85 115.65 20.32 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.197 -0.939 . . . . 0.0 109.521 -179.055 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.466 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -82.54 57.81 3.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 110.015 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.587 ' CD2' ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -80.69 -41.28 23.95 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.168 -0.958 . . . . 0.0 108.417 179.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.546 ' N ' HD21 ' A' ' 107' ' ' LEU . 86.4 t 70.13 126.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.854 -0.529 . . . . 0.0 109.938 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 41.18 81.43 0.03 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.662 HD23 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -42.79 166.7 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.487 -1.008 . . . . 0.0 110.545 -178.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.538 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -143.9 -7.34 0.74 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.325 -0.859 . . . . 0.0 111.846 -178.463 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.585 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . . . 81.02 -31.53 0.11 Allowed 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.91 -1.119 . . . . 0.0 109.024 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -58.3 -16.83 15.74 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.453 -0.779 . . . . 0.0 109.099 179.311 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 33' ' ' LEU . 2.0 m-20 -111.67 -12.86 13.84 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.599 -0.688 . . . . 0.0 109.919 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.715 ' CE1' ' HB3' ' A' ' 33' ' ' LEU . 7.5 m-85 -100.7 148.77 35.47 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.905 . . . . 0.0 109.808 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.58 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 3.5 Cg_exo -64.04 142.1 79.73 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.642 2.228 . . . . 0.0 110.547 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.9 -19.97 70.2 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.04 1.826 . . . . 0.0 110.08 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -45.92 -51.02 13.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 109.25 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.52 ' CB ' HD13 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -94.85 54.68 1.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.618 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.4 mt-10 -64.8 -45.71 75.2 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 2.8 Cg_exo -54.84 -35.38 88.46 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.907 1.738 . . . . 0.0 112.92 -177.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.519 HG13 ' CE2' ' A' ' 84' ' ' PHE . 2.1 t -100.34 -31.94 3.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.579 -1.325 . . . . 0.0 109.243 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.585 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -61.7 -26.99 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.514 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -55.77 -37.63 68.8 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 125' ' ' LYS . 29.1 mmtm -78.09 -35.86 48.79 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.861 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.599 HD13 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -66.6 -21.71 66.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.45 -1.406 . . . . 0.0 107.334 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.539 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 7.2 mtmt -57.69 -35.21 70.3 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 177.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 125' ' ' LYS . 4.2 mtp180 -82.34 -22.97 35.32 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.429 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 1.3 tp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.473 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' APC . . . . . 0.624 ' C6 ' HG22 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' HOH . . . . . 0.422 ' O ' ' O ' ' A' ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ptp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.485 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -136.99 -163.52 1.43 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.383 -0.823 . . . . 0.0 109.109 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.551 ' HG2' ' N ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -109.72 154.11 23.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.011 . . . . 0.0 109.938 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.687 ' CG ' H5'1 ' A' ' 130' ' ' APC . 0.1 OUTLIER -138.25 125.94 22.25 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.54 ' N ' HD21 ' A' ' 4' ' ' LEU . 0.9 OUTLIER -96.25 164.52 12.63 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.313 -1.492 . . . . 0.0 110.091 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.582 HG13 ' N7 ' ' A' ' 130' ' ' APC . 0.1 OUTLIER -131.2 117.82 38.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.495 -0.753 . . . . 0.0 109.046 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.472 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -86.61 63.17 7.83 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.533 ' HB ' ' HA2' ' A' ' 37' ' ' GLY . 1.3 p -78.42 -72.43 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 109.735 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.63 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 57.38 87.65 0.02 OUTLIER Glycine 0 N--CA 1.479 1.528 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.531 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -47.77 168.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.238 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.557 ' CG2' ' CG2' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -131.04 94.62 2.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 O-C-N 121.181 -0.949 . . . . 0.0 109.33 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.575 ' HG2' ' CG2' ' A' ' 18' ' ' ILE . 13.9 mtm180 -75.82 177.36 6.99 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.577 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -151.44 -60.98 0.17 Allowed 'General case' 0 C--O 1.191 -1.977 0 C-N-CA 116.783 -1.967 . . . . 0.0 114.367 -176.296 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.485 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -92.32 -29.65 16.25 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 119.204 -2.185 . . . . 0.0 111.091 -176.124 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -162.16 -43.04 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.528 ' ND2' ' HD2' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -157.43 34.02 0.28 Allowed 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.359 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 105' ' ' MET . 17.1 mt-10 -82.01 87.36 6.45 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 118.005 -1.478 . . . . 0.0 108.88 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.575 ' CG2' ' HG2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -80.0 147.96 6.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.395 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.639 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 7.8 t80 -81.68 45.05 0.86 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.524 HG13 ' N ' ' A' ' 21' ' ' THR . 6.6 tp -79.0 151.78 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-O 122.437 1.113 . . . . 0.0 111.575 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.565 ' CG2' ' NE2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -68.86 84.47 0.31 Allowed 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.438 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.492 ' O ' ' C ' ' A' ' 23' ' ' ARG . 18.2 tpt180 -79.24 84.98 5.13 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.016 -1.053 . . . . 0.0 109.822 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.492 ' C ' ' O ' ' A' ' 22' ' ' ARG . 1.5 ptt180 31.94 62.9 0.27 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.275 0.56 . . . . 0.0 110.319 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -41.92 -41.8 2.57 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.691 -0.631 . . . . 0.0 109.354 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' A' ' 23' ' ' ARG . . . -80.57 -179.96 7.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 109.195 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 26' ' ' ASP . 3.6 p30 -78.79 112.86 16.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 109.328 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 23' ' ' ARG . . . -112.27 -30.18 7.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 109.841 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 49.65 28.38 2.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.011 -1.055 . . . . 0.0 108.448 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.587 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 30.8 mmm -140.03 -100.01 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.392 -0.818 . . . . 0.0 109.976 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.587 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 152.13 -169.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER 78.84 -8.78 1.6 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.158 -0.964 . . . . 0.0 109.03 -179.312 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.488 ' HG2' ' HA ' ' A' ' 23' ' ' ARG . 5.2 tptt -83.4 55.93 3.37 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.671 -0.643 . . . . 0.0 109.857 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.652 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 7.1 mt -120.04 93.09 3.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.288 -0.882 . . . . 0.0 108.779 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.551 ' O ' ' CG ' ' A' ' 35' ' ' PHE . 3.0 tt0 -88.56 -126.76 0.06 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.876 -1.14 . . . . 0.0 110.786 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.551 ' CG ' ' O ' ' A' ' 34' ' ' GLU . 98.9 m-85 -160.07 128.72 3.01 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.756 -1.215 . . . . 0.0 110.247 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.528 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 3.7 Cg_endo -64.79 97.28 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.113 1.875 . . . . 0.0 109.727 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.543 ' CA ' ' HB2' ' A' ' 98' ' ' GLU . . . -55.51 -153.15 0.01 OUTLIER Glycine 0 N--CA 1.492 2.405 0 O-C-N 121.298 -0.876 . . . . 0.0 111.013 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 163.86 -33.67 0.28 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.568 ' HB3' ' H2 ' ' A' ' 133' ' ' HOH . 10.4 tptm 65.85 101.28 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.95 -0.735 . . . . 0.0 110.253 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.585 HG22 ' CD1' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -80.42 135.44 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.039 -1.038 . . . . 0.0 108.693 178.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.525 ' HG3' ' N ' ' A' ' 42' ' ' MET . 6.9 pt-20 -171.12 -31.99 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.422 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.525 ' N ' ' HG3' ' A' ' 41' ' ' GLU . 1.7 mtt -62.08 151.89 34.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.065 -1.022 . . . . 0.0 109.842 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.98 -127.54 43.14 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.35 21.05 0.1 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.443 -1.034 . . . . 0.0 109.209 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.519 HG21 ' HD2' ' A' ' 46' ' ' PRO . 1.8 m -147.01 140.78 15.27 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.593 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 11.0 Cg_exo -45.24 -18.6 0.28 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.067 1.845 . . . . 0.0 111.268 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.488 ' HB2' HG23 ' A' ' 45' ' ' THR . 0.5 OUTLIER -76.87 -80.18 0.1 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.507 -1.37 . . . . 0.0 108.879 178.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.58 ' O ' ' CG ' ' A' ' 52' ' ' ARG . 60.0 mt-30 -48.58 -33.45 9.75 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.087 -1.633 . . . . 0.0 109.207 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.597 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -64.31 -63.6 1.1 Allowed 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.193 -0.942 . . . . 0.0 110.29 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 1.7 p -68.7 -48.87 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.142 -0.974 . . . . 0.0 110.57 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.572 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 2.9 p -56.03 -39.0 55.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-O 121.189 0.519 . . . . 0.0 110.357 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.58 ' CG ' ' O ' ' A' ' 48' ' ' GLN . 18.3 mmt180 -78.65 -32.99 47.47 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.597 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 24.3 mm-40 -71.89 -12.84 61.46 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.581 HD11 ' CD2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -80.09 -55.34 5.01 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.645 0.736 . . . . 0.0 109.331 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.432 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -69.38 -33.92 73.76 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.691 -0.631 . . . . 0.0 111.173 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.586 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -64.26 -25.8 68.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.821 -1.175 . . . . 0.0 111.385 -177.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.539 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -80.34 -80.8 0.13 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.499 -1.375 . . . . 0.0 109.887 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.553 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 69.9 t -80.17 -82.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.145 -0.972 . . . . 0.0 109.463 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.95 21.66 0.12 Allowed Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.632 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.645 ' CG1' ' CD2' ' A' ' 95' ' ' TRP . 1.1 pt -80.17 -144.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.496 -1.591 . . . . 0.0 108.395 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.588 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 2.1 m -151.36 -71.46 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 120.474 -1.392 . . . . 0.0 110.965 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.588 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 1.0 OUTLIER -60.4 -173.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.934 0 C-N-CA 121.082 1.188 . . . . 0.0 109.918 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 1.5 pt20 152.04 -23.55 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.596 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER 47.35 61.64 2.8 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.336 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.43 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 5.1 p90 -60.78 155.43 19.4 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.886 0.851 . . . . 0.0 110.735 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -152.51 139.24 18.85 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.169 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.585 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -66.31 -67.15 0.47 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.854 -1.154 . . . . 0.0 109.814 -179.048 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.603 ' CZ ' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER 81.75 -48.94 0.23 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.281 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER 164.42 176.54 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.093 -1.004 . . . . 0.0 108.412 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.542 ' HE3' ' CE3' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -161.58 175.04 12.51 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.948 -1.095 . . . . 0.0 110.161 -179.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.55 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -136.73 -179.12 5.5 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.387 -0.821 . . . . 0.0 109.758 179.402 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -154.75 90.23 1.29 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.09 162.77 22.41 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.447 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 4.0 mt-10 -118.0 161.08 20.39 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.551 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.608 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -128.98 179.48 1.28 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.608 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 6.9 Cg_exo -52.69 -24.05 21.97 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.522 1.481 . . . . 0.0 109.787 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.426 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 2.2 p30 -171.13 32.55 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.489 ' NH2' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -141.28 93.74 2.61 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.705 -0.622 . . . . 0.0 110.151 -178.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.447 ' CD2' ' HG3' ' A' ' 74' ' ' GLU . 8.9 t-160 -79.1 93.08 5.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.037 -1.039 . . . . 0.0 108.384 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.552 HG22 ' C5 ' ' A' ' 130' ' ' APC . 13.3 mm -83.95 157.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.263 1.03 . . . . 0.0 111.486 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.479 HG23 ' NZ ' ' A' ' 70' ' ' LYS . 2.4 m -131.0 155.27 47.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.524 ' HG ' ' CG2' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -141.83 83.92 1.87 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.495 -1.378 . . . . 0.0 110.72 -179.106 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.585 ' CD1' HG22 ' A' ' 40' ' ' ILE . 72.5 m95 -55.74 109.54 0.58 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.939 -1.101 . . . . 0.0 109.162 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.617 ' CD1' HG23 ' A' ' 122' ' ' VAL . 35.7 m-85 -86.79 75.04 9.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.02 -1.05 . . . . 0.0 109.72 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.63 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 83.9 m95 -79.41 89.39 5.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.051 -1.031 . . . . 0.0 109.456 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.56 HD21 ' CD2' ' A' ' 68' ' ' PHE . 3.3 mm? -68.78 132.38 46.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.843 -1.161 . . . . 0.0 109.831 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.557 ' CG2' ' CG2' ' A' ' 11' ' ' ILE . 0.7 OUTLIER -120.54 170.4 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.603 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.478 ' HG2' ' HB2' ' A' ' 12' ' ' ARG . 37.4 mt-10 -154.33 23.11 0.48 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.201 -1.562 . . . . 0.0 113.453 -178.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.596 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -160.24 55.76 0.34 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 119.832 -1.793 . . . . 0.0 111.138 178.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.629 ' CZ2' ' CD1' ' A' ' 104' ' ' TRP . 4.8 p90 -73.99 157.89 35.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.929 -1.107 . . . . 0.0 109.456 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.618 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -79.88 142.54 35.11 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.136 -0.977 . . . . 0.0 109.559 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 29.89 -82.38 0.0 OUTLIER Glycine 0 N--CA 1.5 2.907 0 O-C-N 121.985 -0.447 . . . . 0.0 112.1 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.618 ' N ' ' O ' ' A' ' 91' ' ' GLU . 2.9 mm-40 -93.74 157.12 38.75 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.216 -1.167 . . . . 0.0 110.74 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.627 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 29.4 Cg_endo -82.52 -157.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.622 2.215 . . . . 0.0 109.805 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.645 ' CD2' ' CG1' ' A' ' 60' ' ' ILE . 0.3 OUTLIER 172.63 114.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.454 0.645 . . . . 0.0 109.881 178.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . 165.2 -36.37 0.27 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.543 ' N ' ' HD3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -39.5 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.667 -0.902 . . . . 0.0 110.789 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.543 ' HB2' ' CA ' ' A' ' 37' ' ' GLY . 3.1 tp10 -68.22 96.3 0.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.014 -1.054 . . . . 0.0 108.423 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.26 46.39 57.14 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.565 ' NE2' ' CG2' ' A' ' 21' ' ' THR . 0.0 OUTLIER -144.5 163.58 33.3 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.552 ' HD2' ' HG3' ' A' ' 100' ' ' GLN . 1.2 Cg_endo -64.1 -51.91 1.92 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 121.402 1.402 . . . . 0.0 109.796 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.639 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 59.25 113.35 0.01 OUTLIER Glycine 0 N--CA 1.479 1.519 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.586 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 12.4 pt-20 -150.33 131.78 14.73 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.211 -1.17 . . . . 0.0 109.858 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.629 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -47.25 133.69 11.89 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.555 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -124.75 121.84 35.75 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 109.614 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.2 t -81.13 63.2 5.39 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.607 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -80.24 -47.75 14.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.346 -0.847 . . . . 0.0 108.971 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 40.7 t 82.2 119.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.841 -0.537 . . . . 0.0 110.081 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 108' ' ' VAL . . . 36.51 82.67 0.01 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.671 HD22 ' CD1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -40.98 164.84 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.625 -0.927 . . . . 0.0 110.67 -178.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.526 ' O ' ' HB2' ' A' ' 112' ' ' ALA . 1.7 t-20 -142.88 -5.19 0.91 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 111.621 -178.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.609 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . . . 77.37 -6.38 2.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.998 -1.064 . . . . 0.0 108.51 -177.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 -18.18 50.94 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.532 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -109.61 -11.15 14.8 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.329 0.585 . . . . 0.0 109.562 -179.454 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.671 ' CD1' HD22 ' A' ' 110' ' ' LEU . 15.7 m-85 -103.76 149.77 37.48 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.905 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.565 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 2.1 Cg_endo -63.8 145.48 90.76 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.718 2.278 . . . . 0.0 110.651 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.481 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 1.3 Cg_endo -66.14 -27.5 49.14 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.27 1.98 . . . . 0.0 110.399 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -43.21 -54.25 4.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.049 -1.032 . . . . 0.0 109.621 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.473 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 7.5 m-80 -90.08 50.46 1.87 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.655 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 5.4 mt-10 -67.54 -37.85 13.71 Favored Pre-proline 0 C--N 1.3 -1.576 0 O-C-N 121.682 -0.636 . . . . 0.0 112.268 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.655 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.2 Cg_exo -55.36 -37.22 94.82 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.392 1.395 . . . . 0.0 112.035 -178.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.617 HG23 ' CD1' ' A' ' 84' ' ' PHE . 2.2 t -99.76 -34.41 4.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.69 -1.257 . . . . 0.0 109.046 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.609 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -60.68 -22.7 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.556 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.555 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -60.7 -36.85 79.82 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.079 0.943 . . . . 0.0 108.501 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.55 -38.92 47.59 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.737 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.603 HD13 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -64.17 -23.07 67.18 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.564 ' CD ' ' HB1' ' A' ' 112' ' ' ALA . 12.7 mtmt -54.96 -38.65 68.02 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.438 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -80.24 -24.43 40.16 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.686 179.233 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.595 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 2.0 tp . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.936 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' APC . . . . . 0.687 H5'1 ' CG ' ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' CON . . . . . 0.603 ' N3 ' ' O2A' ' A' ' 130' ' ' APC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' HOH . . . . . 0.568 ' H2 ' ' HB3' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.464 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.31 0.576 . . . . 0.0 109.657 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.559 ' HD3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 168.56 -164.38 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.227 -179.27 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.559 ' N ' ' HD3' ' A' ' 2' ' ' LYS . 4.0 tmmm? -157.55 149.97 22.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.369 -0.832 . . . . 0.0 108.952 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.579 HD12 ' CG2' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -148.66 132.74 17.26 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.163 -0.961 . . . . 0.0 108.901 178.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.526 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 5.8 mp0 -99.44 155.88 17.32 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.379 -1.451 . . . . 0.0 109.069 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.571 HG13 ' N7 ' ' A' ' 130' ' ' APC . 0.5 OUTLIER -116.97 117.16 54.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.348 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.415 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -84.41 66.19 9.3 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.569 ' CB ' ' O ' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -79.44 -77.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.168 -0.958 . . . . 0.0 110.123 -179.375 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.595 ' CA ' ' N ' ' A' ' 85' ' ' TRP . . . 63.15 93.24 0.02 OUTLIER Glycine 0 N--CA 1.484 1.852 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.547 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -52.95 162.32 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.563 HG21 ' CG1' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -128.79 92.42 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.328 -179.177 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.535 ' HG2' ' CG2' ' A' ' 18' ' ' ILE . 8.9 mtm180 -75.71 177.23 7.01 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.646 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -156.76 -61.5 0.1 Allowed 'General case' 0 C--O 1.191 -2.005 0 C-N-CA 116.069 -2.252 . . . . 0.0 114.716 -176.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.524 ' CB ' ' OE2' ' A' ' 17' ' ' GLU . 5.9 tp10 -91.7 -25.94 18.86 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 119.335 -2.103 . . . . 0.0 111.594 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -161.75 -45.53 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -160.92 35.6 0.15 Allowed 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.524 ' OE2' ' CB ' ' A' ' 14' ' ' GLU . 12.6 mt-10 -79.83 83.82 5.71 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 118.403 -1.319 . . . . 0.0 109.161 -178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.535 ' CG2' ' HG2' ' A' ' 12' ' ' ARG . 18.1 pt -79.19 141.36 15.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.22 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.587 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 13.5 t80 -81.71 45.09 0.86 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.663 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 4.4 tt -80.13 152.29 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-O 121.93 0.872 . . . . 0.0 110.863 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 101' ' ' PRO . 0.6 OUTLIER -69.88 95.34 0.91 Allowed 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.507 ' O ' ' C ' ' A' ' 23' ' ' ARG . 13.2 tpt180 -99.09 90.37 4.58 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.641 -0.662 . . . . 0.0 111.072 -178.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.508 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 32.41 83.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.898 -0.501 . . . . 0.0 110.177 178.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.44 -46.53 4.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.224 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.84 176.43 9.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.432 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -77.47 105.28 8.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.121 -0.987 . . . . 0.0 109.427 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.508 ' CB ' ' HD2' ' A' ' 23' ' ' ARG . . . -104.14 133.8 48.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.12 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -82.25 4.23 24.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 0.0 109.059 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.528 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -102.55 -126.69 0.21 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.603 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 163.62 -4.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.978 -1.076 . . . . 0.0 111.729 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 114' ' ' ASP . 2.9 p-10 -79.24 8.68 5.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.27 -1.519 . . . . 0.0 109.136 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.472 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -81.5 61.34 4.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.588 -0.695 . . . . 0.0 110.105 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.607 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 7.6 mt -123.66 93.11 3.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.868 -1.145 . . . . 0.0 109.291 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.533 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.72 -145.97 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.465 -0.772 . . . . 0.0 109.003 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.497 ' CZ ' ' CG ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -142.53 128.35 10.52 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.745 -1.222 . . . . 0.0 109.49 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.569 ' O ' ' CB ' ' A' ' 8' ' ' VAL . 3.0 Cg_endo -60.05 97.09 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.004 1.803 . . . . 0.0 109.53 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.536 ' HA2' ' CG2' ' A' ' 6' ' ' ILE . . . -54.13 -141.95 0.0 OUTLIER Glycine 0 N--CA 1.496 2.677 0 O-C-N 121.531 -0.73 . . . . 0.0 111.589 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 153.59 -34.78 0.75 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.611 ' HB3' ' H1 ' ' A' ' 133' ' ' HOH . 5.0 tptm 69.15 95.53 0.07 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.039 -0.683 . . . . 0.0 110.465 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.601 HG12 ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.66 135.71 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.204 -0.935 . . . . 0.0 108.833 178.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -170.28 -34.23 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.353 -0.842 . . . . 0.0 109.756 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.415 ' O ' ' C ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -49.35 156.47 0.6 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.243 -0.911 . . . . 0.0 109.514 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' MET . . . 44.23 -122.44 4.46 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.78 21.27 0.09 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.406 -1.055 . . . . 0.0 109.484 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.533 HG21 ' HD2' ' A' ' 46' ' ' PRO . 98.0 m -135.18 141.9 39.72 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.22 -0.925 . . . . 0.0 108.907 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.533 ' HD2' HG21 ' A' ' 45' ' ' THR . 11.2 Cg_exo -50.37 -16.9 2.29 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.573 1.516 . . . . 0.0 110.205 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.493 ' O ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -76.99 -84.08 0.07 Allowed 'General case' 0 C--O 1.202 -1.43 0 O-C-N 121.181 -0.949 . . . . 0.0 108.768 178.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.572 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -45.14 -35.91 3.43 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.484 -1.385 . . . . 0.0 109.747 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.635 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -64.23 -60.67 2.92 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.299 -0.875 . . . . 0.0 110.387 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.565 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 1.8 p -70.32 -48.82 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.897 -1.127 . . . . 0.0 110.548 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.565 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 4.1 p -56.7 -37.41 52.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.823 -0.548 . . . . 0.0 110.575 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 2.9 mmt180 -79.17 -39.73 32.69 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.635 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 19.9 mm-40 -65.98 -15.66 63.2 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.674 ' HB3' ' CZ2' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -80.26 -39.29 29.23 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.752 0.787 . . . . 0.0 109.961 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.61 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 1.8 mt-30 -79.2 -52.55 8.0 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.624 0.726 . . . . 0.0 109.192 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.602 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -44.65 -23.9 0.16 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.644 -0.66 . . . . 0.0 110.097 -179.58 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 3.9 mm-40 -80.16 -95.84 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.864 -1.148 . . . . 0.0 109.516 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.656 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 57.6 t -80.38 -78.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.07 -1.019 . . . . 0.0 109.809 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.64 37.54 0.11 Allowed Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.434 -1.365 . . . . 0.0 111.653 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.677 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -91.56 -147.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.506 -1.585 . . . . 0.0 108.689 178.64 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.5 m -162.73 -64.03 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 120.439 -1.413 . . . . 0.0 112.985 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.55 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 1.8 Cg_endo -56.66 -2.63 0.47 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 122.53 2.153 . . . . 0.0 113.963 -177.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.603 ' HG2' ' CZ2' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -40.24 -26.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.789 -1.194 . . . . 0.0 109.917 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.57 ' N ' ' HG3' ' A' ' 63' ' ' GLN . 0.4 OUTLIER 57.4 -170.16 0.1 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -178.255 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -179.34 158.85 0.89 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.521 -1.362 . . . . 0.0 111.683 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -156.84 147.84 21.91 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.749 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.597 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -70.07 -67.44 0.49 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.888 -1.133 . . . . 0.0 109.655 -179.202 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.597 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 82.31 -52.4 0.22 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.586 ' CB ' ' O ' ' A' ' 68' ' ' PHE . 2.2 mm-40 150.56 133.36 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.798 -0.564 . . . . 0.0 109.819 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.511 ' HG3' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -122.64 -162.74 1.03 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.148 -0.97 . . . . 0.0 109.336 179.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.529 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -145.62 175.79 10.1 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.372 -0.83 . . . . 0.0 109.871 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -148.27 83.26 1.49 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.32 126.23 34.18 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.61 160.69 14.67 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.544 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 3.1 m-85 -128.75 170.02 11.62 Favored Pre-proline 0 C--N 1.296 -1.747 0 O-C-N 121.182 -0.948 . . . . 0.0 109.29 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.2 Cg_exo -48.83 -23.23 5.54 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.083 1.855 . . . . 0.0 109.694 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.0 42.29 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.472 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -153.39 90.0 1.39 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.787 -0.571 . . . . 0.0 109.563 -178.37 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.482 ' C ' ' CD1' ' A' ' 80' ' ' ILE . 7.0 t-160 -80.31 100.28 8.31 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.598 ' CG2' ' C5 ' ' A' ' 130' ' ' APC . 1.2 mm -115.89 144.41 23.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 118.809 -1.156 . . . . 0.0 112.138 -178.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.526 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 1.6 m -119.3 166.24 13.26 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.434 ' HG ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -151.73 76.24 1.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.761 -1.212 . . . . 0.0 110.069 179.81 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.593 ' CD1' HG22 ' A' ' 40' ' ' ILE . 75.6 m95 -51.68 128.37 23.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.123 -0.986 . . . . 0.0 109.142 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.599 ' CD2' HG12 ' A' ' 122' ' ' VAL . 23.5 m-85 -103.62 76.35 1.39 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.039 -1.038 . . . . 0.0 109.782 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.595 ' N ' ' CA ' ' A' ' 9' ' ' GLY . 40.8 m95 -78.39 91.66 4.5 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.997 -1.064 . . . . 0.0 109.209 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.547 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 1.6 mm? -71.8 131.76 43.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.955 -1.091 . . . . 0.0 109.882 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.563 ' CG1' HG21 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -117.67 -178.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.513 ' N ' HG22 ' A' ' 87' ' ' VAL . 43.5 mt-10 -158.07 2.45 0.11 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.139 -1.601 . . . . 0.0 113.397 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.596 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -151.45 68.61 0.92 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 119.623 -1.923 . . . . 0.0 111.723 -179.62 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.692 ' CZ2' ' CD1' ' A' ' 104' ' ' TRP . 9.6 p90 -80.57 167.91 19.53 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.467 -1.395 . . . . 0.0 109.38 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.546 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -92.41 144.15 25.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.137 -0.977 . . . . 0.0 109.435 179.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 40.08 -91.03 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.577 ' O ' ' CG2' ' A' ' 60' ' ' ILE . 13.6 pt-20 -107.07 161.65 22.23 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.214 -1.168 . . . . 0.0 109.77 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.583 ' HG3' ' CD1' ' A' ' 19' ' ' PHE . 9.8 Cg_endo -75.77 -155.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.563 2.175 . . . . 0.0 109.93 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.677 ' CD2' HG13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER 178.96 46.59 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.425 -0.797 . . . . 0.0 109.83 179.277 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -128.1 -20.86 1.58 Allowed Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.751 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.581 ' O ' ' HG2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -49.92 104.04 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.871 -1.37 . . . . 0.0 109.618 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.479 ' HB2' ' C ' ' A' ' 37' ' ' GLY . 9.0 tp10 -82.81 94.29 7.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.9 -1.125 . . . . 0.0 109.244 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.98 13.54 34.38 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.491 ' CG ' ' HB2' ' A' ' 97' ' ' LYS . 1.8 pt20 -114.92 162.74 22.32 Favored Pre-proline 0 N--CA 1.487 1.383 0 O-C-N 121.345 -1.091 . . . . 0.0 108.683 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 102' ' ' GLY . 6.0 Cg_exo -60.32 -44.11 30.27 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.815 1.677 . . . . 0.0 109.728 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.587 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 56.27 112.75 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 3.7 pt-20 -147.24 132.31 18.26 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.8 -1.412 . . . . 0.0 111.068 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.692 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 2.4 m0 -47.8 126.02 9.66 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.5 ' HE1' ' HB2' ' A' ' 22' ' ' ARG . 7.7 tpp -123.31 105.57 9.96 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.347 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.29 81.39 0.74 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.647 ' O ' ' CB ' ' A' ' 108' ' ' VAL . 6.2 tt -80.99 -80.04 0.15 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.471 -0.768 . . . . 0.0 110.614 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.647 ' CB ' ' O ' ' A' ' 107' ' ' LEU . 54.5 t 115.49 103.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.504 ' CA ' ' OXT' ' A' ' 129' ' ' LEU . . . 41.94 78.77 0.06 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.594 -1.803 . . . . 0.0 108.594 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.598 HD22 ' CD1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -39.54 163.66 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.617 -0.931 . . . . 0.0 110.989 -178.639 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 1.5 t-20 -139.68 -8.28 1.25 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.406 -0.809 . . . . 0.0 111.412 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.583 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . . . 83.66 -25.38 0.14 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.301 -0.875 . . . . 0.0 108.713 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.12 -29.69 61.05 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.541 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 9.7 m-20 -94.22 -19.22 20.94 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.663 ' CZ ' ' CD1' ' A' ' 20' ' ' ILE . 6.5 m-85 -95.82 148.05 33.95 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.325 -0.859 . . . . 0.0 109.908 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.488 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.4 Cg_endo -68.0 142.52 56.9 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.409 2.073 . . . . 0.0 110.061 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 118' ' ' ALA . 2.4 Cg_endo -63.04 -27.97 74.25 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.157 1.905 . . . . 0.0 110.476 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -41.43 -48.56 3.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.414 -0.804 . . . . 0.0 109.383 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.497 ' CG ' ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -96.33 55.17 1.46 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.632 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -62.75 -42.33 77.8 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.764 -0.585 . . . . 0.0 112.027 -179.59 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 11.6 Cg_exo -54.02 -47.94 24.33 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 121.846 1.698 . . . . 0.0 112.615 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.599 HG12 ' CD2' ' A' ' 84' ' ' PHE . 1.5 t -88.64 -38.02 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.704 -1.248 . . . . 0.0 109.62 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.583 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 1.1 mp -63.1 -21.0 27.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.535 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -63.64 -31.06 72.12 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -80.32 -40.34 26.92 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.519 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.584 ' CD1' ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -65.09 -21.09 66.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.682 -1.261 . . . . 0.0 107.755 179.366 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.549 ' CD ' ' HB1' ' A' ' 112' ' ' ALA . 1.9 mtmt -58.1 -36.5 72.98 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -83.23 -20.53 34.4 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.503 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 1.2 tp . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.627 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' APC . . . . . 0.598 ' C5 ' ' CG2' ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' HOH . . . . . 0.611 ' H1 ' ' HB3' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.457 0.646 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.488 ' HD3' ' C ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -160.82 -163.54 1.07 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.474 ' CG ' ' N ' ' A' ' 4' ' ' LEU . 8.6 ttpt -151.82 161.18 43.08 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.035 -1.041 . . . . 0.0 109.26 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.64 ' HG ' " O4'" ' A' ' 130' ' ' APC . 0.2 OUTLIER -159.0 110.0 2.07 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.526 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 2.5 mp0 -104.7 169.53 8.4 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.015 -1.053 . . . . 0.0 109.427 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.556 HD13 ' C8 ' ' A' ' 130' ' ' APC . 0.1 OUTLIER -135.23 122.87 37.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.437 -0.79 . . . . 0.0 108.984 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . . . -86.2 62.16 7.27 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -79.15 -77.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.717 -179.514 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.627 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 62.99 89.07 0.03 OUTLIER Glycine 0 N--CA 1.48 1.567 0 N-CA-C 106.956 -2.458 . . . . 0.0 106.956 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.616 ' CG2' ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -55.13 163.93 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.556 ' CG2' ' CG2' ' A' ' 87' ' ' VAL . 2.0 pt -127.42 71.46 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.301 -177.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.592 ' NH1' ' CD2' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -77.99 159.78 28.58 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.266 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.07 -18.61 0.04 OUTLIER 'General case' 0 C--O 1.187 -2.19 0 C-N-CA 115.81 -2.356 . . . . 0.0 115.479 -177.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.513 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 1.4 tm-20 -93.48 -31.67 14.49 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 118.165 -2.834 . . . . 0.0 108.646 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -163.13 -46.51 0.03 OUTLIER 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.485 ' ND2' ' HD2' ' A' ' 12' ' ' ARG . 1.1 t-20 -162.05 37.87 0.12 Allowed 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 176.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 105' ' ' MET . 92.3 mt-10 -91.6 94.29 9.34 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 118.003 -1.479 . . . . 0.0 110.831 -177.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.616 ' CD1' ' CG2' ' A' ' 10' ' ' ILE . 0.6 OUTLIER -96.99 152.36 3.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.544 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.608 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 13.6 t80 -80.39 45.38 0.76 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.548 ' N ' HD13 ' A' ' 18' ' ' ILE . 5.7 tp -81.09 154.78 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.231 -0.918 . . . . 0.0 111.382 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.535 ' O ' ' O ' ' A' ' 32' ' ' LYS . 1.4 t -67.67 92.98 0.35 Allowed 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 23' ' ' ARG . 30.3 tpt180 -100.78 83.92 2.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.46 -0.775 . . . . 0.0 110.534 -178.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.503 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 31.69 86.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.826 -0.546 . . . . 0.0 110.129 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -44.7 -52.32 8.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.089 -1.007 . . . . 0.0 109.532 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.62 -161.04 0.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 0.0 109.11 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.76 -27.56 40.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.205 -0.934 . . . . 0.0 109.231 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.466 ' HB2' ' HD2' ' A' ' 23' ' ' ARG . . . 50.76 -175.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 109.787 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.53 25.78 0.23 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.535 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 0.7 OUTLIER -126.45 -41.69 1.86 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.367 -0.833 . . . . 0.0 110.318 -179.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 78.93 0.86 2.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 110.124 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 25.4 p-10 -92.98 9.86 33.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.829 -1.169 . . . . 0.0 108.565 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.535 ' O ' ' O ' ' A' ' 21' ' ' THR . 0.9 OUTLIER -81.22 36.43 0.41 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.565 -0.709 . . . . 0.0 110.653 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.672 ' CD1' ' CE1' ' A' ' 115' ' ' PHE . 22.3 mt -110.82 88.05 2.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.553 -1.342 . . . . 0.0 109.564 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.455 ' O ' HD12 ' A' ' 20' ' ' ILE . 1.1 tt0 -91.79 -137.38 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.457 -0.777 . . . . 0.0 109.534 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.46 ' HA ' HD12 ' A' ' 20' ' ' ILE . 90.6 m-85 -149.66 130.8 7.23 Favored Pre-proline 0 C--N 1.306 -1.299 0 O-C-N 121.072 -1.017 . . . . 0.0 109.745 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.551 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 2.1 Cg_endo -56.6 95.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.303 2.002 . . . . 0.0 109.894 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -55.69 -147.04 0.01 OUTLIER Glycine 0 N--CA 1.494 2.528 0 O-C-N 121.319 -0.863 . . . . 0.0 111.205 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 158.97 -40.29 0.5 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.554 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 13.4 tptp 73.75 94.49 0.07 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.146 -0.62 . . . . 0.0 110.596 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.594 HG12 ' CB ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -80.92 131.8 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 108.805 178.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 42' ' ' MET . 4.6 pt-20 -171.76 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.963 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.401 ' N ' ' HG2' ' A' ' 41' ' ' GLU . 4.9 mmt -58.7 163.84 3.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -0.913 . . . . 0.0 109.857 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 47.61 -121.73 6.99 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -167.07 24.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.528 -0.984 . . . . 0.0 108.739 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.552 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 30.4 m -146.71 142.87 17.72 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.588 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 11.1 Cg_exo -50.58 -17.22 2.75 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 121.412 1.408 . . . . 0.0 109.957 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.482 ' O ' HG11 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -75.33 -83.36 0.06 Allowed 'General case' 0 C--O 1.201 -1.483 0 O-C-N 121.081 -1.012 . . . . 0.0 108.938 178.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.519 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 32.9 mt-30 -45.52 -36.66 4.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.37 -1.456 . . . . 0.0 109.776 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.594 ' CB ' HG12 ' A' ' 40' ' ' ILE . . . -62.84 -64.99 0.75 Allowed 'General case' 0 C--N 1.289 -2.056 0 O-C-N 120.964 -1.085 . . . . 0.0 110.26 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 1.9 p -65.05 -48.93 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.048 -1.033 . . . . 0.0 111.018 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.577 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 2.9 p -55.66 -46.48 79.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-O 121.384 0.612 . . . . 0.0 110.109 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.565 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 8.0 mmt180 -72.46 -27.61 62.41 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.591 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 29.9 mm-40 -77.81 -14.18 59.66 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.544 ' HB3' ' CH2' ' A' ' 95' ' ' TRP . 0.8 OUTLIER -80.18 -58.52 3.11 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.482 ' CA ' ' CZ3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -63.16 -50.14 71.56 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.738 -0.601 . . . . 0.0 109.722 179.428 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.587 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 1.4 pp20? -53.25 -20.12 3.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.994 -1.066 . . . . 0.0 109.746 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.482 ' OE1' ' HA2' ' A' ' 96' ' ' GLY . 1.6 mt-10 -80.2 -91.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 109.861 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.588 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 41.7 t -79.96 -79.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.436 -0.79 . . . . 0.0 110.016 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.02 27.04 0.17 Allowed Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.212 -1.47 . . . . 0.0 111.448 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.592 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -81.75 -145.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.607 -1.525 . . . . 0.0 107.948 178.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.578 ' CB ' ' CD ' ' A' ' 62' ' ' PRO . 1.3 m -145.23 -70.43 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 120.512 -1.367 . . . . 0.0 109.943 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.599 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 8.8 Cg_endo -66.71 -169.42 0.18 Allowed 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 121.137 1.225 . . . . 0.0 109.636 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.599 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER 134.09 -20.27 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 -179.112 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.515 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.1 OUTLIER 52.12 -164.59 0.07 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -179.485 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -177.22 144.63 0.43 Allowed 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 117.636 -1.626 . . . . 0.0 111.046 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -145.07 143.48 30.46 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.615 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -74.61 -65.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.856 -1.152 . . . . 0.0 110.216 -178.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.615 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 81.89 -50.74 0.24 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.538 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER 164.15 179.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.135 -0.978 . . . . 0.0 109.595 179.306 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.18 142.82 13.37 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.313 -0.867 . . . . 0.0 109.109 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.541 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -96.93 -171.71 2.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.997 -1.064 . . . . 0.0 109.789 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.407 ' HG3' HG22 ' A' ' 81' ' ' THR . 5.3 tt0 -160.24 95.48 1.14 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.5 123.15 27.29 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.412 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 2.1 tt0 -96.87 143.23 27.96 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.537 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.558 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 5.5 m-85 -119.39 169.76 7.74 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 7.6 Cg_exo -49.26 -31.86 23.58 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.441 1.427 . . . . 0.0 109.307 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -160.72 41.04 0.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.212 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.521 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -146.16 95.76 2.67 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.597 -0.689 . . . . 0.0 109.956 -178.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 2' ' ' LYS . 14.6 m80 -82.64 113.02 20.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.015 -1.053 . . . . 0.0 108.781 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.572 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 1.3 mp -110.87 165.09 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -0.987 . . . . 0.0 110.161 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.559 ' N ' ' CG2' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -153.52 149.37 27.62 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.631 ' CD1' HN61 ' A' ' 130' ' ' APC . 0.2 OUTLIER -137.0 77.47 1.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.903 -1.123 . . . . 0.0 109.909 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.579 ' CD1' HG22 ' A' ' 40' ' ' ILE . 81.8 m95 -46.71 116.34 1.3 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.183 -0.948 . . . . 0.0 109.658 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.582 ' CE2' HG12 ' A' ' 122' ' ' VAL . 26.0 m-85 -92.37 71.21 5.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.155 -0.966 . . . . 0.0 109.931 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.627 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 30.9 m95 -75.14 91.8 2.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.843 -1.161 . . . . 0.0 109.06 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 66' ' ' SER . 3.3 mm? -73.02 127.29 32.14 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.774 -1.204 . . . . 0.0 110.281 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.556 ' CG2' ' CG2' ' A' ' 11' ' ' ILE . 0.8 OUTLIER -115.7 172.79 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 43.8 mt-10 -157.48 32.68 0.27 Allowed 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 117.835 -1.546 . . . . 0.0 113.392 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.593 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.21 55.94 0.35 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 119.872 -1.767 . . . . 0.0 111.154 178.251 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.539 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 5.1 p90 -78.94 159.09 27.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.19 -1.569 . . . . 0.0 109.488 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -88.43 138.21 31.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 32.79 -79.72 0.0 OUTLIER Glycine 0 N--CA 1.501 3.025 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.664 ' N ' ' O ' ' A' ' 91' ' ' GLU . 2.8 mm-40 -94.49 144.79 28.53 Favored Pre-proline 0 C--N 1.303 -1.424 0 O-C-N 121.164 -1.198 . . . . 0.0 109.645 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.573 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 14.0 Cg_endo -79.58 -161.62 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.18 1.92 . . . . 0.0 109.651 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.657 ' CD1' ' O ' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -176.21 116.72 0.13 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.016 0.912 . . . . 0.0 109.946 177.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.482 ' HA2' ' OE1' ' A' ' 57' ' ' GLU . . . 167.61 -34.59 0.21 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.562 ' CA ' ' HG2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -39.57 100.51 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.539 -0.977 . . . . 0.0 109.849 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.564 ' CG ' ' O2G' ' A' ' 130' ' ' APC . 18.2 tp10 -80.15 105.48 11.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.311 -0.868 . . . . 0.0 108.822 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 50.53 30.77 20.46 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.562 ' HG2' ' CA ' ' A' ' 97' ' ' LYS . 1.7 pt20 -134.26 165.26 38.05 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.544 -0.974 . . . . 0.0 109.337 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 3.5 Cg_exo -63.47 -45.61 11.28 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.206 1.938 . . . . 0.0 110.484 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.608 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.59 114.42 0.01 OUTLIER Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.607 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 1.8 pt-20 -152.25 134.16 14.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.086 -1.243 . . . . 0.0 110.079 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.522 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 1.7 m-90 -46.15 134.45 8.45 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.609 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -125.97 116.15 21.03 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.135 -0.978 . . . . 0.0 109.031 -179.04 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.528 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -79.52 43.69 0.57 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.428 -0.795 . . . . 0.0 110.858 -178.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.584 ' CD2' ' HA ' ' A' ' 110' ' ' LEU . 9.4 tt -67.01 161.9 23.29 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.511 ' N ' HD21 ' A' ' 107' ' ' LEU . 24.5 t -118.78 114.69 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.048 -1.033 . . . . 0.0 108.935 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 43.18 84.45 0.01 OUTLIER Glycine 0 N--CA 1.493 2.436 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.646 HD23 ' CZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -35.55 157.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.764 0.793 . . . . 0.0 111.33 -178.137 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 3.2 t-20 -138.45 -5.04 1.61 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.687 -0.633 . . . . 0.0 111.346 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.6 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . . . 81.99 -34.93 0.1 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -49.99 -26.59 4.42 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.452 -0.78 . . . . 0.0 109.266 179.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.559 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 62.9 m-20 -104.25 -20.01 13.92 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.753 -0.592 . . . . 0.0 109.503 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.672 ' CE1' ' CD1' ' A' ' 33' ' ' LEU . 9.4 m-85 -98.8 148.36 34.46 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.226 -0.921 . . . . 0.0 109.101 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.526 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 6.1 Cg_exo -62.03 132.27 38.59 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.459 2.106 . . . . 0.0 110.448 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.93 -18.5 42.84 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.948 1.765 . . . . 0.0 110.201 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -46.52 -52.48 13.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.235 -0.916 . . . . 0.0 108.879 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.509 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 10.9 m120 -86.56 46.68 1.38 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.615 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 2.2 mt-10 -57.66 -44.31 99.4 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.667 -0.646 . . . . 0.0 112.485 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 7.1 Cg_exo -53.35 -42.7 63.39 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.877 1.718 . . . . 0.0 113.15 -177.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.582 HG12 ' CE2' ' A' ' 84' ' ' PHE . 1.8 t -96.98 -32.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.458 -1.401 . . . . 0.0 110.06 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.6 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -62.92 -25.85 39.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.555 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -57.59 -33.36 68.12 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.165 0.983 . . . . 0.0 108.419 178.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 68.1 mmtt -80.18 -40.55 27.03 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.704 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.594 ' CD1' ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -66.95 -16.31 64.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.647 -1.283 . . . . 0.0 107.884 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.559 ' CG ' ' O ' ' A' ' 123' ' ' ILE . 12.0 mtmt -61.68 -35.08 76.96 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 177.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 125' ' ' LYS . 1.2 mtp180 -81.91 -19.92 39.82 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.281 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.592 ' CD2' ' NH1' ' A' ' 12' ' ' ARG . 1.2 tp . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.111 -0.947 . . . . 0.0 109.447 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' APC . . . . . 0.64 " O4'" ' HG ' ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' CON . . . . . 0.549 ' N3 ' ' O2A' ' A' ' 130' ' ' APC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.481 ' O ' ' O ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.557 ' HD3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -51.93 -172.2 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.543 -0.723 . . . . 0.0 109.456 -179.436 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.557 ' N ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -150.68 154.05 36.72 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.373 -0.83 . . . . 0.0 108.951 179.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.641 ' CD1' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -142.88 119.42 11.02 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.043 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.492 ' HG3' ' OG1' ' A' ' 81' ' ' THR . 8.4 mp0 -101.57 160.92 14.03 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.727 -1.233 . . . . 0.0 107.844 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.587 HG13 ' N7 ' ' A' ' 130' ' ' APC . 0.1 OUTLIER -123.1 117.76 52.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 C-N-CA 119.351 -0.939 . . . . 0.0 109.288 -179.136 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.56 ' N ' HG23 ' A' ' 40' ' ' ILE . . . -87.44 58.56 5.03 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -78.02 -73.72 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.506 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.629 ' CA ' ' N ' ' A' ' 85' ' ' TRP . . . 60.01 82.24 0.07 OUTLIER Glycine 0 N--CA 1.48 1.603 0 N-CA-C 107.584 -2.207 . . . . 0.0 107.584 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.535 HG13 HD12 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -45.97 160.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.052 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.6 OUTLIER -120.26 95.32 3.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 C-N-CA 119.57 -0.852 . . . . 0.0 108.915 -179.234 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.594 ' HG2' ' CG2' ' A' ' 18' ' ' ILE . 20.3 mtm180 -74.35 173.19 10.59 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.596 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -150.98 -64.41 0.19 Allowed 'General case' 0 C--O 1.188 -2.142 0 C-N-CA 117.18 -1.808 . . . . 0.0 114.222 -176.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 7.7 tp10 -91.81 -32.73 15.25 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 118.957 -2.34 . . . . 0.0 112.014 -175.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.476 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 5.7 t-20 -161.15 -43.96 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.555 ' HB3' ' CD2' ' A' ' 107' ' ' LEU . 7.5 m120 -157.07 35.35 0.29 Allowed 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.545 ' HG2' ' CB ' ' A' ' 106' ' ' SER . 31.5 mt-10 -88.52 83.92 6.79 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 117.778 -1.569 . . . . 0.0 109.629 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.594 ' CG2' ' HG2' ' A' ' 12' ' ' ARG . 3.0 pt -79.82 149.09 5.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.632 ' CE2' ' HG2' ' A' ' 94' ' ' PRO . 7.0 t80 -81.57 43.68 0.76 Allowed 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.534 ' CD1' ' HD3' ' A' ' 36' ' ' PRO . 6.7 tp -83.33 159.9 3.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.93 0.871 . . . . 0.0 110.806 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.525 ' N ' HG13 ' A' ' 20' ' ' ILE . 7.4 t -70.32 98.6 1.42 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 176.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.51 ' O ' ' C ' ' A' ' 23' ' ' ARG . 31.6 tpt180 -99.61 80.39 2.36 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 110.976 -177.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.536 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 32.68 83.63 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.304 0.573 . . . . 0.0 110.137 178.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -43.51 -49.46 7.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -0.942 . . . . 0.0 110.087 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.35 178.65 8.15 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.179 -0.951 . . . . 0.0 108.763 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.444 ' O ' ' O ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -57.96 -30.81 66.3 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.171 -1.012 . . . . 0.0 108.894 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.536 ' CB ' ' HD2' ' A' ' 23' ' ' ARG . . . 58.07 159.12 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.325 -0.86 . . . . 0.0 109.537 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -131.57 25.73 4.75 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.67 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 11.2 mtm -129.08 -95.2 0.41 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.497 -0.752 . . . . 0.0 109.242 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.67 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 137.71 -4.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.61 14.41 5.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.125 -0.984 . . . . 0.0 108.834 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.9 tmtt? -80.98 28.77 0.35 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.468 -0.77 . . . . 0.0 110.708 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.638 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 16.6 mt -107.02 83.36 1.82 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.453 -1.405 . . . . 0.0 110.057 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.491 ' O ' ' CD1' ' A' ' 20' ' ' ILE . 1.7 tt0 -85.46 -143.04 0.09 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.615 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 22.2 m-85 -142.66 127.55 10.05 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.693 -1.255 . . . . 0.0 109.701 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.54 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 5.0 Cg_endo -60.81 95.47 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.813 1.676 . . . . 0.0 109.225 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -54.26 -149.28 0.01 OUTLIER Glycine 0 N--CA 1.493 2.5 0 CA-C-O 122.039 0.799 . . . . 0.0 111.548 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.533 ' N ' ' CG ' ' A' ' 98' ' ' GLU . . . 159.9 -37.1 0.46 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.57 ' CB ' ' O2B' ' A' ' 130' ' ' APC . 20.9 tptp 72.52 98.3 0.07 Allowed 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.172 0.51 . . . . 0.0 110.875 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.576 HG22 ' CD1' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -81.59 130.21 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.306 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -170.51 -32.3 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.428 -0.795 . . . . 0.0 109.76 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.409 ' O ' ' C ' ' A' ' 43' ' ' GLY . 0.7 OUTLIER -53.73 164.26 0.58 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.907 . . . . 0.0 109.378 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' MET . . . 45.08 -122.05 4.9 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -165.89 24.05 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.43 -1.041 . . . . 0.0 108.997 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.529 HG21 ' HD2' ' A' ' 46' ' ' PRO . 88.4 m -144.19 141.93 19.07 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.356 -0.84 . . . . 0.0 108.845 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.529 ' HD2' HG21 ' A' ' 45' ' ' THR . 7.5 Cg_exo -48.89 -18.58 1.74 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.705 1.603 . . . . 0.0 109.804 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 48' ' ' GLN . 0.1 OUTLIER -76.0 -87.57 0.04 OUTLIER 'General case' 0 C--O 1.201 -1.449 0 O-C-N 121.214 -0.929 . . . . 0.0 108.799 178.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.558 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 22.7 mt-30 -42.72 -34.81 0.97 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.744 -1.223 . . . . 0.0 109.977 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.599 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -65.06 -63.87 1.0 Allowed 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.299 -0.875 . . . . 0.0 109.83 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 1.9 p -65.59 -49.37 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.962 -1.086 . . . . 0.0 110.864 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.568 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 3.8 p -56.55 -43.9 79.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.641 -0.662 . . . . 0.0 110.283 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.558 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 27.4 mmm180 -73.83 -28.46 61.62 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.599 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 25.0 mm-40 -76.69 -15.2 59.86 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.608 HD11 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -79.85 -55.51 4.93 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.68 0.752 . . . . 0.0 109.297 -179.732 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.612 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -68.71 -41.21 79.39 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.819 -0.551 . . . . 0.0 110.657 -179.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.564 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 0.9 OUTLIER -59.12 -20.81 56.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.006 -1.059 . . . . 0.0 110.73 -178.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 9.9 mm-40 -80.1 -91.07 0.05 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.812 -1.18 . . . . 0.0 110.445 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.599 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 94.7 t -77.49 -80.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.37 -0.832 . . . . 0.0 110.203 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.76 32.76 0.1 Allowed Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.178 -1.487 . . . . 0.0 111.678 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.644 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.3 pt -89.44 -137.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.552 -1.558 . . . . 0.0 108.305 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.589 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.8 m -154.32 -71.57 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.333 -1.479 . . . . 0.0 111.166 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.589 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 3.6 Cg_endo -64.09 -175.34 0.3 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 120.965 1.11 . . . . 0.0 110.315 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.575 ' NE2' ' HB3' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 151.79 -22.04 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.748 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.571 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 1.0 OUTLIER 48.61 50.53 16.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.479 -0.763 . . . . 0.0 109.748 179.026 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.575 ' HB3' ' NE2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -48.64 149.56 1.67 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.808 0.813 . . . . 0.0 110.68 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 86' ' ' LEU . 3.1 m -153.63 133.58 13.19 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.618 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -56.76 -71.4 0.1 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.856 -1.152 . . . . 0.0 110.482 -179.044 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.618 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 84.78 -52.19 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.58 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 0.8 OUTLIER 154.88 138.77 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.151 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.497 ' N ' ' HG3' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -128.76 -175.17 3.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.972 . . . . 0.0 109.893 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.554 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -125.16 -169.53 2.01 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.669 0.747 . . . . 0.0 109.647 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.502 ' N ' HD11 ' A' ' 71' ' ' LEU . 4.9 tt0 -156.37 83.12 0.98 Allowed 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.78 106.56 10.87 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.51 -170.17 2.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.348 -0.845 . . . . 0.0 109.471 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.569 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 5.6 m-85 -160.33 169.46 10.13 Favored Pre-proline 0 C--N 1.297 -1.681 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.351 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.4 Cg_exo -50.73 -28.85 24.04 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.974 1.783 . . . . 0.0 109.607 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.64 42.07 0.14 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.558 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -151.52 92.88 1.81 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.841 -0.537 . . . . 0.0 109.725 -178.383 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.476 ' C ' ' CD1' ' A' ' 80' ' ' ILE . 24.2 m170 -82.95 104.82 13.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.966 -1.084 . . . . 0.0 109.067 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.608 HG23 ' N6 ' ' A' ' 130' ' ' APC . 0.6 OUTLIER -115.04 138.08 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.005 -1.059 . . . . 0.0 110.284 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.544 ' N ' HG21 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -112.9 179.54 3.94 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.34 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.58 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -160.32 72.53 0.48 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.658 -1.276 . . . . 0.0 110.394 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.576 ' CD1' HG22 ' A' ' 40' ' ' ILE . 79.3 m95 -51.74 131.12 30.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 108.956 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.585 ' CG ' HG13 ' A' ' 122' ' ' VAL . 16.0 m-85 -110.12 71.92 0.77 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.054 -1.029 . . . . 0.0 109.132 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.629 ' N ' ' CA ' ' A' ' 9' ' ' GLY . 38.2 m95 -70.75 85.11 0.65 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.315 -0.865 . . . . 0.0 109.588 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.535 HD12 HG13 ' A' ' 10' ' ' ILE . 3.6 mm? -70.77 124.22 23.79 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.749 -1.181 . . . . 0.0 109.059 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.561 ' CG2' ' CG2' ' A' ' 11' ' ' ILE . 1.1 m -113.72 159.86 13.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 87' ' ' VAL . 17.1 mp0 -148.44 36.56 0.81 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.095 -1.442 . . . . 0.0 112.924 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.591 ' O ' ' CD ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -161.06 31.98 0.14 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 119.881 -1.762 . . . . 0.0 111.532 178.7 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.596 ' CH2' ' HB2' ' A' ' 13' ' ' ASN . 2.8 p90 -54.79 165.5 0.61 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.16 -1.587 . . . . 0.0 108.274 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.539 ' HB3' ' CG ' ' A' ' 62' ' ' PRO . 8.1 pt-20 -77.35 -123.85 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.994 -1.066 . . . . 0.0 110.408 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.46 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -64.83 -50.46 58.24 Favored Glycine 0 N--CA 1.489 2.217 0 O-C-N 120.738 -1.226 . . . . 0.0 110.075 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.584 ' O ' ' CG2' ' A' ' 60' ' ' ILE . 3.1 mt-10 -123.29 156.56 63.35 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.018 -1.283 . . . . 0.0 110.278 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.632 ' HG2' ' CE2' ' A' ' 19' ' ' PHE . 8.4 Cg_endo -73.86 -160.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.731 2.288 . . . . 0.0 110.086 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.644 ' CD2' HG13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER 176.7 48.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 111.049 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . -132.69 2.89 4.95 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.169 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.556 ' HD3' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -80.08 94.91 6.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.383 -1.069 . . . . 0.0 111.239 -179.251 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.533 ' CG ' ' N ' ' A' ' 38' ' ' GLY . 2.8 mm-40 -42.02 -88.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.913 . . . . 0.0 108.729 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.97 1.68 27.15 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.515 ' HG3' ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -73.89 146.98 85.92 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.725 -0.868 . . . . 0.0 109.366 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.515 ' HD2' ' HG3' ' A' ' 100' ' ' GLN . 3.0 Cg_exo -56.39 -29.46 77.46 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 N-CA-C 107.897 -1.616 . . . . 0.0 107.897 178.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.627 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 54.76 110.73 0.01 OUTLIER Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.589 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 2.9 pt-20 -151.83 127.95 10.45 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.07 -1.253 . . . . 0.0 109.19 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.449 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -41.65 141.34 0.8 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.494 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.492 ' HG3' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -139.15 96.05 3.04 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.363 -0.836 . . . . 0.0 108.961 -179.455 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.545 ' CB ' ' HG2' ' A' ' 17' ' ' GLU . 10.4 t -78.51 72.17 5.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.46 -0.775 . . . . 0.0 109.399 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.614 ' CD2' ' N ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -80.03 -10.92 59.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.916 -1.115 . . . . 0.0 109.903 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.614 ' N ' ' CD2' ' A' ' 107' ' ' LEU . 2.5 t 64.93 122.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 108' ' ' VAL . . . 33.26 83.03 0.01 OUTLIER Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.64 ' CD2' ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -41.09 165.07 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.772 -0.84 . . . . 0.0 109.866 -178.068 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 2.0 t-20 -144.3 -4.94 0.78 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.804 -1.185 . . . . 0.0 111.87 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.593 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . . . 81.23 -26.29 0.15 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.961 -1.087 . . . . 0.0 108.56 -177.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -57.24 -40.47 77.64 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.571 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 59.8 m-20 -86.67 -13.12 46.44 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.64 ' CD1' ' CD2' ' A' ' 110' ' ' LEU . 5.1 m-85 -101.3 146.26 31.87 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 110.317 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.521 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 5.9 Cg_exo -60.92 141.66 95.24 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.44 2.094 . . . . 0.0 110.31 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.478 ' O ' ' OE1' ' A' ' 120' ' ' GLU . 1.6 Cg_endo -64.36 -8.1 15.94 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.098 1.866 . . . . 0.0 110.626 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.27 -53.45 52.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.09 -1.006 . . . . 0.0 110.174 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.541 ' CB ' HD11 ' A' ' 123' ' ' ILE . 6.7 m-80 -87.85 42.87 1.08 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 109.764 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.656 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -57.66 -44.3 99.39 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 120.981 -1.074 . . . . 0.0 111.734 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 20.8 Cg_exo -47.15 -44.92 22.84 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.825 1.683 . . . . 0.0 113.043 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.585 HG13 ' CG ' ' A' ' 84' ' ' PHE . 1.7 t -96.37 -35.94 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.306 -1.496 . . . . 0.0 109.215 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.593 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 2.1 mt -62.54 -17.95 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.589 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -63.27 -35.87 81.79 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.0 mmtm -74.21 -42.21 60.14 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.668 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.603 ' CD1' ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -65.46 -20.61 66.43 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.783 -1.198 . . . . 0.0 108.224 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.589 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 11.3 mtmt -57.98 -36.75 73.05 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -23.66 41.35 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.533 HD21 ' ND2' ' A' ' 16' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.539 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' APC . . . . . 0.608 ' N6 ' HG23 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' CON . . . . . 0.606 ' N3 ' ' O2A' ' A' ' 130' ' ' APC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' HOH . . . . . 0.425 ' O ' ' O ' ' A' ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.544 ' HD3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -54.86 -176.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.571 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.556 ' HG3' ' N ' ' A' ' 4' ' ' LEU . 1.7 tttt -160.22 143.06 13.48 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.406 -0.809 . . . . 0.0 109.352 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.623 ' CD2' ' HD2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -139.54 110.0 6.62 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.493 ' O ' HD23 ' A' ' 4' ' ' LEU . 4.2 mp0 -96.93 162.47 13.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.109 -0.994 . . . . 0.0 109.804 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.601 HG13 ' N7 ' ' A' ' 130' ' ' APC . 0.1 OUTLIER -128.92 108.99 18.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.581 ' N ' HG21 ' A' ' 40' ' ' ILE . . . -84.74 64.71 8.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.471 -0.768 . . . . 0.0 109.113 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.572 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . 1.3 p -79.52 -71.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 110.405 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.64 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 60.04 74.04 0.41 Allowed Glycine 0 C--N 1.298 -1.554 0 N-CA-C 106.788 -2.525 . . . . 0.0 106.788 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.568 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -42.27 142.75 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -178.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 2.7 pt -98.14 97.59 6.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.169 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.556 ' CG ' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -77.44 171.47 14.83 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.581 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 6.1 t30 -148.92 -64.5 0.23 Allowed 'General case' 0 C--O 1.188 -2.134 0 C-N-CA 116.86 -1.936 . . . . 0.0 114.74 -177.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.53 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 3.0 tp10 -91.86 -28.91 17.01 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 118.775 -2.453 . . . . 0.0 111.592 -175.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -162.79 -43.03 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.735 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -160.06 31.31 0.18 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 177.582 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 105' ' ' MET . 36.4 mt-10 -83.01 89.31 6.88 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 117.517 -1.673 . . . . 0.0 108.025 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.0 OUTLIER -85.01 150.13 4.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-O 121.644 0.735 . . . . 0.0 110.812 -178.235 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.634 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 14.0 t80 -82.66 43.72 0.85 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.543 HD13 ' N ' ' A' ' 34' ' ' GLU . 6.6 tp -80.78 157.39 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 121.37 -0.831 . . . . 0.0 110.386 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.515 ' N ' HG13 ' A' ' 20' ' ' ILE . 2.0 t -74.01 86.0 1.8 Allowed 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.517 ' NH2' ' OD2' ' A' ' 114' ' ' ASP . 15.6 tpt180 -82.55 84.28 7.29 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.205 -0.934 . . . . 0.0 109.922 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.497 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 30.21 64.69 0.15 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.37 0.605 . . . . 0.0 110.359 -179.625 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -45.81 -54.32 8.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.359 -0.838 . . . . 0.0 109.233 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.73 -177.33 3.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -0.892 . . . . 0.0 108.872 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -76.15 86.58 3.01 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.013 -1.054 . . . . 0.0 109.337 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.451 ' C ' ' N ' ' A' ' 29' ' ' MET . . . -68.19 -27.97 66.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.861 . . . . 0.0 109.805 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.592 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 72.7 t60 49.02 24.71 0.93 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -177.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -152.19 -166.65 2.54 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.821 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.523 ' O ' ' OD1' ' A' ' 31' ' ' ASN . . . -137.44 -153.09 0.47 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.523 ' OD1' ' O ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER 63.8 2.79 1.41 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.218 -0.926 . . . . 0.0 109.504 -179.033 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.462 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -83.47 50.43 1.78 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.196 -0.94 . . . . 0.0 110.316 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.66 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 12.7 mt -128.74 85.77 2.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.975 -1.078 . . . . 0.0 108.197 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.582 ' O ' ' CE1' ' A' ' 115' ' ' PHE . 21.8 mt-10 -91.2 -123.52 0.07 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.176 -0.952 . . . . 0.0 110.842 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.634 ' CE2' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -160.49 124.0 1.95 Allowed Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 120.579 -1.325 . . . . 0.0 109.832 -178.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.604 ' CB ' ' HA ' ' A' ' 97' ' ' LYS . 19.7 Cg_endo -76.7 95.81 1.07 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.415 2.077 . . . . 0.0 110.575 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.572 ' CA ' ' HA ' ' A' ' 8' ' ' VAL . . . -145.62 123.4 1.87 Allowed Glycine 0 N--CA 1.499 2.843 0 O-C-N 120.654 -1.279 . . . . 0.0 110.166 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.571 ' CA ' ' HG3' ' A' ' 98' ' ' GLU . . . -103.77 74.22 0.27 Allowed Glycine 0 N--CA 1.491 2.339 0 O-C-N 121.172 -1.193 . . . . 0.0 111.942 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.623 ' HD2' ' CD2' ' A' ' 4' ' ' LEU . 5.4 tptt 42.07 121.02 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 176.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.583 HG23 ' CD1' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -81.65 129.96 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.475 ' OE1' ' HG2' ' A' ' 39' ' ' LYS . 3.1 pt-20 -171.71 -20.9 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 118.534 -1.267 . . . . 0.0 111.43 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.5 mmt -39.42 -74.28 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.096 -1.003 . . . . 0.0 109.655 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.57 -132.71 7.38 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -134.34 3.1 3.33 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.625 -0.926 . . . . 0.0 109.101 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.538 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 22.5 m -118.64 142.53 31.78 Favored Pre-proline 0 N--CA 1.486 1.338 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 8.2 Cg_exo -52.76 -17.49 7.35 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.395 1.397 . . . . 0.0 109.653 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.457 ' O ' ' C ' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -79.48 -87.97 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.209 -0.932 . . . . 0.0 108.821 178.556 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.563 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 10.6 mt-30 -42.66 -34.29 0.86 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.815 -1.178 . . . . 0.0 109.327 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.594 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -63.88 -62.46 1.63 Allowed 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.069 -1.019 . . . . 0.0 110.119 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 51' ' ' VAL . 2.1 p -69.3 -49.17 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.186 -0.946 . . . . 0.0 110.763 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.558 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 4.2 p -55.32 -44.22 74.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.551 -0.718 . . . . 0.0 110.264 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.563 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -72.35 -36.88 68.9 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 179.375 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.594 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 11.6 mm-40 -69.0 -13.74 62.63 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.594 HD11 ' CD1' ' A' ' 95' ' ' TRP . 0.8 OUTLIER -80.37 -61.39 1.99 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.616 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.536 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -58.13 -50.26 74.1 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.747 -0.596 . . . . 0.0 109.891 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -49.45 -21.57 0.96 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.062 -1.024 . . . . 0.0 110.04 -178.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mt-10 -79.98 -95.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.928 -1.107 . . . . 0.0 109.622 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.607 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 45.4 t -80.12 -78.48 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 110.184 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.06 31.84 0.13 Allowed Glycine 0 N--CA 1.493 2.434 0 C-N-CA 118.626 -1.75 . . . . 0.0 112.476 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.648 HG13 ' CD2' ' A' ' 95' ' ' TRP . 1.2 pp -87.13 -153.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 120.372 -1.664 . . . . 0.0 107.639 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.58 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.8 m -135.95 -70.93 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.389 -1.444 . . . . 0.0 110.584 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 91' ' ' GLU . 5.8 Cg_endo -63.04 -170.61 0.1 Allowed 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 121.433 1.422 . . . . 0.0 110.719 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.574 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 143.0 -24.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.504 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.3 OUTLIER 44.54 71.03 0.28 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.423 -0.798 . . . . 0.0 109.312 178.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.456 ' HB3' ' NE2' ' A' ' 63' ' ' GLN . 8.0 p90 -67.26 141.98 57.06 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.342 -0.849 . . . . 0.0 109.833 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -132.42 135.85 46.36 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.583 HD21 ' CE2' ' A' ' 85' ' ' TRP . 1.3 tm? -57.53 -64.94 0.72 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.977 -1.077 . . . . 0.0 109.36 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.589 ' O ' ' CB ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER 80.66 -50.01 0.31 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.589 ' CB ' ' O ' ' A' ' 68' ' ' PHE . 27.1 tt0 150.16 142.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.35 178.07 7.0 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 110.541 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.526 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -127.47 166.34 18.13 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.725 0.774 . . . . 0.0 109.887 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -141.0 91.4 2.4 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.83 113.4 16.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.426 ' CG ' ' CD2' ' A' ' 79' ' ' HIS . 2.8 tt0 -91.72 146.79 23.49 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.562 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -133.51 173.02 6.35 Favored Pre-proline 0 C--N 1.296 -1.722 0 O-C-N 121.272 -0.893 . . . . 0.0 108.731 -179.585 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 7.3 Cg_exo -47.93 -40.5 32.84 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.818 1.678 . . . . 0.0 109.742 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -151.63 45.75 0.78 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.44 ' HB2' ' CB ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -148.77 93.06 2.07 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.714 -0.616 . . . . 0.0 109.565 -178.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.426 ' CD2' ' CG ' ' A' ' 74' ' ' GLU . 22.7 m80 -91.87 73.36 5.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.137 -0.977 . . . . 0.0 108.74 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.589 HG22 ' C5 ' ' A' ' 130' ' ' APC . 3.1 mm -84.52 154.32 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.995 -1.066 . . . . 0.0 110.486 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.459 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 3.2 m -136.51 154.45 50.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.617 ' O ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -139.77 75.53 1.52 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.74 -1.225 . . . . 0.0 110.021 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.583 ' CD1' HG23 ' A' ' 40' ' ' ILE . 89.4 m95 -48.46 124.1 7.6 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 118.6 -1.24 . . . . 0.0 108.611 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.617 ' CD1' ' O ' ' A' ' 82' ' ' LEU . 40.3 m-85 -102.28 71.77 1.25 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.996 -1.065 . . . . 0.0 110.32 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.64 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 76.7 m95 -75.88 85.52 2.83 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.757 -1.214 . . . . 0.0 108.994 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.568 ' CD1' ' HB ' ' A' ' 10' ' ' ILE . 2.1 mm? -72.58 123.11 22.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.509 -1.369 . . . . 0.0 108.779 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.542 ' O ' ' CG ' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -102.76 176.7 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.542 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 41.3 mt-10 -157.1 16.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.654 -1.218 . . . . 0.0 112.113 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.612 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -159.75 64.39 0.36 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.146 -1.596 . . . . 0.0 111.451 179.131 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.656 ' CH2' ' CD1' ' A' ' 104' ' ' TRP . 2.0 p90 -80.25 168.56 18.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 119.951 -1.718 . . . . 0.0 108.382 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.611 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -89.7 113.95 25.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.077 -1.014 . . . . 0.0 109.05 179.188 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 44.21 -80.87 0.0 OUTLIER Glycine 0 N--CA 1.501 2.984 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.611 ' N ' ' O ' ' A' ' 91' ' ' GLU . 4.8 mt-10 -82.52 145.7 51.91 Favored Pre-proline 0 C--N 1.298 -1.638 0 O-C-N 120.881 -1.364 . . . . 0.0 109.941 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.61 ' CG ' ' CE1' ' A' ' 19' ' ' PHE . 11.7 Cg_endo -79.17 -167.25 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.451 2.101 . . . . 0.0 108.511 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.648 ' CD2' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -179.12 34.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.728 -1.233 . . . . 0.0 112.009 178.235 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.51 ' HA2' HD12 ' A' ' 54' ' ' LEU . . . -121.36 1.7 11.41 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 178.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.604 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -80.83 127.22 32.28 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.446 -1.032 . . . . 0.0 111.863 -179.014 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.571 ' HG3' ' CA ' ' A' ' 38' ' ' GLY . 32.8 mm-40 -81.84 -135.29 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.13 -19.85 47.38 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.414 ' HG2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -55.21 148.96 28.23 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.866 -0.785 . . . . 0.0 109.84 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 21' ' ' THR . 2.2 Cg_endo -65.28 -37.73 30.05 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.89 1.727 . . . . 0.0 108.418 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.634 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 58.09 115.91 0.01 OUTLIER Glycine 0 N--CA 1.481 1.653 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 18.9 pt-20 -150.4 130.0 13.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.038 -1.272 . . . . 0.0 110.174 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.656 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -46.65 131.96 11.18 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.95 123.42 42.42 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.14 -0.975 . . . . 0.0 109.338 -178.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.99 46.87 1.15 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.334 -0.854 . . . . 0.0 108.873 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.561 ' HG ' ' HG ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -75.07 -28.95 60.54 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.506 ' HA ' ' HB3' ' A' ' 16' ' ' ASN . 49.0 t 55.91 123.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.713 -0.617 . . . . 0.0 110.495 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.54 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 42.83 82.77 0.02 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.561 ' HG ' ' HG ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -45.45 175.01 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.562 -0.964 . . . . 0.0 109.433 -177.338 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 112' ' ' ALA . 1.5 t30 -143.8 -5.64 0.8 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.266 -1.521 . . . . 0.0 112.762 -177.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 111' ' ' ASN . . . 82.35 -35.75 0.09 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.039 -1.038 . . . . 0.0 108.405 -177.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -54.76 -24.9 24.56 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.557 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 0.5 OUTLIER -105.38 -17.41 14.45 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.439 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.66 ' CD1' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -91.61 122.43 65.73 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.397 -0.814 . . . . 0.0 109.14 179.09 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.475 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 14.1 Cg_exo -48.49 147.52 9.08 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.836 1.69 . . . . 0.0 110.446 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 118' ' ' ALA . 3.5 Cg_exo -60.27 -30.58 91.46 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.496 2.13 . . . . 0.0 110.99 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.89 -61.59 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 109.57 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.634 ' ND2' ' CE2' ' A' ' 35' ' ' PHE . 4.6 m-20 -88.71 51.6 2.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.353 -0.842 . . . . 0.0 109.134 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.62 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -70.29 -40.68 12.34 Favored Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -179.079 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 5.7 Cg_exo -54.36 -47.21 28.12 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 121.928 1.752 . . . . 0.0 113.12 -177.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 71' ' ' LEU . 2.1 t -87.62 -28.19 5.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 120.581 -1.325 . . . . 0.0 109.118 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.642 ' CG1' ' CG ' ' A' ' 115' ' ' PHE . 1.1 mp -67.48 -23.16 29.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.507 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -58.61 -28.14 65.33 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -81.01 -41.1 23.24 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.265 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.592 ' CD1' ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -64.59 -26.45 68.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.507 -1.371 . . . . 0.0 107.476 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.552 ' CD ' ' HB1' ' A' ' 112' ' ' ALA . 14.8 mtmt -50.75 -37.37 41.53 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -83.53 -27.54 29.28 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.869 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.514 ' HB2' ' HA ' ' A' ' 126' ' ' LEU . 1.1 tp . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.838 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' APC . . . . . 0.622 " O4'" ' HG ' ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' HOH . . . . . 0.467 ' O ' ' O ' ' A' ' 38' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.3 tttt . . . . . 0 N--CA 1.478 0.931 0 CA-C-O 121.51 0.672 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 1.083 ' O ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -158.25 150.87 22.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 1.056 ' N ' HD22 ' A' ' 4' ' ' LEU . 0.9 OUTLIER -121.38 161.59 21.86 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.093 -1.005 . . . . 0.0 109.231 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.621 HG22 HG12 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -124.4 114.94 43.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.253 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.984 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -84.07 64.46 8.2 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -79.21 -79.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.206 -179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.724 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 73.97 85.76 0.26 Allowed Glycine 0 C--N 1.298 -1.571 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.554 HD13 ' HE1' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -49.43 169.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.03 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.922 HG22 HG13 ' A' ' 87' ' ' VAL . 7.1 pt -137.92 78.1 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.271 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.633 ' HB3' HG23 ' A' ' 18' ' ' ILE . 5.7 ptm180 -82.19 137.87 34.82 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.47 ' OD1' ' CH2' ' A' ' 90' ' ' TRP . 0.8 OUTLIER -158.58 0.23 0.09 Allowed 'General case' 0 C--O 1.187 -2.22 0 C-N-CA 116.748 -1.981 . . . . 0.0 114.805 -177.861 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.537 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 22.0 tt0 -92.85 -32.52 14.59 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 118.246 -2.784 . . . . 0.0 106.923 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.402 ' C ' ' OD1' ' A' ' 15' ' ' ASN . 16.4 t-20 -163.79 -48.49 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 101.844 -3.391 . . . . 0.0 101.844 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.728 HD21 HD12 ' A' ' 110' ' ' LEU . 56.1 t30 -161.74 37.4 0.13 Allowed 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 175.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.537 ' CG ' ' HB3' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -90.17 101.45 14.17 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.013 -177.166 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.633 HG23 ' HB3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -89.34 149.78 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 122.003 0.906 . . . . 0.0 110.518 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.779 ' HB3' HD11 ' A' ' 11' ' ' ILE . 44.7 t80 -82.98 41.94 0.77 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.703 HD11 ' C ' ' A' ' 34' ' ' GLU . 6.3 tp -81.07 156.23 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 122.193 0.996 . . . . 0.0 111.58 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.487 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -64.39 95.05 0.12 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.835 ' HD3' HD21 ' A' ' 33' ' ' LEU . 32.4 tpt180 -104.82 78.95 1.47 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.211 -0.931 . . . . 0.0 111.055 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.87 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 25.33 76.44 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 120.97 0.415 . . . . 0.0 110.706 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.69 -48.53 5.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.43 -0.794 . . . . 0.0 109.07 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.65 154.15 27.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.409 -0.807 . . . . 0.0 108.858 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.71 110.93 1.89 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.047 -1.033 . . . . 0.0 109.16 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.87 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -100.0 149.96 22.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 110.003 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.09 -20.54 52.07 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.424 ' SD ' ' N ' ' A' ' 29' ' ' MET . 2.7 mpp? -97.53 -166.78 1.43 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -156.78 18.65 0.32 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.014 -1.054 . . . . 0.0 110.217 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.0 m-20 -99.67 17.28 20.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.072 -1.017 . . . . 0.0 108.879 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.512 ' HD2' ' CA ' ' A' ' 23' ' ' ARG . 1.1 tttp -81.52 39.5 0.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.386 -0.821 . . . . 0.0 111.124 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.853 HD13 ' CE1' ' A' ' 115' ' ' PHE . 19.9 mt -107.33 91.91 3.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.826 -1.171 . . . . 0.0 109.351 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.703 ' C ' HD11 ' A' ' 20' ' ' ILE . 37.9 tt0 -91.16 -128.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.314 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 17.9 m-85 -157.11 131.91 5.31 Favored Pre-proline 0 N--CA 1.485 1.324 0 O-C-N 120.81 -1.181 . . . . 0.0 109.758 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.7 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.4 Cg_endo -61.01 88.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.51 2.14 . . . . 0.0 110.435 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -54.65 -160.16 0.01 OUTLIER Glycine 0 N--CA 1.494 2.518 0 O-C-N 121.314 -0.866 . . . . 0.0 111.061 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 163.87 -28.85 0.23 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.641 ' CD ' HD23 ' A' ' 4' ' ' LEU . 0.1 OUTLIER 69.91 102.32 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.973 -0.722 . . . . 0.0 111.058 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.984 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -81.54 132.32 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.199 -0.938 . . . . 0.0 108.928 178.452 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -171.64 -32.55 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 109.739 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.409 ' HB2' ' HA ' ' A' ' 49' ' ' ALA . 8.7 mmt -53.02 161.61 0.78 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 109.744 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.04 -121.13 12.52 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -168.99 25.03 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.496 -1.002 . . . . 0.0 108.925 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.685 HG23 ' HD2' ' A' ' 46' ' ' PRO . 63.4 m -154.24 144.37 15.64 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.685 ' HD2' HG23 ' A' ' 45' ' ' THR . 10.8 Cg_exo -48.37 -16.43 0.68 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.894 1.73 . . . . 0.0 111.443 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.586 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.5 mt-10 -78.6 -72.71 0.36 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.744 -1.222 . . . . 0.0 109.124 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.554 ' HA ' HG12 ' A' ' 51' ' ' VAL . 7.3 mt-30 -56.48 -30.87 63.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.399 -1.438 . . . . 0.0 109.321 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.675 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -67.14 -63.24 1.1 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.475 -0.766 . . . . 0.0 109.816 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.845 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.3 p -67.91 -48.19 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.051 -1.031 . . . . 0.0 110.463 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.6 p -55.73 -42.57 70.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 121.188 0.518 . . . . 0.0 110.334 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 2.4 mmm180 -77.65 -29.79 51.81 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.631 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 21.1 mm-40 -75.75 -11.88 60.08 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.73 HD12 ' CE2' ' A' ' 95' ' ' TRP . 0.7 OUTLIER -80.17 -57.19 3.74 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.755 0.788 . . . . 0.0 108.989 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.507 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -65.38 -42.0 93.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.896 -0.502 . . . . 0.0 110.946 -179.421 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.595 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -57.57 -24.43 56.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.094 -1.004 . . . . 0.0 111.556 -177.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.57 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -80.21 -83.03 0.11 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.409 -1.432 . . . . 0.0 110.572 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.571 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 74.6 t -80.27 -80.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.037 -1.039 . . . . 0.0 110.007 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.21 32.8 0.1 OUTLIER Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.325 -1.417 . . . . 0.0 110.837 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.053 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.8 pp -94.27 -159.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.809 -1.407 . . . . 0.0 108.419 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.63 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.8 m -135.45 -70.87 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.773 -1.205 . . . . 0.0 110.637 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 2.6 Cg_endo -59.3 -171.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.084 0 C-N-CA 121.487 1.458 . . . . 0.0 110.402 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.584 ' HB2' HG21 ' A' ' 87' ' ' VAL . 2.6 pt20 144.03 -22.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.581 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.3 OUTLIER 43.82 72.12 0.21 Allowed 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -69.54 149.17 48.49 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.836 0.826 . . . . 0.0 110.898 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -143.66 144.91 32.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.319 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.84 HD13 ' N ' ' A' ' 69' ' ' GLU . 1.9 tm? -66.29 -68.72 0.35 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.774 -1.204 . . . . 0.0 110.25 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.825 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 81.35 -51.72 0.28 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 -178.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.84 ' N ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER 167.74 179.12 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 109.242 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -159.72 158.01 30.53 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.045 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.716 HD11 ' HB2' ' A' ' 82' ' ' LEU . 1.1 pp -117.93 -177.26 3.22 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.026 -1.047 . . . . 0.0 110.192 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.677 ' HG3' HG23 ' A' ' 81' ' ' THR . 6.8 tt0 -154.84 89.69 1.25 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.524 ' CE2' ' O ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -79.55 127.12 31.76 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.157 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -100.98 133.84 44.87 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.06 -1.025 . . . . 0.0 109.482 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.538 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -116.9 171.09 5.16 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 108.843 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 6.9 Cg_exo -48.23 -47.24 20.28 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.992 1.794 . . . . 0.0 110.196 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.451 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 5.4 p-10 -141.26 33.05 1.7 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.484 ' O ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -140.15 93.14 2.6 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.554 -0.716 . . . . 0.0 110.32 -179.048 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -82.7 92.94 7.28 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.608 HG22 ' N ' ' A' ' 81' ' ' THR . 0.3 OUTLIER -97.68 163.42 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -0.963 . . . . 0.0 111.26 -177.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.677 HG23 ' HG3' ' A' ' 72' ' ' GLU . 1.3 m -140.46 168.71 19.17 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.716 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -157.31 85.23 0.93 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.539 -1.351 . . . . 0.0 110.595 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.64 ' CD1' HG21 ' A' ' 40' ' ' ILE . 70.6 m95 -58.49 126.56 28.1 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.303 -0.873 . . . . 0.0 109.418 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.775 ' CE2' HG11 ' A' ' 122' ' ' VAL . 19.1 m-85 -101.57 70.73 1.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 0.0 109.878 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.717 ' CE2' HD23 ' A' ' 67' ' ' LEU . 93.6 m95 -74.26 91.25 2.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.943 -1.098 . . . . 0.0 108.983 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.825 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.5 mm? -73.48 126.58 30.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.208 -0.932 . . . . 0.0 110.489 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.922 HG13 HG22 ' A' ' 11' ' ' ILE . 1.5 m -112.02 169.18 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 78.0 mt-10 -149.55 17.37 0.91 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.487 -1.383 . . . . 0.0 112.954 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.605 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.26 67.51 0.36 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.089 -1.632 . . . . 0.0 110.56 178.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.612 ' CE3' ' HB3' ' A' ' 94' ' ' PRO . 1.8 p90 -80.74 164.79 22.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.329 -1.482 . . . . 0.0 109.656 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.667 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.9 OUTLIER -80.86 141.97 34.09 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.105 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.477 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 27.92 -80.33 0.0 OUTLIER Glycine 0 N--CA 1.502 3.046 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 1.053 ' O ' HG21 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -100.55 151.7 37.64 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.335 -1.097 . . . . 0.0 109.63 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.636 ' HG2' ' CD1' ' A' ' 19' ' ' PHE . 9.9 Cg_endo -73.94 -158.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.724 2.282 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.904 ' CE2' HD11 ' A' ' 60' ' ' ILE . 0.2 OUTLIER 177.53 112.53 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.644 -0.66 . . . . 0.0 109.784 179.063 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . 174.47 -40.83 0.13 Allowed Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.405 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.548 ' HB2' ' CG ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -44.4 124.24 3.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.101 -1.235 . . . . 0.0 109.489 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.492 ' OE1' ' HA2' ' A' ' 38' ' ' GLY . 8.2 tp10 -74.7 -111.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.713 -1.242 . . . . 0.0 107.687 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.76 12.25 64.14 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.548 ' CG ' ' HB2' ' A' ' 97' ' ' LYS . 6.4 pt20 -92.97 170.13 9.33 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.696 -0.885 . . . . 0.0 109.495 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -68.69 -48.67 0.95 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.022 1.814 . . . . 0.0 110.281 -179.717 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.594 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.62 118.52 0.01 OUTLIER Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.605 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 4.5 pt-20 -157.18 145.19 19.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.932 -1.334 . . . . 0.0 110.44 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.4 ' HE1' ' HG3' ' A' ' 94' ' ' PRO . 1.3 m0 -48.58 135.16 14.87 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.499 ' HG2' ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -129.88 112.95 14.05 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.081 -1.012 . . . . 0.0 109.492 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.9 t -78.22 73.33 4.78 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.825 HD13 ' HG ' ' A' ' 110' ' ' LEU . 8.0 tt -80.7 -66.51 0.87 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.433 -0.792 . . . . 0.0 109.792 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.635 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 99.3 t 103.75 98.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 41.98 82.57 0.02 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.825 ' HG ' HD13 ' A' ' 107' ' ' LEU . 2.1 mp -29.96 153.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.962 0.887 . . . . 0.0 111.612 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.638 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -132.38 -6.26 3.35 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.692 -0.63 . . . . 0.0 110.618 -178.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 73.88 -3.26 2.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.217 -0.927 . . . . 0.0 108.806 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.82 -22.31 40.11 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.696 ' HB3' HD12 ' A' ' 33' ' ' LEU . 14.9 m-20 -104.92 -10.42 17.3 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.853 ' CE1' HD13 ' A' ' 33' ' ' LEU . 27.7 m-85 -102.7 144.99 29.72 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.395 -0.815 . . . . 0.0 109.557 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.537 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 2.3 Cg_endo -65.6 151.19 85.41 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.547 2.165 . . . . 0.0 110.94 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.518 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . 1.6 Cg_endo -65.33 -23.75 58.54 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.239 1.959 . . . . 0.0 109.824 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.524 ' O ' ' CE2' ' A' ' 73' ' ' TYR . . . -46.14 -58.49 3.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.384 -0.822 . . . . 0.0 109.686 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.561 ' O ' HD12 ' A' ' 123' ' ' ILE . 36.8 m-80 -85.82 45.3 1.19 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 108.892 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.651 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 2.6 mt-10 -59.56 -43.66 96.19 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 121.378 -0.826 . . . . 0.0 112.137 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 7.7 Cg_exo -53.18 -36.44 77.3 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.058 1.839 . . . . 0.0 112.537 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.775 HG11 ' CE2' ' A' ' 84' ' ' PHE . 2.0 t -100.42 -38.0 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.611 -1.305 . . . . 0.0 109.707 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.731 ' HA ' HD22 ' A' ' 126' ' ' LEU . 6.8 mt -56.94 -27.54 26.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.49 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -60.7 -39.0 86.9 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 125' ' ' LYS . 13.7 mmtp -76.11 -40.13 53.59 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.212 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.731 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.2 OUTLIER -55.45 -43.23 75.26 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.546 ' HD3' ' CB ' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -39.58 -41.81 1.08 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.997 0.903 . . . . 0.0 108.652 178.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 129' ' ' LEU . 1.0 OUTLIER -79.21 -50.99 10.09 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.687 HD13 ' HA ' ' A' ' 126' ' ' LEU . 1.8 tp . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.608 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.541 ' CG ' ' O ' ' A' ' 79' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 121.7 0.762 . . . . 0.0 110.339 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 5' ' ' GLN . 0.7 OUTLIER -136.1 -171.92 3.0 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.087 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.761 ' HB2' HG23 ' A' ' 40' ' ' ILE . 7.8 mp0 -144.05 177.96 8.2 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.541 HG22 HG12 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -145.65 109.87 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.72 -178.634 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.034 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -83.0 67.26 9.01 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.753 HG21 ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -78.83 -73.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.177 -0.952 . . . . 0.0 109.385 -179.514 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.721 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 62.61 81.7 0.09 OUTLIER Glycine 0 C--N 1.295 -1.747 0 N-CA-C 107.958 -2.057 . . . . 0.0 107.958 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.48 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -48.04 172.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.318 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.056 HG22 HG22 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -136.73 81.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.121 -178.551 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.949 ' HB3' HG23 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -91.61 134.96 34.23 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.059 -1.026 . . . . 0.0 108.344 179.345 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.505 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 4.2 p30 -161.66 62.2 0.26 Allowed 'General case' 0 C--O 1.189 -2.119 0 C-N-CA 117.596 -1.641 . . . . 0.0 113.158 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.589 ' CB ' ' HG3' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -148.7 -49.55 0.15 Allowed 'General case' 0 C--N 1.269 -2.92 0 CA-C-O 124.499 2.095 . . . . 0.0 105.616 176.18 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -161.17 -48.54 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 100.885 -3.746 . . . . 0.0 100.885 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.489 ' ND2' ' HD2' ' A' ' 12' ' ' ARG . 1.7 t-20 -162.34 42.52 0.13 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.31 -1.768 . . . . 0.0 106.684 175.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.589 ' HG3' ' CB ' ' A' ' 14' ' ' GLU . 9.4 mm-40 -93.46 95.93 9.58 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.962 -1.495 . . . . 0.0 110.901 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.949 HG23 ' HB3' ' A' ' 12' ' ' ARG . 2.7 pt -89.01 153.83 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.637 -0.664 . . . . 0.0 110.362 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.656 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 3.7 t80 -83.15 47.73 1.28 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.692 ' HB ' HD12 ' A' ' 18' ' ' ILE . 5.2 tt -82.36 155.42 3.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.986 0.898 . . . . 0.0 111.299 -177.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.54 HG23 ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -70.07 98.14 1.27 Allowed 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.554 HH22 ' HB1' ' A' ' 30' ' ' ALA . 28.9 tpt180 -104.46 97.3 7.25 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 110.662 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.939 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 24.49 76.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.211 0.529 . . . . 0.0 110.93 179.186 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -44.61 -52.62 7.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.111 -0.993 . . . . 0.0 109.555 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.27 -178.18 6.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.167 -0.958 . . . . 0.0 109.412 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.71 107.06 8.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.24 -0.913 . . . . 0.0 108.934 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.939 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -101.02 171.96 7.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 110.119 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -127.73 16.08 6.94 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.755 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 4.3 mtm -121.29 -106.33 0.37 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.442 -0.786 . . . . 0.0 109.69 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 148.85 -4.32 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.696 -0.627 . . . . 0.0 110.503 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.461 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 50.3 t-20 -76.27 6.65 5.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.616 -1.302 . . . . 0.0 109.425 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' HD23 ' A' ' 33' ' ' LEU . 4.1 tmtm? -81.29 62.85 5.38 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.535 -0.728 . . . . 0.0 110.857 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.706 HD13 ' CE1' ' A' ' 115' ' ' PHE . 10.6 mt -124.22 90.29 3.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.052 -1.03 . . . . 0.0 109.045 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.54 ' H ' HG23 ' A' ' 21' ' ' THR . 1.2 tt0 -90.23 -144.97 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.903 -1.123 . . . . 0.0 108.794 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.753 ' HB3' HG21 ' A' ' 8' ' ' VAL . 66.7 m-85 -145.93 124.27 6.41 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 120.901 -1.124 . . . . 0.0 110.019 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.685 ' O ' HG23 ' A' ' 8' ' ' VAL . 9.5 Cg_endo -65.79 90.48 0.24 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.194 1.929 . . . . 0.0 110.219 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.665 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -131.0 127.65 5.22 Favored Glycine 0 N--CA 1.494 2.562 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.368 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.557 ' HA2' ' CG ' ' A' ' 98' ' ' GLU . . . -106.65 38.26 3.41 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 120.05 -1.072 . . . . 0.0 111.163 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.513 ' HE3' ' HB2' ' A' ' 4' ' ' LEU . 10.5 tptm 60.24 120.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.777 -0.837 . . . . 0.0 111.433 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.034 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -82.59 133.51 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.292 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 42' ' ' MET . 1.8 pt-20 -171.83 -25.64 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.548 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.449 ' HE3' ' HG2' ' A' ' 56' ' ' GLU . 3.3 tpp -54.57 129.65 37.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.856 -1.153 . . . . 0.0 109.27 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.12 -120.78 12.54 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -168.27 22.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.402 -1.058 . . . . 0.0 109.716 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.794 HG22 ' H ' ' A' ' 47' ' ' GLU . 20.6 m -140.9 138.91 18.65 Favored Pre-proline 0 C--O 1.201 -1.486 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.608 ' O ' HG12 ' A' ' 50' ' ' VAL . 8.6 Cg_exo -48.57 -16.52 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.829 1.686 . . . . 0.0 111.344 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.794 ' H ' HG22 ' A' ' 45' ' ' THR . 2.7 mt-10 -80.42 -78.7 0.16 Allowed 'General case' 0 C--O 1.201 -1.491 0 O-C-N 120.587 -1.321 . . . . 0.0 108.61 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.548 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 79.6 mt-30 -50.14 -30.75 11.87 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.389 -1.444 . . . . 0.0 109.364 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.776 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -68.6 -60.36 2.47 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.113 -0.992 . . . . 0.0 110.504 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.766 HG23 ' HB1' ' A' ' 7' ' ' ALA . 4.3 p -70.09 -45.83 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.718 -1.239 . . . . 0.0 110.227 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.583 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 1.4 p -58.12 -47.77 86.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.302 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.583 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -73.48 -36.13 65.78 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.643 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 21.7 mm-40 -65.22 -19.83 66.15 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.133 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -78.31 -63.39 1.41 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.885 -178.697 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.559 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -58.94 -44.5 91.4 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.356 -0.84 . . . . 0.0 110.092 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.588 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -54.92 -20.71 9.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.108 -0.995 . . . . 0.0 110.193 -179.239 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.429 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mt-10 -80.26 -92.82 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.065 -1.022 . . . . 0.0 109.837 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.593 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 47.9 t -80.21 -78.98 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.346 -0.846 . . . . 0.0 110.045 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.88 27.51 0.13 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 118.599 -1.762 . . . . 0.0 112.723 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.102 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.3 pp -81.49 -144.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 120.181 -1.776 . . . . 0.0 107.582 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.619 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.3 m -143.07 -71.26 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.206 -1.559 . . . . 0.0 110.24 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 9.4 Cg_endo -67.01 -170.01 0.21 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.249 1.3 . . . . 0.0 110.127 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.592 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.9 OUTLIER 136.28 -26.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.536 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER 56.64 -163.31 0.17 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.444 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 7.2 p90 177.11 143.75 0.09 Allowed 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.533 -1.267 . . . . 0.0 110.585 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.591 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -144.13 157.06 44.53 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.05 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.619 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -74.29 -69.92 0.42 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.251 -0.906 . . . . 0.0 110.856 -178.699 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.839 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 83.99 -51.85 0.13 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.596 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.2 mt-10 157.3 175.05 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HA ' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -161.42 -168.6 2.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.953 -1.092 . . . . 0.0 110.115 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.844 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -147.36 161.41 41.07 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.49 -0.756 . . . . 0.0 109.947 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 80' ' ' ILE . 2.6 tt0 -137.42 90.09 2.48 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.03 119.88 25.47 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.439 -0.788 . . . . 0.0 109.119 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.522 ' HG3' ' HA ' ' A' ' 79' ' ' HIS . 11.1 tt0 -112.2 155.78 23.41 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.318 -0.864 . . . . 0.0 109.824 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.751 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 67.4 m-85 -136.76 -115.22 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.641 0 CA-C-O 117.341 -1.314 . . . . 0.0 109.3 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.751 ' CD ' ' CB ' ' A' ' 75' ' ' PHE . 1.9 Cg_endo -62.44 -43.81 20.9 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 CA-C-N 122.077 1.777 . . . . 0.0 109.895 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -171.4 29.9 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.413 ' HD2' HD11 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -106.91 88.73 2.81 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.488 -0.757 . . . . 0.0 109.933 -179.221 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.541 ' O ' ' CG ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -79.66 79.84 6.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 108.797 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.61 HD12 ' CD2' ' A' ' 4' ' ' LEU . 2.7 mm -85.0 145.3 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.036 -1.04 . . . . 0.0 110.725 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -120.98 139.43 53.29 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.574 ' CB ' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -124.44 74.07 1.29 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.949 -1.094 . . . . 0.0 109.658 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.451 ' HD1' HG21 ' A' ' 40' ' ' ILE . 80.1 m95 -53.53 114.02 1.37 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.033 -1.042 . . . . 0.0 109.48 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.725 ' CZ ' HG11 ' A' ' 122' ' ' VAL . 32.4 m-85 -89.53 78.11 7.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.138 -0.976 . . . . 0.0 108.379 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.665 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 97.7 m95 -74.37 85.77 1.98 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.014 -1.054 . . . . 0.0 109.228 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.839 HD23 ' CD2' ' A' ' 68' ' ' PHE . 2.5 mm? -68.88 124.91 24.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.397 -1.439 . . . . 0.0 110.061 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.056 HG22 HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -113.01 178.87 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.537 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 13.8 mt-10 -160.16 33.46 0.17 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 118.103 -1.439 . . . . 0.0 112.881 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.565 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -161.02 47.08 0.21 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 119.803 -1.811 . . . . 0.0 112.404 179.117 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.609 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 1.4 p90 -70.57 160.69 32.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 119.863 -1.773 . . . . 0.0 108.991 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -90.29 146.5 24.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.189 -0.944 . . . . 0.0 108.614 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.453 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . 35.94 -82.33 0.0 OUTLIER Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 1.102 ' O ' HG21 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -112.25 157.77 39.0 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.334 -1.097 . . . . 0.0 110.009 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.624 ' HG2' ' CE2' ' A' ' 19' ' ' PHE . 9.0 Cg_endo -76.21 -159.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.993 2.462 . . . . 0.0 110.614 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 1.133 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -177.87 39.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.862 -1.149 . . . . 0.0 111.189 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -124.81 -7.57 6.05 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.021 -1.562 . . . . 0.0 111.497 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.556 ' HD2' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -63.44 103.72 0.55 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.717 -1.461 . . . . 0.0 110.998 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.557 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 9.6 tp10 -70.14 92.43 0.75 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -0.99 . . . . 0.0 108.509 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.22 14.99 42.67 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.505 ' HG2' ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -96.69 146.56 31.52 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.6 -0.941 . . . . 0.0 109.027 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.567 ' O ' ' O ' ' A' ' 102' ' ' GLY . 4.9 Cg_exo -58.63 -21.38 55.12 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 N-CA-C 108.385 -1.429 . . . . 0.0 108.385 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.656 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 37.13 105.03 0.01 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -141.43 131.39 24.52 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.382 -1.658 . . . . 0.0 110.483 179.309 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.434 ' C ' ' O ' ' A' ' 103' ' ' GLU . 1.6 m0 -46.17 129.26 10.05 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.541 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -123.4 117.07 24.35 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.623 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.33 63.31 5.6 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.811 HD13 ' HG ' ' A' ' 110' ' ' LEU . 6.9 tt -69.06 -54.06 17.09 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.59 -0.693 . . . . 0.0 110.118 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.678 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 66.6 t 85.32 108.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 129' ' ' LEU . . . 46.87 82.51 0.03 OUTLIER Glycine 0 N--CA 1.486 1.968 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 -178.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.811 ' HG ' HD13 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -34.48 160.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.981 0.896 . . . . 0.0 111.738 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -156.59 141.42 17.04 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.65 ' HB2' ' HD3' ' A' ' 127' ' ' LYS . . . -65.93 -22.34 66.49 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.92 -25.19 4.29 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.604 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -108.17 -18.77 13.69 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.706 ' CE1' HD13 ' A' ' 33' ' ' LEU . 44.5 m-85 -100.54 149.64 36.29 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.881 . . . . 0.0 110.605 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.439 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -66.95 144.77 71.67 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.518 2.145 . . . . 0.0 109.941 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 1.6 Cg_endo -64.35 -28.22 63.27 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.997 1.798 . . . . 0.0 110.15 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -43.05 -41.08 3.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 109.892 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.415 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 63.2 m-20 -108.71 55.72 0.63 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.246 -0.909 . . . . 0.0 109.357 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.681 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -71.76 -35.96 4.05 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.555 -0.715 . . . . 0.0 112.585 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.9 Cg_exo -59.07 -31.37 95.45 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.653 1.569 . . . . 0.0 113.174 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.725 HG11 ' CZ ' ' A' ' 84' ' ' PHE . 1.8 t -99.97 -38.58 6.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.376 -1.452 . . . . 0.0 109.342 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.785 HD13 HD23 ' A' ' 126' ' ' LEU . 2.0 mm -58.86 -37.31 66.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.515 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -39.74 -37.3 0.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.144 0.973 . . . . 0.0 108.946 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.485 ' HE2' ' OE2' ' A' ' 69' ' ' GLU . 7.2 mmtm -81.65 -47.33 13.14 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.802 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.785 HD23 HD13 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -64.62 -10.33 25.77 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.378 -1.451 . . . . 0.0 109.093 179.531 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.65 ' HD3' ' HB2' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -68.75 -37.71 79.58 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -12.29 59.81 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.333 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.59 HD21 ' CZ ' ' A' ' 12' ' ' ARG . 3.0 tp . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.79 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.522 ' HG2' ' N ' ' A' ' 4' ' ' LEU . 6.1 ttpt . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 121.509 0.671 . . . . 0.0 109.991 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 1.095 ' O ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -154.11 156.06 36.54 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.069 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.912 ' N ' HD22 ' A' ' 4' ' ' LEU . 1.4 mp0 -124.94 173.66 8.49 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.027 -1.046 . . . . 0.0 108.531 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.713 HG22 HG12 ' A' ' 8' ' ' VAL . 1.1 mm -136.47 110.14 9.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.704 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.881 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -84.63 62.17 7.17 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 36' ' ' PRO . 1.1 p -78.29 -70.0 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.363 -0.835 . . . . 0.0 109.902 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.734 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 59.82 80.82 0.09 OUTLIER Glycine 0 C--N 1.297 -1.615 0 N-CA-C 107.055 -2.418 . . . . 0.0 107.055 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -48.4 170.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -178.922 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.688 HD11 ' CB ' ' A' ' 19' ' ' PHE . 7.7 pt -137.67 99.84 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 C-N-CA 119.406 -0.918 . . . . 0.0 108.768 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.77 ' HG2' HG22 ' A' ' 18' ' ' ILE . 13.3 mtm180 -76.68 -176.54 3.85 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.622 ' C ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -157.17 -61.42 0.09 Allowed 'General case' 0 C--O 1.191 -2.01 0 C-N-CA 116.957 -1.897 . . . . 0.0 114.527 -177.457 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.621 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 1.9 tt0 -93.3 -30.12 15.31 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 119.038 -2.289 . . . . 0.0 111.435 -175.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -160.85 -43.52 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.804 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.57 ' OD1' HD23 ' A' ' 129' ' ' LEU . 14.1 t30 -158.32 34.99 0.24 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 177.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.621 ' HG3' ' HB3' ' A' ' 14' ' ' GLU . 2.4 mt-10 -78.74 83.77 4.87 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 117.965 -1.494 . . . . 0.0 108.764 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.77 HG22 ' HG2' ' A' ' 12' ' ' ARG . 4.7 pt -80.08 142.54 13.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 119.684 -0.807 . . . . 0.0 109.425 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.713 ' CZ ' ' HG2' ' A' ' 94' ' ' PRO . 10.2 t80 -80.19 42.9 0.59 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.699 -0.626 . . . . 0.0 109.544 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.79 HG21 HD22 ' A' ' 33' ' ' LEU . 6.8 tp -82.11 155.62 4.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 122.012 0.91 . . . . 0.0 111.579 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.769 ' O ' HG23 ' A' ' 21' ' ' THR . 7.6 t -64.92 96.48 0.19 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.739 ' HD3' HD21 ' A' ' 33' ' ' LEU . 27.1 tpt180 -98.16 87.44 3.93 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.423 -0.798 . . . . 0.0 110.257 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.75 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 36.79 84.43 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.896 -0.503 . . . . 0.0 109.969 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.59 -51.78 5.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.377 -0.827 . . . . 0.0 109.092 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.89 -160.48 0.16 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -76.17 -43.66 41.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.019 -1.051 . . . . 0.0 109.307 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.75 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . 52.89 110.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.35 -0.844 . . . . 0.0 110.24 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -78.96 -6.13 55.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.981 -1.074 . . . . 0.0 108.981 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.728 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 3.1 mpp? -86.81 -124.64 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.188 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 161.49 -2.33 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.833 -1.167 . . . . 0.0 111.647 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 3.8 p-10 -81.96 13.11 3.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.239 -1.538 . . . . 0.0 109.115 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.599 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -81.41 58.99 3.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.599 -0.688 . . . . 0.0 110.322 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.79 HD22 HG21 ' A' ' 20' ' ' ILE . 14.4 mt -130.61 85.46 2.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.945 -1.097 . . . . 0.0 109.097 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.584 ' C ' HD11 ' A' ' 20' ' ' ILE . 3.2 tt0 -92.94 -127.63 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -0.975 . . . . 0.0 108.879 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.673 ' HB2' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -151.9 134.54 8.81 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.942 -1.099 . . . . 0.0 108.46 178.521 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.736 ' O ' HG23 ' A' ' 8' ' ' VAL . 4.5 Cg_endo -62.09 92.91 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.924 1.749 . . . . 0.0 109.541 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.528 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -54.56 -152.86 0.01 OUTLIER Glycine 0 N--CA 1.493 2.455 0 CA-C-O 122.051 0.806 . . . . 0.0 111.378 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.593 ' N ' ' CG ' ' A' ' 98' ' ' GLU . . . 162.07 -26.35 0.25 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.534 ' HE3' ' HB2' ' A' ' 4' ' ' LEU . 15.7 tptm 64.09 96.94 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.933 -0.745 . . . . 0.0 110.183 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.881 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -80.4 133.17 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.206 -0.933 . . . . 0.0 108.574 178.759 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.495 ' HG2' ' N ' ' A' ' 42' ' ' MET . 2.9 pt-20 -170.6 -32.88 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.464 -0.773 . . . . 0.0 109.721 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.495 ' N ' ' HG2' ' A' ' 41' ' ' GLU . 8.0 mtt -59.17 166.43 2.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.203 -0.936 . . . . 0.0 109.696 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 51.66 -125.77 27.12 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -169.38 26.66 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.448 -1.03 . . . . 0.0 109.2 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.783 HG22 ' H ' ' A' ' 47' ' ' GLU . 18.5 m -155.32 141.63 13.11 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.697 ' O ' HG12 ' A' ' 50' ' ' VAL . 15.0 Cg_exo -45.66 -18.44 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.072 1.848 . . . . 0.0 111.176 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.783 ' H ' HG22 ' A' ' 45' ' ' THR . 3.4 mt-10 -77.49 -80.64 0.1 Allowed 'General case' 0 C--O 1.2 -1.541 0 O-C-N 120.827 -1.171 . . . . 0.0 108.773 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.542 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 38.0 mt-30 -48.65 -32.84 8.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.307 -1.496 . . . . 0.0 109.287 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.801 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -65.81 -62.75 1.33 Allowed 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.367 -0.833 . . . . 0.0 110.437 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.881 HG23 ' HB1' ' A' ' 7' ' ' ALA . 4.3 p -70.23 -44.24 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.724 -1.235 . . . . 0.0 110.641 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.4 p -59.4 -43.49 90.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 121.769 -0.582 . . . . 0.0 110.326 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.1 OUTLIER -73.58 -48.19 34.69 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.624 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 7.7 mm-40 -59.95 -18.63 46.82 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.8 HD23 ' O ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -78.8 -65.36 1.0 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.582 0.706 . . . . 0.0 109.479 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -52.45 -55.53 21.25 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.48 -0.762 . . . . 0.0 109.052 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.624 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -43.44 -32.8 0.94 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 109.325 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -76.32 -90.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.452 -0.78 . . . . 0.0 109.656 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.661 HG21 ' HA ' ' A' ' 95' ' ' TRP . 4.9 t -80.03 -78.17 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 121.016 -1.053 . . . . 0.0 109.372 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.65 56.1 0.14 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.205 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.873 HG21 ' O ' ' A' ' 93' ' ' GLU . 2.5 pp -107.73 -140.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 120.757 -1.437 . . . . 0.0 109.024 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.634 ' N ' HD12 ' A' ' 60' ' ' ILE . 2.5 m -159.84 -67.19 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.276 0 O-C-N 119.754 -1.841 . . . . 0.0 112.535 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.656 ' HD2' ' HB3' ' A' ' 91' ' ' GLU . 11.5 Cg_exo -43.17 -67.12 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 122.265 1.977 . . . . 0.0 110.704 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.765 ' HB2' ' CE2' ' A' ' 95' ' ' TRP . 0.8 OUTLIER 29.65 27.71 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 114.603 -1.181 . . . . 0.0 113.638 178.894 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.631 ' C ' ' O ' ' A' ' 63' ' ' GLN . 1.8 t60 -14.03 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.738 0 CA-C-N 120.181 1.355 . . . . 0.0 110.119 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.611 ' N ' ' O ' ' A' ' 63' ' ' GLN . 3.3 p90 -75.71 146.97 39.74 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.92 0.867 . . . . 0.0 112.377 -175.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 86' ' ' LEU . 4.6 m -148.59 151.47 35.1 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.688 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -80.24 -66.96 0.81 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.769 -1.207 . . . . 0.0 109.836 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.886 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 86.32 -56.81 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER 159.71 142.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.602 ' HE3' ' CD2' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -124.45 172.43 9.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.549 -0.719 . . . . 0.0 110.833 -178.73 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.658 ' HB3' HG23 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -121.11 176.72 5.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.819 . . . . 0.0 109.428 178.627 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.485 ' HG3' HG23 ' A' ' 81' ' ' THR . 7.3 tt0 -152.88 85.89 1.24 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.89 148.33 31.34 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -114.58 171.76 7.44 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.766 -1.174 . . . . 0.0 110.277 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.685 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -142.44 -177.14 0.62 Allowed Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.685 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.0 Cg_exo -57.12 -27.83 76.09 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.469 1.446 . . . . 0.0 109.75 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.475 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 56.5 p30 -169.98 36.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.525 ' O ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -136.61 96.52 3.36 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.663 -0.648 . . . . 0.0 109.564 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.575 ' C ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -82.13 116.43 21.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.391 -0.818 . . . . 0.0 109.501 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.582 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -115.65 144.78 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.001 -1.062 . . . . 0.0 110.586 -179.282 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.547 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 0.9 OUTLIER -129.99 142.3 50.65 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.426 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.701 HD21 HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -127.43 80.8 1.98 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.634 -1.291 . . . . 0.0 110.671 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.644 ' CD1' HG21 ' A' ' 40' ' ' ILE . 82.0 m95 -51.62 108.93 0.3 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.172 -0.955 . . . . 0.0 109.161 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.632 ' CE1' HG11 ' A' ' 122' ' ' VAL . 12.1 m-85 -87.46 70.88 9.91 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.215 -0.928 . . . . 0.0 109.684 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.689 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 13.6 m95 -70.51 83.63 0.59 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.91 -1.119 . . . . 0.0 108.791 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.886 HD23 ' CD2' ' A' ' 68' ' ' PHE . 2.9 mm? -71.87 124.91 25.88 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.41 -1.431 . . . . 0.0 110.242 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.638 HG13 HG22 ' A' ' 11' ' ' ILE . 1.5 m -112.31 -178.4 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.638 ' N ' HG23 ' A' ' 87' ' ' VAL . 54.4 mt-10 -155.99 6.24 0.2 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 117.869 -1.533 . . . . 0.0 112.361 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.589 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -153.23 64.51 0.76 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.209 -1.557 . . . . 0.0 110.51 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.613 ' CH2' ' HB2' ' A' ' 13' ' ' ASN . 8.3 p90 -73.93 159.36 32.88 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.796 -1.19 . . . . 0.0 110.039 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.656 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 0.8 OUTLIER -78.02 138.11 38.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.407 -0.808 . . . . 0.0 109.347 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 30.42 -82.0 0.0 OUTLIER Glycine 0 N--CA 1.5 2.939 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.873 ' O ' HG21 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -88.37 158.33 49.1 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.188 -1.184 . . . . 0.0 109.874 -179.393 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.713 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 15.5 Cg_endo -71.41 -156.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.864 2.376 . . . . 0.0 110.332 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.765 ' CE2' ' HB2' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -178.67 120.11 0.08 Allowed 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.324 -0.86 . . . . 0.0 110.167 179.508 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.473 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . 145.25 -48.02 0.72 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.431 -1.842 . . . . 0.0 111.487 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.63 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -39.36 118.18 0.79 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -1.177 . . . . 0.0 110.466 -178.356 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.593 ' CG ' ' N ' ' A' ' 38' ' ' GLY . 3.4 mm-40 -73.31 -143.54 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.41 ' H ' ' HB3' ' A' ' 98' ' ' GLU . . . -53.04 -18.57 6.28 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.96 165.62 12.5 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.38 -1.071 . . . . 0.0 110.749 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.498 ' HG2' ' OG1' ' A' ' 21' ' ' THR . 2.1 Cg_endo -69.05 -60.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.666 2.244 . . . . 0.0 110.006 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.603 ' O ' ' CE1' ' A' ' 19' ' ' PHE . . . 76.22 121.61 0.16 Allowed Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.6 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 5.9 pt-20 -156.29 134.18 11.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.391 -1.064 . . . . 0.0 110.048 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.532 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 1.1 m0 -46.53 133.83 9.81 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.618 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 4.9 tpt -117.98 114.35 23.04 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.031 -1.043 . . . . 0.0 109.432 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.6 t -80.39 61.07 4.03 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.827 HD13 ' HG ' ' A' ' 110' ' ' LEU . 4.7 tt -77.61 -49.1 15.27 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.57 ' CB ' ' O ' ' A' ' 107' ' ' LEU . 21.2 t 89.91 101.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-O 121.568 0.699 . . . . 0.0 109.267 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 46.77 84.57 0.02 OUTLIER Glycine 0 N--CA 1.484 1.85 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.827 ' HG ' HD13 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -37.58 162.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.918 -0.754 . . . . 0.0 110.475 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.694 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 6.0 t-20 -138.73 -8.13 1.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 111.339 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 81.74 -18.06 0.51 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.183 -0.948 . . . . 0.0 108.614 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.0 -21.17 66.81 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.778 ' HB3' HD12 ' A' ' 33' ' ' LEU . 13.0 m-20 -104.96 -15.47 15.12 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.824 ' CE1' HD21 ' A' ' 110' ' ' LEU . 3.2 m-85 -91.42 133.44 31.37 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.151 -0.968 . . . . 0.0 109.121 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.1 131.56 43.5 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 121.398 1.399 . . . . 0.0 108.617 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 3.3 Cg_exo -52.99 -22.04 17.46 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.365 2.043 . . . . 0.0 112.181 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.08 -39.07 68.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.723 -1.235 . . . . 0.0 109.552 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.562 ' O ' HD13 ' A' ' 123' ' ' ILE . 25.8 p30 -96.26 45.12 1.07 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.444 -0.785 . . . . 0.0 109.69 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.66 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.2 mt-10 -70.25 -33.15 3.15 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 113.191 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.2 Cg_exo -55.96 -47.83 22.9 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.218 1.279 . . . . 0.0 112.801 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.658 HG23 ' HB3' ' A' ' 71' ' ' LEU . 1.9 t -92.91 -33.93 5.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 120.531 -1.355 . . . . 0.0 109.489 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 1.009 ' HA ' HD22 ' A' ' 126' ' ' LEU . 1.7 mp -66.56 -20.84 27.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -58.55 -29.47 66.38 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 125' ' ' LYS . 0.4 OUTLIER -80.38 -37.96 31.29 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.915 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 1.009 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.83 -24.78 66.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.461 -1.399 . . . . 0.0 107.336 178.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.54 ' HD3' ' CB ' ' A' ' 112' ' ' ALA . 1.5 mtmp? -55.17 -35.73 65.09 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.459 ' O ' ' C ' ' A' ' 129' ' ' LEU . 1.9 mtp180 -83.93 -24.6 30.65 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.524 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 2.1 tp . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.069 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.434 ' HG3' ' HB3' ' A' ' 79' ' ' HIS . 4.9 ttpt . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 5' ' ' GLN . 0.5 OUTLIER -140.95 177.26 8.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.244 -0.91 . . . . 0.0 109.535 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.63 ' HB2' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -141.55 174.27 10.72 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.701 HG22 HG12 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -141.81 124.69 14.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 O-C-N 121.019 -1.051 . . . . 0.0 109.821 -178.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.951 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -87.0 60.12 6.03 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.973 HG23 ' O ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -78.63 -87.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.79 -178.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.749 ' N ' HG22 ' A' ' 8' ' ' VAL . . . 75.63 88.85 0.25 Allowed Glycine 0 C--N 1.297 -1.625 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.573 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -49.33 175.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.031 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.038 HG22 HG22 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -143.9 92.09 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.577 -1.249 . . . . 0.0 110.349 -178.368 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.748 ' HG2' HG22 ' A' ' 18' ' ' ILE . 8.8 mtm180 -75.62 174.09 10.19 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.562 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -161.14 -46.19 0.04 OUTLIER 'General case' 0 C--O 1.191 -2.017 0 C-N-CA 115.744 -2.382 . . . . 0.0 115.142 -177.343 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.514 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 1.5 tp10 -92.4 -27.97 17.17 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 118.64 -2.537 . . . . 0.0 110.369 -176.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -163.22 -45.21 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.576 ' ND2' ' HD2' ' A' ' 12' ' ' ARG . 0.7 OUTLIER -160.04 35.42 0.18 Allowed 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 177.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 105' ' ' MET . 17.4 mt-10 -84.54 94.08 8.49 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.098 -1.441 . . . . 0.0 110.046 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.748 HG22 ' HG2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -83.03 142.75 13.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.579 -0.701 . . . . 0.0 109.374 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.639 ' CD1' ' CG ' ' A' ' 94' ' ' PRO . 70.1 t80 -82.2 46.36 1.02 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.681 HD11 ' C ' ' A' ' 34' ' ' GLU . 6.7 tp -81.9 151.83 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-O 122.256 1.027 . . . . 0.0 112.016 -177.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.508 ' OG1' ' HG2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -63.88 90.45 0.06 Allowed 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.681 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.616 ' HD3' HD21 ' A' ' 33' ' ' LEU . 28.7 tpt180 -89.49 106.04 18.19 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.135 -0.978 . . . . 0.0 109.73 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.6 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 3.22 76.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 121.317 0.58 . . . . 0.0 110.865 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -39.35 -53.85 1.93 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.25 0.547 . . . . 0.0 109.965 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.54 -177.1 5.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.015 -1.053 . . . . 0.0 109.243 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -80.05 77.35 6.75 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.222 -0.924 . . . . 0.0 109.668 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.415 ' HB3' ' CD ' ' A' ' 23' ' ' ARG . . . -56.79 -31.23 64.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.92 . . . . 0.0 109.357 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.412 ' C ' ' SD ' ' A' ' 29' ' ' MET . 3.5 t60 67.97 8.12 6.26 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.343 -0.848 . . . . 0.0 109.104 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.751 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -120.03 -101.0 0.43 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.276 -0.89 . . . . 0.0 109.096 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 152.31 -10.49 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.703 -0.623 . . . . 0.0 110.329 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 12.2 m120 -78.35 6.03 9.25 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.893 -1.129 . . . . 0.0 109.646 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.514 ' HD2' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -81.91 47.21 1.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.393 -0.817 . . . . 0.0 110.415 -179.578 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.698 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 13.2 mt -117.84 91.03 3.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.851 -1.156 . . . . 0.0 109.125 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.681 ' C ' HD11 ' A' ' 20' ' ' ILE . 11.9 tt0 -90.31 -127.56 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.496 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.533 ' CG ' ' C ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -155.75 128.89 4.34 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.882 -1.136 . . . . 0.0 109.382 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.973 ' O ' HG23 ' A' ' 8' ' ' VAL . 9.6 Cg_endo -69.79 97.85 0.66 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.055 1.837 . . . . 0.0 109.462 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.571 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -109.28 -173.55 21.03 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.308 -1.425 . . . . 0.0 111.455 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.542 ' HA2' ' OE1' ' A' ' 98' ' ' GLU . . . -163.74 20.35 0.15 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.475 ' O ' ' OE2' ' A' ' 53' ' ' GLU . 1.9 tptm 58.83 108.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.528 -0.984 . . . . 0.0 110.106 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.951 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -82.02 130.63 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.825 -1.172 . . . . 0.0 109.227 178.859 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -173.66 -26.07 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.088 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.67 153.48 0.8 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.977 -1.077 . . . . 0.0 109.272 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 46.87 -117.04 2.76 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -170.95 23.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.471 -1.017 . . . . 0.0 109.621 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 47' ' ' GLU . 84.5 m -140.41 139.67 21.15 Favored Pre-proline 0 C--O 1.203 -1.385 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.585 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 6.3 Cg_exo -50.26 -19.07 4.01 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 121.1 1.2 . . . . 0.0 110.128 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.695 ' H ' HG22 ' A' ' 45' ' ' THR . 1.6 mt-10 -79.71 -86.83 0.07 Allowed 'General case' 0 C--O 1.201 -1.481 0 O-C-N 121.108 -0.995 . . . . 0.0 108.536 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.589 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 15.7 mt-30 -43.09 -29.48 0.36 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.704 -1.247 . . . . 0.0 110.081 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.619 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -72.04 -60.99 1.95 Allowed 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.418 -0.801 . . . . 0.0 109.83 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.937 ' O ' HD23 ' A' ' 54' ' ' LEU . 3.8 p -66.84 -45.94 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.008 -1.058 . . . . 0.0 110.184 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.574 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 2.2 p -60.15 -46.89 93.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-O 121.239 0.542 . . . . 0.0 109.662 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.589 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 8.0 mmm180 -74.1 -21.61 59.83 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.599 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 26.5 mm-40 -78.3 -19.7 53.03 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.075 HD12 ' CD1' ' A' ' 95' ' ' TRP . 2.1 mm? -79.87 -42.03 25.06 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.166 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.635 ' HG2' ' CZ3' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -79.91 -42.78 23.43 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.599 -0.688 . . . . 0.0 109.467 -179.399 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.559 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 1.1 pp20? -57.68 -23.27 50.68 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.545 -0.722 . . . . 0.0 110.01 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.5 ' OE2' ' HA3' ' A' ' 38' ' ' GLY . 9.1 mt-10 -80.24 -92.08 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.982 -1.074 . . . . 0.0 110.456 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.631 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 22.2 t -80.07 -78.93 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.486 -0.759 . . . . 0.0 110.745 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.36 35.57 0.14 Allowed Glycine 0 N--CA 1.496 2.698 0 C-N-CA 118.572 -1.775 . . . . 0.0 112.783 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.114 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.1 pp -91.13 -145.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 120.276 -1.72 . . . . 0.0 107.127 177.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.629 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.5 m -141.26 -73.45 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.256 -1.528 . . . . 0.0 110.496 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 6.2 Cg_endo -64.54 -171.5 0.16 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.105 1.203 . . . . 0.0 110.781 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.555 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.5 OUTLIER 149.41 -23.14 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.564 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 13.5 t-160 43.91 80.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.51 ' CZ ' ' HG2' ' A' ' 47' ' ' GLU . 49.6 p90 -76.32 145.02 39.85 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.621 0.724 . . . . 0.0 110.373 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -141.58 142.54 33.48 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.638 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -67.18 -69.73 0.29 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.812 -1.18 . . . . 0.0 110.475 -179.146 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.745 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 83.99 -51.66 0.13 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.2 mt-10 170.31 177.27 0.05 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.592 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -161.16 173.18 15.5 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 109.675 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.684 HD21 ' OD1' ' A' ' 119' ' ' ASN . 0.3 OUTLIER -141.15 178.41 7.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.145 -0.972 . . . . 0.0 110.596 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -151.41 93.94 1.95 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -79.5 129.68 34.7 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.539 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 4.8 tt0 -101.25 106.05 17.21 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.146 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.539 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -81.22 171.07 13.11 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.219 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 9.5 Cg_exo -47.33 -29.62 9.97 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.972 1.781 . . . . 0.0 109.999 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -162.53 28.28 0.1 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.373 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.472 ' HD3' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -134.36 90.95 2.73 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.791 -0.568 . . . . 0.0 109.961 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.662 ' C ' HD12 ' A' ' 80' ' ' ILE . 1.9 t-160 -86.3 110.17 19.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.101 -1.0 . . . . 0.0 108.513 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.662 HD12 ' C ' ' A' ' 79' ' ' HIS . 0.8 OUTLIER -112.56 152.31 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.137 -0.977 . . . . 0.0 110.426 -178.681 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.577 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 4.1 m -125.98 137.23 53.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.892 ' CD2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -128.62 79.64 1.92 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.594 -1.317 . . . . 0.0 110.775 -179.287 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.592 ' CE3' ' HD2' ' A' ' 70' ' ' LYS . 94.3 m95 -51.16 108.82 0.28 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.994 -1.066 . . . . 0.0 108.838 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.783 ' CD2' HG11 ' A' ' 122' ' ' VAL . 12.4 m-85 -82.36 69.32 9.08 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.053 -1.03 . . . . 0.0 109.947 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.652 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 97.5 m95 -71.95 82.8 0.94 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.06 -1.025 . . . . 0.0 109.692 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.745 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.0 mm? -67.05 124.17 22.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.459 -1.4 . . . . 0.0 109.631 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.038 HG22 HG22 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -109.14 177.32 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 70.0 mt-10 -154.59 18.85 0.47 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 117.69 -1.604 . . . . 0.0 113.504 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.564 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -161.08 62.11 0.29 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 119.618 -1.926 . . . . 0.0 112.155 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.705 ' HB2' HD13 ' A' ' 60' ' ' ILE . 6.6 p90 -81.09 158.52 25.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.331 -1.481 . . . . 0.0 108.79 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.574 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -91.63 145.39 24.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.953 -1.092 . . . . 0.0 110.235 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 45.64 -87.44 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 1.114 ' O ' HG21 ' A' ' 60' ' ' ILE . 8.1 pt-20 -111.37 161.44 25.26 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.316 -1.108 . . . . 0.0 109.647 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.639 ' CG ' ' CD1' ' A' ' 19' ' ' PHE . 7.0 Cg_endo -74.68 -161.06 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.554 2.169 . . . . 0.0 109.594 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 1.075 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER 179.02 33.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.111 -0.993 . . . . 0.0 110.793 178.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -117.65 6.14 16.31 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.269 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.624 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 8.0 pttt -79.99 147.59 31.49 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.113 -1.227 . . . . 0.0 110.046 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.542 ' OE1' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -82.18 37.26 0.49 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.53 -0.731 . . . . 0.0 109.658 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.81 -10.54 73.4 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.594 ' CB ' ' CD ' ' A' ' 101' ' ' PRO . 11.8 pt20 -64.49 -172.14 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.451 -1.029 . . . . 0.0 108.677 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 100' ' ' GLN . 4.2 Cg_exo -65.65 -55.88 0.39 Allowed 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.122 1.215 . . . . 0.0 109.351 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.61 ' O ' ' CE1' ' A' ' 19' ' ' PHE . . . 57.26 115.38 0.01 OUTLIER Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 2.9 pt-20 -153.26 133.47 13.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.836 -1.391 . . . . 0.0 110.303 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.455 ' C ' ' O ' ' A' ' 103' ' ' GLU . 3.7 m0 -44.43 136.54 4.11 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -130.26 113.88 14.96 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.267 -179.378 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.65 51.11 1.62 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.486 0.66 . . . . 0.0 109.507 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.844 HD21 ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -65.42 -41.56 93.43 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.801 ' N ' HD23 ' A' ' 107' ' ' LEU . 48.9 t 79.61 116.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.984 -0.447 . . . . 0.0 110.332 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . 39.3 83.55 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 1.106 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -38.65 160.57 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.766 -0.843 . . . . 0.0 110.755 -178.627 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.672 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 11.4 t30 -136.34 -4.81 2.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.483 -0.761 . . . . 0.0 110.932 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 74.91 -4.09 2.45 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.09 -1.006 . . . . 0.0 108.768 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.54 -32.93 36.6 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.584 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -93.19 -11.21 33.27 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 1.106 ' CE1' HD21 ' A' ' 110' ' ' LEU . 5.0 m-85 -98.41 152.62 38.03 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.488 -0.758 . . . . 0.0 109.937 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.508 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 2.8 Cg_endo -68.79 135.44 32.85 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.198 1.932 . . . . 0.0 109.348 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 118' ' ' ALA . 6.3 Cg_exo -59.85 -27.7 85.53 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 121.89 1.727 . . . . 0.0 110.852 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -43.1 -51.18 5.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.107 -0.996 . . . . 0.0 109.572 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.684 ' OD1' HD21 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -88.25 48.46 1.64 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.457 -0.777 . . . . 0.0 109.23 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.676 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -63.33 -41.85 70.82 Favored Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.787 -0.571 . . . . 0.0 112.013 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 8.0 Cg_exo -51.86 -39.18 68.72 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 121.889 1.726 . . . . 0.0 113.088 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.783 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.7 t -100.51 -37.91 6.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 120.446 -1.409 . . . . 0.0 110.037 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.85 ' HA ' HD22 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -60.94 -21.96 25.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.493 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -62.75 -34.52 77.39 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.483 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 9.4 mmtm -79.71 -38.51 33.27 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.982 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.85 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.2 OUTLIER -59.24 -40.51 86.13 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.709 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -38.84 -37.16 0.32 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.09 0.947 . . . . 0.0 108.767 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.514 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -80.03 -51.81 8.58 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.287 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.603 ' CD2' ' NH1' ' A' ' 12' ' ' ARG . 2.5 tp . . . . . 0 N--CA 1.505 2.294 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.66 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 4' ' ' LEU . 2.7 tttt . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.521 ' N ' ' HG3' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -149.56 168.4 23.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.112 178.738 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.859 ' HB2' HG23 ' A' ' 40' ' ' ILE . 1.6 mp0 -142.52 171.35 14.17 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.652 HG22 HG12 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -138.36 115.62 11.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 C-N-CA 118.969 -1.092 . . . . 0.0 109.624 -179.414 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.956 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -84.39 63.68 7.94 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.714 HG13 ' H ' ' A' ' 9' ' ' GLY . 0.7 OUTLIER -79.06 -77.44 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.381 -0.825 . . . . 0.0 110.345 -178.719 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.714 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 67.59 88.26 0.07 OUTLIER Glycine 0 C--N 1.296 -1.68 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 -177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.573 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -50.19 176.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.846 HG22 HG22 ' A' ' 87' ' ' VAL . 2.5 pt -142.54 77.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 C-N-CA 117.856 -1.537 . . . . 0.0 111.087 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.634 ' HB3' HG23 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -78.89 158.68 28.03 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 177.17 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.514 ' CG ' ' CZ3' ' A' ' 90' ' ' TRP . 12.1 p-10 -160.61 -24.33 0.06 Allowed 'General case' 0 C--O 1.188 -2.143 0 C-N-CA 115.608 -2.437 . . . . 0.0 115.5 -177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.541 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 20.6 tt0 -93.51 -27.0 16.91 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 118.05 -2.906 . . . . 0.0 108.911 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -162.44 -48.74 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.491 ' ND2' HD23 ' A' ' 107' ' ' LEU . 60.9 t-20 -162.95 38.09 0.1 Allowed 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.618 ' HA ' ' O ' ' A' ' 105' ' ' MET . 19.8 mt-10 -84.06 88.5 7.18 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 117.92 -1.512 . . . . 0.0 109.973 -177.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.634 HG23 ' HB3' ' A' ' 12' ' ' ARG . 1.5 pt -82.5 147.24 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.964 0.888 . . . . 0.0 111.167 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.62 ' CE1' ' HG2' ' A' ' 94' ' ' PRO . 12.7 t80 -82.58 45.28 0.96 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.622 HD11 ' N ' ' A' ' 34' ' ' GLU . 4.3 tp -80.42 151.35 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.85 0.833 . . . . 0.0 110.645 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.505 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -71.11 88.43 0.8 Allowed 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.383 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.591 ' O ' ' C ' ' A' ' 23' ' ' ARG . 28.2 tpt180 -86.2 94.56 9.33 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.53 -0.731 . . . . 0.0 110.373 -178.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.591 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 17.89 75.97 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.142 0.496 . . . . 0.0 110.346 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -39.36 -55.72 1.69 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.608 -0.683 . . . . 0.0 110.168 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.46 -147.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.158 -0.964 . . . . 0.0 108.988 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.712 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 77.4 m-20 -79.88 -60.77 2.21 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.026 -1.046 . . . . 0.0 109.128 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 26' ' ' ASP . . . 81.78 -28.33 0.12 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.435 -0.791 . . . . 0.0 110.715 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER 49.15 25.3 1.13 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.413 ' N ' ' C ' ' A' ' 27' ' ' ALA . 5.6 mtt -145.08 -164.16 1.87 Allowed 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.463 ' O ' ' OD1' ' A' ' 114' ' ' ASP . . . -164.25 23.13 0.07 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.804 -1.185 . . . . 0.0 110.326 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 114' ' ' ASP . 1.3 m-20 -101.9 15.94 27.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.058 -1.026 . . . . 0.0 108.259 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 1.4 mmtm -81.81 50.72 1.57 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.767 -0.583 . . . . 0.0 111.006 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.904 HD13 HD21 ' A' ' 110' ' ' LEU . 17.0 mt -109.57 86.77 2.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.763 -1.211 . . . . 0.0 108.875 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.622 ' N ' HD11 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -91.5 -135.87 0.14 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.123 -0.986 . . . . 0.0 110.191 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.584 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -150.45 119.44 3.64 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 120.758 -1.214 . . . . 0.0 109.626 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.587 ' O ' HG23 ' A' ' 8' ' ' VAL . 11.5 Cg_endo -71.29 94.39 0.66 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.323 2.015 . . . . 0.0 110.772 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.708 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -127.2 -135.73 4.19 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 118.767 -1.682 . . . . 0.0 111.04 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.537 ' CA ' ' OE1' ' A' ' 98' ' ' GLU . . . 167.65 35.53 0.02 OUTLIER Glycine 0 N--CA 1.487 2.071 0 O-C-N 121.383 -1.069 . . . . 0.0 110.53 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.508 ' HE2' ' O ' ' A' ' 40' ' ' ILE . 14.1 tptm 56.5 110.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.979 -0.718 . . . . 0.0 111.891 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.956 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -81.9 142.13 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.217 -0.927 . . . . 0.0 108.662 177.762 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.401 ' N ' HG12 ' A' ' 40' ' ' ILE . 10.9 pt-20 -172.21 -30.45 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.417 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.3 mmm -55.33 149.0 13.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.148 -0.97 . . . . 0.0 110.011 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.48 -127.44 33.66 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -164.66 18.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.493 -1.004 . . . . 0.0 109.842 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.794 HG22 ' H ' ' A' ' 47' ' ' GLU . 45.4 m -133.39 137.23 28.64 Favored Pre-proline 0 C--O 1.204 -1.332 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.615 ' HG3' ' CH2' ' A' ' 83' ' ' TRP . 3.0 Cg_exo -48.98 -16.37 0.83 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 121.57 1.513 . . . . 0.0 110.281 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.794 ' H ' HG22 ' A' ' 45' ' ' THR . 2.8 mt-10 -75.5 -85.47 0.05 OUTLIER 'General case' 0 C--O 1.203 -1.386 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.557 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 18.6 mt-30 -45.22 -34.75 2.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.66 -1.275 . . . . 0.0 109.778 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.86 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -63.77 -64.03 1.01 Allowed 'General case' 0 C--N 1.292 -1.927 0 O-C-N 121.339 -0.85 . . . . 0.0 109.666 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.905 ' O ' HD23 ' A' ' 54' ' ' LEU . 2.0 p -66.69 -51.89 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.049 -1.032 . . . . 0.0 110.55 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.57 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 3.7 p -51.97 -44.76 39.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.352 -0.843 . . . . 0.0 110.731 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.56 ' N ' HG13 ' A' ' 51' ' ' VAL . 5.8 mmt180 -74.76 -37.79 62.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 108.875 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.594 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 6.5 mm-40 -70.37 -13.08 61.99 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.174 HD12 ' CD1' ' A' ' 95' ' ' TRP . 1.6 mm? -80.06 -63.82 1.33 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.653 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.41 -52.71 64.28 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.833 -0.542 . . . . 0.0 110.176 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.579 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -47.28 -22.35 0.4 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.017 -1.052 . . . . 0.0 109.875 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.441 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 3.4 mt-10 -80.03 -96.79 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.046 -1.034 . . . . 0.0 109.31 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.665 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 57.4 t -80.01 -79.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.215 -0.928 . . . . 0.0 109.322 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 133.66 46.33 0.11 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.247 -1.454 . . . . 0.0 111.777 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.086 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -87.59 -127.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.604 -1.527 . . . . 0.0 108.44 178.586 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.706 ' H ' HD12 ' A' ' 60' ' ' ILE . 1.3 m -159.64 -68.6 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.006 -1.684 . . . . 0.0 112.146 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 2.2 Cg_endo -54.19 -80.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.028 1.819 . . . . 0.0 112.061 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 1.012 ' NE2' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 39.81 61.62 1.41 Allowed 'General case' 0 C--N 1.289 -2.039 0 CA-C-O 121.781 0.8 . . . . 0.0 109.608 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.687 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -53.24 102.22 0.05 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.517 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -95.46 144.28 26.09 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 122.177 0.989 . . . . 0.0 111.362 -177.62 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -143.25 145.0 32.37 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.149 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.856 HD13 ' N ' ' A' ' 69' ' ' GLU . 1.4 tm? -67.95 -64.45 0.86 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.068 -1.02 . . . . 0.0 110.808 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.882 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 83.6 -54.2 0.15 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.357 -0.84 . . . . 0.0 108.796 -179.359 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.856 ' N ' HD13 ' A' ' 67' ' ' LEU . 6.0 tp10 164.86 128.9 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.558 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -118.97 -171.71 2.15 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.443 -0.786 . . . . 0.0 109.868 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 71' ' ' LEU . 0.6 OUTLIER -142.06 -172.04 3.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 110.315 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -159.75 94.26 1.13 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.45 151.3 22.08 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.275 -0.891 . . . . 0.0 108.87 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.437 ' OE2' ' CE1' ' A' ' 79' ' ' HIS . 2.0 tt0 -119.71 137.5 53.88 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.144 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.563 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 1.1 m-30 -106.55 172.92 3.48 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 6.5 Cg_exo -46.24 -39.95 21.48 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.706 1.604 . . . . 0.0 110.31 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.437 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 3.1 m-20 -156.24 40.1 0.36 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.57 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -147.33 101.75 3.41 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.451 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.991 ' C ' HD12 ' A' ' 80' ' ' ILE . 5.5 m170 -77.81 137.26 38.32 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.991 HD12 ' C ' ' A' ' 79' ' ' HIS . 1.9 mp -132.82 153.74 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.767 -1.208 . . . . 0.0 110.653 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.574 ' HB ' ' CB ' ' A' ' 5' ' ' GLN . 1.6 m -141.67 150.45 41.92 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.65 HD21 HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -138.94 77.73 1.64 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.812 -1.18 . . . . 0.0 109.985 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.615 ' CH2' ' HG3' ' A' ' 46' ' ' PRO . 93.4 m95 -50.68 113.65 0.95 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 108.993 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.599 ' O ' ' O ' ' A' ' 67' ' ' LEU . 13.6 m-85 -90.76 70.56 6.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.254 -0.904 . . . . 0.0 110.208 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.656 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 61.5 m95 -77.46 87.6 3.82 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.705 -1.247 . . . . 0.0 109.751 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.882 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.0 mm? -68.2 129.55 40.25 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.524 -1.36 . . . . 0.0 109.974 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.012 HG11 ' NE2' ' A' ' 63' ' ' GLN . 0.8 OUTLIER -116.42 154.74 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.284 -0.885 . . . . 0.0 108.729 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 1.2 mt-10 -143.02 35.38 1.37 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.738 -1.226 . . . . 0.0 113.219 -178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.687 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -161.32 40.49 0.15 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 119.79 -1.819 . . . . 0.0 111.729 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.635 ' CH2' ' CD1' ' A' ' 104' ' ' TRP . 1.3 p90 -67.19 157.09 34.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.02 -1.675 . . . . 0.0 109.37 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.574 ' O ' ' CD1' ' A' ' 90' ' ' TRP . 10.4 pt-20 -77.8 -125.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.234 -0.916 . . . . 0.0 110.439 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.495 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -53.09 -55.22 25.14 Favored Glycine 0 N--CA 1.494 2.51 0 O-C-N 120.658 -1.277 . . . . 0.0 110.735 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 1.086 ' O ' HG21 ' A' ' 60' ' ' ILE . 6.9 pt-20 -132.94 166.91 25.79 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.161 -1.199 . . . . 0.0 109.577 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.76 ' HB3' HD12 ' A' ' 11' ' ' ILE . 9.9 Cg_endo -77.28 -168.14 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.36 2.04 . . . . 0.0 110.123 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 1.174 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -171.0 28.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 0.0 110.086 178.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.613 ' HA2' HD13 ' A' ' 54' ' ' LEU . . . -116.1 3.38 20.72 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.983 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.567 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 11.5 pttt -76.57 136.46 39.26 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.922 -1.34 . . . . 0.0 109.212 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.537 ' OE1' ' CA ' ' A' ' 38' ' ' GLY . 2.6 tp10 -75.61 -117.63 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.64 22.33 36.2 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 107.47 -2.252 . . . . 0.0 107.47 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.483 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 1.5 pt20 -94.97 165.11 17.71 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.731 -0.864 . . . . 0.0 110.136 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 1.4 Cg_endo -66.99 -42.55 8.0 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.994 1.796 . . . . 0.0 109.851 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.589 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 57.69 110.38 0.01 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 7.1 pt-20 -142.96 134.07 25.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.768 -1.43 . . . . 0.0 110.672 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.635 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 1.6 m0 -50.19 127.59 17.34 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.618 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -118.88 116.37 26.36 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.77 45.59 0.71 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.262 -0.899 . . . . 0.0 110.161 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.592 ' HG ' ' N ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -81.41 158.09 24.74 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.051 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.592 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 33.4 t -114.66 134.07 58.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.061 -1.024 . . . . 0.0 109.541 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.484 ' HA2' ' HB3' ' A' ' 129' ' ' LEU . . . 39.52 79.87 0.04 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.904 HD21 HD13 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -41.62 166.13 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.573 -0.957 . . . . 0.0 110.694 -178.766 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.791 ' H ' HD23 ' A' ' 110' ' ' LEU . 4.5 t30 -159.71 151.17 19.92 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.511 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . -55.98 -22.07 24.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 108.563 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -42.72 -36.9 1.57 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.522 -0.736 . . . . 0.0 109.082 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.536 ' CB ' ' CD1' ' A' ' 33' ' ' LEU . 73.8 m-20 -115.29 -8.5 12.29 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.685 -0.634 . . . . 0.0 109.556 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.828 ' HD2' HD22 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -100.93 123.53 45.01 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.339 -0.851 . . . . 0.0 109.709 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.547 ' O ' ' CD1' ' A' ' 123' ' ' ILE . 7.2 Cg_exo -52.62 148.2 28.3 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.415 2.077 . . . . 0.0 111.373 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.475 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . 2.1 Cg_endo -62.61 -26.18 75.69 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.309 2.006 . . . . 0.0 110.699 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.6 -48.57 5.43 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.123 -0.986 . . . . 0.0 109.656 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.868 ' O ' HD12 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -100.15 55.65 0.92 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.631 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 4.6 mt-10 -67.32 -43.19 42.64 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.602 -0.686 . . . . 0.0 112.366 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 6.3 Cg_exo -55.52 -31.78 79.93 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.764 1.643 . . . . 0.0 112.125 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.571 HG11 ' CZ ' ' A' ' 84' ' ' PHE . 2.4 t -101.05 -38.93 6.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.76 -1.212 . . . . 0.0 109.569 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.868 HD12 ' O ' ' A' ' 119' ' ' ASN . 15.2 mt -55.77 -34.55 36.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.27 -38.5 58.45 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.949 0.881 . . . . 0.0 109.137 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -79.81 -37.37 35.31 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.242 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.927 ' HA ' HD13 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -59.3 -39.67 83.76 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.179 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -39.8 -37.66 0.57 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.949 0.88 . . . . 0.0 108.927 178.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.481 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -87.57 -49.9 6.87 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.927 HD13 ' HA ' ' A' ' 126' ' ' LEU . 1.9 tp . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.322 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 17.0 tttt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.949 ' O ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -146.67 131.98 18.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.388 -0.82 . . . . 0.0 109.385 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.544 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 2.1 mp0 -98.51 162.06 13.35 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.441 ' HB ' ' HG ' ' A' ' 82' ' ' LEU . 0.9 OUTLIER -126.0 112.83 31.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.057 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -84.56 65.78 9.17 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.722 HG13 ' H ' ' A' ' 9' ' ' GLY . 1.1 p -78.94 -70.37 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.023 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.722 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 57.5 83.43 0.05 OUTLIER Glycine 0 C--N 1.292 -1.915 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 -178.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.59 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -47.7 168.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -179.031 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.811 HG22 ' CG2' ' A' ' 87' ' ' VAL . 2.7 pt -133.24 95.14 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.344 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.91 ' HG2' HG22 ' A' ' 18' ' ' ILE . 15.8 mtm180 -76.78 179.83 5.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.619 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -158.69 -60.81 0.08 Allowed 'General case' 0 C--O 1.194 -1.856 0 C-N-CA 116.458 -2.097 . . . . 0.0 115.068 -177.119 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.576 ' CB ' ' HG3' ' A' ' 17' ' ' GLU . 6.9 tp10 -92.72 -26.04 17.94 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 119.254 -2.154 . . . . 0.0 111.745 -175.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -161.96 -45.17 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.479 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 14.7 t30 -160.41 35.81 0.17 Allowed 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 177.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 105' ' ' MET . 4.9 mm-40 -78.36 85.86 4.46 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 118.007 -1.477 . . . . 0.0 109.105 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.91 HG22 ' HG2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -79.15 142.49 13.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.714 ' HB3' HD11 ' A' ' 11' ' ' ILE . 11.9 t80 -81.94 46.0 0.96 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.708 HD12 ' CZ ' ' A' ' 115' ' ' PHE . 12.9 tt -79.1 153.0 4.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-O 121.858 0.837 . . . . 0.0 110.463 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.534 ' HB ' ' HD2' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -66.5 89.91 0.15 Allowed 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.255 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.509 ' O ' ' C ' ' A' ' 23' ' ' ARG . 28.5 tpt180 -87.37 81.77 7.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.184 -0.948 . . . . 0.0 110.416 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.715 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 1.1 ptt180 32.53 72.79 0.07 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.917 -0.489 . . . . 0.0 110.269 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.23 -53.31 4.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -0.853 . . . . 0.0 109.302 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.28 -171.54 3.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.232 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -79.92 80.68 6.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.473 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.715 ' HB2' ' HB3' ' A' ' 23' ' ' ARG . . . -61.31 -31.77 71.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.819 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.6 m80 55.41 21.13 4.05 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.746 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 6.1 mmm -127.36 -112.53 0.28 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 160.01 -14.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.064 -1.022 . . . . 0.0 111.065 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -81.53 12.53 3.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.906 -1.122 . . . . 0.0 109.779 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.72 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -81.99 54.79 2.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.476 -0.765 . . . . 0.0 110.642 -179.479 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.72 HD23 ' O ' ' A' ' 32' ' ' LYS . 6.4 mt -120.83 83.75 2.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.644 -1.285 . . . . 0.0 109.75 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.46 -146.98 0.19 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.389 -0.82 . . . . 0.0 109.358 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.65 ' CZ ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -140.16 125.61 11.5 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.864 -1.147 . . . . 0.0 110.157 -178.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.682 ' O ' HG23 ' A' ' 8' ' ' VAL . 13.8 Cg_endo -73.78 100.11 1.23 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.364 2.043 . . . . 0.0 110.118 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.671 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -136.36 135.08 7.53 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.175 -1.488 . . . . 0.0 110.961 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.533 ' CA ' ' OE1' ' A' ' 98' ' ' GLU . . . -108.14 36.53 4.32 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.632 ' HD2' HD23 ' A' ' 4' ' ' LEU . 7.0 tptm 59.26 119.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.54 -0.976 . . . . 0.0 112.083 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.021 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -83.24 135.96 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.132 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -171.31 -31.51 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.906 -1.121 . . . . 0.0 110.266 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.55 142.98 25.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.133 -0.979 . . . . 0.0 109.316 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.22 -115.96 8.71 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -169.23 -15.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.775 -0.838 . . . . 0.0 110.737 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.779 HG22 ' H ' ' A' ' 47' ' ' GLU . 24.9 m -103.82 141.09 21.78 Favored Pre-proline 0 C--O 1.205 -1.28 0 O-C-N 120.876 -1.14 . . . . 0.0 108.353 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.582 ' HD2' HG23 ' A' ' 45' ' ' THR . 7.9 Cg_exo -47.32 -18.06 0.68 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.082 1.855 . . . . 0.0 110.938 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.779 ' H ' HG22 ' A' ' 45' ' ' THR . 0.7 OUTLIER -77.87 -81.89 0.09 Allowed 'General case' 0 C--O 1.202 -1.424 0 O-C-N 120.857 -1.152 . . . . 0.0 108.594 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.544 ' O ' ' CG ' ' A' ' 52' ' ' ARG . 53.0 mt-30 -48.73 -25.56 1.88 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.384 -1.448 . . . . 0.0 109.948 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.827 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -73.51 -59.65 2.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.875 -1.14 . . . . 0.0 109.874 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.057 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.5 p -70.01 -48.94 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.053 -1.029 . . . . 0.0 109.843 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.571 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 2.1 p -56.33 -42.91 75.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 O-C-N 121.797 -0.564 . . . . 0.0 110.4 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 48' ' ' GLN . 21.2 mmt180 -74.86 -35.7 62.33 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.612 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 15.7 mm-40 -68.07 -15.47 63.61 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.802 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -79.09 -62.79 1.59 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.492 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.37 -53.84 53.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.345 -0.847 . . . . 0.0 109.828 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.547 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -50.13 -21.7 1.4 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.334 -0.854 . . . . 0.0 110.496 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.4 mt-10 -80.04 -91.02 0.05 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.059 -1.026 . . . . 0.0 109.967 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.684 HG21 ' HA ' ' A' ' 95' ' ' TRP . 47.3 t -80.06 -78.98 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.448 -0.782 . . . . 0.0 110.302 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.18 22.21 0.1 OUTLIER Glycine 0 N--CA 1.494 2.563 0 C-N-CA 118.77 -1.681 . . . . 0.0 112.472 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.059 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.2 pt -81.19 -136.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.187 -1.772 . . . . 0.0 108.102 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.622 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.2 m -159.08 -68.6 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.465 -1.397 . . . . 0.0 109.967 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 5.7 Cg_endo -62.51 -173.74 0.15 Allowed 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.686 1.591 . . . . 0.0 110.741 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.56 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 4.4 pt20 145.19 -24.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.603 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.2 OUTLIER 43.32 48.96 5.92 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.512 ' HD2' ' NE2' ' A' ' 63' ' ' GLN . 41.5 p90 -42.84 160.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.745 0.783 . . . . 0.0 110.584 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -156.89 136.91 12.63 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.167 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.637 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -59.64 -71.92 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.824 -1.172 . . . . 0.0 110.321 -178.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.747 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 85.08 -56.55 0.09 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.026 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.619 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 30.9 tp10 165.97 123.38 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.604 0.716 . . . . 0.0 109.753 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.571 ' HD2' ' CD2' ' A' ' 83' ' ' TRP . 5.7 ptmt -110.11 170.54 8.01 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.706 -0.621 . . . . 0.0 109.615 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.799 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -122.8 169.8 10.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.097 -1.002 . . . . 0.0 110.14 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.681 ' HG3' HG23 ' A' ' 81' ' ' THR . 15.6 tt0 -147.07 85.78 1.62 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.21 123.77 28.74 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.429 ' CG ' ' NE2' ' A' ' 79' ' ' HIS . 2.6 tt0 -91.85 108.43 19.92 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.281 -0.968 . . . . 0.0 109.017 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.531 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 1.9 m-85 -78.32 170.35 16.65 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.398 -0.814 . . . . 0.0 109.468 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 7.5 Cg_exo -49.65 -38.15 45.13 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.112 1.874 . . . . 0.0 109.714 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.63 43.46 0.44 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.513 ' O ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -148.07 97.54 2.8 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.091 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.459 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -79.82 94.91 5.89 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.607 HG22 ' N ' ' A' ' 81' ' ' THR . 0.4 OUTLIER -102.17 164.52 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.183 -0.948 . . . . 0.0 110.559 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.681 HG23 ' HG3' ' A' ' 72' ' ' GLU . 1.2 m -148.3 151.62 35.7 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.652 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -142.63 79.56 1.66 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.696 -1.253 . . . . 0.0 110.682 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.571 ' CD2' ' HD2' ' A' ' 70' ' ' LYS . 87.5 m95 -53.96 111.37 0.74 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 109.296 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.776 ' CE1' HG11 ' A' ' 122' ' ' VAL . 8.7 m-85 -87.01 71.31 10.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.157 -0.964 . . . . 0.0 109.546 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.688 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 67.5 m95 -75.44 86.6 2.58 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.94 -1.1 . . . . 0.0 109.554 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.747 HD23 ' CD2' ' A' ' 68' ' ' PHE . 1.7 mm? -67.89 130.75 43.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.626 -1.296 . . . . 0.0 109.711 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.811 ' CG2' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -111.37 179.45 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.19 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.512 ' N ' HG23 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -160.93 17.6 0.12 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.341 -1.475 . . . . 0.0 112.57 -179.349 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.603 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -160.52 50.63 0.28 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.048 -1.657 . . . . 0.0 111.139 179.439 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.734 ' HB2' HD13 ' A' ' 60' ' ' ILE . 4.0 p90 -67.4 164.61 18.27 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.687 -1.258 . . . . 0.0 109.351 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.613 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 6.6 tt0 -87.95 140.18 29.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.152 -0.967 . . . . 0.0 109.363 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 36.29 -85.17 0.01 OUTLIER Glycine 0 N--CA 1.497 2.731 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 1.059 ' O ' HG21 ' A' ' 60' ' ' ILE . 10.4 pt-20 -101.61 159.61 28.93 Favored Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.242 -1.152 . . . . 0.0 109.706 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.653 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 15.0 Cg_endo -75.52 -159.94 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.364 2.043 . . . . 0.0 109.669 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.802 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER 175.18 27.21 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.72 -0.612 . . . . 0.0 110.667 178.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.416 ' HA2' ' CD1' ' A' ' 54' ' ' LEU . . . -103.28 -6.15 45.3 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.59 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -81.15 128.54 33.87 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.347 -1.09 . . . . 0.0 110.854 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.533 ' OE1' ' CA ' ' A' ' 38' ' ' GLY . 22.7 tp10 -81.69 -96.14 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.522 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . -89.7 -19.5 47.88 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 107.634 -2.187 . . . . 0.0 107.634 177.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.569 ' HG3' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -61.55 149.29 84.53 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.865 -0.786 . . . . 0.0 109.219 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.569 ' HD2' ' HG3' ' A' ' 100' ' ' GLN . 1.2 Cg_endo -67.6 -37.35 16.93 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.737 1.625 . . . . 0.0 108.79 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.61 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.12 123.2 0.01 OUTLIER Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.558 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 1.4 pp20? -151.79 125.65 9.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.957 -1.319 . . . . 0.0 109.795 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.592 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 1.2 m-90 -45.08 132.62 7.0 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.633 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 7.7 tpt -124.31 120.73 33.02 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.288 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.31 47.51 1.16 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 1.069 HD13 ' HG ' ' A' ' 110' ' ' LEU . 6.8 tt -59.47 -48.0 83.32 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.74 -0.6 . . . . 0.0 109.427 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.634 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 49.3 t 82.79 112.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 40.89 82.79 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 1.069 ' HG ' HD13 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -42.08 164.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.377 -1.073 . . . . 0.0 109.869 -179.211 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.71 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -138.43 -6.97 1.53 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.001 -1.062 . . . . 0.0 111.924 -177.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 82.34 -26.43 0.14 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.219 -0.926 . . . . 0.0 108.87 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.27 -24.42 59.35 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.679 ' OD1' ' HB1' ' A' ' 30' ' ' ALA . 4.4 m-20 -103.07 -13.64 16.75 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.708 ' CZ ' HD12 ' A' ' 20' ' ' ILE . 2.0 m-85 -95.3 143.25 25.79 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.287 -0.883 . . . . 0.0 109.945 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -60.15 132.97 47.14 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.032 1.822 . . . . 0.0 109.575 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.55 -16.29 23.42 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.144 1.896 . . . . 0.0 110.988 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.05 -57.28 9.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.939 -1.1 . . . . 0.0 109.104 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.72 ' O ' HD12 ' A' ' 123' ' ' ILE . 9.8 m-20 -86.67 48.55 1.65 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.806 0.812 . . . . 0.0 109.043 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -56.61 -44.12 99.62 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.778 -0.576 . . . . 0.0 112.427 -179.536 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 11.5 Cg_exo -53.3 -57.55 1.93 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.048 1.832 . . . . 0.0 112.962 -177.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.776 HG11 ' CE1' ' A' ' 84' ' ' PHE . 2.0 t -78.93 -32.99 15.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 120.788 -1.195 . . . . 0.0 109.532 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.72 HD12 ' O ' ' A' ' 119' ' ' ASN . 5.7 mt -64.16 -23.97 34.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.565 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -61.49 -28.45 69.31 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.899 0.857 . . . . 0.0 108.92 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -80.35 -40.09 27.3 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.752 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.778 HD13 ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -66.3 -22.02 66.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.623 -1.298 . . . . 0.0 107.845 179.148 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 12.6 mtmt -58.35 -33.54 69.66 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -87.19 -21.42 25.9 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.602 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 1.6 tp . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.736 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 79' ' ' HIS . 26.8 tttt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.51 0.671 . . . . 0.0 109.89 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 1.069 ' O ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -157.24 144.33 18.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.979 179.099 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.632 ' N ' HD22 ' A' ' 4' ' ' LEU . 9.7 mp0 -108.71 166.08 11.06 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.689 HG22 HG12 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -128.81 114.73 34.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 O-C-N 120.992 -1.067 . . . . 0.0 109.334 -178.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.042 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -85.2 62.61 7.6 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 36' ' ' PRO . 1.2 p -79.01 -70.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.353 -0.842 . . . . 0.0 109.972 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.738 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 59.08 84.48 0.04 OUTLIER Glycine 0 N--CA 1.481 1.649 0 N-CA-C 107.569 -2.212 . . . . 0.0 107.569 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.625 HG22 ' HB ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -48.63 166.76 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.8 HG22 ' CG2' ' A' ' 87' ' ' VAL . 1.8 pt -130.65 78.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.687 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.677 ' HB3' HG23 ' A' ' 18' ' ' ILE . 2.9 ptm180 -83.25 144.92 29.42 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.598 ' OD1' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -161.3 -5.6 0.05 OUTLIER 'General case' 0 C--O 1.185 -2.291 0 C-N-CA 116.769 -1.972 . . . . 0.0 114.203 -179.072 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.612 ' HB2' ' CG ' ' A' ' 17' ' ' GLU . 19.7 mm-40 -94.02 -32.2 13.92 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 118.182 -2.824 . . . . 0.0 107.471 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.605 ' CG ' HG22 ' A' ' 108' ' ' VAL . 24.6 t-20 -162.82 -48.62 0.04 OUTLIER 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 102.382 -3.192 . . . . 0.0 102.382 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.478 ' OD1' HD23 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -161.74 35.78 0.13 Allowed 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 175.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 105' ' ' MET . 0.3 OUTLIER -86.1 92.86 8.85 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.069 -1.452 . . . . 0.0 110.8 -176.449 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.677 HG23 ' HB3' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -84.95 156.66 3.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.536 0.684 . . . . 0.0 109.872 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.615 ' CE1' ' HG2' ' A' ' 94' ' ' PRO . 6.4 t80 -82.97 44.1 0.9 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.58 ' CG2' HG13 ' A' ' 18' ' ' ILE . 7.0 tp -82.05 155.69 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.148 -0.97 . . . . 0.0 110.55 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.68 ' O ' HG23 ' A' ' 21' ' ' THR . 5.0 t -73.08 89.23 1.46 Allowed 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.562 ' HD3' HD21 ' A' ' 33' ' ' LEU . 29.1 tpt180 -90.21 76.06 6.9 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.501 -0.75 . . . . 0.0 110.555 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.872 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 35.26 76.97 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.762 -0.586 . . . . 0.0 110.093 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.55 -52.98 9.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.928 . . . . 0.0 109.875 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.28 -170.23 2.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.119 -0.988 . . . . 0.0 109.489 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -79.5 128.51 33.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.194 -0.941 . . . . 0.0 109.141 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.872 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -124.46 -44.85 1.97 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.132 -0.98 . . . . 0.0 110.184 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.6 t60 56.41 20.44 4.75 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.71 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 6.3 mtp -115.28 -40.99 3.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.654 -0.654 . . . . 0.0 109.372 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 29' ' ' MET . . . 76.18 -177.49 0.13 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.304 -0.872 . . . . 0.0 109.003 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 1.3 t30 78.1 -5.95 2.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 109.403 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.49 ' O ' ' O ' ' A' ' 21' ' ' THR . 3.8 tmtm? -82.59 48.29 1.29 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.433 -0.792 . . . . 0.0 109.871 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.643 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 9.5 mt -117.91 79.93 1.44 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.846 -1.158 . . . . 0.0 109.304 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.607 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 13.2 tt0 -81.3 -134.18 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.345 -0.847 . . . . 0.0 109.132 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.607 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -149.37 124.75 4.94 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.544 -1.348 . . . . 0.0 110.261 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.792 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.7 Cg_endo -57.99 94.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.14 1.893 . . . . 0.0 109.515 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -55.34 -148.14 0.01 OUTLIER Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.287 -0.883 . . . . 0.0 111.757 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.602 ' N ' ' CG ' ' A' ' 98' ' ' GLU . . . 157.41 -31.96 0.53 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 107.538 -2.225 . . . . 0.0 107.538 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.464 ' O ' ' OE2' ' A' ' 53' ' ' GLU . 2.5 tptm 67.18 100.43 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 122.237 -0.567 . . . . 0.0 110.744 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.82 ' O ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -80.74 134.5 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.721 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 42' ' ' MET . 4.0 pt-20 -171.39 -31.94 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.784 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.443 ' O ' ' C ' ' A' ' 43' ' ' GLY . 4.4 mmt -54.69 162.92 1.05 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.113 -0.992 . . . . 0.0 109.252 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 42' ' ' MET . . . 43.93 -125.81 5.68 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -164.6 23.21 0.06 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.474 -1.015 . . . . 0.0 108.948 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.471 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 24.1 m -138.24 140.04 27.34 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.52 ' O ' HG12 ' A' ' 50' ' ' VAL . 10.0 Cg_exo -51.05 -17.84 3.95 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 121.748 1.632 . . . . 0.0 110.136 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.512 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -77.95 -85.14 0.07 Allowed 'General case' 0 C--O 1.202 -1.401 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.519 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.546 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 40.6 mt-30 -43.83 -33.17 1.24 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.569 -1.332 . . . . 0.0 109.715 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.693 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -65.76 -62.63 1.4 Allowed 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.511 -0.743 . . . . 0.0 110.021 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.042 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.6 p -68.99 -49.58 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.216 -0.928 . . . . 0.0 110.316 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.561 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 3.4 p -54.95 -45.48 76.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 121.684 -0.635 . . . . 0.0 110.186 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.552 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 5.4 mmt180 -71.06 -37.35 72.49 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.616 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 17.6 mm-40 -68.9 -14.59 63.13 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.763 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -80.0 -59.94 2.53 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -54.04 46.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.447 -0.783 . . . . 0.0 110.007 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.563 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 1.1 pp20? -47.57 -21.74 0.39 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.039 -1.038 . . . . 0.0 110.075 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.433 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 3.3 mt-10 -80.04 -92.92 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.075 -1.016 . . . . 0.0 109.632 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.776 HG21 ' HA ' ' A' ' 95' ' ' TRP . 36.2 t -79.97 -78.34 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 110.117 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.94 18.89 0.1 OUTLIER Glycine 0 N--CA 1.493 2.496 0 C-N-CA 118.43 -1.843 . . . . 0.0 112.643 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.947 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.6 pp -80.05 -156.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.123 -1.81 . . . . 0.0 107.628 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.624 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.5 m -137.36 -72.25 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.421 -1.424 . . . . 0.0 110.947 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 1.6 Cg_endo -61.43 -169.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 121.029 1.153 . . . . 0.0 110.712 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.584 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER 143.27 -23.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -179.436 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.609 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 1.6 t-80 44.84 53.21 7.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.455 -0.778 . . . . 0.0 109.484 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -45.97 156.05 0.16 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.036 0.922 . . . . 0.0 110.372 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -149.36 140.62 23.14 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.608 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -63.49 -68.1 0.37 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.731 -1.23 . . . . 0.0 109.78 -179.112 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.641 ' CZ ' HD11 ' A' ' 126' ' ' LEU . 0.0 OUTLIER 83.73 -50.53 0.14 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.242 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.599 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.5 mt-10 162.16 174.02 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.36 -172.38 3.36 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.824 -1.172 . . . . 0.0 109.891 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.979 HD21 ' OD1' ' A' ' 119' ' ' ASN . 0.7 OUTLIER -140.18 -177.7 5.13 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.795 0.807 . . . . 0.0 109.891 179.579 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.637 ' HG3' HG23 ' A' ' 81' ' ' THR . 11.3 tt0 -160.18 88.7 0.82 Allowed 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.03 105.48 9.27 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.512 ' HG3' ' NE2' ' A' ' 79' ' ' HIS . 2.8 tt0 -96.72 118.29 32.86 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.119 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -105.69 174.3 2.72 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 2.9 Cg_exo -49.03 -60.51 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 121.418 1.412 . . . . 0.0 109.558 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.5 50.39 1.71 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.434 ' HD2' ' CD1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -150.36 87.97 1.48 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.457 -0.777 . . . . 0.0 109.743 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.554 ' O ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -90.28 98.72 11.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.89 . . . . 0.0 109.386 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.575 ' CG2' ' N ' ' A' ' 81' ' ' THR . 0.5 OUTLIER -113.14 163.55 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.0 110.253 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.637 HG23 ' HG3' ' A' ' 72' ' ' GLU . 0.7 OUTLIER -151.34 147.1 26.52 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.336 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.641 ' CD2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -134.49 73.83 1.51 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.918 -1.114 . . . . 0.0 110.816 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.652 ' CD1' HG21 ' A' ' 40' ' ' ILE . 78.8 m95 -46.35 117.15 1.47 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.06 -1.025 . . . . 0.0 108.563 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.695 ' CE2' HG11 ' A' ' 122' ' ' VAL . 33.9 m-85 -94.03 76.78 4.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.966 -1.084 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.663 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 24.6 m95 -76.89 84.21 3.45 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.902 -1.124 . . . . 0.0 109.372 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.623 HD11 ' CG1' ' A' ' 10' ' ' ILE . 2.4 mm? -69.24 128.04 35.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.671 -1.268 . . . . 0.0 109.212 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.8 ' CG2' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -112.0 175.78 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 87.2 mt-10 -157.14 19.41 0.3 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.48 -1.388 . . . . 0.0 112.786 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.609 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -160.67 64.16 0.31 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.105 -1.622 . . . . 0.0 111.087 178.666 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.61 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 1.5 p90 -80.74 164.6 22.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.747 -1.22 . . . . 0.0 109.156 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.6 OUTLIER -88.27 142.94 27.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.854 -1.154 . . . . 0.0 109.386 178.314 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 38.25 -83.37 0.0 OUTLIER Glycine 0 N--CA 1.498 2.814 0 O-C-N 121.585 -0.697 . . . . 0.0 112.073 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.947 ' O ' HG21 ' A' ' 60' ' ' ILE . 10.6 pt-20 -106.98 164.86 13.93 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.149 -1.206 . . . . 0.0 111.254 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.615 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 11.2 Cg_endo -75.86 -160.91 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 122.717 2.278 . . . . 0.0 109.934 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.776 ' HA ' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER 176.51 54.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.196 -0.94 . . . . 0.0 110.865 178.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . -139.98 0.6 2.12 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 118.334 -1.888 . . . . 0.0 111.814 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.651 ' HE3' HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -78.03 106.94 10.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.403 -1.646 . . . . 0.0 110.772 -179.201 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.602 ' CG ' ' N ' ' A' ' 38' ' ' GLY . 1.2 mm-40 -60.27 -91.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.735 -1.228 . . . . 0.0 107.73 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.74 22.17 34.55 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 106.692 -2.563 . . . . 0.0 106.692 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.506 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -100.11 143.38 26.39 Favored Pre-proline 0 N--CA 1.485 1.289 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 21' ' ' THR . 4.4 Cg_exo -57.31 -30.67 88.5 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 N-CA-C 108.127 -1.528 . . . . 0.0 108.127 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.605 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 53.63 110.97 0.01 OUTLIER Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 4.6 pt-20 -147.8 133.73 19.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.758 -1.437 . . . . 0.0 110.557 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.53 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 7.8 m0 -46.06 123.62 4.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 108.495 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.639 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -115.55 111.07 20.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.08 -1.012 . . . . 0.0 109.764 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.522 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 19.3 t -79.58 63.07 4.06 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.368 -0.832 . . . . 0.0 110.634 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.842 HD12 ' N ' ' A' ' 108' ' ' VAL . 4.2 pp -82.37 -40.38 21.41 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.3 -0.875 . . . . 0.0 109.883 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.842 ' N ' HD12 ' A' ' 107' ' ' LEU . 2.0 t 70.64 118.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 42.53 84.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.621 -1.791 . . . . 0.0 108.621 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.824 HD21 ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -45.74 174.34 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.587 -0.949 . . . . 0.0 110.147 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.669 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 4.4 t-20 -152.77 0.54 0.28 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.979 -1.075 . . . . 0.0 112.069 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 79.78 -32.3 0.13 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.889 -1.132 . . . . 0.0 109.008 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -49.8 -26.51 3.99 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.571 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 9.2 m-20 -108.3 -17.62 13.96 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.809 -0.557 . . . . 0.0 109.872 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.824 ' CD1' HD21 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -91.77 144.32 29.21 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.134 -0.979 . . . . 0.0 109.853 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.531 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.8 Cg_endo -65.2 134.13 38.05 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.269 1.979 . . . . 0.0 109.962 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 118' ' ' ALA . 5.5 Cg_exo -60.65 -25.52 81.04 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.083 1.856 . . . . 0.0 110.731 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.91 -46.58 5.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.215 -0.928 . . . . 0.0 109.231 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.979 ' OD1' HD21 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -95.33 51.78 1.35 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.326 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.644 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -59.97 -44.15 96.1 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.621 -0.674 . . . . 0.0 112.358 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 6.2 Cg_exo -54.34 -32.89 74.13 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.013 1.809 . . . . 0.0 112.872 -177.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.695 HG11 ' CE2' ' A' ' 84' ' ' PHE . 2.4 t -101.41 -36.8 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.522 -1.361 . . . . 0.0 110.153 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.951 ' HA ' HD22 ' A' ' 126' ' ' LEU . 1.1 mp -61.93 -27.85 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.53 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -55.06 -35.08 64.14 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 125' ' ' LYS . 26.0 mmtp -80.11 -41.62 25.16 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.946 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.951 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -60.3 -22.0 62.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.335 -1.478 . . . . 0.0 107.448 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.537 ' HD3' ' CB ' ' A' ' 112' ' ' ALA . 6.3 mttt -57.36 -42.02 81.23 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -79.07 -18.98 52.45 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.634 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 2.5 tp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.984 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HE2' ' CD ' ' A' ' 5' ' ' GLN . 3.6 ttpm? . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 121.36 0.6 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 1.044 ' O ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -148.22 122.11 9.37 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.97 ' N ' HD22 ' A' ' 4' ' ' LEU . 2.9 mp0 -110.65 154.65 23.52 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.114 -0.991 . . . . 0.0 108.339 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.639 HG22 HG12 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -122.5 118.21 54.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.396 -178.805 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.124 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -85.52 60.76 6.44 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.709 HG13 ' H ' ' A' ' 9' ' ' GLY . 1.0 OUTLIER -79.16 -71.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.096 -179.203 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.709 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 59.84 82.23 0.07 OUTLIER Glycine 0 C--N 1.298 -1.57 0 N-CA-C 106.304 -2.719 . . . . 0.0 106.304 -177.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.575 ' O ' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -48.15 154.69 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -178.264 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.931 HG22 ' CG1' ' A' ' 87' ' ' VAL . 4.0 pt -116.48 102.27 13.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.886 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.769 ' HG2' HG23 ' A' ' 18' ' ' ILE . 8.6 mtm180 -76.65 -173.12 2.46 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.619 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -155.43 -66.32 0.12 Allowed 'General case' 0 C--O 1.188 -2.161 0 C-N-CA 116.826 -1.95 . . . . 0.0 114.267 -177.016 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.61 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 29.1 tp10 -91.51 -33.82 15.03 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 118.953 -2.342 . . . . 0.0 111.496 -175.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.483 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 41.8 t-20 -161.73 -42.08 0.04 OUTLIER 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.529 ' OD1' ' NH1' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -155.96 32.8 0.35 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 177.61 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 105' ' ' MET . 1.9 mm-40 -90.1 109.45 20.5 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 118.038 -1.465 . . . . 0.0 108.49 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.78 HD12 ' HB3' ' A' ' 105' ' ' MET . 0.2 OUTLIER -102.92 148.44 8.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.793 -177.558 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.627 ' CE2' ' HG2' ' A' ' 94' ' ' PRO . 20.4 t80 -81.54 38.34 0.49 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.733 HG21 HD22 ' A' ' 33' ' ' LEU . 6.1 tp -78.47 152.55 5.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.259 -0.901 . . . . 0.0 110.442 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.493 ' HB ' ' HD2' ' A' ' 101' ' ' PRO . 1.4 t -65.49 85.5 0.07 Allowed 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.511 ' O ' ' C ' ' A' ' 23' ' ' ARG . 21.2 tpt180 -87.38 93.59 9.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.688 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.939 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 28.55 76.63 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 120.986 0.422 . . . . 0.0 110.385 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.25 -47.52 4.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.363 -0.836 . . . . 0.0 109.105 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.25 155.1 26.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.869 . . . . 0.0 108.992 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -59.6 92.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.07 -1.018 . . . . 0.0 109.649 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.939 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -97.54 96.84 8.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -0.947 . . . . 0.0 109.947 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -48.95 -25.61 2.04 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.305 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.41 ' N ' ' C ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -72.06 -167.29 0.29 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.54 0.686 . . . . 0.0 109.477 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.528 ' O ' ' CB ' ' A' ' 31' ' ' ASN . . . -154.58 -157.98 0.81 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 0.7 OUTLIER 75.26 -2.7 2.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.059 -1.025 . . . . 0.0 109.074 -179.164 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -82.39 59.66 4.69 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.563 -0.71 . . . . 0.0 110.279 -179.534 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.733 HD22 HG21 ' A' ' 20' ' ' ILE . 12.0 mt -122.41 85.09 2.36 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.704 ' C ' HD11 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -80.8 -138.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.15 -1.593 . . . . 0.0 109.443 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.639 ' HB3' HG21 ' A' ' 8' ' ' VAL . 23.6 m-85 -154.22 123.98 3.26 Favored Pre-proline 0 N--CA 1.485 1.317 0 O-C-N 121.066 -1.021 . . . . 0.0 109.464 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.579 ' O ' HG23 ' A' ' 8' ' ' VAL . 2.1 Cg_endo -58.63 88.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.889 1.726 . . . . 0.0 109.464 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.544 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -57.12 -141.41 0.01 OUTLIER Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.569 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . 162.48 -55.35 0.3 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.569 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 99.04 69.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 123.11 0.564 . . . . 0.0 110.352 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.741 ' O ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -53.79 123.45 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.963 -1.086 . . . . 0.0 108.684 179.353 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 42' ' ' MET . 8.1 pt-20 -173.16 -22.52 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.647 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.438 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -38.82 -81.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.133 -0.979 . . . . 0.0 110.153 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.41 -122.95 2.25 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.69 9.07 1.97 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.531 -0.982 . . . . 0.0 109.124 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.553 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 60.4 m -126.01 142.41 42.38 Favored Pre-proline 0 N--CA 1.486 1.335 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.609 ' HG3' ' CZ3' ' A' ' 83' ' ' TRP . 3.6 Cg_exo -52.41 -15.7 4.25 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.545 1.497 . . . . 0.0 110.317 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.696 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.4 tt0 -75.97 -81.25 0.08 Allowed 'General case' 0 C--O 1.201 -1.486 0 O-C-N 120.983 -1.073 . . . . 0.0 108.638 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.544 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 1.3 mt-30 -47.75 -36.02 10.8 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.265 -1.522 . . . . 0.0 109.455 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.702 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -62.17 -64.17 1.01 Allowed 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.198 -0.939 . . . . 0.0 110.136 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.124 HG23 ' HB1' ' A' ' 7' ' ' ALA . 1.3 p -69.47 -49.81 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.305 -0.872 . . . . 0.0 110.657 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.696 HG12 ' O ' ' A' ' 47' ' ' GLU . 3.1 p -55.89 -37.12 46.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.745 -0.597 . . . . 0.0 110.421 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -78.96 -37.16 40.22 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 2.2 mm-40 -69.83 -14.23 62.65 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.006 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -80.08 -65.5 1.0 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.519 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.06 -49.8 74.74 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.697 -0.627 . . . . 0.0 110.479 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.611 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -46.64 -24.76 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.881 -1.137 . . . . 0.0 109.915 -178.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 8.0 mm-40 -80.13 -95.04 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.091 -1.005 . . . . 0.0 109.563 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.632 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 66.3 t -79.96 -79.36 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.098 -1.001 . . . . 0.0 109.911 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.99 37.58 0.09 OUTLIER Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.241 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.086 HG21 ' O ' ' A' ' 93' ' ' GLU . 2.9 pp -93.36 -152.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 120.793 -1.416 . . . . 0.0 108.542 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.829 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.3 m -161.7 -64.96 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 120.327 -1.483 . . . . 0.0 112.511 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 3.8 Cg_exo -51.59 -2.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.827 2.351 . . . . 0.0 114.267 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.508 ' N ' ' HA ' ' A' ' 90' ' ' TRP . 1.3 pt20 -34.89 -29.15 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 119.575 1.079 . . . . 0.0 110.791 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.578 ' N ' ' O ' ' A' ' 62' ' ' PRO . 2.2 t60 55.32 73.37 0.42 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.676 -1.265 . . . . 0.0 108.053 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 15.5 p90 -72.99 146.4 46.01 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.791 0.805 . . . . 0.0 111.179 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -144.4 135.37 25.13 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.257 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.629 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -61.46 -70.16 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.752 -1.217 . . . . 0.0 109.985 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.913 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 84.1 -52.51 0.13 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -178.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.9 mm-40 172.69 177.54 0.09 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.262 -0.899 . . . . 0.0 108.885 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HE2' HG22 ' A' ' 81' ' ' THR . 0.0 OUTLIER -161.37 -174.59 4.36 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.195 -0.941 . . . . 0.0 109.38 -179.389 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -149.02 175.79 11.0 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.135 -0.978 . . . . 0.0 109.986 179.106 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -144.06 89.16 2.01 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.15 123.16 27.11 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.24 156.3 17.3 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.294 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.585 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -133.22 174.13 5.07 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.585 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 5.4 Cg_exo -47.68 -33.35 18.44 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.696 1.597 . . . . 0.0 109.74 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.432 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -164.18 51.59 0.14 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.152 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.534 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -155.64 94.0 1.53 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.652 -0.655 . . . . 0.0 109.778 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.75 ' C ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -78.72 120.7 23.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.047 -1.033 . . . . 0.0 108.707 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.75 HD12 ' C ' ' A' ' 79' ' ' HIS . 1.3 mp -117.89 165.25 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 122.135 0.969 . . . . 0.0 110.592 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.598 ' N ' ' CG2' ' A' ' 80' ' ' ILE . 1.5 m -153.6 155.98 37.13 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.575 ' CD2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -148.49 77.04 1.38 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.912 -1.118 . . . . 0.0 110.301 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.609 ' CZ3' ' HG3' ' A' ' 46' ' ' PRO . 75.9 m95 -49.0 108.59 0.19 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.809 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.878 ' CG ' HG11 ' A' ' 122' ' ' VAL . 19.1 m-85 -85.06 69.81 10.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.134 -0.979 . . . . 0.0 109.593 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.684 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 71.0 m95 -74.23 87.53 1.96 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.905 -1.122 . . . . 0.0 109.361 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.913 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.3 mm? -70.07 126.98 31.26 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 120.67 -1.269 . . . . 0.0 109.573 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.931 ' CG1' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -101.52 179.98 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.01 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.494 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 42.8 mt-10 -153.28 1.69 0.27 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 117.735 -1.586 . . . . 0.0 113.219 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.593 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.32 71.27 0.44 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.002 -1.686 . . . . 0.0 110.95 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.619 ' CH2' ' HB2' ' A' ' 13' ' ' ASN . 2.8 p90 -78.87 165.64 23.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.418 -1.426 . . . . 0.0 110.036 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.573 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 1.5 pt-20 -86.98 137.6 32.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.206 -0.934 . . . . 0.0 109.824 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 41.1 -89.49 0.01 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 1.086 ' O ' HG21 ' A' ' 60' ' ' ILE . 12.6 pt-20 -103.9 162.54 19.64 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.199 -1.177 . . . . 0.0 109.745 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.835 ' HB3' HD12 ' A' ' 11' ' ' ILE . 10.1 Cg_endo -76.64 -155.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.58 2.187 . . . . 0.0 110.067 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 1.006 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER 179.48 49.64 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.336 -0.852 . . . . 0.0 110.56 179.115 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . -130.63 -2.92 4.75 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.078 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.499 ' N ' ' CD ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -56.92 99.47 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.242 -1.152 . . . . 0.0 110.29 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.474 ' HB2' ' C ' ' A' ' 37' ' ' GLY . 5.7 tp10 -82.1 84.43 7.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.114 -0.991 . . . . 0.0 108.821 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.07 16.95 65.05 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.507 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 2.8 pt20 -121.54 164.62 23.5 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.556 -0.967 . . . . 0.0 109.003 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 3.2 Cg_exo -65.65 -49.35 2.4 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 121.742 1.628 . . . . 0.0 109.79 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.622 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.94 119.27 0.01 OUTLIER Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.567 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 2.4 pt-20 -151.96 134.7 15.52 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.037 -1.273 . . . . 0.0 110.846 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.611 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 2.1 m0 -48.85 127.88 14.7 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.78 ' HB3' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -108.23 133.41 52.51 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -178.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.521 ' HA ' ' OE2' ' A' ' 17' ' ' GLU . 1.6 t -84.65 41.12 0.83 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.411 -1.431 . . . . 0.0 109.531 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.608 HD21 ' CA ' ' A' ' 110' ' ' LEU . 1.6 tt -82.54 150.96 26.64 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.483 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 48.4 t -119.52 132.32 69.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 109.293 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 129' ' ' LEU . . . 39.96 80.8 0.03 OUTLIER Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 1.083 HD22 ' CD2' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -41.87 163.71 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.479 -1.013 . . . . 0.0 110.072 -178.177 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.697 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 3.8 t30 -138.79 0.4 2.0 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 111.322 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 82.59 -33.62 0.09 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.221 -0.924 . . . . 0.0 108.632 -178.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -50.87 -28.91 10.55 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.512 -0.742 . . . . 0.0 109.044 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.562 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 8.5 m-20 -101.33 -19.41 15.64 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.538 -0.726 . . . . 0.0 109.406 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 1.083 ' CD2' HD22 ' A' ' 110' ' ' LEU . 1.3 m-85 -86.26 142.46 35.72 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.332 -0.855 . . . . 0.0 108.723 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.57 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.2 Cg_endo -62.94 146.28 94.78 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.276 1.984 . . . . 0.0 110.249 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.508 ' HA ' ' CD ' ' A' ' 120' ' ' GLU . 1.3 Cg_endo -64.4 -18.9 64.68 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.182 1.921 . . . . 0.0 110.994 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.66 -56.48 20.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.094 . . . . 0.0 110.09 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.877 ' O ' HD12 ' A' ' 123' ' ' ILE . 9.0 m-80 -91.62 44.96 1.2 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.094 -1.004 . . . . 0.0 109.852 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.709 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 1.3 tp10 -60.71 -47.07 96.94 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.442 -0.786 . . . . 0.0 112.156 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.709 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 24.6 Cg_exo -43.85 -48.14 9.33 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.115 1.877 . . . . 0.0 112.452 -177.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.878 HG11 ' CG ' ' A' ' 84' ' ' PHE . 2.5 t -91.67 -25.75 5.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 O-C-N 120.619 -1.301 . . . . 0.0 107.874 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.879 ' HA ' HD22 ' A' ' 126' ' ' LEU . 1.5 mt -69.42 -11.55 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.539 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -71.36 -27.68 63.53 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -80.24 -38.83 30.24 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.752 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.879 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -67.03 -22.87 65.86 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.525 -1.359 . . . . 0.0 107.719 179.299 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 2.7 mtmm -56.77 -31.46 64.65 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -89.82 -21.78 22.42 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.327 -0.852 . . . . 0.0 108.711 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 1.4 tp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.77 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.446 ' CG ' ' N ' ' A' ' 4' ' ' LEU . 2.1 ttpt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 121.45 0.643 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -160.48 160.0 31.5 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.133 -0.979 . . . . 0.0 109.161 178.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.794 ' HB2' HG23 ' A' ' 40' ' ' ILE . 15.3 mp0 -131.09 173.22 11.24 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.179 -0.951 . . . . 0.0 108.657 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.85 116.75 7.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 121.131 -0.98 . . . . 0.0 109.084 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.096 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -82.29 67.63 8.39 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.845 HG11 ' CD2' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -79.15 -76.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.273 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.697 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 65.3 78.48 0.22 Allowed Glycine 0 C--N 1.295 -1.697 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 -178.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.835 HD12 ' NH2' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -47.15 168.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -178.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.942 HG22 HG22 ' A' ' 87' ' ' VAL . 3.7 pt -140.38 93.85 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 120.859 -1.15 . . . . 0.0 110.083 -177.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.872 ' NH1' HD13 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -95.56 152.08 18.75 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.471 ' OD1' ' CH2' ' A' ' 90' ' ' TRP . 7.1 p-10 -161.08 -10.39 0.04 OUTLIER 'General case' 0 C--O 1.188 -2.182 0 C-N-CA 116.663 -2.015 . . . . 0.0 115.444 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.452 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -94.47 -31.16 14.07 Favored 'General case' 0 N--CA 1.51 2.548 0 O-C-N 118.047 -2.908 . . . . 0.0 108.458 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -162.8 -48.75 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 102.174 -3.269 . . . . 0.0 102.174 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.43 ' C ' ' OE1' ' A' ' 17' ' ' GLU . 16.9 t30 -162.03 38.31 0.12 Allowed 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 175.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -85.35 93.14 8.65 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.432 -1.307 . . . . 0.0 110.697 -177.056 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 2.0 pt -79.12 146.83 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.63 0.729 . . . . 0.0 111.063 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.687 ' HB3' HD11 ' A' ' 11' ' ' ILE . 6.3 t80 -82.75 43.68 0.86 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.837 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -80.67 151.11 4.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.07 0.938 . . . . 0.0 110.49 -178.274 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.695 ' O ' HG23 ' A' ' 21' ' ' THR . 5.3 t -66.56 91.34 0.18 Allowed 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.713 ' HD2' HD21 ' A' ' 33' ' ' LEU . 21.4 tpt180 -94.47 140.5 29.75 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.281 -0.887 . . . . 0.0 108.712 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.841 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -32.21 91.19 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . -42.82 -54.44 4.13 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.493 -0.754 . . . . 0.0 109.149 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.69 -163.09 0.53 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.712 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 73.2 m-20 -70.09 -49.96 45.72 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.908 -1.12 . . . . 0.0 109.805 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.841 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . 81.98 -24.16 0.19 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.346 -0.846 . . . . 0.0 110.212 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.498 ' O ' ' HG2' ' A' ' 29' ' ' MET . 0.1 OUTLIER 47.77 25.43 0.71 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.79 -1.193 . . . . 0.0 108.047 -178.723 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 28' ' ' HIS . 20.7 mmt -154.94 -167.68 2.65 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.545 ' HB1' ' OD1' ' A' ' 114' ' ' ASP . . . -153.09 -162.47 1.49 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 108.929 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 1.0 OUTLIER 77.18 -2.71 2.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.443 -0.786 . . . . 0.0 109.327 -179.625 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.656 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -82.09 55.34 2.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.47 -0.769 . . . . 0.0 110.097 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.713 HD21 ' HD2' ' A' ' 22' ' ' ARG . 6.6 mt -124.06 86.53 2.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.805 -1.184 . . . . 0.0 108.544 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.837 ' O ' HD11 ' A' ' 20' ' ' ILE . 4.6 tt0 -82.38 -123.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.078 -1.014 . . . . 0.0 110.32 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -161.38 123.68 1.75 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 120.646 -1.284 . . . . 0.0 109.277 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.777 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.9 Cg_endo -65.03 99.09 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.884 1.723 . . . . 0.0 109.725 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -95.02 -130.77 6.19 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.994 -1.098 . . . . 0.0 111.663 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.505 ' HA2' ' OE1' ' A' ' 98' ' ' GLU . . . 150.06 -8.65 0.81 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 15.2 tptm 72.78 106.13 0.07 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.39 0.614 . . . . 0.0 111.056 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.87 HG12 ' HB1' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -81.63 134.7 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.414 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 42' ' ' MET . 2.4 pt-20 -172.33 -29.37 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.216 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.428 ' O ' ' C ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -55.17 160.63 2.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.923 -1.111 . . . . 0.0 108.914 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.454 ' C ' ' HG2' ' A' ' 44' ' ' GLU . . . 46.35 -127.14 9.69 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.454 ' HG2' ' C ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -166.57 23.46 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.35 -1.088 . . . . 0.0 109.046 179.061 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.565 HG23 ' HD2' ' A' ' 46' ' ' PRO . 87.4 m -142.73 142.67 23.3 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.573 ' O ' HG12 ' A' ' 50' ' ' VAL . 9.0 Cg_exo -48.94 -16.8 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.899 1.732 . . . . 0.0 111.107 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.528 ' O ' HG12 ' A' ' 51' ' ' VAL . 4.8 mt-10 -78.5 -80.4 0.11 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.747 -1.221 . . . . 0.0 108.63 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.595 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 30.6 mt-30 -51.69 -23.94 5.07 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.396 -1.44 . . . . 0.0 109.164 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.87 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -72.1 -64.08 1.01 Allowed 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.484 -0.76 . . . . 0.0 109.737 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.096 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.6 p -70.06 -49.14 58.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.251 -0.906 . . . . 0.0 110.192 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.566 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 1.4 p -52.96 -44.62 50.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 O-C-N 121.749 -0.594 . . . . 0.0 110.292 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 7.8 mmt180 -73.57 -39.66 64.51 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.604 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 6.3 mm-40 -66.67 -15.12 63.27 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.792 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -80.19 -61.08 2.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -54.55 43.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.799 . . . . 0.0 109.906 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.568 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -46.0 -24.22 0.39 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -0.963 . . . . 0.0 109.658 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.44 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.2 mt-10 -79.99 -95.67 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.169 -0.957 . . . . 0.0 109.525 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.607 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 46.9 t -80.0 -78.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 110.109 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.12 24.19 0.12 Allowed Glycine 0 N--CA 1.494 2.507 0 C-N-CA 118.922 -1.609 . . . . 0.0 112.361 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.047 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.1 pp -84.38 -146.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.325 -1.691 . . . . 0.0 107.827 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.708 ' H ' HD12 ' A' ' 60' ' ' ILE . 1.2 m -161.03 -66.92 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 120.174 -1.579 . . . . 0.0 112.329 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.599 ' O ' ' CG ' ' A' ' 63' ' ' GLN . 10.2 Cg_exo -43.54 -94.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.169 1.912 . . . . 0.0 112.426 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.778 ' OE1' HG11 ' A' ' 87' ' ' VAL . 3.2 pt20 54.05 6.21 0.09 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.197 -0.939 . . . . 0.0 111.382 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.598 ' C ' ' O ' ' A' ' 63' ' ' GLN . 5.3 t-160 22.32 50.69 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.58 0 O-C-N 120.962 -1.086 . . . . 0.0 110.444 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 63' ' ' GLN . 1.7 p90 -35.52 141.34 0.08 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.091 0.948 . . . . 0.0 112.127 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -145.2 147.58 32.59 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.609 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -77.85 -65.28 0.99 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.79 -1.194 . . . . 0.0 110.13 -179.004 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.824 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 82.71 -51.33 0.18 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.302 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER 163.42 178.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 0.0 109.496 179.144 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.602 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 15.1 ptmt -160.96 170.3 20.86 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.301 -0.874 . . . . 0.0 109.727 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.74 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -136.16 171.58 14.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.098 179.582 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -150.09 94.15 2.11 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.01 122.23 26.48 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.599 ' HG3' ' CE1' ' A' ' 79' ' ' HIS . 15.0 tt0 -96.67 127.64 42.85 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.108 -0.995 . . . . 0.0 109.468 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.563 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 7.1 m-85 -106.7 168.34 8.24 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.362 -0.836 . . . . 0.0 109.17 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 7.5 Cg_exo -48.7 -28.48 12.68 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.943 1.762 . . . . 0.0 109.77 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.495 ' O ' ' HD2' ' A' ' 78' ' ' ARG . 8.0 m-20 -162.25 31.08 0.11 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.546 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.66 89.98 2.36 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.71 -0.619 . . . . 0.0 109.961 -178.804 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.859 ' C ' HD12 ' A' ' 80' ' ' ILE . 0.4 OUTLIER -89.86 113.3 24.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.911 -1.118 . . . . 0.0 109.126 179.58 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.859 HD12 ' C ' ' A' ' 79' ' ' HIS . 1.6 mp -118.54 155.71 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.974 -1.079 . . . . 0.0 110.446 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.551 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 1.9 m -136.14 137.84 41.39 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.845 ' CD2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -127.22 75.89 1.62 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.815 -1.178 . . . . 0.0 110.101 -179.206 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.602 ' CE3' ' HD2' ' A' ' 70' ' ' LYS . 92.2 m95 -51.79 111.24 0.57 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.265 -0.897 . . . . 0.0 109.45 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.548 ' O ' ' O ' ' A' ' 67' ' ' LEU . 45.5 m-85 -86.92 73.04 10.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.9 . . . . 0.0 110.178 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.697 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 12.7 m95 -71.94 85.76 0.99 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.819 -1.176 . . . . 0.0 108.328 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.824 HD23 ' CD2' ' A' ' 68' ' ' PHE . 2.8 mm? -67.78 125.78 27.33 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.478 -1.389 . . . . 0.0 110.024 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.942 HG22 HG22 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -112.29 169.81 4.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 38.8 mt-10 -160.54 29.59 0.16 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 117.972 -1.491 . . . . 0.0 112.552 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.581 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.85 30.19 0.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.329 -1.482 . . . . 0.0 109.943 179.235 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.67 ' HB2' HD13 ' A' ' 60' ' ' ILE . 1.6 p90 -48.96 148.78 2.12 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.951 -1.093 . . . . 0.0 109.967 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.574 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 1.6 tt0 -81.26 133.11 35.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.387 -0.821 . . . . 0.0 109.722 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 45.75 -86.89 0.01 OUTLIER Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 1.047 ' O ' HG21 ' A' ' 60' ' ' ILE . 17.1 pt-20 -100.6 161.89 22.51 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.301 -1.117 . . . . 0.0 110.051 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.621 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 13.9 Cg_endo -79.05 -162.6 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.772 2.315 . . . . 0.0 109.908 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.792 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER 177.8 26.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.218 -0.927 . . . . 0.0 111.011 178.574 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.407 ' HA2' ' CD1' ' A' ' 54' ' ' LEU . . . -93.88 -48.67 2.64 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.521 -1.323 . . . . 0.0 110.24 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.687 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -42.47 146.07 0.37 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -1.117 . . . . 0.0 111.243 -179.291 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.505 ' OE1' ' HA2' ' A' ' 38' ' ' GLY . 6.2 tp10 -81.08 -97.32 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.449 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . -108.64 3.95 32.51 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.547 ' HG2' ' HB2' ' A' ' 97' ' ' LYS . 3.1 pt20 -74.85 174.85 4.62 Favored Pre-proline 0 N--CA 1.482 1.166 0 O-C-N 121.826 -0.808 . . . . 0.0 109.199 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 102' ' ' GLY . 2.1 Cg_endo -69.63 -50.86 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.95 1.767 . . . . 0.0 109.591 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.604 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 61.78 114.38 0.01 OUTLIER Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.064 -2.015 . . . . 0.0 108.064 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.574 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 7.1 pt-20 -148.61 135.85 20.23 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.113 -1.228 . . . . 0.0 110.441 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.622 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 5.0 m0 -48.18 129.29 15.1 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -119.79 119.2 32.92 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.85 -1.157 . . . . 0.0 110.032 -178.646 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.35 68.12 5.26 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.884 HD13 ' HG ' ' A' ' 110' ' ' LEU . 7.4 tt -81.86 -54.36 5.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 109.188 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.633 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 48.6 t 86.29 112.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 40.3 83.79 0.01 OUTLIER Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 1.099 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -40.22 165.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.725 -0.868 . . . . 0.0 110.596 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.601 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 14.6 t30 -144.15 1.75 1.12 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.126 -0.984 . . . . 0.0 111.234 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.628 ' HB2' HG23 ' A' ' 123' ' ' ILE . . . 70.24 -3.42 1.82 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.914 -1.116 . . . . 0.0 109.282 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -80.95 -24.68 37.95 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.545 ' OD1' ' HB1' ' A' ' 30' ' ' ALA . 3.3 m-20 -102.11 -13.11 17.62 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 1.099 ' CE1' HD21 ' A' ' 110' ' ' LEU . 4.0 m-85 -95.08 150.98 38.49 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.293 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.54 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.3 Cg_endo -66.63 139.75 54.21 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.498 2.132 . . . . 0.0 109.63 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 118' ' ' ALA . 2.4 Cg_endo -61.93 -31.15 84.46 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.224 1.949 . . . . 0.0 111.179 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.64 -44.83 4.42 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.004 -1.06 . . . . 0.0 110.187 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.585 ' OD1' HD21 ' A' ' 71' ' ' LEU . 3.5 m-80 -99.16 51.61 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 109.273 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.672 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.4 mt-10 -69.36 -36.57 7.31 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.558 -0.714 . . . . 0.0 112.437 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.3 Cg_exo -56.35 -34.89 95.3 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.511 1.474 . . . . 0.0 112.047 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.542 HG11 ' CE1' ' A' ' 84' ' ' PHE . 1.7 t -99.77 -36.48 5.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.583 -1.323 . . . . 0.0 108.829 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.628 ' HA ' HD22 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -66.64 -15.56 19.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.565 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.52 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -62.83 -29.9 71.09 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.485 ' HE2' ' OE2' ' A' ' 69' ' ' GLU . 12.8 mmtm -81.53 -39.43 24.69 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.094 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.78 HD12 HD13 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -66.62 -22.05 66.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.733 -1.229 . . . . 0.0 108.195 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.612 ' HD2' ' HB3' ' A' ' 112' ' ' ALA . 1.7 mtmt -53.23 -31.13 41.75 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.03 -27.85 22.95 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.361 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.78 HD13 HD12 ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.681 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 79' ' ' HIS . 9.1 tttt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 121.428 0.632 . . . . 0.0 109.804 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 1.059 ' O ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -158.67 147.36 18.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.478 -0.764 . . . . 0.0 109.007 178.785 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.708 ' HB2' HG23 ' A' ' 40' ' ' ILE . 1.6 mp0 -111.7 170.13 8.35 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 109.094 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.607 HG23 ' HA3' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -135.04 108.15 9.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.202 -179.501 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.034 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -82.81 72.68 9.88 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.541 -0.725 . . . . 0.0 109.327 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.786 HG22 ' N ' ' A' ' 9' ' ' GLY . 0.2 OUTLIER -83.81 -84.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.415 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.786 ' N ' HG22 ' A' ' 8' ' ' VAL . . . 81.33 78.37 0.97 Allowed Glycine 0 C--N 1.299 -1.475 0 N-CA-C 106.947 -2.461 . . . . 0.0 106.947 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.697 ' O ' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -48.21 150.5 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -178.731 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.815 HG22 ' CG1' ' A' ' 87' ' ' VAL . 10.0 pt -120.48 75.87 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.394 -177.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 1.012 ' NH1' HD21 ' A' ' 129' ' ' LEU . 0.5 OUTLIER -79.69 153.95 28.94 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.46 ' OD1' ' CH2' ' A' ' 90' ' ' TRP . 2.6 p-10 -154.14 -20.98 0.13 Allowed 'General case' 0 C--O 1.187 -2.225 0 C-N-CA 117.218 -1.793 . . . . 0.0 114.901 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.577 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 3.4 tt0 -93.41 -32.31 14.29 Favored 'General case' 0 N--CA 1.511 2.605 0 O-C-N 118.076 -2.89 . . . . 0.0 109.486 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.52 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 61.9 t30 -161.68 -47.44 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 102.971 -2.974 . . . . 0.0 102.971 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.659 ' OD1' HD23 ' A' ' 129' ' ' LEU . 0.9 OUTLIER -161.87 38.07 0.13 Allowed 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 176.397 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.644 ' HA ' ' O ' ' A' ' 105' ' ' MET . 84.0 mt-10 -85.1 84.51 7.68 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.143 -1.423 . . . . 0.0 110.43 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.865 HG23 ' HB3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -78.97 153.85 4.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.434 0.635 . . . . 0.0 109.942 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.737 ' CB ' HD11 ' A' ' 11' ' ' ILE . 6.8 t80 -83.16 42.77 0.83 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.732 HD11 ' C ' ' A' ' 34' ' ' GLU . 5.5 tp -80.69 148.81 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-O 122.585 1.183 . . . . 0.0 111.734 -176.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.614 ' H ' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -58.43 89.41 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.259 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.593 ' O ' ' C ' ' A' ' 23' ' ' ARG . 32.0 tpt180 -97.24 91.89 5.75 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.724 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.836 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 13.68 79.4 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.356 0.598 . . . . 0.0 110.971 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -41.56 -56.05 2.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.424 -0.798 . . . . 0.0 110.287 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.75 -179.04 3.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.069 -1.019 . . . . 0.0 109.476 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.96 84.44 4.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.214 -0.929 . . . . 0.0 109.534 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.836 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -72.54 -36.92 68.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.243 -0.911 . . . . 0.0 109.324 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 49.92 23.57 1.1 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.583 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -117.12 -33.96 4.53 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.563 -0.711 . . . . 0.0 109.1 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.616 ' HB1' ' OD1' ' A' ' 114' ' ' ASP . . . 69.19 -177.65 0.21 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.437 -0.789 . . . . 0.0 109.822 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 1.1 t30 78.96 -8.63 1.62 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.523 -0.736 . . . . 0.0 109.523 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.567 ' HD2' ' CA ' ' A' ' 23' ' ' ARG . 4.8 tttp -83.29 51.47 1.98 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.385 -0.822 . . . . 0.0 110.227 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.944 HD13 HD21 ' A' ' 110' ' ' LEU . 17.4 mt -107.73 85.84 2.19 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.732 ' C ' HD11 ' A' ' 20' ' ' ILE . 1.5 tt0 -87.4 -137.28 0.09 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.388 -1.445 . . . . 0.0 109.614 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.679 ' CE2' ' CE1' ' A' ' 115' ' ' PHE . 10.9 m-85 -153.31 126.61 4.2 Favored Pre-proline 0 N--CA 1.486 1.364 0 O-C-N 121.048 -1.032 . . . . 0.0 109.586 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.726 ' O ' HG23 ' A' ' 8' ' ' VAL . 5.4 Cg_endo -65.64 89.17 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.011 1.807 . . . . 0.0 108.483 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.607 ' HA3' HG23 ' A' ' 6' ' ' ILE . . . -115.34 107.18 1.7 Allowed Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.714 -1.231 . . . . 0.0 111.525 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.513 ' HA2' ' CD ' ' A' ' 98' ' ' GLU . . . -82.14 16.81 20.61 Favored Glycine 0 N--CA 1.489 2.181 0 O-C-N 121.576 -0.955 . . . . 0.0 111.168 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.594 ' CD ' HD23 ' A' ' 4' ' ' LEU . 3.1 tptm 63.9 108.25 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 118.244 1.022 . . . . 0.0 110.984 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.034 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -80.37 138.67 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.924 -1.11 . . . . 0.0 109.017 178.691 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -172.28 -32.81 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.89 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.437 ' SD ' ' HB3' ' A' ' 52' ' ' ARG . 38.5 mtt -55.74 159.34 3.1 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.128 -0.982 . . . . 0.0 109.511 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.56 -130.5 9.39 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.16 24.44 0.11 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.435 -1.038 . . . . 0.0 108.749 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.54 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 27.4 m -136.82 140.86 33.03 Favored Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.574 ' HG3' ' CH2' ' A' ' 83' ' ' TRP . 7.1 Cg_exo -50.09 -20.35 5.2 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.815 1.677 . . . . 0.0 109.897 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 51' ' ' VAL . 3.2 mt-10 -75.72 -87.35 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.346 -0.846 . . . . 0.0 108.763 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.536 ' O ' ' CG ' ' A' ' 52' ' ' ARG . 42.3 mt-30 -41.72 -33.01 0.43 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.845 -1.159 . . . . 0.0 110.147 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.797 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -67.19 -63.26 1.1 Allowed 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.024 -1.047 . . . . 0.0 109.674 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.887 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.2 p -66.72 -49.38 75.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.645 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.573 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 4.1 p -57.31 -44.65 84.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.547 -0.721 . . . . 0.0 110.34 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.536 ' CG ' ' O ' ' A' ' 48' ' ' GLN . 14.9 mmt180 -72.05 -32.25 66.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.009 -1.057 . . . . 0.0 108.665 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.616 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 12.4 mm-40 -75.22 -15.96 60.51 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.949 HD12 ' CG ' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -79.97 -62.62 1.63 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.749 0.785 . . . . 0.0 108.997 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.49 ' N ' ' CZ3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.45 -51.74 68.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.784 -0.572 . . . . 0.0 109.691 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.598 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -47.15 -26.22 1.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.888 -1.133 . . . . 0.0 108.868 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 54' ' ' LEU . 3.6 mt-10 -80.05 -95.3 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.355 -0.841 . . . . 0.0 109.377 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.725 HG21 ' HA ' ' A' ' 95' ' ' TRP . 28.2 t -80.21 -78.91 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.304 -0.873 . . . . 0.0 110.321 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 138.2 32.5 0.21 Allowed Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.374 -1.394 . . . . 0.0 111.275 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.001 HD13 ' HB2' ' A' ' 90' ' ' TRP . 1.1 pp -90.75 -152.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.589 -1.536 . . . . 0.0 108.278 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.72 ' H ' HD12 ' A' ' 60' ' ' ILE . 1.6 m -162.23 -63.16 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.349 -1.469 . . . . 0.0 112.73 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.639 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 6.3 Cg_exo -55.9 0.62 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.537 2.158 . . . . 0.0 114.373 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.834 HE21 ' HZ2' ' A' ' 95' ' ' TRP . 4.4 pt20 -39.18 -27.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.623 -1.298 . . . . 0.0 110.289 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 62' ' ' PRO . 1.9 t60 51.84 88.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.429 ' HE2' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -88.87 159.31 17.76 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.377 1.084 . . . . 0.0 111.901 -177.594 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -153.64 141.15 19.81 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.242 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.614 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -63.31 -67.22 0.44 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.878 -1.139 . . . . 0.0 110.272 -178.688 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.666 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 84.05 -51.75 0.13 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.264 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.578 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 4.9 tp10 159.54 135.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.563 ' HE3' ' CD2' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -125.6 -177.76 4.02 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.467 -0.771 . . . . 0.0 109.515 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -136.51 -177.41 4.71 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.341 -0.85 . . . . 0.0 109.938 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -151.71 86.16 1.32 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.15 104.01 9.48 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -95.18 154.41 17.2 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.416 -0.914 . . . . 0.0 108.587 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.577 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -141.73 173.09 5.1 Favored Pre-proline 0 C--N 1.297 -1.677 0 O-C-N 121.214 -0.929 . . . . 0.0 109.104 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 7.3 Cg_exo -48.23 -39.39 34.54 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 121.776 1.651 . . . . 0.0 109.703 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.452 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 4.7 p-10 -148.21 35.14 0.81 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.476 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -142.73 78.95 1.63 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.549 -0.719 . . . . 0.0 110.077 -178.745 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.953 ' C ' HD12 ' A' ' 80' ' ' ILE . 1.8 m-70 -82.35 119.58 24.33 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.953 HD12 ' C ' ' A' ' 79' ' ' HIS . 2.3 mp -129.69 162.75 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 118.793 -1.163 . . . . 0.0 111.433 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.602 ' N ' HG22 ' A' ' 80' ' ' ILE . 2.0 m -147.32 148.84 31.8 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.32 82.96 1.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.716 -1.24 . . . . 0.0 110.348 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.694 ' CD1' HG21 ' A' ' 40' ' ' ILE . 89.8 m95 -54.05 111.76 0.82 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.267 -0.896 . . . . 0.0 109.034 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.653 ' CE2' HG11 ' A' ' 122' ' ' VAL . 11.6 m-85 -88.6 68.05 8.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.247 -0.908 . . . . 0.0 109.793 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.641 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 75.3 m95 -72.36 84.29 1.08 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.794 -1.191 . . . . 0.0 109.747 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.697 HD13 ' O ' ' A' ' 10' ' ' ILE . 3.2 mm? -68.07 129.44 39.91 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.566 -1.334 . . . . 0.0 109.942 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.815 ' CG1' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -111.2 -175.08 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.653 ' N ' HG23 ' A' ' 87' ' ' VAL . 1.2 mt-10 -159.89 8.13 0.1 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 117.612 -1.635 . . . . 0.0 113.54 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.572 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.73 71.96 0.44 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 119.855 -1.778 . . . . 0.0 110.651 178.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 1.001 ' HB2' HD13 ' A' ' 60' ' ' ILE . 17.4 p90 -80.69 163.0 23.9 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.718 -1.239 . . . . 0.0 110.191 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.648 ' O ' ' N ' ' A' ' 93' ' ' GLU . 5.0 pt-20 -81.81 135.53 35.45 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.179 -0.951 . . . . 0.0 109.762 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 35.02 -80.34 0.0 OUTLIER Glycine 0 N--CA 1.502 3.088 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.966 ' O ' HG21 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -98.82 153.32 37.92 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.333 -1.098 . . . . 0.0 109.219 -179.572 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.64 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 20.2 Cg_endo -80.85 -159.07 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.787 2.325 . . . . 0.0 110.025 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.949 ' CG ' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER 178.58 132.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.771 0.796 . . . . 0.0 110.017 178.184 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . 152.93 -40.04 0.72 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.509 ' N ' ' CD ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -41.09 107.51 0.07 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.517 -0.99 . . . . 0.0 109.526 -179.528 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 5.5 tp10 -77.38 87.28 3.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.273 -0.892 . . . . 0.0 108.712 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.35 30.71 65.04 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.497 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 7.4 pt20 -125.96 168.08 15.05 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.475 -1.015 . . . . 0.0 109.299 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 9.8 Cg_endo -78.21 42.6 1.24 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.562 2.175 . . . . 0.0 110.842 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.57 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . -44.78 123.82 5.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.615 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -146.79 144.38 29.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -1.118 . . . . 0.0 109.8 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.48 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 1.2 m-90 -52.35 139.84 23.47 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.968 -1.083 . . . . 0.0 108.225 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.644 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -139.06 108.85 6.26 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.286 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.524 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -81.33 46.79 0.97 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.597 -0.689 . . . . 0.0 109.351 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 1.066 HD22 ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -64.72 -12.7 49.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 108.859 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.879 ' N ' HD13 ' A' ' 107' ' ' LEU . 1.4 t 59.63 121.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.452 -0.78 . . . . 0.0 110.189 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.634 ' HA2' ' HB3' ' A' ' 129' ' ' LEU . . . 38.12 74.06 0.13 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 1.188 HD22 ' CD2' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -38.19 158.24 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.914 -0.756 . . . . 0.0 109.905 -178.193 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.88 ' H ' HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -154.76 143.77 20.98 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.139 -0.976 . . . . 0.0 110.182 -178.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . . . -44.07 -27.84 0.42 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -42.07 -53.93 3.76 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.317 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.616 ' OD1' ' HB1' ' A' ' 30' ' ' ALA . 14.3 m-20 -97.94 -9.75 25.7 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 1.188 ' CD2' HD22 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -91.96 136.92 25.55 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.543 -0.723 . . . . 0.0 109.754 -179.26 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' A' ' 123' ' ' ILE . 2.5 Cg_endo -68.24 153.6 74.14 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.373 2.049 . . . . 0.0 110.22 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 118' ' ' ALA . 1.7 Cg_endo -65.12 -36.37 37.53 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.212 1.941 . . . . 0.0 110.817 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -39.37 -47.79 1.81 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.408 -0.807 . . . . 0.0 110.123 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.596 ' O ' HD12 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -98.64 55.83 1.09 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.372 -0.83 . . . . 0.0 109.034 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.651 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -69.13 -47.17 29.53 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.722 -0.611 . . . . 0.0 111.688 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 8.2 Cg_exo -52.25 -40.12 70.55 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.194 1.929 . . . . 0.0 112.846 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.653 HG11 ' CE2' ' A' ' 84' ' ' PHE . 2.2 t -98.21 -34.05 4.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 O-C-N 120.642 -1.286 . . . . 0.0 109.5 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.855 HD13 ' HB3' ' A' ' 115' ' ' PHE . 31.4 mt -59.0 -29.18 40.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.539 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -59.44 -35.08 73.35 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.928 0.871 . . . . 0.0 109.129 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.0 mmmt -77.68 -35.58 52.11 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.567 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 1.099 HD23 ' CE2' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -66.71 -34.62 78.26 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.158 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 7.1 mtpt -45.4 -29.01 0.97 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.568 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -91.2 -34.65 14.91 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.297 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 1.012 HD21 ' NH1' ' A' ' 12' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.508 2.426 0 CA-C-O 118.035 -0.983 . . . . 0.0 111.635 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.422 ' CG ' ' N ' ' A' ' 4' ' ' LEU . 15.1 tttt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.333 0.587 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 1.07 ' O ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -158.38 143.84 16.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.808 . . . . 0.0 109.278 179.105 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.653 ' HB2' HG23 ' A' ' 40' ' ' ILE . 1.4 mp0 -113.53 166.74 11.21 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.86 -1.15 . . . . 0.0 108.394 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.532 ' CG2' ' HA2' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -127.23 110.95 23.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.957 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -81.85 68.55 8.27 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.745 HG22 ' N ' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -79.47 -83.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.465 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.745 ' N ' HG22 ' A' ' 8' ' ' VAL . . . 75.61 82.3 0.48 Allowed Glycine 0 N--CA 1.479 1.517 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 -178.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.607 ' O ' HD13 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -49.13 157.2 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.939 HG22 HG22 ' A' ' 87' ' ' VAL . 1.6 pt -124.54 85.27 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.866 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -77.51 167.75 21.12 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.2 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.487 ' OD1' ' HB2' ' A' ' 17' ' ' GLU . 2.0 p-10 -161.94 -26.11 0.05 OUTLIER 'General case' 0 C--O 1.185 -2.31 0 C-N-CA 115.966 -2.294 . . . . 0.0 114.889 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HB3' ' OE2' ' A' ' 17' ' ' GLU . 4.9 tt0 -95.01 -34.22 12.43 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 118.36 -2.712 . . . . 0.0 109.132 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -162.35 -45.95 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 103.211 -2.885 . . . . 0.0 103.211 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.67 ' OD1' HD23 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -160.37 36.2 0.17 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 176.511 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -88.14 98.95 11.84 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.088 -1.445 . . . . 0.0 109.234 -178.474 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.604 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -92.34 150.09 3.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.927 0.87 . . . . 0.0 111.265 -178.414 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.657 ' CE1' ' HA ' ' A' ' 103' ' ' GLU . 14.3 t80 -82.2 43.71 0.81 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.721 HD11 ' C ' ' A' ' 34' ' ' GLU . 5.1 tp -81.02 154.96 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-O 122.053 0.93 . . . . 0.0 111.269 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.52 ' H ' HD12 ' A' ' 20' ' ' ILE . 1.4 t -66.14 93.72 0.22 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.739 ' HD3' HD21 ' A' ' 33' ' ' LEU . 23.7 tpt180 -102.05 149.01 24.69 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.668 -0.645 . . . . 0.0 109.601 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.866 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -34.34 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . -46.55 -54.34 9.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.382 -0.823 . . . . 0.0 110.393 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.49 -151.1 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.006 -1.058 . . . . 0.0 109.204 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.35 -51.39 10.92 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.292 -0.88 . . . . 0.0 109.066 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.866 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . 57.7 -168.45 0.12 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.639 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -162.34 -35.07 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.648 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 1.5 mpt? -49.61 -46.44 49.31 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.337 -0.852 . . . . 0.0 109.398 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 29' ' ' MET . . . 72.34 5.63 5.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.288 -0.883 . . . . 0.0 109.456 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -98.65 11.64 37.85 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.24 -0.912 . . . . 0.0 108.853 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -81.8 54.78 2.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.602 -0.686 . . . . 0.0 110.402 -179.639 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.739 HD21 ' HD3' ' A' ' 22' ' ' ARG . 15.0 mt -122.49 84.55 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.64 -1.287 . . . . 0.0 109.666 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.721 ' C ' HD11 ' A' ' 20' ' ' ILE . 1.4 tt0 -82.84 -136.86 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.987 -1.071 . . . . 0.0 109.983 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.711 ' HE2' HD11 ' A' ' 123' ' ' ILE . 77.7 m-85 -152.0 125.37 4.22 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.124 -0.985 . . . . 0.0 109.338 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.648 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -58.09 90.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.616 1.544 . . . . 0.0 109.127 178.663 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.532 ' HA2' ' CG2' ' A' ' 6' ' ' ILE . . . -56.27 -142.46 0.01 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 154.56 -33.3 0.69 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 69.89 97.02 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 122.185 -0.597 . . . . 0.0 109.397 -179.519 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.957 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -80.23 132.62 31.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.794 179.346 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.504 ' HB3' ' NZ ' ' A' ' 39' ' ' LYS . 6.6 pt-20 -170.67 -34.14 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.47 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -47.85 147.16 2.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.337 -0.852 . . . . 0.0 109.54 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 53.03 -120.92 13.76 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.06 23.07 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.647 -0.914 . . . . 0.0 109.125 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.458 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 56.1 m -138.68 139.13 23.34 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.609 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 14.2 Cg_exo -49.3 -17.25 1.45 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.004 1.803 . . . . 0.0 110.606 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.49 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.4 mt-10 -77.89 -83.14 0.08 Allowed 'General case' 0 C--O 1.203 -1.352 0 O-C-N 120.934 -1.104 . . . . 0.0 108.557 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.527 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 36.9 mt-30 -45.67 -33.62 3.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.502 -1.374 . . . . 0.0 109.54 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.732 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -65.2 -63.34 1.13 Allowed 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.452 -0.78 . . . . 0.0 110.24 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.814 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.4 p -68.82 -48.99 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.912 -1.118 . . . . 0.0 110.607 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.575 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 2.3 p -54.63 -44.06 68.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 121.371 0.605 . . . . 0.0 110.295 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.551 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 18.7 mmt180 -74.87 -34.49 62.26 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.642 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 20.8 mm-40 -71.21 -13.39 61.9 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.006 HD12 ' NE1' ' A' ' 95' ' ' TRP . 1.1 mm? -79.34 -64.31 1.22 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.519 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.12 -51.49 69.1 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.54 -0.725 . . . . 0.0 110.187 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.59 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 1.3 pp20? -50.18 -21.08 1.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.052 -1.03 . . . . 0.0 110.479 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -80.14 -92.22 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.918 -1.114 . . . . 0.0 110.038 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.789 HG21 ' HA ' ' A' ' 95' ' ' TRP . 21.0 t -79.98 -79.17 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.426 -0.796 . . . . 0.0 109.678 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.54 22.72 0.1 Allowed Glycine 0 N--CA 1.495 2.605 0 C-N-CA 118.485 -1.817 . . . . 0.0 112.554 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.094 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.6 pp -82.93 -166.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.283 -1.716 . . . . 0.0 108.031 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.67 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 2.0 m -123.36 -71.73 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.434 -1.416 . . . . 0.0 110.844 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.67 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 5.7 Cg_endo -64.19 -170.82 0.13 Allowed 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.078 1.185 . . . . 0.0 109.707 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.601 ' HG2' ' CZ2' ' A' ' 95' ' ' TRP . 0.7 OUTLIER 139.54 -23.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -179.204 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.537 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 1.9 t60 57.23 -167.41 0.13 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' A' ' 64' ' ' HIS . 28.3 p90 -179.38 150.83 0.45 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.414 -1.314 . . . . 0.0 110.676 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -159.35 141.89 13.9 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.61 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -65.95 -66.71 0.52 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.04 -1.037 . . . . 0.0 109.313 -179.507 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.871 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 85.38 -55.07 0.09 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.576 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.562 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 9.5 tp10 169.62 151.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.613 ' HA ' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -143.67 -164.53 1.89 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.847 -1.158 . . . . 0.0 109.295 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.675 HD12 ' C ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -150.96 -177.13 5.83 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.208 -0.933 . . . . 0.0 110.419 -179.643 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -149.51 90.78 1.75 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -78.21 108.35 11.46 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.433 ' HG3' ' NE2' ' A' ' 79' ' ' HIS . 25.0 tt0 -92.62 99.57 12.25 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.488 -0.758 . . . . 0.0 110.158 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.52 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -79.26 170.97 13.75 Favored Pre-proline 0 C--N 1.301 -1.503 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.338 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.52 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 5.5 Cg_exo -51.89 -55.02 4.31 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.872 1.715 . . . . 0.0 109.606 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.04 35.88 4.08 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.513 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -144.31 91.52 2.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.521 -0.737 . . . . 0.0 109.682 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.498 ' C ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -82.15 90.99 6.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.752 -1.218 . . . . 0.0 109.087 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.761 HG13 HD11 ' A' ' 4' ' ' LEU . 1.0 OUTLIER -98.84 157.28 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.005 -1.059 . . . . 0.0 110.272 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.608 ' N ' HG22 ' A' ' 80' ' ' ILE . 2.2 m -136.34 170.6 15.77 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.651 HD22 ' OD1' ' A' ' 119' ' ' ASN . 0.2 OUTLIER -159.5 85.8 0.79 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.601 -1.312 . . . . 0.0 110.035 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.604 ' CD1' HG21 ' A' ' 40' ' ' ILE . 97.3 m95 -65.43 115.12 5.35 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.786 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.873 ' CD2' HG11 ' A' ' 122' ' ' VAL . 10.1 m-85 -89.56 71.32 7.91 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.938 -1.101 . . . . 0.0 109.606 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.693 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 88.4 m95 -72.28 87.81 1.14 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.015 -1.053 . . . . 0.0 109.149 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.871 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.0 mm? -68.39 130.16 42.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.755 -1.216 . . . . 0.0 110.121 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.939 HG22 HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -117.61 176.89 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.061 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.551 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 23.4 mt-10 -159.76 28.88 0.19 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.386 -1.446 . . . . 0.0 112.944 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.595 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -159.62 57.98 0.38 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 119.878 -1.764 . . . . 0.0 111.721 178.766 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.588 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 2.4 p90 -79.15 162.37 25.83 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.222 -1.549 . . . . 0.0 109.267 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.629 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -92.94 145.86 24.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.999 -1.063 . . . . 0.0 109.583 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 39.29 -87.51 0.01 OUTLIER Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 1.094 ' O ' HG21 ' A' ' 60' ' ' ILE . 2.8 pt-20 -105.34 157.04 35.3 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.235 -1.156 . . . . 0.0 109.868 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.61 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 10.6 Cg_endo -75.59 -159.07 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.93 2.42 . . . . 0.0 110.263 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 1.006 ' NE1' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -179.56 66.16 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.291 -0.881 . . . . 0.0 110.36 178.789 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . -139.07 -33.71 0.17 Allowed Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.367 -1.397 . . . . 0.0 110.688 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.588 ' HG3' ' CE2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -39.62 106.79 0.06 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.129 -1.218 . . . . 0.0 110.496 -179.063 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.504 ' HB2' ' C ' ' A' ' 37' ' ' GLY . 8.0 tp10 -80.43 100.59 8.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.265 -0.897 . . . . 0.0 109.139 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 54.12 21.96 19.66 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.587 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 7.8 pt20 -122.75 170.82 7.41 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.497 -1.002 . . . . 0.0 108.868 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.587 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 4.2 Cg_exo -63.14 -46.14 10.87 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.0 1.8 . . . . 0.0 110.785 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.58 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 59.69 112.81 0.01 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.657 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 5.2 pt-20 -152.76 137.25 16.76 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.136 -1.214 . . . . 0.0 110.493 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.499 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 1.7 m-90 -48.64 135.7 14.32 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.602 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -125.85 115.65 20.32 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.197 -0.939 . . . . 0.0 109.521 -179.055 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.469 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -82.54 57.81 3.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 110.015 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.854 HD21 ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -80.69 -41.28 23.95 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.168 -0.958 . . . . 0.0 108.417 179.421 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.794 ' N ' HD23 ' A' ' 107' ' ' LEU . 86.4 t 70.13 126.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.854 -0.529 . . . . 0.0 109.938 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 41.18 81.43 0.03 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 1.158 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -42.79 166.7 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.487 -1.008 . . . . 0.0 110.545 -178.696 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.685 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -143.9 -7.34 0.74 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.325 -0.859 . . . . 0.0 111.846 -178.463 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 81.02 -31.53 0.11 Allowed 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.91 -1.119 . . . . 0.0 109.024 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.3 -16.83 15.74 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.453 -0.779 . . . . 0.0 109.099 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.582 ' HB3' HD12 ' A' ' 33' ' ' LEU . 2.0 m-20 -111.67 -12.86 13.84 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.599 -0.688 . . . . 0.0 109.919 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 1.158 ' CE1' HD21 ' A' ' 110' ' ' LEU . 7.5 m-85 -100.7 148.77 35.47 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.905 . . . . 0.0 109.808 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.58 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 3.5 Cg_exo -64.04 142.1 79.73 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.642 2.228 . . . . 0.0 110.547 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 2.3 Cg_endo -62.9 -19.97 70.2 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.04 1.826 . . . . 0.0 110.08 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -45.92 -51.02 13.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 109.25 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.754 ' O ' HD12 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -94.85 54.68 1.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.629 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 2.4 mt-10 -64.8 -45.71 75.2 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 2.8 Cg_exo -54.84 -35.38 88.46 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.907 1.738 . . . . 0.0 112.92 -177.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.873 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.1 t -100.34 -31.94 3.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.579 -1.325 . . . . 0.0 109.243 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.928 ' HA ' HD22 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -61.7 -26.99 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.526 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -55.77 -37.63 68.8 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 29.1 mmtm -78.09 -35.86 48.79 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.861 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.928 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.6 -21.71 66.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.45 -1.406 . . . . 0.0 107.334 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 7.2 mtmt -57.69 -35.21 70.3 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 177.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 125' ' ' LYS . 4.2 mtp180 -82.34 -22.97 35.32 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.429 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.67 HD23 ' OD1' ' A' ' 16' ' ' ASN . 1.3 tp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.473 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.541 ' HG2' ' N ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.695 0.76 . . . . 0.0 109.938 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.967 ' O ' HD13 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -138.25 125.94 22.25 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.773 ' N ' HD22 ' A' ' 4' ' ' LEU . 0.9 OUTLIER -96.25 164.52 12.63 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.313 -1.492 . . . . 0.0 110.091 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.726 HG22 HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -131.2 117.82 38.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.495 -0.753 . . . . 0.0 109.046 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.048 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -86.61 63.17 7.83 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 36' ' ' PRO . 1.3 p -78.42 -72.43 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 109.735 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.768 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 57.38 87.65 0.02 OUTLIER Glycine 0 N--CA 1.479 1.528 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.602 ' CG1' HD11 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -47.77 168.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.238 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.062 HG22 ' CG2' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -131.04 94.62 2.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 O-C-N 121.181 -0.949 . . . . 0.0 109.33 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.61 ' HG2' HG22 ' A' ' 18' ' ' ILE . 13.9 mtm180 -75.82 177.36 6.99 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.598 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -151.44 -60.98 0.17 Allowed 'General case' 0 C--O 1.191 -1.977 0 C-N-CA 116.783 -1.967 . . . . 0.0 114.367 -176.296 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.506 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -92.32 -29.65 16.25 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 119.204 -2.185 . . . . 0.0 111.091 -176.124 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -162.16 -43.04 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.635 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -157.43 34.02 0.28 Allowed 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.359 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 105' ' ' MET . 17.1 mt-10 -82.01 87.36 6.45 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 118.005 -1.478 . . . . 0.0 108.88 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -80.0 147.96 6.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.395 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.667 ' CZ ' ' HG2' ' A' ' 94' ' ' PRO . 7.8 t80 -81.68 45.05 0.86 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.693 HD11 ' N ' ' A' ' 34' ' ' GLU . 6.6 tp -79.0 151.78 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-O 122.437 1.113 . . . . 0.0 111.575 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.517 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -68.86 84.47 0.31 Allowed 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.438 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.695 ' HD2' HD21 ' A' ' 33' ' ' LEU . 18.2 tpt180 -79.24 84.98 5.13 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.016 -1.053 . . . . 0.0 109.822 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.753 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 1.5 ptt180 31.94 62.9 0.27 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.275 0.56 . . . . 0.0 110.319 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -41.92 -41.8 2.57 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.691 -0.631 . . . . 0.0 109.354 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' A' ' 23' ' ' ARG . . . -80.57 -179.96 7.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 109.195 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 26' ' ' ASP . 3.6 p30 -78.79 112.86 16.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 109.328 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.753 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -112.27 -30.18 7.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 109.841 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 49.65 28.38 2.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.011 -1.055 . . . . 0.0 108.448 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.712 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 30.8 mmm -140.03 -100.01 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.392 -0.818 . . . . 0.0 109.976 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 152.13 -169.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER 78.84 -8.78 1.6 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.158 -0.964 . . . . 0.0 109.03 -179.312 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.613 ' O ' HD23 ' A' ' 33' ' ' LEU . 5.2 tptt -83.4 55.93 3.37 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.671 -0.643 . . . . 0.0 109.857 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.695 HD21 ' HD2' ' A' ' 22' ' ' ARG . 7.1 mt -120.04 93.09 3.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.288 -0.882 . . . . 0.0 108.779 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.693 ' N ' HD11 ' A' ' 20' ' ' ILE . 3.0 tt0 -88.56 -126.76 0.06 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.876 -1.14 . . . . 0.0 110.786 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.734 ' HB3' HG21 ' A' ' 8' ' ' VAL . 98.9 m-85 -160.07 128.72 3.01 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.756 -1.215 . . . . 0.0 110.247 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.898 ' O ' HG23 ' A' ' 8' ' ' VAL . 3.7 Cg_endo -64.79 97.28 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.113 1.875 . . . . 0.0 109.727 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.562 ' CA ' ' HB2' ' A' ' 98' ' ' GLU . . . -55.51 -153.15 0.01 OUTLIER Glycine 0 N--CA 1.492 2.405 0 O-C-N 121.298 -0.876 . . . . 0.0 111.013 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 163.86 -33.67 0.28 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.709 ' CD ' HD21 ' A' ' 4' ' ' LEU . 10.4 tptm 65.85 101.28 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.95 -0.735 . . . . 0.0 110.253 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.838 ' O ' HD13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -80.42 135.44 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.039 -1.038 . . . . 0.0 108.693 178.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.544 ' HG3' ' N ' ' A' ' 42' ' ' MET . 6.9 pt-20 -171.12 -31.99 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.422 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.544 ' N ' ' HG3' ' A' ' 41' ' ' GLU . 1.7 mtt -62.08 151.89 34.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.065 -1.022 . . . . 0.0 109.842 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.98 -127.54 43.14 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.35 21.05 0.1 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.443 -1.034 . . . . 0.0 109.209 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.919 HG22 ' H ' ' A' ' 47' ' ' GLU . 1.8 m -147.01 140.78 15.27 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.613 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 11.0 Cg_exo -45.24 -18.6 0.28 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.067 1.845 . . . . 0.0 111.268 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.919 ' H ' HG22 ' A' ' 45' ' ' THR . 0.5 OUTLIER -76.87 -80.18 0.1 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.507 -1.37 . . . . 0.0 108.879 178.846 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.58 ' O ' ' CG ' ' A' ' 52' ' ' ARG . 60.0 mt-30 -48.58 -33.45 9.75 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.087 -1.633 . . . . 0.0 109.207 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.736 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -64.31 -63.6 1.1 Allowed 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.193 -0.942 . . . . 0.0 110.29 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.048 HG23 ' HB1' ' A' ' 7' ' ' ALA . 1.7 p -68.7 -48.87 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.142 -0.974 . . . . 0.0 110.57 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.9 p -56.03 -39.0 55.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-O 121.189 0.519 . . . . 0.0 110.357 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.58 ' CG ' ' O ' ' A' ' 48' ' ' GLN . 18.3 mmt180 -78.65 -32.99 47.47 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.606 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 24.3 mm-40 -71.89 -12.84 61.46 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.831 HD12 ' CE2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -80.09 -55.34 5.01 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.645 0.736 . . . . 0.0 109.331 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.453 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 2.6 pp0? -69.38 -33.92 73.76 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.691 -0.631 . . . . 0.0 111.173 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.606 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -64.26 -25.8 68.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.821 -1.175 . . . . 0.0 111.385 -177.869 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.539 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -80.34 -80.8 0.13 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.499 -1.375 . . . . 0.0 109.887 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.582 HG21 ' HA ' ' A' ' 95' ' ' TRP . 69.9 t -80.17 -82.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.145 -0.972 . . . . 0.0 109.463 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.95 21.66 0.12 Allowed Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.632 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.957 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.1 pt -80.17 -144.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.496 -1.591 . . . . 0.0 108.395 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.665 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 2.1 m -151.36 -71.46 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 120.474 -1.392 . . . . 0.0 110.965 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.665 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 1.0 OUTLIER -60.4 -173.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.934 0 C-N-CA 121.082 1.188 . . . . 0.0 109.918 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 1.5 pt20 152.04 -23.55 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.648 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER 47.35 61.64 2.8 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.336 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.43 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 5.1 p90 -60.78 155.43 19.4 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.886 0.851 . . . . 0.0 110.735 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -152.51 139.24 18.85 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.169 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.588 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -66.31 -67.15 0.47 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.854 -1.154 . . . . 0.0 109.814 -179.048 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.774 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 81.75 -48.94 0.23 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.281 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER 164.42 176.54 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.093 -1.004 . . . . 0.0 108.412 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.562 ' HE3' ' CE3' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -161.58 175.04 12.51 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.948 -1.095 . . . . 0.0 110.161 -179.542 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.801 HD21 ' OD1' ' A' ' 119' ' ' ASN . 0.3 OUTLIER -136.73 -179.12 5.5 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.387 -0.821 . . . . 0.0 109.758 179.402 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.596 ' HG3' HG23 ' A' ' 81' ' ' THR . 7.6 tt0 -154.75 90.23 1.29 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.09 162.77 22.41 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -118.0 161.08 20.39 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.551 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.652 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -128.98 179.48 1.28 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.652 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 6.9 Cg_exo -52.69 -24.05 21.97 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.522 1.481 . . . . 0.0 109.787 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.441 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 2.2 p30 -171.13 32.55 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.493 ' NH2' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -141.28 93.74 2.61 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.705 -0.622 . . . . 0.0 110.151 -178.913 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 3' ' ' LYS . 0.9 OUTLIER -79.1 93.08 5.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.037 -1.039 . . . . 0.0 108.384 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.738 HG23 HD12 ' A' ' 4' ' ' LEU . 13.3 mm -83.95 157.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.263 1.03 . . . . 0.0 111.486 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.596 HG23 ' HG3' ' A' ' 72' ' ' GLU . 2.4 m -131.0 155.27 47.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.561 HD12 ' HB ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -141.83 83.92 1.87 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.495 -1.378 . . . . 0.0 110.72 -179.106 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.604 ' CZ3' ' HG3' ' A' ' 46' ' ' PRO . 72.5 m95 -55.74 109.54 0.58 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.939 -1.101 . . . . 0.0 109.162 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.797 ' CD2' HG11 ' A' ' 122' ' ' VAL . 35.7 m-85 -86.79 75.04 9.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.02 -1.05 . . . . 0.0 109.72 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.667 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 83.9 m95 -79.41 89.39 5.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.051 -1.031 . . . . 0.0 109.456 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.774 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.3 mm? -68.78 132.38 46.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.843 -1.161 . . . . 0.0 109.831 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.062 ' CG2' HG22 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -120.54 170.4 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.603 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 37.4 mt-10 -154.33 23.11 0.48 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.201 -1.562 . . . . 0.0 113.453 -178.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.648 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -160.24 55.76 0.34 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 119.832 -1.793 . . . . 0.0 111.138 178.789 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.84 ' HB2' HD13 ' A' ' 60' ' ' ILE . 4.8 p90 -73.99 157.89 35.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.929 -1.107 . . . . 0.0 109.456 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.618 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -79.88 142.54 35.11 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.136 -0.977 . . . . 0.0 109.559 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 29.89 -82.38 0.0 OUTLIER Glycine 0 N--CA 1.5 2.907 0 O-C-N 121.985 -0.447 . . . . 0.0 112.1 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.957 ' O ' HG21 ' A' ' 60' ' ' ILE . 2.9 mm-40 -93.74 157.12 38.75 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.216 -1.167 . . . . 0.0 110.74 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.667 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 29.4 Cg_endo -82.52 -157.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.622 2.215 . . . . 0.0 109.805 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.831 ' CE2' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER 172.63 114.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.454 0.645 . . . . 0.0 109.881 178.726 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . 165.2 -36.37 0.27 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.55 ' N ' ' HD3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -39.5 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.667 -0.902 . . . . 0.0 110.789 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.562 ' HB2' ' CA ' ' A' ' 37' ' ' GLY . 3.1 tp10 -68.22 96.3 0.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.014 -1.054 . . . . 0.0 108.423 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.26 46.39 57.14 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.559 ' HG3' ' N ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -144.5 163.58 33.3 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.559 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 1.2 Cg_endo -64.1 -51.91 1.92 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 121.402 1.402 . . . . 0.0 109.796 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.639 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 59.25 113.35 0.01 OUTLIER Glycine 0 N--CA 1.479 1.519 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.596 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 12.4 pt-20 -150.33 131.78 14.73 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.211 -1.17 . . . . 0.0 109.858 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.629 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -47.25 133.69 11.89 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -124.75 121.84 35.75 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 109.614 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.2 t -81.13 63.2 5.39 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.87 HD21 ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -80.24 -47.75 14.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.346 -0.847 . . . . 0.0 108.971 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.821 ' N ' HD23 ' A' ' 107' ' ' LEU . 40.7 t 82.2 119.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.841 -0.537 . . . . 0.0 110.081 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 108' ' ' VAL . . . 36.51 82.67 0.01 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 1.151 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -40.98 164.84 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.625 -0.927 . . . . 0.0 110.67 -178.484 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.675 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -142.88 -5.19 0.91 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 111.621 -178.281 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 77.37 -6.38 2.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.998 -1.064 . . . . 0.0 108.51 -177.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 -18.18 50.94 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.552 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -109.61 -11.15 14.8 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.329 0.585 . . . . 0.0 109.562 -179.454 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 1.151 ' CE1' HD21 ' A' ' 110' ' ' LEU . 15.7 m-85 -103.76 149.77 37.48 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.905 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.565 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 2.1 Cg_endo -63.8 145.48 90.76 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.718 2.278 . . . . 0.0 110.651 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.518 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . 1.3 Cg_endo -66.14 -27.5 49.14 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.27 1.98 . . . . 0.0 110.399 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -43.21 -54.25 4.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.049 -1.032 . . . . 0.0 109.621 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.801 ' OD1' HD21 ' A' ' 71' ' ' LEU . 7.5 m-80 -90.08 50.46 1.87 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.655 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 5.4 mt-10 -67.54 -37.85 13.71 Favored Pre-proline 0 C--N 1.3 -1.576 0 O-C-N 121.682 -0.636 . . . . 0.0 112.268 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.655 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.2 Cg_exo -55.36 -37.22 94.82 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.392 1.395 . . . . 0.0 112.035 -178.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.797 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.2 t -99.76 -34.41 4.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.69 -1.257 . . . . 0.0 109.046 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.866 ' HA ' HD22 ' A' ' 126' ' ' LEU . 0.5 OUTLIER -60.68 -22.7 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.556 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.567 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -60.7 -36.85 79.82 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.079 0.943 . . . . 0.0 108.501 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.55 -38.92 47.59 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.737 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.866 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -64.17 -23.07 67.18 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.87 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.567 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 12.7 mtmt -54.96 -38.65 68.02 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.438 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -80.24 -24.43 40.16 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.686 179.233 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.624 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 2.0 tp . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.936 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 4.0 tmmm? . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.991 ' O ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -148.66 132.74 17.26 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.163 -0.961 . . . . 0.0 108.901 178.851 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.555 ' HB2' HG23 ' A' ' 40' ' ' ILE . 5.8 mp0 -99.44 155.88 17.32 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.379 -1.451 . . . . 0.0 109.069 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.552 ' CG2' ' HA2' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -116.97 117.16 54.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.348 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.01 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -84.41 66.19 9.3 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -79.44 -77.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.168 -0.958 . . . . 0.0 110.123 -179.375 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.702 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 63.15 93.24 0.02 OUTLIER Glycine 0 N--CA 1.484 1.852 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.578 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -52.95 162.32 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.98 HG22 ' CG2' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -128.79 92.42 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.328 -179.177 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.959 ' HG2' HG22 ' A' ' 18' ' ' ILE . 8.9 mtm180 -75.71 177.23 7.01 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.646 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -156.76 -61.5 0.1 Allowed 'General case' 0 C--O 1.191 -2.005 0 C-N-CA 116.069 -2.252 . . . . 0.0 114.716 -176.844 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.524 ' CB ' ' OE2' ' A' ' 17' ' ' GLU . 5.9 tp10 -91.7 -25.94 18.86 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 119.335 -2.103 . . . . 0.0 111.594 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -161.75 -45.53 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.454 ' HA ' HH21 ' A' ' 12' ' ' ARG . 53.7 t-20 -160.92 35.6 0.15 Allowed 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.524 ' OE2' ' CB ' ' A' ' 14' ' ' GLU . 12.6 mt-10 -79.83 83.82 5.71 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 118.403 -1.319 . . . . 0.0 109.161 -178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.959 HG22 ' HG2' ' A' ' 12' ' ' ARG . 18.1 pt -79.19 141.36 15.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.22 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.624 ' HB3' HD11 ' A' ' 11' ' ' ILE . 13.5 t80 -81.71 45.09 0.86 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.713 HG22 HG13 ' A' ' 18' ' ' ILE . 4.4 tt -80.13 152.29 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-O 121.93 0.872 . . . . 0.0 110.863 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.472 ' HB ' ' HD2' ' A' ' 101' ' ' PRO . 0.6 OUTLIER -69.88 95.34 0.91 Allowed 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.673 ' HD3' HD21 ' A' ' 33' ' ' LEU . 13.2 tpt180 -99.09 90.37 4.58 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.641 -0.662 . . . . 0.0 111.072 -178.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.994 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 32.41 83.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.898 -0.501 . . . . 0.0 110.177 178.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.44 -46.53 4.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.224 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.84 176.43 9.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.432 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -77.47 105.28 8.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.121 -0.987 . . . . 0.0 109.427 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.994 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -104.14 133.8 48.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.12 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -82.25 4.23 24.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 0.0 109.059 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.738 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -102.55 -126.69 0.21 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.603 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 163.62 -4.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.978 -1.076 . . . . 0.0 111.729 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 114' ' ' ASP . 2.9 p-10 -79.24 8.68 5.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.27 -1.519 . . . . 0.0 109.136 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.629 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -81.5 61.34 4.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.588 -0.695 . . . . 0.0 110.105 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.673 HD21 ' HD3' ' A' ' 22' ' ' ARG . 7.6 mt -123.66 93.11 3.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.868 -1.145 . . . . 0.0 109.291 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.594 ' O ' HD11 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.72 -145.97 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.465 -0.772 . . . . 0.0 109.003 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.497 ' CZ ' ' CG ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -142.53 128.35 10.52 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.745 -1.222 . . . . 0.0 109.49 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.703 ' O ' HG23 ' A' ' 8' ' ' VAL . 3.0 Cg_endo -60.05 97.09 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.004 1.803 . . . . 0.0 109.53 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.552 ' HA2' ' CG2' ' A' ' 6' ' ' ILE . . . -54.13 -141.95 0.0 OUTLIER Glycine 0 N--CA 1.496 2.677 0 O-C-N 121.531 -0.73 . . . . 0.0 111.589 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 153.59 -34.78 0.75 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.523 ' HD2' HD23 ' A' ' 4' ' ' LEU . 5.0 tptm 69.15 95.53 0.07 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.039 -0.683 . . . . 0.0 110.465 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.749 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -80.66 135.71 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.204 -0.935 . . . . 0.0 108.833 178.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -170.28 -34.23 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.353 -0.842 . . . . 0.0 109.756 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.415 ' O ' ' C ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -49.35 156.47 0.6 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.243 -0.911 . . . . 0.0 109.514 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' MET . . . 44.23 -122.44 4.46 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.78 21.27 0.09 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.406 -1.055 . . . . 0.0 109.484 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.699 HG22 ' H ' ' A' ' 47' ' ' GLU . 98.0 m -135.18 141.9 39.72 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.22 -0.925 . . . . 0.0 108.907 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.565 ' HD2' HG23 ' A' ' 45' ' ' THR . 11.2 Cg_exo -50.37 -16.9 2.29 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.573 1.516 . . . . 0.0 110.205 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.699 ' H ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -76.99 -84.08 0.07 Allowed 'General case' 0 C--O 1.202 -1.43 0 O-C-N 121.181 -0.949 . . . . 0.0 108.768 178.709 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.564 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 1.5 mt-30 -45.14 -35.91 3.43 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.484 -1.385 . . . . 0.0 109.747 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.635 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -64.23 -60.67 2.92 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.299 -0.875 . . . . 0.0 110.387 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.01 HG23 ' HB1' ' A' ' 7' ' ' ALA . 1.8 p -70.32 -48.82 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.897 -1.127 . . . . 0.0 110.548 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 47' ' ' GLU . 4.1 p -56.7 -37.41 52.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.823 -0.548 . . . . 0.0 110.575 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.564 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 2.9 mmt180 -79.17 -39.73 32.69 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.65 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 19.9 mm-40 -65.98 -15.66 63.2 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.054 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -80.26 -39.29 29.23 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.752 0.787 . . . . 0.0 109.961 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.63 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 1.8 mt-30 -79.2 -52.55 8.0 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.624 0.726 . . . . 0.0 109.192 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.65 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -44.65 -23.9 0.16 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.644 -0.66 . . . . 0.0 110.097 -179.58 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 3.9 mm-40 -80.16 -95.84 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.864 -1.148 . . . . 0.0 109.516 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.668 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 57.6 t -80.38 -78.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.07 -1.019 . . . . 0.0 109.809 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.64 37.54 0.11 Allowed Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.434 -1.365 . . . . 0.0 111.653 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.103 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -91.56 -147.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.506 -1.585 . . . . 0.0 108.689 178.64 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.608 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.5 m -162.73 -64.03 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 120.439 -1.413 . . . . 0.0 112.985 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.608 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 1.8 Cg_endo -56.66 -2.63 0.47 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 122.53 2.153 . . . . 0.0 113.963 -177.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.849 ' HB3' HD11 ' A' ' 60' ' ' ILE . 1.4 pt20 -40.24 -26.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.789 -1.194 . . . . 0.0 109.917 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.577 ' N ' ' HG3' ' A' ' 63' ' ' GLN . 0.4 OUTLIER 57.4 -170.16 0.1 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -178.255 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -179.34 158.85 0.89 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.521 -1.362 . . . . 0.0 111.683 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -156.84 147.84 21.91 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.749 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.619 HD23 ' CE2' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -70.07 -67.44 0.49 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.888 -1.133 . . . . 0.0 109.655 -179.202 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.861 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 82.31 -52.4 0.22 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.586 ' CB ' ' O ' ' A' ' 68' ' ' PHE . 2.2 mm-40 150.56 133.36 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.798 -0.564 . . . . 0.0 109.819 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.526 ' HA ' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -122.64 -162.74 1.03 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.148 -0.97 . . . . 0.0 109.336 179.355 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.71 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -145.62 175.79 10.1 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.372 -0.83 . . . . 0.0 109.871 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -148.27 83.26 1.49 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.32 126.23 34.18 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.61 160.69 14.67 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 3.1 m-85 -128.75 170.02 11.62 Favored Pre-proline 0 C--N 1.296 -1.747 0 O-C-N 121.182 -0.948 . . . . 0.0 109.29 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 6.2 Cg_exo -48.83 -23.23 5.54 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.083 1.855 . . . . 0.0 109.694 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.0 42.29 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.56 ' HD3' HD11 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -153.39 90.0 1.39 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.787 -0.571 . . . . 0.0 109.563 -178.37 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.992 ' C ' HD13 ' A' ' 80' ' ' ILE . 7.0 t-160 -80.31 100.28 8.31 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.992 HD13 ' C ' ' A' ' 79' ' ' HIS . 1.2 mm -115.89 144.41 23.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 118.809 -1.156 . . . . 0.0 112.138 -178.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.534 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 1.6 m -119.3 166.24 13.26 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.692 ' CD2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -151.73 76.24 1.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.761 -1.212 . . . . 0.0 110.069 179.81 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.668 ' CD1' HG21 ' A' ' 40' ' ' ILE . 75.6 m95 -51.68 128.37 23.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.123 -0.986 . . . . 0.0 109.142 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.843 ' CE2' HG11 ' A' ' 122' ' ' VAL . 23.5 m-85 -103.62 76.35 1.39 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.039 -1.038 . . . . 0.0 109.782 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.619 ' CE2' HD23 ' A' ' 67' ' ' LEU . 40.8 m95 -78.39 91.66 4.5 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.997 -1.064 . . . . 0.0 109.209 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.861 HD23 ' CD2' ' A' ' 68' ' ' PHE . 1.6 mm? -71.8 131.76 43.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.955 -1.091 . . . . 0.0 109.882 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.98 ' CG2' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -117.67 -178.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.533 ' N ' HG23 ' A' ' 87' ' ' VAL . 43.5 mt-10 -158.07 2.45 0.11 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.139 -1.601 . . . . 0.0 113.397 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.596 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -151.45 68.61 0.92 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 119.623 -1.923 . . . . 0.0 111.723 -179.62 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 1.03 ' HB2' HD13 ' A' ' 60' ' ' ILE . 9.6 p90 -80.57 167.91 19.53 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.467 -1.395 . . . . 0.0 109.38 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.569 ' CB ' ' HG2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -92.41 144.15 25.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.137 -0.977 . . . . 0.0 109.435 179.71 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 40.08 -91.03 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 1.103 ' O ' HG21 ' A' ' 60' ' ' ILE . 13.6 pt-20 -107.07 161.65 22.23 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.214 -1.168 . . . . 0.0 109.77 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.61 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 9.8 Cg_endo -75.77 -155.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.563 2.175 . . . . 0.0 109.93 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 1.054 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER 178.96 46.59 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.425 -0.797 . . . . 0.0 109.83 179.277 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -128.1 -20.86 1.58 Allowed Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.751 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.582 ' O ' ' HG2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -49.92 104.04 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.871 -1.37 . . . . 0.0 109.618 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.509 ' HB2' ' C ' ' A' ' 37' ' ' GLY . 9.0 tp10 -82.81 94.29 7.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.9 -1.125 . . . . 0.0 109.244 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.98 13.54 34.38 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.496 ' CG ' ' HB2' ' A' ' 97' ' ' LYS . 6.4 pt20 -114.92 162.74 22.32 Favored Pre-proline 0 N--CA 1.487 1.383 0 O-C-N 121.345 -1.091 . . . . 0.0 108.683 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 102' ' ' GLY . 6.0 Cg_exo -60.32 -44.11 30.27 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.815 1.677 . . . . 0.0 109.728 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.587 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 56.27 112.75 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 3.7 pt-20 -147.24 132.31 18.26 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.8 -1.412 . . . . 0.0 111.068 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.692 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 2.4 m0 -47.8 126.02 9.66 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.503 ' HE3' ' HB2' ' A' ' 22' ' ' ARG . 7.7 tpp -123.31 105.57 9.96 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.347 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.29 81.39 0.74 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.647 ' O ' ' CB ' ' A' ' 108' ' ' VAL . 6.2 tt -80.99 -80.04 0.15 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.471 -0.768 . . . . 0.0 110.614 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.647 ' CB ' ' O ' ' A' ' 107' ' ' LEU . 54.5 t 115.49 103.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.504 ' CA ' ' OXT' ' A' ' 129' ' ' LEU . . . 41.94 78.77 0.06 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.594 -1.803 . . . . 0.0 108.594 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 1.107 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -39.54 163.66 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.617 -0.931 . . . . 0.0 110.989 -178.639 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.697 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -139.68 -8.28 1.25 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.406 -0.809 . . . . 0.0 111.412 -178.185 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 83.66 -25.38 0.14 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.301 -0.875 . . . . 0.0 108.713 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.12 -29.69 61.05 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.658 ' HB3' HD12 ' A' ' 33' ' ' LEU . 9.7 m-20 -94.22 -19.22 20.94 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 1.107 ' CE1' HD21 ' A' ' 110' ' ' LEU . 6.5 m-85 -95.82 148.05 33.95 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.325 -0.859 . . . . 0.0 109.908 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.488 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.4 Cg_endo -68.0 142.52 56.9 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.409 2.073 . . . . 0.0 110.061 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 118' ' ' ALA . 2.4 Cg_endo -63.04 -27.97 74.25 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.157 1.905 . . . . 0.0 110.476 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -41.43 -48.56 3.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.414 -0.804 . . . . 0.0 109.383 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.648 ' HB3' HD13 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -96.33 55.17 1.46 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.641 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -62.75 -42.33 77.8 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.764 -0.585 . . . . 0.0 112.027 -179.59 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 11.6 Cg_exo -54.02 -47.94 24.33 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 121.846 1.698 . . . . 0.0 112.615 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.843 HG11 ' CE2' ' A' ' 84' ' ' PHE . 1.5 t -88.64 -38.02 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.704 -1.248 . . . . 0.0 109.62 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.862 ' HA ' HD22 ' A' ' 126' ' ' LEU . 1.1 mp -63.1 -21.0 27.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.544 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -63.64 -31.06 72.12 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -80.32 -40.34 26.92 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.519 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.862 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.09 -21.09 66.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.682 -1.261 . . . . 0.0 107.755 179.366 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 1.9 mtmt -58.1 -36.5 72.98 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -83.23 -20.53 34.4 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.503 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.558 HD13 HD12 ' A' ' 126' ' ' LEU . 1.2 tp . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.627 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.474 ' CG ' ' N ' ' A' ' 4' ' ' LEU . 8.6 ttpt . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 121.632 0.73 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.548 HD13 ' N ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -159.0 110.0 2.07 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.548 ' N ' HD13 ' A' ' 4' ' ' LEU . 2.5 mp0 -104.7 169.53 8.4 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.015 -1.053 . . . . 0.0 109.427 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.714 HG22 HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -135.23 122.87 37.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.437 -0.79 . . . . 0.0 108.984 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.975 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -86.2 62.16 7.27 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -79.15 -77.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.717 -179.514 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.717 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 62.99 89.07 0.03 OUTLIER Glycine 0 N--CA 1.48 1.567 0 N-CA-C 106.956 -2.458 . . . . 0.0 106.956 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.112 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -55.13 163.93 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.675 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.04 HG22 ' CG2' ' A' ' 87' ' ' VAL . 2.0 pt -127.42 71.46 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.301 -177.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.909 ' HB3' HG22 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -77.99 159.78 28.58 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.266 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -162.07 -18.61 0.04 OUTLIER 'General case' 0 C--O 1.187 -2.19 0 C-N-CA 115.81 -2.356 . . . . 0.0 115.479 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.52 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 1.4 tm-20 -93.48 -31.67 14.49 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 118.165 -2.834 . . . . 0.0 108.646 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -163.13 -46.51 0.03 OUTLIER 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.483 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 1.1 t-20 -162.05 37.87 0.12 Allowed 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 176.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 105' ' ' MET . 92.3 mt-10 -91.6 94.29 9.34 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 118.003 -1.479 . . . . 0.0 110.831 -177.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.112 ' CD1' HG22 ' A' ' 10' ' ' ILE . 0.6 OUTLIER -96.99 152.36 3.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.544 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.667 ' N ' HD12 ' A' ' 18' ' ' ILE . 13.6 t80 -80.39 45.38 0.76 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.654 HD11 ' C ' ' A' ' 34' ' ' GLU . 5.7 tp -81.09 154.78 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.231 -0.918 . . . . 0.0 111.382 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.535 ' O ' ' O ' ' A' ' 32' ' ' LYS . 1.4 t -67.67 92.98 0.35 Allowed 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.841 ' HD3' HD21 ' A' ' 33' ' ' LEU . 30.3 tpt180 -100.78 83.92 2.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.46 -0.775 . . . . 0.0 110.534 -178.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.765 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 31.69 86.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.826 -0.546 . . . . 0.0 110.129 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -44.7 -52.32 8.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.089 -1.007 . . . . 0.0 109.532 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.62 -161.04 0.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 0.0 109.11 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.76 -27.56 40.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.205 -0.934 . . . . 0.0 109.231 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.765 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . 50.76 -175.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 109.787 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.53 25.78 0.23 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.717 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 0.7 OUTLIER -126.45 -41.69 1.86 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.367 -0.833 . . . . 0.0 110.318 -179.517 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 29' ' ' MET . . . 78.93 0.86 2.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 110.124 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 25.4 p-10 -92.98 9.86 33.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.829 -1.169 . . . . 0.0 108.565 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.535 ' O ' ' O ' ' A' ' 21' ' ' THR . 0.9 OUTLIER -81.22 36.43 0.41 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.565 -0.709 . . . . 0.0 110.653 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.069 HD13 ' CE1' ' A' ' 115' ' ' PHE . 22.3 mt -110.82 88.05 2.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.553 -1.342 . . . . 0.0 109.564 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.654 ' C ' HD11 ' A' ' 20' ' ' ILE . 1.1 tt0 -91.79 -137.38 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.457 -0.777 . . . . 0.0 109.534 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.669 ' HB3' HG21 ' A' ' 8' ' ' VAL . 90.6 m-85 -149.66 130.8 7.23 Favored Pre-proline 0 C--N 1.306 -1.299 0 O-C-N 121.072 -1.017 . . . . 0.0 109.745 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.744 ' O ' HG23 ' A' ' 8' ' ' VAL . 2.1 Cg_endo -56.6 95.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.303 2.002 . . . . 0.0 109.894 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -55.69 -147.04 0.01 OUTLIER Glycine 0 N--CA 1.494 2.528 0 O-C-N 121.319 -0.863 . . . . 0.0 111.205 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 158.97 -40.29 0.5 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.571 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 13.4 tptp 73.75 94.49 0.07 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.146 -0.62 . . . . 0.0 110.596 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.783 ' O ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -80.92 131.8 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 108.805 178.704 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.417 ' HG2' ' N ' ' A' ' 42' ' ' MET . 4.6 pt-20 -171.76 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.963 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.417 ' N ' ' HG2' ' A' ' 41' ' ' GLU . 4.9 mmt -58.7 163.84 3.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -0.913 . . . . 0.0 109.857 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 47.61 -121.73 6.99 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -167.07 24.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.528 -0.984 . . . . 0.0 108.739 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.554 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 30.4 m -146.71 142.87 17.72 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.597 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 11.1 Cg_exo -50.58 -17.22 2.75 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 121.412 1.408 . . . . 0.0 109.957 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -75.33 -83.36 0.06 Allowed 'General case' 0 C--O 1.201 -1.483 0 O-C-N 121.081 -1.012 . . . . 0.0 108.938 178.647 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.529 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 32.9 mt-30 -45.52 -36.66 4.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.37 -1.456 . . . . 0.0 109.776 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.617 ' CB ' HG12 ' A' ' 40' ' ' ILE . . . -62.84 -64.99 0.75 Allowed 'General case' 0 C--N 1.289 -2.056 0 O-C-N 120.964 -1.085 . . . . 0.0 110.26 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.975 HG23 ' HB1' ' A' ' 7' ' ' ALA . 1.9 p -65.05 -48.93 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.048 -1.033 . . . . 0.0 111.018 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.577 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 2.9 p -55.66 -46.48 79.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-O 121.384 0.612 . . . . 0.0 110.109 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.565 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 8.0 mmt180 -72.46 -27.61 62.41 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.591 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 29.9 mm-40 -77.81 -14.18 59.66 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.752 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.8 OUTLIER -80.18 -58.52 3.11 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.493 ' HA ' ' CZ3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -63.16 -50.14 71.56 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.738 -0.601 . . . . 0.0 109.722 179.428 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.585 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 1.4 pp20? -53.25 -20.12 3.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.994 -1.066 . . . . 0.0 109.746 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.483 ' OE1' ' HA2' ' A' ' 96' ' ' GLY . 1.6 mt-10 -80.2 -91.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 109.861 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.866 HG21 ' HA ' ' A' ' 95' ' ' TRP . 41.7 t -79.96 -79.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.436 -0.79 . . . . 0.0 110.016 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.02 27.04 0.17 Allowed Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.212 -1.47 . . . . 0.0 111.448 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.031 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -81.75 -145.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.607 -1.525 . . . . 0.0 107.948 178.708 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.635 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.3 m -145.23 -70.43 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 120.512 -1.367 . . . . 0.0 109.943 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.635 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 8.8 Cg_endo -66.71 -169.42 0.18 Allowed 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 121.137 1.225 . . . . 0.0 109.636 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.628 ' HB2' HG21 ' A' ' 87' ' ' VAL . 0.8 OUTLIER 134.09 -20.27 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 -179.112 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.551 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.1 OUTLIER 52.12 -164.59 0.07 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -179.485 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -177.22 144.63 0.43 Allowed 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 117.636 -1.626 . . . . 0.0 111.046 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -145.07 143.48 30.46 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.624 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -74.61 -65.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.856 -1.152 . . . . 0.0 110.216 -178.96 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.624 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 81.89 -50.74 0.24 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.27 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.538 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER 164.15 179.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.135 -0.978 . . . . 0.0 109.595 179.306 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.18 142.82 13.37 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.313 -0.867 . . . . 0.0 109.109 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -96.93 -171.71 2.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.997 -1.064 . . . . 0.0 109.789 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HG3' HG23 ' A' ' 81' ' ' THR . 5.3 tt0 -160.24 95.48 1.14 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.5 123.15 27.29 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.434 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 2.1 tt0 -96.87 143.23 27.96 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.537 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.556 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 5.5 m-85 -119.39 169.76 7.74 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 7.6 Cg_exo -49.26 -31.86 23.58 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.441 1.427 . . . . 0.0 109.307 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -160.72 41.04 0.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.212 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.546 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -146.16 95.76 2.67 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.597 -0.689 . . . . 0.0 109.956 -178.906 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.753 ' C ' HD12 ' A' ' 80' ' ' ILE . 14.6 m80 -82.64 113.02 20.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.015 -1.053 . . . . 0.0 108.781 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.753 HD12 ' C ' ' A' ' 79' ' ' HIS . 1.3 mp -110.87 165.09 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -0.987 . . . . 0.0 110.161 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.559 ' N ' ' CG2' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -153.52 149.37 27.62 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.726 HD23 HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -137.0 77.47 1.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.903 -1.123 . . . . 0.0 109.909 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.645 ' CD1' HG21 ' A' ' 40' ' ' ILE . 81.8 m95 -46.71 116.34 1.3 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.183 -0.948 . . . . 0.0 109.658 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.812 ' CE2' HG11 ' A' ' 122' ' ' VAL . 26.0 m-85 -92.37 71.21 5.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.155 -0.966 . . . . 0.0 109.931 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.663 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 30.9 m95 -75.14 91.8 2.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.843 -1.161 . . . . 0.0 109.06 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.56 HD11 ' CG1' ' A' ' 10' ' ' ILE . 3.3 mm? -73.02 127.29 32.14 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.774 -1.204 . . . . 0.0 110.281 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.04 ' CG2' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -115.7 172.79 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.497 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 43.8 mt-10 -157.48 32.68 0.27 Allowed 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 117.835 -1.546 . . . . 0.0 113.392 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.593 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.21 55.94 0.35 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 119.872 -1.767 . . . . 0.0 111.154 178.251 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.539 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 5.1 p90 -78.94 159.09 27.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.19 -1.569 . . . . 0.0 109.488 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -88.43 138.21 31.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 32.79 -79.72 0.0 OUTLIER Glycine 0 N--CA 1.501 3.025 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 1.031 ' O ' HG21 ' A' ' 60' ' ' ILE . 2.8 mm-40 -94.49 144.79 28.53 Favored Pre-proline 0 C--N 1.303 -1.424 0 O-C-N 121.164 -1.198 . . . . 0.0 109.645 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.582 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 14.0 Cg_endo -79.58 -161.62 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.18 1.92 . . . . 0.0 109.651 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.866 ' HA ' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -176.21 116.72 0.13 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.016 0.912 . . . . 0.0 109.946 177.867 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.483 ' HA2' ' OE1' ' A' ' 57' ' ' GLU . . . 167.61 -34.59 0.21 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.581 ' CA ' ' HG2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -39.57 100.51 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.539 -0.977 . . . . 0.0 109.849 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.476 ' OE1' ' HA2' ' A' ' 38' ' ' GLY . 18.2 tp10 -80.15 105.48 11.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.311 -0.868 . . . . 0.0 108.822 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 50.53 30.77 20.46 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.581 ' HG2' ' CA ' ' A' ' 97' ' ' LYS . 1.7 pt20 -134.26 165.26 38.05 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.544 -0.974 . . . . 0.0 109.337 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 3.5 Cg_exo -63.47 -45.61 11.28 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.206 1.938 . . . . 0.0 110.484 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.608 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.59 114.42 0.01 OUTLIER Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.625 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 1.8 pt-20 -152.25 134.16 14.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.086 -1.243 . . . . 0.0 110.079 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.522 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 1.7 m-90 -46.15 134.45 8.45 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.624 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -125.97 116.15 21.03 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.135 -0.978 . . . . 0.0 109.031 -179.04 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.563 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -79.52 43.69 0.57 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.428 -0.795 . . . . 0.0 110.858 -178.97 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.765 HD21 ' HA ' ' A' ' 110' ' ' LEU . 9.4 tt -67.01 161.9 23.29 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.723 ' N ' HD23 ' A' ' 107' ' ' LEU . 24.5 t -118.78 114.69 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.048 -1.033 . . . . 0.0 108.935 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 43.18 84.45 0.01 OUTLIER Glycine 0 N--CA 1.493 2.436 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.983 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -35.55 157.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.764 0.793 . . . . 0.0 111.33 -178.137 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.737 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -138.45 -5.04 1.61 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.687 -0.633 . . . . 0.0 111.346 -178.035 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.737 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 81.99 -34.93 0.1 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.99 -26.59 4.42 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.452 -0.78 . . . . 0.0 109.266 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 1.013 ' HB3' HD12 ' A' ' 33' ' ' LEU . 62.9 m-20 -104.25 -20.01 13.92 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.753 -0.592 . . . . 0.0 109.503 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 1.069 ' CE1' HD13 ' A' ' 33' ' ' LEU . 9.4 m-85 -98.8 148.36 34.46 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.226 -0.921 . . . . 0.0 109.101 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.566 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 6.1 Cg_exo -62.03 132.27 38.59 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.459 2.106 . . . . 0.0 110.448 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.93 -18.5 42.84 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.948 1.765 . . . . 0.0 110.201 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -46.52 -52.48 13.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.235 -0.916 . . . . 0.0 108.879 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.522 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 30.0 m-80 -86.56 46.68 1.38 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.647 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 2.2 mt-10 -57.66 -44.31 99.4 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.667 -0.646 . . . . 0.0 112.485 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 7.1 Cg_exo -53.35 -42.7 63.39 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.877 1.718 . . . . 0.0 113.15 -177.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.812 HG11 ' CE2' ' A' ' 84' ' ' PHE . 1.8 t -96.98 -32.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.458 -1.401 . . . . 0.0 110.06 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.76 ' HA ' HD22 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -62.92 -25.85 39.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.571 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -57.59 -33.36 68.12 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.165 0.983 . . . . 0.0 108.419 178.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 68.1 mmtt -80.18 -40.55 27.03 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.704 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.8 HD13 ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -66.95 -16.31 64.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.647 -1.283 . . . . 0.0 107.884 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 12.0 mtmt -61.68 -35.08 76.96 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 177.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 125' ' ' LYS . 1.2 mtp180 -81.91 -19.92 39.82 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.281 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.757 HD23 ' NH1' ' A' ' 12' ' ' ARG . 1.2 tp . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.111 -0.947 . . . . 0.0 109.447 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.499 ' CD ' ' C ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 1.095 ' O ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -142.88 119.42 11.02 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.043 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.861 ' N ' HD22 ' A' ' 4' ' ' LEU . 8.4 mp0 -101.57 160.92 14.03 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.727 -1.233 . . . . 0.0 107.844 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.892 HG22 HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -123.1 117.76 52.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 C-N-CA 119.351 -0.939 . . . . 0.0 109.288 -179.136 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.912 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -87.44 58.56 5.03 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.892 HG12 HG22 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -78.02 -73.72 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.506 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.756 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 60.01 82.24 0.07 OUTLIER Glycine 0 N--CA 1.48 1.603 0 N-CA-C 107.584 -2.207 . . . . 0.0 107.584 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.639 HD12 HD11 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -45.97 160.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.052 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.089 HG22 ' CG2' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -120.26 95.32 3.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 C-N-CA 119.57 -0.852 . . . . 0.0 108.915 -179.234 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 1.096 ' HG2' HG22 ' A' ' 18' ' ' ILE . 20.3 mtm180 -74.35 173.19 10.59 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.62 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -150.98 -64.41 0.19 Allowed 'General case' 0 C--O 1.188 -2.142 0 C-N-CA 117.18 -1.808 . . . . 0.0 114.222 -176.73 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 7.7 tp10 -91.81 -32.73 15.25 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 118.957 -2.34 . . . . 0.0 112.014 -175.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.476 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 5.7 t-20 -161.15 -43.96 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.584 ' HB3' ' CD2' ' A' ' 107' ' ' LEU . 7.5 m120 -157.07 35.35 0.29 Allowed 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.549 ' HG2' ' CB ' ' A' ' 106' ' ' SER . 31.5 mt-10 -88.52 83.92 6.79 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 117.778 -1.569 . . . . 0.0 109.629 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.096 HG22 ' HG2' ' A' ' 12' ' ' ARG . 3.0 pt -79.82 149.09 5.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.645 ' CE2' ' HG2' ' A' ' 94' ' ' PRO . 7.0 t80 -81.57 43.68 0.76 Allowed 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.636 HG21 HD22 ' A' ' 33' ' ' LEU . 6.7 tp -83.33 159.9 3.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.93 0.871 . . . . 0.0 110.806 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.754 ' O ' HG23 ' A' ' 21' ' ' THR . 7.4 t -70.32 98.6 1.42 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 176.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.676 ' HD3' HD21 ' A' ' 33' ' ' LEU . 31.6 tpt180 -99.61 80.39 2.36 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 110.976 -177.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.539 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 32.68 83.63 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.304 0.573 . . . . 0.0 110.137 178.759 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -43.51 -49.46 7.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -0.942 . . . . 0.0 110.087 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.35 178.65 8.15 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.179 -0.951 . . . . 0.0 108.763 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.444 ' O ' ' O ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -57.96 -30.81 66.3 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.171 -1.012 . . . . 0.0 108.894 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.539 ' CB ' ' HD2' ' A' ' 23' ' ' ARG . . . 58.07 159.12 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.325 -0.86 . . . . 0.0 109.537 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -131.57 25.73 4.75 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.67 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 11.2 mtm -129.08 -95.2 0.41 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.497 -0.752 . . . . 0.0 109.242 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.67 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 137.71 -4.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -85.61 14.41 5.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.125 -0.984 . . . . 0.0 108.834 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.9 tmtt? -80.98 28.77 0.35 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.468 -0.77 . . . . 0.0 110.708 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.71 HD12 ' HB3' ' A' ' 114' ' ' ASP . 16.6 mt -107.02 83.36 1.82 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.453 -1.405 . . . . 0.0 110.057 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.61 ' C ' HD11 ' A' ' 20' ' ' ILE . 1.7 tt0 -85.46 -143.04 0.09 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.64 ' HB3' HG21 ' A' ' 8' ' ' VAL . 22.2 m-85 -142.66 127.55 10.05 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.693 -1.255 . . . . 0.0 109.701 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.834 ' O ' HG23 ' A' ' 8' ' ' VAL . 5.0 Cg_endo -60.81 95.47 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.813 1.676 . . . . 0.0 109.225 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -54.26 -149.28 0.01 OUTLIER Glycine 0 N--CA 1.493 2.5 0 CA-C-O 122.039 0.799 . . . . 0.0 111.548 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.533 ' N ' ' CG ' ' A' ' 98' ' ' GLU . . . 159.9 -37.1 0.46 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.643 ' HE2' HD23 ' A' ' 4' ' ' LEU . 20.9 tptp 72.52 98.3 0.07 Allowed 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.172 0.51 . . . . 0.0 110.875 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.982 ' O ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -81.59 130.21 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.306 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -170.51 -32.3 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.428 -0.795 . . . . 0.0 109.76 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.419 ' HB2' ' HA ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -53.73 164.26 0.58 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.907 . . . . 0.0 109.378 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' MET . . . 45.08 -122.05 4.9 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -165.89 24.05 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.43 -1.041 . . . . 0.0 108.997 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.654 HG22 ' H ' ' A' ' 47' ' ' GLU . 88.4 m -144.19 141.93 19.07 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.356 -0.84 . . . . 0.0 108.845 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 45' ' ' THR . 7.5 Cg_exo -48.89 -18.58 1.74 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.705 1.603 . . . . 0.0 109.804 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.654 ' H ' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -76.0 -87.57 0.04 OUTLIER 'General case' 0 C--O 1.201 -1.449 0 O-C-N 121.214 -0.929 . . . . 0.0 108.799 178.873 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.55 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 22.7 mt-30 -42.72 -34.81 0.97 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.744 -1.223 . . . . 0.0 109.977 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.599 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -65.06 -63.87 1.0 Allowed 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.299 -0.875 . . . . 0.0 109.83 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.806 HG23 ' HB1' ' A' ' 7' ' ' ALA . 1.9 p -65.59 -49.37 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.962 -1.086 . . . . 0.0 110.864 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.568 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 3.8 p -56.55 -43.9 79.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.641 -0.662 . . . . 0.0 110.283 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 27.4 mmm180 -73.83 -28.46 61.62 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.599 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 25.0 mm-40 -76.69 -15.2 59.86 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.018 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -79.85 -55.51 4.93 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.68 0.752 . . . . 0.0 109.297 -179.732 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.635 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -68.71 -41.21 79.39 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.819 -0.551 . . . . 0.0 110.657 -179.617 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.575 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.9 OUTLIER -59.12 -20.81 56.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.006 -1.059 . . . . 0.0 110.73 -178.847 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 9.9 mm-40 -80.1 -91.07 0.05 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.812 -1.18 . . . . 0.0 110.445 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.611 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 94.7 t -77.49 -80.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.37 -0.832 . . . . 0.0 110.203 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.76 32.76 0.1 Allowed Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.178 -1.487 . . . . 0.0 111.678 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.063 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.3 pt -89.44 -137.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.552 -1.558 . . . . 0.0 108.305 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.662 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.8 m -154.32 -71.57 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.333 -1.479 . . . . 0.0 111.166 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.662 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 3.6 Cg_endo -64.09 -175.34 0.3 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 120.965 1.11 . . . . 0.0 110.315 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.705 ' HB2' HG21 ' A' ' 87' ' ' VAL . 3.8 pt20 151.79 -22.04 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.593 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 1.0 OUTLIER 48.61 50.53 16.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.479 -0.763 . . . . 0.0 109.748 179.026 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.574 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -48.64 149.56 1.67 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.808 0.813 . . . . 0.0 110.68 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 86' ' ' LEU . 3.1 m -153.63 133.58 13.19 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.627 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -56.76 -71.4 0.1 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.856 -1.152 . . . . 0.0 110.482 -179.044 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.818 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 84.78 -52.19 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.58 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 0.8 OUTLIER 154.88 138.77 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.151 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.546 ' HA ' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -128.76 -175.17 3.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.972 . . . . 0.0 109.893 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.82 HD11 ' HB2' ' A' ' 82' ' ' LEU . 0.9 OUTLIER -125.16 -169.53 2.01 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.669 0.747 . . . . 0.0 109.647 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.604 ' HG3' HG23 ' A' ' 81' ' ' THR . 4.9 tt0 -156.37 83.12 0.98 Allowed 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.78 106.56 10.87 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.51 -170.17 2.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.348 -0.845 . . . . 0.0 109.471 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.592 ' HB2' ' CB ' ' A' ' 78' ' ' ARG . 5.6 m-85 -160.33 169.46 10.13 Favored Pre-proline 0 C--N 1.297 -1.681 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.351 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.4 Cg_exo -50.73 -28.85 24.04 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.974 1.783 . . . . 0.0 109.607 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.64 42.07 0.14 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.592 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -151.52 92.88 1.81 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.841 -0.537 . . . . 0.0 109.725 -178.383 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.667 ' C ' HD12 ' A' ' 80' ' ' ILE . 1.5 m-70 -82.95 104.82 13.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.966 -1.084 . . . . 0.0 109.067 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.863 HG13 HD12 ' A' ' 4' ' ' LEU . 0.6 OUTLIER -115.04 138.08 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.005 -1.059 . . . . 0.0 110.284 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.604 HG23 ' HG3' ' A' ' 72' ' ' GLU . 1.0 OUTLIER -112.9 179.54 3.94 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.34 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.984 HD23 ' CE1' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -160.32 72.53 0.48 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.658 -1.276 . . . . 0.0 110.394 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.629 ' CD1' HG21 ' A' ' 40' ' ' ILE . 79.3 m95 -51.74 131.12 30.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 108.956 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.984 ' CE1' HD23 ' A' ' 82' ' ' LEU . 16.0 m-85 -110.12 71.92 0.77 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.054 -1.029 . . . . 0.0 109.132 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.638 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 38.2 m95 -70.75 85.11 0.65 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.315 -0.865 . . . . 0.0 109.588 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.818 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.6 mm? -70.77 124.22 23.79 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.749 -1.181 . . . . 0.0 109.059 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.089 ' CG2' HG22 ' A' ' 11' ' ' ILE . 1.1 m -113.72 159.86 13.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 87' ' ' VAL . 17.1 mp0 -148.44 36.56 0.81 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.095 -1.442 . . . . 0.0 112.924 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.593 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -161.06 31.98 0.14 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 119.881 -1.762 . . . . 0.0 111.532 178.7 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.767 ' HB2' HD13 ' A' ' 60' ' ' ILE . 2.8 p90 -54.79 165.5 0.61 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.16 -1.587 . . . . 0.0 108.274 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.567 ' HG2' ' HB ' ' A' ' 60' ' ' ILE . 8.1 pt-20 -77.35 -123.85 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.994 -1.066 . . . . 0.0 110.408 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.454 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -64.83 -50.46 58.24 Favored Glycine 0 N--CA 1.489 2.217 0 O-C-N 120.738 -1.226 . . . . 0.0 110.075 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 1.063 ' O ' HG21 ' A' ' 60' ' ' ILE . 3.1 mt-10 -123.29 156.56 63.35 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.018 -1.283 . . . . 0.0 110.278 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.691 ' HB3' HD12 ' A' ' 11' ' ' ILE . 8.4 Cg_endo -73.86 -160.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.731 2.288 . . . . 0.0 110.086 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 1.018 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER 176.7 48.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 111.049 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . -132.69 2.89 4.95 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.169 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -80.08 94.91 6.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.383 -1.069 . . . . 0.0 111.239 -179.251 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.533 ' CG ' ' N ' ' A' ' 38' ' ' GLY . 2.8 mm-40 -42.02 -88.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.913 . . . . 0.0 108.729 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.97 1.68 27.15 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.564 ' HG3' ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -73.89 146.98 85.92 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.725 -0.868 . . . . 0.0 109.366 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.564 ' HD2' ' HG3' ' A' ' 100' ' ' GLN . 3.0 Cg_exo -56.39 -29.46 77.46 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 N-CA-C 107.897 -1.616 . . . . 0.0 107.897 178.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.627 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 54.76 110.73 0.01 OUTLIER Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.585 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 2.9 pt-20 -151.83 127.95 10.45 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.07 -1.253 . . . . 0.0 109.19 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.449 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -41.65 141.34 0.8 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.494 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.513 ' HG3' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -139.15 96.05 3.04 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.363 -0.836 . . . . 0.0 108.961 -179.455 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.549 ' CB ' ' HG2' ' A' ' 17' ' ' GLU . 10.4 t -78.51 72.17 5.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.46 -0.775 . . . . 0.0 109.399 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.782 HD23 ' N ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -80.03 -10.92 59.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.916 -1.115 . . . . 0.0 109.903 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.782 ' N ' HD23 ' A' ' 107' ' ' LEU . 2.5 t 64.93 122.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 108' ' ' VAL . . . 33.26 83.03 0.01 OUTLIER Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.966 HD21 ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -41.09 165.07 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.772 -0.84 . . . . 0.0 109.866 -178.068 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.713 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 2.0 t-20 -144.3 -4.94 0.78 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.804 -1.185 . . . . 0.0 111.87 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 81.23 -26.29 0.15 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.961 -1.087 . . . . 0.0 108.56 -177.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -57.24 -40.47 77.64 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.71 ' HB3' HD12 ' A' ' 33' ' ' LEU . 59.8 m-20 -86.67 -13.12 46.44 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.966 ' CD1' HD21 ' A' ' 110' ' ' LEU . 5.1 m-85 -101.3 146.26 31.87 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 110.317 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 5.9 Cg_exo -60.92 141.66 95.24 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.44 2.094 . . . . 0.0 110.31 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.478 ' O ' ' OE1' ' A' ' 120' ' ' GLU . 1.6 Cg_endo -64.36 -8.1 15.94 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.098 1.866 . . . . 0.0 110.626 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.27 -53.45 52.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.09 -1.006 . . . . 0.0 110.174 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.715 ' OD1' HD21 ' A' ' 71' ' ' LEU . 6.7 m-80 -87.85 42.87 1.08 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 109.764 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.691 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -57.66 -44.3 99.39 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 120.981 -1.074 . . . . 0.0 111.734 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.691 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 20.8 Cg_exo -47.15 -44.92 22.84 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.825 1.683 . . . . 0.0 113.043 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.691 HG21 ' CD1' ' A' ' 84' ' ' PHE . 1.7 t -96.37 -35.94 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.306 -1.496 . . . . 0.0 109.215 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.859 ' HA ' HD22 ' A' ' 126' ' ' LEU . 2.1 mt -62.54 -17.95 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.592 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -63.27 -35.87 81.79 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.0 mmtm -74.21 -42.21 60.14 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.668 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.859 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.46 -20.61 66.43 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.783 -1.198 . . . . 0.0 108.224 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.592 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 11.3 mtmt -57.98 -36.75 73.05 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -23.66 41.35 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.584 HD13 HD12 ' A' ' 126' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.539 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.569 ' HG3' ' N ' ' A' ' 4' ' ' LEU . 1.7 tttt . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 1.087 ' CD1' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -139.54 110.0 6.62 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.785 ' N ' HD22 ' A' ' 4' ' ' LEU . 4.2 mp0 -96.93 162.47 13.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.109 -0.994 . . . . 0.0 109.804 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.587 HG22 HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -128.92 108.99 18.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.04 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -84.74 64.71 8.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.471 -0.768 . . . . 0.0 109.113 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.741 HG13 ' H ' ' A' ' 9' ' ' GLY . 1.3 p -79.52 -71.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 110.405 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.741 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 60.04 74.04 0.41 Allowed Glycine 0 C--N 1.298 -1.554 0 N-CA-C 106.788 -2.525 . . . . 0.0 106.788 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.679 ' CG1' HD11 ' A' ' 86' ' ' LEU . 0.6 OUTLIER -42.27 142.75 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -178.752 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.647 HD11 ' CB ' ' A' ' 19' ' ' PHE . 2.7 pt -98.14 97.59 6.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.169 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.956 ' HG2' HG23 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -77.44 171.47 14.83 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.608 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 6.1 t30 -148.92 -64.5 0.23 Allowed 'General case' 0 C--O 1.188 -2.134 0 C-N-CA 116.86 -1.936 . . . . 0.0 114.74 -177.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.549 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 3.0 tp10 -91.86 -28.91 17.01 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 118.775 -2.453 . . . . 0.0 111.592 -175.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -162.79 -43.03 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.735 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -160.06 31.31 0.18 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 177.582 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 105' ' ' MET . 36.4 mt-10 -83.01 89.31 6.88 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 117.517 -1.673 . . . . 0.0 108.025 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.956 HG23 ' HG2' ' A' ' 12' ' ' ARG . 1.0 OUTLIER -85.01 150.13 4.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-O 121.644 0.735 . . . . 0.0 110.812 -178.235 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.647 ' CB ' HD11 ' A' ' 11' ' ' ILE . 14.0 t80 -82.66 43.72 0.85 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.639 HD11 ' N ' ' A' ' 34' ' ' GLU . 6.6 tp -80.78 157.39 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 121.37 -0.831 . . . . 0.0 110.386 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.532 ' O ' HG23 ' A' ' 21' ' ' THR . 2.0 t -74.01 86.0 1.8 Allowed 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.609 ' HD2' HD21 ' A' ' 33' ' ' LEU . 15.6 tpt180 -82.55 84.28 7.29 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.205 -0.934 . . . . 0.0 109.922 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.532 ' CB ' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 30.21 64.69 0.15 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.37 0.605 . . . . 0.0 110.359 -179.625 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -45.81 -54.32 8.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.359 -0.838 . . . . 0.0 109.233 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.73 -177.33 3.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -0.892 . . . . 0.0 108.872 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -76.15 86.58 3.01 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.013 -1.054 . . . . 0.0 109.337 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.532 ' HB2' ' CB ' ' A' ' 23' ' ' ARG . . . -68.19 -27.97 66.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.861 . . . . 0.0 109.805 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.592 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 72.7 t60 49.02 24.71 0.93 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -177.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -152.19 -166.65 2.54 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.821 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.523 ' O ' ' OD1' ' A' ' 31' ' ' ASN . . . -137.44 -153.09 0.47 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.523 ' OD1' ' O ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER 63.8 2.79 1.41 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.218 -0.926 . . . . 0.0 109.504 -179.033 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.59 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -83.47 50.43 1.78 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.196 -0.94 . . . . 0.0 110.316 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.728 HD12 ' HB3' ' A' ' 114' ' ' ASP . 12.7 mt -128.74 85.77 2.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.975 -1.078 . . . . 0.0 108.197 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.639 ' N ' HD11 ' A' ' 20' ' ' ILE . 21.8 mt-10 -91.2 -123.52 0.07 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.176 -0.952 . . . . 0.0 110.842 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.707 ' CB ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -160.49 124.0 1.95 Allowed Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 120.579 -1.325 . . . . 0.0 109.832 -178.749 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.62 ' CB ' ' HA ' ' A' ' 97' ' ' LYS . 19.7 Cg_endo -76.7 95.81 1.07 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.415 2.077 . . . . 0.0 110.575 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' CA ' ' HA ' ' A' ' 8' ' ' VAL . . . -145.62 123.4 1.87 Allowed Glycine 0 N--CA 1.499 2.843 0 O-C-N 120.654 -1.279 . . . . 0.0 110.166 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.588 ' HA3' ' OE1' ' A' ' 98' ' ' GLU . . . -103.77 74.22 0.27 Allowed Glycine 0 N--CA 1.491 2.339 0 O-C-N 121.172 -1.193 . . . . 0.0 111.942 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.695 ' CD ' HD23 ' A' ' 4' ' ' LEU . 5.4 tptt 42.07 121.02 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 176.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.04 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -81.65 129.96 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.995 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.495 ' OE1' ' HG2' ' A' ' 39' ' ' LYS . 3.1 pt-20 -171.71 -20.9 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 118.534 -1.267 . . . . 0.0 111.43 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.446 ' HG3' ' HG2' ' A' ' 53' ' ' GLU . 2.5 mmt -39.42 -74.28 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.096 -1.003 . . . . 0.0 109.655 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.57 -132.71 7.38 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -134.34 3.1 3.33 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.625 -0.926 . . . . 0.0 109.101 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.544 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 22.5 m -118.64 142.53 31.78 Favored Pre-proline 0 N--CA 1.486 1.338 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 8.2 Cg_exo -52.76 -17.49 7.35 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.395 1.397 . . . . 0.0 109.653 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.498 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -79.48 -87.97 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.209 -0.932 . . . . 0.0 108.821 178.556 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.571 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 10.6 mt-30 -42.66 -34.29 0.86 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.815 -1.178 . . . . 0.0 109.327 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.643 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -63.88 -62.46 1.63 Allowed 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.069 -1.019 . . . . 0.0 110.119 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.808 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.1 p -69.3 -49.17 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.186 -0.946 . . . . 0.0 110.763 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.558 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 4.2 p -55.32 -44.22 74.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.551 -0.718 . . . . 0.0 110.264 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.571 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -72.35 -36.88 68.9 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 179.375 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.598 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 11.6 mm-40 -69.0 -13.74 62.63 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.847 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.8 OUTLIER -80.37 -61.39 1.99 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.616 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.563 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -58.13 -50.26 74.1 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.747 -0.596 . . . . 0.0 109.891 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.598 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -49.45 -21.57 0.96 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.062 -1.024 . . . . 0.0 110.04 -178.991 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.461 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mt-10 -79.98 -95.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.928 -1.107 . . . . 0.0 109.622 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.612 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 45.4 t -80.12 -78.48 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 110.184 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.06 31.84 0.13 Allowed Glycine 0 N--CA 1.493 2.434 0 C-N-CA 118.626 -1.75 . . . . 0.0 112.476 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.137 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.2 pp -87.13 -153.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 120.372 -1.664 . . . . 0.0 107.639 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.653 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.8 m -135.95 -70.93 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.389 -1.444 . . . . 0.0 110.584 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.653 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 5.8 Cg_endo -63.04 -170.61 0.1 Allowed 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 121.433 1.422 . . . . 0.0 110.719 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.911 HE21 ' HZ2' ' A' ' 95' ' ' TRP . 3.1 pt20 143.0 -24.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.555 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.3 OUTLIER 44.54 71.03 0.28 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.423 -0.798 . . . . 0.0 109.312 178.999 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -67.26 141.98 57.06 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.342 -0.849 . . . . 0.0 109.833 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -132.42 135.85 46.36 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.562 ' O ' ' O ' ' A' ' 84' ' ' PHE . 1.3 tm? -57.53 -64.94 0.72 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.977 -1.077 . . . . 0.0 109.36 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.825 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 80.66 -50.01 0.31 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.589 ' CB ' ' O ' ' A' ' 68' ' ' PHE . 27.1 tt0 150.16 142.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -131.35 178.07 7.0 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 110.541 -178.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.839 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -127.47 166.34 18.13 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.725 0.774 . . . . 0.0 109.887 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -141.0 91.4 2.4 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.83 113.4 16.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.426 ' CG ' ' CD2' ' A' ' 79' ' ' HIS . 2.8 tt0 -91.72 146.79 23.49 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.576 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -133.51 173.02 6.35 Favored Pre-proline 0 C--N 1.296 -1.722 0 O-C-N 121.272 -0.893 . . . . 0.0 108.731 -179.585 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.576 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 7.3 Cg_exo -47.93 -40.5 32.84 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.818 1.678 . . . . 0.0 109.742 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -151.63 45.75 0.78 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HB2' ' CB ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -148.77 93.06 2.07 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.714 -0.616 . . . . 0.0 109.565 -178.962 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.426 ' CD2' ' CG ' ' A' ' 74' ' ' GLU . 22.7 m80 -91.87 73.36 5.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.137 -0.977 . . . . 0.0 108.74 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.087 HG23 ' CD1' ' A' ' 4' ' ' LEU . 3.1 mm -84.52 154.32 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.995 -1.066 . . . . 0.0 110.486 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.468 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 3.2 m -136.51 154.45 50.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.617 ' O ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -139.77 75.53 1.52 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.74 -1.225 . . . . 0.0 110.021 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.593 ' CD1' HG21 ' A' ' 40' ' ' ILE . 89.4 m95 -48.46 124.1 7.6 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 118.6 -1.24 . . . . 0.0 108.611 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.617 ' CD1' ' O ' ' A' ' 82' ' ' LEU . 40.3 m-85 -102.28 71.77 1.25 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.996 -1.065 . . . . 0.0 110.32 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.676 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 76.7 m95 -75.88 85.52 2.83 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.757 -1.214 . . . . 0.0 108.994 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.825 HD23 ' CD2' ' A' ' 68' ' ' PHE . 2.1 mm? -72.58 123.11 22.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.509 -1.369 . . . . 0.0 108.779 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.542 ' O ' ' CG ' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -102.76 176.7 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.542 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 41.3 mt-10 -157.1 16.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.654 -1.218 . . . . 0.0 112.113 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.612 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -159.75 64.39 0.36 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.146 -1.596 . . . . 0.0 111.451 179.131 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.656 ' CH2' ' CD1' ' A' ' 104' ' ' TRP . 2.0 p90 -80.25 168.56 18.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 119.951 -1.718 . . . . 0.0 108.382 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.634 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -89.7 113.95 25.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.077 -1.014 . . . . 0.0 109.05 179.188 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 44.21 -80.87 0.0 OUTLIER Glycine 0 N--CA 1.501 2.984 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 1.137 ' O ' HG21 ' A' ' 60' ' ' ILE . 4.8 mt-10 -82.52 145.7 51.91 Favored Pre-proline 0 C--N 1.298 -1.638 0 O-C-N 120.881 -1.364 . . . . 0.0 109.941 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.627 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 11.7 Cg_endo -79.17 -167.25 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.451 2.101 . . . . 0.0 108.511 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.911 ' HZ2' HE21 ' A' ' 63' ' ' GLN . 0.2 OUTLIER -179.12 34.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.728 -1.233 . . . . 0.0 112.009 178.235 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . -121.36 1.7 11.41 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 178.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.62 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -80.83 127.22 32.28 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.446 -1.032 . . . . 0.0 111.863 -179.014 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.588 ' OE1' ' HA3' ' A' ' 38' ' ' GLY . 32.8 mm-40 -81.84 -135.29 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.13 -19.85 47.38 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.444 ' HG2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -55.21 148.96 28.23 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.866 -0.785 . . . . 0.0 109.84 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 21' ' ' THR . 2.2 Cg_endo -65.28 -37.73 30.05 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.89 1.727 . . . . 0.0 108.418 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.634 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 58.09 115.91 0.01 OUTLIER Glycine 0 N--CA 1.481 1.653 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 18.9 pt-20 -150.4 130.0 13.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.038 -1.272 . . . . 0.0 110.174 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.656 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -46.65 131.96 11.18 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.563 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.95 123.42 42.42 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.14 -0.975 . . . . 0.0 109.338 -178.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.99 46.87 1.15 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.334 -0.854 . . . . 0.0 108.873 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.997 HD22 ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -75.07 -28.95 60.54 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.916 ' N ' HD13 ' A' ' 107' ' ' LEU . 49.0 t 55.91 123.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.713 -0.617 . . . . 0.0 110.495 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.54 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 42.83 82.77 0.02 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.814 HD22 ' HD2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -45.45 175.01 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.562 -0.964 . . . . 0.0 109.433 -177.338 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.729 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 1.5 t30 -143.8 -5.64 0.8 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.266 -1.521 . . . . 0.0 112.762 -177.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 82.35 -35.75 0.09 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.039 -1.038 . . . . 0.0 108.405 -177.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -54.76 -24.9 24.56 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.728 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -105.38 -17.41 14.45 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.439 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.814 ' HD2' HD22 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -91.61 122.43 65.73 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.397 -0.814 . . . . 0.0 109.14 179.09 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.516 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 14.1 Cg_exo -48.49 147.52 9.08 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.836 1.69 . . . . 0.0 110.446 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.455 ' HA ' ' CG ' ' A' ' 120' ' ' GLU . 3.5 Cg_exo -60.27 -30.58 91.46 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.496 2.13 . . . . 0.0 110.99 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.89 -61.59 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 109.57 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.551 ' CG ' ' CZ ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -88.71 51.6 2.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.353 -0.842 . . . . 0.0 109.134 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.627 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -70.29 -40.68 12.34 Favored Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -179.079 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 5.7 Cg_exo -54.36 -47.21 28.12 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 121.928 1.752 . . . . 0.0 113.12 -177.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 71' ' ' LEU . 2.1 t -87.62 -28.19 5.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 120.581 -1.325 . . . . 0.0 109.118 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.877 ' HA ' HD22 ' A' ' 126' ' ' LEU . 1.1 mp -67.48 -23.16 29.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.511 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -58.61 -28.14 65.33 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -81.01 -41.1 23.24 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.265 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.877 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -64.59 -26.45 68.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.507 -1.371 . . . . 0.0 107.476 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 14.8 mtmt -50.75 -37.37 41.53 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -83.53 -27.54 29.28 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.869 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 126' ' ' LEU . 1.1 tp . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.838 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.101 0.477 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.554 ' HG2' ' N ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -150.94 171.4 17.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.04 -1.038 . . . . 0.0 109.471 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.554 ' N ' ' HG2' ' A' ' 2' ' ' LYS . 20.3 tttt -145.17 152.67 40.38 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.868 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 1.083 ' O ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -158.25 150.87 22.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 1.056 ' N ' HD22 ' A' ' 4' ' ' LEU . 0.9 OUTLIER -121.38 161.59 21.86 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.093 -1.005 . . . . 0.0 109.231 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.639 HD11 ' C8 ' ' A' ' 130' ' ' APC . 0.3 OUTLIER -124.4 114.94 43.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.253 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.984 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -84.07 64.46 8.2 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -79.21 -79.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.206 -179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.724 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 73.97 85.76 0.26 Allowed Glycine 0 C--N 1.298 -1.571 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.554 HD13 ' HE1' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -49.43 169.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.03 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.922 HG22 HG13 ' A' ' 87' ' ' VAL . 7.1 pt -137.92 78.1 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.271 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.633 ' HB3' HG23 ' A' ' 18' ' ' ILE . 5.7 ptm180 -82.19 137.87 34.82 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.47 ' OD1' ' CH2' ' A' ' 90' ' ' TRP . 0.8 OUTLIER -158.58 0.23 0.09 Allowed 'General case' 0 C--O 1.187 -2.22 0 C-N-CA 116.748 -1.981 . . . . 0.0 114.805 -177.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.537 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 22.0 tt0 -92.85 -32.52 14.59 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 118.246 -2.784 . . . . 0.0 106.923 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.402 ' C ' ' OD1' ' A' ' 15' ' ' ASN . 16.4 t-20 -163.79 -48.49 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 101.844 -3.391 . . . . 0.0 101.844 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.728 HD21 HD12 ' A' ' 110' ' ' LEU . 56.1 t30 -161.74 37.4 0.13 Allowed 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 175.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.537 ' CG ' ' HB3' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -90.17 101.45 14.17 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.013 -177.166 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.633 HG23 ' HB3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -89.34 149.78 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 122.003 0.906 . . . . 0.0 110.518 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.779 ' HB3' HD11 ' A' ' 11' ' ' ILE . 44.7 t80 -82.98 41.94 0.77 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.703 HD11 ' C ' ' A' ' 34' ' ' GLU . 6.3 tp -81.07 156.23 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 122.193 0.996 . . . . 0.0 111.58 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.487 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -64.39 95.05 0.12 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.835 ' HD3' HD21 ' A' ' 33' ' ' LEU . 32.4 tpt180 -104.82 78.95 1.47 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.211 -0.931 . . . . 0.0 111.055 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.87 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 25.33 76.44 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 120.97 0.415 . . . . 0.0 110.706 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.69 -48.53 5.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.43 -0.794 . . . . 0.0 109.07 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.65 154.15 27.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.409 -0.807 . . . . 0.0 108.858 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.71 110.93 1.89 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.047 -1.033 . . . . 0.0 109.16 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.87 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -100.0 149.96 22.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 110.003 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.09 -20.54 52.07 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.424 ' SD ' ' N ' ' A' ' 29' ' ' MET . 2.7 mpp? -97.53 -166.78 1.43 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -156.78 18.65 0.32 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.014 -1.054 . . . . 0.0 110.217 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.0 m-20 -99.67 17.28 20.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.072 -1.017 . . . . 0.0 108.879 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.512 ' HD2' ' CA ' ' A' ' 23' ' ' ARG . 1.1 tttp -81.52 39.5 0.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.386 -0.821 . . . . 0.0 111.124 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.853 HD13 ' CE1' ' A' ' 115' ' ' PHE . 19.9 mt -107.33 91.91 3.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.826 -1.171 . . . . 0.0 109.351 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.703 ' C ' HD11 ' A' ' 20' ' ' ILE . 37.9 tt0 -91.16 -128.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.314 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 17.9 m-85 -157.11 131.91 5.31 Favored Pre-proline 0 N--CA 1.485 1.324 0 O-C-N 120.81 -1.181 . . . . 0.0 109.758 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.7 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.4 Cg_endo -61.01 88.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.51 2.14 . . . . 0.0 110.435 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -54.65 -160.16 0.01 OUTLIER Glycine 0 N--CA 1.494 2.518 0 O-C-N 121.314 -0.866 . . . . 0.0 111.061 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 163.87 -28.85 0.23 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.641 ' CD ' HD23 ' A' ' 4' ' ' LEU . 0.1 OUTLIER 69.91 102.32 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.973 -0.722 . . . . 0.0 111.058 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.984 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -81.54 132.32 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.199 -0.938 . . . . 0.0 108.928 178.452 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -171.64 -32.55 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 109.739 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.409 ' HB2' ' HA ' ' A' ' 49' ' ' ALA . 8.7 mmt -53.02 161.61 0.78 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 109.744 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.04 -121.13 12.52 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -168.99 25.03 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.496 -1.002 . . . . 0.0 108.925 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.685 HG23 ' HD2' ' A' ' 46' ' ' PRO . 63.4 m -154.24 144.37 15.64 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.685 ' HD2' HG23 ' A' ' 45' ' ' THR . 10.8 Cg_exo -48.37 -16.43 0.68 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.894 1.73 . . . . 0.0 111.443 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.586 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.5 mt-10 -78.6 -72.71 0.36 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.744 -1.222 . . . . 0.0 109.124 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.554 ' HA ' HG12 ' A' ' 51' ' ' VAL . 7.3 mt-30 -56.48 -30.87 63.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.399 -1.438 . . . . 0.0 109.321 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.675 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -67.14 -63.24 1.1 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.475 -0.766 . . . . 0.0 109.816 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.845 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.3 p -67.91 -48.19 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.051 -1.031 . . . . 0.0 110.463 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.6 p -55.73 -42.57 70.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 121.188 0.518 . . . . 0.0 110.334 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 2.4 mmm180 -77.65 -29.79 51.81 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.631 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 21.1 mm-40 -75.75 -11.88 60.08 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.73 HD12 ' CE2' ' A' ' 95' ' ' TRP . 0.7 OUTLIER -80.17 -57.19 3.74 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.755 0.788 . . . . 0.0 108.989 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.507 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -65.38 -42.0 93.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.896 -0.502 . . . . 0.0 110.946 -179.421 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.595 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -57.57 -24.43 56.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.094 -1.004 . . . . 0.0 111.556 -177.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.57 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -80.21 -83.03 0.11 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.409 -1.432 . . . . 0.0 110.572 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.571 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 74.6 t -80.27 -80.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.037 -1.039 . . . . 0.0 110.007 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.21 32.8 0.1 OUTLIER Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.325 -1.417 . . . . 0.0 110.837 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.053 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.8 pp -94.27 -159.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.809 -1.407 . . . . 0.0 108.419 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.63 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.8 m -135.45 -70.87 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.773 -1.205 . . . . 0.0 110.637 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 2.6 Cg_endo -59.3 -171.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.084 0 C-N-CA 121.487 1.458 . . . . 0.0 110.402 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.584 ' HB2' HG21 ' A' ' 87' ' ' VAL . 2.6 pt20 144.03 -22.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.581 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.3 OUTLIER 43.82 72.12 0.21 Allowed 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -69.54 149.17 48.49 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.836 0.826 . . . . 0.0 110.898 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -143.66 144.91 32.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.319 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.84 HD13 ' N ' ' A' ' 69' ' ' GLU . 1.9 tm? -66.29 -68.72 0.35 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.774 -1.204 . . . . 0.0 110.25 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.825 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 81.35 -51.72 0.28 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 -178.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.84 ' N ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER 167.74 179.12 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 109.242 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -159.72 158.01 30.53 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.045 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.716 HD11 ' HB2' ' A' ' 82' ' ' LEU . 1.1 pp -117.93 -177.26 3.22 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.026 -1.047 . . . . 0.0 110.192 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.677 ' HG3' HG23 ' A' ' 81' ' ' THR . 6.8 tt0 -154.84 89.69 1.25 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.524 ' CE2' ' O ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -79.55 127.12 31.76 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.157 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -100.98 133.84 44.87 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.06 -1.025 . . . . 0.0 109.482 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.538 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -116.9 171.09 5.16 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 108.843 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 6.9 Cg_exo -48.23 -47.24 20.28 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.992 1.794 . . . . 0.0 110.196 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.451 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 5.4 p-10 -141.26 33.05 1.7 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.484 ' O ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -140.15 93.14 2.6 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.554 -0.716 . . . . 0.0 110.32 -179.048 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -82.7 92.94 7.28 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.62 HG21 ' C6 ' ' A' ' 130' ' ' APC . 0.3 OUTLIER -97.68 163.42 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -0.963 . . . . 0.0 111.26 -177.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.677 HG23 ' HG3' ' A' ' 72' ' ' GLU . 1.3 m -140.46 168.71 19.17 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.716 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -157.31 85.23 0.93 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.539 -1.351 . . . . 0.0 110.595 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.64 ' CD1' HG21 ' A' ' 40' ' ' ILE . 70.6 m95 -58.49 126.56 28.1 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.303 -0.873 . . . . 0.0 109.418 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.775 ' CE2' HG11 ' A' ' 122' ' ' VAL . 19.1 m-85 -101.57 70.73 1.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 0.0 109.878 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.717 ' CE2' HD23 ' A' ' 67' ' ' LEU . 93.6 m95 -74.26 91.25 2.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.943 -1.098 . . . . 0.0 108.983 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.825 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.5 mm? -73.48 126.58 30.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.208 -0.932 . . . . 0.0 110.489 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.922 HG13 HG22 ' A' ' 11' ' ' ILE . 1.5 m -112.02 169.18 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 78.0 mt-10 -149.55 17.37 0.91 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.487 -1.383 . . . . 0.0 112.954 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.605 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.26 67.51 0.36 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.089 -1.632 . . . . 0.0 110.56 178.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.612 ' CE3' ' HB3' ' A' ' 94' ' ' PRO . 1.8 p90 -80.74 164.79 22.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.329 -1.482 . . . . 0.0 109.656 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.667 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.9 OUTLIER -80.86 141.97 34.09 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.105 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.477 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 27.92 -80.33 0.0 OUTLIER Glycine 0 N--CA 1.502 3.046 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 1.053 ' O ' HG21 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -100.55 151.7 37.64 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.335 -1.097 . . . . 0.0 109.63 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.636 ' HG2' ' CD1' ' A' ' 19' ' ' PHE . 9.9 Cg_endo -73.94 -158.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.724 2.282 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.904 ' CE2' HD11 ' A' ' 60' ' ' ILE . 0.2 OUTLIER 177.53 112.53 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.644 -0.66 . . . . 0.0 109.784 179.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . 174.47 -40.83 0.13 Allowed Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.405 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.548 ' HB2' ' CG ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -44.4 124.24 3.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.101 -1.235 . . . . 0.0 109.489 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.51 ' OE1' ' O2G' ' A' ' 130' ' ' APC . 8.2 tp10 -74.7 -111.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.713 -1.242 . . . . 0.0 107.687 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.76 12.25 64.14 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.548 ' CG ' ' HB2' ' A' ' 97' ' ' LYS . 6.4 pt20 -92.97 170.13 9.33 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.696 -0.885 . . . . 0.0 109.495 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -68.69 -48.67 0.95 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.022 1.814 . . . . 0.0 110.281 -179.717 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.594 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.62 118.52 0.01 OUTLIER Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.605 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 4.5 pt-20 -157.18 145.19 19.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.932 -1.334 . . . . 0.0 110.44 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.4 ' HE1' ' HG3' ' A' ' 94' ' ' PRO . 1.3 m0 -48.58 135.16 14.87 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.499 ' HG2' ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -129.88 112.95 14.05 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.081 -1.012 . . . . 0.0 109.492 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.9 t -78.22 73.33 4.78 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.825 HD13 ' HG ' ' A' ' 110' ' ' LEU . 8.0 tt -80.7 -66.51 0.87 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.433 -0.792 . . . . 0.0 109.792 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.635 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 99.3 t 103.75 98.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 41.98 82.57 0.02 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.825 ' HG ' HD13 ' A' ' 107' ' ' LEU . 2.1 mp -29.96 153.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.962 0.887 . . . . 0.0 111.612 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.638 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -132.38 -6.26 3.35 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.692 -0.63 . . . . 0.0 110.618 -178.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 73.88 -3.26 2.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.217 -0.927 . . . . 0.0 108.806 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.82 -22.31 40.11 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.696 ' HB3' HD12 ' A' ' 33' ' ' LEU . 14.9 m-20 -104.92 -10.42 17.3 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.853 ' CE1' HD13 ' A' ' 33' ' ' LEU . 27.7 m-85 -102.7 144.99 29.72 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.395 -0.815 . . . . 0.0 109.557 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.537 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 2.3 Cg_endo -65.6 151.19 85.41 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.547 2.165 . . . . 0.0 110.94 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.518 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . 1.6 Cg_endo -65.33 -23.75 58.54 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.239 1.959 . . . . 0.0 109.824 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.524 ' O ' ' CE2' ' A' ' 73' ' ' TYR . . . -46.14 -58.49 3.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.384 -0.822 . . . . 0.0 109.686 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.561 ' O ' HD12 ' A' ' 123' ' ' ILE . 36.8 m-80 -85.82 45.3 1.19 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 108.892 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.651 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 2.6 mt-10 -59.56 -43.66 96.19 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 121.378 -0.826 . . . . 0.0 112.137 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 7.7 Cg_exo -53.18 -36.44 77.3 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.058 1.839 . . . . 0.0 112.537 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.775 HG11 ' CE2' ' A' ' 84' ' ' PHE . 2.0 t -100.42 -38.0 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.611 -1.305 . . . . 0.0 109.707 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.731 ' HA ' HD22 ' A' ' 126' ' ' LEU . 6.8 mt -56.94 -27.54 26.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.49 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -60.7 -39.0 86.9 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 125' ' ' LYS . 13.7 mmtp -76.11 -40.13 53.59 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.212 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.731 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.2 OUTLIER -55.45 -43.23 75.26 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.546 ' HD3' ' CB ' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -39.58 -41.81 1.08 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.997 0.903 . . . . 0.0 108.652 178.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 129' ' ' LEU . 1.0 OUTLIER -79.21 -50.99 10.09 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.687 HD13 ' HA ' ' A' ' 126' ' ' LEU . 1.8 tp . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.608 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 130' ' ' APC . . . . . 0.639 ' C8 ' HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.512 ' HD3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -159.05 -131.05 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.175 -0.953 . . . . 0.0 109.033 179.845 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.541 ' CG ' ' O ' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -148.99 158.69 44.38 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.234 -1.541 . . . . 0.0 110.339 -178.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 5' ' ' GLN . 0.7 OUTLIER -136.1 -171.92 3.0 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.087 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.761 ' HB2' HG23 ' A' ' 40' ' ' ILE . 7.8 mp0 -144.05 177.96 8.2 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.586 HG13 ' N7 ' ' A' ' 130' ' ' APC . 0.2 OUTLIER -145.65 109.87 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.72 -178.634 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.034 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -83.0 67.26 9.01 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.753 HG21 ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -78.83 -73.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.177 -0.952 . . . . 0.0 109.385 -179.514 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.721 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 62.61 81.7 0.09 OUTLIER Glycine 0 C--N 1.295 -1.747 0 N-CA-C 107.958 -2.057 . . . . 0.0 107.958 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.48 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -48.04 172.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.318 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.056 HG22 HG22 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -136.73 81.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.121 -178.551 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.949 ' HB3' HG23 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -91.61 134.96 34.23 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.059 -1.026 . . . . 0.0 108.344 179.345 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.505 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 4.2 p30 -161.66 62.2 0.26 Allowed 'General case' 0 C--O 1.189 -2.119 0 C-N-CA 117.596 -1.641 . . . . 0.0 113.158 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.589 ' CB ' ' HG3' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -148.7 -49.55 0.15 Allowed 'General case' 0 C--N 1.269 -2.92 0 CA-C-O 124.499 2.095 . . . . 0.0 105.616 176.18 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -161.17 -48.54 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 100.885 -3.746 . . . . 0.0 100.885 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.489 ' ND2' ' HD2' ' A' ' 12' ' ' ARG . 1.7 t-20 -162.34 42.52 0.13 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.31 -1.768 . . . . 0.0 106.684 175.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.589 ' HG3' ' CB ' ' A' ' 14' ' ' GLU . 9.4 mm-40 -93.46 95.93 9.58 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.962 -1.495 . . . . 0.0 110.901 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.949 HG23 ' HB3' ' A' ' 12' ' ' ARG . 2.7 pt -89.01 153.83 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.637 -0.664 . . . . 0.0 110.362 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.656 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 3.7 t80 -83.15 47.73 1.28 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.692 ' HB ' HD12 ' A' ' 18' ' ' ILE . 5.2 tt -82.36 155.42 3.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.986 0.898 . . . . 0.0 111.299 -177.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.54 HG23 ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -70.07 98.14 1.27 Allowed 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.554 HH22 ' HB1' ' A' ' 30' ' ' ALA . 28.9 tpt180 -104.46 97.3 7.25 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 110.662 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.939 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 24.49 76.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.211 0.529 . . . . 0.0 110.93 179.186 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -44.61 -52.62 7.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.111 -0.993 . . . . 0.0 109.555 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.27 -178.18 6.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.167 -0.958 . . . . 0.0 109.412 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.71 107.06 8.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.24 -0.913 . . . . 0.0 108.934 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.939 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -101.02 171.96 7.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 110.119 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -127.73 16.08 6.94 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.755 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 4.3 mtm -121.29 -106.33 0.37 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.442 -0.786 . . . . 0.0 109.69 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 148.85 -4.32 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.696 -0.627 . . . . 0.0 110.503 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.461 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 50.3 t-20 -76.27 6.65 5.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.616 -1.302 . . . . 0.0 109.425 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' HD23 ' A' ' 33' ' ' LEU . 4.1 tmtm? -81.29 62.85 5.38 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.535 -0.728 . . . . 0.0 110.857 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.706 HD13 ' CE1' ' A' ' 115' ' ' PHE . 10.6 mt -124.22 90.29 3.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.052 -1.03 . . . . 0.0 109.045 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.54 ' H ' HG23 ' A' ' 21' ' ' THR . 1.2 tt0 -90.23 -144.97 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.903 -1.123 . . . . 0.0 108.794 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.753 ' HB3' HG21 ' A' ' 8' ' ' VAL . 66.7 m-85 -145.93 124.27 6.41 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 120.901 -1.124 . . . . 0.0 110.019 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.685 ' O ' HG23 ' A' ' 8' ' ' VAL . 9.5 Cg_endo -65.79 90.48 0.24 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.194 1.929 . . . . 0.0 110.219 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.665 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -131.0 127.65 5.22 Favored Glycine 0 N--CA 1.494 2.562 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.368 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.557 ' HA2' ' CG ' ' A' ' 98' ' ' GLU . . . -106.65 38.26 3.41 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 120.05 -1.072 . . . . 0.0 111.163 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.59 ' HB2' H3A2 ' A' ' 130' ' ' APC . 10.5 tptm 60.24 120.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.777 -0.837 . . . . 0.0 111.433 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.034 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -82.59 133.51 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.292 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 42' ' ' MET . 1.8 pt-20 -171.83 -25.64 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.548 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.449 ' HE3' ' HG2' ' A' ' 56' ' ' GLU . 3.3 tpp -54.57 129.65 37.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.856 -1.153 . . . . 0.0 109.27 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.12 -120.78 12.54 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -168.27 22.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.402 -1.058 . . . . 0.0 109.716 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.794 HG22 ' H ' ' A' ' 47' ' ' GLU . 20.6 m -140.9 138.91 18.65 Favored Pre-proline 0 C--O 1.201 -1.486 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.608 ' O ' HG12 ' A' ' 50' ' ' VAL . 8.6 Cg_exo -48.57 -16.52 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.829 1.686 . . . . 0.0 111.344 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.794 ' H ' HG22 ' A' ' 45' ' ' THR . 2.7 mt-10 -80.42 -78.7 0.16 Allowed 'General case' 0 C--O 1.201 -1.491 0 O-C-N 120.587 -1.321 . . . . 0.0 108.61 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.548 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 79.6 mt-30 -50.14 -30.75 11.87 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.389 -1.444 . . . . 0.0 109.364 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.776 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -68.6 -60.36 2.47 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.113 -0.992 . . . . 0.0 110.504 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.766 HG23 ' HB1' ' A' ' 7' ' ' ALA . 4.3 p -70.09 -45.83 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.718 -1.239 . . . . 0.0 110.227 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.583 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 1.4 p -58.12 -47.77 86.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.302 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.583 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -73.48 -36.13 65.78 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.643 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 21.7 mm-40 -65.22 -19.83 66.15 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.133 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -78.31 -63.39 1.41 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.885 -178.697 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.559 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -58.94 -44.5 91.4 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.356 -0.84 . . . . 0.0 110.092 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.588 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -54.92 -20.71 9.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.108 -0.995 . . . . 0.0 110.193 -179.239 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.429 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mt-10 -80.26 -92.82 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.065 -1.022 . . . . 0.0 109.837 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.593 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 47.9 t -80.21 -78.98 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.346 -0.846 . . . . 0.0 110.045 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.88 27.51 0.13 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 118.599 -1.762 . . . . 0.0 112.723 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.102 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.3 pp -81.49 -144.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 120.181 -1.776 . . . . 0.0 107.582 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.619 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.3 m -143.07 -71.26 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.206 -1.559 . . . . 0.0 110.24 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 9.4 Cg_endo -67.01 -170.01 0.21 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.249 1.3 . . . . 0.0 110.127 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.592 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.9 OUTLIER 136.28 -26.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.536 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 0.2 OUTLIER 56.64 -163.31 0.17 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.444 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 7.2 p90 177.11 143.75 0.09 Allowed 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.533 -1.267 . . . . 0.0 110.585 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.591 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -144.13 157.06 44.53 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.05 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.619 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -74.29 -69.92 0.42 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.251 -0.906 . . . . 0.0 110.856 -178.699 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.839 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 83.99 -51.85 0.13 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.596 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.2 mt-10 157.3 175.05 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HA ' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -161.42 -168.6 2.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.953 -1.092 . . . . 0.0 110.115 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.844 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -147.36 161.41 41.07 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.49 -0.756 . . . . 0.0 109.947 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 80' ' ' ILE . 2.6 tt0 -137.42 90.09 2.48 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.03 119.88 25.47 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.439 -0.788 . . . . 0.0 109.119 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.522 ' HG3' ' HA ' ' A' ' 79' ' ' HIS . 11.1 tt0 -112.2 155.78 23.41 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.318 -0.864 . . . . 0.0 109.824 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.751 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 67.4 m-85 -136.76 -115.22 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.641 0 CA-C-O 117.341 -1.314 . . . . 0.0 109.3 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.751 ' CD ' ' CB ' ' A' ' 75' ' ' PHE . 1.9 Cg_endo -62.44 -43.81 20.9 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 CA-C-N 122.077 1.777 . . . . 0.0 109.895 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -171.4 29.9 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.413 ' HD2' HD11 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -106.91 88.73 2.81 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.488 -0.757 . . . . 0.0 109.933 -179.221 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.541 ' O ' ' CG ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -79.66 79.84 6.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 108.797 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.134 HG21 ' C5 ' ' A' ' 130' ' ' APC . 2.7 mm -85.0 145.3 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.036 -1.04 . . . . 0.0 110.725 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -120.98 139.43 53.29 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.757 HD13 HN61 ' A' ' 130' ' ' APC . 0.2 OUTLIER -124.44 74.07 1.29 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.949 -1.094 . . . . 0.0 109.658 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.451 ' HD1' HG21 ' A' ' 40' ' ' ILE . 80.1 m95 -53.53 114.02 1.37 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.033 -1.042 . . . . 0.0 109.48 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.725 ' CZ ' HG11 ' A' ' 122' ' ' VAL . 32.4 m-85 -89.53 78.11 7.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.138 -0.976 . . . . 0.0 108.379 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.665 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 97.7 m95 -74.37 85.77 1.98 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.014 -1.054 . . . . 0.0 109.228 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.839 HD23 ' CD2' ' A' ' 68' ' ' PHE . 2.5 mm? -68.88 124.91 24.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.397 -1.439 . . . . 0.0 110.061 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.056 HG22 HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -113.01 178.87 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.537 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 13.8 mt-10 -160.16 33.46 0.17 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 118.103 -1.439 . . . . 0.0 112.881 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.565 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -161.02 47.08 0.21 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 119.803 -1.811 . . . . 0.0 112.404 179.117 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.609 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 1.4 p90 -70.57 160.69 32.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 119.863 -1.773 . . . . 0.0 108.991 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -90.29 146.5 24.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.189 -0.944 . . . . 0.0 108.614 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.453 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . 35.94 -82.33 0.0 OUTLIER Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 1.102 ' O ' HG21 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -112.25 157.77 39.0 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.334 -1.097 . . . . 0.0 110.009 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.624 ' HG2' ' CE2' ' A' ' 19' ' ' PHE . 9.0 Cg_endo -76.21 -159.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.993 2.462 . . . . 0.0 110.614 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 1.133 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -177.87 39.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.862 -1.149 . . . . 0.0 111.189 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -124.81 -7.57 6.05 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.021 -1.562 . . . . 0.0 111.497 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.556 ' HD2' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -63.44 103.72 0.55 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.717 -1.461 . . . . 0.0 110.998 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.557 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 9.6 tp10 -70.14 92.43 0.75 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -0.99 . . . . 0.0 108.509 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.22 14.99 42.67 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.505 ' HG2' ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -96.69 146.56 31.52 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.6 -0.941 . . . . 0.0 109.027 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.567 ' O ' ' O ' ' A' ' 102' ' ' GLY . 4.9 Cg_exo -58.63 -21.38 55.12 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 N-CA-C 108.385 -1.429 . . . . 0.0 108.385 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.656 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 37.13 105.03 0.01 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -141.43 131.39 24.52 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.382 -1.658 . . . . 0.0 110.483 179.309 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.434 ' C ' ' O ' ' A' ' 103' ' ' GLU . 1.6 m0 -46.17 129.26 10.05 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.541 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -123.4 117.07 24.35 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.623 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.33 63.31 5.6 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.811 HD13 ' HG ' ' A' ' 110' ' ' LEU . 6.9 tt -69.06 -54.06 17.09 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.59 -0.693 . . . . 0.0 110.118 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.678 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 66.6 t 85.32 108.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 129' ' ' LEU . . . 46.87 82.51 0.03 OUTLIER Glycine 0 N--CA 1.486 1.968 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 -178.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.811 ' HG ' HD13 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -34.48 160.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.981 0.896 . . . . 0.0 111.738 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -156.59 141.42 17.04 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.65 ' HB2' ' HD3' ' A' ' 127' ' ' LYS . . . -65.93 -22.34 66.49 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.92 -25.19 4.29 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.604 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -108.17 -18.77 13.69 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.706 ' CE1' HD13 ' A' ' 33' ' ' LEU . 44.5 m-85 -100.54 149.64 36.29 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.881 . . . . 0.0 110.605 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.439 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -66.95 144.77 71.67 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.518 2.145 . . . . 0.0 109.941 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 1.6 Cg_endo -64.35 -28.22 63.27 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.997 1.798 . . . . 0.0 110.15 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -43.05 -41.08 3.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 109.892 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.415 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 63.2 m-20 -108.71 55.72 0.63 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.246 -0.909 . . . . 0.0 109.357 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.681 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -71.76 -35.96 4.05 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.555 -0.715 . . . . 0.0 112.585 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.9 Cg_exo -59.07 -31.37 95.45 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.653 1.569 . . . . 0.0 113.174 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.725 HG11 ' CZ ' ' A' ' 84' ' ' PHE . 1.8 t -99.97 -38.58 6.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.376 -1.452 . . . . 0.0 109.342 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.785 HD13 HD23 ' A' ' 126' ' ' LEU . 2.0 mm -58.86 -37.31 66.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.515 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -39.74 -37.3 0.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.144 0.973 . . . . 0.0 108.946 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.485 ' HE2' ' OE2' ' A' ' 69' ' ' GLU . 7.2 mmtm -81.65 -47.33 13.14 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.802 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.785 HD23 HD13 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -64.62 -10.33 25.77 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.378 -1.451 . . . . 0.0 109.093 179.531 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.65 ' HD3' ' HB2' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -68.75 -37.71 79.58 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -12.29 59.81 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.333 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.59 HD21 ' CZ ' ' A' ' 12' ' ' ARG . 3.0 tp . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.79 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 130' ' ' APC . . . . . 1.134 ' C5 ' HG21 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' CON . . . . . 0.621 ' N3 ' ' O2A' ' A' ' 130' ' ' APC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.418 ' C ' ' HG3' ' A' ' 2' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.515 0.674 . . . . 0.0 109.386 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.454 ' HD3' ' C ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -178.19 -165.2 0.09 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.363 -0.835 . . . . 0.0 109.019 -179.802 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.522 ' HG2' ' N ' ' A' ' 4' ' ' LEU . 6.1 ttpt -143.63 153.24 42.31 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.061 -1.025 . . . . 0.0 109.991 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 1.095 ' O ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -154.11 156.06 36.54 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.069 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.912 ' N ' HD22 ' A' ' 4' ' ' LEU . 1.4 mp0 -124.94 173.66 8.49 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.027 -1.046 . . . . 0.0 108.531 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.713 HG22 HG12 ' A' ' 8' ' ' VAL . 1.1 mm -136.47 110.14 9.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.704 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.881 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -84.63 62.17 7.17 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 36' ' ' PRO . 1.1 p -78.29 -70.0 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.363 -0.835 . . . . 0.0 109.902 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.734 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 59.82 80.82 0.09 OUTLIER Glycine 0 C--N 1.297 -1.615 0 N-CA-C 107.055 -2.418 . . . . 0.0 107.055 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -48.4 170.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -178.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.688 HD11 ' CB ' ' A' ' 19' ' ' PHE . 7.7 pt -137.67 99.84 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 C-N-CA 119.406 -0.918 . . . . 0.0 108.768 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.77 ' HG2' HG22 ' A' ' 18' ' ' ILE . 13.3 mtm180 -76.68 -176.54 3.85 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.622 ' C ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -157.17 -61.42 0.09 Allowed 'General case' 0 C--O 1.191 -2.01 0 C-N-CA 116.957 -1.897 . . . . 0.0 114.527 -177.457 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.621 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 1.9 tt0 -93.3 -30.12 15.31 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 119.038 -2.289 . . . . 0.0 111.435 -175.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -160.85 -43.52 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.804 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.57 ' OD1' HD23 ' A' ' 129' ' ' LEU . 14.1 t30 -158.32 34.99 0.24 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 177.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.621 ' HG3' ' HB3' ' A' ' 14' ' ' GLU . 2.4 mt-10 -78.74 83.77 4.87 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 117.965 -1.494 . . . . 0.0 108.764 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.77 HG22 ' HG2' ' A' ' 12' ' ' ARG . 4.7 pt -80.08 142.54 13.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 119.684 -0.807 . . . . 0.0 109.425 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.713 ' CZ ' ' HG2' ' A' ' 94' ' ' PRO . 10.2 t80 -80.19 42.9 0.59 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.699 -0.626 . . . . 0.0 109.544 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.79 HG21 HD22 ' A' ' 33' ' ' LEU . 6.8 tp -82.11 155.62 4.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 122.012 0.91 . . . . 0.0 111.579 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.769 ' O ' HG23 ' A' ' 21' ' ' THR . 7.6 t -64.92 96.48 0.19 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.739 ' HD3' HD21 ' A' ' 33' ' ' LEU . 27.1 tpt180 -98.16 87.44 3.93 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.423 -0.798 . . . . 0.0 110.257 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.75 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 36.79 84.43 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.896 -0.503 . . . . 0.0 109.969 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.59 -51.78 5.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.377 -0.827 . . . . 0.0 109.092 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.89 -160.48 0.16 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -76.17 -43.66 41.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.019 -1.051 . . . . 0.0 109.307 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.75 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . 52.89 110.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.35 -0.844 . . . . 0.0 110.24 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -78.96 -6.13 55.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.981 -1.074 . . . . 0.0 108.981 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.728 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 3.1 mpp? -86.81 -124.64 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.188 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 161.49 -2.33 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.833 -1.167 . . . . 0.0 111.647 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 3.8 p-10 -81.96 13.11 3.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.239 -1.538 . . . . 0.0 109.115 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.599 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -81.41 58.99 3.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.599 -0.688 . . . . 0.0 110.322 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.79 HD22 HG21 ' A' ' 20' ' ' ILE . 14.4 mt -130.61 85.46 2.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.945 -1.097 . . . . 0.0 109.097 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.584 ' C ' HD11 ' A' ' 20' ' ' ILE . 3.2 tt0 -92.94 -127.63 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -0.975 . . . . 0.0 108.879 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.673 ' HB2' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -151.9 134.54 8.81 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.942 -1.099 . . . . 0.0 108.46 178.521 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.736 ' O ' HG23 ' A' ' 8' ' ' VAL . 4.5 Cg_endo -62.09 92.91 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.924 1.749 . . . . 0.0 109.541 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.528 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -54.56 -152.86 0.01 OUTLIER Glycine 0 N--CA 1.493 2.455 0 CA-C-O 122.051 0.806 . . . . 0.0 111.378 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.593 ' N ' ' CG ' ' A' ' 98' ' ' GLU . . . 162.07 -26.35 0.25 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' HD3' " O5'" ' A' ' 130' ' ' APC . 15.7 tptm 64.09 96.94 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.933 -0.745 . . . . 0.0 110.183 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.881 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -80.4 133.17 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.206 -0.933 . . . . 0.0 108.574 178.759 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.495 ' HG2' ' N ' ' A' ' 42' ' ' MET . 2.9 pt-20 -170.6 -32.88 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.464 -0.773 . . . . 0.0 109.721 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.495 ' N ' ' HG2' ' A' ' 41' ' ' GLU . 8.0 mtt -59.17 166.43 2.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.203 -0.936 . . . . 0.0 109.696 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 51.66 -125.77 27.12 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -169.38 26.66 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.448 -1.03 . . . . 0.0 109.2 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.783 HG22 ' H ' ' A' ' 47' ' ' GLU . 18.5 m -155.32 141.63 13.11 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.697 ' O ' HG12 ' A' ' 50' ' ' VAL . 15.0 Cg_exo -45.66 -18.44 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.072 1.848 . . . . 0.0 111.176 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.783 ' H ' HG22 ' A' ' 45' ' ' THR . 3.4 mt-10 -77.49 -80.64 0.1 Allowed 'General case' 0 C--O 1.2 -1.541 0 O-C-N 120.827 -1.171 . . . . 0.0 108.773 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.542 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 38.0 mt-30 -48.65 -32.84 8.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.307 -1.496 . . . . 0.0 109.287 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.801 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -65.81 -62.75 1.33 Allowed 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.367 -0.833 . . . . 0.0 110.437 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.881 HG23 ' HB1' ' A' ' 7' ' ' ALA . 4.3 p -70.23 -44.24 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.724 -1.235 . . . . 0.0 110.641 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.4 p -59.4 -43.49 90.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 121.769 -0.582 . . . . 0.0 110.326 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.1 OUTLIER -73.58 -48.19 34.69 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.624 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 7.7 mm-40 -59.95 -18.63 46.82 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.8 HD23 ' O ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -78.8 -65.36 1.0 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.582 0.706 . . . . 0.0 109.479 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -52.45 -55.53 21.25 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.48 -0.762 . . . . 0.0 109.052 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.624 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -43.44 -32.8 0.94 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 109.325 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -76.32 -90.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.452 -0.78 . . . . 0.0 109.656 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.661 HG21 ' HA ' ' A' ' 95' ' ' TRP . 4.9 t -80.03 -78.17 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 121.016 -1.053 . . . . 0.0 109.372 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.65 56.1 0.14 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.205 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.873 HG21 ' O ' ' A' ' 93' ' ' GLU . 2.5 pp -107.73 -140.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 120.757 -1.437 . . . . 0.0 109.024 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.634 ' N ' HD12 ' A' ' 60' ' ' ILE . 2.5 m -159.84 -67.19 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.276 0 O-C-N 119.754 -1.841 . . . . 0.0 112.535 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.656 ' HD2' ' HB3' ' A' ' 91' ' ' GLU . 11.5 Cg_exo -43.17 -67.12 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 122.265 1.977 . . . . 0.0 110.704 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.765 ' HB2' ' CE2' ' A' ' 95' ' ' TRP . 0.8 OUTLIER 29.65 27.71 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 114.603 -1.181 . . . . 0.0 113.638 178.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.631 ' C ' ' O ' ' A' ' 63' ' ' GLN . 1.8 t60 -14.03 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.738 0 CA-C-N 120.181 1.355 . . . . 0.0 110.119 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.611 ' N ' ' O ' ' A' ' 63' ' ' GLN . 3.3 p90 -75.71 146.97 39.74 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.92 0.867 . . . . 0.0 112.377 -175.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 86' ' ' LEU . 4.6 m -148.59 151.47 35.1 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.688 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -80.24 -66.96 0.81 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.769 -1.207 . . . . 0.0 109.836 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.886 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 86.32 -56.81 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER 159.71 142.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.602 ' HE3' ' CD2' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -124.45 172.43 9.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.549 -0.719 . . . . 0.0 110.833 -178.73 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.658 ' HB3' HG23 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -121.11 176.72 5.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.819 . . . . 0.0 109.428 178.627 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.485 ' HG3' HG23 ' A' ' 81' ' ' THR . 7.3 tt0 -152.88 85.89 1.24 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.89 148.33 31.34 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -114.58 171.76 7.44 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.766 -1.174 . . . . 0.0 110.277 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.685 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -142.44 -177.14 0.62 Allowed Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.685 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.0 Cg_exo -57.12 -27.83 76.09 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.469 1.446 . . . . 0.0 109.75 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.475 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 56.5 p30 -169.98 36.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.525 ' O ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -136.61 96.52 3.36 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.663 -0.648 . . . . 0.0 109.564 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.575 ' C ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -82.13 116.43 21.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.391 -0.818 . . . . 0.0 109.501 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.788 HG21 ' C6 ' ' A' ' 130' ' ' APC . 0.4 OUTLIER -115.65 144.78 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.001 -1.062 . . . . 0.0 110.586 -179.282 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.547 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 0.9 OUTLIER -129.99 142.3 50.65 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.426 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.701 HD21 HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -127.43 80.8 1.98 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.634 -1.291 . . . . 0.0 110.671 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.644 ' CD1' HG21 ' A' ' 40' ' ' ILE . 82.0 m95 -51.62 108.93 0.3 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.172 -0.955 . . . . 0.0 109.161 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.632 ' CE1' HG11 ' A' ' 122' ' ' VAL . 12.1 m-85 -87.46 70.88 9.91 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.215 -0.928 . . . . 0.0 109.684 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.689 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 13.6 m95 -70.51 83.63 0.59 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.91 -1.119 . . . . 0.0 108.791 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.886 HD23 ' CD2' ' A' ' 68' ' ' PHE . 2.9 mm? -71.87 124.91 25.88 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.41 -1.431 . . . . 0.0 110.242 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.638 HG13 HG22 ' A' ' 11' ' ' ILE . 1.5 m -112.31 -178.4 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.638 ' N ' HG23 ' A' ' 87' ' ' VAL . 54.4 mt-10 -155.99 6.24 0.2 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 117.869 -1.533 . . . . 0.0 112.361 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.589 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -153.23 64.51 0.76 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.209 -1.557 . . . . 0.0 110.51 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.613 ' CH2' ' HB2' ' A' ' 13' ' ' ASN . 8.3 p90 -73.93 159.36 32.88 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.796 -1.19 . . . . 0.0 110.039 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.656 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 0.8 OUTLIER -78.02 138.11 38.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.407 -0.808 . . . . 0.0 109.347 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 30.42 -82.0 0.0 OUTLIER Glycine 0 N--CA 1.5 2.939 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.873 ' O ' HG21 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -88.37 158.33 49.1 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.188 -1.184 . . . . 0.0 109.874 -179.393 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.713 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 15.5 Cg_endo -71.41 -156.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.864 2.376 . . . . 0.0 110.332 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.765 ' CE2' ' HB2' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -178.67 120.11 0.08 Allowed 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.324 -0.86 . . . . 0.0 110.167 179.508 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.473 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . 145.25 -48.02 0.72 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.431 -1.842 . . . . 0.0 111.487 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.63 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -39.36 118.18 0.79 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -1.177 . . . . 0.0 110.466 -178.356 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.593 ' CG ' ' N ' ' A' ' 38' ' ' GLY . 3.4 mm-40 -73.31 -143.54 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' H ' ' HB3' ' A' ' 98' ' ' GLU . . . -53.04 -18.57 6.28 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.96 165.62 12.5 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.38 -1.071 . . . . 0.0 110.749 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.498 ' HG2' ' OG1' ' A' ' 21' ' ' THR . 2.1 Cg_endo -69.05 -60.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.666 2.244 . . . . 0.0 110.006 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.603 ' O ' ' CE1' ' A' ' 19' ' ' PHE . . . 76.22 121.61 0.16 Allowed Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.6 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 5.9 pt-20 -156.29 134.18 11.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.391 -1.064 . . . . 0.0 110.048 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.532 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 1.1 m0 -46.53 133.83 9.81 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.618 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 4.9 tpt -117.98 114.35 23.04 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.031 -1.043 . . . . 0.0 109.432 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.6 t -80.39 61.07 4.03 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.827 HD13 ' HG ' ' A' ' 110' ' ' LEU . 4.7 tt -77.61 -49.1 15.27 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.57 ' CB ' ' O ' ' A' ' 107' ' ' LEU . 21.2 t 89.91 101.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-O 121.568 0.699 . . . . 0.0 109.267 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 46.77 84.57 0.02 OUTLIER Glycine 0 N--CA 1.484 1.85 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.827 ' HG ' HD13 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -37.58 162.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.918 -0.754 . . . . 0.0 110.475 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.694 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 6.0 t-20 -138.73 -8.13 1.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 111.339 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 81.74 -18.06 0.51 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.183 -0.948 . . . . 0.0 108.614 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.0 -21.17 66.81 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.778 ' HB3' HD12 ' A' ' 33' ' ' LEU . 13.0 m-20 -104.96 -15.47 15.12 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.824 ' CE1' HD21 ' A' ' 110' ' ' LEU . 3.2 m-85 -91.42 133.44 31.37 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.151 -0.968 . . . . 0.0 109.121 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.1 131.56 43.5 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 121.398 1.399 . . . . 0.0 108.617 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 3.3 Cg_exo -52.99 -22.04 17.46 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.365 2.043 . . . . 0.0 112.181 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.08 -39.07 68.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.723 -1.235 . . . . 0.0 109.552 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.562 ' O ' HD13 ' A' ' 123' ' ' ILE . 25.8 p30 -96.26 45.12 1.07 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.444 -0.785 . . . . 0.0 109.69 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.66 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.2 mt-10 -70.25 -33.15 3.15 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 113.191 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.2 Cg_exo -55.96 -47.83 22.9 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.218 1.279 . . . . 0.0 112.801 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.658 HG23 ' HB3' ' A' ' 71' ' ' LEU . 1.9 t -92.91 -33.93 5.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 120.531 -1.355 . . . . 0.0 109.489 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 1.009 ' HA ' HD22 ' A' ' 126' ' ' LEU . 1.7 mp -66.56 -20.84 27.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -58.55 -29.47 66.38 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 125' ' ' LYS . 0.4 OUTLIER -80.38 -37.96 31.29 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.915 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 1.009 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.83 -24.78 66.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.461 -1.399 . . . . 0.0 107.336 178.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.54 ' HD3' ' CB ' ' A' ' 112' ' ' ALA . 1.5 mtmp? -55.17 -35.73 65.09 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.459 ' O ' ' C ' ' A' ' 129' ' ' LEU . 1.9 mtp180 -83.93 -24.6 30.65 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.524 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 2.1 tp . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.069 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 130' ' ' APC . . . . . 0.788 ' C6 ' HG21 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.408 ' HB2' ' OD1' ' A' ' 77' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.44 ' HD3' ' C ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -159.82 179.07 9.14 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.366 -0.834 . . . . 0.0 109.292 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.434 ' HG3' ' HB3' ' A' ' 79' ' ' HIS . 4.9 ttpt -156.02 145.14 20.6 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.195 -0.941 . . . . 0.0 109.312 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.697 HD22 " O4'" ' A' ' 130' ' ' APC . 0.5 OUTLIER -140.95 177.26 8.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.244 -0.91 . . . . 0.0 109.535 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.63 ' HB2' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -141.55 174.27 10.72 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.701 HG22 HG12 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -141.81 124.69 14.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 O-C-N 121.019 -1.051 . . . . 0.0 109.821 -178.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.951 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -87.0 60.12 6.03 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.973 HG23 ' O ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -78.63 -87.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.79 -178.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.749 ' N ' HG22 ' A' ' 8' ' ' VAL . . . 75.63 88.85 0.25 Allowed Glycine 0 C--N 1.297 -1.625 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.573 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -49.33 175.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.031 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.038 HG22 HG22 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -143.9 92.09 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.577 -1.249 . . . . 0.0 110.349 -178.368 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.748 ' HG2' HG22 ' A' ' 18' ' ' ILE . 8.8 mtm180 -75.62 174.09 10.19 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.562 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -161.14 -46.19 0.04 OUTLIER 'General case' 0 C--O 1.191 -2.017 0 C-N-CA 115.744 -2.382 . . . . 0.0 115.142 -177.343 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.514 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 1.5 tp10 -92.4 -27.97 17.17 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 118.64 -2.537 . . . . 0.0 110.369 -176.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -163.22 -45.21 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.576 ' ND2' ' HD2' ' A' ' 12' ' ' ARG . 0.7 OUTLIER -160.04 35.42 0.18 Allowed 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 177.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 105' ' ' MET . 17.4 mt-10 -84.54 94.08 8.49 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.098 -1.441 . . . . 0.0 110.046 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.748 HG22 ' HG2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -83.03 142.75 13.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.579 -0.701 . . . . 0.0 109.374 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.639 ' CD1' ' CG ' ' A' ' 94' ' ' PRO . 70.1 t80 -82.2 46.36 1.02 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.681 HD11 ' C ' ' A' ' 34' ' ' GLU . 6.7 tp -81.9 151.83 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-O 122.256 1.027 . . . . 0.0 112.016 -177.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.508 ' OG1' ' HG2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -63.88 90.45 0.06 Allowed 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.616 ' HD3' HD21 ' A' ' 33' ' ' LEU . 28.7 tpt180 -89.49 106.04 18.19 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.135 -0.978 . . . . 0.0 109.73 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.6 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 3.22 76.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 121.317 0.58 . . . . 0.0 110.865 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -39.35 -53.85 1.93 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.25 0.547 . . . . 0.0 109.965 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.54 -177.1 5.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.015 -1.053 . . . . 0.0 109.243 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -80.05 77.35 6.75 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.222 -0.924 . . . . 0.0 109.668 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.415 ' HB3' ' CD ' ' A' ' 23' ' ' ARG . . . -56.79 -31.23 64.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.92 . . . . 0.0 109.357 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.412 ' C ' ' SD ' ' A' ' 29' ' ' MET . 3.5 t60 67.97 8.12 6.26 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.343 -0.848 . . . . 0.0 109.104 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.751 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -120.03 -101.0 0.43 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.276 -0.89 . . . . 0.0 109.096 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 152.31 -10.49 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.703 -0.623 . . . . 0.0 110.329 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 12.2 m120 -78.35 6.03 9.25 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.893 -1.129 . . . . 0.0 109.646 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.514 ' HD2' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -81.91 47.21 1.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.393 -0.817 . . . . 0.0 110.415 -179.578 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.698 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 13.2 mt -117.84 91.03 3.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.851 -1.156 . . . . 0.0 109.125 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.681 ' C ' HD11 ' A' ' 20' ' ' ILE . 11.9 tt0 -90.31 -127.56 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.496 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.533 ' CG ' ' C ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -155.75 128.89 4.34 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.882 -1.136 . . . . 0.0 109.382 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.973 ' O ' HG23 ' A' ' 8' ' ' VAL . 9.6 Cg_endo -69.79 97.85 0.66 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.055 1.837 . . . . 0.0 109.462 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.571 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -109.28 -173.55 21.03 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.308 -1.425 . . . . 0.0 111.455 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.542 ' HA2' ' OE1' ' A' ' 98' ' ' GLU . . . -163.74 20.35 0.15 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.612 ' HD3' " C5'" ' A' ' 130' ' ' APC . 1.9 tptm 58.83 108.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.528 -0.984 . . . . 0.0 110.106 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.951 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -82.02 130.63 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.825 -1.172 . . . . 0.0 109.227 178.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -173.66 -26.07 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.088 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.67 153.48 0.8 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.977 -1.077 . . . . 0.0 109.272 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 46.87 -117.04 2.76 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -170.95 23.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.471 -1.017 . . . . 0.0 109.621 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 47' ' ' GLU . 84.5 m -140.41 139.67 21.15 Favored Pre-proline 0 C--O 1.203 -1.385 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.585 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 6.3 Cg_exo -50.26 -19.07 4.01 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 121.1 1.2 . . . . 0.0 110.128 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.695 ' H ' HG22 ' A' ' 45' ' ' THR . 1.6 mt-10 -79.71 -86.83 0.07 Allowed 'General case' 0 C--O 1.201 -1.481 0 O-C-N 121.108 -0.995 . . . . 0.0 108.536 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.589 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 15.7 mt-30 -43.09 -29.48 0.36 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.704 -1.247 . . . . 0.0 110.081 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.619 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -72.04 -60.99 1.95 Allowed 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.418 -0.801 . . . . 0.0 109.83 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.937 ' O ' HD23 ' A' ' 54' ' ' LEU . 3.8 p -66.84 -45.94 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.008 -1.058 . . . . 0.0 110.184 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.574 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 2.2 p -60.15 -46.89 93.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-O 121.239 0.542 . . . . 0.0 109.662 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.589 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 8.0 mmm180 -74.1 -21.61 59.83 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.599 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 26.5 mm-40 -78.3 -19.7 53.03 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.075 HD12 ' CD1' ' A' ' 95' ' ' TRP . 2.1 mm? -79.87 -42.03 25.06 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.166 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.635 ' HG2' ' CZ3' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -79.91 -42.78 23.43 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.599 -0.688 . . . . 0.0 109.467 -179.399 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.559 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 1.1 pp20? -57.68 -23.27 50.68 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.545 -0.722 . . . . 0.0 110.01 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.5 ' OE2' ' HA3' ' A' ' 38' ' ' GLY . 9.1 mt-10 -80.24 -92.08 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.982 -1.074 . . . . 0.0 110.456 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.631 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 22.2 t -80.07 -78.93 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.486 -0.759 . . . . 0.0 110.745 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.36 35.57 0.14 Allowed Glycine 0 N--CA 1.496 2.698 0 C-N-CA 118.572 -1.775 . . . . 0.0 112.783 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.114 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.1 pp -91.13 -145.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 120.276 -1.72 . . . . 0.0 107.127 177.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.629 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.5 m -141.26 -73.45 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.256 -1.528 . . . . 0.0 110.496 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 6.2 Cg_endo -64.54 -171.5 0.16 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.105 1.203 . . . . 0.0 110.781 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.555 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.5 OUTLIER 149.41 -23.14 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.564 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 13.5 t-160 43.91 80.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.51 ' CZ ' ' HG2' ' A' ' 47' ' ' GLU . 49.6 p90 -76.32 145.02 39.85 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.621 0.724 . . . . 0.0 110.373 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -141.58 142.54 33.48 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.638 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -67.18 -69.73 0.29 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.812 -1.18 . . . . 0.0 110.475 -179.146 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.745 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 83.99 -51.66 0.13 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.2 mt-10 170.31 177.27 0.05 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.592 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -161.16 173.18 15.5 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 109.675 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.684 HD21 ' OD1' ' A' ' 119' ' ' ASN . 0.3 OUTLIER -141.15 178.41 7.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.145 -0.972 . . . . 0.0 110.596 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -151.41 93.94 1.95 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -79.5 129.68 34.7 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.539 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 4.8 tt0 -101.25 106.05 17.21 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.146 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.539 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -81.22 171.07 13.11 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.219 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 9.5 Cg_exo -47.33 -29.62 9.97 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.972 1.781 . . . . 0.0 109.999 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -162.53 28.28 0.1 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.373 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.472 ' HD3' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -134.36 90.95 2.73 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.791 -0.568 . . . . 0.0 109.961 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.662 ' C ' HD12 ' A' ' 80' ' ' ILE . 1.9 t-160 -86.3 110.17 19.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.101 -1.0 . . . . 0.0 108.513 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.662 HD12 ' C ' ' A' ' 79' ' ' HIS . 0.8 OUTLIER -112.56 152.31 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.137 -0.977 . . . . 0.0 110.426 -178.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.577 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 4.1 m -125.98 137.23 53.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.892 ' CD2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -128.62 79.64 1.92 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.594 -1.317 . . . . 0.0 110.775 -179.287 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.592 ' CE3' ' HD2' ' A' ' 70' ' ' LYS . 94.3 m95 -51.16 108.82 0.28 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.994 -1.066 . . . . 0.0 108.838 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.783 ' CD2' HG11 ' A' ' 122' ' ' VAL . 12.4 m-85 -82.36 69.32 9.08 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.053 -1.03 . . . . 0.0 109.947 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.652 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 97.5 m95 -71.95 82.8 0.94 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.06 -1.025 . . . . 0.0 109.692 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.745 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.0 mm? -67.05 124.17 22.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.459 -1.4 . . . . 0.0 109.631 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.038 HG22 HG22 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -109.14 177.32 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 70.0 mt-10 -154.59 18.85 0.47 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 117.69 -1.604 . . . . 0.0 113.504 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.564 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -161.08 62.11 0.29 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 119.618 -1.926 . . . . 0.0 112.155 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.705 ' HB2' HD13 ' A' ' 60' ' ' ILE . 6.6 p90 -81.09 158.52 25.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.331 -1.481 . . . . 0.0 108.79 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.574 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -91.63 145.39 24.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.953 -1.092 . . . . 0.0 110.235 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 45.64 -87.44 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 1.114 ' O ' HG21 ' A' ' 60' ' ' ILE . 8.1 pt-20 -111.37 161.44 25.26 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.316 -1.108 . . . . 0.0 109.647 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.639 ' CG ' ' CD1' ' A' ' 19' ' ' PHE . 7.0 Cg_endo -74.68 -161.06 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.554 2.169 . . . . 0.0 109.594 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 1.075 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER 179.02 33.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.111 -0.993 . . . . 0.0 110.793 178.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -117.65 6.14 16.31 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.269 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.624 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 8.0 pttt -79.99 147.59 31.49 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.113 -1.227 . . . . 0.0 110.046 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.542 ' OE1' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -82.18 37.26 0.49 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.53 -0.731 . . . . 0.0 109.658 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.81 -10.54 73.4 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.594 ' CB ' ' CD ' ' A' ' 101' ' ' PRO . 11.8 pt20 -64.49 -172.14 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.451 -1.029 . . . . 0.0 108.677 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 100' ' ' GLN . 4.2 Cg_exo -65.65 -55.88 0.39 Allowed 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.122 1.215 . . . . 0.0 109.351 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.61 ' O ' ' CE1' ' A' ' 19' ' ' PHE . . . 57.26 115.38 0.01 OUTLIER Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 2.9 pt-20 -153.26 133.47 13.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.836 -1.391 . . . . 0.0 110.303 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.455 ' C ' ' O ' ' A' ' 103' ' ' GLU . 3.7 m0 -44.43 136.54 4.11 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -130.26 113.88 14.96 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.267 -179.378 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.65 51.11 1.62 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.486 0.66 . . . . 0.0 109.507 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.844 HD21 ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -65.42 -41.56 93.43 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.801 ' N ' HD23 ' A' ' 107' ' ' LEU . 48.9 t 79.61 116.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.984 -0.447 . . . . 0.0 110.332 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . 39.3 83.55 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.106 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -38.65 160.57 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.766 -0.843 . . . . 0.0 110.755 -178.627 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.672 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 11.4 t30 -136.34 -4.81 2.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.483 -0.761 . . . . 0.0 110.932 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 74.91 -4.09 2.45 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.09 -1.006 . . . . 0.0 108.768 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.54 -32.93 36.6 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.584 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -93.19 -11.21 33.27 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 1.106 ' CE1' HD21 ' A' ' 110' ' ' LEU . 5.0 m-85 -98.41 152.62 38.03 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.488 -0.758 . . . . 0.0 109.937 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.508 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 2.8 Cg_endo -68.79 135.44 32.85 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.198 1.932 . . . . 0.0 109.348 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 118' ' ' ALA . 6.3 Cg_exo -59.85 -27.7 85.53 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 121.89 1.727 . . . . 0.0 110.852 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -43.1 -51.18 5.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.107 -0.996 . . . . 0.0 109.572 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.684 ' OD1' HD21 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -88.25 48.46 1.64 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.457 -0.777 . . . . 0.0 109.23 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.676 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -63.33 -41.85 70.82 Favored Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.787 -0.571 . . . . 0.0 112.013 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 8.0 Cg_exo -51.86 -39.18 68.72 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 121.889 1.726 . . . . 0.0 113.088 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.783 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.7 t -100.51 -37.91 6.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 120.446 -1.409 . . . . 0.0 110.037 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.85 ' HA ' HD22 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -60.94 -21.96 25.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.493 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -62.75 -34.52 77.39 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.483 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 9.4 mmtm -79.71 -38.51 33.27 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.982 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.85 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.2 OUTLIER -59.24 -40.51 86.13 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.709 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -38.84 -37.16 0.32 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.09 0.947 . . . . 0.0 108.767 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.514 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -80.03 -51.81 8.58 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.287 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.603 ' CD2' ' NH1' ' A' ' 12' ' ' ARG . 2.5 tp . . . . . 0 N--CA 1.505 2.294 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.66 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 130' ' ' APC . . . . . 0.697 " O4'" HD22 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.481 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 1.1 tpp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.596 ' N ' ' HD3' ' A' ' 2' ' ' LYS . 0.2 OUTLIER 176.76 -152.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.474 -0.766 . . . . 0.0 109.243 -179.529 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.564 ' N ' ' HG2' ' A' ' 2' ' ' LYS . 2.7 tttt -102.1 151.82 21.72 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.698 HD22 " O4'" ' A' ' 130' ' ' APC . 0.2 OUTLIER -149.56 168.4 23.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.112 178.738 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.859 ' HB2' HG23 ' A' ' 40' ' ' ILE . 1.6 mp0 -142.52 171.35 14.17 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.652 HG22 HG12 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -138.36 115.62 11.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 C-N-CA 118.969 -1.092 . . . . 0.0 109.624 -179.414 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.956 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -84.39 63.68 7.94 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.714 HG13 ' H ' ' A' ' 9' ' ' GLY . 0.7 OUTLIER -79.06 -77.44 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.381 -0.825 . . . . 0.0 110.345 -178.719 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.714 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 67.59 88.26 0.07 OUTLIER Glycine 0 C--N 1.296 -1.68 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 -177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.573 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -50.19 176.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.846 HG22 HG22 ' A' ' 87' ' ' VAL . 2.5 pt -142.54 77.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 C-N-CA 117.856 -1.537 . . . . 0.0 111.087 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.634 ' HB3' HG23 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -78.89 158.68 28.03 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 177.17 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.514 ' CG ' ' CZ3' ' A' ' 90' ' ' TRP . 12.1 p-10 -160.61 -24.33 0.06 Allowed 'General case' 0 C--O 1.188 -2.143 0 C-N-CA 115.608 -2.437 . . . . 0.0 115.5 -177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.541 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 20.6 tt0 -93.51 -27.0 16.91 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 118.05 -2.906 . . . . 0.0 108.911 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -162.44 -48.74 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.491 ' ND2' HD23 ' A' ' 107' ' ' LEU . 60.9 t-20 -162.95 38.09 0.1 Allowed 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.618 ' HA ' ' O ' ' A' ' 105' ' ' MET . 19.8 mt-10 -84.06 88.5 7.18 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 117.92 -1.512 . . . . 0.0 109.973 -177.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.634 HG23 ' HB3' ' A' ' 12' ' ' ARG . 1.5 pt -82.5 147.24 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.964 0.888 . . . . 0.0 111.167 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.62 ' CE1' ' HG2' ' A' ' 94' ' ' PRO . 12.7 t80 -82.58 45.28 0.96 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.622 HD11 ' N ' ' A' ' 34' ' ' GLU . 4.3 tp -80.42 151.35 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.85 0.833 . . . . 0.0 110.645 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.505 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -71.11 88.43 0.8 Allowed 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.383 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.591 ' O ' ' C ' ' A' ' 23' ' ' ARG . 28.2 tpt180 -86.2 94.56 9.33 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.53 -0.731 . . . . 0.0 110.373 -178.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.591 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 17.89 75.97 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.142 0.496 . . . . 0.0 110.346 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -39.36 -55.72 1.69 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.608 -0.683 . . . . 0.0 110.168 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.46 -147.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.158 -0.964 . . . . 0.0 108.988 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.712 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 77.4 m-20 -79.88 -60.77 2.21 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.026 -1.046 . . . . 0.0 109.128 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 26' ' ' ASP . . . 81.78 -28.33 0.12 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.435 -0.791 . . . . 0.0 110.715 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER 49.15 25.3 1.13 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.413 ' N ' ' C ' ' A' ' 27' ' ' ALA . 5.6 mtt -145.08 -164.16 1.87 Allowed 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.463 ' O ' ' OD1' ' A' ' 114' ' ' ASP . . . -164.25 23.13 0.07 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.804 -1.185 . . . . 0.0 110.326 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 114' ' ' ASP . 1.3 m-20 -101.9 15.94 27.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.058 -1.026 . . . . 0.0 108.259 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 1.4 mmtm -81.81 50.72 1.57 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.767 -0.583 . . . . 0.0 111.006 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.904 HD13 HD21 ' A' ' 110' ' ' LEU . 17.0 mt -109.57 86.77 2.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.763 -1.211 . . . . 0.0 108.875 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.622 ' N ' HD11 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -91.5 -135.87 0.14 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.123 -0.986 . . . . 0.0 110.191 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.584 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -150.45 119.44 3.64 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 120.758 -1.214 . . . . 0.0 109.626 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.587 ' O ' HG23 ' A' ' 8' ' ' VAL . 11.5 Cg_endo -71.29 94.39 0.66 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.323 2.015 . . . . 0.0 110.772 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.708 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -127.2 -135.73 4.19 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 118.767 -1.682 . . . . 0.0 111.04 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.537 ' CA ' ' OE1' ' A' ' 98' ' ' GLU . . . 167.65 35.53 0.02 OUTLIER Glycine 0 N--CA 1.487 2.071 0 O-C-N 121.383 -1.069 . . . . 0.0 110.53 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.617 ' HD3' H5'1 ' A' ' 130' ' ' APC . 14.1 tptm 56.5 110.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.979 -0.718 . . . . 0.0 111.891 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.956 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -81.9 142.13 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.217 -0.927 . . . . 0.0 108.662 177.762 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.401 ' N ' HG12 ' A' ' 40' ' ' ILE . 10.9 pt-20 -172.21 -30.45 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.417 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.3 mmm -55.33 149.0 13.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.148 -0.97 . . . . 0.0 110.011 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.48 -127.44 33.66 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -164.66 18.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.493 -1.004 . . . . 0.0 109.842 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.794 HG22 ' H ' ' A' ' 47' ' ' GLU . 45.4 m -133.39 137.23 28.64 Favored Pre-proline 0 C--O 1.204 -1.332 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.615 ' HG3' ' CH2' ' A' ' 83' ' ' TRP . 3.0 Cg_exo -48.98 -16.37 0.83 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 121.57 1.513 . . . . 0.0 110.281 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.794 ' H ' HG22 ' A' ' 45' ' ' THR . 2.8 mt-10 -75.5 -85.47 0.05 OUTLIER 'General case' 0 C--O 1.203 -1.386 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.557 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 18.6 mt-30 -45.22 -34.75 2.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.66 -1.275 . . . . 0.0 109.778 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.86 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -63.77 -64.03 1.01 Allowed 'General case' 0 C--N 1.292 -1.927 0 O-C-N 121.339 -0.85 . . . . 0.0 109.666 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.905 ' O ' HD23 ' A' ' 54' ' ' LEU . 2.0 p -66.69 -51.89 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.049 -1.032 . . . . 0.0 110.55 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.57 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 3.7 p -51.97 -44.76 39.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.352 -0.843 . . . . 0.0 110.731 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.56 ' N ' HG13 ' A' ' 51' ' ' VAL . 5.8 mmt180 -74.76 -37.79 62.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 108.875 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.594 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 6.5 mm-40 -70.37 -13.08 61.99 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.174 HD12 ' CD1' ' A' ' 95' ' ' TRP . 1.6 mm? -80.06 -63.82 1.33 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.653 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.41 -52.71 64.28 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.833 -0.542 . . . . 0.0 110.176 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.579 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -47.28 -22.35 0.4 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.017 -1.052 . . . . 0.0 109.875 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.441 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 3.4 mt-10 -80.03 -96.79 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.046 -1.034 . . . . 0.0 109.31 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.665 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 57.4 t -80.01 -79.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.215 -0.928 . . . . 0.0 109.322 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 133.66 46.33 0.11 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.247 -1.454 . . . . 0.0 111.777 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.086 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -87.59 -127.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.604 -1.527 . . . . 0.0 108.44 178.586 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.706 ' H ' HD12 ' A' ' 60' ' ' ILE . 1.3 m -159.64 -68.6 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.006 -1.684 . . . . 0.0 112.146 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 2.2 Cg_endo -54.19 -80.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.028 1.819 . . . . 0.0 112.061 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 1.012 ' NE2' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 39.81 61.62 1.41 Allowed 'General case' 0 C--N 1.289 -2.039 0 CA-C-O 121.781 0.8 . . . . 0.0 109.608 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.687 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -53.24 102.22 0.05 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.517 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -95.46 144.28 26.09 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 122.177 0.989 . . . . 0.0 111.362 -177.62 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -143.25 145.0 32.37 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.149 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.856 HD13 ' N ' ' A' ' 69' ' ' GLU . 1.4 tm? -67.95 -64.45 0.86 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.068 -1.02 . . . . 0.0 110.808 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.882 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 83.6 -54.2 0.15 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.357 -0.84 . . . . 0.0 108.796 -179.359 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.856 ' N ' HD13 ' A' ' 67' ' ' LEU . 6.0 tp10 164.86 128.9 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.558 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -118.97 -171.71 2.15 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.443 -0.786 . . . . 0.0 109.868 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.643 HD12 ' C ' ' A' ' 71' ' ' LEU . 0.6 OUTLIER -142.06 -172.04 3.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 110.315 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -159.75 94.26 1.13 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.45 151.3 22.08 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.275 -0.891 . . . . 0.0 108.87 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.437 ' OE2' ' CE1' ' A' ' 79' ' ' HIS . 2.0 tt0 -119.71 137.5 53.88 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.144 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.563 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 1.1 m-30 -106.55 172.92 3.48 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 6.5 Cg_exo -46.24 -39.95 21.48 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.706 1.604 . . . . 0.0 110.31 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.437 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 3.1 m-20 -156.24 40.1 0.36 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.57 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -147.33 101.75 3.41 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.451 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.991 ' C ' HD12 ' A' ' 80' ' ' ILE . 5.5 m170 -77.81 137.26 38.32 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.991 HD12 ' C ' ' A' ' 79' ' ' HIS . 1.9 mp -132.82 153.74 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.767 -1.208 . . . . 0.0 110.653 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.574 ' HB ' ' CB ' ' A' ' 5' ' ' GLN . 1.6 m -141.67 150.45 41.92 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.65 HD21 HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -138.94 77.73 1.64 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.812 -1.18 . . . . 0.0 109.985 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.615 ' CH2' ' HG3' ' A' ' 46' ' ' PRO . 93.4 m95 -50.68 113.65 0.95 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 108.993 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.599 ' O ' ' O ' ' A' ' 67' ' ' LEU . 13.6 m-85 -90.76 70.56 6.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.254 -0.904 . . . . 0.0 110.208 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.656 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 61.5 m95 -77.46 87.6 3.82 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.705 -1.247 . . . . 0.0 109.751 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.882 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.0 mm? -68.2 129.55 40.25 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.524 -1.36 . . . . 0.0 109.974 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.012 HG11 ' NE2' ' A' ' 63' ' ' GLN . 0.8 OUTLIER -116.42 154.74 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.284 -0.885 . . . . 0.0 108.729 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 1.2 mt-10 -143.02 35.38 1.37 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.738 -1.226 . . . . 0.0 113.219 -178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.687 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -161.32 40.49 0.15 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 119.79 -1.819 . . . . 0.0 111.729 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.635 ' CH2' ' CD1' ' A' ' 104' ' ' TRP . 1.3 p90 -67.19 157.09 34.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.02 -1.675 . . . . 0.0 109.37 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.574 ' O ' ' CD1' ' A' ' 90' ' ' TRP . 10.4 pt-20 -77.8 -125.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.234 -0.916 . . . . 0.0 110.439 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.495 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -53.09 -55.22 25.14 Favored Glycine 0 N--CA 1.494 2.51 0 O-C-N 120.658 -1.277 . . . . 0.0 110.735 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 1.086 ' O ' HG21 ' A' ' 60' ' ' ILE . 6.9 pt-20 -132.94 166.91 25.79 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.161 -1.199 . . . . 0.0 109.577 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.76 ' HB3' HD12 ' A' ' 11' ' ' ILE . 9.9 Cg_endo -77.28 -168.14 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.36 2.04 . . . . 0.0 110.123 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 1.174 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -171.0 28.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 0.0 110.086 178.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.613 ' HA2' HD13 ' A' ' 54' ' ' LEU . . . -116.1 3.38 20.72 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.983 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.567 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 11.5 pttt -76.57 136.46 39.26 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.922 -1.34 . . . . 0.0 109.212 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.602 ' HG3' ' PG ' ' A' ' 130' ' ' APC . 2.6 tp10 -75.61 -117.63 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.64 22.33 36.2 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 107.47 -2.252 . . . . 0.0 107.47 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.483 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 1.5 pt20 -94.97 165.11 17.71 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.731 -0.864 . . . . 0.0 110.136 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 1.4 Cg_endo -66.99 -42.55 8.0 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.994 1.796 . . . . 0.0 109.851 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.589 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 57.69 110.38 0.01 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 7.1 pt-20 -142.96 134.07 25.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.768 -1.43 . . . . 0.0 110.672 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.635 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 1.6 m0 -50.19 127.59 17.34 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.618 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -118.88 116.37 26.36 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.77 45.59 0.71 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.262 -0.899 . . . . 0.0 110.161 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.592 ' HG ' ' N ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -81.41 158.09 24.74 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.051 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.592 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 33.4 t -114.66 134.07 58.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.061 -1.024 . . . . 0.0 109.541 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.484 ' HA2' ' HB3' ' A' ' 129' ' ' LEU . . . 39.52 79.87 0.04 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.904 HD21 HD13 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -41.62 166.13 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.573 -0.957 . . . . 0.0 110.694 -178.766 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.791 ' H ' HD23 ' A' ' 110' ' ' LEU . 4.5 t30 -159.71 151.17 19.92 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.511 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . -55.98 -22.07 24.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 108.563 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -42.72 -36.9 1.57 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.522 -0.736 . . . . 0.0 109.082 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.536 ' CB ' ' CD1' ' A' ' 33' ' ' LEU . 73.8 m-20 -115.29 -8.5 12.29 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.685 -0.634 . . . . 0.0 109.556 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.828 ' HD2' HD22 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -100.93 123.53 45.01 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.339 -0.851 . . . . 0.0 109.709 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.547 ' O ' ' CD1' ' A' ' 123' ' ' ILE . 7.2 Cg_exo -52.62 148.2 28.3 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.415 2.077 . . . . 0.0 111.373 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.475 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . 2.1 Cg_endo -62.61 -26.18 75.69 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.309 2.006 . . . . 0.0 110.699 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.6 -48.57 5.43 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.123 -0.986 . . . . 0.0 109.656 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.868 ' O ' HD12 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -100.15 55.65 0.92 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.631 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 4.6 mt-10 -67.32 -43.19 42.64 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.602 -0.686 . . . . 0.0 112.366 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 6.3 Cg_exo -55.52 -31.78 79.93 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.764 1.643 . . . . 0.0 112.125 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.571 HG11 ' CZ ' ' A' ' 84' ' ' PHE . 2.4 t -101.05 -38.93 6.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.76 -1.212 . . . . 0.0 109.569 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.868 HD12 ' O ' ' A' ' 119' ' ' ASN . 15.2 mt -55.77 -34.55 36.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.27 -38.5 58.45 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.949 0.881 . . . . 0.0 109.137 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -79.81 -37.37 35.31 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.242 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.927 ' HA ' HD13 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -59.3 -39.67 83.76 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.179 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -39.8 -37.66 0.57 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.949 0.88 . . . . 0.0 108.927 178.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.481 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -87.57 -49.9 6.87 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.927 HD13 ' HA ' ' A' ' 126' ' ' LEU . 1.9 tp . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.322 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 130' ' ' APC . . . . . 0.698 " O4'" HD22 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' CON . . . . . 0.575 ' N3 ' ' O2A' ' A' ' 130' ' ' APC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.406 ' C ' ' HG3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.539 ' HE3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 178.79 -166.77 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.224 -0.923 . . . . 0.0 109.359 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.539 ' N ' ' HE3' ' A' ' 2' ' ' LYS . 17.0 tttt -140.83 140.28 34.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.084 -1.01 . . . . 0.0 109.343 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.949 ' O ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -146.67 131.98 18.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.388 -0.82 . . . . 0.0 109.385 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.544 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 2.1 mp0 -98.51 162.06 13.35 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.565 HG13 ' N7 ' ' A' ' 130' ' ' APC . 0.9 OUTLIER -126.0 112.83 31.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.057 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -84.56 65.78 9.17 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.722 HG13 ' H ' ' A' ' 9' ' ' GLY . 1.1 p -78.94 -70.37 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.023 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.722 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 57.5 83.43 0.05 OUTLIER Glycine 0 C--N 1.292 -1.915 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 -178.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.59 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -47.7 168.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -179.031 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.811 HG22 ' CG2' ' A' ' 87' ' ' VAL . 2.7 pt -133.24 95.14 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.344 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.91 ' HG2' HG22 ' A' ' 18' ' ' ILE . 15.8 mtm180 -76.78 179.83 5.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.619 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -158.69 -60.81 0.08 Allowed 'General case' 0 C--O 1.194 -1.856 0 C-N-CA 116.458 -2.097 . . . . 0.0 115.068 -177.119 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.576 ' CB ' ' HG3' ' A' ' 17' ' ' GLU . 6.9 tp10 -92.72 -26.04 17.94 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 119.254 -2.154 . . . . 0.0 111.745 -175.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -161.96 -45.17 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.479 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 14.7 t30 -160.41 35.81 0.17 Allowed 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 177.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 105' ' ' MET . 4.9 mm-40 -78.36 85.86 4.46 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 118.007 -1.477 . . . . 0.0 109.105 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.91 HG22 ' HG2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -79.15 142.49 13.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.714 ' HB3' HD11 ' A' ' 11' ' ' ILE . 11.9 t80 -81.94 46.0 0.96 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.708 HD12 ' CZ ' ' A' ' 115' ' ' PHE . 12.9 tt -79.1 153.0 4.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-O 121.858 0.837 . . . . 0.0 110.463 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.534 ' HB ' ' HD2' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -66.5 89.91 0.15 Allowed 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.255 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.509 ' O ' ' C ' ' A' ' 23' ' ' ARG . 28.5 tpt180 -87.37 81.77 7.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.184 -0.948 . . . . 0.0 110.416 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.715 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 1.1 ptt180 32.53 72.79 0.07 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.917 -0.489 . . . . 0.0 110.269 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.23 -53.31 4.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -0.853 . . . . 0.0 109.302 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.28 -171.54 3.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.232 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -79.92 80.68 6.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.473 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.715 ' HB2' ' HB3' ' A' ' 23' ' ' ARG . . . -61.31 -31.77 71.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.819 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.6 m80 55.41 21.13 4.05 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.746 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 6.1 mmm -127.36 -112.53 0.28 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 160.01 -14.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.064 -1.022 . . . . 0.0 111.065 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -81.53 12.53 3.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.906 -1.122 . . . . 0.0 109.779 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.72 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -81.99 54.79 2.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.476 -0.765 . . . . 0.0 110.642 -179.479 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.72 HD23 ' O ' ' A' ' 32' ' ' LYS . 6.4 mt -120.83 83.75 2.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.644 -1.285 . . . . 0.0 109.75 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.46 -146.98 0.19 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.389 -0.82 . . . . 0.0 109.358 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.65 ' CZ ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -140.16 125.61 11.5 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.864 -1.147 . . . . 0.0 110.157 -178.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.682 ' O ' HG23 ' A' ' 8' ' ' VAL . 13.8 Cg_endo -73.78 100.11 1.23 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.364 2.043 . . . . 0.0 110.118 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.671 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -136.36 135.08 7.53 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.175 -1.488 . . . . 0.0 110.961 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.533 ' CA ' ' OE1' ' A' ' 98' ' ' GLU . . . -108.14 36.53 4.32 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.632 ' HD2' HD23 ' A' ' 4' ' ' LEU . 7.0 tptm 59.26 119.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.54 -0.976 . . . . 0.0 112.083 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.021 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -83.24 135.96 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.132 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -171.31 -31.51 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.906 -1.121 . . . . 0.0 110.266 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.55 142.98 25.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.133 -0.979 . . . . 0.0 109.316 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.22 -115.96 8.71 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -169.23 -15.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.775 -0.838 . . . . 0.0 110.737 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.779 HG22 ' H ' ' A' ' 47' ' ' GLU . 24.9 m -103.82 141.09 21.78 Favored Pre-proline 0 C--O 1.205 -1.28 0 O-C-N 120.876 -1.14 . . . . 0.0 108.353 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.582 ' HD2' HG23 ' A' ' 45' ' ' THR . 7.9 Cg_exo -47.32 -18.06 0.68 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.082 1.855 . . . . 0.0 110.938 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.779 ' H ' HG22 ' A' ' 45' ' ' THR . 0.7 OUTLIER -77.87 -81.89 0.09 Allowed 'General case' 0 C--O 1.202 -1.424 0 O-C-N 120.857 -1.152 . . . . 0.0 108.594 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.544 ' O ' ' CG ' ' A' ' 52' ' ' ARG . 53.0 mt-30 -48.73 -25.56 1.88 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.384 -1.448 . . . . 0.0 109.948 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.827 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -73.51 -59.65 2.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.875 -1.14 . . . . 0.0 109.874 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.057 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.5 p -70.01 -48.94 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.053 -1.029 . . . . 0.0 109.843 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.571 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 2.1 p -56.33 -42.91 75.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 O-C-N 121.797 -0.564 . . . . 0.0 110.4 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 48' ' ' GLN . 21.2 mmt180 -74.86 -35.7 62.33 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.612 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 15.7 mm-40 -68.07 -15.47 63.61 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.802 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -79.09 -62.79 1.59 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.492 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.37 -53.84 53.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.345 -0.847 . . . . 0.0 109.828 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.547 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -50.13 -21.7 1.4 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.334 -0.854 . . . . 0.0 110.496 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.4 mt-10 -80.04 -91.02 0.05 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.059 -1.026 . . . . 0.0 109.967 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.684 HG21 ' HA ' ' A' ' 95' ' ' TRP . 47.3 t -80.06 -78.98 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.448 -0.782 . . . . 0.0 110.302 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.18 22.21 0.1 OUTLIER Glycine 0 N--CA 1.494 2.563 0 C-N-CA 118.77 -1.681 . . . . 0.0 112.472 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.059 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.2 pt -81.19 -136.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.187 -1.772 . . . . 0.0 108.102 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.622 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.2 m -159.08 -68.6 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.465 -1.397 . . . . 0.0 109.967 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 5.7 Cg_endo -62.51 -173.74 0.15 Allowed 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.686 1.591 . . . . 0.0 110.741 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.56 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 4.4 pt20 145.19 -24.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.603 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.2 OUTLIER 43.32 48.96 5.92 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.512 ' HD2' ' NE2' ' A' ' 63' ' ' GLN . 41.5 p90 -42.84 160.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.745 0.783 . . . . 0.0 110.584 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -156.89 136.91 12.63 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.167 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.637 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -59.64 -71.92 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.824 -1.172 . . . . 0.0 110.321 -178.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.747 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 85.08 -56.55 0.09 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.026 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.619 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 30.9 tp10 165.97 123.38 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.604 0.716 . . . . 0.0 109.753 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.571 ' HD2' ' CD2' ' A' ' 83' ' ' TRP . 5.7 ptmt -110.11 170.54 8.01 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.706 -0.621 . . . . 0.0 109.615 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.799 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -122.8 169.8 10.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.097 -1.002 . . . . 0.0 110.14 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.681 ' HG3' HG23 ' A' ' 81' ' ' THR . 15.6 tt0 -147.07 85.78 1.62 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.21 123.77 28.74 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.429 ' CG ' ' NE2' ' A' ' 79' ' ' HIS . 2.6 tt0 -91.85 108.43 19.92 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.281 -0.968 . . . . 0.0 109.017 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.531 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 1.9 m-85 -78.32 170.35 16.65 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.398 -0.814 . . . . 0.0 109.468 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 7.5 Cg_exo -49.65 -38.15 45.13 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.112 1.874 . . . . 0.0 109.714 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.63 43.46 0.44 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.513 ' O ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -148.07 97.54 2.8 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.091 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.459 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -79.82 94.91 5.89 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.607 HG22 ' N ' ' A' ' 81' ' ' THR . 0.4 OUTLIER -102.17 164.52 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.183 -0.948 . . . . 0.0 110.559 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.681 HG23 ' HG3' ' A' ' 72' ' ' GLU . 1.2 m -148.3 151.62 35.7 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.815 HD13 HN61 ' A' ' 130' ' ' APC . 0.2 OUTLIER -142.63 79.56 1.66 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.696 -1.253 . . . . 0.0 110.682 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.571 ' CD2' ' HD2' ' A' ' 70' ' ' LYS . 87.5 m95 -53.96 111.37 0.74 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 109.296 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.776 ' CE1' HG11 ' A' ' 122' ' ' VAL . 8.7 m-85 -87.01 71.31 10.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.157 -0.964 . . . . 0.0 109.546 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.688 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 67.5 m95 -75.44 86.6 2.58 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.94 -1.1 . . . . 0.0 109.554 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.747 HD23 ' CD2' ' A' ' 68' ' ' PHE . 1.7 mm? -67.89 130.75 43.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.626 -1.296 . . . . 0.0 109.711 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.811 ' CG2' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -111.37 179.45 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.19 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.512 ' N ' HG23 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -160.93 17.6 0.12 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.341 -1.475 . . . . 0.0 112.57 -179.349 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.603 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -160.52 50.63 0.28 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.048 -1.657 . . . . 0.0 111.139 179.439 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.734 ' HB2' HD13 ' A' ' 60' ' ' ILE . 4.0 p90 -67.4 164.61 18.27 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.687 -1.258 . . . . 0.0 109.351 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.613 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 6.6 tt0 -87.95 140.18 29.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.152 -0.967 . . . . 0.0 109.363 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 36.29 -85.17 0.01 OUTLIER Glycine 0 N--CA 1.497 2.731 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 1.059 ' O ' HG21 ' A' ' 60' ' ' ILE . 10.4 pt-20 -101.61 159.61 28.93 Favored Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.242 -1.152 . . . . 0.0 109.706 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.653 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 15.0 Cg_endo -75.52 -159.94 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.364 2.043 . . . . 0.0 109.669 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.802 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER 175.18 27.21 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.72 -0.612 . . . . 0.0 110.667 178.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.416 ' HA2' ' CD1' ' A' ' 54' ' ' LEU . . . -103.28 -6.15 45.3 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.59 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -81.15 128.54 33.87 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.347 -1.09 . . . . 0.0 110.854 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.533 ' OE1' ' CA ' ' A' ' 38' ' ' GLY . 22.7 tp10 -81.69 -96.14 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.522 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . -89.7 -19.5 47.88 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 107.634 -2.187 . . . . 0.0 107.634 177.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.569 ' HG3' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -61.55 149.29 84.53 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.865 -0.786 . . . . 0.0 109.219 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.569 ' HD2' ' HG3' ' A' ' 100' ' ' GLN . 1.2 Cg_endo -67.6 -37.35 16.93 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.737 1.625 . . . . 0.0 108.79 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.61 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.12 123.2 0.01 OUTLIER Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.558 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 1.4 pp20? -151.79 125.65 9.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.957 -1.319 . . . . 0.0 109.795 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.592 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 1.2 m-90 -45.08 132.62 7.0 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.633 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 7.7 tpt -124.31 120.73 33.02 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.288 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.31 47.51 1.16 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 1.069 HD13 ' HG ' ' A' ' 110' ' ' LEU . 6.8 tt -59.47 -48.0 83.32 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.74 -0.6 . . . . 0.0 109.427 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.634 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 49.3 t 82.79 112.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 40.89 82.79 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.069 ' HG ' HD13 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -42.08 164.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.377 -1.073 . . . . 0.0 109.869 -179.211 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.71 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -138.43 -6.97 1.53 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.001 -1.062 . . . . 0.0 111.924 -177.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 82.34 -26.43 0.14 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.219 -0.926 . . . . 0.0 108.87 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.27 -24.42 59.35 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.679 ' OD1' ' HB1' ' A' ' 30' ' ' ALA . 4.4 m-20 -103.07 -13.64 16.75 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.708 ' CZ ' HD12 ' A' ' 20' ' ' ILE . 2.0 m-85 -95.3 143.25 25.79 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.287 -0.883 . . . . 0.0 109.945 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -60.15 132.97 47.14 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.032 1.822 . . . . 0.0 109.575 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.55 -16.29 23.42 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.144 1.896 . . . . 0.0 110.988 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.05 -57.28 9.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.939 -1.1 . . . . 0.0 109.104 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.72 ' O ' HD12 ' A' ' 123' ' ' ILE . 9.8 m-20 -86.67 48.55 1.65 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.806 0.812 . . . . 0.0 109.043 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -56.61 -44.12 99.62 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.778 -0.576 . . . . 0.0 112.427 -179.536 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 11.5 Cg_exo -53.3 -57.55 1.93 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.048 1.832 . . . . 0.0 112.962 -177.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.776 HG11 ' CE1' ' A' ' 84' ' ' PHE . 2.0 t -78.93 -32.99 15.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 120.788 -1.195 . . . . 0.0 109.532 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.72 HD12 ' O ' ' A' ' 119' ' ' ASN . 5.7 mt -64.16 -23.97 34.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.565 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -61.49 -28.45 69.31 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.899 0.857 . . . . 0.0 108.92 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -80.35 -40.09 27.3 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.752 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.778 HD13 ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -66.3 -22.02 66.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.623 -1.298 . . . . 0.0 107.845 179.148 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 12.6 mtmt -58.35 -33.54 69.66 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -87.19 -21.42 25.9 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.602 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 1.6 tp . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.736 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 130' ' ' APC . . . . . 0.815 HN61 HD13 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 2' ' ' LYS . 2.9 ptt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.509 ' HE2' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -47.43 176.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 0.0 109.467 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.509 ' N ' ' HE2' ' A' ' 2' ' ' LYS . 26.8 tttt -158.72 149.15 19.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.976 . . . . 0.0 109.89 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 1.069 ' O ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -157.24 144.33 18.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.979 179.099 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.632 ' N ' HD22 ' A' ' 4' ' ' LEU . 9.7 mp0 -108.71 166.08 11.06 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.689 HG22 HG12 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -128.81 114.73 34.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 O-C-N 120.992 -1.067 . . . . 0.0 109.334 -178.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.042 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -85.2 62.61 7.6 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 36' ' ' PRO . 1.2 p -79.01 -70.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.353 -0.842 . . . . 0.0 109.972 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.738 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 59.08 84.48 0.04 OUTLIER Glycine 0 N--CA 1.481 1.649 0 N-CA-C 107.569 -2.212 . . . . 0.0 107.569 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.625 HG22 ' HB ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -48.63 166.76 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.8 HG22 ' CG2' ' A' ' 87' ' ' VAL . 1.8 pt -130.65 78.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.687 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.677 ' HB3' HG23 ' A' ' 18' ' ' ILE . 2.9 ptm180 -83.25 144.92 29.42 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.598 ' OD1' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -161.3 -5.6 0.05 OUTLIER 'General case' 0 C--O 1.185 -2.291 0 C-N-CA 116.769 -1.972 . . . . 0.0 114.203 -179.072 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.612 ' HB2' ' CG ' ' A' ' 17' ' ' GLU . 19.7 mm-40 -94.02 -32.2 13.92 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 118.182 -2.824 . . . . 0.0 107.471 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.605 ' CG ' HG22 ' A' ' 108' ' ' VAL . 24.6 t-20 -162.82 -48.62 0.04 OUTLIER 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 102.382 -3.192 . . . . 0.0 102.382 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.478 ' OD1' HD23 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -161.74 35.78 0.13 Allowed 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 175.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 105' ' ' MET . 0.3 OUTLIER -86.1 92.86 8.85 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.069 -1.452 . . . . 0.0 110.8 -176.449 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.677 HG23 ' HB3' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -84.95 156.66 3.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.536 0.684 . . . . 0.0 109.872 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.615 ' CE1' ' HG2' ' A' ' 94' ' ' PRO . 6.4 t80 -82.97 44.1 0.9 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.58 ' CG2' HG13 ' A' ' 18' ' ' ILE . 7.0 tp -82.05 155.69 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.148 -0.97 . . . . 0.0 110.55 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.68 ' O ' HG23 ' A' ' 21' ' ' THR . 5.0 t -73.08 89.23 1.46 Allowed 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.562 ' HD3' HD21 ' A' ' 33' ' ' LEU . 29.1 tpt180 -90.21 76.06 6.9 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.501 -0.75 . . . . 0.0 110.555 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.872 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 35.26 76.97 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.762 -0.586 . . . . 0.0 110.093 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.55 -52.98 9.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.928 . . . . 0.0 109.875 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.28 -170.23 2.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.119 -0.988 . . . . 0.0 109.489 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -79.5 128.51 33.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.194 -0.941 . . . . 0.0 109.141 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.872 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -124.46 -44.85 1.97 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.132 -0.98 . . . . 0.0 110.184 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.6 t60 56.41 20.44 4.75 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.71 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 6.3 mtp -115.28 -40.99 3.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.654 -0.654 . . . . 0.0 109.372 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 29' ' ' MET . . . 76.18 -177.49 0.13 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.304 -0.872 . . . . 0.0 109.003 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 1.3 t30 78.1 -5.95 2.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 109.403 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.49 ' O ' ' O ' ' A' ' 21' ' ' THR . 3.8 tmtm? -82.59 48.29 1.29 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.433 -0.792 . . . . 0.0 109.871 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.643 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 9.5 mt -117.91 79.93 1.44 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.846 -1.158 . . . . 0.0 109.304 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.607 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 13.2 tt0 -81.3 -134.18 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.345 -0.847 . . . . 0.0 109.132 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.607 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -149.37 124.75 4.94 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.544 -1.348 . . . . 0.0 110.261 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.792 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.7 Cg_endo -57.99 94.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.14 1.893 . . . . 0.0 109.515 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -55.34 -148.14 0.01 OUTLIER Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.287 -0.883 . . . . 0.0 111.757 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.602 ' N ' ' CG ' ' A' ' 98' ' ' GLU . . . 157.41 -31.96 0.53 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 107.538 -2.225 . . . . 0.0 107.538 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.464 ' O ' ' OE2' ' A' ' 53' ' ' GLU . 2.5 tptm 67.18 100.43 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 122.237 -0.567 . . . . 0.0 110.744 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.82 ' O ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -80.74 134.5 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.721 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 42' ' ' MET . 4.0 pt-20 -171.39 -31.94 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.784 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.443 ' O ' ' C ' ' A' ' 43' ' ' GLY . 4.4 mmt -54.69 162.92 1.05 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.113 -0.992 . . . . 0.0 109.252 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 42' ' ' MET . . . 43.93 -125.81 5.68 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -164.6 23.21 0.06 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.474 -1.015 . . . . 0.0 108.948 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.471 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 24.1 m -138.24 140.04 27.34 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.52 ' O ' HG12 ' A' ' 50' ' ' VAL . 10.0 Cg_exo -51.05 -17.84 3.95 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 121.748 1.632 . . . . 0.0 110.136 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.512 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -77.95 -85.14 0.07 Allowed 'General case' 0 C--O 1.202 -1.401 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.519 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.546 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 40.6 mt-30 -43.83 -33.17 1.24 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.569 -1.332 . . . . 0.0 109.715 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.693 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -65.76 -62.63 1.4 Allowed 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.511 -0.743 . . . . 0.0 110.021 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.042 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.6 p -68.99 -49.58 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.216 -0.928 . . . . 0.0 110.316 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.561 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 3.4 p -54.95 -45.48 76.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 121.684 -0.635 . . . . 0.0 110.186 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.552 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 5.4 mmt180 -71.06 -37.35 72.49 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.616 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 17.6 mm-40 -68.9 -14.59 63.13 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.763 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -80.0 -59.94 2.53 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -54.04 46.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.447 -0.783 . . . . 0.0 110.007 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.563 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 1.1 pp20? -47.57 -21.74 0.39 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.039 -1.038 . . . . 0.0 110.075 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.433 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 3.3 mt-10 -80.04 -92.92 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.075 -1.016 . . . . 0.0 109.632 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.776 HG21 ' HA ' ' A' ' 95' ' ' TRP . 36.2 t -79.97 -78.34 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 110.117 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.94 18.89 0.1 OUTLIER Glycine 0 N--CA 1.493 2.496 0 C-N-CA 118.43 -1.843 . . . . 0.0 112.643 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.947 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.6 pp -80.05 -156.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.123 -1.81 . . . . 0.0 107.628 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.624 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.5 m -137.36 -72.25 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.421 -1.424 . . . . 0.0 110.947 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 1.6 Cg_endo -61.43 -169.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 121.029 1.153 . . . . 0.0 110.712 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.584 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER 143.27 -23.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -179.436 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.609 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 1.6 t-80 44.84 53.21 7.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.455 -0.778 . . . . 0.0 109.484 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -45.97 156.05 0.16 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.036 0.922 . . . . 0.0 110.372 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -149.36 140.62 23.14 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.608 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -63.49 -68.1 0.37 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.731 -1.23 . . . . 0.0 109.78 -179.112 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.641 ' CZ ' HD11 ' A' ' 126' ' ' LEU . 0.0 OUTLIER 83.73 -50.53 0.14 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.242 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.599 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.5 mt-10 162.16 174.02 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.36 -172.38 3.36 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.824 -1.172 . . . . 0.0 109.891 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.979 HD21 ' OD1' ' A' ' 119' ' ' ASN . 0.7 OUTLIER -140.18 -177.7 5.13 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.795 0.807 . . . . 0.0 109.891 179.579 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.637 ' HG3' HG23 ' A' ' 81' ' ' THR . 11.3 tt0 -160.18 88.7 0.82 Allowed 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.03 105.48 9.27 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.512 ' HG3' ' NE2' ' A' ' 79' ' ' HIS . 2.8 tt0 -96.72 118.29 32.86 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.119 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -105.69 174.3 2.72 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 2.9 Cg_exo -49.03 -60.51 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 121.418 1.412 . . . . 0.0 109.558 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.5 50.39 1.71 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.434 ' HD2' ' CD1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -150.36 87.97 1.48 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.457 -0.777 . . . . 0.0 109.743 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.554 ' O ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -90.28 98.72 11.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.89 . . . . 0.0 109.386 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.641 HG21 ' C6 ' ' A' ' 130' ' ' APC . 0.5 OUTLIER -113.14 163.55 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.0 110.253 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.637 HG23 ' HG3' ' A' ' 72' ' ' GLU . 0.7 OUTLIER -151.34 147.1 26.52 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.336 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.641 ' CD2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -134.49 73.83 1.51 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.918 -1.114 . . . . 0.0 110.816 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.652 ' CD1' HG21 ' A' ' 40' ' ' ILE . 78.8 m95 -46.35 117.15 1.47 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.06 -1.025 . . . . 0.0 108.563 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.695 ' CE2' HG11 ' A' ' 122' ' ' VAL . 33.9 m-85 -94.03 76.78 4.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.966 -1.084 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.663 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 24.6 m95 -76.89 84.21 3.45 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.902 -1.124 . . . . 0.0 109.372 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.623 HD11 ' CG1' ' A' ' 10' ' ' ILE . 2.4 mm? -69.24 128.04 35.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.671 -1.268 . . . . 0.0 109.212 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.8 ' CG2' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -112.0 175.78 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 87.2 mt-10 -157.14 19.41 0.3 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.48 -1.388 . . . . 0.0 112.786 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.609 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -160.67 64.16 0.31 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.105 -1.622 . . . . 0.0 111.087 178.666 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.61 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 1.5 p90 -80.74 164.6 22.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.747 -1.22 . . . . 0.0 109.156 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.6 OUTLIER -88.27 142.94 27.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.854 -1.154 . . . . 0.0 109.386 178.314 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 38.25 -83.37 0.0 OUTLIER Glycine 0 N--CA 1.498 2.814 0 O-C-N 121.585 -0.697 . . . . 0.0 112.073 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.947 ' O ' HG21 ' A' ' 60' ' ' ILE . 10.6 pt-20 -106.98 164.86 13.93 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.149 -1.206 . . . . 0.0 111.254 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.615 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 11.2 Cg_endo -75.86 -160.91 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 122.717 2.278 . . . . 0.0 109.934 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.776 ' HA ' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER 176.51 54.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.196 -0.94 . . . . 0.0 110.865 178.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . -139.98 0.6 2.12 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 118.334 -1.888 . . . . 0.0 111.814 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.651 ' HE3' HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -78.03 106.94 10.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.403 -1.646 . . . . 0.0 110.772 -179.201 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.602 ' CG ' ' N ' ' A' ' 38' ' ' GLY . 1.2 mm-40 -60.27 -91.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.735 -1.228 . . . . 0.0 107.73 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.74 22.17 34.55 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 106.692 -2.563 . . . . 0.0 106.692 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.506 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -100.11 143.38 26.39 Favored Pre-proline 0 N--CA 1.485 1.289 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 21' ' ' THR . 4.4 Cg_exo -57.31 -30.67 88.5 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 N-CA-C 108.127 -1.528 . . . . 0.0 108.127 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.605 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 53.63 110.97 0.01 OUTLIER Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 4.6 pt-20 -147.8 133.73 19.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.758 -1.437 . . . . 0.0 110.557 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.53 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 7.8 m0 -46.06 123.62 4.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 108.495 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.639 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -115.55 111.07 20.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.08 -1.012 . . . . 0.0 109.764 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.522 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 19.3 t -79.58 63.07 4.06 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.368 -0.832 . . . . 0.0 110.634 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.842 HD12 ' N ' ' A' ' 108' ' ' VAL . 4.2 pp -82.37 -40.38 21.41 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.3 -0.875 . . . . 0.0 109.883 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.842 ' N ' HD12 ' A' ' 107' ' ' LEU . 2.0 t 70.64 118.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 42.53 84.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.621 -1.791 . . . . 0.0 108.621 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.824 HD21 ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -45.74 174.34 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.587 -0.949 . . . . 0.0 110.147 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.669 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 4.4 t-20 -152.77 0.54 0.28 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.979 -1.075 . . . . 0.0 112.069 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 79.78 -32.3 0.13 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.889 -1.132 . . . . 0.0 109.008 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -49.8 -26.51 3.99 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.571 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 9.2 m-20 -108.3 -17.62 13.96 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.809 -0.557 . . . . 0.0 109.872 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.824 ' CD1' HD21 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -91.77 144.32 29.21 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.134 -0.979 . . . . 0.0 109.853 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.531 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.8 Cg_endo -65.2 134.13 38.05 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.269 1.979 . . . . 0.0 109.962 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 118' ' ' ALA . 5.5 Cg_exo -60.65 -25.52 81.04 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.083 1.856 . . . . 0.0 110.731 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.91 -46.58 5.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.215 -0.928 . . . . 0.0 109.231 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.979 ' OD1' HD21 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -95.33 51.78 1.35 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.326 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.644 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -59.97 -44.15 96.1 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.621 -0.674 . . . . 0.0 112.358 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 6.2 Cg_exo -54.34 -32.89 74.13 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.013 1.809 . . . . 0.0 112.872 -177.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.695 HG11 ' CE2' ' A' ' 84' ' ' PHE . 2.4 t -101.41 -36.8 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.522 -1.361 . . . . 0.0 110.153 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.951 ' HA ' HD22 ' A' ' 126' ' ' LEU . 1.1 mp -61.93 -27.85 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.53 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -55.06 -35.08 64.14 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 125' ' ' LYS . 26.0 mmtp -80.11 -41.62 25.16 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.946 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.951 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -60.3 -22.0 62.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.335 -1.478 . . . . 0.0 107.448 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.537 ' HD3' ' CB ' ' A' ' 112' ' ' ALA . 6.3 mttt -57.36 -42.02 81.23 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -79.07 -18.98 52.45 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.634 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 2.5 tp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.984 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 130' ' ' APC . . . . . 0.641 ' C6 ' HG21 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.412 0.625 . . . . 0.0 109.452 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.538 ' HE3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -156.49 -173.91 4.7 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.408 -0.808 . . . . 0.0 109.2 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.538 ' N ' ' HE3' ' A' ' 2' ' ' LYS . 3.6 ttpm? -121.88 153.81 37.92 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.194 -0.941 . . . . 0.0 109.443 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 1.044 ' O ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -148.22 122.11 9.37 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.97 ' N ' HD22 ' A' ' 4' ' ' LEU . 2.9 mp0 -110.65 154.65 23.52 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.114 -0.991 . . . . 0.0 108.339 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.639 HG22 HG12 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -122.5 118.21 54.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.396 -178.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.124 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -85.52 60.76 6.44 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.709 HG13 ' H ' ' A' ' 9' ' ' GLY . 1.0 OUTLIER -79.16 -71.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.096 -179.203 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.709 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 59.84 82.23 0.07 OUTLIER Glycine 0 C--N 1.298 -1.57 0 N-CA-C 106.304 -2.719 . . . . 0.0 106.304 -177.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.575 ' O ' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -48.15 154.69 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -178.264 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.931 HG22 ' CG1' ' A' ' 87' ' ' VAL . 4.0 pt -116.48 102.27 13.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.886 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.769 ' HG2' HG23 ' A' ' 18' ' ' ILE . 8.6 mtm180 -76.65 -173.12 2.46 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.619 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -155.43 -66.32 0.12 Allowed 'General case' 0 C--O 1.188 -2.161 0 C-N-CA 116.826 -1.95 . . . . 0.0 114.267 -177.016 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.61 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 29.1 tp10 -91.51 -33.82 15.03 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 118.953 -2.342 . . . . 0.0 111.496 -175.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.483 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 41.8 t-20 -161.73 -42.08 0.04 OUTLIER 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.529 ' OD1' ' NH1' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -155.96 32.8 0.35 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 177.61 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 105' ' ' MET . 1.9 mm-40 -90.1 109.45 20.5 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 118.038 -1.465 . . . . 0.0 108.49 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.78 HD12 ' HB3' ' A' ' 105' ' ' MET . 0.2 OUTLIER -102.92 148.44 8.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.793 -177.558 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.627 ' CE2' ' HG2' ' A' ' 94' ' ' PRO . 20.4 t80 -81.54 38.34 0.49 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.733 HG21 HD22 ' A' ' 33' ' ' LEU . 6.1 tp -78.47 152.55 5.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.259 -0.901 . . . . 0.0 110.442 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.493 ' HB ' ' HD2' ' A' ' 101' ' ' PRO . 1.4 t -65.49 85.5 0.07 Allowed 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.511 ' O ' ' C ' ' A' ' 23' ' ' ARG . 21.2 tpt180 -87.38 93.59 9.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.688 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.939 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 28.55 76.63 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 120.986 0.422 . . . . 0.0 110.385 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.25 -47.52 4.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.363 -0.836 . . . . 0.0 109.105 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.25 155.1 26.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.869 . . . . 0.0 108.992 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -59.6 92.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.07 -1.018 . . . . 0.0 109.649 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.939 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -97.54 96.84 8.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -0.947 . . . . 0.0 109.947 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -48.95 -25.61 2.04 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.305 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.41 ' N ' ' C ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -72.06 -167.29 0.29 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.54 0.686 . . . . 0.0 109.477 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.528 ' O ' ' CB ' ' A' ' 31' ' ' ASN . . . -154.58 -157.98 0.81 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 0.7 OUTLIER 75.26 -2.7 2.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.059 -1.025 . . . . 0.0 109.074 -179.164 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -82.39 59.66 4.69 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.563 -0.71 . . . . 0.0 110.279 -179.534 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.733 HD22 HG21 ' A' ' 20' ' ' ILE . 12.0 mt -122.41 85.09 2.36 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.704 ' C ' HD11 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -80.8 -138.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.15 -1.593 . . . . 0.0 109.443 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.639 ' HB3' HG21 ' A' ' 8' ' ' VAL . 23.6 m-85 -154.22 123.98 3.26 Favored Pre-proline 0 N--CA 1.485 1.317 0 O-C-N 121.066 -1.021 . . . . 0.0 109.464 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.579 ' O ' HG23 ' A' ' 8' ' ' VAL . 2.1 Cg_endo -58.63 88.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.889 1.726 . . . . 0.0 109.464 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.544 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -57.12 -141.41 0.01 OUTLIER Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.569 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . 162.48 -55.35 0.3 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HB2' ' PB ' ' A' ' 130' ' ' APC . 0.0 OUTLIER 99.04 69.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 123.11 0.564 . . . . 0.0 110.352 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.741 ' O ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -53.79 123.45 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.963 -1.086 . . . . 0.0 108.684 179.353 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 42' ' ' MET . 8.1 pt-20 -173.16 -22.52 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.647 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.438 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -38.82 -81.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.133 -0.979 . . . . 0.0 110.153 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.41 -122.95 2.25 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.69 9.07 1.97 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.531 -0.982 . . . . 0.0 109.124 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.553 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 60.4 m -126.01 142.41 42.38 Favored Pre-proline 0 N--CA 1.486 1.335 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.609 ' HG3' ' CZ3' ' A' ' 83' ' ' TRP . 3.6 Cg_exo -52.41 -15.7 4.25 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.545 1.497 . . . . 0.0 110.317 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.696 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.4 tt0 -75.97 -81.25 0.08 Allowed 'General case' 0 C--O 1.201 -1.486 0 O-C-N 120.983 -1.073 . . . . 0.0 108.638 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.544 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 1.3 mt-30 -47.75 -36.02 10.8 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.265 -1.522 . . . . 0.0 109.455 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.702 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -62.17 -64.17 1.01 Allowed 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.198 -0.939 . . . . 0.0 110.136 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.124 HG23 ' HB1' ' A' ' 7' ' ' ALA . 1.3 p -69.47 -49.81 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.305 -0.872 . . . . 0.0 110.657 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.696 HG12 ' O ' ' A' ' 47' ' ' GLU . 3.1 p -55.89 -37.12 46.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.745 -0.597 . . . . 0.0 110.421 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -78.96 -37.16 40.22 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 2.2 mm-40 -69.83 -14.23 62.65 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.006 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -80.08 -65.5 1.0 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.519 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.06 -49.8 74.74 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.697 -0.627 . . . . 0.0 110.479 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.611 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -46.64 -24.76 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.881 -1.137 . . . . 0.0 109.915 -178.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 8.0 mm-40 -80.13 -95.04 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.091 -1.005 . . . . 0.0 109.563 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.632 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 66.3 t -79.96 -79.36 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.098 -1.001 . . . . 0.0 109.911 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.99 37.58 0.09 OUTLIER Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.241 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.086 HG21 ' O ' ' A' ' 93' ' ' GLU . 2.9 pp -93.36 -152.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 120.793 -1.416 . . . . 0.0 108.542 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.829 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.3 m -161.7 -64.96 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 120.327 -1.483 . . . . 0.0 112.511 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 3.8 Cg_exo -51.59 -2.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.827 2.351 . . . . 0.0 114.267 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.508 ' N ' ' HA ' ' A' ' 90' ' ' TRP . 1.3 pt20 -34.89 -29.15 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 119.575 1.079 . . . . 0.0 110.791 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.578 ' N ' ' O ' ' A' ' 62' ' ' PRO . 2.2 t60 55.32 73.37 0.42 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.676 -1.265 . . . . 0.0 108.053 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 15.5 p90 -72.99 146.4 46.01 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.791 0.805 . . . . 0.0 111.179 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -144.4 135.37 25.13 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.257 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.629 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -61.46 -70.16 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.752 -1.217 . . . . 0.0 109.985 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.913 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 84.1 -52.51 0.13 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -178.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.9 mm-40 172.69 177.54 0.09 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.262 -0.899 . . . . 0.0 108.885 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HE2' HG22 ' A' ' 81' ' ' THR . 0.0 OUTLIER -161.37 -174.59 4.36 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.195 -0.941 . . . . 0.0 109.38 -179.389 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -149.02 175.79 11.0 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.135 -0.978 . . . . 0.0 109.986 179.106 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -144.06 89.16 2.01 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.15 123.16 27.11 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.24 156.3 17.3 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.294 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.585 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -133.22 174.13 5.07 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.585 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 5.4 Cg_exo -47.68 -33.35 18.44 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.696 1.597 . . . . 0.0 109.74 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 1' ' ' MET . 0.5 OUTLIER -164.18 51.59 0.14 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.152 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.534 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -155.64 94.0 1.53 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.652 -0.655 . . . . 0.0 109.778 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.75 ' C ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -78.72 120.7 23.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.047 -1.033 . . . . 0.0 108.707 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.75 HD12 ' C ' ' A' ' 79' ' ' HIS . 1.3 mp -117.89 165.25 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 122.135 0.969 . . . . 0.0 110.592 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.598 ' N ' ' CG2' ' A' ' 80' ' ' ILE . 1.5 m -153.6 155.98 37.13 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.575 ' CD2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -148.49 77.04 1.38 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.912 -1.118 . . . . 0.0 110.301 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.609 ' CZ3' ' HG3' ' A' ' 46' ' ' PRO . 75.9 m95 -49.0 108.59 0.19 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.809 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.878 ' CG ' HG11 ' A' ' 122' ' ' VAL . 19.1 m-85 -85.06 69.81 10.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.134 -0.979 . . . . 0.0 109.593 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.684 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 71.0 m95 -74.23 87.53 1.96 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.905 -1.122 . . . . 0.0 109.361 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.913 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.3 mm? -70.07 126.98 31.26 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 120.67 -1.269 . . . . 0.0 109.573 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.931 ' CG1' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -101.52 179.98 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.01 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.494 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 42.8 mt-10 -153.28 1.69 0.27 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 117.735 -1.586 . . . . 0.0 113.219 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.593 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.32 71.27 0.44 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.002 -1.686 . . . . 0.0 110.95 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.619 ' CH2' ' HB2' ' A' ' 13' ' ' ASN . 2.8 p90 -78.87 165.64 23.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.418 -1.426 . . . . 0.0 110.036 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.573 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 1.5 pt-20 -86.98 137.6 32.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.206 -0.934 . . . . 0.0 109.824 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 41.1 -89.49 0.01 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 1.086 ' O ' HG21 ' A' ' 60' ' ' ILE . 12.6 pt-20 -103.9 162.54 19.64 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.199 -1.177 . . . . 0.0 109.745 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.835 ' HB3' HD12 ' A' ' 11' ' ' ILE . 10.1 Cg_endo -76.64 -155.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.58 2.187 . . . . 0.0 110.067 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 1.006 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER 179.48 49.64 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.336 -0.852 . . . . 0.0 110.56 179.115 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . -130.63 -2.92 4.75 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.078 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.499 ' N ' ' CD ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -56.92 99.47 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.242 -1.152 . . . . 0.0 110.29 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.474 ' HB2' ' C ' ' A' ' 37' ' ' GLY . 5.7 tp10 -82.1 84.43 7.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.114 -0.991 . . . . 0.0 108.821 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.07 16.95 65.05 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.507 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 2.8 pt20 -121.54 164.62 23.5 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.556 -0.967 . . . . 0.0 109.003 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 3.2 Cg_exo -65.65 -49.35 2.4 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 121.742 1.628 . . . . 0.0 109.79 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.622 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.94 119.27 0.01 OUTLIER Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.567 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 2.4 pt-20 -151.96 134.7 15.52 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.037 -1.273 . . . . 0.0 110.846 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.611 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 2.1 m0 -48.85 127.88 14.7 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.78 ' HB3' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -108.23 133.41 52.51 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -178.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.521 ' HA ' ' OE2' ' A' ' 17' ' ' GLU . 1.6 t -84.65 41.12 0.83 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.411 -1.431 . . . . 0.0 109.531 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.608 HD21 ' CA ' ' A' ' 110' ' ' LEU . 1.6 tt -82.54 150.96 26.64 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.483 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 48.4 t -119.52 132.32 69.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 109.293 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 129' ' ' LEU . . . 39.96 80.8 0.03 OUTLIER Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.083 HD22 ' CD2' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -41.87 163.71 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.479 -1.013 . . . . 0.0 110.072 -178.177 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.697 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 3.8 t30 -138.79 0.4 2.0 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 111.322 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 82.59 -33.62 0.09 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.221 -0.924 . . . . 0.0 108.632 -178.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -50.87 -28.91 10.55 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.512 -0.742 . . . . 0.0 109.044 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.562 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 8.5 m-20 -101.33 -19.41 15.64 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.538 -0.726 . . . . 0.0 109.406 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 1.083 ' CD2' HD22 ' A' ' 110' ' ' LEU . 1.3 m-85 -86.26 142.46 35.72 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.332 -0.855 . . . . 0.0 108.723 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.57 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.2 Cg_endo -62.94 146.28 94.78 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.276 1.984 . . . . 0.0 110.249 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.508 ' HA ' ' CD ' ' A' ' 120' ' ' GLU . 1.3 Cg_endo -64.4 -18.9 64.68 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.182 1.921 . . . . 0.0 110.994 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.66 -56.48 20.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.094 . . . . 0.0 110.09 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.877 ' O ' HD12 ' A' ' 123' ' ' ILE . 9.0 m-80 -91.62 44.96 1.2 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.094 -1.004 . . . . 0.0 109.852 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.709 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 1.3 tp10 -60.71 -47.07 96.94 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.442 -0.786 . . . . 0.0 112.156 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.709 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 24.6 Cg_exo -43.85 -48.14 9.33 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.115 1.877 . . . . 0.0 112.452 -177.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.878 HG11 ' CG ' ' A' ' 84' ' ' PHE . 2.5 t -91.67 -25.75 5.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 O-C-N 120.619 -1.301 . . . . 0.0 107.874 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.879 ' HA ' HD22 ' A' ' 126' ' ' LEU . 1.5 mt -69.42 -11.55 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.539 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -71.36 -27.68 63.53 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -80.24 -38.83 30.24 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.752 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.879 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -67.03 -22.87 65.86 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.525 -1.359 . . . . 0.0 107.719 179.299 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 2.7 mtmm -56.77 -31.46 64.65 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -89.82 -21.78 22.42 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.327 -0.852 . . . . 0.0 108.711 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 1.4 tp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.77 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 130' ' ' APC . . . . . 0.675 ' C6 ' HG21 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' CON . . . . . 0.584 ' N3 ' ' O2A' ' A' ' 130' ' ' APC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.558 ' O ' ' O ' ' A' ' 2' ' ' LYS . 1.8 tpt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.558 ' O ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 45.04 167.36 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 122.065 0.936 . . . . 0.0 111.962 179.574 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.446 ' CG ' ' N ' ' A' ' 4' ' ' LEU . 2.1 ttpt -162.5 159.07 24.49 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.058 -1.026 . . . . 0.0 109.77 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.761 HD22 " O4'" ' A' ' 130' ' ' APC . 0.2 OUTLIER -160.48 160.0 31.5 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.133 -0.979 . . . . 0.0 109.161 178.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.794 ' HB2' HG23 ' A' ' 40' ' ' ILE . 15.3 mp0 -131.09 173.22 11.24 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.179 -0.951 . . . . 0.0 108.657 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.633 HG13 ' N7 ' ' A' ' 130' ' ' APC . 0.1 OUTLIER -140.85 116.75 7.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 121.131 -0.98 . . . . 0.0 109.084 -179.388 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.096 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -82.29 67.63 8.39 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.845 HG11 ' CD2' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -79.15 -76.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.273 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.697 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 65.3 78.48 0.22 Allowed Glycine 0 C--N 1.295 -1.697 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 -178.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.835 HD12 ' NH2' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -47.15 168.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -178.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.942 HG22 HG22 ' A' ' 87' ' ' VAL . 3.7 pt -140.38 93.85 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 120.859 -1.15 . . . . 0.0 110.083 -177.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.872 ' NH1' HD13 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -95.56 152.08 18.75 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.471 ' OD1' ' CH2' ' A' ' 90' ' ' TRP . 7.1 p-10 -161.08 -10.39 0.04 OUTLIER 'General case' 0 C--O 1.188 -2.182 0 C-N-CA 116.663 -2.015 . . . . 0.0 115.444 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.452 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -94.47 -31.16 14.07 Favored 'General case' 0 N--CA 1.51 2.548 0 O-C-N 118.047 -2.908 . . . . 0.0 108.458 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -162.8 -48.75 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 102.174 -3.269 . . . . 0.0 102.174 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.43 ' C ' ' OE1' ' A' ' 17' ' ' GLU . 16.9 t30 -162.03 38.31 0.12 Allowed 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 175.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -85.35 93.14 8.65 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.432 -1.307 . . . . 0.0 110.697 -177.056 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 2.0 pt -79.12 146.83 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.63 0.729 . . . . 0.0 111.063 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.687 ' HB3' HD11 ' A' ' 11' ' ' ILE . 6.3 t80 -82.75 43.68 0.86 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.837 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -80.67 151.11 4.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.07 0.938 . . . . 0.0 110.49 -178.274 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.695 ' O ' HG23 ' A' ' 21' ' ' THR . 5.3 t -66.56 91.34 0.18 Allowed 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.713 ' HD2' HD21 ' A' ' 33' ' ' LEU . 21.4 tpt180 -94.47 140.5 29.75 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.281 -0.887 . . . . 0.0 108.712 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.841 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -32.21 91.19 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . -42.82 -54.44 4.13 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.493 -0.754 . . . . 0.0 109.149 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.69 -163.09 0.53 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.712 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 73.2 m-20 -70.09 -49.96 45.72 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.908 -1.12 . . . . 0.0 109.805 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.841 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . 81.98 -24.16 0.19 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.346 -0.846 . . . . 0.0 110.212 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.498 ' O ' ' HG2' ' A' ' 29' ' ' MET . 0.1 OUTLIER 47.77 25.43 0.71 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.79 -1.193 . . . . 0.0 108.047 -178.723 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 28' ' ' HIS . 20.7 mmt -154.94 -167.68 2.65 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.545 ' HB1' ' OD1' ' A' ' 114' ' ' ASP . . . -153.09 -162.47 1.49 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 108.929 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 1.0 OUTLIER 77.18 -2.71 2.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.443 -0.786 . . . . 0.0 109.327 -179.625 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.656 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -82.09 55.34 2.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.47 -0.769 . . . . 0.0 110.097 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.713 HD21 ' HD2' ' A' ' 22' ' ' ARG . 6.6 mt -124.06 86.53 2.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.805 -1.184 . . . . 0.0 108.544 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.837 ' O ' HD11 ' A' ' 20' ' ' ILE . 4.6 tt0 -82.38 -123.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.078 -1.014 . . . . 0.0 110.32 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -161.38 123.68 1.75 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 120.646 -1.284 . . . . 0.0 109.277 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.777 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.9 Cg_endo -65.03 99.09 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.884 1.723 . . . . 0.0 109.725 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -95.02 -130.77 6.19 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.994 -1.098 . . . . 0.0 111.663 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.505 ' HA2' ' OE1' ' A' ' 98' ' ' GLU . . . 150.06 -8.65 0.81 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.614 ' HD3' " C5'" ' A' ' 130' ' ' APC . 15.2 tptm 72.78 106.13 0.07 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.39 0.614 . . . . 0.0 111.056 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.87 HG12 ' HB1' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -81.63 134.7 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.414 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 42' ' ' MET . 2.4 pt-20 -172.33 -29.37 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.216 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.428 ' O ' ' C ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -55.17 160.63 2.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.923 -1.111 . . . . 0.0 108.914 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.454 ' C ' ' HG2' ' A' ' 44' ' ' GLU . . . 46.35 -127.14 9.69 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.454 ' HG2' ' C ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -166.57 23.46 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.35 -1.088 . . . . 0.0 109.046 179.061 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.565 HG23 ' HD2' ' A' ' 46' ' ' PRO . 87.4 m -142.73 142.67 23.3 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.573 ' O ' HG12 ' A' ' 50' ' ' VAL . 9.0 Cg_exo -48.94 -16.8 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.899 1.732 . . . . 0.0 111.107 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.528 ' O ' HG12 ' A' ' 51' ' ' VAL . 4.8 mt-10 -78.5 -80.4 0.11 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.747 -1.221 . . . . 0.0 108.63 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.595 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 30.6 mt-30 -51.69 -23.94 5.07 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.396 -1.44 . . . . 0.0 109.164 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.87 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -72.1 -64.08 1.01 Allowed 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.484 -0.76 . . . . 0.0 109.737 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.096 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.6 p -70.06 -49.14 58.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.251 -0.906 . . . . 0.0 110.192 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.566 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 1.4 p -52.96 -44.62 50.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 O-C-N 121.749 -0.594 . . . . 0.0 110.292 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 7.8 mmt180 -73.57 -39.66 64.51 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.604 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 6.3 mm-40 -66.67 -15.12 63.27 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.792 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -80.19 -61.08 2.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -54.55 43.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.799 . . . . 0.0 109.906 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.568 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -46.0 -24.22 0.39 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -0.963 . . . . 0.0 109.658 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.44 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.2 mt-10 -79.99 -95.67 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.169 -0.957 . . . . 0.0 109.525 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.607 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 46.9 t -80.0 -78.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 110.109 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.12 24.19 0.12 Allowed Glycine 0 N--CA 1.494 2.507 0 C-N-CA 118.922 -1.609 . . . . 0.0 112.361 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.047 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.1 pp -84.38 -146.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.325 -1.691 . . . . 0.0 107.827 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.708 ' H ' HD12 ' A' ' 60' ' ' ILE . 1.2 m -161.03 -66.92 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 120.174 -1.579 . . . . 0.0 112.329 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.599 ' O ' ' CG ' ' A' ' 63' ' ' GLN . 10.2 Cg_exo -43.54 -94.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.169 1.912 . . . . 0.0 112.426 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.778 ' OE1' HG11 ' A' ' 87' ' ' VAL . 3.2 pt20 54.05 6.21 0.09 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.197 -0.939 . . . . 0.0 111.382 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.598 ' C ' ' O ' ' A' ' 63' ' ' GLN . 5.3 t-160 22.32 50.69 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.58 0 O-C-N 120.962 -1.086 . . . . 0.0 110.444 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 63' ' ' GLN . 1.7 p90 -35.52 141.34 0.08 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.091 0.948 . . . . 0.0 112.127 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -145.2 147.58 32.59 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.609 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -77.85 -65.28 0.99 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.79 -1.194 . . . . 0.0 110.13 -179.004 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.824 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 82.71 -51.33 0.18 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.302 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER 163.42 178.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 0.0 109.496 179.144 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.602 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 15.1 ptmt -160.96 170.3 20.86 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.301 -0.874 . . . . 0.0 109.727 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.74 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -136.16 171.58 14.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.098 179.582 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -150.09 94.15 2.11 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.01 122.23 26.48 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.599 ' HG3' ' CE1' ' A' ' 79' ' ' HIS . 15.0 tt0 -96.67 127.64 42.85 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.108 -0.995 . . . . 0.0 109.468 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.563 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 7.1 m-85 -106.7 168.34 8.24 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.362 -0.836 . . . . 0.0 109.17 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 7.5 Cg_exo -48.7 -28.48 12.68 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.943 1.762 . . . . 0.0 109.77 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.495 ' O ' ' HD2' ' A' ' 78' ' ' ARG . 8.0 m-20 -162.25 31.08 0.11 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.546 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.66 89.98 2.36 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.71 -0.619 . . . . 0.0 109.961 -178.804 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.859 ' C ' HD12 ' A' ' 80' ' ' ILE . 0.4 OUTLIER -89.86 113.3 24.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.911 -1.118 . . . . 0.0 109.126 179.58 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.859 HD12 ' C ' ' A' ' 79' ' ' HIS . 1.6 mp -118.54 155.71 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.974 -1.079 . . . . 0.0 110.446 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.551 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 1.9 m -136.14 137.84 41.39 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.845 ' CD2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -127.22 75.89 1.62 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.815 -1.178 . . . . 0.0 110.101 -179.206 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.602 ' CE3' ' HD2' ' A' ' 70' ' ' LYS . 92.2 m95 -51.79 111.24 0.57 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.265 -0.897 . . . . 0.0 109.45 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.548 ' O ' ' O ' ' A' ' 67' ' ' LEU . 45.5 m-85 -86.92 73.04 10.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.9 . . . . 0.0 110.178 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.697 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 12.7 m95 -71.94 85.76 0.99 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.819 -1.176 . . . . 0.0 108.328 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.824 HD23 ' CD2' ' A' ' 68' ' ' PHE . 2.8 mm? -67.78 125.78 27.33 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.478 -1.389 . . . . 0.0 110.024 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.942 HG22 HG22 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -112.29 169.81 4.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 38.8 mt-10 -160.54 29.59 0.16 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 117.972 -1.491 . . . . 0.0 112.552 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.581 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.85 30.19 0.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.329 -1.482 . . . . 0.0 109.943 179.235 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.67 ' HB2' HD13 ' A' ' 60' ' ' ILE . 1.6 p90 -48.96 148.78 2.12 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.951 -1.093 . . . . 0.0 109.967 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.574 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 1.6 tt0 -81.26 133.11 35.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.387 -0.821 . . . . 0.0 109.722 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 45.75 -86.89 0.01 OUTLIER Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 1.047 ' O ' HG21 ' A' ' 60' ' ' ILE . 17.1 pt-20 -100.6 161.89 22.51 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.301 -1.117 . . . . 0.0 110.051 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.621 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 13.9 Cg_endo -79.05 -162.6 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.772 2.315 . . . . 0.0 109.908 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.792 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER 177.8 26.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.218 -0.927 . . . . 0.0 111.011 178.574 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.407 ' HA2' ' CD1' ' A' ' 54' ' ' LEU . . . -93.88 -48.67 2.64 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.521 -1.323 . . . . 0.0 110.24 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.687 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -42.47 146.07 0.37 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -1.117 . . . . 0.0 111.243 -179.291 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.505 ' OE1' ' HA2' ' A' ' 38' ' ' GLY . 6.2 tp10 -81.08 -97.32 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.449 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . -108.64 3.95 32.51 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.547 ' HG2' ' HB2' ' A' ' 97' ' ' LYS . 3.1 pt20 -74.85 174.85 4.62 Favored Pre-proline 0 N--CA 1.482 1.166 0 O-C-N 121.826 -0.808 . . . . 0.0 109.199 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 102' ' ' GLY . 2.1 Cg_endo -69.63 -50.86 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.95 1.767 . . . . 0.0 109.591 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.604 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 61.78 114.38 0.01 OUTLIER Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.064 -2.015 . . . . 0.0 108.064 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.574 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 7.1 pt-20 -148.61 135.85 20.23 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.113 -1.228 . . . . 0.0 110.441 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.622 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 5.0 m0 -48.18 129.29 15.1 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -119.79 119.2 32.92 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.85 -1.157 . . . . 0.0 110.032 -178.646 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.35 68.12 5.26 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.884 HD13 ' HG ' ' A' ' 110' ' ' LEU . 7.4 tt -81.86 -54.36 5.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 109.188 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.633 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 48.6 t 86.29 112.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 40.3 83.79 0.01 OUTLIER Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.099 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -40.22 165.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.725 -0.868 . . . . 0.0 110.596 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.601 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 14.6 t30 -144.15 1.75 1.12 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.126 -0.984 . . . . 0.0 111.234 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.628 ' HB2' HG23 ' A' ' 123' ' ' ILE . . . 70.24 -3.42 1.82 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.914 -1.116 . . . . 0.0 109.282 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -80.95 -24.68 37.95 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.545 ' OD1' ' HB1' ' A' ' 30' ' ' ALA . 3.3 m-20 -102.11 -13.11 17.62 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 1.099 ' CE1' HD21 ' A' ' 110' ' ' LEU . 4.0 m-85 -95.08 150.98 38.49 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.293 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.54 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.3 Cg_endo -66.63 139.75 54.21 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.498 2.132 . . . . 0.0 109.63 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 118' ' ' ALA . 2.4 Cg_endo -61.93 -31.15 84.46 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.224 1.949 . . . . 0.0 111.179 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.64 -44.83 4.42 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.004 -1.06 . . . . 0.0 110.187 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.585 ' OD1' HD21 ' A' ' 71' ' ' LEU . 3.5 m-80 -99.16 51.61 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 109.273 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.672 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.4 mt-10 -69.36 -36.57 7.31 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.558 -0.714 . . . . 0.0 112.437 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.3 Cg_exo -56.35 -34.89 95.3 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.511 1.474 . . . . 0.0 112.047 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.542 HG11 ' CE1' ' A' ' 84' ' ' PHE . 1.7 t -99.77 -36.48 5.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.583 -1.323 . . . . 0.0 108.829 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.628 ' HA ' HD22 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -66.64 -15.56 19.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.565 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.52 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -62.83 -29.9 71.09 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.485 ' HE2' ' OE2' ' A' ' 69' ' ' GLU . 12.8 mmtm -81.53 -39.43 24.69 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.094 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.78 HD12 HD13 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -66.62 -22.05 66.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.733 -1.229 . . . . 0.0 108.195 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.612 ' HD2' ' HB3' ' A' ' 112' ' ' ALA . 1.7 mtmt -53.23 -31.13 41.75 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.03 -27.85 22.95 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.361 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.78 HD13 HD12 ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.681 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 130' ' ' APC . . . . . 0.761 " O4'" HD22 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.499 ' HG2' ' HA ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.542 ' HD3' ' O ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -111.94 165.88 11.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.107 -0.996 . . . . 0.0 109.373 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 79' ' ' HIS . 9.1 tttt -162.1 150.96 15.33 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.804 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 1.059 ' O ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -158.67 147.36 18.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.478 -0.764 . . . . 0.0 109.007 178.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.708 ' HB2' HG23 ' A' ' 40' ' ' ILE . 1.6 mp0 -111.7 170.13 8.35 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 109.094 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.699 HD11 ' H8 ' ' A' ' 130' ' ' APC . 0.2 OUTLIER -135.04 108.15 9.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.202 -179.501 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.034 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -82.81 72.68 9.88 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.541 -0.725 . . . . 0.0 109.327 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.786 HG22 ' N ' ' A' ' 9' ' ' GLY . 0.2 OUTLIER -83.81 -84.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.415 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.786 ' N ' HG22 ' A' ' 8' ' ' VAL . . . 81.33 78.37 0.97 Allowed Glycine 0 C--N 1.299 -1.475 0 N-CA-C 106.947 -2.461 . . . . 0.0 106.947 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.697 ' O ' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -48.21 150.5 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -178.731 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.815 HG22 ' CG1' ' A' ' 87' ' ' VAL . 10.0 pt -120.48 75.87 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.394 -177.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 1.012 ' NH1' HD21 ' A' ' 129' ' ' LEU . 0.5 OUTLIER -79.69 153.95 28.94 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.46 ' OD1' ' CH2' ' A' ' 90' ' ' TRP . 2.6 p-10 -154.14 -20.98 0.13 Allowed 'General case' 0 C--O 1.187 -2.225 0 C-N-CA 117.218 -1.793 . . . . 0.0 114.901 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.577 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 3.4 tt0 -93.41 -32.31 14.29 Favored 'General case' 0 N--CA 1.511 2.605 0 O-C-N 118.076 -2.89 . . . . 0.0 109.486 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.52 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 61.9 t30 -161.68 -47.44 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 102.971 -2.974 . . . . 0.0 102.971 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.659 ' OD1' HD23 ' A' ' 129' ' ' LEU . 0.9 OUTLIER -161.87 38.07 0.13 Allowed 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 176.397 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.644 ' HA ' ' O ' ' A' ' 105' ' ' MET . 84.0 mt-10 -85.1 84.51 7.68 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.143 -1.423 . . . . 0.0 110.43 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.865 HG23 ' HB3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -78.97 153.85 4.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.434 0.635 . . . . 0.0 109.942 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.737 ' CB ' HD11 ' A' ' 11' ' ' ILE . 6.8 t80 -83.16 42.77 0.83 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.732 HD11 ' C ' ' A' ' 34' ' ' GLU . 5.5 tp -80.69 148.81 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-O 122.585 1.183 . . . . 0.0 111.734 -176.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.614 ' H ' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -58.43 89.41 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.259 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.593 ' O ' ' C ' ' A' ' 23' ' ' ARG . 32.0 tpt180 -97.24 91.89 5.75 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.724 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.836 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 13.68 79.4 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.356 0.598 . . . . 0.0 110.971 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -41.56 -56.05 2.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.424 -0.798 . . . . 0.0 110.287 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.75 -179.04 3.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.069 -1.019 . . . . 0.0 109.476 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.96 84.44 4.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.214 -0.929 . . . . 0.0 109.534 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.836 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -72.54 -36.92 68.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.243 -0.911 . . . . 0.0 109.324 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 49.92 23.57 1.1 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.583 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -117.12 -33.96 4.53 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.563 -0.711 . . . . 0.0 109.1 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.616 ' HB1' ' OD1' ' A' ' 114' ' ' ASP . . . 69.19 -177.65 0.21 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.437 -0.789 . . . . 0.0 109.822 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 1.1 t30 78.96 -8.63 1.62 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.523 -0.736 . . . . 0.0 109.523 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.567 ' HD2' ' CA ' ' A' ' 23' ' ' ARG . 4.8 tttp -83.29 51.47 1.98 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.385 -0.822 . . . . 0.0 110.227 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.944 HD13 HD21 ' A' ' 110' ' ' LEU . 17.4 mt -107.73 85.84 2.19 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.732 ' C ' HD11 ' A' ' 20' ' ' ILE . 1.5 tt0 -87.4 -137.28 0.09 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.388 -1.445 . . . . 0.0 109.614 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.679 ' CE2' ' CE1' ' A' ' 115' ' ' PHE . 10.9 m-85 -153.31 126.61 4.2 Favored Pre-proline 0 N--CA 1.486 1.364 0 O-C-N 121.048 -1.032 . . . . 0.0 109.586 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.726 ' O ' HG23 ' A' ' 8' ' ' VAL . 5.4 Cg_endo -65.64 89.17 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.011 1.807 . . . . 0.0 108.483 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.607 ' HA3' HG23 ' A' ' 6' ' ' ILE . . . -115.34 107.18 1.7 Allowed Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.714 -1.231 . . . . 0.0 111.525 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.513 ' HA2' ' CD ' ' A' ' 98' ' ' GLU . . . -82.14 16.81 20.61 Favored Glycine 0 N--CA 1.489 2.181 0 O-C-N 121.576 -0.955 . . . . 0.0 111.168 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.594 ' CD ' HD23 ' A' ' 4' ' ' LEU . 3.1 tptm 63.9 108.25 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 118.244 1.022 . . . . 0.0 110.984 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.034 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -80.37 138.67 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.924 -1.11 . . . . 0.0 109.017 178.691 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -172.28 -32.81 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.89 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.437 ' SD ' ' HB3' ' A' ' 52' ' ' ARG . 38.5 mtt -55.74 159.34 3.1 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.128 -0.982 . . . . 0.0 109.511 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.56 -130.5 9.39 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.16 24.44 0.11 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.435 -1.038 . . . . 0.0 108.749 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.54 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 27.4 m -136.82 140.86 33.03 Favored Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.574 ' HG3' ' CH2' ' A' ' 83' ' ' TRP . 7.1 Cg_exo -50.09 -20.35 5.2 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.815 1.677 . . . . 0.0 109.897 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 51' ' ' VAL . 3.2 mt-10 -75.72 -87.35 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.346 -0.846 . . . . 0.0 108.763 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.536 ' O ' ' CG ' ' A' ' 52' ' ' ARG . 42.3 mt-30 -41.72 -33.01 0.43 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.845 -1.159 . . . . 0.0 110.147 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.797 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -67.19 -63.26 1.1 Allowed 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.024 -1.047 . . . . 0.0 109.674 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.887 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.2 p -66.72 -49.38 75.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.645 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.573 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 4.1 p -57.31 -44.65 84.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.547 -0.721 . . . . 0.0 110.34 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.536 ' CG ' ' O ' ' A' ' 48' ' ' GLN . 14.9 mmt180 -72.05 -32.25 66.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.009 -1.057 . . . . 0.0 108.665 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.616 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 12.4 mm-40 -75.22 -15.96 60.51 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.949 HD12 ' CG ' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -79.97 -62.62 1.63 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.749 0.785 . . . . 0.0 108.997 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.49 ' N ' ' CZ3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.45 -51.74 68.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.784 -0.572 . . . . 0.0 109.691 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.598 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -47.15 -26.22 1.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.888 -1.133 . . . . 0.0 108.868 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 54' ' ' LEU . 3.6 mt-10 -80.05 -95.3 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.355 -0.841 . . . . 0.0 109.377 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.725 HG21 ' HA ' ' A' ' 95' ' ' TRP . 28.2 t -80.21 -78.91 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.304 -0.873 . . . . 0.0 110.321 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 138.2 32.5 0.21 Allowed Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.374 -1.394 . . . . 0.0 111.275 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.001 HD13 ' HB2' ' A' ' 90' ' ' TRP . 1.1 pp -90.75 -152.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.589 -1.536 . . . . 0.0 108.278 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.72 ' H ' HD12 ' A' ' 60' ' ' ILE . 1.6 m -162.23 -63.16 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.349 -1.469 . . . . 0.0 112.73 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.639 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 6.3 Cg_exo -55.9 0.62 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.537 2.158 . . . . 0.0 114.373 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.834 HE21 ' HZ2' ' A' ' 95' ' ' TRP . 4.4 pt20 -39.18 -27.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.623 -1.298 . . . . 0.0 110.289 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 62' ' ' PRO . 1.9 t60 51.84 88.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.429 ' HE2' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -88.87 159.31 17.76 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.377 1.084 . . . . 0.0 111.901 -177.594 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -153.64 141.15 19.81 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.242 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.614 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -63.31 -67.22 0.44 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.878 -1.139 . . . . 0.0 110.272 -178.688 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.666 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 84.05 -51.75 0.13 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.264 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.578 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 4.9 tp10 159.54 135.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.563 ' HE3' ' CD2' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -125.6 -177.76 4.02 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.467 -0.771 . . . . 0.0 109.515 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -136.51 -177.41 4.71 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.341 -0.85 . . . . 0.0 109.938 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -151.71 86.16 1.32 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.15 104.01 9.48 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -95.18 154.41 17.2 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.416 -0.914 . . . . 0.0 108.587 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.577 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -141.73 173.09 5.1 Favored Pre-proline 0 C--N 1.297 -1.677 0 O-C-N 121.214 -0.929 . . . . 0.0 109.104 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 7.3 Cg_exo -48.23 -39.39 34.54 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 121.776 1.651 . . . . 0.0 109.703 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.499 ' HA ' ' HG2' ' A' ' 1' ' ' MET . 4.7 p-10 -148.21 35.14 0.81 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.476 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -142.73 78.95 1.63 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.549 -0.719 . . . . 0.0 110.077 -178.745 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.953 ' C ' HD12 ' A' ' 80' ' ' ILE . 1.8 m-70 -82.35 119.58 24.33 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.953 HD12 ' C ' ' A' ' 79' ' ' HIS . 2.3 mp -129.69 162.75 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 118.793 -1.163 . . . . 0.0 111.433 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.602 ' N ' HG22 ' A' ' 80' ' ' ILE . 2.0 m -147.32 148.84 31.8 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.504 ' CD1' HN61 ' A' ' 130' ' ' APC . 0.2 OUTLIER -141.32 82.96 1.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.716 -1.24 . . . . 0.0 110.348 -179.395 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.694 ' CD1' HG21 ' A' ' 40' ' ' ILE . 89.8 m95 -54.05 111.76 0.82 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.267 -0.896 . . . . 0.0 109.034 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.653 ' CE2' HG11 ' A' ' 122' ' ' VAL . 11.6 m-85 -88.6 68.05 8.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.247 -0.908 . . . . 0.0 109.793 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.641 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 75.3 m95 -72.36 84.29 1.08 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.794 -1.191 . . . . 0.0 109.747 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.697 HD13 ' O ' ' A' ' 10' ' ' ILE . 3.2 mm? -68.07 129.44 39.91 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.566 -1.334 . . . . 0.0 109.942 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.815 ' CG1' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -111.2 -175.08 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.653 ' N ' HG23 ' A' ' 87' ' ' VAL . 1.2 mt-10 -159.89 8.13 0.1 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 117.612 -1.635 . . . . 0.0 113.54 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.572 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.73 71.96 0.44 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 119.855 -1.778 . . . . 0.0 110.651 178.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 1.001 ' HB2' HD13 ' A' ' 60' ' ' ILE . 17.4 p90 -80.69 163.0 23.9 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.718 -1.239 . . . . 0.0 110.191 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.648 ' O ' ' N ' ' A' ' 93' ' ' GLU . 5.0 pt-20 -81.81 135.53 35.45 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.179 -0.951 . . . . 0.0 109.762 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 35.02 -80.34 0.0 OUTLIER Glycine 0 N--CA 1.502 3.088 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.966 ' O ' HG21 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -98.82 153.32 37.92 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.333 -1.098 . . . . 0.0 109.219 -179.572 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.64 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 20.2 Cg_endo -80.85 -159.07 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.787 2.325 . . . . 0.0 110.025 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.949 ' CG ' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER 178.58 132.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.771 0.796 . . . . 0.0 110.017 178.184 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . 152.93 -40.04 0.72 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.509 ' N ' ' CD ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -41.09 107.51 0.07 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.517 -0.99 . . . . 0.0 109.526 -179.528 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 5.5 tp10 -77.38 87.28 3.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.273 -0.892 . . . . 0.0 108.712 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.35 30.71 65.04 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.497 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 7.4 pt20 -125.96 168.08 15.05 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.475 -1.015 . . . . 0.0 109.299 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 9.8 Cg_endo -78.21 42.6 1.24 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.562 2.175 . . . . 0.0 110.842 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.57 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . -44.78 123.82 5.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.615 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -146.79 144.38 29.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -1.118 . . . . 0.0 109.8 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.48 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 1.2 m-90 -52.35 139.84 23.47 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.968 -1.083 . . . . 0.0 108.225 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.644 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -139.06 108.85 6.26 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.286 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.524 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -81.33 46.79 0.97 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.597 -0.689 . . . . 0.0 109.351 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 1.066 HD22 ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -64.72 -12.7 49.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 108.859 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.879 ' N ' HD13 ' A' ' 107' ' ' LEU . 1.4 t 59.63 121.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.452 -0.78 . . . . 0.0 110.189 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.634 ' HA2' ' HB3' ' A' ' 129' ' ' LEU . . . 38.12 74.06 0.13 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.188 HD22 ' CD2' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -38.19 158.24 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.914 -0.756 . . . . 0.0 109.905 -178.193 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.88 ' H ' HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -154.76 143.77 20.98 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.139 -0.976 . . . . 0.0 110.182 -178.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . . . -44.07 -27.84 0.42 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -42.07 -53.93 3.76 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.317 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.616 ' OD1' ' HB1' ' A' ' 30' ' ' ALA . 14.3 m-20 -97.94 -9.75 25.7 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 1.188 ' CD2' HD22 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -91.96 136.92 25.55 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.543 -0.723 . . . . 0.0 109.754 -179.26 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' A' ' 123' ' ' ILE . 2.5 Cg_endo -68.24 153.6 74.14 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.373 2.049 . . . . 0.0 110.22 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 118' ' ' ALA . 1.7 Cg_endo -65.12 -36.37 37.53 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.212 1.941 . . . . 0.0 110.817 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -39.37 -47.79 1.81 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.408 -0.807 . . . . 0.0 110.123 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.596 ' O ' HD12 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -98.64 55.83 1.09 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.372 -0.83 . . . . 0.0 109.034 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.651 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -69.13 -47.17 29.53 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.722 -0.611 . . . . 0.0 111.688 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 8.2 Cg_exo -52.25 -40.12 70.55 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.194 1.929 . . . . 0.0 112.846 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.653 HG11 ' CE2' ' A' ' 84' ' ' PHE . 2.2 t -98.21 -34.05 4.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 O-C-N 120.642 -1.286 . . . . 0.0 109.5 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.855 HD13 ' HB3' ' A' ' 115' ' ' PHE . 31.4 mt -59.0 -29.18 40.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.539 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -59.44 -35.08 73.35 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.928 0.871 . . . . 0.0 109.129 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.0 mmmt -77.68 -35.58 52.11 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.567 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 1.099 HD23 ' CE2' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -66.71 -34.62 78.26 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.158 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 7.1 mtpt -45.4 -29.01 0.97 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.568 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -91.2 -34.65 14.91 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.297 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 1.012 HD21 ' NH1' ' A' ' 12' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.508 2.426 0 CA-C-O 118.035 -0.983 . . . . 0.0 111.635 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 130' ' ' APC . . . . . 0.699 ' H8 ' HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' CON . . . . . 0.443 ' N3 ' ' O2A' ' A' ' 130' ' ' APC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.405 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.488 ' HD3' ' O ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -51.95 164.14 0.29 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.021 -1.049 . . . . 0.0 109.552 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.458 ' N ' ' HE3' ' A' ' 2' ' ' LYS . 15.1 tttt -160.57 157.31 27.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 0.0 109.542 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 1.07 ' O ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -158.38 143.84 16.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.808 . . . . 0.0 109.278 179.105 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.653 ' HB2' HG23 ' A' ' 40' ' ' ILE . 1.4 mp0 -113.53 166.74 11.21 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.86 -1.15 . . . . 0.0 108.394 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.563 HD11 ' C8 ' ' A' ' 130' ' ' APC . 0.3 OUTLIER -127.23 110.95 23.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.957 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -81.85 68.55 8.27 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.745 HG22 ' N ' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -79.47 -83.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.465 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.745 ' N ' HG22 ' A' ' 8' ' ' VAL . . . 75.61 82.3 0.48 Allowed Glycine 0 N--CA 1.479 1.517 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 -178.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.607 ' O ' HD13 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -49.13 157.2 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.939 HG22 HG22 ' A' ' 87' ' ' VAL . 1.6 pt -124.54 85.27 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.866 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -77.51 167.75 21.12 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.2 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.487 ' OD1' ' HB2' ' A' ' 17' ' ' GLU . 2.0 p-10 -161.94 -26.11 0.05 OUTLIER 'General case' 0 C--O 1.185 -2.31 0 C-N-CA 115.966 -2.294 . . . . 0.0 114.889 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HB3' ' OE2' ' A' ' 17' ' ' GLU . 4.9 tt0 -95.01 -34.22 12.43 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 118.36 -2.712 . . . . 0.0 109.132 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -162.35 -45.95 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 103.211 -2.885 . . . . 0.0 103.211 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.67 ' OD1' HD23 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -160.37 36.2 0.17 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 176.511 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -88.14 98.95 11.84 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.088 -1.445 . . . . 0.0 109.234 -178.474 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.604 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -92.34 150.09 3.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.927 0.87 . . . . 0.0 111.265 -178.414 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.657 ' CE1' ' HA ' ' A' ' 103' ' ' GLU . 14.3 t80 -82.2 43.71 0.81 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.721 HD11 ' C ' ' A' ' 34' ' ' GLU . 5.1 tp -81.02 154.96 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-O 122.053 0.93 . . . . 0.0 111.269 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.52 ' H ' HD12 ' A' ' 20' ' ' ILE . 1.4 t -66.14 93.72 0.22 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.739 ' HD3' HD21 ' A' ' 33' ' ' LEU . 23.7 tpt180 -102.05 149.01 24.69 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.668 -0.645 . . . . 0.0 109.601 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.866 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -34.34 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . -46.55 -54.34 9.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.382 -0.823 . . . . 0.0 110.393 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.49 -151.1 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.006 -1.058 . . . . 0.0 109.204 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.35 -51.39 10.92 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.292 -0.88 . . . . 0.0 109.066 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.866 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . 57.7 -168.45 0.12 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.639 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -162.34 -35.07 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.648 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 1.5 mpt? -49.61 -46.44 49.31 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.337 -0.852 . . . . 0.0 109.398 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 29' ' ' MET . . . 72.34 5.63 5.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.288 -0.883 . . . . 0.0 109.456 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -98.65 11.64 37.85 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.24 -0.912 . . . . 0.0 108.853 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -81.8 54.78 2.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.602 -0.686 . . . . 0.0 110.402 -179.639 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.739 HD21 ' HD3' ' A' ' 22' ' ' ARG . 15.0 mt -122.49 84.55 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.64 -1.287 . . . . 0.0 109.666 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.721 ' C ' HD11 ' A' ' 20' ' ' ILE . 1.4 tt0 -82.84 -136.86 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.987 -1.071 . . . . 0.0 109.983 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.711 ' HE2' HD11 ' A' ' 123' ' ' ILE . 77.7 m-85 -152.0 125.37 4.22 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.124 -0.985 . . . . 0.0 109.338 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.648 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -58.09 90.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.616 1.544 . . . . 0.0 109.127 178.663 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.532 ' HA2' ' CG2' ' A' ' 6' ' ' ILE . . . -56.27 -142.46 0.01 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 154.56 -33.3 0.69 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.61 ' HD3' " C5'" ' A' ' 130' ' ' APC . 0.0 OUTLIER 69.89 97.02 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 122.185 -0.597 . . . . 0.0 109.397 -179.519 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.957 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -80.23 132.62 31.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.794 179.346 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.504 ' HB3' ' NZ ' ' A' ' 39' ' ' LYS . 6.6 pt-20 -170.67 -34.14 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.47 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -47.85 147.16 2.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.337 -0.852 . . . . 0.0 109.54 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 53.03 -120.92 13.76 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.06 23.07 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.647 -0.914 . . . . 0.0 109.125 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.458 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 56.1 m -138.68 139.13 23.34 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.609 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 14.2 Cg_exo -49.3 -17.25 1.45 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.004 1.803 . . . . 0.0 110.606 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.49 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.4 mt-10 -77.89 -83.14 0.08 Allowed 'General case' 0 C--O 1.203 -1.352 0 O-C-N 120.934 -1.104 . . . . 0.0 108.557 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.527 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 36.9 mt-30 -45.67 -33.62 3.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.502 -1.374 . . . . 0.0 109.54 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.732 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -65.2 -63.34 1.13 Allowed 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.452 -0.78 . . . . 0.0 110.24 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.814 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.4 p -68.82 -48.99 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.912 -1.118 . . . . 0.0 110.607 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.575 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 2.3 p -54.63 -44.06 68.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 121.371 0.605 . . . . 0.0 110.295 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.551 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 18.7 mmt180 -74.87 -34.49 62.26 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.642 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 20.8 mm-40 -71.21 -13.39 61.9 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.006 HD12 ' NE1' ' A' ' 95' ' ' TRP . 1.1 mm? -79.34 -64.31 1.22 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.519 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.12 -51.49 69.1 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.54 -0.725 . . . . 0.0 110.187 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.59 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 1.3 pp20? -50.18 -21.08 1.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.052 -1.03 . . . . 0.0 110.479 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -80.14 -92.22 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.918 -1.114 . . . . 0.0 110.038 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.789 HG21 ' HA ' ' A' ' 95' ' ' TRP . 21.0 t -79.98 -79.17 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.426 -0.796 . . . . 0.0 109.678 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.54 22.72 0.1 Allowed Glycine 0 N--CA 1.495 2.605 0 C-N-CA 118.485 -1.817 . . . . 0.0 112.554 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.094 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.6 pp -82.93 -166.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.283 -1.716 . . . . 0.0 108.031 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.67 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 2.0 m -123.36 -71.73 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.434 -1.416 . . . . 0.0 110.844 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.67 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 5.7 Cg_endo -64.19 -170.82 0.13 Allowed 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.078 1.185 . . . . 0.0 109.707 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.601 ' HG2' ' CZ2' ' A' ' 95' ' ' TRP . 0.7 OUTLIER 139.54 -23.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -179.204 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.537 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 1.9 t60 57.23 -167.41 0.13 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' A' ' 64' ' ' HIS . 28.3 p90 -179.38 150.83 0.45 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.414 -1.314 . . . . 0.0 110.676 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -159.35 141.89 13.9 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.61 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -65.95 -66.71 0.52 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.04 -1.037 . . . . 0.0 109.313 -179.507 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.871 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 85.38 -55.07 0.09 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.576 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.562 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 9.5 tp10 169.62 151.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.613 ' HA ' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -143.67 -164.53 1.89 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.847 -1.158 . . . . 0.0 109.295 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.675 HD12 ' C ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -150.96 -177.13 5.83 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.208 -0.933 . . . . 0.0 110.419 -179.643 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -149.51 90.78 1.75 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -78.21 108.35 11.46 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.433 ' HG3' ' NE2' ' A' ' 79' ' ' HIS . 25.0 tt0 -92.62 99.57 12.25 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.488 -0.758 . . . . 0.0 110.158 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.52 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -79.26 170.97 13.75 Favored Pre-proline 0 C--N 1.301 -1.503 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.338 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.52 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 5.5 Cg_exo -51.89 -55.02 4.31 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.872 1.715 . . . . 0.0 109.606 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.04 35.88 4.08 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.513 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -144.31 91.52 2.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.521 -0.737 . . . . 0.0 109.682 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.498 ' C ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -82.15 90.99 6.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.752 -1.218 . . . . 0.0 109.087 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.761 HG13 HD11 ' A' ' 4' ' ' LEU . 1.0 OUTLIER -98.84 157.28 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.005 -1.059 . . . . 0.0 110.272 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.608 ' N ' HG22 ' A' ' 80' ' ' ILE . 2.2 m -136.34 170.6 15.77 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.651 HD22 ' OD1' ' A' ' 119' ' ' ASN . 0.2 OUTLIER -159.5 85.8 0.79 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.601 -1.312 . . . . 0.0 110.035 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.604 ' CD1' HG21 ' A' ' 40' ' ' ILE . 97.3 m95 -65.43 115.12 5.35 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.786 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.873 ' CD2' HG11 ' A' ' 122' ' ' VAL . 10.1 m-85 -89.56 71.32 7.91 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.938 -1.101 . . . . 0.0 109.606 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.693 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 88.4 m95 -72.28 87.81 1.14 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.015 -1.053 . . . . 0.0 109.149 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.871 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.0 mm? -68.39 130.16 42.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.755 -1.216 . . . . 0.0 110.121 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.939 HG22 HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -117.61 176.89 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.061 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.551 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 23.4 mt-10 -159.76 28.88 0.19 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.386 -1.446 . . . . 0.0 112.944 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.595 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -159.62 57.98 0.38 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 119.878 -1.764 . . . . 0.0 111.721 178.766 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.588 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 2.4 p90 -79.15 162.37 25.83 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.222 -1.549 . . . . 0.0 109.267 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.629 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -92.94 145.86 24.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.999 -1.063 . . . . 0.0 109.583 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 39.29 -87.51 0.01 OUTLIER Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 1.094 ' O ' HG21 ' A' ' 60' ' ' ILE . 2.8 pt-20 -105.34 157.04 35.3 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.235 -1.156 . . . . 0.0 109.868 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.61 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 10.6 Cg_endo -75.59 -159.07 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.93 2.42 . . . . 0.0 110.263 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 1.006 ' NE1' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -179.56 66.16 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.291 -0.881 . . . . 0.0 110.36 178.789 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . -139.07 -33.71 0.17 Allowed Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.367 -1.397 . . . . 0.0 110.688 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.588 ' HG3' ' CE2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -39.62 106.79 0.06 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.129 -1.218 . . . . 0.0 110.496 -179.063 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.504 ' HB2' ' C ' ' A' ' 37' ' ' GLY . 8.0 tp10 -80.43 100.59 8.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.265 -0.897 . . . . 0.0 109.139 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 54.12 21.96 19.66 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.587 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 7.8 pt20 -122.75 170.82 7.41 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.497 -1.002 . . . . 0.0 108.868 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.587 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 4.2 Cg_exo -63.14 -46.14 10.87 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.0 1.8 . . . . 0.0 110.785 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.58 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 59.69 112.81 0.01 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.657 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 5.2 pt-20 -152.76 137.25 16.76 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.136 -1.214 . . . . 0.0 110.493 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.499 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 1.7 m-90 -48.64 135.7 14.32 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.602 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -125.85 115.65 20.32 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.197 -0.939 . . . . 0.0 109.521 -179.055 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.469 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -82.54 57.81 3.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 110.015 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.854 HD21 ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -80.69 -41.28 23.95 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.168 -0.958 . . . . 0.0 108.417 179.421 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.794 ' N ' HD23 ' A' ' 107' ' ' LEU . 86.4 t 70.13 126.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.854 -0.529 . . . . 0.0 109.938 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 41.18 81.43 0.03 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.158 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -42.79 166.7 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.487 -1.008 . . . . 0.0 110.545 -178.696 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.685 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -143.9 -7.34 0.74 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.325 -0.859 . . . . 0.0 111.846 -178.463 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 81.02 -31.53 0.11 Allowed 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.91 -1.119 . . . . 0.0 109.024 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.3 -16.83 15.74 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.453 -0.779 . . . . 0.0 109.099 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.582 ' HB3' HD12 ' A' ' 33' ' ' LEU . 2.0 m-20 -111.67 -12.86 13.84 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.599 -0.688 . . . . 0.0 109.919 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 1.158 ' CE1' HD21 ' A' ' 110' ' ' LEU . 7.5 m-85 -100.7 148.77 35.47 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.905 . . . . 0.0 109.808 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.58 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 3.5 Cg_exo -64.04 142.1 79.73 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.642 2.228 . . . . 0.0 110.547 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 2.3 Cg_endo -62.9 -19.97 70.2 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.04 1.826 . . . . 0.0 110.08 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -45.92 -51.02 13.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 109.25 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.754 ' O ' HD12 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -94.85 54.68 1.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.629 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 2.4 mt-10 -64.8 -45.71 75.2 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 2.8 Cg_exo -54.84 -35.38 88.46 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.907 1.738 . . . . 0.0 112.92 -177.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.873 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.1 t -100.34 -31.94 3.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.579 -1.325 . . . . 0.0 109.243 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.928 ' HA ' HD22 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -61.7 -26.99 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.526 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -55.77 -37.63 68.8 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 29.1 mmtm -78.09 -35.86 48.79 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.861 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.928 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.6 -21.71 66.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.45 -1.406 . . . . 0.0 107.334 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 7.2 mtmt -57.69 -35.21 70.3 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 177.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 125' ' ' LYS . 4.2 mtp180 -82.34 -22.97 35.32 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.429 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.67 HD23 ' OD1' ' A' ' 16' ' ' ASN . 1.3 tp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.473 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 130' ' ' APC . . . . . 0.629 ' C6 ' HG21 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ptp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.485 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -136.99 -163.52 1.43 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.383 -0.823 . . . . 0.0 109.109 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.541 ' HG2' ' N ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -109.72 154.11 23.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.011 . . . . 0.0 109.938 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.967 ' O ' HD13 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -138.25 125.94 22.25 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.773 ' N ' HD22 ' A' ' 4' ' ' LEU . 0.9 OUTLIER -96.25 164.52 12.63 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.313 -1.492 . . . . 0.0 110.091 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.726 HG22 HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -131.2 117.82 38.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.495 -0.753 . . . . 0.0 109.046 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.048 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -86.61 63.17 7.83 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 36' ' ' PRO . 1.3 p -78.42 -72.43 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 109.735 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.768 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 57.38 87.65 0.02 OUTLIER Glycine 0 N--CA 1.479 1.528 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.602 ' CG1' HD11 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -47.77 168.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.238 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.062 HG22 ' CG2' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -131.04 94.62 2.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 O-C-N 121.181 -0.949 . . . . 0.0 109.33 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.61 ' HG2' HG22 ' A' ' 18' ' ' ILE . 13.9 mtm180 -75.82 177.36 6.99 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.598 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -151.44 -60.98 0.17 Allowed 'General case' 0 C--O 1.191 -1.977 0 C-N-CA 116.783 -1.967 . . . . 0.0 114.367 -176.296 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.506 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -92.32 -29.65 16.25 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 119.204 -2.185 . . . . 0.0 111.091 -176.124 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -162.16 -43.04 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.635 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -157.43 34.02 0.28 Allowed 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.359 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 105' ' ' MET . 17.1 mt-10 -82.01 87.36 6.45 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 118.005 -1.478 . . . . 0.0 108.88 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -80.0 147.96 6.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.395 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.667 ' CZ ' ' HG2' ' A' ' 94' ' ' PRO . 7.8 t80 -81.68 45.05 0.86 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.693 HD11 ' N ' ' A' ' 34' ' ' GLU . 6.6 tp -79.0 151.78 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-O 122.437 1.113 . . . . 0.0 111.575 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.517 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -68.86 84.47 0.31 Allowed 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.438 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.695 ' HD2' HD21 ' A' ' 33' ' ' LEU . 18.2 tpt180 -79.24 84.98 5.13 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.016 -1.053 . . . . 0.0 109.822 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.753 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 1.5 ptt180 31.94 62.9 0.27 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.275 0.56 . . . . 0.0 110.319 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -41.92 -41.8 2.57 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.691 -0.631 . . . . 0.0 109.354 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' A' ' 23' ' ' ARG . . . -80.57 -179.96 7.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 109.195 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 26' ' ' ASP . 3.6 p30 -78.79 112.86 16.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 109.328 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.753 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -112.27 -30.18 7.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 109.841 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 49.65 28.38 2.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.011 -1.055 . . . . 0.0 108.448 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.712 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 30.8 mmm -140.03 -100.01 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.392 -0.818 . . . . 0.0 109.976 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 152.13 -169.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER 78.84 -8.78 1.6 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.158 -0.964 . . . . 0.0 109.03 -179.312 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.613 ' O ' HD23 ' A' ' 33' ' ' LEU . 5.2 tptt -83.4 55.93 3.37 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.671 -0.643 . . . . 0.0 109.857 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.695 HD21 ' HD2' ' A' ' 22' ' ' ARG . 7.1 mt -120.04 93.09 3.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.288 -0.882 . . . . 0.0 108.779 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.693 ' N ' HD11 ' A' ' 20' ' ' ILE . 3.0 tt0 -88.56 -126.76 0.06 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.876 -1.14 . . . . 0.0 110.786 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.734 ' HB3' HG21 ' A' ' 8' ' ' VAL . 98.9 m-85 -160.07 128.72 3.01 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.756 -1.215 . . . . 0.0 110.247 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.898 ' O ' HG23 ' A' ' 8' ' ' VAL . 3.7 Cg_endo -64.79 97.28 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.113 1.875 . . . . 0.0 109.727 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.562 ' CA ' ' HB2' ' A' ' 98' ' ' GLU . . . -55.51 -153.15 0.01 OUTLIER Glycine 0 N--CA 1.492 2.405 0 O-C-N 121.298 -0.876 . . . . 0.0 111.013 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 163.86 -33.67 0.28 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.709 ' CD ' HD21 ' A' ' 4' ' ' LEU . 10.4 tptm 65.85 101.28 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.95 -0.735 . . . . 0.0 110.253 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.838 ' O ' HD13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -80.42 135.44 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.039 -1.038 . . . . 0.0 108.693 178.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.544 ' HG3' ' N ' ' A' ' 42' ' ' MET . 6.9 pt-20 -171.12 -31.99 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.422 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.544 ' N ' ' HG3' ' A' ' 41' ' ' GLU . 1.7 mtt -62.08 151.89 34.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.065 -1.022 . . . . 0.0 109.842 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.98 -127.54 43.14 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.35 21.05 0.1 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.443 -1.034 . . . . 0.0 109.209 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.919 HG22 ' H ' ' A' ' 47' ' ' GLU . 1.8 m -147.01 140.78 15.27 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.613 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 11.0 Cg_exo -45.24 -18.6 0.28 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.067 1.845 . . . . 0.0 111.268 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.919 ' H ' HG22 ' A' ' 45' ' ' THR . 0.5 OUTLIER -76.87 -80.18 0.1 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.507 -1.37 . . . . 0.0 108.879 178.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.58 ' O ' ' CG ' ' A' ' 52' ' ' ARG . 60.0 mt-30 -48.58 -33.45 9.75 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.087 -1.633 . . . . 0.0 109.207 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.736 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -64.31 -63.6 1.1 Allowed 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.193 -0.942 . . . . 0.0 110.29 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.048 HG23 ' HB1' ' A' ' 7' ' ' ALA . 1.7 p -68.7 -48.87 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.142 -0.974 . . . . 0.0 110.57 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.9 p -56.03 -39.0 55.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-O 121.189 0.519 . . . . 0.0 110.357 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.58 ' CG ' ' O ' ' A' ' 48' ' ' GLN . 18.3 mmt180 -78.65 -32.99 47.47 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.606 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 24.3 mm-40 -71.89 -12.84 61.46 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.831 HD12 ' CE2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -80.09 -55.34 5.01 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.645 0.736 . . . . 0.0 109.331 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.453 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 2.6 pp0? -69.38 -33.92 73.76 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.691 -0.631 . . . . 0.0 111.173 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.606 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -64.26 -25.8 68.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.821 -1.175 . . . . 0.0 111.385 -177.869 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.539 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -80.34 -80.8 0.13 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.499 -1.375 . . . . 0.0 109.887 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.582 HG21 ' HA ' ' A' ' 95' ' ' TRP . 69.9 t -80.17 -82.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.145 -0.972 . . . . 0.0 109.463 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.95 21.66 0.12 Allowed Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.632 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.957 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.1 pt -80.17 -144.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.496 -1.591 . . . . 0.0 108.395 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.665 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 2.1 m -151.36 -71.46 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 120.474 -1.392 . . . . 0.0 110.965 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.665 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 1.0 OUTLIER -60.4 -173.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.934 0 C-N-CA 121.082 1.188 . . . . 0.0 109.918 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 1.5 pt20 152.04 -23.55 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.648 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER 47.35 61.64 2.8 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.336 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.43 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 5.1 p90 -60.78 155.43 19.4 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.886 0.851 . . . . 0.0 110.735 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -152.51 139.24 18.85 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.169 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.588 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -66.31 -67.15 0.47 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.854 -1.154 . . . . 0.0 109.814 -179.048 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.774 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 81.75 -48.94 0.23 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.281 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER 164.42 176.54 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.093 -1.004 . . . . 0.0 108.412 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.562 ' HE3' ' CE3' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -161.58 175.04 12.51 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.948 -1.095 . . . . 0.0 110.161 -179.542 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.801 HD21 ' OD1' ' A' ' 119' ' ' ASN . 0.3 OUTLIER -136.73 -179.12 5.5 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.387 -0.821 . . . . 0.0 109.758 179.402 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.596 ' HG3' HG23 ' A' ' 81' ' ' THR . 7.6 tt0 -154.75 90.23 1.29 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.09 162.77 22.41 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -118.0 161.08 20.39 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.551 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.652 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -128.98 179.48 1.28 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.652 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 6.9 Cg_exo -52.69 -24.05 21.97 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.522 1.481 . . . . 0.0 109.787 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.441 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 2.2 p30 -171.13 32.55 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.493 ' NH2' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -141.28 93.74 2.61 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.705 -0.622 . . . . 0.0 110.151 -178.913 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 3' ' ' LYS . 0.9 OUTLIER -79.1 93.08 5.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.037 -1.039 . . . . 0.0 108.384 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.901 HG21 ' C5 ' ' A' ' 130' ' ' APC . 13.3 mm -83.95 157.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.263 1.03 . . . . 0.0 111.486 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.596 HG23 ' HG3' ' A' ' 72' ' ' GLU . 2.4 m -131.0 155.27 47.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.561 HD12 ' HB ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -141.83 83.92 1.87 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.495 -1.378 . . . . 0.0 110.72 -179.106 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.604 ' CZ3' ' HG3' ' A' ' 46' ' ' PRO . 72.5 m95 -55.74 109.54 0.58 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.939 -1.101 . . . . 0.0 109.162 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.797 ' CD2' HG11 ' A' ' 122' ' ' VAL . 35.7 m-85 -86.79 75.04 9.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.02 -1.05 . . . . 0.0 109.72 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.667 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 83.9 m95 -79.41 89.39 5.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.051 -1.031 . . . . 0.0 109.456 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.774 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.3 mm? -68.78 132.38 46.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.843 -1.161 . . . . 0.0 109.831 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.062 ' CG2' HG22 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -120.54 170.4 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.603 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 37.4 mt-10 -154.33 23.11 0.48 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.201 -1.562 . . . . 0.0 113.453 -178.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.648 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -160.24 55.76 0.34 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 119.832 -1.793 . . . . 0.0 111.138 178.789 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.84 ' HB2' HD13 ' A' ' 60' ' ' ILE . 4.8 p90 -73.99 157.89 35.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.929 -1.107 . . . . 0.0 109.456 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.618 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -79.88 142.54 35.11 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.136 -0.977 . . . . 0.0 109.559 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 29.89 -82.38 0.0 OUTLIER Glycine 0 N--CA 1.5 2.907 0 O-C-N 121.985 -0.447 . . . . 0.0 112.1 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.957 ' O ' HG21 ' A' ' 60' ' ' ILE . 2.9 mm-40 -93.74 157.12 38.75 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.216 -1.167 . . . . 0.0 110.74 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.667 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 29.4 Cg_endo -82.52 -157.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.622 2.215 . . . . 0.0 109.805 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.831 ' CE2' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER 172.63 114.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.454 0.645 . . . . 0.0 109.881 178.726 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . 165.2 -36.37 0.27 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.55 ' N ' ' HD3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -39.5 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.667 -0.902 . . . . 0.0 110.789 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.562 ' HB2' ' CA ' ' A' ' 37' ' ' GLY . 3.1 tp10 -68.22 96.3 0.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.014 -1.054 . . . . 0.0 108.423 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.26 46.39 57.14 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.559 ' HG3' ' N ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -144.5 163.58 33.3 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.559 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 1.2 Cg_endo -64.1 -51.91 1.92 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 121.402 1.402 . . . . 0.0 109.796 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.639 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 59.25 113.35 0.01 OUTLIER Glycine 0 N--CA 1.479 1.519 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.596 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 12.4 pt-20 -150.33 131.78 14.73 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.211 -1.17 . . . . 0.0 109.858 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.629 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -47.25 133.69 11.89 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -124.75 121.84 35.75 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 109.614 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.2 t -81.13 63.2 5.39 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.87 HD21 ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -80.24 -47.75 14.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.346 -0.847 . . . . 0.0 108.971 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.821 ' N ' HD23 ' A' ' 107' ' ' LEU . 40.7 t 82.2 119.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.841 -0.537 . . . . 0.0 110.081 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 108' ' ' VAL . . . 36.51 82.67 0.01 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.151 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -40.98 164.84 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.625 -0.927 . . . . 0.0 110.67 -178.484 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.675 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -142.88 -5.19 0.91 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 111.621 -178.281 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 77.37 -6.38 2.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.998 -1.064 . . . . 0.0 108.51 -177.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 -18.18 50.94 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.552 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -109.61 -11.15 14.8 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.329 0.585 . . . . 0.0 109.562 -179.454 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 1.151 ' CE1' HD21 ' A' ' 110' ' ' LEU . 15.7 m-85 -103.76 149.77 37.48 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.905 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.565 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 2.1 Cg_endo -63.8 145.48 90.76 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.718 2.278 . . . . 0.0 110.651 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.518 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . 1.3 Cg_endo -66.14 -27.5 49.14 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.27 1.98 . . . . 0.0 110.399 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -43.21 -54.25 4.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.049 -1.032 . . . . 0.0 109.621 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.801 ' OD1' HD21 ' A' ' 71' ' ' LEU . 7.5 m-80 -90.08 50.46 1.87 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.655 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 5.4 mt-10 -67.54 -37.85 13.71 Favored Pre-proline 0 C--N 1.3 -1.576 0 O-C-N 121.682 -0.636 . . . . 0.0 112.268 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.655 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.2 Cg_exo -55.36 -37.22 94.82 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.392 1.395 . . . . 0.0 112.035 -178.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.797 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.2 t -99.76 -34.41 4.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.69 -1.257 . . . . 0.0 109.046 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.866 ' HA ' HD22 ' A' ' 126' ' ' LEU . 0.5 OUTLIER -60.68 -22.7 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.556 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.567 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -60.7 -36.85 79.82 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.079 0.943 . . . . 0.0 108.501 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.55 -38.92 47.59 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.737 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.866 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -64.17 -23.07 67.18 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.567 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 12.7 mtmt -54.96 -38.65 68.02 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.438 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -80.24 -24.43 40.16 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.686 179.233 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.624 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 2.0 tp . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.936 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 130' ' ' APC . . . . . 0.901 ' C5 ' HG21 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' CON . . . . . 0.603 ' N3 ' ' O2A' ' A' ' 130' ' ' APC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.464 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.31 0.576 . . . . 0.0 109.657 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.576 ' HD3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 168.56 -164.38 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.227 -179.27 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.576 ' N ' ' HD3' ' A' ' 2' ' ' LYS . 4.0 tmmm? -157.55 149.97 22.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.369 -0.832 . . . . 0.0 108.952 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.991 ' O ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -148.66 132.74 17.26 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.163 -0.961 . . . . 0.0 108.901 178.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.555 ' HB2' HG23 ' A' ' 40' ' ' ILE . 5.8 mp0 -99.44 155.88 17.32 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.379 -1.451 . . . . 0.0 109.069 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.59 HG13 ' N7 ' ' A' ' 130' ' ' APC . 0.5 OUTLIER -116.97 117.16 54.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.348 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.01 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -84.41 66.19 9.3 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -79.44 -77.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.168 -0.958 . . . . 0.0 110.123 -179.375 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.702 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 63.15 93.24 0.02 OUTLIER Glycine 0 N--CA 1.484 1.852 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.578 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -52.95 162.32 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.98 HG22 ' CG2' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -128.79 92.42 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.328 -179.177 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.959 ' HG2' HG22 ' A' ' 18' ' ' ILE . 8.9 mtm180 -75.71 177.23 7.01 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.646 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -156.76 -61.5 0.1 Allowed 'General case' 0 C--O 1.191 -2.005 0 C-N-CA 116.069 -2.252 . . . . 0.0 114.716 -176.844 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.524 ' CB ' ' OE2' ' A' ' 17' ' ' GLU . 5.9 tp10 -91.7 -25.94 18.86 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 119.335 -2.103 . . . . 0.0 111.594 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -161.75 -45.53 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.454 ' HA ' HH21 ' A' ' 12' ' ' ARG . 53.7 t-20 -160.92 35.6 0.15 Allowed 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.524 ' OE2' ' CB ' ' A' ' 14' ' ' GLU . 12.6 mt-10 -79.83 83.82 5.71 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 118.403 -1.319 . . . . 0.0 109.161 -178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.959 HG22 ' HG2' ' A' ' 12' ' ' ARG . 18.1 pt -79.19 141.36 15.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.22 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.624 ' HB3' HD11 ' A' ' 11' ' ' ILE . 13.5 t80 -81.71 45.09 0.86 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.713 HG22 HG13 ' A' ' 18' ' ' ILE . 4.4 tt -80.13 152.29 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-O 121.93 0.872 . . . . 0.0 110.863 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.472 ' HB ' ' HD2' ' A' ' 101' ' ' PRO . 0.6 OUTLIER -69.88 95.34 0.91 Allowed 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.673 ' HD3' HD21 ' A' ' 33' ' ' LEU . 13.2 tpt180 -99.09 90.37 4.58 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.641 -0.662 . . . . 0.0 111.072 -178.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.994 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 32.41 83.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.898 -0.501 . . . . 0.0 110.177 178.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.44 -46.53 4.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.224 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.84 176.43 9.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.432 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -77.47 105.28 8.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.121 -0.987 . . . . 0.0 109.427 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.994 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -104.14 133.8 48.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.12 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -82.25 4.23 24.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 0.0 109.059 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.738 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -102.55 -126.69 0.21 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.603 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 163.62 -4.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.978 -1.076 . . . . 0.0 111.729 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 114' ' ' ASP . 2.9 p-10 -79.24 8.68 5.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.27 -1.519 . . . . 0.0 109.136 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.629 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -81.5 61.34 4.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.588 -0.695 . . . . 0.0 110.105 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.673 HD21 ' HD3' ' A' ' 22' ' ' ARG . 7.6 mt -123.66 93.11 3.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.868 -1.145 . . . . 0.0 109.291 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.594 ' O ' HD11 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.72 -145.97 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.465 -0.772 . . . . 0.0 109.003 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.497 ' CZ ' ' CG ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -142.53 128.35 10.52 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.745 -1.222 . . . . 0.0 109.49 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.703 ' O ' HG23 ' A' ' 8' ' ' VAL . 3.0 Cg_endo -60.05 97.09 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.004 1.803 . . . . 0.0 109.53 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.552 ' HA2' ' CG2' ' A' ' 6' ' ' ILE . . . -54.13 -141.95 0.0 OUTLIER Glycine 0 N--CA 1.496 2.677 0 O-C-N 121.531 -0.73 . . . . 0.0 111.589 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 153.59 -34.78 0.75 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.599 ' HD3' " C5'" ' A' ' 130' ' ' APC . 5.0 tptm 69.15 95.53 0.07 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.039 -0.683 . . . . 0.0 110.465 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.749 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -80.66 135.71 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.204 -0.935 . . . . 0.0 108.833 178.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -170.28 -34.23 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.353 -0.842 . . . . 0.0 109.756 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.415 ' O ' ' C ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -49.35 156.47 0.6 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.243 -0.911 . . . . 0.0 109.514 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' MET . . . 44.23 -122.44 4.46 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.78 21.27 0.09 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.406 -1.055 . . . . 0.0 109.484 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.699 HG22 ' H ' ' A' ' 47' ' ' GLU . 98.0 m -135.18 141.9 39.72 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.22 -0.925 . . . . 0.0 108.907 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.565 ' HD2' HG23 ' A' ' 45' ' ' THR . 11.2 Cg_exo -50.37 -16.9 2.29 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.573 1.516 . . . . 0.0 110.205 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.699 ' H ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -76.99 -84.08 0.07 Allowed 'General case' 0 C--O 1.202 -1.43 0 O-C-N 121.181 -0.949 . . . . 0.0 108.768 178.709 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.564 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 1.5 mt-30 -45.14 -35.91 3.43 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.484 -1.385 . . . . 0.0 109.747 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.635 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -64.23 -60.67 2.92 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.299 -0.875 . . . . 0.0 110.387 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.01 HG23 ' HB1' ' A' ' 7' ' ' ALA . 1.8 p -70.32 -48.82 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.897 -1.127 . . . . 0.0 110.548 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 47' ' ' GLU . 4.1 p -56.7 -37.41 52.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.823 -0.548 . . . . 0.0 110.575 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.564 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 2.9 mmt180 -79.17 -39.73 32.69 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.65 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 19.9 mm-40 -65.98 -15.66 63.2 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.054 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -80.26 -39.29 29.23 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.752 0.787 . . . . 0.0 109.961 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.63 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 1.8 mt-30 -79.2 -52.55 8.0 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.624 0.726 . . . . 0.0 109.192 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.65 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -44.65 -23.9 0.16 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.644 -0.66 . . . . 0.0 110.097 -179.58 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 3.9 mm-40 -80.16 -95.84 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.864 -1.148 . . . . 0.0 109.516 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.668 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 57.6 t -80.38 -78.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.07 -1.019 . . . . 0.0 109.809 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.64 37.54 0.11 Allowed Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.434 -1.365 . . . . 0.0 111.653 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.103 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -91.56 -147.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.506 -1.585 . . . . 0.0 108.689 178.64 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.608 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.5 m -162.73 -64.03 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 120.439 -1.413 . . . . 0.0 112.985 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.608 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 1.8 Cg_endo -56.66 -2.63 0.47 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 122.53 2.153 . . . . 0.0 113.963 -177.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.849 ' HB3' HD11 ' A' ' 60' ' ' ILE . 1.4 pt20 -40.24 -26.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.789 -1.194 . . . . 0.0 109.917 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.577 ' N ' ' HG3' ' A' ' 63' ' ' GLN . 0.4 OUTLIER 57.4 -170.16 0.1 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -178.255 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -179.34 158.85 0.89 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.521 -1.362 . . . . 0.0 111.683 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -156.84 147.84 21.91 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.749 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.619 HD23 ' CE2' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -70.07 -67.44 0.49 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.888 -1.133 . . . . 0.0 109.655 -179.202 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.861 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 82.31 -52.4 0.22 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.586 ' CB ' ' O ' ' A' ' 68' ' ' PHE . 2.2 mm-40 150.56 133.36 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.798 -0.564 . . . . 0.0 109.819 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.526 ' HA ' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -122.64 -162.74 1.03 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.148 -0.97 . . . . 0.0 109.336 179.355 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.71 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -145.62 175.79 10.1 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.372 -0.83 . . . . 0.0 109.871 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -148.27 83.26 1.49 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.32 126.23 34.18 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.61 160.69 14.67 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 3.1 m-85 -128.75 170.02 11.62 Favored Pre-proline 0 C--N 1.296 -1.747 0 O-C-N 121.182 -0.948 . . . . 0.0 109.29 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 6.2 Cg_exo -48.83 -23.23 5.54 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.083 1.855 . . . . 0.0 109.694 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.0 42.29 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.56 ' HD3' HD11 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -153.39 90.0 1.39 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.787 -0.571 . . . . 0.0 109.563 -178.37 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.992 ' C ' HD13 ' A' ' 80' ' ' ILE . 7.0 t-160 -80.31 100.28 8.31 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.111 HG21 ' C5 ' ' A' ' 130' ' ' APC . 1.2 mm -115.89 144.41 23.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 118.809 -1.156 . . . . 0.0 112.138 -178.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.534 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 1.6 m -119.3 166.24 13.26 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.692 ' CD2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -151.73 76.24 1.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.761 -1.212 . . . . 0.0 110.069 179.81 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.668 ' CD1' HG21 ' A' ' 40' ' ' ILE . 75.6 m95 -51.68 128.37 23.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.123 -0.986 . . . . 0.0 109.142 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.843 ' CE2' HG11 ' A' ' 122' ' ' VAL . 23.5 m-85 -103.62 76.35 1.39 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.039 -1.038 . . . . 0.0 109.782 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.619 ' CE2' HD23 ' A' ' 67' ' ' LEU . 40.8 m95 -78.39 91.66 4.5 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.997 -1.064 . . . . 0.0 109.209 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.861 HD23 ' CD2' ' A' ' 68' ' ' PHE . 1.6 mm? -71.8 131.76 43.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.955 -1.091 . . . . 0.0 109.882 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.98 ' CG2' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -117.67 -178.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.533 ' N ' HG23 ' A' ' 87' ' ' VAL . 43.5 mt-10 -158.07 2.45 0.11 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.139 -1.601 . . . . 0.0 113.397 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.596 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -151.45 68.61 0.92 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 119.623 -1.923 . . . . 0.0 111.723 -179.62 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 1.03 ' HB2' HD13 ' A' ' 60' ' ' ILE . 9.6 p90 -80.57 167.91 19.53 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.467 -1.395 . . . . 0.0 109.38 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.569 ' CB ' ' HG2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -92.41 144.15 25.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.137 -0.977 . . . . 0.0 109.435 179.71 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 40.08 -91.03 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 1.103 ' O ' HG21 ' A' ' 60' ' ' ILE . 13.6 pt-20 -107.07 161.65 22.23 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.214 -1.168 . . . . 0.0 109.77 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.61 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 9.8 Cg_endo -75.77 -155.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.563 2.175 . . . . 0.0 109.93 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 1.054 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER 178.96 46.59 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.425 -0.797 . . . . 0.0 109.83 179.277 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -128.1 -20.86 1.58 Allowed Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.751 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.582 ' O ' ' HG2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -49.92 104.04 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.871 -1.37 . . . . 0.0 109.618 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.509 ' HB2' ' C ' ' A' ' 37' ' ' GLY . 9.0 tp10 -82.81 94.29 7.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.9 -1.125 . . . . 0.0 109.244 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.98 13.54 34.38 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.496 ' CG ' ' HB2' ' A' ' 97' ' ' LYS . 6.4 pt20 -114.92 162.74 22.32 Favored Pre-proline 0 N--CA 1.487 1.383 0 O-C-N 121.345 -1.091 . . . . 0.0 108.683 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 102' ' ' GLY . 6.0 Cg_exo -60.32 -44.11 30.27 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.815 1.677 . . . . 0.0 109.728 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.587 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 56.27 112.75 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 3.7 pt-20 -147.24 132.31 18.26 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.8 -1.412 . . . . 0.0 111.068 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.692 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 2.4 m0 -47.8 126.02 9.66 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.503 ' HE3' ' HB2' ' A' ' 22' ' ' ARG . 7.7 tpp -123.31 105.57 9.96 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.347 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.29 81.39 0.74 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.647 ' O ' ' CB ' ' A' ' 108' ' ' VAL . 6.2 tt -80.99 -80.04 0.15 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.471 -0.768 . . . . 0.0 110.614 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.647 ' CB ' ' O ' ' A' ' 107' ' ' LEU . 54.5 t 115.49 103.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.504 ' CA ' ' OXT' ' A' ' 129' ' ' LEU . . . 41.94 78.77 0.06 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.594 -1.803 . . . . 0.0 108.594 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 1.107 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -39.54 163.66 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.617 -0.931 . . . . 0.0 110.989 -178.639 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.697 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -139.68 -8.28 1.25 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.406 -0.809 . . . . 0.0 111.412 -178.185 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 83.66 -25.38 0.14 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.301 -0.875 . . . . 0.0 108.713 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.12 -29.69 61.05 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.658 ' HB3' HD12 ' A' ' 33' ' ' LEU . 9.7 m-20 -94.22 -19.22 20.94 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 1.107 ' CE1' HD21 ' A' ' 110' ' ' LEU . 6.5 m-85 -95.82 148.05 33.95 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.325 -0.859 . . . . 0.0 109.908 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.488 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.4 Cg_endo -68.0 142.52 56.9 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.409 2.073 . . . . 0.0 110.061 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 118' ' ' ALA . 2.4 Cg_endo -63.04 -27.97 74.25 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.157 1.905 . . . . 0.0 110.476 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -41.43 -48.56 3.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.414 -0.804 . . . . 0.0 109.383 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.648 ' HB3' HD13 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -96.33 55.17 1.46 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.641 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -62.75 -42.33 77.8 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.764 -0.585 . . . . 0.0 112.027 -179.59 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 11.6 Cg_exo -54.02 -47.94 24.33 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 121.846 1.698 . . . . 0.0 112.615 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.843 HG11 ' CE2' ' A' ' 84' ' ' PHE . 1.5 t -88.64 -38.02 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.704 -1.248 . . . . 0.0 109.62 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.862 ' HA ' HD22 ' A' ' 126' ' ' LEU . 1.1 mp -63.1 -21.0 27.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.544 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -63.64 -31.06 72.12 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -80.32 -40.34 26.92 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.519 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.862 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.09 -21.09 66.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.682 -1.261 . . . . 0.0 107.755 179.366 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 1.9 mtmt -58.1 -36.5 72.98 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -83.23 -20.53 34.4 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.503 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.558 HD13 HD12 ' A' ' 126' ' ' LEU . 1.2 tp . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.627 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 130' ' ' APC . . . . . 1.111 ' C5 ' HG21 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.457 0.646 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.485 ' HD3' ' C ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -160.82 -163.54 1.07 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.474 ' CG ' ' N ' ' A' ' 4' ' ' LEU . 8.6 ttpt -151.82 161.18 43.08 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.035 -1.041 . . . . 0.0 109.26 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.784 HD21 H5'2 ' A' ' 130' ' ' APC . 0.2 OUTLIER -159.0 110.0 2.07 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.548 ' N ' HD13 ' A' ' 4' ' ' LEU . 2.5 mp0 -104.7 169.53 8.4 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.015 -1.053 . . . . 0.0 109.427 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.714 HG22 HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -135.23 122.87 37.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.437 -0.79 . . . . 0.0 108.984 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.975 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -86.2 62.16 7.27 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -79.15 -77.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.717 -179.514 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.717 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 62.99 89.07 0.03 OUTLIER Glycine 0 N--CA 1.48 1.567 0 N-CA-C 106.956 -2.458 . . . . 0.0 106.956 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.112 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -55.13 163.93 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.675 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.04 HG22 ' CG2' ' A' ' 87' ' ' VAL . 2.0 pt -127.42 71.46 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.301 -177.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.909 ' HB3' HG22 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -77.99 159.78 28.58 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.266 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -162.07 -18.61 0.04 OUTLIER 'General case' 0 C--O 1.187 -2.19 0 C-N-CA 115.81 -2.356 . . . . 0.0 115.479 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.52 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 1.4 tm-20 -93.48 -31.67 14.49 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 118.165 -2.834 . . . . 0.0 108.646 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -163.13 -46.51 0.03 OUTLIER 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.483 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 1.1 t-20 -162.05 37.87 0.12 Allowed 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 176.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 105' ' ' MET . 92.3 mt-10 -91.6 94.29 9.34 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 118.003 -1.479 . . . . 0.0 110.831 -177.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.112 ' CD1' HG22 ' A' ' 10' ' ' ILE . 0.6 OUTLIER -96.99 152.36 3.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.544 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.667 ' N ' HD12 ' A' ' 18' ' ' ILE . 13.6 t80 -80.39 45.38 0.76 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.654 HD11 ' C ' ' A' ' 34' ' ' GLU . 5.7 tp -81.09 154.78 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.231 -0.918 . . . . 0.0 111.382 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.535 ' O ' ' O ' ' A' ' 32' ' ' LYS . 1.4 t -67.67 92.98 0.35 Allowed 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.841 ' HD3' HD21 ' A' ' 33' ' ' LEU . 30.3 tpt180 -100.78 83.92 2.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.46 -0.775 . . . . 0.0 110.534 -178.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.765 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 31.69 86.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.826 -0.546 . . . . 0.0 110.129 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -44.7 -52.32 8.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.089 -1.007 . . . . 0.0 109.532 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.62 -161.04 0.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 0.0 109.11 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.76 -27.56 40.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.205 -0.934 . . . . 0.0 109.231 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.765 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . 50.76 -175.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 109.787 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.53 25.78 0.23 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.717 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 0.7 OUTLIER -126.45 -41.69 1.86 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.367 -0.833 . . . . 0.0 110.318 -179.517 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 29' ' ' MET . . . 78.93 0.86 2.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 110.124 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 25.4 p-10 -92.98 9.86 33.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.829 -1.169 . . . . 0.0 108.565 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.535 ' O ' ' O ' ' A' ' 21' ' ' THR . 0.9 OUTLIER -81.22 36.43 0.41 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.565 -0.709 . . . . 0.0 110.653 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.069 HD13 ' CE1' ' A' ' 115' ' ' PHE . 22.3 mt -110.82 88.05 2.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.553 -1.342 . . . . 0.0 109.564 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.654 ' C ' HD11 ' A' ' 20' ' ' ILE . 1.1 tt0 -91.79 -137.38 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.457 -0.777 . . . . 0.0 109.534 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.669 ' HB3' HG21 ' A' ' 8' ' ' VAL . 90.6 m-85 -149.66 130.8 7.23 Favored Pre-proline 0 C--N 1.306 -1.299 0 O-C-N 121.072 -1.017 . . . . 0.0 109.745 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.744 ' O ' HG23 ' A' ' 8' ' ' VAL . 2.1 Cg_endo -56.6 95.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.303 2.002 . . . . 0.0 109.894 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -55.69 -147.04 0.01 OUTLIER Glycine 0 N--CA 1.494 2.528 0 O-C-N 121.319 -0.863 . . . . 0.0 111.205 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 158.97 -40.29 0.5 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.574 ' HB2' H3A2 ' A' ' 130' ' ' APC . 13.4 tptp 73.75 94.49 0.07 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.146 -0.62 . . . . 0.0 110.596 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.783 ' O ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -80.92 131.8 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 108.805 178.704 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.417 ' HG2' ' N ' ' A' ' 42' ' ' MET . 4.6 pt-20 -171.76 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.963 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.417 ' N ' ' HG2' ' A' ' 41' ' ' GLU . 4.9 mmt -58.7 163.84 3.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -0.913 . . . . 0.0 109.857 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 47.61 -121.73 6.99 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -167.07 24.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.528 -0.984 . . . . 0.0 108.739 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.554 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 30.4 m -146.71 142.87 17.72 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.597 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 11.1 Cg_exo -50.58 -17.22 2.75 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 121.412 1.408 . . . . 0.0 109.957 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -75.33 -83.36 0.06 Allowed 'General case' 0 C--O 1.201 -1.483 0 O-C-N 121.081 -1.012 . . . . 0.0 108.938 178.647 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.529 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 32.9 mt-30 -45.52 -36.66 4.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.37 -1.456 . . . . 0.0 109.776 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.617 ' CB ' HG12 ' A' ' 40' ' ' ILE . . . -62.84 -64.99 0.75 Allowed 'General case' 0 C--N 1.289 -2.056 0 O-C-N 120.964 -1.085 . . . . 0.0 110.26 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.975 HG23 ' HB1' ' A' ' 7' ' ' ALA . 1.9 p -65.05 -48.93 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.048 -1.033 . . . . 0.0 111.018 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.577 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 2.9 p -55.66 -46.48 79.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-O 121.384 0.612 . . . . 0.0 110.109 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.565 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 8.0 mmt180 -72.46 -27.61 62.41 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.591 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 29.9 mm-40 -77.81 -14.18 59.66 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.752 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.8 OUTLIER -80.18 -58.52 3.11 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.493 ' HA ' ' CZ3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -63.16 -50.14 71.56 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.738 -0.601 . . . . 0.0 109.722 179.428 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.585 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 1.4 pp20? -53.25 -20.12 3.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.994 -1.066 . . . . 0.0 109.746 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.483 ' OE1' ' HA2' ' A' ' 96' ' ' GLY . 1.6 mt-10 -80.2 -91.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 109.861 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.866 HG21 ' HA ' ' A' ' 95' ' ' TRP . 41.7 t -79.96 -79.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.436 -0.79 . . . . 0.0 110.016 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.02 27.04 0.17 Allowed Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.212 -1.47 . . . . 0.0 111.448 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.031 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -81.75 -145.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.607 -1.525 . . . . 0.0 107.948 178.708 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.635 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.3 m -145.23 -70.43 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 120.512 -1.367 . . . . 0.0 109.943 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.635 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 8.8 Cg_endo -66.71 -169.42 0.18 Allowed 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 121.137 1.225 . . . . 0.0 109.636 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.628 ' HB2' HG21 ' A' ' 87' ' ' VAL . 0.8 OUTLIER 134.09 -20.27 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 -179.112 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.551 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.1 OUTLIER 52.12 -164.59 0.07 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -179.485 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -177.22 144.63 0.43 Allowed 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 117.636 -1.626 . . . . 0.0 111.046 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -145.07 143.48 30.46 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.624 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -74.61 -65.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.856 -1.152 . . . . 0.0 110.216 -178.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.624 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 81.89 -50.74 0.24 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.27 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.538 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER 164.15 179.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.135 -0.978 . . . . 0.0 109.595 179.306 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.18 142.82 13.37 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.313 -0.867 . . . . 0.0 109.109 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -96.93 -171.71 2.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.997 -1.064 . . . . 0.0 109.789 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HG3' HG23 ' A' ' 81' ' ' THR . 5.3 tt0 -160.24 95.48 1.14 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.5 123.15 27.29 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.434 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 2.1 tt0 -96.87 143.23 27.96 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.537 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.556 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 5.5 m-85 -119.39 169.76 7.74 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 7.6 Cg_exo -49.26 -31.86 23.58 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.441 1.427 . . . . 0.0 109.307 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -160.72 41.04 0.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.212 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.546 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -146.16 95.76 2.67 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.597 -0.689 . . . . 0.0 109.956 -178.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.753 ' C ' HD12 ' A' ' 80' ' ' ILE . 14.6 m80 -82.64 113.02 20.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.015 -1.053 . . . . 0.0 108.781 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.753 HD12 ' C ' ' A' ' 79' ' ' HIS . 1.3 mp -110.87 165.09 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -0.987 . . . . 0.0 110.161 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.559 ' N ' ' CG2' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -153.52 149.37 27.62 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.726 HD23 HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -137.0 77.47 1.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.903 -1.123 . . . . 0.0 109.909 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.645 ' CD1' HG21 ' A' ' 40' ' ' ILE . 81.8 m95 -46.71 116.34 1.3 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.183 -0.948 . . . . 0.0 109.658 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.812 ' CE2' HG11 ' A' ' 122' ' ' VAL . 26.0 m-85 -92.37 71.21 5.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.155 -0.966 . . . . 0.0 109.931 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.663 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 30.9 m95 -75.14 91.8 2.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.843 -1.161 . . . . 0.0 109.06 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.56 HD11 ' CG1' ' A' ' 10' ' ' ILE . 3.3 mm? -73.02 127.29 32.14 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.774 -1.204 . . . . 0.0 110.281 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.04 ' CG2' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -115.7 172.79 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.497 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 43.8 mt-10 -157.48 32.68 0.27 Allowed 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 117.835 -1.546 . . . . 0.0 113.392 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.593 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.21 55.94 0.35 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 119.872 -1.767 . . . . 0.0 111.154 178.251 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.539 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 5.1 p90 -78.94 159.09 27.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.19 -1.569 . . . . 0.0 109.488 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -88.43 138.21 31.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 32.79 -79.72 0.0 OUTLIER Glycine 0 N--CA 1.501 3.025 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 1.031 ' O ' HG21 ' A' ' 60' ' ' ILE . 2.8 mm-40 -94.49 144.79 28.53 Favored Pre-proline 0 C--N 1.303 -1.424 0 O-C-N 121.164 -1.198 . . . . 0.0 109.645 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.582 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 14.0 Cg_endo -79.58 -161.62 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.18 1.92 . . . . 0.0 109.651 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.866 ' HA ' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -176.21 116.72 0.13 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.016 0.912 . . . . 0.0 109.946 177.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.483 ' HA2' ' OE1' ' A' ' 57' ' ' GLU . . . 167.61 -34.59 0.21 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.581 ' CA ' ' HG2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -39.57 100.51 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.539 -0.977 . . . . 0.0 109.849 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.564 ' CG ' ' O2G' ' A' ' 130' ' ' APC . 18.2 tp10 -80.15 105.48 11.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.311 -0.868 . . . . 0.0 108.822 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 50.53 30.77 20.46 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.581 ' HG2' ' CA ' ' A' ' 97' ' ' LYS . 1.7 pt20 -134.26 165.26 38.05 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.544 -0.974 . . . . 0.0 109.337 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 3.5 Cg_exo -63.47 -45.61 11.28 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.206 1.938 . . . . 0.0 110.484 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.608 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.59 114.42 0.01 OUTLIER Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.625 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 1.8 pt-20 -152.25 134.16 14.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.086 -1.243 . . . . 0.0 110.079 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.522 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 1.7 m-90 -46.15 134.45 8.45 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.624 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -125.97 116.15 21.03 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.135 -0.978 . . . . 0.0 109.031 -179.04 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.563 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -79.52 43.69 0.57 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.428 -0.795 . . . . 0.0 110.858 -178.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.765 HD21 ' HA ' ' A' ' 110' ' ' LEU . 9.4 tt -67.01 161.9 23.29 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.723 ' N ' HD23 ' A' ' 107' ' ' LEU . 24.5 t -118.78 114.69 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.048 -1.033 . . . . 0.0 108.935 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 43.18 84.45 0.01 OUTLIER Glycine 0 N--CA 1.493 2.436 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.983 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -35.55 157.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.764 0.793 . . . . 0.0 111.33 -178.137 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.737 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -138.45 -5.04 1.61 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.687 -0.633 . . . . 0.0 111.346 -178.035 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.737 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 81.99 -34.93 0.1 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.99 -26.59 4.42 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.452 -0.78 . . . . 0.0 109.266 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 1.013 ' HB3' HD12 ' A' ' 33' ' ' LEU . 62.9 m-20 -104.25 -20.01 13.92 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.753 -0.592 . . . . 0.0 109.503 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 1.069 ' CE1' HD13 ' A' ' 33' ' ' LEU . 9.4 m-85 -98.8 148.36 34.46 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.226 -0.921 . . . . 0.0 109.101 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.566 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 6.1 Cg_exo -62.03 132.27 38.59 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.459 2.106 . . . . 0.0 110.448 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.93 -18.5 42.84 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.948 1.765 . . . . 0.0 110.201 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -46.52 -52.48 13.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.235 -0.916 . . . . 0.0 108.879 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.522 ' O ' ' HB ' ' A' ' 123' ' ' ILE . 30.0 m-80 -86.56 46.68 1.38 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.647 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 2.2 mt-10 -57.66 -44.31 99.4 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.667 -0.646 . . . . 0.0 112.485 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 7.1 Cg_exo -53.35 -42.7 63.39 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.877 1.718 . . . . 0.0 113.15 -177.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.812 HG11 ' CE2' ' A' ' 84' ' ' PHE . 1.8 t -96.98 -32.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.458 -1.401 . . . . 0.0 110.06 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.76 ' HA ' HD22 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -62.92 -25.85 39.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.571 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -57.59 -33.36 68.12 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.165 0.983 . . . . 0.0 108.419 178.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 68.1 mmtt -80.18 -40.55 27.03 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.704 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.8 HD13 ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -66.95 -16.31 64.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.647 -1.283 . . . . 0.0 107.884 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 12.0 mtmt -61.68 -35.08 76.96 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 177.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 125' ' ' LYS . 1.2 mtp180 -81.91 -19.92 39.82 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.281 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.757 HD23 ' NH1' ' A' ' 12' ' ' ARG . 1.2 tp . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.111 -0.947 . . . . 0.0 109.447 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 130' ' ' APC . . . . . 0.784 H5'2 HD21 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' CON . . . . . 0.549 ' N3 ' ' O2A' ' A' ' 130' ' ' APC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.481 ' O ' ' O ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.581 ' HD3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -51.93 -172.2 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.543 -0.723 . . . . 0.0 109.456 -179.436 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.581 ' N ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -150.68 154.05 36.72 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.373 -0.83 . . . . 0.0 108.951 179.165 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 1.095 ' O ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -142.88 119.42 11.02 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.043 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.861 ' N ' HD22 ' A' ' 4' ' ' LEU . 8.4 mp0 -101.57 160.92 14.03 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.727 -1.233 . . . . 0.0 107.844 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.892 HG22 HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -123.1 117.76 52.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 C-N-CA 119.351 -0.939 . . . . 0.0 109.288 -179.136 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.912 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -87.44 58.56 5.03 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.892 HG12 HG22 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -78.02 -73.72 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.506 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.756 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 60.01 82.24 0.07 OUTLIER Glycine 0 N--CA 1.48 1.603 0 N-CA-C 107.584 -2.207 . . . . 0.0 107.584 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.639 HD12 HD11 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -45.97 160.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.052 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.089 HG22 ' CG2' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -120.26 95.32 3.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 C-N-CA 119.57 -0.852 . . . . 0.0 108.915 -179.234 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 1.096 ' HG2' HG22 ' A' ' 18' ' ' ILE . 20.3 mtm180 -74.35 173.19 10.59 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.62 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -150.98 -64.41 0.19 Allowed 'General case' 0 C--O 1.188 -2.142 0 C-N-CA 117.18 -1.808 . . . . 0.0 114.222 -176.73 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 7.7 tp10 -91.81 -32.73 15.25 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 118.957 -2.34 . . . . 0.0 112.014 -175.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.476 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 5.7 t-20 -161.15 -43.96 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.584 ' HB3' ' CD2' ' A' ' 107' ' ' LEU . 7.5 m120 -157.07 35.35 0.29 Allowed 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.549 ' HG2' ' CB ' ' A' ' 106' ' ' SER . 31.5 mt-10 -88.52 83.92 6.79 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 117.778 -1.569 . . . . 0.0 109.629 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.096 HG22 ' HG2' ' A' ' 12' ' ' ARG . 3.0 pt -79.82 149.09 5.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.645 ' CE2' ' HG2' ' A' ' 94' ' ' PRO . 7.0 t80 -81.57 43.68 0.76 Allowed 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.636 HG21 HD22 ' A' ' 33' ' ' LEU . 6.7 tp -83.33 159.9 3.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.93 0.871 . . . . 0.0 110.806 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.754 ' O ' HG23 ' A' ' 21' ' ' THR . 7.4 t -70.32 98.6 1.42 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 176.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.676 ' HD3' HD21 ' A' ' 33' ' ' LEU . 31.6 tpt180 -99.61 80.39 2.36 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 110.976 -177.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.539 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 32.68 83.63 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.304 0.573 . . . . 0.0 110.137 178.759 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -43.51 -49.46 7.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -0.942 . . . . 0.0 110.087 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.35 178.65 8.15 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.179 -0.951 . . . . 0.0 108.763 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.444 ' O ' ' O ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -57.96 -30.81 66.3 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.171 -1.012 . . . . 0.0 108.894 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.539 ' CB ' ' HD2' ' A' ' 23' ' ' ARG . . . 58.07 159.12 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.325 -0.86 . . . . 0.0 109.537 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -131.57 25.73 4.75 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.67 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 11.2 mtm -129.08 -95.2 0.41 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.497 -0.752 . . . . 0.0 109.242 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.67 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 137.71 -4.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -85.61 14.41 5.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.125 -0.984 . . . . 0.0 108.834 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.9 tmtt? -80.98 28.77 0.35 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.468 -0.77 . . . . 0.0 110.708 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.71 HD12 ' HB3' ' A' ' 114' ' ' ASP . 16.6 mt -107.02 83.36 1.82 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.453 -1.405 . . . . 0.0 110.057 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.61 ' C ' HD11 ' A' ' 20' ' ' ILE . 1.7 tt0 -85.46 -143.04 0.09 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.64 ' HB3' HG21 ' A' ' 8' ' ' VAL . 22.2 m-85 -142.66 127.55 10.05 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.693 -1.255 . . . . 0.0 109.701 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.834 ' O ' HG23 ' A' ' 8' ' ' VAL . 5.0 Cg_endo -60.81 95.47 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.813 1.676 . . . . 0.0 109.225 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -54.26 -149.28 0.01 OUTLIER Glycine 0 N--CA 1.493 2.5 0 CA-C-O 122.039 0.799 . . . . 0.0 111.548 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.533 ' N ' ' CG ' ' A' ' 98' ' ' GLU . . . 159.9 -37.1 0.46 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.643 ' HE2' HD23 ' A' ' 4' ' ' LEU . 20.9 tptp 72.52 98.3 0.07 Allowed 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.172 0.51 . . . . 0.0 110.875 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.982 ' O ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -81.59 130.21 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.306 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -170.51 -32.3 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.428 -0.795 . . . . 0.0 109.76 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.419 ' HB2' ' HA ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -53.73 164.26 0.58 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.907 . . . . 0.0 109.378 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' MET . . . 45.08 -122.05 4.9 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -165.89 24.05 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.43 -1.041 . . . . 0.0 108.997 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.654 HG22 ' H ' ' A' ' 47' ' ' GLU . 88.4 m -144.19 141.93 19.07 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.356 -0.84 . . . . 0.0 108.845 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 45' ' ' THR . 7.5 Cg_exo -48.89 -18.58 1.74 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.705 1.603 . . . . 0.0 109.804 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.654 ' H ' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -76.0 -87.57 0.04 OUTLIER 'General case' 0 C--O 1.201 -1.449 0 O-C-N 121.214 -0.929 . . . . 0.0 108.799 178.873 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.55 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 22.7 mt-30 -42.72 -34.81 0.97 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.744 -1.223 . . . . 0.0 109.977 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.599 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -65.06 -63.87 1.0 Allowed 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.299 -0.875 . . . . 0.0 109.83 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.806 HG23 ' HB1' ' A' ' 7' ' ' ALA . 1.9 p -65.59 -49.37 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.962 -1.086 . . . . 0.0 110.864 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.568 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 3.8 p -56.55 -43.9 79.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.641 -0.662 . . . . 0.0 110.283 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 27.4 mmm180 -73.83 -28.46 61.62 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.599 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 25.0 mm-40 -76.69 -15.2 59.86 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.018 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -79.85 -55.51 4.93 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.68 0.752 . . . . 0.0 109.297 -179.732 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.635 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -68.71 -41.21 79.39 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.819 -0.551 . . . . 0.0 110.657 -179.617 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.575 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.9 OUTLIER -59.12 -20.81 56.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.006 -1.059 . . . . 0.0 110.73 -178.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 9.9 mm-40 -80.1 -91.07 0.05 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.812 -1.18 . . . . 0.0 110.445 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.611 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 94.7 t -77.49 -80.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.37 -0.832 . . . . 0.0 110.203 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.76 32.76 0.1 Allowed Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.178 -1.487 . . . . 0.0 111.678 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.063 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.3 pt -89.44 -137.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.552 -1.558 . . . . 0.0 108.305 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.662 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.8 m -154.32 -71.57 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.333 -1.479 . . . . 0.0 111.166 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.662 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 3.6 Cg_endo -64.09 -175.34 0.3 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 120.965 1.11 . . . . 0.0 110.315 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.705 ' HB2' HG21 ' A' ' 87' ' ' VAL . 3.8 pt20 151.79 -22.04 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.593 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 1.0 OUTLIER 48.61 50.53 16.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.479 -0.763 . . . . 0.0 109.748 179.026 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.574 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -48.64 149.56 1.67 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.808 0.813 . . . . 0.0 110.68 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 86' ' ' LEU . 3.1 m -153.63 133.58 13.19 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.627 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -56.76 -71.4 0.1 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.856 -1.152 . . . . 0.0 110.482 -179.044 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.818 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 84.78 -52.19 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.58 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 0.8 OUTLIER 154.88 138.77 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.151 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.546 ' HA ' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -128.76 -175.17 3.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.972 . . . . 0.0 109.893 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.82 HD11 ' HB2' ' A' ' 82' ' ' LEU . 0.9 OUTLIER -125.16 -169.53 2.01 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.669 0.747 . . . . 0.0 109.647 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.604 ' HG3' HG23 ' A' ' 81' ' ' THR . 4.9 tt0 -156.37 83.12 0.98 Allowed 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.78 106.56 10.87 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.51 -170.17 2.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.348 -0.845 . . . . 0.0 109.471 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.592 ' HB2' ' CB ' ' A' ' 78' ' ' ARG . 5.6 m-85 -160.33 169.46 10.13 Favored Pre-proline 0 C--N 1.297 -1.681 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.351 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.4 Cg_exo -50.73 -28.85 24.04 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.974 1.783 . . . . 0.0 109.607 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.64 42.07 0.14 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.592 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -151.52 92.88 1.81 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.841 -0.537 . . . . 0.0 109.725 -178.383 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.667 ' C ' HD12 ' A' ' 80' ' ' ILE . 1.5 m-70 -82.95 104.82 13.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.966 -1.084 . . . . 0.0 109.067 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.083 HG21 ' C6 ' ' A' ' 130' ' ' APC . 0.6 OUTLIER -115.04 138.08 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.005 -1.059 . . . . 0.0 110.284 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.604 HG23 ' HG3' ' A' ' 72' ' ' GLU . 1.0 OUTLIER -112.9 179.54 3.94 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.34 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.984 HD23 ' CE1' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -160.32 72.53 0.48 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.658 -1.276 . . . . 0.0 110.394 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.629 ' CD1' HG21 ' A' ' 40' ' ' ILE . 79.3 m95 -51.74 131.12 30.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 108.956 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.984 ' CE1' HD23 ' A' ' 82' ' ' LEU . 16.0 m-85 -110.12 71.92 0.77 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.054 -1.029 . . . . 0.0 109.132 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.638 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 38.2 m95 -70.75 85.11 0.65 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.315 -0.865 . . . . 0.0 109.588 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.818 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.6 mm? -70.77 124.22 23.79 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.749 -1.181 . . . . 0.0 109.059 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.089 ' CG2' HG22 ' A' ' 11' ' ' ILE . 1.1 m -113.72 159.86 13.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 87' ' ' VAL . 17.1 mp0 -148.44 36.56 0.81 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.095 -1.442 . . . . 0.0 112.924 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.593 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -161.06 31.98 0.14 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 119.881 -1.762 . . . . 0.0 111.532 178.7 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.767 ' HB2' HD13 ' A' ' 60' ' ' ILE . 2.8 p90 -54.79 165.5 0.61 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.16 -1.587 . . . . 0.0 108.274 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.567 ' HG2' ' HB ' ' A' ' 60' ' ' ILE . 8.1 pt-20 -77.35 -123.85 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.994 -1.066 . . . . 0.0 110.408 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.454 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -64.83 -50.46 58.24 Favored Glycine 0 N--CA 1.489 2.217 0 O-C-N 120.738 -1.226 . . . . 0.0 110.075 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 1.063 ' O ' HG21 ' A' ' 60' ' ' ILE . 3.1 mt-10 -123.29 156.56 63.35 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.018 -1.283 . . . . 0.0 110.278 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.691 ' HB3' HD12 ' A' ' 11' ' ' ILE . 8.4 Cg_endo -73.86 -160.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.731 2.288 . . . . 0.0 110.086 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 1.018 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER 176.7 48.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 111.049 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . -132.69 2.89 4.95 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.169 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -80.08 94.91 6.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.383 -1.069 . . . . 0.0 111.239 -179.251 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.533 ' CG ' ' N ' ' A' ' 38' ' ' GLY . 2.8 mm-40 -42.02 -88.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.913 . . . . 0.0 108.729 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.97 1.68 27.15 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.564 ' HG3' ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -73.89 146.98 85.92 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.725 -0.868 . . . . 0.0 109.366 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.564 ' HD2' ' HG3' ' A' ' 100' ' ' GLN . 3.0 Cg_exo -56.39 -29.46 77.46 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 N-CA-C 107.897 -1.616 . . . . 0.0 107.897 178.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.627 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 54.76 110.73 0.01 OUTLIER Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.585 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 2.9 pt-20 -151.83 127.95 10.45 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.07 -1.253 . . . . 0.0 109.19 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.449 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -41.65 141.34 0.8 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.494 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.513 ' HG3' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -139.15 96.05 3.04 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.363 -0.836 . . . . 0.0 108.961 -179.455 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.549 ' CB ' ' HG2' ' A' ' 17' ' ' GLU . 10.4 t -78.51 72.17 5.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.46 -0.775 . . . . 0.0 109.399 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.782 HD23 ' N ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -80.03 -10.92 59.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.916 -1.115 . . . . 0.0 109.903 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.782 ' N ' HD23 ' A' ' 107' ' ' LEU . 2.5 t 64.93 122.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 108' ' ' VAL . . . 33.26 83.03 0.01 OUTLIER Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.966 HD21 ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -41.09 165.07 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.772 -0.84 . . . . 0.0 109.866 -178.068 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.713 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 2.0 t-20 -144.3 -4.94 0.78 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.804 -1.185 . . . . 0.0 111.87 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 81.23 -26.29 0.15 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.961 -1.087 . . . . 0.0 108.56 -177.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -57.24 -40.47 77.64 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.71 ' HB3' HD12 ' A' ' 33' ' ' LEU . 59.8 m-20 -86.67 -13.12 46.44 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.966 ' CD1' HD21 ' A' ' 110' ' ' LEU . 5.1 m-85 -101.3 146.26 31.87 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 110.317 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 5.9 Cg_exo -60.92 141.66 95.24 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.44 2.094 . . . . 0.0 110.31 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.478 ' O ' ' OE1' ' A' ' 120' ' ' GLU . 1.6 Cg_endo -64.36 -8.1 15.94 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.098 1.866 . . . . 0.0 110.626 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.27 -53.45 52.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.09 -1.006 . . . . 0.0 110.174 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.715 ' OD1' HD21 ' A' ' 71' ' ' LEU . 6.7 m-80 -87.85 42.87 1.08 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 109.764 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.691 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -57.66 -44.3 99.39 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 120.981 -1.074 . . . . 0.0 111.734 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.691 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 20.8 Cg_exo -47.15 -44.92 22.84 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.825 1.683 . . . . 0.0 113.043 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.691 HG21 ' CD1' ' A' ' 84' ' ' PHE . 1.7 t -96.37 -35.94 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.306 -1.496 . . . . 0.0 109.215 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.859 ' HA ' HD22 ' A' ' 126' ' ' LEU . 2.1 mt -62.54 -17.95 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.592 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -63.27 -35.87 81.79 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.0 mmtm -74.21 -42.21 60.14 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.668 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.859 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.46 -20.61 66.43 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.783 -1.198 . . . . 0.0 108.224 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.592 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 11.3 mtmt -57.98 -36.75 73.05 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -23.66 41.35 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.584 HD13 HD12 ' A' ' 126' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.539 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 130' ' ' APC . . . . . 1.083 ' C6 ' HG21 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' CON . . . . . 0.606 ' N3 ' ' O2A' ' A' ' 130' ' ' APC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.565 ' HD3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -54.86 -176.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.571 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.569 ' HG3' ' N ' ' A' ' 4' ' ' LEU . 1.7 tttt -160.22 143.06 13.48 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.406 -0.809 . . . . 0.0 109.352 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 1.087 ' CD1' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -139.54 110.0 6.62 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.785 ' N ' HD22 ' A' ' 4' ' ' LEU . 4.2 mp0 -96.93 162.47 13.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.109 -0.994 . . . . 0.0 109.804 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.639 HD11 ' H8 ' ' A' ' 130' ' ' APC . 0.1 OUTLIER -128.92 108.99 18.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.04 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -84.74 64.71 8.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.471 -0.768 . . . . 0.0 109.113 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.741 HG13 ' H ' ' A' ' 9' ' ' GLY . 1.3 p -79.52 -71.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 110.405 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.741 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 60.04 74.04 0.41 Allowed Glycine 0 C--N 1.298 -1.554 0 N-CA-C 106.788 -2.525 . . . . 0.0 106.788 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.679 ' CG1' HD11 ' A' ' 86' ' ' LEU . 0.6 OUTLIER -42.27 142.75 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -178.752 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.647 HD11 ' CB ' ' A' ' 19' ' ' PHE . 2.7 pt -98.14 97.59 6.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.169 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.956 ' HG2' HG23 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -77.44 171.47 14.83 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.608 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 6.1 t30 -148.92 -64.5 0.23 Allowed 'General case' 0 C--O 1.188 -2.134 0 C-N-CA 116.86 -1.936 . . . . 0.0 114.74 -177.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.549 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 3.0 tp10 -91.86 -28.91 17.01 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 118.775 -2.453 . . . . 0.0 111.592 -175.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -162.79 -43.03 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.735 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -160.06 31.31 0.18 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 177.582 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 105' ' ' MET . 36.4 mt-10 -83.01 89.31 6.88 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 117.517 -1.673 . . . . 0.0 108.025 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.956 HG23 ' HG2' ' A' ' 12' ' ' ARG . 1.0 OUTLIER -85.01 150.13 4.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-O 121.644 0.735 . . . . 0.0 110.812 -178.235 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.647 ' CB ' HD11 ' A' ' 11' ' ' ILE . 14.0 t80 -82.66 43.72 0.85 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.639 HD11 ' N ' ' A' ' 34' ' ' GLU . 6.6 tp -80.78 157.39 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 121.37 -0.831 . . . . 0.0 110.386 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.532 ' O ' HG23 ' A' ' 21' ' ' THR . 2.0 t -74.01 86.0 1.8 Allowed 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.609 ' HD2' HD21 ' A' ' 33' ' ' LEU . 15.6 tpt180 -82.55 84.28 7.29 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.205 -0.934 . . . . 0.0 109.922 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.532 ' CB ' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 30.21 64.69 0.15 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.37 0.605 . . . . 0.0 110.359 -179.625 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -45.81 -54.32 8.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.359 -0.838 . . . . 0.0 109.233 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.73 -177.33 3.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -0.892 . . . . 0.0 108.872 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -76.15 86.58 3.01 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.013 -1.054 . . . . 0.0 109.337 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.532 ' HB2' ' CB ' ' A' ' 23' ' ' ARG . . . -68.19 -27.97 66.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.861 . . . . 0.0 109.805 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.592 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 72.7 t60 49.02 24.71 0.93 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -177.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -152.19 -166.65 2.54 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.821 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.523 ' O ' ' OD1' ' A' ' 31' ' ' ASN . . . -137.44 -153.09 0.47 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.523 ' OD1' ' O ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER 63.8 2.79 1.41 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.218 -0.926 . . . . 0.0 109.504 -179.033 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.59 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -83.47 50.43 1.78 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.196 -0.94 . . . . 0.0 110.316 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.728 HD12 ' HB3' ' A' ' 114' ' ' ASP . 12.7 mt -128.74 85.77 2.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.975 -1.078 . . . . 0.0 108.197 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.639 ' N ' HD11 ' A' ' 20' ' ' ILE . 21.8 mt-10 -91.2 -123.52 0.07 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.176 -0.952 . . . . 0.0 110.842 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.707 ' CB ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -160.49 124.0 1.95 Allowed Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 120.579 -1.325 . . . . 0.0 109.832 -178.749 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.62 ' CB ' ' HA ' ' A' ' 97' ' ' LYS . 19.7 Cg_endo -76.7 95.81 1.07 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.415 2.077 . . . . 0.0 110.575 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' CA ' ' HA ' ' A' ' 8' ' ' VAL . . . -145.62 123.4 1.87 Allowed Glycine 0 N--CA 1.499 2.843 0 O-C-N 120.654 -1.279 . . . . 0.0 110.166 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.588 ' HA3' ' OE1' ' A' ' 98' ' ' GLU . . . -103.77 74.22 0.27 Allowed Glycine 0 N--CA 1.491 2.339 0 O-C-N 121.172 -1.193 . . . . 0.0 111.942 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.695 ' CD ' HD23 ' A' ' 4' ' ' LEU . 5.4 tptt 42.07 121.02 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 176.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.04 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -81.65 129.96 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.495 ' OE1' ' HG2' ' A' ' 39' ' ' LYS . 3.1 pt-20 -171.71 -20.9 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 118.534 -1.267 . . . . 0.0 111.43 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.446 ' HG3' ' HG2' ' A' ' 53' ' ' GLU . 2.5 mmt -39.42 -74.28 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.096 -1.003 . . . . 0.0 109.655 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.57 -132.71 7.38 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -134.34 3.1 3.33 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.625 -0.926 . . . . 0.0 109.101 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.544 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 22.5 m -118.64 142.53 31.78 Favored Pre-proline 0 N--CA 1.486 1.338 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 8.2 Cg_exo -52.76 -17.49 7.35 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.395 1.397 . . . . 0.0 109.653 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.498 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -79.48 -87.97 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.209 -0.932 . . . . 0.0 108.821 178.556 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.571 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 10.6 mt-30 -42.66 -34.29 0.86 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.815 -1.178 . . . . 0.0 109.327 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.643 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -63.88 -62.46 1.63 Allowed 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.069 -1.019 . . . . 0.0 110.119 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.808 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.1 p -69.3 -49.17 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.186 -0.946 . . . . 0.0 110.763 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.558 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 4.2 p -55.32 -44.22 74.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.551 -0.718 . . . . 0.0 110.264 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.571 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -72.35 -36.88 68.9 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 179.375 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.598 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 11.6 mm-40 -69.0 -13.74 62.63 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.847 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.8 OUTLIER -80.37 -61.39 1.99 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.616 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.563 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -58.13 -50.26 74.1 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.747 -0.596 . . . . 0.0 109.891 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.598 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -49.45 -21.57 0.96 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.062 -1.024 . . . . 0.0 110.04 -178.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mt-10 -79.98 -95.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.928 -1.107 . . . . 0.0 109.622 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.612 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 45.4 t -80.12 -78.48 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 110.184 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.06 31.84 0.13 Allowed Glycine 0 N--CA 1.493 2.434 0 C-N-CA 118.626 -1.75 . . . . 0.0 112.476 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.137 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.2 pp -87.13 -153.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 120.372 -1.664 . . . . 0.0 107.639 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.653 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.8 m -135.95 -70.93 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.389 -1.444 . . . . 0.0 110.584 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.653 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 5.8 Cg_endo -63.04 -170.61 0.1 Allowed 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 121.433 1.422 . . . . 0.0 110.719 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.911 HE21 ' HZ2' ' A' ' 95' ' ' TRP . 3.1 pt20 143.0 -24.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.555 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.3 OUTLIER 44.54 71.03 0.28 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.423 -0.798 . . . . 0.0 109.312 178.999 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -67.26 141.98 57.06 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.342 -0.849 . . . . 0.0 109.833 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -132.42 135.85 46.36 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.562 ' O ' ' O ' ' A' ' 84' ' ' PHE . 1.3 tm? -57.53 -64.94 0.72 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.977 -1.077 . . . . 0.0 109.36 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.825 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 80.66 -50.01 0.31 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.589 ' CB ' ' O ' ' A' ' 68' ' ' PHE . 27.1 tt0 150.16 142.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -131.35 178.07 7.0 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 110.541 -178.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.839 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -127.47 166.34 18.13 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.725 0.774 . . . . 0.0 109.887 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -141.0 91.4 2.4 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.83 113.4 16.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.426 ' CG ' ' CD2' ' A' ' 79' ' ' HIS . 2.8 tt0 -91.72 146.79 23.49 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.576 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -133.51 173.02 6.35 Favored Pre-proline 0 C--N 1.296 -1.722 0 O-C-N 121.272 -0.893 . . . . 0.0 108.731 -179.585 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.576 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 7.3 Cg_exo -47.93 -40.5 32.84 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.818 1.678 . . . . 0.0 109.742 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -151.63 45.75 0.78 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HB2' ' CB ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -148.77 93.06 2.07 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.714 -0.616 . . . . 0.0 109.565 -178.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.426 ' CD2' ' CG ' ' A' ' 74' ' ' GLU . 22.7 m80 -91.87 73.36 5.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.137 -0.977 . . . . 0.0 108.74 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.087 HG23 ' CD1' ' A' ' 4' ' ' LEU . 3.1 mm -84.52 154.32 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.995 -1.066 . . . . 0.0 110.486 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.468 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 3.2 m -136.51 154.45 50.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.617 ' O ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -139.77 75.53 1.52 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.74 -1.225 . . . . 0.0 110.021 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.593 ' CD1' HG21 ' A' ' 40' ' ' ILE . 89.4 m95 -48.46 124.1 7.6 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 118.6 -1.24 . . . . 0.0 108.611 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.617 ' CD1' ' O ' ' A' ' 82' ' ' LEU . 40.3 m-85 -102.28 71.77 1.25 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.996 -1.065 . . . . 0.0 110.32 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.676 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 76.7 m95 -75.88 85.52 2.83 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.757 -1.214 . . . . 0.0 108.994 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.825 HD23 ' CD2' ' A' ' 68' ' ' PHE . 2.1 mm? -72.58 123.11 22.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.509 -1.369 . . . . 0.0 108.779 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.542 ' O ' ' CG ' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -102.76 176.7 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.542 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 41.3 mt-10 -157.1 16.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.654 -1.218 . . . . 0.0 112.113 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.612 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -159.75 64.39 0.36 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.146 -1.596 . . . . 0.0 111.451 179.131 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.656 ' CH2' ' CD1' ' A' ' 104' ' ' TRP . 2.0 p90 -80.25 168.56 18.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 119.951 -1.718 . . . . 0.0 108.382 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.634 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -89.7 113.95 25.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.077 -1.014 . . . . 0.0 109.05 179.188 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 44.21 -80.87 0.0 OUTLIER Glycine 0 N--CA 1.501 2.984 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 1.137 ' O ' HG21 ' A' ' 60' ' ' ILE . 4.8 mt-10 -82.52 145.7 51.91 Favored Pre-proline 0 C--N 1.298 -1.638 0 O-C-N 120.881 -1.364 . . . . 0.0 109.941 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.627 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 11.7 Cg_endo -79.17 -167.25 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.451 2.101 . . . . 0.0 108.511 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.911 ' HZ2' HE21 ' A' ' 63' ' ' GLN . 0.2 OUTLIER -179.12 34.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.728 -1.233 . . . . 0.0 112.009 178.235 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . -121.36 1.7 11.41 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 178.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.62 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -80.83 127.22 32.28 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.446 -1.032 . . . . 0.0 111.863 -179.014 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.588 ' OE1' ' HA3' ' A' ' 38' ' ' GLY . 32.8 mm-40 -81.84 -135.29 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.13 -19.85 47.38 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.444 ' HG2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -55.21 148.96 28.23 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.866 -0.785 . . . . 0.0 109.84 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 21' ' ' THR . 2.2 Cg_endo -65.28 -37.73 30.05 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.89 1.727 . . . . 0.0 108.418 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.634 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 58.09 115.91 0.01 OUTLIER Glycine 0 N--CA 1.481 1.653 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 18.9 pt-20 -150.4 130.0 13.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.038 -1.272 . . . . 0.0 110.174 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.656 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -46.65 131.96 11.18 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.563 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.95 123.42 42.42 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.14 -0.975 . . . . 0.0 109.338 -178.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.99 46.87 1.15 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.334 -0.854 . . . . 0.0 108.873 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.997 HD22 ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -75.07 -28.95 60.54 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.916 ' N ' HD13 ' A' ' 107' ' ' LEU . 49.0 t 55.91 123.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.713 -0.617 . . . . 0.0 110.495 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.54 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 42.83 82.77 0.02 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.814 HD22 ' HD2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -45.45 175.01 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.562 -0.964 . . . . 0.0 109.433 -177.338 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.729 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 1.5 t30 -143.8 -5.64 0.8 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.266 -1.521 . . . . 0.0 112.762 -177.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 82.35 -35.75 0.09 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.039 -1.038 . . . . 0.0 108.405 -177.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -54.76 -24.9 24.56 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.728 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -105.38 -17.41 14.45 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.439 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.814 ' HD2' HD22 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -91.61 122.43 65.73 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.397 -0.814 . . . . 0.0 109.14 179.09 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.516 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 14.1 Cg_exo -48.49 147.52 9.08 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.836 1.69 . . . . 0.0 110.446 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.455 ' HA ' ' CG ' ' A' ' 120' ' ' GLU . 3.5 Cg_exo -60.27 -30.58 91.46 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.496 2.13 . . . . 0.0 110.99 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.89 -61.59 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 109.57 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.551 ' CG ' ' CZ ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -88.71 51.6 2.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.353 -0.842 . . . . 0.0 109.134 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.627 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -70.29 -40.68 12.34 Favored Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -179.079 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 5.7 Cg_exo -54.36 -47.21 28.12 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 121.928 1.752 . . . . 0.0 113.12 -177.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 71' ' ' LEU . 2.1 t -87.62 -28.19 5.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 120.581 -1.325 . . . . 0.0 109.118 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.877 ' HA ' HD22 ' A' ' 126' ' ' LEU . 1.1 mp -67.48 -23.16 29.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.511 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -58.61 -28.14 65.33 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -81.01 -41.1 23.24 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.265 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.877 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -64.59 -26.45 68.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.507 -1.371 . . . . 0.0 107.476 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 14.8 mtmt -50.75 -37.37 41.53 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -83.53 -27.54 29.28 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.869 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 126' ' ' LEU . 1.1 tp . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.838 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 130' ' ' APC . . . . . 0.883 ' C6 ' HG21 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.504 ' HE2' ' NE2' ' A' ' 5' ' ' GLN . 20.3 tttt . . . . . 0 N--CA 1.478 0.931 0 CA-C-O 121.51 0.672 . . . . 0.0 109.868 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 1.083 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -158.25 150.87 22.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 1.056 ' N ' HD22 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -121.38 161.59 21.86 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.093 -1.005 . . . . 0.0 109.231 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.621 HG22 HG12 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -124.4 114.94 43.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.253 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.984 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -84.07 64.46 8.2 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -79.21 -79.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.206 -179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.724 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 73.97 85.76 0.26 Allowed Glycine 0 C--N 1.298 -1.571 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.554 HD13 ' HE1' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -49.43 169.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.03 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.922 HG22 HG13 ' A' ' 87' ' ' VAL . 7.1 pt -137.92 78.1 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.271 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.633 ' HB3' HG23 ' A' ' 18' ' ' ILE . 5.7 ptm180 -82.19 137.87 34.82 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.62 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -158.58 0.23 0.09 Allowed 'General case' 0 C--O 1.187 -2.22 0 C-N-CA 116.748 -1.981 . . . . 0.0 114.805 -177.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.537 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 22.0 tt0 -92.85 -32.52 14.59 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 118.246 -2.784 . . . . 0.0 106.923 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.402 ' C ' ' OD1' ' A' ' 15' ' ' ASN . 16.4 t-20 -163.79 -48.49 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 101.844 -3.391 . . . . 0.0 101.844 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.728 HD21 HD12 ' A' ' 110' ' ' LEU . 56.1 t30 -161.74 37.4 0.13 Allowed 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 175.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.537 ' CG ' ' HB3' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -90.17 101.45 14.17 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.013 -177.166 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.633 HG23 ' HB3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -89.34 149.78 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 122.003 0.906 . . . . 0.0 110.518 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.779 ' HB3' HD11 ' A' ' 11' ' ' ILE . 44.7 t80 -82.98 41.94 0.77 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.703 HD11 ' C ' ' A' ' 34' ' ' GLU . 6.3 tp -81.07 156.23 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 122.193 0.996 . . . . 0.0 111.58 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.487 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -64.39 95.05 0.12 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.835 ' HD3' HD21 ' A' ' 33' ' ' LEU . 32.4 tpt180 -104.82 78.95 1.47 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.211 -0.931 . . . . 0.0 111.055 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.87 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 25.33 76.44 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 120.97 0.415 . . . . 0.0 110.706 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.69 -48.53 5.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.43 -0.794 . . . . 0.0 109.07 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.65 154.15 27.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.409 -0.807 . . . . 0.0 108.858 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.71 110.93 1.89 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.047 -1.033 . . . . 0.0 109.16 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.87 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -100.0 149.96 22.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 110.003 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.09 -20.54 52.07 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.424 ' SD ' ' N ' ' A' ' 29' ' ' MET . 2.7 mpp? -97.53 -166.78 1.43 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -156.78 18.65 0.32 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.014 -1.054 . . . . 0.0 110.217 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.0 m-20 -99.67 17.28 20.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.072 -1.017 . . . . 0.0 108.879 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.512 ' HD2' ' CA ' ' A' ' 23' ' ' ARG . 1.1 tttp -81.52 39.5 0.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.386 -0.821 . . . . 0.0 111.124 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.853 HD13 ' CE1' ' A' ' 115' ' ' PHE . 19.9 mt -107.33 91.91 3.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.826 -1.171 . . . . 0.0 109.351 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.703 ' C ' HD11 ' A' ' 20' ' ' ILE . 37.9 tt0 -91.16 -128.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.314 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 17.9 m-85 -157.11 131.91 5.31 Favored Pre-proline 0 N--CA 1.485 1.324 0 O-C-N 120.81 -1.181 . . . . 0.0 109.758 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.7 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.4 Cg_endo -61.01 88.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.51 2.14 . . . . 0.0 110.435 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -54.65 -160.16 0.01 OUTLIER Glycine 0 N--CA 1.494 2.518 0 O-C-N 121.314 -0.866 . . . . 0.0 111.061 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 163.87 -28.85 0.23 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.641 ' CD ' HD23 ' A' ' 4' ' ' LEU . 0.1 OUTLIER 69.91 102.32 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.973 -0.722 . . . . 0.0 111.058 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.984 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -81.54 132.32 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.199 -0.938 . . . . 0.0 108.928 178.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -171.64 -32.55 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 109.739 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.409 ' HB2' ' HA ' ' A' ' 49' ' ' ALA . 8.7 mmt -53.02 161.61 0.78 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 109.744 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.04 -121.13 12.52 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -168.99 25.03 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.496 -1.002 . . . . 0.0 108.925 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.685 HG23 ' HD2' ' A' ' 46' ' ' PRO . 63.4 m -154.24 144.37 15.64 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.685 ' HD2' HG23 ' A' ' 45' ' ' THR . 10.8 Cg_exo -48.37 -16.43 0.68 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.894 1.73 . . . . 0.0 111.443 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.586 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.5 mt-10 -78.6 -72.71 0.36 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.744 -1.222 . . . . 0.0 109.124 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.554 ' HA ' HG12 ' A' ' 51' ' ' VAL . 3.8 mt-30 -56.48 -30.87 63.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.399 -1.438 . . . . 0.0 109.321 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.675 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -67.14 -63.24 1.1 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.475 -0.766 . . . . 0.0 109.816 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.845 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.3 p -67.91 -48.19 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.051 -1.031 . . . . 0.0 110.463 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.6 p -55.73 -42.57 70.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 121.188 0.518 . . . . 0.0 110.334 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 2.4 mmm180 -77.65 -29.79 51.81 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.631 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 21.1 mm-40 -75.75 -11.88 60.08 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.73 HD12 ' CE2' ' A' ' 95' ' ' TRP . 0.7 OUTLIER -80.17 -57.19 3.74 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.755 0.788 . . . . 0.0 108.989 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.507 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -65.38 -42.0 93.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.896 -0.502 . . . . 0.0 110.946 -179.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.595 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -57.57 -24.43 56.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.094 -1.004 . . . . 0.0 111.556 -177.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.57 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -80.21 -83.03 0.11 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.409 -1.432 . . . . 0.0 110.572 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.571 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 74.6 t -80.27 -80.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.037 -1.039 . . . . 0.0 110.007 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.21 32.8 0.1 OUTLIER Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.325 -1.417 . . . . 0.0 110.837 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.053 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.8 pp -94.27 -159.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.809 -1.407 . . . . 0.0 108.419 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.63 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.8 m -135.45 -70.87 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.773 -1.205 . . . . 0.0 110.637 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 2.6 Cg_endo -59.3 -171.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.084 0 C-N-CA 121.487 1.458 . . . . 0.0 110.402 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.584 ' HB2' HG21 ' A' ' 87' ' ' VAL . 2.6 pt20 144.03 -22.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.581 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.3 OUTLIER 43.82 72.12 0.21 Allowed 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -69.54 149.17 48.49 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.836 0.826 . . . . 0.0 110.898 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -143.66 144.91 32.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.84 HD13 ' N ' ' A' ' 69' ' ' GLU . 1.9 tm? -66.29 -68.72 0.35 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.774 -1.204 . . . . 0.0 110.25 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.825 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 81.35 -51.72 0.28 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 -178.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.84 ' N ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER 167.74 179.12 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 109.242 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -159.72 158.01 30.53 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.045 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.781 HD21 HD22 ' A' ' 119' ' ' ASN . 1.1 pp -117.93 -177.26 3.22 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.026 -1.047 . . . . 0.0 110.192 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.677 ' HG3' HG23 ' A' ' 81' ' ' THR . 6.8 tt0 -154.84 89.69 1.25 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.524 ' CE2' ' O ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -79.55 127.12 31.76 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.157 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -100.98 133.84 44.87 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.06 -1.025 . . . . 0.0 109.482 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.538 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -116.9 171.09 5.16 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 108.843 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 6.9 Cg_exo -48.23 -47.24 20.28 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.992 1.794 . . . . 0.0 110.196 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.451 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 5.4 p-10 -141.26 33.05 1.7 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.484 ' O ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -140.15 93.14 2.6 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.554 -0.716 . . . . 0.0 110.32 -179.048 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -82.7 92.94 7.28 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.608 HG22 ' N ' ' A' ' 81' ' ' THR . 0.3 OUTLIER -97.68 163.42 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -0.963 . . . . 0.0 111.26 -177.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.677 HG23 ' HG3' ' A' ' 72' ' ' GLU . 1.3 m -140.46 168.71 19.17 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.716 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -157.31 85.23 0.93 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.539 -1.351 . . . . 0.0 110.595 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.64 ' CD1' HG21 ' A' ' 40' ' ' ILE . 70.6 m95 -58.49 126.56 28.1 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.303 -0.873 . . . . 0.0 109.418 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.775 ' CE2' HG11 ' A' ' 122' ' ' VAL . 19.1 m-85 -101.57 70.73 1.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 0.0 109.878 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.717 ' CE2' HD23 ' A' ' 67' ' ' LEU . 93.6 m95 -74.26 91.25 2.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.943 -1.098 . . . . 0.0 108.983 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.825 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.5 mm? -73.48 126.58 30.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.208 -0.932 . . . . 0.0 110.489 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.922 HG13 HG22 ' A' ' 11' ' ' ILE . 1.5 m -112.02 169.18 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 78.0 mt-10 -149.55 17.37 0.91 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.487 -1.383 . . . . 0.0 112.954 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.605 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.26 67.51 0.36 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.089 -1.632 . . . . 0.0 110.56 178.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.62 ' CH2' ' ND2' ' A' ' 13' ' ' ASN . 1.8 p90 -80.74 164.79 22.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.329 -1.482 . . . . 0.0 109.656 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.667 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.9 OUTLIER -80.86 141.97 34.09 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.477 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 27.92 -80.33 0.0 OUTLIER Glycine 0 N--CA 1.502 3.046 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 1.053 ' O ' HG21 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -100.55 151.7 37.64 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.335 -1.097 . . . . 0.0 109.63 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.636 ' HG2' ' CD1' ' A' ' 19' ' ' PHE . 9.9 Cg_endo -73.94 -158.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.724 2.282 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.904 ' CE2' HD11 ' A' ' 60' ' ' ILE . 0.2 OUTLIER 177.53 112.53 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.644 -0.66 . . . . 0.0 109.784 179.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . 174.47 -40.83 0.13 Allowed Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.405 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.548 ' HB2' ' CG ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -44.4 124.24 3.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.101 -1.235 . . . . 0.0 109.489 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.492 ' OE1' ' HA2' ' A' ' 38' ' ' GLY . 8.2 tp10 -74.7 -111.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.713 -1.242 . . . . 0.0 107.687 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.76 12.25 64.14 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.548 ' CG ' ' HB2' ' A' ' 97' ' ' LYS . 6.4 pt20 -92.97 170.13 9.33 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.696 -0.885 . . . . 0.0 109.495 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -68.69 -48.67 0.95 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.022 1.814 . . . . 0.0 110.281 -179.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.594 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.62 118.52 0.01 OUTLIER Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.605 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 4.5 pt-20 -157.18 145.19 19.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.932 -1.334 . . . . 0.0 110.44 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.4 ' HE1' ' HG3' ' A' ' 94' ' ' PRO . 1.3 m0 -48.58 135.16 14.87 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.499 ' HG2' ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -129.88 112.95 14.05 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.081 -1.012 . . . . 0.0 109.492 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.9 t -78.22 73.33 4.78 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.825 HD13 ' HG ' ' A' ' 110' ' ' LEU . 8.0 tt -80.7 -66.51 0.87 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.433 -0.792 . . . . 0.0 109.792 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.635 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 99.3 t 103.75 98.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 41.98 82.57 0.02 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.825 ' HG ' HD13 ' A' ' 107' ' ' LEU . 2.1 mp -29.96 153.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.962 0.887 . . . . 0.0 111.612 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.638 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -132.38 -6.26 3.35 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.692 -0.63 . . . . 0.0 110.618 -178.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 73.88 -3.26 2.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.217 -0.927 . . . . 0.0 108.806 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.82 -22.31 40.11 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.696 ' HB3' HD12 ' A' ' 33' ' ' LEU . 14.9 m-20 -104.92 -10.42 17.3 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.853 ' CE1' HD13 ' A' ' 33' ' ' LEU . 27.7 m-85 -102.7 144.99 29.72 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.395 -0.815 . . . . 0.0 109.557 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.537 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 2.3 Cg_endo -65.6 151.19 85.41 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.547 2.165 . . . . 0.0 110.94 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.518 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . 1.6 Cg_endo -65.33 -23.75 58.54 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.239 1.959 . . . . 0.0 109.824 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.524 ' O ' ' CE2' ' A' ' 73' ' ' TYR . . . -46.14 -58.49 3.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.384 -0.822 . . . . 0.0 109.686 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.781 HD22 HD21 ' A' ' 71' ' ' LEU . 12.7 m120 -85.82 45.3 1.19 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 108.892 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.651 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 2.6 mt-10 -59.56 -43.66 96.19 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 121.378 -0.826 . . . . 0.0 112.137 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 7.7 Cg_exo -53.18 -36.44 77.3 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.058 1.839 . . . . 0.0 112.537 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.775 HG11 ' CE2' ' A' ' 84' ' ' PHE . 2.0 t -100.42 -38.0 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.611 -1.305 . . . . 0.0 109.707 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.731 ' HA ' HD22 ' A' ' 126' ' ' LEU . 6.8 mt -56.94 -27.54 26.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.49 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -60.7 -39.0 86.9 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 125' ' ' LYS . 13.7 mmtp -76.11 -40.13 53.59 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.212 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.731 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.2 OUTLIER -55.45 -43.23 75.26 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.546 ' HD3' ' CB ' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -39.58 -41.81 1.08 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.997 0.903 . . . . 0.0 108.652 178.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 129' ' ' LEU . 1.0 OUTLIER -79.21 -50.99 10.09 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.687 HD13 ' HA ' ' A' ' 126' ' ' LEU . 1.8 tp . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.608 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.541 ' CG ' ' O ' ' A' ' 79' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 121.7 0.762 . . . . 0.0 110.339 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 5' ' ' GLN . 0.7 OUTLIER -136.1 -171.92 3.0 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.087 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.761 ' HB2' HG23 ' A' ' 40' ' ' ILE . 7.8 mp0 -144.05 177.96 8.2 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.541 HG22 HG12 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -145.65 109.87 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.72 -178.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.034 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -83.0 67.26 9.01 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.753 HG21 ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -78.83 -73.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.177 -0.952 . . . . 0.0 109.385 -179.514 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.721 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 62.61 81.7 0.09 OUTLIER Glycine 0 C--N 1.295 -1.747 0 N-CA-C 107.958 -2.057 . . . . 0.0 107.958 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.48 ' HB ' HD11 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -48.04 172.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.056 HG22 HG22 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -136.73 81.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.121 -178.551 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.949 ' HB3' HG23 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -91.61 134.96 34.23 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.059 -1.026 . . . . 0.0 108.344 179.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.542 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 5.2 p-10 -161.66 62.2 0.26 Allowed 'General case' 0 C--O 1.189 -2.119 0 C-N-CA 117.596 -1.641 . . . . 0.0 113.158 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.589 ' CB ' ' HG3' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -148.7 -49.55 0.15 Allowed 'General case' 0 C--N 1.269 -2.92 0 CA-C-O 124.499 2.095 . . . . 0.0 105.616 176.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -161.17 -48.54 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 100.885 -3.746 . . . . 0.0 100.885 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.489 ' ND2' ' HD2' ' A' ' 12' ' ' ARG . 1.7 t-20 -162.34 42.52 0.13 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.31 -1.768 . . . . 0.0 106.684 175.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.589 ' HG3' ' CB ' ' A' ' 14' ' ' GLU . 9.4 mm-40 -93.46 95.93 9.58 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.962 -1.495 . . . . 0.0 110.901 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.949 HG23 ' HB3' ' A' ' 12' ' ' ARG . 2.7 pt -89.01 153.83 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.637 -0.664 . . . . 0.0 110.362 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.656 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 3.7 t80 -83.15 47.73 1.28 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.692 ' HB ' HD12 ' A' ' 18' ' ' ILE . 5.2 tt -82.36 155.42 3.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.986 0.898 . . . . 0.0 111.299 -177.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.54 HG23 ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -70.07 98.14 1.27 Allowed 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.554 HH22 ' HB1' ' A' ' 30' ' ' ALA . 28.9 tpt180 -104.46 97.3 7.25 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 110.662 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.939 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 24.49 76.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.211 0.529 . . . . 0.0 110.93 179.186 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -44.61 -52.62 7.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.111 -0.993 . . . . 0.0 109.555 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.27 -178.18 6.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.167 -0.958 . . . . 0.0 109.412 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.71 107.06 8.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.24 -0.913 . . . . 0.0 108.934 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.939 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -101.02 171.96 7.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 110.119 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -127.73 16.08 6.94 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.755 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 4.3 mtm -121.29 -106.33 0.37 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.442 -0.786 . . . . 0.0 109.69 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 148.85 -4.32 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.696 -0.627 . . . . 0.0 110.503 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 31' ' ' ASN . 50.3 t-20 -76.27 6.65 5.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.616 -1.302 . . . . 0.0 109.425 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' HD23 ' A' ' 33' ' ' LEU . 4.1 tmtm? -81.29 62.85 5.38 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.535 -0.728 . . . . 0.0 110.857 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.706 HD13 ' CE1' ' A' ' 115' ' ' PHE . 10.6 mt -124.22 90.29 3.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.052 -1.03 . . . . 0.0 109.045 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.54 ' H ' HG23 ' A' ' 21' ' ' THR . 1.2 tt0 -90.23 -144.97 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.903 -1.123 . . . . 0.0 108.794 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.753 ' HB3' HG21 ' A' ' 8' ' ' VAL . 66.7 m-85 -145.93 124.27 6.41 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 120.901 -1.124 . . . . 0.0 110.019 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.685 ' O ' HG23 ' A' ' 8' ' ' VAL . 9.5 Cg_endo -65.79 90.48 0.24 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.194 1.929 . . . . 0.0 110.219 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.665 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -131.0 127.65 5.22 Favored Glycine 0 N--CA 1.494 2.562 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.368 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.557 ' HA2' ' CG ' ' A' ' 98' ' ' GLU . . . -106.65 38.26 3.41 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 120.05 -1.072 . . . . 0.0 111.163 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.513 ' HE3' ' HB2' ' A' ' 4' ' ' LEU . 10.5 tptm 60.24 120.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.777 -0.837 . . . . 0.0 111.433 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.034 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -82.59 133.51 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 42' ' ' MET . 1.8 pt-20 -171.83 -25.64 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.548 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.449 ' HE3' ' HG2' ' A' ' 56' ' ' GLU . 3.3 tpp -54.57 129.65 37.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.856 -1.153 . . . . 0.0 109.27 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.12 -120.78 12.54 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -168.27 22.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.402 -1.058 . . . . 0.0 109.716 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.794 HG22 ' H ' ' A' ' 47' ' ' GLU . 20.6 m -140.9 138.91 18.65 Favored Pre-proline 0 C--O 1.201 -1.486 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.608 ' O ' HG12 ' A' ' 50' ' ' VAL . 8.6 Cg_exo -48.57 -16.52 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.829 1.686 . . . . 0.0 111.344 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.794 ' H ' HG22 ' A' ' 45' ' ' THR . 2.7 mt-10 -80.42 -78.7 0.16 Allowed 'General case' 0 C--O 1.201 -1.491 0 O-C-N 120.587 -1.321 . . . . 0.0 108.61 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.548 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 24.7 mt-30 -50.14 -30.75 11.87 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.389 -1.444 . . . . 0.0 109.364 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.776 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -68.6 -60.36 2.47 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.113 -0.992 . . . . 0.0 110.504 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.766 HG23 ' HB1' ' A' ' 7' ' ' ALA . 4.3 p -70.09 -45.83 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.718 -1.239 . . . . 0.0 110.227 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.583 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 1.4 p -58.12 -47.77 86.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.302 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.583 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -73.48 -36.13 65.78 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.643 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 21.7 mm-40 -65.22 -19.83 66.15 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.133 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -78.31 -63.39 1.41 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.885 -178.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.559 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -58.94 -44.5 91.4 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.356 -0.84 . . . . 0.0 110.092 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.588 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -54.92 -20.71 9.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.108 -0.995 . . . . 0.0 110.193 -179.239 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.429 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mt-10 -80.26 -92.82 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.065 -1.022 . . . . 0.0 109.837 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.593 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 47.9 t -80.21 -78.98 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.346 -0.846 . . . . 0.0 110.045 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.88 27.51 0.13 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 118.599 -1.762 . . . . 0.0 112.723 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.102 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.3 pp -81.49 -144.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 120.181 -1.776 . . . . 0.0 107.582 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.619 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.3 m -143.07 -71.26 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.206 -1.559 . . . . 0.0 110.24 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 9.4 Cg_endo -67.01 -170.01 0.21 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.249 1.3 . . . . 0.0 110.127 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.592 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 136.28 -26.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.535 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.2 OUTLIER 56.64 -163.31 0.17 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.444 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 7.2 p90 177.11 143.75 0.09 Allowed 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.533 -1.267 . . . . 0.0 110.585 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.591 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -144.13 157.06 44.53 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.619 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -74.29 -69.92 0.42 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.251 -0.906 . . . . 0.0 110.856 -178.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.839 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 83.99 -51.85 0.13 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.2 mt-10 157.3 175.05 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HA ' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -161.42 -168.6 2.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.953 -1.092 . . . . 0.0 110.115 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.844 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -147.36 161.41 41.07 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.49 -0.756 . . . . 0.0 109.947 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 80' ' ' ILE . 2.6 tt0 -137.42 90.09 2.48 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.03 119.88 25.47 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.439 -0.788 . . . . 0.0 109.119 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.522 ' HG3' ' HA ' ' A' ' 79' ' ' HIS . 11.1 tt0 -112.2 155.78 23.41 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.318 -0.864 . . . . 0.0 109.824 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.751 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 67.4 m-85 -136.76 -115.22 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.641 0 CA-C-O 117.341 -1.314 . . . . 0.0 109.3 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.751 ' CD ' ' CB ' ' A' ' 75' ' ' PHE . 1.9 Cg_endo -62.44 -43.81 20.9 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 CA-C-N 122.077 1.777 . . . . 0.0 109.895 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -171.4 29.9 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.413 ' HD2' HD11 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -106.91 88.73 2.81 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.488 -0.757 . . . . 0.0 109.933 -179.221 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.541 ' O ' ' CG ' ' A' ' 3' ' ' LYS . 0.3 OUTLIER -79.66 79.84 6.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 108.797 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.61 HD12 ' CD2' ' A' ' 4' ' ' LEU . 2.7 mm -85.0 145.3 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.036 -1.04 . . . . 0.0 110.725 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -120.98 139.43 53.29 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.574 ' CB ' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -124.44 74.07 1.29 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.949 -1.094 . . . . 0.0 109.658 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.451 ' HD1' HG21 ' A' ' 40' ' ' ILE . 80.1 m95 -53.53 114.02 1.37 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.033 -1.042 . . . . 0.0 109.48 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.725 ' CZ ' HG11 ' A' ' 122' ' ' VAL . 32.4 m-85 -89.53 78.11 7.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.138 -0.976 . . . . 0.0 108.379 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.665 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 97.7 m95 -74.37 85.77 1.98 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.014 -1.054 . . . . 0.0 109.228 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.839 HD23 ' CD2' ' A' ' 68' ' ' PHE . 2.5 mm? -68.88 124.91 24.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.397 -1.439 . . . . 0.0 110.061 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.056 HG22 HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -113.01 178.87 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.537 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 13.8 mt-10 -160.16 33.46 0.17 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 118.103 -1.439 . . . . 0.0 112.881 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.565 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -161.02 47.08 0.21 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 119.803 -1.811 . . . . 0.0 112.404 179.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.609 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 1.4 p90 -70.57 160.69 32.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 119.863 -1.773 . . . . 0.0 108.991 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -90.29 146.5 24.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.189 -0.944 . . . . 0.0 108.614 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.453 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . 35.94 -82.33 0.0 OUTLIER Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 1.102 ' O ' HG21 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -112.25 157.77 39.0 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.334 -1.097 . . . . 0.0 110.009 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.624 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 9.0 Cg_endo -76.21 -159.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.993 2.462 . . . . 0.0 110.614 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 1.133 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -177.87 39.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.862 -1.149 . . . . 0.0 111.189 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -124.81 -7.57 6.05 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.021 -1.562 . . . . 0.0 111.497 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.556 ' HD2' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -63.44 103.72 0.55 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.717 -1.461 . . . . 0.0 110.998 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.557 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 9.6 tp10 -70.14 92.43 0.75 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -0.99 . . . . 0.0 108.509 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.22 14.99 42.67 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.505 ' HG2' ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -96.69 146.56 31.52 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.6 -0.941 . . . . 0.0 109.027 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.567 ' O ' ' O ' ' A' ' 102' ' ' GLY . 4.9 Cg_exo -58.63 -21.38 55.12 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 N-CA-C 108.385 -1.429 . . . . 0.0 108.385 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.656 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 37.13 105.03 0.01 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -141.43 131.39 24.52 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.382 -1.658 . . . . 0.0 110.483 179.309 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.434 ' C ' ' O ' ' A' ' 103' ' ' GLU . 1.6 m0 -46.17 129.26 10.05 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.541 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -123.4 117.07 24.35 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.623 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.33 63.31 5.6 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.811 HD13 ' HG ' ' A' ' 110' ' ' LEU . 6.9 tt -69.06 -54.06 17.09 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.59 -0.693 . . . . 0.0 110.118 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.678 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 66.6 t 85.32 108.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 129' ' ' LEU . . . 46.87 82.51 0.03 OUTLIER Glycine 0 N--CA 1.486 1.968 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 -178.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.811 ' HG ' HD13 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -34.48 160.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.981 0.896 . . . . 0.0 111.738 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -156.59 141.42 17.04 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.65 ' HB2' ' HD3' ' A' ' 127' ' ' LYS . . . -65.93 -22.34 66.49 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.92 -25.19 4.29 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.604 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -108.17 -18.77 13.69 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.706 ' CE1' HD13 ' A' ' 33' ' ' LEU . 44.5 m-85 -100.54 149.64 36.29 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.881 . . . . 0.0 110.605 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.439 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -66.95 144.77 71.67 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.518 2.145 . . . . 0.0 109.941 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 1.6 Cg_endo -64.35 -28.22 63.27 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.997 1.798 . . . . 0.0 110.15 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -43.05 -41.08 3.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 109.892 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.415 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 9.3 m120 -108.71 55.72 0.63 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.246 -0.909 . . . . 0.0 109.357 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.681 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -71.76 -35.96 4.05 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.555 -0.715 . . . . 0.0 112.585 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.9 Cg_exo -59.07 -31.37 95.45 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.653 1.569 . . . . 0.0 113.174 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.725 HG11 ' CZ ' ' A' ' 84' ' ' PHE . 1.8 t -99.97 -38.58 6.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.376 -1.452 . . . . 0.0 109.342 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.785 HD13 HD23 ' A' ' 126' ' ' LEU . 2.0 mm -58.86 -37.31 66.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.515 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -39.74 -37.3 0.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.144 0.973 . . . . 0.0 108.946 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.485 ' HE2' ' OE2' ' A' ' 69' ' ' GLU . 7.2 mmtm -81.65 -47.33 13.14 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.802 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.785 HD23 HD13 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -64.62 -10.33 25.77 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.378 -1.451 . . . . 0.0 109.093 179.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.65 ' HD3' ' HB2' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -68.75 -37.71 79.58 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -12.29 59.81 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.333 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.59 HD21 ' CZ ' ' A' ' 12' ' ' ARG . 3.0 tp . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.79 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.522 ' HG2' ' N ' ' A' ' 4' ' ' LEU . 6.1 ttpt . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 121.509 0.671 . . . . 0.0 109.991 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 1.095 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -154.11 156.06 36.54 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.069 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.912 ' N ' HD22 ' A' ' 4' ' ' LEU . 14.1 mp0 -124.94 173.66 8.49 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.027 -1.046 . . . . 0.0 108.531 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.713 HG22 HG12 ' A' ' 8' ' ' VAL . 1.1 mm -136.47 110.14 9.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.704 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.881 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -84.63 62.17 7.17 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 36' ' ' PRO . 1.1 p -78.29 -70.0 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.363 -0.835 . . . . 0.0 109.902 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.734 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 59.82 80.82 0.09 OUTLIER Glycine 0 C--N 1.297 -1.615 0 N-CA-C 107.055 -2.418 . . . . 0.0 107.055 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -48.4 170.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -178.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.688 HD11 ' CB ' ' A' ' 19' ' ' PHE . 7.7 pt -137.67 99.84 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 C-N-CA 119.406 -0.918 . . . . 0.0 108.768 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.77 ' HG2' HG22 ' A' ' 18' ' ' ILE . 13.3 mtm180 -76.68 -176.54 3.85 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.613 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -157.17 -61.42 0.09 Allowed 'General case' 0 C--O 1.191 -2.01 0 C-N-CA 116.957 -1.897 . . . . 0.0 114.527 -177.457 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.621 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 1.9 tt0 -93.3 -30.12 15.31 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 119.038 -2.289 . . . . 0.0 111.435 -175.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -160.85 -43.52 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.804 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.57 ' OD1' HD23 ' A' ' 129' ' ' LEU . 14.1 t30 -158.32 34.99 0.24 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 177.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.621 ' HG3' ' HB3' ' A' ' 14' ' ' GLU . 2.4 mt-10 -78.74 83.77 4.87 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 117.965 -1.494 . . . . 0.0 108.764 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.77 HG22 ' HG2' ' A' ' 12' ' ' ARG . 4.7 pt -80.08 142.54 13.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 119.684 -0.807 . . . . 0.0 109.425 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.713 ' CZ ' ' HG2' ' A' ' 94' ' ' PRO . 10.2 t80 -80.19 42.9 0.59 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.699 -0.626 . . . . 0.0 109.544 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.79 HG21 HD22 ' A' ' 33' ' ' LEU . 6.8 tp -82.11 155.62 4.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 122.012 0.91 . . . . 0.0 111.579 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.769 HG23 ' O ' ' A' ' 21' ' ' THR . 7.6 t -64.92 96.48 0.19 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.739 ' HD3' HD21 ' A' ' 33' ' ' LEU . 27.1 tpt180 -98.16 87.44 3.93 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.423 -0.798 . . . . 0.0 110.257 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.75 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 36.79 84.43 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.896 -0.503 . . . . 0.0 109.969 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.59 -51.78 5.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.377 -0.827 . . . . 0.0 109.092 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.89 -160.48 0.16 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -76.17 -43.66 41.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.019 -1.051 . . . . 0.0 109.307 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.75 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . 52.89 110.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.35 -0.844 . . . . 0.0 110.24 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -78.96 -6.13 55.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.981 -1.074 . . . . 0.0 108.981 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.728 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 3.1 mpp? -86.81 -124.64 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.188 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 161.49 -2.33 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.833 -1.167 . . . . 0.0 111.647 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 3.8 p-10 -81.96 13.11 3.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.239 -1.538 . . . . 0.0 109.115 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.599 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -81.41 58.99 3.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.599 -0.688 . . . . 0.0 110.322 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.79 HD22 HG21 ' A' ' 20' ' ' ILE . 14.4 mt -130.61 85.46 2.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.945 -1.097 . . . . 0.0 109.097 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.584 ' C ' HD11 ' A' ' 20' ' ' ILE . 3.2 tt0 -92.94 -127.63 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -0.975 . . . . 0.0 108.879 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.673 ' HB2' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -151.9 134.54 8.81 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.942 -1.099 . . . . 0.0 108.46 178.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.736 ' O ' HG23 ' A' ' 8' ' ' VAL . 4.5 Cg_endo -62.09 92.91 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.924 1.749 . . . . 0.0 109.541 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.528 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -54.56 -152.86 0.01 OUTLIER Glycine 0 N--CA 1.493 2.455 0 CA-C-O 122.051 0.806 . . . . 0.0 111.378 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.593 ' N ' ' CG ' ' A' ' 98' ' ' GLU . . . 162.07 -26.35 0.25 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.534 ' HE3' ' HB2' ' A' ' 4' ' ' LEU . 15.7 tptm 64.09 96.94 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.933 -0.745 . . . . 0.0 110.183 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.881 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -80.4 133.17 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.206 -0.933 . . . . 0.0 108.574 178.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.495 ' HG2' ' N ' ' A' ' 42' ' ' MET . 2.9 pt-20 -170.6 -32.88 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.464 -0.773 . . . . 0.0 109.721 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.495 ' N ' ' HG2' ' A' ' 41' ' ' GLU . 8.0 mtt -59.17 166.43 2.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.203 -0.936 . . . . 0.0 109.696 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 51.66 -125.77 27.12 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -169.38 26.66 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.448 -1.03 . . . . 0.0 109.2 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.783 HG22 ' H ' ' A' ' 47' ' ' GLU . 18.5 m -155.32 141.63 13.11 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.697 ' O ' HG12 ' A' ' 50' ' ' VAL . 15.0 Cg_exo -45.66 -18.44 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.072 1.848 . . . . 0.0 111.176 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.783 ' H ' HG22 ' A' ' 45' ' ' THR . 3.4 mt-10 -77.49 -80.64 0.1 Allowed 'General case' 0 C--O 1.2 -1.541 0 O-C-N 120.827 -1.171 . . . . 0.0 108.773 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.542 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 38.0 mt-30 -48.65 -32.84 8.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.307 -1.496 . . . . 0.0 109.287 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.801 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -65.81 -62.75 1.33 Allowed 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.367 -0.833 . . . . 0.0 110.437 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.881 HG23 ' HB1' ' A' ' 7' ' ' ALA . 4.3 p -70.23 -44.24 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.724 -1.235 . . . . 0.0 110.641 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.4 p -59.4 -43.49 90.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 121.769 -0.582 . . . . 0.0 110.326 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.1 OUTLIER -73.58 -48.19 34.69 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.624 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 7.7 mm-40 -59.95 -18.63 46.82 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.8 HD23 ' O ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -78.8 -65.36 1.0 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.582 0.706 . . . . 0.0 109.479 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -52.45 -55.53 21.25 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.48 -0.762 . . . . 0.0 109.052 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.624 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -43.44 -32.8 0.94 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 109.325 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -76.32 -90.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.452 -0.78 . . . . 0.0 109.656 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.661 HG21 ' HA ' ' A' ' 95' ' ' TRP . 4.9 t -80.03 -78.17 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 121.016 -1.053 . . . . 0.0 109.372 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.65 56.1 0.14 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.205 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.873 HG21 ' O ' ' A' ' 93' ' ' GLU . 2.5 pp -107.73 -140.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 120.757 -1.437 . . . . 0.0 109.024 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.634 ' N ' HD12 ' A' ' 60' ' ' ILE . 2.5 m -159.84 -67.19 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.276 0 O-C-N 119.754 -1.841 . . . . 0.0 112.535 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.656 ' HD2' ' HB3' ' A' ' 91' ' ' GLU . 11.5 Cg_exo -43.17 -67.12 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 122.265 1.977 . . . . 0.0 110.704 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.765 ' HB2' ' CE2' ' A' ' 95' ' ' TRP . 0.8 OUTLIER 29.65 27.71 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 114.603 -1.181 . . . . 0.0 113.638 178.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.631 ' C ' ' O ' ' A' ' 63' ' ' GLN . 20.2 t-160 -14.03 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.738 0 CA-C-N 120.181 1.355 . . . . 0.0 110.119 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.611 ' N ' ' O ' ' A' ' 63' ' ' GLN . 3.3 p90 -75.71 146.97 39.74 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.92 0.867 . . . . 0.0 112.377 -175.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 86' ' ' LEU . 4.6 m -148.59 151.47 35.1 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.688 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -80.24 -66.96 0.81 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.769 -1.207 . . . . 0.0 109.836 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.886 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 86.32 -56.81 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER 159.71 142.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.602 ' HE3' ' CD2' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -124.45 172.43 9.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.549 -0.719 . . . . 0.0 110.833 -178.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.658 ' HB3' HG23 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -121.11 176.72 5.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.819 . . . . 0.0 109.428 178.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.485 ' HG3' HG23 ' A' ' 81' ' ' THR . 7.3 tt0 -152.88 85.89 1.24 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.89 148.33 31.34 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -114.58 171.76 7.44 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.766 -1.174 . . . . 0.0 110.277 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.685 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -142.44 -177.14 0.62 Allowed Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.685 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.0 Cg_exo -57.12 -27.83 76.09 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.469 1.446 . . . . 0.0 109.75 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.475 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 56.5 p30 -169.98 36.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.525 ' O ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -136.61 96.52 3.36 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.663 -0.648 . . . . 0.0 109.564 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.575 ' C ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -82.13 116.43 21.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.391 -0.818 . . . . 0.0 109.501 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.582 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -115.65 144.78 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.001 -1.062 . . . . 0.0 110.586 -179.282 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.547 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 0.9 OUTLIER -129.99 142.3 50.65 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.701 HD21 HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -127.43 80.8 1.98 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.634 -1.291 . . . . 0.0 110.671 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.644 ' CD1' HG21 ' A' ' 40' ' ' ILE . 82.0 m95 -51.62 108.93 0.3 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.172 -0.955 . . . . 0.0 109.161 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.632 ' CE1' HG11 ' A' ' 122' ' ' VAL . 12.1 m-85 -87.46 70.88 9.91 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.215 -0.928 . . . . 0.0 109.684 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.689 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 13.6 m95 -70.51 83.63 0.59 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.91 -1.119 . . . . 0.0 108.791 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.886 HD23 ' CD2' ' A' ' 68' ' ' PHE . 2.9 mm? -71.87 124.91 25.88 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.41 -1.431 . . . . 0.0 110.242 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.638 HG13 HG22 ' A' ' 11' ' ' ILE . 1.5 m -112.31 -178.4 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.638 ' N ' HG23 ' A' ' 87' ' ' VAL . 54.4 mt-10 -155.99 6.24 0.2 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 117.869 -1.533 . . . . 0.0 112.361 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.589 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -153.23 64.51 0.76 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.209 -1.557 . . . . 0.0 110.51 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.613 ' CH2' ' HB2' ' A' ' 13' ' ' ASN . 8.3 p90 -73.93 159.36 32.88 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.796 -1.19 . . . . 0.0 110.039 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.656 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 0.8 OUTLIER -78.02 138.11 38.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.407 -0.808 . . . . 0.0 109.347 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 30.42 -82.0 0.0 OUTLIER Glycine 0 N--CA 1.5 2.939 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.873 ' O ' HG21 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -88.37 158.33 49.1 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.188 -1.184 . . . . 0.0 109.874 -179.393 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.713 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 15.5 Cg_endo -71.41 -156.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.864 2.376 . . . . 0.0 110.332 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.765 ' CE2' ' HB2' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -178.67 120.11 0.08 Allowed 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.324 -0.86 . . . . 0.0 110.167 179.508 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.473 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . 145.25 -48.02 0.72 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.431 -1.842 . . . . 0.0 111.487 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.63 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -39.36 118.18 0.79 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -1.177 . . . . 0.0 110.466 -178.356 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.593 ' CG ' ' N ' ' A' ' 38' ' ' GLY . 3.4 mm-40 -73.31 -143.54 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.41 ' H ' ' HB3' ' A' ' 98' ' ' GLU . . . -53.04 -18.57 6.28 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.96 165.62 12.5 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.38 -1.071 . . . . 0.0 110.749 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.498 ' HG2' ' OG1' ' A' ' 21' ' ' THR . 2.1 Cg_endo -69.05 -60.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.666 2.244 . . . . 0.0 110.006 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.603 ' O ' ' CE1' ' A' ' 19' ' ' PHE . . . 76.22 121.61 0.16 Allowed Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.6 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 5.9 pt-20 -156.29 134.18 11.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.391 -1.064 . . . . 0.0 110.048 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.532 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 1.1 m0 -46.53 133.83 9.81 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.618 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 4.9 tpt -117.98 114.35 23.04 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.031 -1.043 . . . . 0.0 109.432 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.6 t -80.39 61.07 4.03 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.827 HD13 ' HG ' ' A' ' 110' ' ' LEU . 4.7 tt -77.61 -49.1 15.27 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.57 ' CB ' ' O ' ' A' ' 107' ' ' LEU . 21.2 t 89.91 101.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-O 121.568 0.699 . . . . 0.0 109.267 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 46.77 84.57 0.02 OUTLIER Glycine 0 N--CA 1.484 1.85 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.827 ' HG ' HD13 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -37.58 162.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.918 -0.754 . . . . 0.0 110.475 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.694 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 6.0 t-20 -138.73 -8.13 1.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 111.339 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 81.74 -18.06 0.51 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.183 -0.948 . . . . 0.0 108.614 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.0 -21.17 66.81 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.778 ' HB3' HD12 ' A' ' 33' ' ' LEU . 13.0 m-20 -104.96 -15.47 15.12 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.824 ' CE1' HD21 ' A' ' 110' ' ' LEU . 3.2 m-85 -91.42 133.44 31.37 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.151 -0.968 . . . . 0.0 109.121 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.1 131.56 43.5 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 121.398 1.399 . . . . 0.0 108.617 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 3.3 Cg_exo -52.99 -22.04 17.46 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.365 2.043 . . . . 0.0 112.181 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.08 -39.07 68.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.723 -1.235 . . . . 0.0 109.552 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.562 ' O ' HD13 ' A' ' 123' ' ' ILE . 25.8 p30 -96.26 45.12 1.07 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.444 -0.785 . . . . 0.0 109.69 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.66 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.2 mt-10 -70.25 -33.15 3.15 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 113.191 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.2 Cg_exo -55.96 -47.83 22.9 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.218 1.279 . . . . 0.0 112.801 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.658 HG23 ' HB3' ' A' ' 71' ' ' LEU . 1.9 t -92.91 -33.93 5.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 120.531 -1.355 . . . . 0.0 109.489 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 1.009 ' HA ' HD22 ' A' ' 126' ' ' LEU . 1.7 mp -66.56 -20.84 27.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -58.55 -29.47 66.38 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 125' ' ' LYS . 0.4 OUTLIER -80.38 -37.96 31.29 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.915 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 1.009 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.83 -24.78 66.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.461 -1.399 . . . . 0.0 107.336 178.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.54 ' HD3' ' CB ' ' A' ' 112' ' ' ALA . 1.5 mtmp? -55.17 -35.73 65.09 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.459 ' O ' ' C ' ' A' ' 129' ' ' LEU . 1.9 mtp180 -83.93 -24.6 30.65 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.524 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 2.1 tp . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.069 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.434 ' HG3' ' HB3' ' A' ' 79' ' ' HIS . 4.9 ttpt . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 5' ' ' GLN . 0.5 OUTLIER -140.95 177.26 8.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.244 -0.91 . . . . 0.0 109.535 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.63 ' HB2' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -141.55 174.27 10.72 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.701 HG22 HG12 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -141.81 124.69 14.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 O-C-N 121.019 -1.051 . . . . 0.0 109.821 -178.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.951 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -87.0 60.12 6.03 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.973 HG23 ' O ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -78.63 -87.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.79 -178.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.749 ' N ' HG22 ' A' ' 8' ' ' VAL . . . 75.63 88.85 0.25 Allowed Glycine 0 C--N 1.297 -1.625 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.573 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -49.33 175.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.031 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.038 HG22 HG22 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -143.9 92.09 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.577 -1.249 . . . . 0.0 110.349 -178.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.748 ' HG2' HG22 ' A' ' 18' ' ' ILE . 8.8 mtm180 -75.62 174.09 10.19 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.562 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -161.14 -46.19 0.04 OUTLIER 'General case' 0 C--O 1.191 -2.017 0 C-N-CA 115.744 -2.382 . . . . 0.0 115.142 -177.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.514 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 1.5 tp10 -92.4 -27.97 17.17 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 118.64 -2.537 . . . . 0.0 110.369 -176.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -163.22 -45.21 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.576 ' ND2' ' HD2' ' A' ' 12' ' ' ARG . 0.7 OUTLIER -160.04 35.42 0.18 Allowed 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 177.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 105' ' ' MET . 17.4 mt-10 -84.54 94.08 8.49 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.098 -1.441 . . . . 0.0 110.046 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.748 HG22 ' HG2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -83.03 142.75 13.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.579 -0.701 . . . . 0.0 109.374 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.639 ' CD1' ' CG ' ' A' ' 94' ' ' PRO . 70.1 t80 -82.2 46.36 1.02 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.681 HD11 ' C ' ' A' ' 34' ' ' GLU . 6.7 tp -81.9 151.83 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-O 122.256 1.027 . . . . 0.0 112.016 -177.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.508 ' OG1' ' HG2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -63.88 90.45 0.06 Allowed 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.616 ' HD3' HD21 ' A' ' 33' ' ' LEU . 28.7 tpt180 -89.49 106.04 18.19 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.135 -0.978 . . . . 0.0 109.73 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.6 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 3.22 76.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 121.317 0.58 . . . . 0.0 110.865 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -39.35 -53.85 1.93 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.25 0.547 . . . . 0.0 109.965 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.54 -177.1 5.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.015 -1.053 . . . . 0.0 109.243 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -80.05 77.35 6.75 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.222 -0.924 . . . . 0.0 109.668 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.415 ' HB3' ' CD ' ' A' ' 23' ' ' ARG . . . -56.79 -31.23 64.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.92 . . . . 0.0 109.357 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.412 ' C ' ' SD ' ' A' ' 29' ' ' MET . 3.5 t60 67.97 8.12 6.26 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.343 -0.848 . . . . 0.0 109.104 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.751 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -120.03 -101.0 0.43 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.276 -0.89 . . . . 0.0 109.096 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 152.31 -10.49 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.703 -0.623 . . . . 0.0 110.329 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 12.2 m120 -78.35 6.03 9.25 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.893 -1.129 . . . . 0.0 109.646 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.514 ' O ' ' HD2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -81.91 47.21 1.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.393 -0.817 . . . . 0.0 110.415 -179.578 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.698 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 13.2 mt -117.84 91.03 3.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.851 -1.156 . . . . 0.0 109.125 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.681 ' C ' HD11 ' A' ' 20' ' ' ILE . 11.9 tt0 -90.31 -127.56 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.496 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.533 ' CG ' ' C ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -155.75 128.89 4.34 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.882 -1.136 . . . . 0.0 109.382 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.973 ' O ' HG23 ' A' ' 8' ' ' VAL . 9.6 Cg_endo -69.79 97.85 0.66 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.055 1.837 . . . . 0.0 109.462 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.571 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -109.28 -173.55 21.03 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.308 -1.425 . . . . 0.0 111.455 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.542 ' HA2' ' OE1' ' A' ' 98' ' ' GLU . . . -163.74 20.35 0.15 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.475 ' O ' ' OE2' ' A' ' 53' ' ' GLU . 1.9 tptm 58.83 108.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.528 -0.984 . . . . 0.0 110.106 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.951 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -82.02 130.63 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.825 -1.172 . . . . 0.0 109.227 178.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -173.66 -26.07 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.088 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.67 153.48 0.8 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.977 -1.077 . . . . 0.0 109.272 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 46.87 -117.04 2.76 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -170.95 23.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.471 -1.017 . . . . 0.0 109.621 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 47' ' ' GLU . 84.5 m -140.41 139.67 21.15 Favored Pre-proline 0 C--O 1.203 -1.385 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.585 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 6.3 Cg_exo -50.26 -19.07 4.01 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 121.1 1.2 . . . . 0.0 110.128 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.695 ' H ' HG22 ' A' ' 45' ' ' THR . 1.6 mt-10 -79.71 -86.83 0.07 Allowed 'General case' 0 C--O 1.201 -1.481 0 O-C-N 121.108 -0.995 . . . . 0.0 108.536 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.589 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 15.7 mt-30 -43.09 -29.48 0.36 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.704 -1.247 . . . . 0.0 110.081 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.619 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -72.04 -60.99 1.95 Allowed 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.418 -0.801 . . . . 0.0 109.83 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.937 ' O ' HD23 ' A' ' 54' ' ' LEU . 3.8 p -66.84 -45.94 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.008 -1.058 . . . . 0.0 110.184 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.574 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 2.2 p -60.15 -46.89 93.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-O 121.239 0.542 . . . . 0.0 109.662 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.589 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 8.0 mmm180 -74.1 -21.61 59.83 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.599 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 26.5 mm-40 -78.3 -19.7 53.03 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.075 HD12 ' CD1' ' A' ' 95' ' ' TRP . 2.1 mm? -79.87 -42.03 25.06 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.166 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.635 ' HG2' ' CZ3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -79.91 -42.78 23.43 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.599 -0.688 . . . . 0.0 109.467 -179.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.559 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 1.1 pp20? -57.68 -23.27 50.68 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.545 -0.722 . . . . 0.0 110.01 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.5 ' OE2' ' HA3' ' A' ' 38' ' ' GLY . 9.1 mt-10 -80.24 -92.08 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.982 -1.074 . . . . 0.0 110.456 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.631 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 22.2 t -80.07 -78.93 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.486 -0.759 . . . . 0.0 110.745 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.36 35.57 0.14 Allowed Glycine 0 N--CA 1.496 2.698 0 C-N-CA 118.572 -1.775 . . . . 0.0 112.783 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.114 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.1 pp -91.13 -145.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 120.276 -1.72 . . . . 0.0 107.127 177.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.629 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.5 m -141.26 -73.45 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.256 -1.528 . . . . 0.0 110.496 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 6.2 Cg_endo -64.54 -171.5 0.16 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.105 1.203 . . . . 0.0 110.781 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.555 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 149.41 -23.14 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.564 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 13.5 t-160 43.91 80.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.51 ' CZ ' ' HG2' ' A' ' 47' ' ' GLU . 49.6 p90 -76.32 145.02 39.85 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.621 0.724 . . . . 0.0 110.373 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -141.58 142.54 33.48 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.638 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -67.18 -69.73 0.29 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.812 -1.18 . . . . 0.0 110.475 -179.146 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.745 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 83.99 -51.66 0.13 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.2 mt-10 170.31 177.27 0.05 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.592 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -161.16 173.18 15.5 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 109.675 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.684 HD21 ' OD1' ' A' ' 119' ' ' ASN . 0.3 OUTLIER -141.15 178.41 7.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.145 -0.972 . . . . 0.0 110.596 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -151.41 93.94 1.95 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -79.5 129.68 34.7 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.539 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 4.8 tt0 -101.25 106.05 17.21 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.146 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.539 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -81.22 171.07 13.11 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.219 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 9.5 Cg_exo -47.33 -29.62 9.97 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.972 1.781 . . . . 0.0 109.999 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -162.53 28.28 0.1 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.472 ' HD3' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -134.36 90.95 2.73 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.791 -0.568 . . . . 0.0 109.961 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.662 ' C ' HD12 ' A' ' 80' ' ' ILE . 1.9 t-160 -86.3 110.17 19.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.101 -1.0 . . . . 0.0 108.513 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.662 HD12 ' C ' ' A' ' 79' ' ' HIS . 0.8 OUTLIER -112.56 152.31 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.137 -0.977 . . . . 0.0 110.426 -178.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.577 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 4.1 m -125.98 137.23 53.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.892 ' CD2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -128.62 79.64 1.92 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.594 -1.317 . . . . 0.0 110.775 -179.287 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.592 ' CE3' ' HD2' ' A' ' 70' ' ' LYS . 94.3 m95 -51.16 108.82 0.28 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.994 -1.066 . . . . 0.0 108.838 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.783 ' CD2' HG11 ' A' ' 122' ' ' VAL . 12.4 m-85 -82.36 69.32 9.08 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.053 -1.03 . . . . 0.0 109.947 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.652 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 97.5 m95 -71.95 82.8 0.94 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.06 -1.025 . . . . 0.0 109.692 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.745 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.0 mm? -67.05 124.17 22.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.459 -1.4 . . . . 0.0 109.631 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.038 HG22 HG22 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -109.14 177.32 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 70.0 mt-10 -154.59 18.85 0.47 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 117.69 -1.604 . . . . 0.0 113.504 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.564 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -161.08 62.11 0.29 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 119.618 -1.926 . . . . 0.0 112.155 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.705 ' HB2' HD13 ' A' ' 60' ' ' ILE . 6.6 p90 -81.09 158.52 25.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.331 -1.481 . . . . 0.0 108.79 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.574 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -91.63 145.39 24.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.953 -1.092 . . . . 0.0 110.235 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 45.64 -87.44 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 1.114 ' O ' HG21 ' A' ' 60' ' ' ILE . 8.1 pt-20 -111.37 161.44 25.26 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.316 -1.108 . . . . 0.0 109.647 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.639 ' CG ' ' CD1' ' A' ' 19' ' ' PHE . 7.0 Cg_endo -74.68 -161.06 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.554 2.169 . . . . 0.0 109.594 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 1.075 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER 179.02 33.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.111 -0.993 . . . . 0.0 110.793 178.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -117.65 6.14 16.31 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.269 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.624 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 8.0 pttt -79.99 147.59 31.49 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.113 -1.227 . . . . 0.0 110.046 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.542 ' OE1' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -82.18 37.26 0.49 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.53 -0.731 . . . . 0.0 109.658 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.81 -10.54 73.4 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.594 ' CB ' ' CD ' ' A' ' 101' ' ' PRO . 11.8 pt20 -64.49 -172.14 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.451 -1.029 . . . . 0.0 108.677 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 100' ' ' GLN . 4.2 Cg_exo -65.65 -55.88 0.39 Allowed 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.122 1.215 . . . . 0.0 109.351 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.61 ' O ' ' CE1' ' A' ' 19' ' ' PHE . . . 57.26 115.38 0.01 OUTLIER Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 2.9 pt-20 -153.26 133.47 13.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.836 -1.391 . . . . 0.0 110.303 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.455 ' C ' ' O ' ' A' ' 103' ' ' GLU . 3.7 m0 -44.43 136.54 4.11 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -130.26 113.88 14.96 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.267 -179.378 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.65 51.11 1.62 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.486 0.66 . . . . 0.0 109.507 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.844 HD21 ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -65.42 -41.56 93.43 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.801 ' N ' HD23 ' A' ' 107' ' ' LEU . 48.9 t 79.61 116.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.984 -0.447 . . . . 0.0 110.332 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . 39.3 83.55 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 1.106 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -38.65 160.57 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.766 -0.843 . . . . 0.0 110.755 -178.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.672 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 11.4 t30 -136.34 -4.81 2.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.483 -0.761 . . . . 0.0 110.932 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 74.91 -4.09 2.45 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.09 -1.006 . . . . 0.0 108.768 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.54 -32.93 36.6 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.584 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -93.19 -11.21 33.27 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 1.106 ' CE1' HD21 ' A' ' 110' ' ' LEU . 5.0 m-85 -98.41 152.62 38.03 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.488 -0.758 . . . . 0.0 109.937 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.508 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 2.8 Cg_endo -68.79 135.44 32.85 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.198 1.932 . . . . 0.0 109.348 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 118' ' ' ALA . 6.3 Cg_exo -59.85 -27.7 85.53 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 121.89 1.727 . . . . 0.0 110.852 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -43.1 -51.18 5.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.107 -0.996 . . . . 0.0 109.572 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.684 ' OD1' HD21 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -88.25 48.46 1.64 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.457 -0.777 . . . . 0.0 109.23 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.676 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -63.33 -41.85 70.82 Favored Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.787 -0.571 . . . . 0.0 112.013 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 8.0 Cg_exo -51.86 -39.18 68.72 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 121.889 1.726 . . . . 0.0 113.088 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.783 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.7 t -100.51 -37.91 6.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 120.446 -1.409 . . . . 0.0 110.037 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.85 ' HA ' HD22 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -60.94 -21.96 25.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.493 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -62.75 -34.52 77.39 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.483 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 9.4 mmtm -79.71 -38.51 33.27 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.982 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.85 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.2 OUTLIER -59.24 -40.51 86.13 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -38.84 -37.16 0.32 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.09 0.947 . . . . 0.0 108.767 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.514 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -80.03 -51.81 8.58 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.287 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.603 ' CD2' ' NH1' ' A' ' 12' ' ' ARG . 2.5 tp . . . . . 0 N--CA 1.505 2.294 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.66 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 4' ' ' LEU . 2.7 tttt . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.521 ' N ' ' HG3' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -149.56 168.4 23.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.112 178.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.859 ' HB2' HG23 ' A' ' 40' ' ' ILE . 1.6 mp0 -142.52 171.35 14.17 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.652 HG22 HG12 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -138.36 115.62 11.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 C-N-CA 118.969 -1.092 . . . . 0.0 109.624 -179.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.956 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -84.39 63.68 7.94 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.714 HG13 ' H ' ' A' ' 9' ' ' GLY . 0.7 OUTLIER -79.06 -77.44 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.381 -0.825 . . . . 0.0 110.345 -178.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.714 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 67.59 88.26 0.07 OUTLIER Glycine 0 C--N 1.296 -1.68 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 -177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.573 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -50.19 176.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.846 HG22 HG22 ' A' ' 87' ' ' VAL . 2.5 pt -142.54 77.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 C-N-CA 117.856 -1.537 . . . . 0.0 111.087 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.634 ' HB3' HG23 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -78.89 158.68 28.03 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 177.17 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.514 ' CG ' ' CZ3' ' A' ' 90' ' ' TRP . 12.1 p-10 -160.61 -24.33 0.06 Allowed 'General case' 0 C--O 1.188 -2.143 0 C-N-CA 115.608 -2.437 . . . . 0.0 115.5 -177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.541 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 20.6 tt0 -93.51 -27.0 16.91 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 118.05 -2.906 . . . . 0.0 108.911 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.44 -48.74 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.491 ' ND2' HD23 ' A' ' 107' ' ' LEU . 60.9 t-20 -162.95 38.09 0.1 Allowed 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.618 ' HA ' ' O ' ' A' ' 105' ' ' MET . 19.8 mt-10 -84.06 88.5 7.18 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 117.92 -1.512 . . . . 0.0 109.973 -177.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.634 HG23 ' HB3' ' A' ' 12' ' ' ARG . 1.5 pt -82.5 147.24 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.964 0.888 . . . . 0.0 111.167 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.62 ' CE1' ' HG2' ' A' ' 94' ' ' PRO . 12.7 t80 -82.58 45.28 0.96 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.622 HD11 ' N ' ' A' ' 34' ' ' GLU . 4.3 tp -80.42 151.35 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.85 0.833 . . . . 0.0 110.645 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.505 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -71.11 88.43 0.8 Allowed 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.591 ' O ' ' C ' ' A' ' 23' ' ' ARG . 28.2 tpt180 -86.2 94.56 9.33 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.53 -0.731 . . . . 0.0 110.373 -178.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.591 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 17.89 75.97 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.142 0.496 . . . . 0.0 110.346 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -39.36 -55.72 1.69 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.608 -0.683 . . . . 0.0 110.168 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.46 -147.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.158 -0.964 . . . . 0.0 108.988 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.712 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 77.4 m-20 -79.88 -60.77 2.21 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.026 -1.046 . . . . 0.0 109.128 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 26' ' ' ASP . . . 81.78 -28.33 0.12 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.435 -0.791 . . . . 0.0 110.715 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER 49.15 25.3 1.13 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.413 ' N ' ' C ' ' A' ' 27' ' ' ALA . 5.6 mtt -145.08 -164.16 1.87 Allowed 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.463 ' O ' ' OD1' ' A' ' 114' ' ' ASP . . . -164.25 23.13 0.07 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.804 -1.185 . . . . 0.0 110.326 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 114' ' ' ASP . 1.3 m-20 -101.9 15.94 27.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.058 -1.026 . . . . 0.0 108.259 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 1.4 mmtm -81.81 50.72 1.57 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.767 -0.583 . . . . 0.0 111.006 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.904 HD13 HD21 ' A' ' 110' ' ' LEU . 17.0 mt -109.57 86.77 2.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.763 -1.211 . . . . 0.0 108.875 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.622 ' N ' HD11 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -91.5 -135.87 0.14 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.123 -0.986 . . . . 0.0 110.191 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.584 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -150.45 119.44 3.64 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 120.758 -1.214 . . . . 0.0 109.626 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.587 ' O ' HG23 ' A' ' 8' ' ' VAL . 11.5 Cg_endo -71.29 94.39 0.66 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.323 2.015 . . . . 0.0 110.772 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.708 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -127.2 -135.73 4.19 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 118.767 -1.682 . . . . 0.0 111.04 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.537 ' CA ' ' OE1' ' A' ' 98' ' ' GLU . . . 167.65 35.53 0.02 OUTLIER Glycine 0 N--CA 1.487 2.071 0 O-C-N 121.383 -1.069 . . . . 0.0 110.53 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.508 ' HE2' ' O ' ' A' ' 40' ' ' ILE . 14.1 tptm 56.5 110.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.979 -0.718 . . . . 0.0 111.891 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.956 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -81.9 142.13 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.217 -0.927 . . . . 0.0 108.662 177.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.401 ' N ' HG12 ' A' ' 40' ' ' ILE . 10.9 pt-20 -172.21 -30.45 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.417 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.3 mmm -55.33 149.0 13.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.148 -0.97 . . . . 0.0 110.011 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.48 -127.44 33.66 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -164.66 18.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.493 -1.004 . . . . 0.0 109.842 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.794 HG22 ' H ' ' A' ' 47' ' ' GLU . 45.4 m -133.39 137.23 28.64 Favored Pre-proline 0 C--O 1.204 -1.332 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.615 ' HG3' ' CH2' ' A' ' 83' ' ' TRP . 3.0 Cg_exo -48.98 -16.37 0.83 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 121.57 1.513 . . . . 0.0 110.281 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.794 ' H ' HG22 ' A' ' 45' ' ' THR . 2.8 mt-10 -75.5 -85.47 0.05 OUTLIER 'General case' 0 C--O 1.203 -1.386 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.557 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 18.6 mt-30 -45.22 -34.75 2.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.66 -1.275 . . . . 0.0 109.778 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.86 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -63.77 -64.03 1.01 Allowed 'General case' 0 C--N 1.292 -1.927 0 O-C-N 121.339 -0.85 . . . . 0.0 109.666 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.905 ' O ' HD23 ' A' ' 54' ' ' LEU . 2.0 p -66.69 -51.89 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.049 -1.032 . . . . 0.0 110.55 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.57 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 3.7 p -51.97 -44.76 39.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.352 -0.843 . . . . 0.0 110.731 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.56 ' N ' HG13 ' A' ' 51' ' ' VAL . 5.8 mmt180 -74.76 -37.79 62.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 108.875 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.594 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 6.5 mm-40 -70.37 -13.08 61.99 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.174 HD12 ' CD1' ' A' ' 95' ' ' TRP . 1.6 mm? -80.06 -63.82 1.33 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.653 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.41 -52.71 64.28 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.833 -0.542 . . . . 0.0 110.176 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.579 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -47.28 -22.35 0.4 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.017 -1.052 . . . . 0.0 109.875 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.441 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 3.4 mt-10 -80.03 -96.79 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.046 -1.034 . . . . 0.0 109.31 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.665 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 57.4 t -80.01 -79.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.215 -0.928 . . . . 0.0 109.322 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 133.66 46.33 0.11 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.247 -1.454 . . . . 0.0 111.777 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.086 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -87.59 -127.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.604 -1.527 . . . . 0.0 108.44 178.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.706 ' H ' HD12 ' A' ' 60' ' ' ILE . 1.3 m -159.64 -68.6 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.006 -1.684 . . . . 0.0 112.146 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 2.2 Cg_endo -54.19 -80.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.028 1.819 . . . . 0.0 112.061 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 1.012 ' NE2' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 39.81 61.62 1.41 Allowed 'General case' 0 C--N 1.289 -2.039 0 CA-C-O 121.781 0.8 . . . . 0.0 109.608 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.687 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -53.24 102.22 0.05 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -95.46 144.28 26.09 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 122.177 0.989 . . . . 0.0 111.362 -177.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -143.25 145.0 32.37 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.149 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.856 HD13 ' N ' ' A' ' 69' ' ' GLU . 1.4 tm? -67.95 -64.45 0.86 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.068 -1.02 . . . . 0.0 110.808 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.882 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 83.6 -54.2 0.15 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.357 -0.84 . . . . 0.0 108.796 -179.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.856 ' N ' HD13 ' A' ' 67' ' ' LEU . 6.0 tp10 164.86 128.9 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.558 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -118.97 -171.71 2.15 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.443 -0.786 . . . . 0.0 109.868 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.643 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -142.06 -172.04 3.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 110.315 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -159.75 94.26 1.13 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.45 151.3 22.08 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.275 -0.891 . . . . 0.0 108.87 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.437 ' OE2' ' CE1' ' A' ' 79' ' ' HIS . 2.0 tt0 -119.71 137.5 53.88 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.144 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.563 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 1.1 m-30 -106.55 172.92 3.48 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 6.5 Cg_exo -46.24 -39.95 21.48 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.706 1.604 . . . . 0.0 110.31 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.437 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 3.1 m-20 -156.24 40.1 0.36 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.57 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -147.33 101.75 3.41 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.991 ' C ' HD12 ' A' ' 80' ' ' ILE . 5.5 m170 -77.81 137.26 38.32 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.991 HD12 ' C ' ' A' ' 79' ' ' HIS . 1.9 mp -132.82 153.74 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.767 -1.208 . . . . 0.0 110.653 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.574 ' HB ' ' CB ' ' A' ' 5' ' ' GLN . 1.6 m -141.67 150.45 41.92 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.65 HD21 HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -138.94 77.73 1.64 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.812 -1.18 . . . . 0.0 109.985 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.615 ' CH2' ' HG3' ' A' ' 46' ' ' PRO . 93.4 m95 -50.68 113.65 0.95 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 108.993 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.599 ' O ' ' O ' ' A' ' 67' ' ' LEU . 13.6 m-85 -90.76 70.56 6.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.254 -0.904 . . . . 0.0 110.208 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.656 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 61.5 m95 -77.46 87.6 3.82 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.705 -1.247 . . . . 0.0 109.751 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.882 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.0 mm? -68.2 129.55 40.25 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.524 -1.36 . . . . 0.0 109.974 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.012 HG11 ' NE2' ' A' ' 63' ' ' GLN . 0.8 OUTLIER -116.42 154.74 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.284 -0.885 . . . . 0.0 108.729 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 1.2 mt-10 -143.02 35.38 1.37 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.738 -1.226 . . . . 0.0 113.219 -178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.687 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -161.32 40.49 0.15 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 119.79 -1.819 . . . . 0.0 111.729 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.635 ' CH2' ' CD1' ' A' ' 104' ' ' TRP . 1.3 p90 -67.19 157.09 34.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.02 -1.675 . . . . 0.0 109.37 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.574 ' O ' ' CD1' ' A' ' 90' ' ' TRP . 10.4 pt-20 -77.8 -125.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.234 -0.916 . . . . 0.0 110.439 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.495 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -53.09 -55.22 25.14 Favored Glycine 0 N--CA 1.494 2.51 0 O-C-N 120.658 -1.277 . . . . 0.0 110.735 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 1.086 ' O ' HG21 ' A' ' 60' ' ' ILE . 6.9 pt-20 -132.94 166.91 25.79 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.161 -1.199 . . . . 0.0 109.577 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.76 ' HB3' HD12 ' A' ' 11' ' ' ILE . 9.9 Cg_endo -77.28 -168.14 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.36 2.04 . . . . 0.0 110.123 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 1.174 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -171.0 28.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 0.0 110.086 178.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.613 ' HA2' HD13 ' A' ' 54' ' ' LEU . . . -116.1 3.38 20.72 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.983 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.567 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 11.5 pttt -76.57 136.46 39.26 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.922 -1.34 . . . . 0.0 109.212 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.537 ' OE1' ' CA ' ' A' ' 38' ' ' GLY . 2.6 tp10 -75.61 -117.63 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.64 22.33 36.2 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 107.47 -2.252 . . . . 0.0 107.47 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.483 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 1.5 pt20 -94.97 165.11 17.71 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.731 -0.864 . . . . 0.0 110.136 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 1.4 Cg_endo -66.99 -42.55 8.0 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.994 1.796 . . . . 0.0 109.851 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.589 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 57.69 110.38 0.01 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 7.1 pt-20 -142.96 134.07 25.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.768 -1.43 . . . . 0.0 110.672 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.635 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 1.6 m0 -50.19 127.59 17.34 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.618 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -118.88 116.37 26.36 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.77 45.59 0.71 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.262 -0.899 . . . . 0.0 110.161 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.592 ' HG ' ' N ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -81.41 158.09 24.74 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.051 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.592 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 33.4 t -114.66 134.07 58.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.061 -1.024 . . . . 0.0 109.541 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.484 ' HA2' ' HB3' ' A' ' 129' ' ' LEU . . . 39.52 79.87 0.04 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.904 HD21 HD13 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -41.62 166.13 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.573 -0.957 . . . . 0.0 110.694 -178.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.791 ' H ' HD23 ' A' ' 110' ' ' LEU . 4.5 t30 -159.71 151.17 19.92 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.511 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . -55.98 -22.07 24.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 108.563 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -42.72 -36.9 1.57 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.522 -0.736 . . . . 0.0 109.082 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.536 ' CB ' ' CD1' ' A' ' 33' ' ' LEU . 73.8 m-20 -115.29 -8.5 12.29 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.685 -0.634 . . . . 0.0 109.556 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.828 ' HD2' HD22 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -100.93 123.53 45.01 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.339 -0.851 . . . . 0.0 109.709 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.547 ' O ' ' CD1' ' A' ' 123' ' ' ILE . 7.2 Cg_exo -52.62 148.2 28.3 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.415 2.077 . . . . 0.0 111.373 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.475 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . 2.1 Cg_endo -62.61 -26.18 75.69 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.309 2.006 . . . . 0.0 110.699 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.6 -48.57 5.43 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.123 -0.986 . . . . 0.0 109.656 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.868 ' O ' HD12 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -100.15 55.65 0.92 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.631 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 4.6 mt-10 -67.32 -43.19 42.64 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.602 -0.686 . . . . 0.0 112.366 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 6.3 Cg_exo -55.52 -31.78 79.93 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.764 1.643 . . . . 0.0 112.125 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.571 HG11 ' CZ ' ' A' ' 84' ' ' PHE . 2.4 t -101.05 -38.93 6.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.76 -1.212 . . . . 0.0 109.569 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.868 HD12 ' O ' ' A' ' 119' ' ' ASN . 15.2 mt -55.77 -34.55 36.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.27 -38.5 58.45 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.949 0.881 . . . . 0.0 109.137 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -79.81 -37.37 35.31 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.242 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.927 ' HA ' HD13 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -59.3 -39.67 83.76 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.179 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -39.8 -37.66 0.57 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.949 0.88 . . . . 0.0 108.927 178.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.481 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -87.57 -49.9 6.87 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.927 HD13 ' HA ' ' A' ' 126' ' ' LEU . 1.9 tp . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.322 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 17.0 tttt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.949 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -146.67 131.98 18.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.388 -0.82 . . . . 0.0 109.385 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.544 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 2.1 mp0 -98.51 162.06 13.35 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.441 ' HB ' ' HG ' ' A' ' 82' ' ' LEU . 0.9 OUTLIER -126.0 112.83 31.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.057 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -84.56 65.78 9.17 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.722 HG13 ' H ' ' A' ' 9' ' ' GLY . 1.1 p -78.94 -70.37 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.023 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.722 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 57.5 83.43 0.05 OUTLIER Glycine 0 C--N 1.292 -1.915 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 -178.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.59 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -47.7 168.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -179.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.811 HG22 ' CG2' ' A' ' 87' ' ' VAL . 2.7 pt -133.24 95.14 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.344 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.91 ' HG2' HG22 ' A' ' 18' ' ' ILE . 15.8 mtm180 -76.78 179.83 5.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.619 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -158.69 -60.81 0.08 Allowed 'General case' 0 C--O 1.194 -1.856 0 C-N-CA 116.458 -2.097 . . . . 0.0 115.068 -177.119 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.576 ' CB ' ' HG3' ' A' ' 17' ' ' GLU . 6.9 tp10 -92.72 -26.04 17.94 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 119.254 -2.154 . . . . 0.0 111.745 -175.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -161.96 -45.17 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.479 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 14.7 t30 -160.41 35.81 0.17 Allowed 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 177.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 105' ' ' MET . 4.9 mm-40 -78.36 85.86 4.46 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 118.007 -1.477 . . . . 0.0 109.105 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.91 HG22 ' HG2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -79.15 142.49 13.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.714 ' HB3' HD11 ' A' ' 11' ' ' ILE . 11.9 t80 -81.94 46.0 0.96 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.708 HD12 ' CZ ' ' A' ' 115' ' ' PHE . 12.9 tt -79.1 153.0 4.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-O 121.858 0.837 . . . . 0.0 110.463 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.534 ' HB ' ' HD2' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -66.5 89.91 0.15 Allowed 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.509 ' O ' ' C ' ' A' ' 23' ' ' ARG . 28.5 tpt180 -87.37 81.77 7.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.184 -0.948 . . . . 0.0 110.416 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.715 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 1.1 ptt180 32.53 72.79 0.07 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.917 -0.489 . . . . 0.0 110.269 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.23 -53.31 4.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -0.853 . . . . 0.0 109.302 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.28 -171.54 3.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.232 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -79.92 80.68 6.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.473 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.715 ' HB2' ' HB3' ' A' ' 23' ' ' ARG . . . -61.31 -31.77 71.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.819 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 55.41 21.13 4.05 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.746 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 6.1 mmm -127.36 -112.53 0.28 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 160.01 -14.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.064 -1.022 . . . . 0.0 111.065 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -81.53 12.53 3.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.906 -1.122 . . . . 0.0 109.779 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.72 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -81.99 54.79 2.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.476 -0.765 . . . . 0.0 110.642 -179.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.72 HD23 ' O ' ' A' ' 32' ' ' LYS . 6.4 mt -120.83 83.75 2.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.644 -1.285 . . . . 0.0 109.75 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.46 -146.98 0.19 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.389 -0.82 . . . . 0.0 109.358 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.65 ' CZ ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -140.16 125.61 11.5 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.864 -1.147 . . . . 0.0 110.157 -178.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.682 ' O ' HG23 ' A' ' 8' ' ' VAL . 13.8 Cg_endo -73.78 100.11 1.23 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.364 2.043 . . . . 0.0 110.118 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.671 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -136.36 135.08 7.53 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.175 -1.488 . . . . 0.0 110.961 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.533 ' CA ' ' OE1' ' A' ' 98' ' ' GLU . . . -108.14 36.53 4.32 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.632 ' HD2' HD23 ' A' ' 4' ' ' LEU . 7.0 tptm 59.26 119.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.54 -0.976 . . . . 0.0 112.083 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.021 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -83.24 135.96 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -171.31 -31.51 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.906 -1.121 . . . . 0.0 110.266 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.55 142.98 25.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.133 -0.979 . . . . 0.0 109.316 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.22 -115.96 8.71 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -169.23 -15.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.775 -0.838 . . . . 0.0 110.737 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.779 HG22 ' H ' ' A' ' 47' ' ' GLU . 24.9 m -103.82 141.09 21.78 Favored Pre-proline 0 C--O 1.205 -1.28 0 O-C-N 120.876 -1.14 . . . . 0.0 108.353 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.582 ' HD2' HG23 ' A' ' 45' ' ' THR . 7.9 Cg_exo -47.32 -18.06 0.68 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.082 1.855 . . . . 0.0 110.938 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.779 ' H ' HG22 ' A' ' 45' ' ' THR . 0.7 OUTLIER -77.87 -81.89 0.09 Allowed 'General case' 0 C--O 1.202 -1.424 0 O-C-N 120.857 -1.152 . . . . 0.0 108.594 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.544 ' O ' ' CG ' ' A' ' 52' ' ' ARG . 53.0 mt-30 -48.73 -25.56 1.88 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.384 -1.448 . . . . 0.0 109.948 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.827 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -73.51 -59.65 2.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.875 -1.14 . . . . 0.0 109.874 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.057 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.5 p -70.01 -48.94 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.053 -1.029 . . . . 0.0 109.843 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.571 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 2.1 p -56.33 -42.91 75.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 O-C-N 121.797 -0.564 . . . . 0.0 110.4 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 48' ' ' GLN . 21.2 mmt180 -74.86 -35.7 62.33 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.612 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 15.7 mm-40 -68.07 -15.47 63.61 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.802 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -79.09 -62.79 1.59 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.493 ' NE2' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -57.37 -53.84 53.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.345 -0.847 . . . . 0.0 109.828 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.547 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -50.13 -21.7 1.4 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.334 -0.854 . . . . 0.0 110.496 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.4 mt-10 -80.04 -91.02 0.05 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.059 -1.026 . . . . 0.0 109.967 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.684 HG21 ' HA ' ' A' ' 95' ' ' TRP . 47.3 t -80.06 -78.98 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.448 -0.782 . . . . 0.0 110.302 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.18 22.21 0.1 OUTLIER Glycine 0 N--CA 1.494 2.563 0 C-N-CA 118.77 -1.681 . . . . 0.0 112.472 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.059 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.2 pt -81.19 -136.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.187 -1.772 . . . . 0.0 108.102 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.622 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.2 m -159.08 -68.6 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.465 -1.397 . . . . 0.0 109.967 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 5.7 Cg_endo -62.51 -173.74 0.15 Allowed 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.686 1.591 . . . . 0.0 110.741 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.56 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 1.1 pt20 145.19 -24.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.603 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.2 OUTLIER 43.32 48.96 5.92 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -42.84 160.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.745 0.783 . . . . 0.0 110.584 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -156.89 136.91 12.63 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.167 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.637 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -59.64 -71.92 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.824 -1.172 . . . . 0.0 110.321 -178.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.747 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 85.08 -56.55 0.09 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.026 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.619 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 30.9 tp10 165.97 123.38 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.604 0.716 . . . . 0.0 109.753 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.571 ' HD2' ' CD2' ' A' ' 83' ' ' TRP . 5.7 ptmt -110.11 170.54 8.01 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.706 -0.621 . . . . 0.0 109.615 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.799 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -122.8 169.8 10.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.097 -1.002 . . . . 0.0 110.14 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.681 ' HG3' HG23 ' A' ' 81' ' ' THR . 15.6 tt0 -147.07 85.78 1.62 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.21 123.77 28.74 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.429 ' CG ' ' NE2' ' A' ' 79' ' ' HIS . 2.6 tt0 -91.85 108.43 19.92 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.281 -0.968 . . . . 0.0 109.017 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.531 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 1.9 m-85 -78.32 170.35 16.65 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.398 -0.814 . . . . 0.0 109.468 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 7.5 Cg_exo -49.65 -38.15 45.13 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.112 1.874 . . . . 0.0 109.714 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.63 43.46 0.44 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.513 ' O ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -148.07 97.54 2.8 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.459 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -79.82 94.91 5.89 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.607 HG22 ' N ' ' A' ' 81' ' ' THR . 0.4 OUTLIER -102.17 164.52 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.183 -0.948 . . . . 0.0 110.559 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.681 HG23 ' HG3' ' A' ' 72' ' ' GLU . 1.2 m -148.3 151.62 35.7 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.652 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -142.63 79.56 1.66 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.696 -1.253 . . . . 0.0 110.682 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.571 ' CD2' ' HD2' ' A' ' 70' ' ' LYS . 87.5 m95 -53.96 111.37 0.74 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 109.296 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.776 ' CE1' HG11 ' A' ' 122' ' ' VAL . 8.7 m-85 -87.01 71.31 10.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.157 -0.964 . . . . 0.0 109.546 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.688 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 67.5 m95 -75.44 86.6 2.58 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.94 -1.1 . . . . 0.0 109.554 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.747 HD23 ' CD2' ' A' ' 68' ' ' PHE . 1.7 mm? -67.89 130.75 43.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.626 -1.296 . . . . 0.0 109.711 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.811 ' CG2' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -111.37 179.45 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.19 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.512 ' N ' HG23 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -160.93 17.6 0.12 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.341 -1.475 . . . . 0.0 112.57 -179.349 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.603 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -160.52 50.63 0.28 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.048 -1.657 . . . . 0.0 111.139 179.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.734 ' HB2' HD13 ' A' ' 60' ' ' ILE . 4.0 p90 -67.4 164.61 18.27 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.687 -1.258 . . . . 0.0 109.351 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.613 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 6.6 tt0 -87.95 140.18 29.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.152 -0.967 . . . . 0.0 109.363 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 36.29 -85.17 0.01 OUTLIER Glycine 0 N--CA 1.497 2.731 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 1.059 ' O ' HG21 ' A' ' 60' ' ' ILE . 10.4 pt-20 -101.61 159.61 28.93 Favored Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.242 -1.152 . . . . 0.0 109.706 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.653 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 15.0 Cg_endo -75.52 -159.94 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.364 2.043 . . . . 0.0 109.669 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.802 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER 175.18 27.21 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.72 -0.612 . . . . 0.0 110.667 178.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.416 ' HA2' ' CD1' ' A' ' 54' ' ' LEU . . . -103.28 -6.15 45.3 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.59 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -81.15 128.54 33.87 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.347 -1.09 . . . . 0.0 110.854 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.533 ' OE1' ' CA ' ' A' ' 38' ' ' GLY . 22.7 tp10 -81.69 -96.14 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.522 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . -89.7 -19.5 47.88 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 107.634 -2.187 . . . . 0.0 107.634 177.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.569 ' HG3' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -61.55 149.29 84.53 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.865 -0.786 . . . . 0.0 109.219 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.569 ' HD2' ' HG3' ' A' ' 100' ' ' GLN . 1.2 Cg_endo -67.6 -37.35 16.93 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.737 1.625 . . . . 0.0 108.79 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.61 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.12 123.2 0.01 OUTLIER Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.558 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 1.4 pp20? -151.79 125.65 9.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.957 -1.319 . . . . 0.0 109.795 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.592 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 1.2 m-90 -45.08 132.62 7.0 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.633 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 7.7 tpt -124.31 120.73 33.02 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.288 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.31 47.51 1.16 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 1.069 HD13 ' HG ' ' A' ' 110' ' ' LEU . 6.8 tt -59.47 -48.0 83.32 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.74 -0.6 . . . . 0.0 109.427 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.634 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 49.3 t 82.79 112.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 40.89 82.79 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 1.069 ' HG ' HD13 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -42.08 164.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.377 -1.073 . . . . 0.0 109.869 -179.211 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.71 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 3.6 t-20 -138.43 -6.97 1.53 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.001 -1.062 . . . . 0.0 111.924 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 82.34 -26.43 0.14 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.219 -0.926 . . . . 0.0 108.87 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.27 -24.42 59.35 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.679 ' OD1' ' HB1' ' A' ' 30' ' ' ALA . 4.4 m-20 -103.07 -13.64 16.75 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.708 ' CZ ' HD12 ' A' ' 20' ' ' ILE . 2.0 m-85 -95.3 143.25 25.79 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.287 -0.883 . . . . 0.0 109.945 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -60.15 132.97 47.14 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.032 1.822 . . . . 0.0 109.575 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.55 -16.29 23.42 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.144 1.896 . . . . 0.0 110.988 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.05 -57.28 9.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.939 -1.1 . . . . 0.0 109.104 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.72 ' O ' HD12 ' A' ' 123' ' ' ILE . 9.8 m-20 -86.67 48.55 1.65 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.806 0.812 . . . . 0.0 109.043 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -56.61 -44.12 99.62 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.778 -0.576 . . . . 0.0 112.427 -179.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 11.5 Cg_exo -53.3 -57.55 1.93 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.048 1.832 . . . . 0.0 112.962 -177.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.776 HG11 ' CE1' ' A' ' 84' ' ' PHE . 2.0 t -78.93 -32.99 15.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 120.788 -1.195 . . . . 0.0 109.532 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.72 HD12 ' O ' ' A' ' 119' ' ' ASN . 5.7 mt -64.16 -23.97 34.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.565 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -61.49 -28.45 69.31 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.899 0.857 . . . . 0.0 108.92 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -80.35 -40.09 27.3 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.752 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.778 ' N ' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -66.3 -22.02 66.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.623 -1.298 . . . . 0.0 107.845 179.148 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 12.6 mtmt -58.35 -33.54 69.66 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -87.19 -21.42 25.9 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.602 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 1.6 tp . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.736 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 79' ' ' HIS . 26.8 tttt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.51 0.671 . . . . 0.0 109.89 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 1.069 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -157.24 144.33 18.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.979 179.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.632 ' N ' HD22 ' A' ' 4' ' ' LEU . 9.7 mp0 -108.71 166.08 11.06 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.689 HG22 HG12 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -128.81 114.73 34.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 O-C-N 120.992 -1.067 . . . . 0.0 109.334 -178.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.042 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -85.2 62.61 7.6 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 36' ' ' PRO . 1.2 p -79.01 -70.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.353 -0.842 . . . . 0.0 109.972 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.738 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 59.08 84.48 0.04 OUTLIER Glycine 0 N--CA 1.481 1.649 0 N-CA-C 107.569 -2.212 . . . . 0.0 107.569 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.625 HG22 ' HB ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -48.63 166.76 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.8 HG22 ' CG2' ' A' ' 87' ' ' VAL . 1.8 pt -130.65 78.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.687 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.677 ' HB3' HG23 ' A' ' 18' ' ' ILE . 2.9 ptm180 -83.25 144.92 29.42 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.598 ' OD1' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -161.3 -5.6 0.05 OUTLIER 'General case' 0 C--O 1.185 -2.291 0 C-N-CA 116.769 -1.972 . . . . 0.0 114.203 -179.072 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.612 ' HB2' ' CG ' ' A' ' 17' ' ' GLU . 19.7 mm-40 -94.02 -32.2 13.92 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 118.182 -2.824 . . . . 0.0 107.471 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.605 ' CG ' HG22 ' A' ' 108' ' ' VAL . 24.6 t-20 -162.82 -48.62 0.04 OUTLIER 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 102.382 -3.192 . . . . 0.0 102.382 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.478 ' OD1' HD23 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -161.74 35.78 0.13 Allowed 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 175.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 105' ' ' MET . 0.3 OUTLIER -86.1 92.86 8.85 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.069 -1.452 . . . . 0.0 110.8 -176.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.677 HG23 ' HB3' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -84.95 156.66 3.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.536 0.684 . . . . 0.0 109.872 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.615 ' CE1' ' HG2' ' A' ' 94' ' ' PRO . 6.4 t80 -82.97 44.1 0.9 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.58 ' CG2' HG13 ' A' ' 18' ' ' ILE . 7.0 tp -82.05 155.69 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.148 -0.97 . . . . 0.0 110.55 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 21' ' ' THR . 5.0 t -73.08 89.23 1.46 Allowed 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.562 ' HD3' HD21 ' A' ' 33' ' ' LEU . 29.1 tpt180 -90.21 76.06 6.9 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.501 -0.75 . . . . 0.0 110.555 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.872 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 35.26 76.97 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.762 -0.586 . . . . 0.0 110.093 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.55 -52.98 9.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.928 . . . . 0.0 109.875 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.28 -170.23 2.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.119 -0.988 . . . . 0.0 109.489 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -79.5 128.51 33.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.194 -0.941 . . . . 0.0 109.141 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.872 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -124.46 -44.85 1.97 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.132 -0.98 . . . . 0.0 110.184 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.6 t60 56.41 20.44 4.75 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.71 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 6.3 mtp -115.28 -40.99 3.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.654 -0.654 . . . . 0.0 109.372 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 29' ' ' MET . . . 76.18 -177.49 0.13 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.304 -0.872 . . . . 0.0 109.003 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 1.3 t30 78.1 -5.95 2.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 109.403 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.49 ' O ' ' O ' ' A' ' 21' ' ' THR . 3.8 tmtm? -82.59 48.29 1.29 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.433 -0.792 . . . . 0.0 109.871 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.643 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 9.5 mt -117.91 79.93 1.44 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.846 -1.158 . . . . 0.0 109.304 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.607 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 13.2 tt0 -81.3 -134.18 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.345 -0.847 . . . . 0.0 109.132 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.607 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -149.37 124.75 4.94 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.544 -1.348 . . . . 0.0 110.261 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.792 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.7 Cg_endo -57.99 94.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.14 1.893 . . . . 0.0 109.515 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -55.34 -148.14 0.01 OUTLIER Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.287 -0.883 . . . . 0.0 111.757 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.602 ' N ' ' CG ' ' A' ' 98' ' ' GLU . . . 157.41 -31.96 0.53 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 107.538 -2.225 . . . . 0.0 107.538 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.464 ' O ' ' OE2' ' A' ' 53' ' ' GLU . 2.5 tptm 67.18 100.43 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 122.237 -0.567 . . . . 0.0 110.744 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.82 HD13 ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -80.74 134.5 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.721 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 42' ' ' MET . 4.0 pt-20 -171.39 -31.94 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.784 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.443 ' O ' ' C ' ' A' ' 43' ' ' GLY . 4.4 mmt -54.69 162.92 1.05 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.113 -0.992 . . . . 0.0 109.252 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 42' ' ' MET . . . 43.93 -125.81 5.68 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -164.6 23.21 0.06 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.474 -1.015 . . . . 0.0 108.948 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.471 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 24.1 m -138.24 140.04 27.34 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.52 ' O ' HG12 ' A' ' 50' ' ' VAL . 10.0 Cg_exo -51.05 -17.84 3.95 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 121.748 1.632 . . . . 0.0 110.136 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.512 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -77.95 -85.14 0.07 Allowed 'General case' 0 C--O 1.202 -1.401 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.519 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.546 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 14.3 mt-30 -43.83 -33.17 1.24 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.569 -1.332 . . . . 0.0 109.715 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.693 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -65.76 -62.63 1.4 Allowed 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.511 -0.743 . . . . 0.0 110.021 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.042 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.6 p -68.99 -49.58 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.216 -0.928 . . . . 0.0 110.316 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.561 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 3.4 p -54.95 -45.48 76.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 121.684 -0.635 . . . . 0.0 110.186 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.552 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 5.4 mmt180 -71.06 -37.35 72.49 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.616 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 17.6 mm-40 -68.9 -14.59 63.13 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.763 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -80.0 -59.94 2.53 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -54.04 46.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.447 -0.783 . . . . 0.0 110.007 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.563 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 1.1 pp20? -47.57 -21.74 0.39 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.039 -1.038 . . . . 0.0 110.075 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.433 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 3.3 mt-10 -80.04 -92.92 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.075 -1.016 . . . . 0.0 109.632 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.776 HG21 ' HA ' ' A' ' 95' ' ' TRP . 36.2 t -79.97 -78.34 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 110.117 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.94 18.89 0.1 OUTLIER Glycine 0 N--CA 1.493 2.496 0 C-N-CA 118.43 -1.843 . . . . 0.0 112.643 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.947 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.6 pp -80.05 -156.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.123 -1.81 . . . . 0.0 107.628 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.624 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.5 m -137.36 -72.25 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.421 -1.424 . . . . 0.0 110.947 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 1.6 Cg_endo -61.43 -169.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 121.029 1.153 . . . . 0.0 110.712 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.584 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER 143.27 -23.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -179.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.609 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 1.6 t-80 44.84 53.21 7.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.455 -0.778 . . . . 0.0 109.484 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -45.97 156.05 0.16 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.036 0.922 . . . . 0.0 110.372 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -149.36 140.62 23.14 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.608 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -63.49 -68.1 0.37 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.731 -1.23 . . . . 0.0 109.78 -179.112 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.641 ' CZ ' HD11 ' A' ' 126' ' ' LEU . 0.0 OUTLIER 83.73 -50.53 0.14 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.599 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.5 mt-10 162.16 174.02 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.36 -172.38 3.36 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.824 -1.172 . . . . 0.0 109.891 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.979 HD21 ' OD1' ' A' ' 119' ' ' ASN . 0.7 OUTLIER -140.18 -177.7 5.13 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.795 0.807 . . . . 0.0 109.891 179.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.637 ' HG3' HG23 ' A' ' 81' ' ' THR . 11.3 tt0 -160.18 88.7 0.82 Allowed 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.03 105.48 9.27 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.512 ' HG3' ' NE2' ' A' ' 79' ' ' HIS . 2.8 tt0 -96.72 118.29 32.86 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.119 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -105.69 174.3 2.72 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 2.9 Cg_exo -49.03 -60.51 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 121.418 1.412 . . . . 0.0 109.558 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.5 50.39 1.71 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.434 ' HD2' ' CD1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -150.36 87.97 1.48 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.457 -0.777 . . . . 0.0 109.743 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.554 ' O ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -90.28 98.72 11.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.89 . . . . 0.0 109.386 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.575 ' CG2' ' N ' ' A' ' 81' ' ' THR . 0.5 OUTLIER -113.14 163.55 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.0 110.253 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.637 HG23 ' HG3' ' A' ' 72' ' ' GLU . 0.7 OUTLIER -151.34 147.1 26.52 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.336 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.641 ' CD2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -134.49 73.83 1.51 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.918 -1.114 . . . . 0.0 110.816 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.652 ' CD1' HG21 ' A' ' 40' ' ' ILE . 78.8 m95 -46.35 117.15 1.47 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.06 -1.025 . . . . 0.0 108.563 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.695 ' CE2' HG11 ' A' ' 122' ' ' VAL . 33.9 m-85 -94.03 76.78 4.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.966 -1.084 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.663 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 24.6 m95 -76.89 84.21 3.45 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.902 -1.124 . . . . 0.0 109.372 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.623 HD11 ' CG1' ' A' ' 10' ' ' ILE . 2.4 mm? -69.24 128.04 35.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.671 -1.268 . . . . 0.0 109.212 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.8 ' CG2' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -112.0 175.78 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 87.2 mt-10 -157.14 19.41 0.3 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.48 -1.388 . . . . 0.0 112.786 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.609 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -160.67 64.16 0.31 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.105 -1.622 . . . . 0.0 111.087 178.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.61 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 1.5 p90 -80.74 164.6 22.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.747 -1.22 . . . . 0.0 109.156 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.6 OUTLIER -88.27 142.94 27.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.854 -1.154 . . . . 0.0 109.386 178.314 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 38.25 -83.37 0.0 OUTLIER Glycine 0 N--CA 1.498 2.814 0 O-C-N 121.585 -0.697 . . . . 0.0 112.073 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.947 ' O ' HG21 ' A' ' 60' ' ' ILE . 10.6 pt-20 -106.98 164.86 13.93 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.149 -1.206 . . . . 0.0 111.254 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.615 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 11.2 Cg_endo -75.86 -160.91 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 122.717 2.278 . . . . 0.0 109.934 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.776 ' HA ' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER 176.51 54.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.196 -0.94 . . . . 0.0 110.865 178.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . -139.98 0.6 2.12 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 118.334 -1.888 . . . . 0.0 111.814 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.651 ' HE3' HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -78.03 106.94 10.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.403 -1.646 . . . . 0.0 110.772 -179.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.602 ' CG ' ' N ' ' A' ' 38' ' ' GLY . 1.2 mm-40 -60.27 -91.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.735 -1.228 . . . . 0.0 107.73 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.74 22.17 34.55 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 106.692 -2.563 . . . . 0.0 106.692 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.506 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -100.11 143.38 26.39 Favored Pre-proline 0 N--CA 1.485 1.289 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 21' ' ' THR . 4.4 Cg_exo -57.31 -30.67 88.5 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 N-CA-C 108.127 -1.528 . . . . 0.0 108.127 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.605 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 53.63 110.97 0.01 OUTLIER Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 4.6 pt-20 -147.8 133.73 19.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.758 -1.437 . . . . 0.0 110.557 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.53 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 7.8 m0 -46.06 123.62 4.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 108.495 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.639 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -115.55 111.07 20.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.08 -1.012 . . . . 0.0 109.764 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.522 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 19.3 t -79.58 63.07 4.06 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.368 -0.832 . . . . 0.0 110.634 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.842 HD12 ' N ' ' A' ' 108' ' ' VAL . 4.2 pp -82.37 -40.38 21.41 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.3 -0.875 . . . . 0.0 109.883 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.842 ' N ' HD12 ' A' ' 107' ' ' LEU . 2.0 t 70.64 118.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 42.53 84.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.621 -1.791 . . . . 0.0 108.621 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.824 HD21 ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -45.74 174.34 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.587 -0.949 . . . . 0.0 110.147 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.669 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 4.4 t-20 -152.77 0.54 0.28 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.979 -1.075 . . . . 0.0 112.069 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 79.78 -32.3 0.13 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.889 -1.132 . . . . 0.0 109.008 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -49.8 -26.51 3.99 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.571 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 9.2 m-20 -108.3 -17.62 13.96 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.809 -0.557 . . . . 0.0 109.872 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.824 ' CD1' HD21 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -91.77 144.32 29.21 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.134 -0.979 . . . . 0.0 109.853 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.531 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.8 Cg_endo -65.2 134.13 38.05 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.269 1.979 . . . . 0.0 109.962 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 118' ' ' ALA . 5.5 Cg_exo -60.65 -25.52 81.04 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.083 1.856 . . . . 0.0 110.731 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.91 -46.58 5.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.215 -0.928 . . . . 0.0 109.231 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.979 ' OD1' HD21 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -95.33 51.78 1.35 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.326 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.644 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -59.97 -44.15 96.1 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.621 -0.674 . . . . 0.0 112.358 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 6.2 Cg_exo -54.34 -32.89 74.13 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.013 1.809 . . . . 0.0 112.872 -177.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.695 HG11 ' CE2' ' A' ' 84' ' ' PHE . 2.4 t -101.41 -36.8 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.522 -1.361 . . . . 0.0 110.153 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.951 ' HA ' HD22 ' A' ' 126' ' ' LEU . 1.1 mp -61.93 -27.85 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.53 ' HA ' ' CE ' ' A' ' 127' ' ' LYS . . . -55.06 -35.08 64.14 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.462 ' HD3' ' HA ' ' A' ' 125' ' ' LYS . 26.0 mmtp -80.11 -41.62 25.16 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.946 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.951 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -60.3 -22.0 62.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.335 -1.478 . . . . 0.0 107.448 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.537 ' HD3' ' CB ' ' A' ' 112' ' ' ALA . 6.3 mttt -57.36 -42.02 81.23 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -79.07 -18.98 52.45 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.634 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 2.5 tp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.984 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HE2' ' CD ' ' A' ' 5' ' ' GLN . 3.6 ttpm? . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 121.36 0.6 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 1.044 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -148.22 122.11 9.37 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.97 ' N ' HD22 ' A' ' 4' ' ' LEU . 2.9 mp0 -110.65 154.65 23.52 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.114 -0.991 . . . . 0.0 108.339 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.639 HG22 HG12 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -122.5 118.21 54.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.396 -178.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.124 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -85.52 60.76 6.44 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.709 HG13 ' H ' ' A' ' 9' ' ' GLY . 1.0 OUTLIER -79.16 -71.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.096 -179.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.709 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 59.84 82.23 0.07 OUTLIER Glycine 0 C--N 1.298 -1.57 0 N-CA-C 106.304 -2.719 . . . . 0.0 106.304 -177.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.575 ' O ' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -48.15 154.69 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -178.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.931 HG22 ' CG1' ' A' ' 87' ' ' VAL . 4.0 pt -116.48 102.27 13.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.886 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.769 ' HG2' HG23 ' A' ' 18' ' ' ILE . 8.6 mtm180 -76.65 -173.12 2.46 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.619 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -155.43 -66.32 0.12 Allowed 'General case' 0 C--O 1.188 -2.161 0 C-N-CA 116.826 -1.95 . . . . 0.0 114.267 -177.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.61 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 29.1 tp10 -91.51 -33.82 15.03 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 118.953 -2.342 . . . . 0.0 111.496 -175.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.483 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 41.8 t-20 -161.73 -42.08 0.04 OUTLIER 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.529 ' OD1' ' NH1' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -155.96 32.8 0.35 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 177.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 105' ' ' MET . 1.9 mm-40 -90.1 109.45 20.5 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 118.038 -1.465 . . . . 0.0 108.49 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.78 HD12 ' HB3' ' A' ' 105' ' ' MET . 0.2 OUTLIER -102.92 148.44 8.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.793 -177.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.627 ' CE2' ' HG2' ' A' ' 94' ' ' PRO . 20.4 t80 -81.54 38.34 0.49 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.733 HG21 HD22 ' A' ' 33' ' ' LEU . 6.1 tp -78.47 152.55 5.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.259 -0.901 . . . . 0.0 110.442 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.493 ' HB ' ' HD2' ' A' ' 101' ' ' PRO . 1.4 t -65.49 85.5 0.07 Allowed 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.511 ' O ' ' C ' ' A' ' 23' ' ' ARG . 21.2 tpt180 -87.38 93.59 9.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.688 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.939 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 28.55 76.63 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 120.986 0.422 . . . . 0.0 110.385 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.25 -47.52 4.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.363 -0.836 . . . . 0.0 109.105 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.25 155.1 26.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.869 . . . . 0.0 108.992 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -59.6 92.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.07 -1.018 . . . . 0.0 109.649 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.939 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -97.54 96.84 8.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -0.947 . . . . 0.0 109.947 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -48.95 -25.61 2.04 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.41 ' N ' ' C ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -72.06 -167.29 0.29 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.54 0.686 . . . . 0.0 109.477 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.528 ' O ' ' CB ' ' A' ' 31' ' ' ASN . . . -154.58 -157.98 0.81 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 0.7 OUTLIER 75.26 -2.7 2.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.059 -1.025 . . . . 0.0 109.074 -179.164 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -82.39 59.66 4.69 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.563 -0.71 . . . . 0.0 110.279 -179.534 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.733 HD22 HG21 ' A' ' 20' ' ' ILE . 12.0 mt -122.41 85.09 2.36 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.704 ' C ' HD11 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -80.8 -138.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.15 -1.593 . . . . 0.0 109.443 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.639 ' HB3' HG21 ' A' ' 8' ' ' VAL . 23.6 m-85 -154.22 123.98 3.26 Favored Pre-proline 0 N--CA 1.485 1.317 0 O-C-N 121.066 -1.021 . . . . 0.0 109.464 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.579 ' O ' HG23 ' A' ' 8' ' ' VAL . 2.1 Cg_endo -58.63 88.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.889 1.726 . . . . 0.0 109.464 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.544 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -57.12 -141.41 0.01 OUTLIER Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.569 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . 162.48 -55.35 0.3 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.569 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 99.04 69.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 123.11 0.564 . . . . 0.0 110.352 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.741 HD13 ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -53.79 123.45 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.963 -1.086 . . . . 0.0 108.684 179.353 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 42' ' ' MET . 8.1 pt-20 -173.16 -22.52 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.647 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.438 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -38.82 -81.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.133 -0.979 . . . . 0.0 110.153 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.41 -122.95 2.25 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.69 9.07 1.97 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.531 -0.982 . . . . 0.0 109.124 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.553 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 60.4 m -126.01 142.41 42.38 Favored Pre-proline 0 N--CA 1.486 1.335 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.609 ' HG3' ' CZ3' ' A' ' 83' ' ' TRP . 3.6 Cg_exo -52.41 -15.7 4.25 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.545 1.497 . . . . 0.0 110.317 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.696 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.4 tt0 -75.97 -81.25 0.08 Allowed 'General case' 0 C--O 1.201 -1.486 0 O-C-N 120.983 -1.073 . . . . 0.0 108.638 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.544 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 1.3 mt-30 -47.75 -36.02 10.8 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.265 -1.522 . . . . 0.0 109.455 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.702 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -62.17 -64.17 1.01 Allowed 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.198 -0.939 . . . . 0.0 110.136 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.124 HG23 ' HB1' ' A' ' 7' ' ' ALA . 1.3 p -69.47 -49.81 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.305 -0.872 . . . . 0.0 110.657 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.696 HG12 ' O ' ' A' ' 47' ' ' GLU . 3.1 p -55.89 -37.12 46.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.745 -0.597 . . . . 0.0 110.421 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -78.96 -37.16 40.22 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 2.2 mm-40 -69.83 -14.23 62.65 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.006 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -80.08 -65.5 1.0 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.519 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.06 -49.8 74.74 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.697 -0.627 . . . . 0.0 110.479 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.611 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -46.64 -24.76 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.881 -1.137 . . . . 0.0 109.915 -178.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 8.0 mm-40 -80.13 -95.04 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.091 -1.005 . . . . 0.0 109.563 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.632 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 66.3 t -79.96 -79.36 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.098 -1.001 . . . . 0.0 109.911 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.99 37.58 0.09 OUTLIER Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.241 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.086 HG21 ' O ' ' A' ' 93' ' ' GLU . 2.9 pp -93.36 -152.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 120.793 -1.416 . . . . 0.0 108.542 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.829 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.3 m -161.7 -64.96 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 120.327 -1.483 . . . . 0.0 112.511 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 3.8 Cg_exo -51.59 -2.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.827 2.351 . . . . 0.0 114.267 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.508 ' N ' ' HA ' ' A' ' 90' ' ' TRP . 1.3 pt20 -34.89 -29.15 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 119.575 1.079 . . . . 0.0 110.791 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.578 ' N ' ' O ' ' A' ' 62' ' ' PRO . 2.2 t60 55.32 73.37 0.42 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.676 -1.265 . . . . 0.0 108.053 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 15.5 p90 -72.99 146.4 46.01 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.791 0.805 . . . . 0.0 111.179 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -144.4 135.37 25.13 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.629 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -61.46 -70.16 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.752 -1.217 . . . . 0.0 109.985 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.913 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 84.1 -52.51 0.13 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -178.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.9 mm-40 172.69 177.54 0.09 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.262 -0.899 . . . . 0.0 108.885 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HE2' HG22 ' A' ' 81' ' ' THR . 0.0 OUTLIER -161.37 -174.59 4.36 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.195 -0.941 . . . . 0.0 109.38 -179.389 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -149.02 175.79 11.0 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.135 -0.978 . . . . 0.0 109.986 179.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -144.06 89.16 2.01 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.15 123.16 27.11 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.24 156.3 17.3 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.294 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.585 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -133.22 174.13 5.07 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.585 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 5.4 Cg_exo -47.68 -33.35 18.44 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.696 1.597 . . . . 0.0 109.74 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.432 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -164.18 51.59 0.14 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.534 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -155.64 94.0 1.53 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.652 -0.655 . . . . 0.0 109.778 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.75 ' C ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -78.72 120.7 23.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.047 -1.033 . . . . 0.0 108.707 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.75 HD12 ' C ' ' A' ' 79' ' ' HIS . 1.3 mp -117.89 165.25 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 122.135 0.969 . . . . 0.0 110.592 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.598 ' N ' ' CG2' ' A' ' 80' ' ' ILE . 1.5 m -153.6 155.98 37.13 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.575 ' CD2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -148.49 77.04 1.38 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.912 -1.118 . . . . 0.0 110.301 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.609 ' CZ3' ' HG3' ' A' ' 46' ' ' PRO . 75.9 m95 -49.0 108.59 0.19 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.809 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.878 ' CG ' HG11 ' A' ' 122' ' ' VAL . 19.1 m-85 -85.06 69.81 10.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.134 -0.979 . . . . 0.0 109.593 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.684 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 71.0 m95 -74.23 87.53 1.96 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.905 -1.122 . . . . 0.0 109.361 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.913 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.3 mm? -70.07 126.98 31.26 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 120.67 -1.269 . . . . 0.0 109.573 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.931 ' CG1' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -101.52 179.98 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.01 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.494 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 42.8 mt-10 -153.28 1.69 0.27 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 117.735 -1.586 . . . . 0.0 113.219 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.593 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.32 71.27 0.44 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.002 -1.686 . . . . 0.0 110.95 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.619 ' CH2' ' HB2' ' A' ' 13' ' ' ASN . 2.8 p90 -78.87 165.64 23.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.418 -1.426 . . . . 0.0 110.036 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.573 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 1.5 pt-20 -86.98 137.6 32.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.206 -0.934 . . . . 0.0 109.824 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 41.1 -89.49 0.01 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 1.086 ' O ' HG21 ' A' ' 60' ' ' ILE . 12.6 pt-20 -103.9 162.54 19.64 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.199 -1.177 . . . . 0.0 109.745 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.835 ' HB3' HD12 ' A' ' 11' ' ' ILE . 10.1 Cg_endo -76.64 -155.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.58 2.187 . . . . 0.0 110.067 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 1.006 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER 179.48 49.64 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.336 -0.852 . . . . 0.0 110.56 179.115 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . -130.63 -2.92 4.75 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.078 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.499 ' N ' ' CD ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -56.92 99.47 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.242 -1.152 . . . . 0.0 110.29 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.474 ' HB2' ' C ' ' A' ' 37' ' ' GLY . 5.7 tp10 -82.1 84.43 7.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.114 -0.991 . . . . 0.0 108.821 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.07 16.95 65.05 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.507 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 2.8 pt20 -121.54 164.62 23.5 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.556 -0.967 . . . . 0.0 109.003 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 3.2 Cg_exo -65.65 -49.35 2.4 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 121.742 1.628 . . . . 0.0 109.79 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.622 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.94 119.27 0.01 OUTLIER Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.567 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 2.4 pt-20 -151.96 134.7 15.52 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.037 -1.273 . . . . 0.0 110.846 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.611 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 2.1 m0 -48.85 127.88 14.7 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.78 ' HB3' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -108.23 133.41 52.51 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -178.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.521 ' HA ' ' OE2' ' A' ' 17' ' ' GLU . 1.6 t -84.65 41.12 0.83 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.411 -1.431 . . . . 0.0 109.531 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.608 HD21 ' CA ' ' A' ' 110' ' ' LEU . 1.6 tt -82.54 150.96 26.64 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.483 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 48.4 t -119.52 132.32 69.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 109.293 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 129' ' ' LEU . . . 39.96 80.8 0.03 OUTLIER Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 1.083 HD22 ' CD2' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -41.87 163.71 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.479 -1.013 . . . . 0.0 110.072 -178.177 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.697 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 3.8 t30 -138.79 0.4 2.0 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 111.322 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 82.59 -33.62 0.09 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.221 -0.924 . . . . 0.0 108.632 -178.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -50.87 -28.91 10.55 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.512 -0.742 . . . . 0.0 109.044 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.562 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 8.5 m-20 -101.33 -19.41 15.64 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.538 -0.726 . . . . 0.0 109.406 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 1.083 ' CD2' HD22 ' A' ' 110' ' ' LEU . 1.3 m-85 -86.26 142.46 35.72 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.332 -0.855 . . . . 0.0 108.723 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.57 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.2 Cg_endo -62.94 146.28 94.78 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.276 1.984 . . . . 0.0 110.249 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.508 ' HA ' ' CD ' ' A' ' 120' ' ' GLU . 1.3 Cg_endo -64.4 -18.9 64.68 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.182 1.921 . . . . 0.0 110.994 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.66 -56.48 20.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.094 . . . . 0.0 110.09 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.877 ' O ' HD12 ' A' ' 123' ' ' ILE . 9.0 m-80 -91.62 44.96 1.2 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.094 -1.004 . . . . 0.0 109.852 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.709 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 1.3 tp10 -60.71 -47.07 96.94 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.442 -0.786 . . . . 0.0 112.156 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.709 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 24.6 Cg_exo -43.85 -48.14 9.33 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.115 1.877 . . . . 0.0 112.452 -177.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.878 HG11 ' CG ' ' A' ' 84' ' ' PHE . 2.5 t -91.67 -25.75 5.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 O-C-N 120.619 -1.301 . . . . 0.0 107.874 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.879 ' HA ' HD22 ' A' ' 126' ' ' LEU . 1.5 mt -69.42 -11.55 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.539 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -71.36 -27.68 63.53 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -80.24 -38.83 30.24 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.752 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.879 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -67.03 -22.87 65.86 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.525 -1.359 . . . . 0.0 107.719 179.299 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 2.7 mtmm -56.77 -31.46 64.65 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -89.82 -21.78 22.42 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.327 -0.852 . . . . 0.0 108.711 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 1.4 tp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.77 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.446 ' CG ' ' N ' ' A' ' 4' ' ' LEU . 2.1 ttpt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 121.45 0.643 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -160.48 160.0 31.5 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.133 -0.979 . . . . 0.0 109.161 178.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.794 ' HB2' HG23 ' A' ' 40' ' ' ILE . 15.3 mp0 -131.09 173.22 11.24 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.179 -0.951 . . . . 0.0 108.657 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.85 116.75 7.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 121.131 -0.98 . . . . 0.0 109.084 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.096 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -82.29 67.63 8.39 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.845 HG11 ' CD2' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -79.15 -76.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.273 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.697 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 65.3 78.48 0.22 Allowed Glycine 0 C--N 1.295 -1.697 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 -178.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.835 HD12 ' NH2' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -47.15 168.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -178.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.942 HG22 HG22 ' A' ' 87' ' ' VAL . 3.7 pt -140.38 93.85 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 120.859 -1.15 . . . . 0.0 110.083 -177.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.872 ' NH1' HD13 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -95.56 152.08 18.75 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.621 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -161.08 -10.39 0.04 OUTLIER 'General case' 0 C--O 1.188 -2.182 0 C-N-CA 116.663 -2.015 . . . . 0.0 115.444 -177.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.452 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -94.47 -31.16 14.07 Favored 'General case' 0 N--CA 1.51 2.548 0 O-C-N 118.047 -2.908 . . . . 0.0 108.458 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.8 -48.75 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 102.174 -3.269 . . . . 0.0 102.174 177.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.43 ' C ' ' OE1' ' A' ' 17' ' ' GLU . 16.9 t30 -162.03 38.31 0.12 Allowed 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 175.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -85.35 93.14 8.65 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.432 -1.307 . . . . 0.0 110.697 -177.056 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 2.0 pt -79.12 146.83 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.63 0.729 . . . . 0.0 111.063 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.687 ' HB3' HD11 ' A' ' 11' ' ' ILE . 6.3 t80 -82.75 43.68 0.86 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.837 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -80.67 151.11 4.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.07 0.938 . . . . 0.0 110.49 -178.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.695 HG23 ' O ' ' A' ' 21' ' ' THR . 5.3 t -66.56 91.34 0.18 Allowed 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.713 ' HD2' HD21 ' A' ' 33' ' ' LEU . 21.4 tpt180 -94.47 140.5 29.75 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.281 -0.887 . . . . 0.0 108.712 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.841 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -32.21 91.19 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . -42.82 -54.44 4.13 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.493 -0.754 . . . . 0.0 109.149 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.69 -163.09 0.53 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.712 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 73.2 m-20 -70.09 -49.96 45.72 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.908 -1.12 . . . . 0.0 109.805 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.841 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . 81.98 -24.16 0.19 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.346 -0.846 . . . . 0.0 110.212 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.498 ' O ' ' HG2' ' A' ' 29' ' ' MET . 0.1 OUTLIER 47.77 25.43 0.71 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.79 -1.193 . . . . 0.0 108.047 -178.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 28' ' ' HIS . 20.7 mmt -154.94 -167.68 2.65 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.545 ' HB1' ' OD1' ' A' ' 114' ' ' ASP . . . -153.09 -162.47 1.49 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 108.929 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 1.0 OUTLIER 77.18 -2.71 2.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.443 -0.786 . . . . 0.0 109.327 -179.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.656 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -82.09 55.34 2.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.47 -0.769 . . . . 0.0 110.097 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.713 HD21 ' HD2' ' A' ' 22' ' ' ARG . 6.6 mt -124.06 86.53 2.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.805 -1.184 . . . . 0.0 108.544 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.837 ' O ' HD11 ' A' ' 20' ' ' ILE . 4.6 tt0 -82.38 -123.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.078 -1.014 . . . . 0.0 110.32 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -161.38 123.68 1.75 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 120.646 -1.284 . . . . 0.0 109.277 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.777 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.9 Cg_endo -65.03 99.09 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.884 1.723 . . . . 0.0 109.725 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -95.02 -130.77 6.19 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.994 -1.098 . . . . 0.0 111.663 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.505 ' HA2' ' OE1' ' A' ' 98' ' ' GLU . . . 150.06 -8.65 0.81 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 15.2 tptm 72.78 106.13 0.07 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.39 0.614 . . . . 0.0 111.056 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.87 HG12 ' HB1' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -81.63 134.7 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.414 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 42' ' ' MET . 2.4 pt-20 -172.33 -29.37 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.216 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.428 ' O ' ' C ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -55.17 160.63 2.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.923 -1.111 . . . . 0.0 108.914 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.454 ' C ' ' HG2' ' A' ' 44' ' ' GLU . . . 46.35 -127.14 9.69 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.454 ' HG2' ' C ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -166.57 23.46 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.35 -1.088 . . . . 0.0 109.046 179.061 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.565 HG23 ' HD2' ' A' ' 46' ' ' PRO . 87.4 m -142.73 142.67 23.3 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.573 ' O ' HG12 ' A' ' 50' ' ' VAL . 9.0 Cg_exo -48.94 -16.8 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.899 1.732 . . . . 0.0 111.107 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.528 ' O ' HG12 ' A' ' 51' ' ' VAL . 4.8 mt-10 -78.5 -80.4 0.11 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.747 -1.221 . . . . 0.0 108.63 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.595 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 30.6 mt-30 -51.69 -23.94 5.07 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.396 -1.44 . . . . 0.0 109.164 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.87 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -72.1 -64.08 1.01 Allowed 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.484 -0.76 . . . . 0.0 109.737 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.096 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.6 p -70.06 -49.14 58.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.251 -0.906 . . . . 0.0 110.192 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.566 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 1.4 p -52.96 -44.62 50.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 O-C-N 121.749 -0.594 . . . . 0.0 110.292 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 7.8 mmt180 -73.57 -39.66 64.51 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.604 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 6.3 mm-40 -66.67 -15.12 63.27 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.792 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -80.19 -61.08 2.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -54.55 43.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.799 . . . . 0.0 109.906 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.568 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -46.0 -24.22 0.39 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -0.963 . . . . 0.0 109.658 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.44 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.2 mt-10 -79.99 -95.67 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.169 -0.957 . . . . 0.0 109.525 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.607 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 46.9 t -80.0 -78.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 110.109 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.12 24.19 0.12 Allowed Glycine 0 N--CA 1.494 2.507 0 C-N-CA 118.922 -1.609 . . . . 0.0 112.361 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.047 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.1 pp -84.38 -146.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.325 -1.691 . . . . 0.0 107.827 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.708 ' H ' HD12 ' A' ' 60' ' ' ILE . 1.2 m -161.03 -66.92 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 120.174 -1.579 . . . . 0.0 112.329 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.599 ' O ' ' CG ' ' A' ' 63' ' ' GLN . 10.2 Cg_exo -43.54 -94.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.169 1.912 . . . . 0.0 112.426 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.778 ' OE1' HG11 ' A' ' 87' ' ' VAL . 3.2 pt20 54.05 6.21 0.09 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.197 -0.939 . . . . 0.0 111.382 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.598 ' C ' ' O ' ' A' ' 63' ' ' GLN . 5.3 t-160 22.32 50.69 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.58 0 O-C-N 120.962 -1.086 . . . . 0.0 110.444 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 63' ' ' GLN . 1.7 p90 -35.52 141.34 0.08 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.091 0.948 . . . . 0.0 112.127 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -145.2 147.58 32.59 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.609 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -77.85 -65.28 0.99 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.79 -1.194 . . . . 0.0 110.13 -179.004 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.824 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 82.71 -51.33 0.18 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.302 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER 163.42 178.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 0.0 109.496 179.144 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.602 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 15.1 ptmt -160.96 170.3 20.86 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.301 -0.874 . . . . 0.0 109.727 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.74 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -136.16 171.58 14.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.098 179.582 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -150.09 94.15 2.11 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.01 122.23 26.48 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.483 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 15.0 tt0 -96.67 127.64 42.85 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.108 -0.995 . . . . 0.0 109.468 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.563 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 7.1 m-85 -106.7 168.34 8.24 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.362 -0.836 . . . . 0.0 109.17 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 7.5 Cg_exo -48.7 -28.48 12.68 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.943 1.762 . . . . 0.0 109.77 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.495 ' O ' ' HD2' ' A' ' 78' ' ' ARG . 8.0 m-20 -162.25 31.08 0.11 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.546 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.66 89.98 2.36 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.71 -0.619 . . . . 0.0 109.961 -178.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.859 ' C ' HD12 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -89.86 113.3 24.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.911 -1.118 . . . . 0.0 109.126 179.58 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.859 HD12 ' C ' ' A' ' 79' ' ' HIS . 1.6 mp -118.54 155.71 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.974 -1.079 . . . . 0.0 110.446 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.551 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 1.9 m -136.14 137.84 41.39 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.845 ' CD2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -127.22 75.89 1.62 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.815 -1.178 . . . . 0.0 110.101 -179.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.602 ' CE3' ' HD2' ' A' ' 70' ' ' LYS . 92.2 m95 -51.79 111.24 0.57 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.265 -0.897 . . . . 0.0 109.45 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.548 ' O ' ' O ' ' A' ' 67' ' ' LEU . 45.5 m-85 -86.92 73.04 10.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.9 . . . . 0.0 110.178 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.697 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 12.7 m95 -71.94 85.76 0.99 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.819 -1.176 . . . . 0.0 108.328 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.824 HD23 ' CD2' ' A' ' 68' ' ' PHE . 2.8 mm? -67.78 125.78 27.33 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.478 -1.389 . . . . 0.0 110.024 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.942 HG22 HG22 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -112.29 169.81 4.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 38.8 mt-10 -160.54 29.59 0.16 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 117.972 -1.491 . . . . 0.0 112.552 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.581 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.85 30.19 0.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.329 -1.482 . . . . 0.0 109.943 179.235 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.67 ' HB2' HD13 ' A' ' 60' ' ' ILE . 1.6 p90 -48.96 148.78 2.12 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.951 -1.093 . . . . 0.0 109.967 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.574 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 1.6 tt0 -81.26 133.11 35.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.387 -0.821 . . . . 0.0 109.722 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 45.75 -86.89 0.01 OUTLIER Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 1.047 ' O ' HG21 ' A' ' 60' ' ' ILE . 17.1 pt-20 -100.6 161.89 22.51 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.301 -1.117 . . . . 0.0 110.051 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.621 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 13.9 Cg_endo -79.05 -162.6 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.772 2.315 . . . . 0.0 109.908 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.792 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER 177.8 26.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.218 -0.927 . . . . 0.0 111.011 178.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.407 ' HA2' ' CD1' ' A' ' 54' ' ' LEU . . . -93.88 -48.67 2.64 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.521 -1.323 . . . . 0.0 110.24 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.687 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -42.47 146.07 0.37 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -1.117 . . . . 0.0 111.243 -179.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.505 ' OE1' ' HA2' ' A' ' 38' ' ' GLY . 6.2 tp10 -81.08 -97.32 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.449 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . -108.64 3.95 32.51 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.547 ' HG2' ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -74.85 174.85 4.62 Favored Pre-proline 0 N--CA 1.482 1.166 0 O-C-N 121.826 -0.808 . . . . 0.0 109.199 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 102' ' ' GLY . 2.1 Cg_endo -69.63 -50.86 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.95 1.767 . . . . 0.0 109.591 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.604 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 61.78 114.38 0.01 OUTLIER Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.064 -2.015 . . . . 0.0 108.064 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.574 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 7.1 pt-20 -148.61 135.85 20.23 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.113 -1.228 . . . . 0.0 110.441 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.622 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 5.0 m0 -48.18 129.29 15.1 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -119.79 119.2 32.92 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.85 -1.157 . . . . 0.0 110.032 -178.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.35 68.12 5.26 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.884 HD13 ' HG ' ' A' ' 110' ' ' LEU . 7.4 tt -81.86 -54.36 5.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 109.188 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.633 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 48.6 t 86.29 112.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 40.3 83.79 0.01 OUTLIER Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 1.099 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -40.22 165.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.725 -0.868 . . . . 0.0 110.596 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.601 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 14.6 t30 -144.15 1.75 1.12 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.126 -0.984 . . . . 0.0 111.234 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.628 ' HB2' HG23 ' A' ' 123' ' ' ILE . . . 70.24 -3.42 1.82 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.914 -1.116 . . . . 0.0 109.282 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -80.95 -24.68 37.95 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.545 ' OD1' ' HB1' ' A' ' 30' ' ' ALA . 3.3 m-20 -102.11 -13.11 17.62 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 1.099 ' CE1' HD21 ' A' ' 110' ' ' LEU . 4.0 m-85 -95.08 150.98 38.49 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.293 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.54 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.3 Cg_endo -66.63 139.75 54.21 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.498 2.132 . . . . 0.0 109.63 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 118' ' ' ALA . 2.4 Cg_endo -61.93 -31.15 84.46 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.224 1.949 . . . . 0.0 111.179 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.64 -44.83 4.42 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.004 -1.06 . . . . 0.0 110.187 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.585 ' OD1' HD21 ' A' ' 71' ' ' LEU . 3.5 m-80 -99.16 51.61 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 109.273 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.672 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.4 mt-10 -69.36 -36.57 7.31 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.558 -0.714 . . . . 0.0 112.437 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.3 Cg_exo -56.35 -34.89 95.3 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.511 1.474 . . . . 0.0 112.047 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.542 HG11 ' CE1' ' A' ' 84' ' ' PHE . 1.7 t -99.77 -36.48 5.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.583 -1.323 . . . . 0.0 108.829 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.628 HG23 ' HB2' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -66.64 -15.56 19.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.565 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.52 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -62.83 -29.9 71.09 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.485 ' HE2' ' OE2' ' A' ' 69' ' ' GLU . 12.8 mmtm -81.53 -39.43 24.69 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.094 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.78 HD12 HD13 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -66.62 -22.05 66.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.733 -1.229 . . . . 0.0 108.195 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.612 ' HD2' ' HB3' ' A' ' 112' ' ' ALA . 1.7 mtmt -53.23 -31.13 41.75 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.03 -27.85 22.95 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.361 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.78 HD13 HD12 ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.681 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 79' ' ' HIS . 9.1 tttt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 121.428 0.632 . . . . 0.0 109.804 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 1.059 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -158.67 147.36 18.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.478 -0.764 . . . . 0.0 109.007 178.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.708 ' HB2' HG23 ' A' ' 40' ' ' ILE . 1.6 mp0 -111.7 170.13 8.35 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 109.094 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.607 HG23 ' HA3' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -135.04 108.15 9.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.202 -179.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.034 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -82.81 72.68 9.88 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.541 -0.725 . . . . 0.0 109.327 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.786 HG22 ' N ' ' A' ' 9' ' ' GLY . 0.2 OUTLIER -83.81 -84.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.415 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.786 ' N ' HG22 ' A' ' 8' ' ' VAL . . . 81.33 78.37 0.97 Allowed Glycine 0 C--N 1.299 -1.475 0 N-CA-C 106.947 -2.461 . . . . 0.0 106.947 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.697 ' O ' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -48.21 150.5 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -178.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.815 HG22 ' CG1' ' A' ' 87' ' ' VAL . 10.0 pt -120.48 75.87 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.394 -177.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 1.012 ' NH1' HD21 ' A' ' 129' ' ' LEU . 0.5 OUTLIER -79.69 153.95 28.94 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.46 ' OD1' ' CH2' ' A' ' 90' ' ' TRP . 2.6 p-10 -154.14 -20.98 0.13 Allowed 'General case' 0 C--O 1.187 -2.225 0 C-N-CA 117.218 -1.793 . . . . 0.0 114.901 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.577 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 3.4 tt0 -93.41 -32.31 14.29 Favored 'General case' 0 N--CA 1.511 2.605 0 O-C-N 118.076 -2.89 . . . . 0.0 109.486 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.466 HD22 HG13 ' A' ' 108' ' ' VAL . 61.9 t30 -161.68 -47.44 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 102.971 -2.974 . . . . 0.0 102.971 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.793 ' ND2' HD23 ' A' ' 129' ' ' LEU . 1.5 m120 -161.87 38.07 0.13 Allowed 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.644 ' HA ' ' O ' ' A' ' 105' ' ' MET . 84.0 mt-10 -85.1 84.51 7.68 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.143 -1.423 . . . . 0.0 110.43 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.865 HG23 ' HB3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -78.97 153.85 4.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.434 0.635 . . . . 0.0 109.942 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.737 ' CB ' HD11 ' A' ' 11' ' ' ILE . 6.8 t80 -83.16 42.77 0.83 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.732 HD11 ' C ' ' A' ' 34' ' ' GLU . 5.5 tp -80.69 148.81 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-O 122.585 1.183 . . . . 0.0 111.734 -176.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.614 ' H ' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -58.43 89.41 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.593 ' O ' ' C ' ' A' ' 23' ' ' ARG . 32.0 tpt180 -97.24 91.89 5.75 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.724 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.836 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 13.68 79.4 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.356 0.598 . . . . 0.0 110.971 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -41.56 -56.05 2.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.424 -0.798 . . . . 0.0 110.287 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.75 -179.04 3.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.069 -1.019 . . . . 0.0 109.476 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.96 84.44 4.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.214 -0.929 . . . . 0.0 109.534 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.836 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -72.54 -36.92 68.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.243 -0.911 . . . . 0.0 109.324 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 49.92 23.57 1.1 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.583 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -117.12 -33.96 4.53 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.563 -0.711 . . . . 0.0 109.1 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.616 ' HB1' ' OD1' ' A' ' 114' ' ' ASP . . . 69.19 -177.65 0.21 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.437 -0.789 . . . . 0.0 109.822 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 1.1 t30 78.96 -8.63 1.62 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.523 -0.736 . . . . 0.0 109.523 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.567 ' HD2' ' CA ' ' A' ' 23' ' ' ARG . 4.8 tttp -83.29 51.47 1.98 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.385 -0.822 . . . . 0.0 110.227 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.944 HD13 HD21 ' A' ' 110' ' ' LEU . 17.4 mt -107.73 85.84 2.19 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.732 ' C ' HD11 ' A' ' 20' ' ' ILE . 1.5 tt0 -87.4 -137.28 0.09 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.388 -1.445 . . . . 0.0 109.614 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.679 ' CE2' ' CE1' ' A' ' 115' ' ' PHE . 10.9 m-85 -153.31 126.61 4.2 Favored Pre-proline 0 N--CA 1.486 1.364 0 O-C-N 121.048 -1.032 . . . . 0.0 109.586 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.726 ' O ' HG23 ' A' ' 8' ' ' VAL . 5.4 Cg_endo -65.64 89.17 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.011 1.807 . . . . 0.0 108.483 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.607 ' HA3' HG23 ' A' ' 6' ' ' ILE . . . -115.34 107.18 1.7 Allowed Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.714 -1.231 . . . . 0.0 111.525 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.513 ' HA2' ' CD ' ' A' ' 98' ' ' GLU . . . -82.14 16.81 20.61 Favored Glycine 0 N--CA 1.489 2.181 0 O-C-N 121.576 -0.955 . . . . 0.0 111.168 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.594 ' CD ' HD23 ' A' ' 4' ' ' LEU . 3.1 tptm 63.9 108.25 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 118.244 1.022 . . . . 0.0 110.984 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.034 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -80.37 138.67 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.924 -1.11 . . . . 0.0 109.017 178.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -172.28 -32.81 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.89 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.437 ' SD ' ' HB3' ' A' ' 52' ' ' ARG . 38.5 mtt -55.74 159.34 3.1 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.128 -0.982 . . . . 0.0 109.511 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.56 -130.5 9.39 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.16 24.44 0.11 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.435 -1.038 . . . . 0.0 108.749 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.54 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 27.4 m -136.82 140.86 33.03 Favored Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.574 ' HG3' ' CH2' ' A' ' 83' ' ' TRP . 7.1 Cg_exo -50.09 -20.35 5.2 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.815 1.677 . . . . 0.0 109.897 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 51' ' ' VAL . 3.2 mt-10 -75.72 -87.35 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.346 -0.846 . . . . 0.0 108.763 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.536 ' O ' ' CG ' ' A' ' 52' ' ' ARG . 42.3 mt-30 -41.72 -33.01 0.43 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.845 -1.159 . . . . 0.0 110.147 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.797 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -67.19 -63.26 1.1 Allowed 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.024 -1.047 . . . . 0.0 109.674 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.887 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.2 p -66.72 -49.38 75.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.645 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.573 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 4.1 p -57.31 -44.65 84.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.547 -0.721 . . . . 0.0 110.34 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.536 ' CG ' ' O ' ' A' ' 48' ' ' GLN . 14.9 mmt180 -72.05 -32.25 66.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.009 -1.057 . . . . 0.0 108.665 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.616 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 12.4 mm-40 -75.22 -15.96 60.51 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.949 HD12 ' CG ' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -79.97 -62.62 1.63 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.749 0.785 . . . . 0.0 108.997 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.49 ' N ' ' CZ3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.45 -51.74 68.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.784 -0.572 . . . . 0.0 109.691 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.598 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -47.15 -26.22 1.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.888 -1.133 . . . . 0.0 108.868 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 54' ' ' LEU . 3.6 mt-10 -80.05 -95.3 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.355 -0.841 . . . . 0.0 109.377 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.725 HG21 ' HA ' ' A' ' 95' ' ' TRP . 28.2 t -80.21 -78.91 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.304 -0.873 . . . . 0.0 110.321 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 138.2 32.5 0.21 Allowed Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.374 -1.394 . . . . 0.0 111.275 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.001 HD13 ' HB2' ' A' ' 90' ' ' TRP . 1.1 pp -90.75 -152.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.589 -1.536 . . . . 0.0 108.278 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.72 ' H ' HD12 ' A' ' 60' ' ' ILE . 1.6 m -162.23 -63.16 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.349 -1.469 . . . . 0.0 112.73 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.639 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 6.3 Cg_exo -55.9 0.62 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.537 2.158 . . . . 0.0 114.373 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.778 ' HB3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -39.18 -27.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.623 -1.298 . . . . 0.0 110.289 -179.07 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 62' ' ' PRO . 1.9 t60 51.84 88.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.495 ' HB3' ' NE2' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -88.87 159.31 17.76 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.377 1.084 . . . . 0.0 111.901 -177.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -153.64 141.15 19.81 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.242 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.614 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -63.31 -67.22 0.44 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.878 -1.139 . . . . 0.0 110.272 -178.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.666 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 84.05 -51.75 0.13 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.264 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.578 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 4.9 tp10 159.54 135.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.563 ' HE3' ' CD2' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -125.6 -177.76 4.02 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.467 -0.771 . . . . 0.0 109.515 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -136.51 -177.41 4.71 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.341 -0.85 . . . . 0.0 109.938 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -151.71 86.16 1.32 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.15 104.01 9.48 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -95.18 154.41 17.2 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.416 -0.914 . . . . 0.0 108.587 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.577 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -141.73 173.09 5.1 Favored Pre-proline 0 C--N 1.297 -1.677 0 O-C-N 121.214 -0.929 . . . . 0.0 109.104 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 7.3 Cg_exo -48.23 -39.39 34.54 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 121.776 1.651 . . . . 0.0 109.703 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.452 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 4.7 p-10 -148.21 35.14 0.81 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.476 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -142.73 78.95 1.63 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.549 -0.719 . . . . 0.0 110.077 -178.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.953 ' C ' HD12 ' A' ' 80' ' ' ILE . 24.5 m170 -82.35 119.58 24.33 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.953 HD12 ' C ' ' A' ' 79' ' ' HIS . 2.3 mp -129.69 162.75 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 118.793 -1.163 . . . . 0.0 111.433 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.602 ' N ' HG22 ' A' ' 80' ' ' ILE . 2.0 m -147.32 148.84 31.8 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.32 82.96 1.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.716 -1.24 . . . . 0.0 110.348 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.694 ' CD1' HG21 ' A' ' 40' ' ' ILE . 89.8 m95 -54.05 111.76 0.82 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.267 -0.896 . . . . 0.0 109.034 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.653 ' CE2' HG11 ' A' ' 122' ' ' VAL . 11.6 m-85 -88.6 68.05 8.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.247 -0.908 . . . . 0.0 109.793 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.641 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 75.3 m95 -72.36 84.29 1.08 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.794 -1.191 . . . . 0.0 109.747 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.697 HD13 ' O ' ' A' ' 10' ' ' ILE . 3.2 mm? -68.07 129.44 39.91 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.566 -1.334 . . . . 0.0 109.942 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.815 ' CG1' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -111.2 -175.08 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.653 ' N ' HG23 ' A' ' 87' ' ' VAL . 1.2 mt-10 -159.89 8.13 0.1 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 117.612 -1.635 . . . . 0.0 113.54 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.572 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.73 71.96 0.44 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 119.855 -1.778 . . . . 0.0 110.651 178.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 1.001 ' HB2' HD13 ' A' ' 60' ' ' ILE . 17.4 p90 -80.69 163.0 23.9 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.718 -1.239 . . . . 0.0 110.191 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.648 ' O ' ' N ' ' A' ' 93' ' ' GLU . 5.0 pt-20 -81.81 135.53 35.45 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.179 -0.951 . . . . 0.0 109.762 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 35.02 -80.34 0.0 OUTLIER Glycine 0 N--CA 1.502 3.088 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.966 ' O ' HG21 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -98.82 153.32 37.92 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.333 -1.098 . . . . 0.0 109.219 -179.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.64 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 20.2 Cg_endo -80.85 -159.07 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.787 2.325 . . . . 0.0 110.025 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.949 ' CG ' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER 178.58 132.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.771 0.796 . . . . 0.0 110.017 178.184 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . 152.93 -40.04 0.72 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.509 ' N ' ' CD ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -41.09 107.51 0.07 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.517 -0.99 . . . . 0.0 109.526 -179.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 5.5 tp10 -77.38 87.28 3.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.273 -0.892 . . . . 0.0 108.712 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.35 30.71 65.04 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.497 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 7.4 pt20 -125.96 168.08 15.05 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.475 -1.015 . . . . 0.0 109.299 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 9.8 Cg_endo -78.21 42.6 1.24 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.562 2.175 . . . . 0.0 110.842 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.57 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . -44.78 123.82 5.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.615 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -146.79 144.38 29.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -1.118 . . . . 0.0 109.8 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.48 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 1.2 m-90 -52.35 139.84 23.47 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.968 -1.083 . . . . 0.0 108.225 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.644 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -139.06 108.85 6.26 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.286 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.524 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -81.33 46.79 0.97 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.597 -0.689 . . . . 0.0 109.351 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 1.066 HD22 ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -64.72 -12.7 49.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 108.859 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.879 ' N ' HD13 ' A' ' 107' ' ' LEU . 1.4 t 59.63 121.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.452 -0.78 . . . . 0.0 110.189 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.634 ' HA2' ' HB3' ' A' ' 129' ' ' LEU . . . 38.12 74.06 0.13 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 1.188 HD22 ' CD2' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -38.19 158.24 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.914 -0.756 . . . . 0.0 109.905 -178.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.88 ' H ' HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -154.76 143.77 20.98 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.139 -0.976 . . . . 0.0 110.182 -178.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . . . -44.07 -27.84 0.42 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -42.07 -53.93 3.76 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.317 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.616 ' OD1' ' HB1' ' A' ' 30' ' ' ALA . 14.3 m-20 -97.94 -9.75 25.7 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 1.188 ' CD2' HD22 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -91.96 136.92 25.55 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.543 -0.723 . . . . 0.0 109.754 -179.26 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' A' ' 123' ' ' ILE . 2.5 Cg_endo -68.24 153.6 74.14 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.373 2.049 . . . . 0.0 110.22 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 118' ' ' ALA . 1.7 Cg_endo -65.12 -36.37 37.53 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.212 1.941 . . . . 0.0 110.817 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -39.37 -47.79 1.81 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.408 -0.807 . . . . 0.0 110.123 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.596 ' O ' HD12 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -98.64 55.83 1.09 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.372 -0.83 . . . . 0.0 109.034 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.651 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -69.13 -47.17 29.53 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.722 -0.611 . . . . 0.0 111.688 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 8.2 Cg_exo -52.25 -40.12 70.55 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.194 1.929 . . . . 0.0 112.846 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.653 HG11 ' CE2' ' A' ' 84' ' ' PHE . 2.2 t -98.21 -34.05 4.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 O-C-N 120.642 -1.286 . . . . 0.0 109.5 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.855 HD13 ' HB3' ' A' ' 115' ' ' PHE . 31.4 mt -59.0 -29.18 40.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.539 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -59.44 -35.08 73.35 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.928 0.871 . . . . 0.0 109.129 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.0 mmmt -77.68 -35.58 52.11 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.567 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 1.099 HD23 ' CE2' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -66.71 -34.62 78.26 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.158 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 7.1 mtpt -45.4 -29.01 0.97 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.568 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -91.2 -34.65 14.91 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.297 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 1.012 HD21 ' NH1' ' A' ' 12' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.508 2.426 0 CA-C-O 118.035 -0.983 . . . . 0.0 111.635 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.422 ' CG ' ' N ' ' A' ' 4' ' ' LEU . 15.1 tttt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.333 0.587 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 1.07 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -158.38 143.84 16.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.808 . . . . 0.0 109.278 179.105 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.653 ' HB2' HG23 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -113.53 166.74 11.21 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.86 -1.15 . . . . 0.0 108.394 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.532 ' CG2' ' HA2' ' A' ' 37' ' ' GLY . 0.3 OUTLIER -127.23 110.95 23.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.957 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -81.85 68.55 8.27 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.745 HG22 ' N ' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -79.47 -83.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.465 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.745 ' N ' HG22 ' A' ' 8' ' ' VAL . . . 75.61 82.3 0.48 Allowed Glycine 0 N--CA 1.479 1.517 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 -178.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.607 ' O ' HD13 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -49.13 157.2 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.939 HG22 HG22 ' A' ' 87' ' ' VAL . 1.6 pt -124.54 85.27 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.866 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -77.51 167.75 21.12 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.2 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.487 ' OD1' ' HB2' ' A' ' 17' ' ' GLU . 2.0 p-10 -161.94 -26.11 0.05 OUTLIER 'General case' 0 C--O 1.185 -2.31 0 C-N-CA 115.966 -2.294 . . . . 0.0 114.889 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HB3' ' OE2' ' A' ' 17' ' ' GLU . 4.9 tt0 -95.01 -34.22 12.43 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 118.36 -2.712 . . . . 0.0 109.132 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -162.35 -45.95 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 103.211 -2.885 . . . . 0.0 103.211 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.67 ' OD1' HD23 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -160.37 36.2 0.17 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 176.511 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -88.14 98.95 11.84 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.088 -1.445 . . . . 0.0 109.234 -178.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.604 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -92.34 150.09 3.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.927 0.87 . . . . 0.0 111.265 -178.414 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.657 ' CE1' ' HA ' ' A' ' 103' ' ' GLU . 14.3 t80 -82.2 43.71 0.81 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.721 HD11 ' C ' ' A' ' 34' ' ' GLU . 5.1 tp -81.02 154.96 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-O 122.053 0.93 . . . . 0.0 111.269 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.52 ' H ' HD12 ' A' ' 20' ' ' ILE . 1.4 t -66.14 93.72 0.22 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.739 ' HD3' HD21 ' A' ' 33' ' ' LEU . 23.7 tpt180 -102.05 149.01 24.69 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.668 -0.645 . . . . 0.0 109.601 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.866 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -34.34 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . -46.55 -54.34 9.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.382 -0.823 . . . . 0.0 110.393 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.49 -151.1 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.006 -1.058 . . . . 0.0 109.204 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.35 -51.39 10.92 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.292 -0.88 . . . . 0.0 109.066 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.866 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . 57.7 -168.45 0.12 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.639 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -162.34 -35.07 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.648 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 1.5 mpt? -49.61 -46.44 49.31 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.337 -0.852 . . . . 0.0 109.398 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 29' ' ' MET . . . 72.34 5.63 5.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.288 -0.883 . . . . 0.0 109.456 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -98.65 11.64 37.85 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.24 -0.912 . . . . 0.0 108.853 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -81.8 54.78 2.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.602 -0.686 . . . . 0.0 110.402 -179.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.739 HD21 ' HD3' ' A' ' 22' ' ' ARG . 15.0 mt -122.49 84.55 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.64 -1.287 . . . . 0.0 109.666 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.721 ' C ' HD11 ' A' ' 20' ' ' ILE . 1.4 tt0 -82.84 -136.86 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.987 -1.071 . . . . 0.0 109.983 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.711 ' HE2' HD11 ' A' ' 123' ' ' ILE . 77.7 m-85 -152.0 125.37 4.22 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.124 -0.985 . . . . 0.0 109.338 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.648 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -58.09 90.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.616 1.544 . . . . 0.0 109.127 178.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.532 ' HA2' ' CG2' ' A' ' 6' ' ' ILE . . . -56.27 -142.46 0.01 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 154.56 -33.3 0.69 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 69.89 97.02 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 122.185 -0.597 . . . . 0.0 109.397 -179.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.957 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -80.23 132.62 31.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.794 179.346 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.504 ' HB3' ' NZ ' ' A' ' 39' ' ' LYS . 6.6 pt-20 -170.67 -34.14 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.47 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -47.85 147.16 2.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.337 -0.852 . . . . 0.0 109.54 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 53.03 -120.92 13.76 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.06 23.07 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.647 -0.914 . . . . 0.0 109.125 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.458 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 56.1 m -138.68 139.13 23.34 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.609 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 14.2 Cg_exo -49.3 -17.25 1.45 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.004 1.803 . . . . 0.0 110.606 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.49 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.4 mt-10 -77.89 -83.14 0.08 Allowed 'General case' 0 C--O 1.203 -1.352 0 O-C-N 120.934 -1.104 . . . . 0.0 108.557 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.527 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 36.9 mt-30 -45.67 -33.62 3.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.502 -1.374 . . . . 0.0 109.54 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.732 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -65.2 -63.34 1.13 Allowed 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.452 -0.78 . . . . 0.0 110.24 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.814 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.4 p -68.82 -48.99 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.912 -1.118 . . . . 0.0 110.607 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.575 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 2.3 p -54.63 -44.06 68.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 121.371 0.605 . . . . 0.0 110.295 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.551 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 18.7 mmt180 -74.87 -34.49 62.26 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.642 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 20.8 mm-40 -71.21 -13.39 61.9 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.006 HD12 ' NE1' ' A' ' 95' ' ' TRP . 1.1 mm? -79.34 -64.31 1.22 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.519 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.12 -51.49 69.1 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.54 -0.725 . . . . 0.0 110.187 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.59 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 1.3 pp20? -50.18 -21.08 1.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.052 -1.03 . . . . 0.0 110.479 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -80.14 -92.22 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.918 -1.114 . . . . 0.0 110.038 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.789 HG21 ' HA ' ' A' ' 95' ' ' TRP . 21.0 t -79.98 -79.17 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.426 -0.796 . . . . 0.0 109.678 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.54 22.72 0.1 Allowed Glycine 0 N--CA 1.495 2.605 0 C-N-CA 118.485 -1.817 . . . . 0.0 112.554 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.094 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.6 pp -82.93 -166.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.283 -1.716 . . . . 0.0 108.031 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.67 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 2.0 m -123.36 -71.73 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.434 -1.416 . . . . 0.0 110.844 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.67 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 5.7 Cg_endo -64.19 -170.82 0.13 Allowed 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.078 1.185 . . . . 0.0 109.707 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.601 ' HG2' ' CZ2' ' A' ' 95' ' ' TRP . 0.7 OUTLIER 139.54 -23.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -179.204 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.537 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 1.9 t60 57.23 -167.41 0.13 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' A' ' 64' ' ' HIS . 28.3 p90 -179.38 150.83 0.45 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.414 -1.314 . . . . 0.0 110.676 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -159.35 141.89 13.9 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.61 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -65.95 -66.71 0.52 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.04 -1.037 . . . . 0.0 109.313 -179.507 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.871 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 85.38 -55.07 0.09 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.562 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 9.5 tp10 169.62 151.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.613 ' HA ' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -143.67 -164.53 1.89 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.847 -1.158 . . . . 0.0 109.295 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.675 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -150.96 -177.13 5.83 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.208 -0.933 . . . . 0.0 110.419 -179.643 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -149.51 90.78 1.75 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -78.21 108.35 11.46 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.433 ' HG3' ' NE2' ' A' ' 79' ' ' HIS . 25.0 tt0 -92.62 99.57 12.25 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.488 -0.758 . . . . 0.0 110.158 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.52 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -79.26 170.97 13.75 Favored Pre-proline 0 C--N 1.301 -1.503 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.338 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.52 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 5.5 Cg_exo -51.89 -55.02 4.31 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.872 1.715 . . . . 0.0 109.606 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.04 35.88 4.08 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.513 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -144.31 91.52 2.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.521 -0.737 . . . . 0.0 109.682 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.498 ' C ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -82.15 90.99 6.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.752 -1.218 . . . . 0.0 109.087 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.761 HG13 HD11 ' A' ' 4' ' ' LEU . 1.0 OUTLIER -98.84 157.28 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.005 -1.059 . . . . 0.0 110.272 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.608 ' N ' HG22 ' A' ' 80' ' ' ILE . 2.2 m -136.34 170.6 15.77 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.651 HD22 ' OD1' ' A' ' 119' ' ' ASN . 0.2 OUTLIER -159.5 85.8 0.79 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.601 -1.312 . . . . 0.0 110.035 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.604 ' CD1' HG21 ' A' ' 40' ' ' ILE . 97.3 m95 -65.43 115.12 5.35 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.786 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.873 ' CD2' HG11 ' A' ' 122' ' ' VAL . 10.1 m-85 -89.56 71.32 7.91 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.938 -1.101 . . . . 0.0 109.606 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.693 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 88.4 m95 -72.28 87.81 1.14 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.015 -1.053 . . . . 0.0 109.149 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.871 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.0 mm? -68.39 130.16 42.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.755 -1.216 . . . . 0.0 110.121 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.939 HG22 HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -117.61 176.89 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.551 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 23.4 mt-10 -159.76 28.88 0.19 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.386 -1.446 . . . . 0.0 112.944 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.595 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -159.62 57.98 0.38 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 119.878 -1.764 . . . . 0.0 111.721 178.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.588 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 2.4 p90 -79.15 162.37 25.83 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.222 -1.549 . . . . 0.0 109.267 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.629 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -92.94 145.86 24.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.999 -1.063 . . . . 0.0 109.583 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 39.29 -87.51 0.01 OUTLIER Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 1.094 ' O ' HG21 ' A' ' 60' ' ' ILE . 2.8 pt-20 -105.34 157.04 35.3 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.235 -1.156 . . . . 0.0 109.868 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.61 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 10.6 Cg_endo -75.59 -159.07 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.93 2.42 . . . . 0.0 110.263 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 1.006 ' NE1' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -179.56 66.16 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.291 -0.881 . . . . 0.0 110.36 178.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . -139.07 -33.71 0.17 Allowed Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.367 -1.397 . . . . 0.0 110.688 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.588 ' HG3' ' CE2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -39.62 106.79 0.06 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.129 -1.218 . . . . 0.0 110.496 -179.063 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.504 ' HB2' ' C ' ' A' ' 37' ' ' GLY . 8.0 tp10 -80.43 100.59 8.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.265 -0.897 . . . . 0.0 109.139 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 54.12 21.96 19.66 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.587 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 7.8 pt20 -122.75 170.82 7.41 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.497 -1.002 . . . . 0.0 108.868 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.587 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 4.2 Cg_exo -63.14 -46.14 10.87 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.0 1.8 . . . . 0.0 110.785 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.58 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 59.69 112.81 0.01 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.657 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 5.2 pt-20 -152.76 137.25 16.76 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.136 -1.214 . . . . 0.0 110.493 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.499 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 1.7 m-90 -48.64 135.7 14.32 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.602 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -125.85 115.65 20.32 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.197 -0.939 . . . . 0.0 109.521 -179.055 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.469 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -82.54 57.81 3.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 110.015 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.854 HD21 ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -80.69 -41.28 23.95 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.168 -0.958 . . . . 0.0 108.417 179.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.794 ' N ' HD23 ' A' ' 107' ' ' LEU . 86.4 t 70.13 126.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.854 -0.529 . . . . 0.0 109.938 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 41.18 81.43 0.03 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 1.158 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -42.79 166.7 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.487 -1.008 . . . . 0.0 110.545 -178.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.685 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -143.9 -7.34 0.74 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.325 -0.859 . . . . 0.0 111.846 -178.463 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 81.02 -31.53 0.11 Allowed 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.91 -1.119 . . . . 0.0 109.024 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.3 -16.83 15.74 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.453 -0.779 . . . . 0.0 109.099 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.582 ' HB3' HD12 ' A' ' 33' ' ' LEU . 2.0 m-20 -111.67 -12.86 13.84 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.599 -0.688 . . . . 0.0 109.919 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 1.158 ' CE1' HD21 ' A' ' 110' ' ' LEU . 7.5 m-85 -100.7 148.77 35.47 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.905 . . . . 0.0 109.808 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.58 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 3.5 Cg_exo -64.04 142.1 79.73 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.642 2.228 . . . . 0.0 110.547 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 2.3 Cg_endo -62.9 -19.97 70.2 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.04 1.826 . . . . 0.0 110.08 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -45.92 -51.02 13.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 109.25 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.754 ' O ' HD12 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -94.85 54.68 1.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.629 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 2.4 mt-10 -64.8 -45.71 75.2 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 2.8 Cg_exo -54.84 -35.38 88.46 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.907 1.738 . . . . 0.0 112.92 -177.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.873 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.1 t -100.34 -31.94 3.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.579 -1.325 . . . . 0.0 109.243 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.928 ' HA ' HD22 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -61.7 -26.99 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.526 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -55.77 -37.63 68.8 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 29.1 mmtm -78.09 -35.86 48.79 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.861 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.928 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.6 -21.71 66.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.45 -1.406 . . . . 0.0 107.334 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 7.2 mtmt -57.69 -35.21 70.3 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 177.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 125' ' ' LYS . 4.2 mtp180 -82.34 -22.97 35.32 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.429 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.67 HD23 ' OD1' ' A' ' 16' ' ' ASN . 1.3 tp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.473 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.541 ' HG2' ' N ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.695 0.76 . . . . 0.0 109.938 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.967 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -138.25 125.94 22.25 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.773 ' N ' HD22 ' A' ' 4' ' ' LEU . 0.9 OUTLIER -96.25 164.52 12.63 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.313 -1.492 . . . . 0.0 110.091 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.726 HG22 HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -131.2 117.82 38.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.495 -0.753 . . . . 0.0 109.046 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.048 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -86.61 63.17 7.83 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 36' ' ' PRO . 1.3 p -78.42 -72.43 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 109.735 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.768 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 57.38 87.65 0.02 OUTLIER Glycine 0 N--CA 1.479 1.528 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.602 ' CG1' HD11 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -47.77 168.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.238 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.062 HG22 ' CG2' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -131.04 94.62 2.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 O-C-N 121.181 -0.949 . . . . 0.0 109.33 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.61 ' HG2' HG22 ' A' ' 18' ' ' ILE . 13.9 mtm180 -75.82 177.36 6.99 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.598 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -151.44 -60.98 0.17 Allowed 'General case' 0 C--O 1.191 -1.977 0 C-N-CA 116.783 -1.967 . . . . 0.0 114.367 -176.296 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.506 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -92.32 -29.65 16.25 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 119.204 -2.185 . . . . 0.0 111.091 -176.124 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -162.16 -43.04 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.635 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -157.43 34.02 0.28 Allowed 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.359 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 105' ' ' MET . 17.1 mt-10 -82.01 87.36 6.45 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 118.005 -1.478 . . . . 0.0 108.88 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -80.0 147.96 6.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.395 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.667 ' CZ ' ' HG2' ' A' ' 94' ' ' PRO . 7.8 t80 -81.68 45.05 0.86 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.693 HD11 ' N ' ' A' ' 34' ' ' GLU . 6.6 tp -79.0 151.78 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-O 122.437 1.113 . . . . 0.0 111.575 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.565 ' CG2' ' NE2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -68.86 84.47 0.31 Allowed 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.438 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.695 ' HD2' HD21 ' A' ' 33' ' ' LEU . 18.2 tpt180 -79.24 84.98 5.13 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.016 -1.053 . . . . 0.0 109.822 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.753 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 1.5 ptt180 31.94 62.9 0.27 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.275 0.56 . . . . 0.0 110.319 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -41.92 -41.8 2.57 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.691 -0.631 . . . . 0.0 109.354 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' A' ' 23' ' ' ARG . . . -80.57 -179.96 7.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 109.195 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 3.6 p30 -78.79 112.86 16.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 109.328 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.753 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -112.27 -30.18 7.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 109.841 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 49.65 28.38 2.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.011 -1.055 . . . . 0.0 108.448 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.712 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 30.8 mmm -140.03 -100.01 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.392 -0.818 . . . . 0.0 109.976 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 152.13 -169.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER 78.84 -8.78 1.6 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.158 -0.964 . . . . 0.0 109.03 -179.312 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.613 ' O ' HD23 ' A' ' 33' ' ' LEU . 5.2 tptt -83.4 55.93 3.37 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.671 -0.643 . . . . 0.0 109.857 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.695 HD21 ' HD2' ' A' ' 22' ' ' ARG . 7.1 mt -120.04 93.09 3.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.288 -0.882 . . . . 0.0 108.779 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.693 ' N ' HD11 ' A' ' 20' ' ' ILE . 3.0 tt0 -88.56 -126.76 0.06 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.876 -1.14 . . . . 0.0 110.786 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.734 ' HB3' HG21 ' A' ' 8' ' ' VAL . 98.9 m-85 -160.07 128.72 3.01 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.756 -1.215 . . . . 0.0 110.247 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.898 ' O ' HG23 ' A' ' 8' ' ' VAL . 3.7 Cg_endo -64.79 97.28 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.113 1.875 . . . . 0.0 109.727 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.562 ' CA ' ' HB2' ' A' ' 98' ' ' GLU . . . -55.51 -153.15 0.01 OUTLIER Glycine 0 N--CA 1.492 2.405 0 O-C-N 121.298 -0.876 . . . . 0.0 111.013 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 163.86 -33.67 0.28 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.709 ' CD ' HD21 ' A' ' 4' ' ' LEU . 10.4 tptm 65.85 101.28 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.95 -0.735 . . . . 0.0 110.253 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.838 HD13 ' O ' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -80.42 135.44 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.039 -1.038 . . . . 0.0 108.693 178.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.544 ' HG3' ' N ' ' A' ' 42' ' ' MET . 6.9 pt-20 -171.12 -31.99 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.422 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.544 ' N ' ' HG3' ' A' ' 41' ' ' GLU . 1.7 mtt -62.08 151.89 34.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.065 -1.022 . . . . 0.0 109.842 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.98 -127.54 43.14 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.35 21.05 0.1 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.443 -1.034 . . . . 0.0 109.209 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.919 HG22 ' H ' ' A' ' 47' ' ' GLU . 1.8 m -147.01 140.78 15.27 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.613 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 11.0 Cg_exo -45.24 -18.6 0.28 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.067 1.845 . . . . 0.0 111.268 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.919 ' H ' HG22 ' A' ' 45' ' ' THR . 0.5 OUTLIER -76.87 -80.18 0.1 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.507 -1.37 . . . . 0.0 108.879 178.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.58 ' O ' ' CG ' ' A' ' 52' ' ' ARG . 60.0 mt-30 -48.58 -33.45 9.75 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.087 -1.633 . . . . 0.0 109.207 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.736 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -64.31 -63.6 1.1 Allowed 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.193 -0.942 . . . . 0.0 110.29 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.048 HG23 ' HB1' ' A' ' 7' ' ' ALA . 1.7 p -68.7 -48.87 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.142 -0.974 . . . . 0.0 110.57 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.9 p -56.03 -39.0 55.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-O 121.189 0.519 . . . . 0.0 110.357 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.58 ' CG ' ' O ' ' A' ' 48' ' ' GLN . 18.3 mmt180 -78.65 -32.99 47.47 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.606 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 24.3 mm-40 -71.89 -12.84 61.46 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.831 HD12 ' CE2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -80.09 -55.34 5.01 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.645 0.736 . . . . 0.0 109.331 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.453 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -69.38 -33.92 73.76 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.691 -0.631 . . . . 0.0 111.173 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.606 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -64.26 -25.8 68.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.821 -1.175 . . . . 0.0 111.385 -177.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.539 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -80.34 -80.8 0.13 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.499 -1.375 . . . . 0.0 109.887 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.582 ' HB ' ' HB3' ' A' ' 95' ' ' TRP . 69.9 t -80.17 -82.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.145 -0.972 . . . . 0.0 109.463 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.95 21.66 0.12 Allowed Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.632 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.957 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.1 pt -80.17 -144.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.496 -1.591 . . . . 0.0 108.395 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.665 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 2.1 m -151.36 -71.46 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 120.474 -1.392 . . . . 0.0 110.965 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.665 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 1.0 OUTLIER -60.4 -173.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.934 0 C-N-CA 121.082 1.188 . . . . 0.0 109.918 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 1.5 pt20 152.04 -23.55 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.648 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER 47.35 61.64 2.8 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.43 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 5.1 p90 -60.78 155.43 19.4 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.886 0.851 . . . . 0.0 110.735 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -152.51 139.24 18.85 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.169 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.588 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -66.31 -67.15 0.47 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.854 -1.154 . . . . 0.0 109.814 -179.048 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.774 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 81.75 -48.94 0.23 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.281 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER 164.42 176.54 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.093 -1.004 . . . . 0.0 108.412 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.562 ' HE3' ' CE3' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -161.58 175.04 12.51 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.948 -1.095 . . . . 0.0 110.161 -179.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.801 HD21 ' OD1' ' A' ' 119' ' ' ASN . 0.3 OUTLIER -136.73 -179.12 5.5 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.387 -0.821 . . . . 0.0 109.758 179.402 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.596 ' HG3' HG23 ' A' ' 81' ' ' THR . 7.6 tt0 -154.75 90.23 1.29 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.09 162.77 22.41 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.473 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 4.0 mt-10 -118.0 161.08 20.39 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.551 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.652 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -128.98 179.48 1.28 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.652 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 6.9 Cg_exo -52.69 -24.05 21.97 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.522 1.481 . . . . 0.0 109.787 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.441 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 2.2 p30 -171.13 32.55 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.493 ' NH2' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -141.28 93.74 2.61 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.705 -0.622 . . . . 0.0 110.151 -178.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.473 ' CD2' ' HG3' ' A' ' 74' ' ' GLU . 8.9 t-160 -79.1 93.08 5.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.037 -1.039 . . . . 0.0 108.384 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.738 HG23 HD12 ' A' ' 4' ' ' LEU . 13.3 mm -83.95 157.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.263 1.03 . . . . 0.0 111.486 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.596 HG23 ' HG3' ' A' ' 72' ' ' GLU . 2.4 m -131.0 155.27 47.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.561 HD12 ' HB ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -141.83 83.92 1.87 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.495 -1.378 . . . . 0.0 110.72 -179.106 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.604 ' CD1' HG21 ' A' ' 40' ' ' ILE . 72.5 m95 -55.74 109.54 0.58 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.939 -1.101 . . . . 0.0 109.162 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.797 ' CD2' HG11 ' A' ' 122' ' ' VAL . 35.7 m-85 -86.79 75.04 9.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.02 -1.05 . . . . 0.0 109.72 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.667 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 83.9 m95 -79.41 89.39 5.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.051 -1.031 . . . . 0.0 109.456 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.774 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.3 mm? -68.78 132.38 46.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.843 -1.161 . . . . 0.0 109.831 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.062 ' CG2' HG22 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -120.54 170.4 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.603 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 37.4 mt-10 -154.33 23.11 0.48 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.201 -1.562 . . . . 0.0 113.453 -178.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.648 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -160.24 55.76 0.34 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 119.832 -1.793 . . . . 0.0 111.138 178.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.84 ' HB2' HD13 ' A' ' 60' ' ' ILE . 4.8 p90 -73.99 157.89 35.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.929 -1.107 . . . . 0.0 109.456 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.618 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -79.88 142.54 35.11 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.136 -0.977 . . . . 0.0 109.559 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 29.89 -82.38 0.0 OUTLIER Glycine 0 N--CA 1.5 2.907 0 O-C-N 121.985 -0.447 . . . . 0.0 112.1 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.957 ' O ' HG21 ' A' ' 60' ' ' ILE . 2.9 mm-40 -93.74 157.12 38.75 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.216 -1.167 . . . . 0.0 110.74 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.667 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 29.4 Cg_endo -82.52 -157.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.622 2.215 . . . . 0.0 109.805 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.831 ' CE2' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER 172.63 114.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.454 0.645 . . . . 0.0 109.881 178.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . 165.2 -36.37 0.27 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.55 ' HD3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -39.5 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.667 -0.902 . . . . 0.0 110.789 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.562 ' HB2' ' CA ' ' A' ' 37' ' ' GLY . 3.1 tp10 -68.22 96.3 0.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.014 -1.054 . . . . 0.0 108.423 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.26 46.39 57.14 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.565 ' NE2' ' CG2' ' A' ' 21' ' ' THR . 0.0 OUTLIER -144.5 163.58 33.3 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.559 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 1.2 Cg_endo -64.1 -51.91 1.92 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 121.402 1.402 . . . . 0.0 109.796 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.639 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 59.25 113.35 0.01 OUTLIER Glycine 0 N--CA 1.479 1.519 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.596 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 12.4 pt-20 -150.33 131.78 14.73 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.211 -1.17 . . . . 0.0 109.858 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.629 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -47.25 133.69 11.89 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -124.75 121.84 35.75 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 109.614 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.2 t -81.13 63.2 5.39 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.87 HD21 ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -80.24 -47.75 14.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.346 -0.847 . . . . 0.0 108.971 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.821 ' N ' HD23 ' A' ' 107' ' ' LEU . 40.7 t 82.2 119.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.841 -0.537 . . . . 0.0 110.081 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 108' ' ' VAL . . . 36.51 82.67 0.01 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 1.151 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -40.98 164.84 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.625 -0.927 . . . . 0.0 110.67 -178.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.675 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 1.7 t-20 -142.88 -5.19 0.91 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 111.621 -178.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 77.37 -6.38 2.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.998 -1.064 . . . . 0.0 108.51 -177.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 -18.18 50.94 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.552 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -109.61 -11.15 14.8 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.329 0.585 . . . . 0.0 109.562 -179.454 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 1.151 ' CE1' HD21 ' A' ' 110' ' ' LEU . 15.7 m-85 -103.76 149.77 37.48 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.905 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.565 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 2.1 Cg_endo -63.8 145.48 90.76 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.718 2.278 . . . . 0.0 110.651 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.518 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . 1.3 Cg_endo -66.14 -27.5 49.14 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.27 1.98 . . . . 0.0 110.399 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -43.21 -54.25 4.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.049 -1.032 . . . . 0.0 109.621 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.801 ' OD1' HD21 ' A' ' 71' ' ' LEU . 7.5 m-80 -90.08 50.46 1.87 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.655 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 5.4 mt-10 -67.54 -37.85 13.71 Favored Pre-proline 0 C--N 1.3 -1.576 0 O-C-N 121.682 -0.636 . . . . 0.0 112.268 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.655 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.2 Cg_exo -55.36 -37.22 94.82 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.392 1.395 . . . . 0.0 112.035 -178.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.797 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.2 t -99.76 -34.41 4.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.69 -1.257 . . . . 0.0 109.046 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.866 ' HA ' HD22 ' A' ' 126' ' ' LEU . 0.5 OUTLIER -60.68 -22.7 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.567 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -60.7 -36.85 79.82 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.079 0.943 . . . . 0.0 108.501 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.55 -38.92 47.59 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.737 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.866 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -64.17 -23.07 67.18 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.567 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 12.7 mtmt -54.96 -38.65 68.02 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.438 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -80.24 -24.43 40.16 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.686 179.233 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.624 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 2.0 tp . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.936 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 79' ' ' HIS . 4.0 tmmm? . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.991 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -148.66 132.74 17.26 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.163 -0.961 . . . . 0.0 108.901 178.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.555 ' HB2' HG23 ' A' ' 40' ' ' ILE . 5.8 mp0 -99.44 155.88 17.32 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.379 -1.451 . . . . 0.0 109.069 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.552 ' CG2' ' HA2' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -116.97 117.16 54.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.348 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.01 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -84.41 66.19 9.3 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -79.44 -77.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.168 -0.958 . . . . 0.0 110.123 -179.375 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.702 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 63.15 93.24 0.02 OUTLIER Glycine 0 N--CA 1.484 1.852 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.578 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -52.95 162.32 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.98 HG22 ' CG2' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -128.79 92.42 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.328 -179.177 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.959 ' HG2' HG22 ' A' ' 18' ' ' ILE . 8.9 mtm180 -75.71 177.23 7.01 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.646 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -156.76 -61.5 0.1 Allowed 'General case' 0 C--O 1.191 -2.005 0 C-N-CA 116.069 -2.252 . . . . 0.0 114.716 -176.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.524 ' CB ' ' OE2' ' A' ' 17' ' ' GLU . 5.9 tp10 -91.7 -25.94 18.86 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 119.335 -2.103 . . . . 0.0 111.594 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -161.75 -45.53 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.454 ' HA ' HH21 ' A' ' 12' ' ' ARG . 53.7 t-20 -160.92 35.6 0.15 Allowed 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.524 ' OE2' ' CB ' ' A' ' 14' ' ' GLU . 12.6 mt-10 -79.83 83.82 5.71 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 118.403 -1.319 . . . . 0.0 109.161 -178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.959 HG22 ' HG2' ' A' ' 12' ' ' ARG . 18.1 pt -79.19 141.36 15.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.22 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.624 ' HB3' HD11 ' A' ' 11' ' ' ILE . 13.5 t80 -81.71 45.09 0.86 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.713 HG22 HG13 ' A' ' 18' ' ' ILE . 4.4 tt -80.13 152.29 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-O 121.93 0.872 . . . . 0.0 110.863 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.472 ' HB ' ' HD2' ' A' ' 101' ' ' PRO . 0.6 OUTLIER -69.88 95.34 0.91 Allowed 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.673 ' HD3' HD21 ' A' ' 33' ' ' LEU . 13.2 tpt180 -99.09 90.37 4.58 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.641 -0.662 . . . . 0.0 111.072 -178.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.994 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 32.41 83.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.898 -0.501 . . . . 0.0 110.177 178.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.44 -46.53 4.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.224 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.84 176.43 9.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.432 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -77.47 105.28 8.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.121 -0.987 . . . . 0.0 109.427 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.994 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -104.14 133.8 48.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.12 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -82.25 4.23 24.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 0.0 109.059 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.738 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -102.55 -126.69 0.21 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.603 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 163.62 -4.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.978 -1.076 . . . . 0.0 111.729 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 114' ' ' ASP . 2.9 p-10 -79.24 8.68 5.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.27 -1.519 . . . . 0.0 109.136 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.629 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -81.5 61.34 4.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.588 -0.695 . . . . 0.0 110.105 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.673 HD21 ' HD3' ' A' ' 22' ' ' ARG . 7.6 mt -123.66 93.11 3.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.868 -1.145 . . . . 0.0 109.291 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.594 ' O ' HD11 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.72 -145.97 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.465 -0.772 . . . . 0.0 109.003 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.497 ' CZ ' ' CG ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -142.53 128.35 10.52 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.745 -1.222 . . . . 0.0 109.49 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.703 ' O ' HG23 ' A' ' 8' ' ' VAL . 3.0 Cg_endo -60.05 97.09 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.004 1.803 . . . . 0.0 109.53 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.552 ' HA2' ' CG2' ' A' ' 6' ' ' ILE . . . -54.13 -141.95 0.0 OUTLIER Glycine 0 N--CA 1.496 2.677 0 O-C-N 121.531 -0.73 . . . . 0.0 111.589 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 153.59 -34.78 0.75 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.523 ' HD2' HD23 ' A' ' 4' ' ' LEU . 5.0 tptm 69.15 95.53 0.07 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.039 -0.683 . . . . 0.0 110.465 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.749 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -80.66 135.71 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.204 -0.935 . . . . 0.0 108.833 178.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -170.28 -34.23 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.353 -0.842 . . . . 0.0 109.756 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.415 ' O ' ' C ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -49.35 156.47 0.6 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.243 -0.911 . . . . 0.0 109.514 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' MET . . . 44.23 -122.44 4.46 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.78 21.27 0.09 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.406 -1.055 . . . . 0.0 109.484 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.699 HG22 ' H ' ' A' ' 47' ' ' GLU . 98.0 m -135.18 141.9 39.72 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.22 -0.925 . . . . 0.0 108.907 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.565 ' HD2' HG23 ' A' ' 45' ' ' THR . 11.2 Cg_exo -50.37 -16.9 2.29 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.573 1.516 . . . . 0.0 110.205 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.699 ' H ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -76.99 -84.08 0.07 Allowed 'General case' 0 C--O 1.202 -1.43 0 O-C-N 121.181 -0.949 . . . . 0.0 108.768 178.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.564 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -45.14 -35.91 3.43 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.484 -1.385 . . . . 0.0 109.747 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.635 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -64.23 -60.67 2.92 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.299 -0.875 . . . . 0.0 110.387 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.01 HG23 ' HB1' ' A' ' 7' ' ' ALA . 1.8 p -70.32 -48.82 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.897 -1.127 . . . . 0.0 110.548 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 47' ' ' GLU . 4.1 p -56.7 -37.41 52.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.823 -0.548 . . . . 0.0 110.575 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.564 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 2.9 mmt180 -79.17 -39.73 32.69 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.65 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 19.9 mm-40 -65.98 -15.66 63.2 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.054 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -80.26 -39.29 29.23 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.752 0.787 . . . . 0.0 109.961 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.63 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 1.8 mt-30 -79.2 -52.55 8.0 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.624 0.726 . . . . 0.0 109.192 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.65 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -44.65 -23.9 0.16 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.644 -0.66 . . . . 0.0 110.097 -179.58 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 3.9 mm-40 -80.16 -95.84 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.864 -1.148 . . . . 0.0 109.516 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.668 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 57.6 t -80.38 -78.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.07 -1.019 . . . . 0.0 109.809 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.64 37.54 0.11 Allowed Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.434 -1.365 . . . . 0.0 111.653 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.103 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -91.56 -147.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.506 -1.585 . . . . 0.0 108.689 178.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.608 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.5 m -162.73 -64.03 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 120.439 -1.413 . . . . 0.0 112.985 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.608 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 1.8 Cg_endo -56.66 -2.63 0.47 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 122.53 2.153 . . . . 0.0 113.963 -177.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.849 ' HB3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -40.24 -26.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.789 -1.194 . . . . 0.0 109.917 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.577 ' N ' ' HG3' ' A' ' 63' ' ' GLN . 0.4 OUTLIER 57.4 -170.16 0.1 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -178.255 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -179.34 158.85 0.89 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.521 -1.362 . . . . 0.0 111.683 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -156.84 147.84 21.91 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.749 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.619 HD23 ' CE2' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -70.07 -67.44 0.49 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.888 -1.133 . . . . 0.0 109.655 -179.202 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.861 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 82.31 -52.4 0.22 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.586 ' CB ' ' O ' ' A' ' 68' ' ' PHE . 2.2 mm-40 150.56 133.36 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.798 -0.564 . . . . 0.0 109.819 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.526 ' HA ' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -122.64 -162.74 1.03 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.148 -0.97 . . . . 0.0 109.336 179.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.71 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -145.62 175.79 10.1 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.372 -0.83 . . . . 0.0 109.871 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -148.27 83.26 1.49 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.32 126.23 34.18 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.61 160.69 14.67 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 3.1 m-85 -128.75 170.02 11.62 Favored Pre-proline 0 C--N 1.296 -1.747 0 O-C-N 121.182 -0.948 . . . . 0.0 109.29 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 6.2 Cg_exo -48.83 -23.23 5.54 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.083 1.855 . . . . 0.0 109.694 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.0 42.29 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.56 ' HD3' HD11 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -153.39 90.0 1.39 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.787 -0.571 . . . . 0.0 109.563 -178.37 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.992 ' C ' HD13 ' A' ' 80' ' ' ILE . 7.0 t-160 -80.31 100.28 8.31 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.992 HD13 ' C ' ' A' ' 79' ' ' HIS . 1.2 mm -115.89 144.41 23.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 118.809 -1.156 . . . . 0.0 112.138 -178.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.534 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 1.6 m -119.3 166.24 13.26 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.692 ' CD2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -151.73 76.24 1.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.761 -1.212 . . . . 0.0 110.069 179.81 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.668 ' CD1' HG21 ' A' ' 40' ' ' ILE . 75.6 m95 -51.68 128.37 23.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.123 -0.986 . . . . 0.0 109.142 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.843 ' CE2' HG11 ' A' ' 122' ' ' VAL . 23.5 m-85 -103.62 76.35 1.39 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.039 -1.038 . . . . 0.0 109.782 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.619 ' CE2' HD23 ' A' ' 67' ' ' LEU . 40.8 m95 -78.39 91.66 4.5 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.997 -1.064 . . . . 0.0 109.209 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.861 HD23 ' CD2' ' A' ' 68' ' ' PHE . 1.6 mm? -71.8 131.76 43.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.955 -1.091 . . . . 0.0 109.882 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.98 ' CG2' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -117.67 -178.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.533 ' N ' HG23 ' A' ' 87' ' ' VAL . 43.5 mt-10 -158.07 2.45 0.11 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.139 -1.601 . . . . 0.0 113.397 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.596 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -151.45 68.61 0.92 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 119.623 -1.923 . . . . 0.0 111.723 -179.62 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 1.03 ' HB2' HD13 ' A' ' 60' ' ' ILE . 9.6 p90 -80.57 167.91 19.53 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.467 -1.395 . . . . 0.0 109.38 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.569 ' CB ' ' HG2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -92.41 144.15 25.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.137 -0.977 . . . . 0.0 109.435 179.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 40.08 -91.03 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 1.103 ' O ' HG21 ' A' ' 60' ' ' ILE . 13.6 pt-20 -107.07 161.65 22.23 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.214 -1.168 . . . . 0.0 109.77 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.61 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 9.8 Cg_endo -75.77 -155.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.563 2.175 . . . . 0.0 109.93 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 1.054 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER 178.96 46.59 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.425 -0.797 . . . . 0.0 109.83 179.277 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -128.1 -20.86 1.58 Allowed Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.751 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -49.92 104.04 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.871 -1.37 . . . . 0.0 109.618 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.509 ' HB2' ' C ' ' A' ' 37' ' ' GLY . 9.0 tp10 -82.81 94.29 7.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.9 -1.125 . . . . 0.0 109.244 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.98 13.54 34.38 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.496 ' CG ' ' HB2' ' A' ' 97' ' ' LYS . 1.8 pt20 -114.92 162.74 22.32 Favored Pre-proline 0 N--CA 1.487 1.383 0 O-C-N 121.345 -1.091 . . . . 0.0 108.683 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 102' ' ' GLY . 6.0 Cg_exo -60.32 -44.11 30.27 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.815 1.677 . . . . 0.0 109.728 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.587 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 56.27 112.75 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 3.7 pt-20 -147.24 132.31 18.26 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.8 -1.412 . . . . 0.0 111.068 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.692 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 2.4 m0 -47.8 126.02 9.66 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.503 ' HE3' ' HB2' ' A' ' 22' ' ' ARG . 7.7 tpp -123.31 105.57 9.96 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.347 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.29 81.39 0.74 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.647 ' O ' ' CB ' ' A' ' 108' ' ' VAL . 6.2 tt -80.99 -80.04 0.15 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.471 -0.768 . . . . 0.0 110.614 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.647 ' CB ' ' O ' ' A' ' 107' ' ' LEU . 54.5 t 115.49 103.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.504 ' CA ' ' OXT' ' A' ' 129' ' ' LEU . . . 41.94 78.77 0.06 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.594 -1.803 . . . . 0.0 108.594 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 1.107 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -39.54 163.66 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.617 -0.931 . . . . 0.0 110.989 -178.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.697 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 1.5 t-20 -139.68 -8.28 1.25 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.406 -0.809 . . . . 0.0 111.412 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 83.66 -25.38 0.14 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.301 -0.875 . . . . 0.0 108.713 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.12 -29.69 61.05 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.658 ' HB3' HD12 ' A' ' 33' ' ' LEU . 9.7 m-20 -94.22 -19.22 20.94 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 1.107 ' CE1' HD21 ' A' ' 110' ' ' LEU . 6.5 m-85 -95.82 148.05 33.95 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.325 -0.859 . . . . 0.0 109.908 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.488 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.4 Cg_endo -68.0 142.52 56.9 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.409 2.073 . . . . 0.0 110.061 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 118' ' ' ALA . 2.4 Cg_endo -63.04 -27.97 74.25 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.157 1.905 . . . . 0.0 110.476 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -41.43 -48.56 3.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.414 -0.804 . . . . 0.0 109.383 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.648 ' HB3' HD13 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -96.33 55.17 1.46 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.641 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -62.75 -42.33 77.8 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.764 -0.585 . . . . 0.0 112.027 -179.59 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 11.6 Cg_exo -54.02 -47.94 24.33 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 121.846 1.698 . . . . 0.0 112.615 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.843 HG11 ' CE2' ' A' ' 84' ' ' PHE . 1.5 t -88.64 -38.02 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.704 -1.248 . . . . 0.0 109.62 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.862 ' HA ' HD22 ' A' ' 126' ' ' LEU . 1.1 mp -63.1 -21.0 27.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.544 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -63.64 -31.06 72.12 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -80.32 -40.34 26.92 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.519 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.862 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.09 -21.09 66.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.682 -1.261 . . . . 0.0 107.755 179.366 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 1.9 mtmt -58.1 -36.5 72.98 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -83.23 -20.53 34.4 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.503 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.558 HD13 HD12 ' A' ' 126' ' ' LEU . 1.2 tp . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.627 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.474 ' CG ' ' N ' ' A' ' 4' ' ' LEU . 8.6 ttpt . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 121.632 0.73 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.548 HD13 ' N ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -159.0 110.0 2.07 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.548 ' N ' HD13 ' A' ' 4' ' ' LEU . 2.5 mp0 -104.7 169.53 8.4 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.015 -1.053 . . . . 0.0 109.427 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.714 HG22 HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -135.23 122.87 37.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.437 -0.79 . . . . 0.0 108.984 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.975 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -86.2 62.16 7.27 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -79.15 -77.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.717 -179.514 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.717 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 62.99 89.07 0.03 OUTLIER Glycine 0 N--CA 1.48 1.567 0 N-CA-C 106.956 -2.458 . . . . 0.0 106.956 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.112 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -55.13 163.93 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.04 HG22 ' CG2' ' A' ' 87' ' ' VAL . 2.0 pt -127.42 71.46 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.301 -177.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.909 ' HB3' HG22 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -77.99 159.78 28.58 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.266 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.07 -18.61 0.04 OUTLIER 'General case' 0 C--O 1.187 -2.19 0 C-N-CA 115.81 -2.356 . . . . 0.0 115.479 -177.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.52 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 1.4 tm-20 -93.48 -31.67 14.49 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 118.165 -2.834 . . . . 0.0 108.646 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -163.13 -46.51 0.03 OUTLIER 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.483 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 1.1 t-20 -162.05 37.87 0.12 Allowed 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 176.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 105' ' ' MET . 92.3 mt-10 -91.6 94.29 9.34 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 118.003 -1.479 . . . . 0.0 110.831 -177.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.112 ' CD1' HG22 ' A' ' 10' ' ' ILE . 0.6 OUTLIER -96.99 152.36 3.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.544 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.667 ' N ' HD12 ' A' ' 18' ' ' ILE . 13.6 t80 -80.39 45.38 0.76 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.654 HD11 ' C ' ' A' ' 34' ' ' GLU . 5.7 tp -81.09 154.78 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.231 -0.918 . . . . 0.0 111.382 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.535 ' O ' ' O ' ' A' ' 32' ' ' LYS . 1.4 t -67.67 92.98 0.35 Allowed 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.841 ' HD3' HD21 ' A' ' 33' ' ' LEU . 30.3 tpt180 -100.78 83.92 2.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.46 -0.775 . . . . 0.0 110.534 -178.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.765 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 31.69 86.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.826 -0.546 . . . . 0.0 110.129 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -44.7 -52.32 8.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.089 -1.007 . . . . 0.0 109.532 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.62 -161.04 0.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 0.0 109.11 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.76 -27.56 40.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.205 -0.934 . . . . 0.0 109.231 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.765 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . 50.76 -175.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 109.787 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.53 25.78 0.23 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.717 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 0.7 OUTLIER -126.45 -41.69 1.86 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.367 -0.833 . . . . 0.0 110.318 -179.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 29' ' ' MET . . . 78.93 0.86 2.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 110.124 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 25.4 p-10 -92.98 9.86 33.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.829 -1.169 . . . . 0.0 108.565 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.535 ' O ' ' O ' ' A' ' 21' ' ' THR . 0.9 OUTLIER -81.22 36.43 0.41 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.565 -0.709 . . . . 0.0 110.653 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.069 HD13 ' CE1' ' A' ' 115' ' ' PHE . 22.3 mt -110.82 88.05 2.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.553 -1.342 . . . . 0.0 109.564 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.654 ' C ' HD11 ' A' ' 20' ' ' ILE . 1.1 tt0 -91.79 -137.38 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.457 -0.777 . . . . 0.0 109.534 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.669 ' HB3' HG21 ' A' ' 8' ' ' VAL . 90.6 m-85 -149.66 130.8 7.23 Favored Pre-proline 0 C--N 1.306 -1.299 0 O-C-N 121.072 -1.017 . . . . 0.0 109.745 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.744 ' O ' HG23 ' A' ' 8' ' ' VAL . 2.1 Cg_endo -56.6 95.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.303 2.002 . . . . 0.0 109.894 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -55.69 -147.04 0.01 OUTLIER Glycine 0 N--CA 1.494 2.528 0 O-C-N 121.319 -0.863 . . . . 0.0 111.205 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 158.97 -40.29 0.5 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.571 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 13.4 tptp 73.75 94.49 0.07 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.146 -0.62 . . . . 0.0 110.596 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.783 HD13 ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -80.92 131.8 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 108.805 178.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.417 ' HG2' ' N ' ' A' ' 42' ' ' MET . 4.6 pt-20 -171.76 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.963 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.417 ' N ' ' HG2' ' A' ' 41' ' ' GLU . 4.9 mmt -58.7 163.84 3.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -0.913 . . . . 0.0 109.857 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 47.61 -121.73 6.99 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -167.07 24.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.528 -0.984 . . . . 0.0 108.739 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.554 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 30.4 m -146.71 142.87 17.72 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.597 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 11.1 Cg_exo -50.58 -17.22 2.75 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 121.412 1.408 . . . . 0.0 109.957 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -75.33 -83.36 0.06 Allowed 'General case' 0 C--O 1.201 -1.483 0 O-C-N 121.081 -1.012 . . . . 0.0 108.938 178.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.529 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 32.9 mt-30 -45.52 -36.66 4.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.37 -1.456 . . . . 0.0 109.776 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.617 ' CB ' HG12 ' A' ' 40' ' ' ILE . . . -62.84 -64.99 0.75 Allowed 'General case' 0 C--N 1.289 -2.056 0 O-C-N 120.964 -1.085 . . . . 0.0 110.26 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.975 HG23 ' HB1' ' A' ' 7' ' ' ALA . 1.9 p -65.05 -48.93 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.048 -1.033 . . . . 0.0 111.018 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.577 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 2.9 p -55.66 -46.48 79.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-O 121.384 0.612 . . . . 0.0 110.109 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.565 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 8.0 mmt180 -72.46 -27.61 62.41 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.591 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 29.9 mm-40 -77.81 -14.18 59.66 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.752 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.8 OUTLIER -80.18 -58.52 3.11 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.493 ' HA ' ' CZ3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -63.16 -50.14 71.56 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.738 -0.601 . . . . 0.0 109.722 179.428 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.585 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 1.4 pp20? -53.25 -20.12 3.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.994 -1.066 . . . . 0.0 109.746 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.483 ' OE1' ' HA2' ' A' ' 96' ' ' GLY . 1.6 mt-10 -80.2 -91.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 109.861 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.866 HG21 ' HA ' ' A' ' 95' ' ' TRP . 41.7 t -79.96 -79.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.436 -0.79 . . . . 0.0 110.016 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.02 27.04 0.17 Allowed Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.212 -1.47 . . . . 0.0 111.448 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.031 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -81.75 -145.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.607 -1.525 . . . . 0.0 107.948 178.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.635 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.3 m -145.23 -70.43 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 120.512 -1.367 . . . . 0.0 109.943 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.635 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 8.8 Cg_endo -66.71 -169.42 0.18 Allowed 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 121.137 1.225 . . . . 0.0 109.636 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.628 ' HB2' HG21 ' A' ' 87' ' ' VAL . 0.8 OUTLIER 134.09 -20.27 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 -179.112 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.551 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.1 OUTLIER 52.12 -164.59 0.07 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -179.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -177.22 144.63 0.43 Allowed 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 117.636 -1.626 . . . . 0.0 111.046 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -145.07 143.48 30.46 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.624 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -74.61 -65.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.856 -1.152 . . . . 0.0 110.216 -178.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.624 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 81.89 -50.74 0.24 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.538 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER 164.15 179.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.135 -0.978 . . . . 0.0 109.595 179.306 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.18 142.82 13.37 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.313 -0.867 . . . . 0.0 109.109 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.839 HD21 HD22 ' A' ' 119' ' ' ASN . 0.5 OUTLIER -96.93 -171.71 2.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.997 -1.064 . . . . 0.0 109.789 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HG3' HG23 ' A' ' 81' ' ' THR . 5.3 tt0 -160.24 95.48 1.14 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.5 123.15 27.29 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.434 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 2.1 tt0 -96.87 143.23 27.96 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.537 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.556 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 5.5 m-85 -119.39 169.76 7.74 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 7.6 Cg_exo -49.26 -31.86 23.58 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.441 1.427 . . . . 0.0 109.307 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -160.72 41.04 0.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.212 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.546 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -146.16 95.76 2.67 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.597 -0.689 . . . . 0.0 109.956 -178.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.753 ' C ' HD12 ' A' ' 80' ' ' ILE . 14.6 m80 -82.64 113.02 20.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.015 -1.053 . . . . 0.0 108.781 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.753 HD12 ' C ' ' A' ' 79' ' ' HIS . 1.3 mp -110.87 165.09 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -0.987 . . . . 0.0 110.161 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.559 ' N ' ' CG2' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -153.52 149.37 27.62 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.726 HD23 HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -137.0 77.47 1.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.903 -1.123 . . . . 0.0 109.909 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.645 ' CD1' HG21 ' A' ' 40' ' ' ILE . 81.8 m95 -46.71 116.34 1.3 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.183 -0.948 . . . . 0.0 109.658 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.812 ' CE2' HG11 ' A' ' 122' ' ' VAL . 26.0 m-85 -92.37 71.21 5.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.155 -0.966 . . . . 0.0 109.931 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.663 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 30.9 m95 -75.14 91.8 2.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.843 -1.161 . . . . 0.0 109.06 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.56 HD11 ' CG1' ' A' ' 10' ' ' ILE . 3.3 mm? -73.02 127.29 32.14 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.774 -1.204 . . . . 0.0 110.281 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.04 ' CG2' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -115.7 172.79 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 43.8 mt-10 -157.48 32.68 0.27 Allowed 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 117.835 -1.546 . . . . 0.0 113.392 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.593 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.21 55.94 0.35 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 119.872 -1.767 . . . . 0.0 111.154 178.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.539 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 5.1 p90 -78.94 159.09 27.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.19 -1.569 . . . . 0.0 109.488 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -88.43 138.21 31.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 32.79 -79.72 0.0 OUTLIER Glycine 0 N--CA 1.501 3.025 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 1.031 ' O ' HG21 ' A' ' 60' ' ' ILE . 2.8 mm-40 -94.49 144.79 28.53 Favored Pre-proline 0 C--N 1.303 -1.424 0 O-C-N 121.164 -1.198 . . . . 0.0 109.645 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.582 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 14.0 Cg_endo -79.58 -161.62 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.18 1.92 . . . . 0.0 109.651 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.866 ' HA ' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -176.21 116.72 0.13 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.016 0.912 . . . . 0.0 109.946 177.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.483 ' HA2' ' OE1' ' A' ' 57' ' ' GLU . . . 167.61 -34.59 0.21 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.581 ' CA ' ' HG2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -39.57 100.51 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.539 -0.977 . . . . 0.0 109.849 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.476 ' OE1' ' HA2' ' A' ' 38' ' ' GLY . 18.2 tp10 -80.15 105.48 11.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.311 -0.868 . . . . 0.0 108.822 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 50.53 30.77 20.46 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.581 ' HG2' ' CA ' ' A' ' 97' ' ' LYS . 1.7 pt20 -134.26 165.26 38.05 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.544 -0.974 . . . . 0.0 109.337 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 3.5 Cg_exo -63.47 -45.61 11.28 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.206 1.938 . . . . 0.0 110.484 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.608 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.59 114.42 0.01 OUTLIER Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.625 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 1.8 pt-20 -152.25 134.16 14.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.086 -1.243 . . . . 0.0 110.079 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.522 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 1.7 m-90 -46.15 134.45 8.45 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.624 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -125.97 116.15 21.03 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.135 -0.978 . . . . 0.0 109.031 -179.04 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.563 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -79.52 43.69 0.57 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.428 -0.795 . . . . 0.0 110.858 -178.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.765 HD21 ' HA ' ' A' ' 110' ' ' LEU . 9.4 tt -67.01 161.9 23.29 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.723 ' N ' HD23 ' A' ' 107' ' ' LEU . 24.5 t -118.78 114.69 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.048 -1.033 . . . . 0.0 108.935 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 43.18 84.45 0.01 OUTLIER Glycine 0 N--CA 1.493 2.436 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.983 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -35.55 157.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.764 0.793 . . . . 0.0 111.33 -178.137 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.737 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 3.2 t-20 -138.45 -5.04 1.61 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.687 -0.633 . . . . 0.0 111.346 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.737 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 81.99 -34.93 0.1 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.99 -26.59 4.42 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.452 -0.78 . . . . 0.0 109.266 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 1.013 ' HB3' HD12 ' A' ' 33' ' ' LEU . 62.9 m-20 -104.25 -20.01 13.92 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.753 -0.592 . . . . 0.0 109.503 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 1.069 ' CE1' HD13 ' A' ' 33' ' ' LEU . 9.4 m-85 -98.8 148.36 34.46 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.226 -0.921 . . . . 0.0 109.101 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.566 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 6.1 Cg_exo -62.03 132.27 38.59 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.459 2.106 . . . . 0.0 110.448 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.93 -18.5 42.84 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.948 1.765 . . . . 0.0 110.201 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -46.52 -52.48 13.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.235 -0.916 . . . . 0.0 108.879 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.839 HD22 HD21 ' A' ' 71' ' ' LEU . 10.9 m120 -86.56 46.68 1.38 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.647 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 2.2 mt-10 -57.66 -44.31 99.4 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.667 -0.646 . . . . 0.0 112.485 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 7.1 Cg_exo -53.35 -42.7 63.39 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.877 1.718 . . . . 0.0 113.15 -177.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.812 HG11 ' CE2' ' A' ' 84' ' ' PHE . 1.8 t -96.98 -32.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.458 -1.401 . . . . 0.0 110.06 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.76 ' HA ' HD22 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -62.92 -25.85 39.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.571 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -57.59 -33.36 68.12 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.165 0.983 . . . . 0.0 108.419 178.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 68.1 mmtt -80.18 -40.55 27.03 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.704 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.8 ' N ' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -66.95 -16.31 64.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.647 -1.283 . . . . 0.0 107.884 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 12.0 mtmt -61.68 -35.08 76.96 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 177.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 125' ' ' LYS . 1.2 mtp180 -81.91 -19.92 39.82 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.281 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.757 HD23 ' NH1' ' A' ' 12' ' ' ARG . 1.2 tp . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.111 -0.947 . . . . 0.0 109.447 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.499 ' C ' ' CD ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 1.095 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -142.88 119.42 11.02 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.043 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.861 ' N ' HD22 ' A' ' 4' ' ' LEU . 8.4 mp0 -101.57 160.92 14.03 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.727 -1.233 . . . . 0.0 107.844 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.892 HG22 HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -123.1 117.76 52.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 C-N-CA 119.351 -0.939 . . . . 0.0 109.288 -179.136 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.912 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -87.44 58.56 5.03 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.892 HG12 HG22 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -78.02 -73.72 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.506 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.756 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 60.01 82.24 0.07 OUTLIER Glycine 0 N--CA 1.48 1.603 0 N-CA-C 107.584 -2.207 . . . . 0.0 107.584 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.639 HD12 HD11 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -45.97 160.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.052 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.089 HG22 ' CG2' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -120.26 95.32 3.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 C-N-CA 119.57 -0.852 . . . . 0.0 108.915 -179.234 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 1.096 ' HG2' HG22 ' A' ' 18' ' ' ILE . 20.3 mtm180 -74.35 173.19 10.59 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.62 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -150.98 -64.41 0.19 Allowed 'General case' 0 C--O 1.188 -2.142 0 C-N-CA 117.18 -1.808 . . . . 0.0 114.222 -176.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 7.7 tp10 -91.81 -32.73 15.25 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 118.957 -2.34 . . . . 0.0 112.014 -175.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.476 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 5.7 t-20 -161.15 -43.96 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.584 ' HB3' ' CD2' ' A' ' 107' ' ' LEU . 7.5 m120 -157.07 35.35 0.29 Allowed 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.549 ' HG2' ' CB ' ' A' ' 106' ' ' SER . 31.5 mt-10 -88.52 83.92 6.79 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 117.778 -1.569 . . . . 0.0 109.629 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.096 HG22 ' HG2' ' A' ' 12' ' ' ARG . 3.0 pt -79.82 149.09 5.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.645 ' CE2' ' HG2' ' A' ' 94' ' ' PRO . 7.0 t80 -81.57 43.68 0.76 Allowed 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.636 HG21 HD22 ' A' ' 33' ' ' LEU . 6.7 tp -83.33 159.9 3.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.93 0.871 . . . . 0.0 110.806 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.754 HG23 ' O ' ' A' ' 21' ' ' THR . 7.4 t -70.32 98.6 1.42 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 176.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.676 ' HD3' HD21 ' A' ' 33' ' ' LEU . 31.6 tpt180 -99.61 80.39 2.36 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 110.976 -177.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.539 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 32.68 83.63 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.304 0.573 . . . . 0.0 110.137 178.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -43.51 -49.46 7.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -0.942 . . . . 0.0 110.087 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.35 178.65 8.15 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.179 -0.951 . . . . 0.0 108.763 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.444 ' O ' ' O ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -57.96 -30.81 66.3 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.171 -1.012 . . . . 0.0 108.894 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.539 ' CB ' ' HD2' ' A' ' 23' ' ' ARG . . . 58.07 159.12 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.325 -0.86 . . . . 0.0 109.537 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -131.57 25.73 4.75 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.67 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 11.2 mtm -129.08 -95.2 0.41 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.497 -0.752 . . . . 0.0 109.242 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.67 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 137.71 -4.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.61 14.41 5.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.125 -0.984 . . . . 0.0 108.834 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.9 tmtt? -80.98 28.77 0.35 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.468 -0.77 . . . . 0.0 110.708 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.71 HD12 ' HB3' ' A' ' 114' ' ' ASP . 16.6 mt -107.02 83.36 1.82 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.453 -1.405 . . . . 0.0 110.057 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.61 ' C ' HD11 ' A' ' 20' ' ' ILE . 1.7 tt0 -85.46 -143.04 0.09 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.64 ' HB3' HG21 ' A' ' 8' ' ' VAL . 22.2 m-85 -142.66 127.55 10.05 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.693 -1.255 . . . . 0.0 109.701 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.834 ' O ' HG23 ' A' ' 8' ' ' VAL . 5.0 Cg_endo -60.81 95.47 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.813 1.676 . . . . 0.0 109.225 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -54.26 -149.28 0.01 OUTLIER Glycine 0 N--CA 1.493 2.5 0 CA-C-O 122.039 0.799 . . . . 0.0 111.548 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.533 ' N ' ' CG ' ' A' ' 98' ' ' GLU . . . 159.9 -37.1 0.46 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.643 ' HE2' HD23 ' A' ' 4' ' ' LEU . 20.9 tptp 72.52 98.3 0.07 Allowed 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.172 0.51 . . . . 0.0 110.875 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.982 HD13 ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -81.59 130.21 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.306 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -170.51 -32.3 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.428 -0.795 . . . . 0.0 109.76 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.419 ' HB2' ' HA ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -53.73 164.26 0.58 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.907 . . . . 0.0 109.378 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' MET . . . 45.08 -122.05 4.9 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -165.89 24.05 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.43 -1.041 . . . . 0.0 108.997 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.654 HG22 ' H ' ' A' ' 47' ' ' GLU . 88.4 m -144.19 141.93 19.07 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.356 -0.84 . . . . 0.0 108.845 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 45' ' ' THR . 7.5 Cg_exo -48.89 -18.58 1.74 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.705 1.603 . . . . 0.0 109.804 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.654 ' H ' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -76.0 -87.57 0.04 OUTLIER 'General case' 0 C--O 1.201 -1.449 0 O-C-N 121.214 -0.929 . . . . 0.0 108.799 178.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.55 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 22.7 mt-30 -42.72 -34.81 0.97 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.744 -1.223 . . . . 0.0 109.977 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.599 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -65.06 -63.87 1.0 Allowed 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.299 -0.875 . . . . 0.0 109.83 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.806 HG23 ' HB1' ' A' ' 7' ' ' ALA . 1.9 p -65.59 -49.37 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.962 -1.086 . . . . 0.0 110.864 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.568 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 3.8 p -56.55 -43.9 79.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.641 -0.662 . . . . 0.0 110.283 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 27.4 mmm180 -73.83 -28.46 61.62 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.599 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 25.0 mm-40 -76.69 -15.2 59.86 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.018 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -79.85 -55.51 4.93 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.68 0.752 . . . . 0.0 109.297 -179.732 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.635 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -68.71 -41.21 79.39 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.819 -0.551 . . . . 0.0 110.657 -179.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.575 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.9 OUTLIER -59.12 -20.81 56.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.006 -1.059 . . . . 0.0 110.73 -178.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 9.9 mm-40 -80.1 -91.07 0.05 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.812 -1.18 . . . . 0.0 110.445 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.611 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 94.7 t -77.49 -80.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.37 -0.832 . . . . 0.0 110.203 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.76 32.76 0.1 Allowed Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.178 -1.487 . . . . 0.0 111.678 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.063 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.3 pt -89.44 -137.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.552 -1.558 . . . . 0.0 108.305 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.662 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.8 m -154.32 -71.57 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.333 -1.479 . . . . 0.0 111.166 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.662 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 3.6 Cg_endo -64.09 -175.34 0.3 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 120.965 1.11 . . . . 0.0 110.315 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.705 ' HB2' HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 151.79 -22.04 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.748 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.593 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 1.0 OUTLIER 48.61 50.53 16.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.479 -0.763 . . . . 0.0 109.748 179.026 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.587 ' HB3' ' NE2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -48.64 149.56 1.67 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.808 0.813 . . . . 0.0 110.68 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 86' ' ' LEU . 3.1 m -153.63 133.58 13.19 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.627 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -56.76 -71.4 0.1 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.856 -1.152 . . . . 0.0 110.482 -179.044 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.818 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 84.78 -52.19 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.58 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 0.8 OUTLIER 154.88 138.77 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.151 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.546 ' HA ' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -128.76 -175.17 3.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.972 . . . . 0.0 109.893 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.82 HD11 ' HB2' ' A' ' 82' ' ' LEU . 0.9 OUTLIER -125.16 -169.53 2.01 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.669 0.747 . . . . 0.0 109.647 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.604 ' HG3' HG23 ' A' ' 81' ' ' THR . 4.9 tt0 -156.37 83.12 0.98 Allowed 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.78 106.56 10.87 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.51 -170.17 2.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.348 -0.845 . . . . 0.0 109.471 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.592 ' HB2' ' CB ' ' A' ' 78' ' ' ARG . 5.6 m-85 -160.33 169.46 10.13 Favored Pre-proline 0 C--N 1.297 -1.681 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.351 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.4 Cg_exo -50.73 -28.85 24.04 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.974 1.783 . . . . 0.0 109.607 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.64 42.07 0.14 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.592 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -151.52 92.88 1.81 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.841 -0.537 . . . . 0.0 109.725 -178.383 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.667 ' C ' HD12 ' A' ' 80' ' ' ILE . 24.2 m170 -82.95 104.82 13.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.966 -1.084 . . . . 0.0 109.067 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.863 HG13 HD12 ' A' ' 4' ' ' LEU . 0.6 OUTLIER -115.04 138.08 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.005 -1.059 . . . . 0.0 110.284 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.604 HG23 ' HG3' ' A' ' 72' ' ' GLU . 1.0 OUTLIER -112.9 179.54 3.94 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.34 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.984 HD23 ' CE1' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -160.32 72.53 0.48 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.658 -1.276 . . . . 0.0 110.394 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.629 ' CD1' HG21 ' A' ' 40' ' ' ILE . 79.3 m95 -51.74 131.12 30.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 108.956 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.984 ' CE1' HD23 ' A' ' 82' ' ' LEU . 16.0 m-85 -110.12 71.92 0.77 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.054 -1.029 . . . . 0.0 109.132 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.638 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 38.2 m95 -70.75 85.11 0.65 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.315 -0.865 . . . . 0.0 109.588 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.818 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.6 mm? -70.77 124.22 23.79 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.749 -1.181 . . . . 0.0 109.059 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.089 ' CG2' HG22 ' A' ' 11' ' ' ILE . 1.1 m -113.72 159.86 13.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 87' ' ' VAL . 17.1 mp0 -148.44 36.56 0.81 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.095 -1.442 . . . . 0.0 112.924 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.593 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -161.06 31.98 0.14 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 119.881 -1.762 . . . . 0.0 111.532 178.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.767 ' HB2' HD13 ' A' ' 60' ' ' ILE . 2.8 p90 -54.79 165.5 0.61 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.16 -1.587 . . . . 0.0 108.274 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.567 ' HG2' ' HB ' ' A' ' 60' ' ' ILE . 8.1 pt-20 -77.35 -123.85 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.994 -1.066 . . . . 0.0 110.408 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.454 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -64.83 -50.46 58.24 Favored Glycine 0 N--CA 1.489 2.217 0 O-C-N 120.738 -1.226 . . . . 0.0 110.075 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 1.063 ' O ' HG21 ' A' ' 60' ' ' ILE . 3.1 mt-10 -123.29 156.56 63.35 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.018 -1.283 . . . . 0.0 110.278 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.691 ' HB3' HD12 ' A' ' 11' ' ' ILE . 8.4 Cg_endo -73.86 -160.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.731 2.288 . . . . 0.0 110.086 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 1.018 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER 176.7 48.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 111.049 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . -132.69 2.89 4.95 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.169 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -80.08 94.91 6.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.383 -1.069 . . . . 0.0 111.239 -179.251 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.533 ' CG ' ' N ' ' A' ' 38' ' ' GLY . 2.8 mm-40 -42.02 -88.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.913 . . . . 0.0 108.729 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.97 1.68 27.15 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.564 ' HG3' ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -73.89 146.98 85.92 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.725 -0.868 . . . . 0.0 109.366 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.564 ' HD2' ' HG3' ' A' ' 100' ' ' GLN . 3.0 Cg_exo -56.39 -29.46 77.46 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 N-CA-C 107.897 -1.616 . . . . 0.0 107.897 178.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.627 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 54.76 110.73 0.01 OUTLIER Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.585 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 2.9 pt-20 -151.83 127.95 10.45 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.07 -1.253 . . . . 0.0 109.19 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.449 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -41.65 141.34 0.8 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.513 ' HG3' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -139.15 96.05 3.04 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.363 -0.836 . . . . 0.0 108.961 -179.455 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.549 ' CB ' ' HG2' ' A' ' 17' ' ' GLU . 10.4 t -78.51 72.17 5.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.46 -0.775 . . . . 0.0 109.399 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.782 HD23 ' N ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -80.03 -10.92 59.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.916 -1.115 . . . . 0.0 109.903 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.782 ' N ' HD23 ' A' ' 107' ' ' LEU . 2.5 t 64.93 122.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 108' ' ' VAL . . . 33.26 83.03 0.01 OUTLIER Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.966 HD21 ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -41.09 165.07 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.772 -0.84 . . . . 0.0 109.866 -178.068 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.713 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 2.0 t-20 -144.3 -4.94 0.78 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.804 -1.185 . . . . 0.0 111.87 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 81.23 -26.29 0.15 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.961 -1.087 . . . . 0.0 108.56 -177.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -57.24 -40.47 77.64 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.71 ' HB3' HD12 ' A' ' 33' ' ' LEU . 59.8 m-20 -86.67 -13.12 46.44 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.966 ' CD1' HD21 ' A' ' 110' ' ' LEU . 5.1 m-85 -101.3 146.26 31.87 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 110.317 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 5.9 Cg_exo -60.92 141.66 95.24 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.44 2.094 . . . . 0.0 110.31 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.478 ' O ' ' OE1' ' A' ' 120' ' ' GLU . 1.6 Cg_endo -64.36 -8.1 15.94 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.098 1.866 . . . . 0.0 110.626 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.27 -53.45 52.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.09 -1.006 . . . . 0.0 110.174 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.715 ' OD1' HD21 ' A' ' 71' ' ' LEU . 6.7 m-80 -87.85 42.87 1.08 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 109.764 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.691 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -57.66 -44.3 99.39 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 120.981 -1.074 . . . . 0.0 111.734 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.691 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 20.8 Cg_exo -47.15 -44.92 22.84 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.825 1.683 . . . . 0.0 113.043 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.691 HG21 ' CD1' ' A' ' 84' ' ' PHE . 1.7 t -96.37 -35.94 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.306 -1.496 . . . . 0.0 109.215 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.859 ' HA ' HD22 ' A' ' 126' ' ' LEU . 2.1 mt -62.54 -17.95 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.592 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -63.27 -35.87 81.79 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.0 mmtm -74.21 -42.21 60.14 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.668 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.859 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.46 -20.61 66.43 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.783 -1.198 . . . . 0.0 108.224 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.592 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 11.3 mtmt -57.98 -36.75 73.05 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -23.66 41.35 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.584 HD13 HD12 ' A' ' 126' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.539 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.569 ' HG3' ' N ' ' A' ' 4' ' ' LEU . 1.7 tttt . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 1.087 ' CD1' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -139.54 110.0 6.62 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.785 ' N ' HD22 ' A' ' 4' ' ' LEU . 4.2 mp0 -96.93 162.47 13.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.109 -0.994 . . . . 0.0 109.804 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.587 HG22 HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -128.92 108.99 18.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.04 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -84.74 64.71 8.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.471 -0.768 . . . . 0.0 109.113 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.741 HG13 ' H ' ' A' ' 9' ' ' GLY . 1.3 p -79.52 -71.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 110.405 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.741 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 60.04 74.04 0.41 Allowed Glycine 0 C--N 1.298 -1.554 0 N-CA-C 106.788 -2.525 . . . . 0.0 106.788 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.679 ' CG1' HD11 ' A' ' 86' ' ' LEU . 0.6 OUTLIER -42.27 142.75 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -178.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.647 HD11 ' CB ' ' A' ' 19' ' ' PHE . 2.7 pt -98.14 97.59 6.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.169 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.956 ' HG2' HG23 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -77.44 171.47 14.83 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.608 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 6.1 t30 -148.92 -64.5 0.23 Allowed 'General case' 0 C--O 1.188 -2.134 0 C-N-CA 116.86 -1.936 . . . . 0.0 114.74 -177.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.549 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 3.0 tp10 -91.86 -28.91 17.01 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 118.775 -2.453 . . . . 0.0 111.592 -175.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -162.79 -43.03 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.735 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -160.06 31.31 0.18 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 177.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 105' ' ' MET . 36.4 mt-10 -83.01 89.31 6.88 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 117.517 -1.673 . . . . 0.0 108.025 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.956 HG23 ' HG2' ' A' ' 12' ' ' ARG . 1.0 OUTLIER -85.01 150.13 4.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-O 121.644 0.735 . . . . 0.0 110.812 -178.235 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.647 ' CB ' HD11 ' A' ' 11' ' ' ILE . 14.0 t80 -82.66 43.72 0.85 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.639 HD11 ' N ' ' A' ' 34' ' ' GLU . 6.6 tp -80.78 157.39 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 121.37 -0.831 . . . . 0.0 110.386 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 21' ' ' THR . 2.0 t -74.01 86.0 1.8 Allowed 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.609 ' HD2' HD21 ' A' ' 33' ' ' LEU . 15.6 tpt180 -82.55 84.28 7.29 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.205 -0.934 . . . . 0.0 109.922 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.532 ' CB ' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 30.21 64.69 0.15 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.37 0.605 . . . . 0.0 110.359 -179.625 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -45.81 -54.32 8.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.359 -0.838 . . . . 0.0 109.233 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.73 -177.33 3.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -0.892 . . . . 0.0 108.872 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -76.15 86.58 3.01 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.013 -1.054 . . . . 0.0 109.337 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.532 ' HB2' ' CB ' ' A' ' 23' ' ' ARG . . . -68.19 -27.97 66.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.861 . . . . 0.0 109.805 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.592 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 72.7 t60 49.02 24.71 0.93 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -177.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -152.19 -166.65 2.54 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.523 ' O ' ' OD1' ' A' ' 31' ' ' ASN . . . -137.44 -153.09 0.47 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.523 ' OD1' ' O ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER 63.8 2.79 1.41 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.218 -0.926 . . . . 0.0 109.504 -179.033 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.59 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -83.47 50.43 1.78 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.196 -0.94 . . . . 0.0 110.316 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.728 HD12 ' HB3' ' A' ' 114' ' ' ASP . 12.7 mt -128.74 85.77 2.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.975 -1.078 . . . . 0.0 108.197 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.639 ' N ' HD11 ' A' ' 20' ' ' ILE . 21.8 mt-10 -91.2 -123.52 0.07 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.176 -0.952 . . . . 0.0 110.842 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.707 ' CB ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -160.49 124.0 1.95 Allowed Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 120.579 -1.325 . . . . 0.0 109.832 -178.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.62 ' CB ' ' HA ' ' A' ' 97' ' ' LYS . 19.7 Cg_endo -76.7 95.81 1.07 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.415 2.077 . . . . 0.0 110.575 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' CA ' ' HA ' ' A' ' 8' ' ' VAL . . . -145.62 123.4 1.87 Allowed Glycine 0 N--CA 1.499 2.843 0 O-C-N 120.654 -1.279 . . . . 0.0 110.166 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.588 ' HA3' ' OE1' ' A' ' 98' ' ' GLU . . . -103.77 74.22 0.27 Allowed Glycine 0 N--CA 1.491 2.339 0 O-C-N 121.172 -1.193 . . . . 0.0 111.942 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.695 ' CD ' HD23 ' A' ' 4' ' ' LEU . 5.4 tptt 42.07 121.02 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 176.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.04 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -81.65 129.96 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.495 ' OE1' ' HG2' ' A' ' 39' ' ' LYS . 3.1 pt-20 -171.71 -20.9 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 118.534 -1.267 . . . . 0.0 111.43 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.446 ' HG3' ' HG2' ' A' ' 53' ' ' GLU . 2.5 mmt -39.42 -74.28 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.096 -1.003 . . . . 0.0 109.655 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.57 -132.71 7.38 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -134.34 3.1 3.33 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.625 -0.926 . . . . 0.0 109.101 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.544 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 22.5 m -118.64 142.53 31.78 Favored Pre-proline 0 N--CA 1.486 1.338 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 8.2 Cg_exo -52.76 -17.49 7.35 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.395 1.397 . . . . 0.0 109.653 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.498 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -79.48 -87.97 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.209 -0.932 . . . . 0.0 108.821 178.556 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.571 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 10.6 mt-30 -42.66 -34.29 0.86 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.815 -1.178 . . . . 0.0 109.327 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.643 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -63.88 -62.46 1.63 Allowed 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.069 -1.019 . . . . 0.0 110.119 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.808 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.1 p -69.3 -49.17 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.186 -0.946 . . . . 0.0 110.763 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.558 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 4.2 p -55.32 -44.22 74.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.551 -0.718 . . . . 0.0 110.264 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.571 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -72.35 -36.88 68.9 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 179.375 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.598 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 11.6 mm-40 -69.0 -13.74 62.63 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.847 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.8 OUTLIER -80.37 -61.39 1.99 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.563 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -58.13 -50.26 74.1 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.747 -0.596 . . . . 0.0 109.891 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.598 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -49.45 -21.57 0.96 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.062 -1.024 . . . . 0.0 110.04 -178.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.461 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mt-10 -79.98 -95.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.928 -1.107 . . . . 0.0 109.622 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.612 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 45.4 t -80.12 -78.48 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 110.184 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.06 31.84 0.13 Allowed Glycine 0 N--CA 1.493 2.434 0 C-N-CA 118.626 -1.75 . . . . 0.0 112.476 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.137 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.2 pp -87.13 -153.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 120.372 -1.664 . . . . 0.0 107.639 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.653 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.8 m -135.95 -70.93 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.389 -1.444 . . . . 0.0 110.584 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.653 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 5.8 Cg_endo -63.04 -170.61 0.1 Allowed 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 121.433 1.422 . . . . 0.0 110.719 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.577 ' NE2' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 143.0 -24.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.555 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.3 OUTLIER 44.54 71.03 0.28 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.423 -0.798 . . . . 0.0 109.312 178.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.447 ' HB3' ' NE2' ' A' ' 63' ' ' GLN . 8.0 p90 -67.26 141.98 57.06 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.342 -0.849 . . . . 0.0 109.833 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -132.42 135.85 46.36 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.562 ' O ' ' O ' ' A' ' 84' ' ' PHE . 1.3 tm? -57.53 -64.94 0.72 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.977 -1.077 . . . . 0.0 109.36 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.825 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 80.66 -50.01 0.31 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.589 ' CB ' ' O ' ' A' ' 68' ' ' PHE . 27.1 tt0 150.16 142.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -131.35 178.07 7.0 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 110.541 -178.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.839 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -127.47 166.34 18.13 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.725 0.774 . . . . 0.0 109.887 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -141.0 91.4 2.4 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.83 113.4 16.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.426 ' CG ' ' CD2' ' A' ' 79' ' ' HIS . 2.8 tt0 -91.72 146.79 23.49 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.576 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -133.51 173.02 6.35 Favored Pre-proline 0 C--N 1.296 -1.722 0 O-C-N 121.272 -0.893 . . . . 0.0 108.731 -179.585 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.576 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 7.3 Cg_exo -47.93 -40.5 32.84 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.818 1.678 . . . . 0.0 109.742 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -151.63 45.75 0.78 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HB2' ' CB ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -148.77 93.06 2.07 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.714 -0.616 . . . . 0.0 109.565 -178.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.426 ' CD2' ' CG ' ' A' ' 74' ' ' GLU . 22.7 m80 -91.87 73.36 5.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.137 -0.977 . . . . 0.0 108.74 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.087 HG23 ' CD1' ' A' ' 4' ' ' LEU . 3.1 mm -84.52 154.32 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.995 -1.066 . . . . 0.0 110.486 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.468 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 3.2 m -136.51 154.45 50.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.619 HD22 ' ND2' ' A' ' 119' ' ' ASN . 0.2 OUTLIER -139.77 75.53 1.52 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.74 -1.225 . . . . 0.0 110.021 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.593 ' CD1' HG21 ' A' ' 40' ' ' ILE . 89.4 m95 -48.46 124.1 7.6 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 118.6 -1.24 . . . . 0.0 108.611 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.617 ' CD1' ' O ' ' A' ' 82' ' ' LEU . 40.3 m-85 -102.28 71.77 1.25 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.996 -1.065 . . . . 0.0 110.32 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.676 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 76.7 m95 -75.88 85.52 2.83 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.757 -1.214 . . . . 0.0 108.994 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.825 HD23 ' CD2' ' A' ' 68' ' ' PHE . 2.1 mm? -72.58 123.11 22.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.509 -1.369 . . . . 0.0 108.779 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.577 HG11 ' NE2' ' A' ' 63' ' ' GLN . 0.9 OUTLIER -102.76 176.7 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.542 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 41.3 mt-10 -157.1 16.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.654 -1.218 . . . . 0.0 112.113 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.612 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -159.75 64.39 0.36 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.146 -1.596 . . . . 0.0 111.451 179.131 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.656 ' CH2' ' CD1' ' A' ' 104' ' ' TRP . 2.0 p90 -80.25 168.56 18.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 119.951 -1.718 . . . . 0.0 108.382 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.634 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -89.7 113.95 25.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.077 -1.014 . . . . 0.0 109.05 179.188 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 44.21 -80.87 0.0 OUTLIER Glycine 0 N--CA 1.501 2.984 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 1.137 ' O ' HG21 ' A' ' 60' ' ' ILE . 4.8 mt-10 -82.52 145.7 51.91 Favored Pre-proline 0 C--N 1.298 -1.638 0 O-C-N 120.881 -1.364 . . . . 0.0 109.941 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.627 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 11.7 Cg_endo -79.17 -167.25 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.451 2.101 . . . . 0.0 108.511 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.847 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -179.12 34.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.728 -1.233 . . . . 0.0 112.009 178.235 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . -121.36 1.7 11.41 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 178.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.62 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -80.83 127.22 32.28 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.446 -1.032 . . . . 0.0 111.863 -179.014 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.588 ' OE1' ' HA3' ' A' ' 38' ' ' GLY . 32.8 mm-40 -81.84 -135.29 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.13 -19.85 47.38 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.444 ' HG2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -55.21 148.96 28.23 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.866 -0.785 . . . . 0.0 109.84 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 21' ' ' THR . 2.2 Cg_endo -65.28 -37.73 30.05 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.89 1.727 . . . . 0.0 108.418 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.634 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 58.09 115.91 0.01 OUTLIER Glycine 0 N--CA 1.481 1.653 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 18.9 pt-20 -150.4 130.0 13.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.038 -1.272 . . . . 0.0 110.174 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.656 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -46.65 131.96 11.18 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.563 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.95 123.42 42.42 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.14 -0.975 . . . . 0.0 109.338 -178.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.99 46.87 1.15 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.334 -0.854 . . . . 0.0 108.873 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.997 HD22 ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -75.07 -28.95 60.54 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.916 ' N ' HD13 ' A' ' 107' ' ' LEU . 49.0 t 55.91 123.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.713 -0.617 . . . . 0.0 110.495 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.54 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 42.83 82.77 0.02 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.814 HD22 ' HD2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -45.45 175.01 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.562 -0.964 . . . . 0.0 109.433 -177.338 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.729 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 1.5 t30 -143.8 -5.64 0.8 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.266 -1.521 . . . . 0.0 112.762 -177.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 82.35 -35.75 0.09 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.039 -1.038 . . . . 0.0 108.405 -177.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -54.76 -24.9 24.56 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.728 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -105.38 -17.41 14.45 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.439 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.814 ' HD2' HD22 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -91.61 122.43 65.73 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.397 -0.814 . . . . 0.0 109.14 179.09 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.516 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 14.1 Cg_exo -48.49 147.52 9.08 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.836 1.69 . . . . 0.0 110.446 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.455 ' HA ' ' CG ' ' A' ' 120' ' ' GLU . 3.5 Cg_exo -60.27 -30.58 91.46 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.496 2.13 . . . . 0.0 110.99 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.89 -61.59 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 109.57 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.634 ' ND2' ' CE2' ' A' ' 35' ' ' PHE . 4.6 m-20 -88.71 51.6 2.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.353 -0.842 . . . . 0.0 109.134 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.627 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -70.29 -40.68 12.34 Favored Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -179.079 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 5.7 Cg_exo -54.36 -47.21 28.12 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 121.928 1.752 . . . . 0.0 113.12 -177.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 71' ' ' LEU . 2.1 t -87.62 -28.19 5.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 120.581 -1.325 . . . . 0.0 109.118 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.877 ' HA ' HD22 ' A' ' 126' ' ' LEU . 1.1 mp -67.48 -23.16 29.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.511 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -58.61 -28.14 65.33 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -81.01 -41.1 23.24 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.265 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.877 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -64.59 -26.45 68.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.507 -1.371 . . . . 0.0 107.476 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 14.8 mtmt -50.75 -37.37 41.53 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -83.53 -27.54 29.28 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.869 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 126' ' ' LEU . 1.1 tp . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.838 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.101 0.477 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.554 ' HG2' ' N ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -150.94 171.4 17.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.04 -1.038 . . . . 0.0 109.471 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.554 ' N ' ' HG2' ' A' ' 2' ' ' LYS . 20.3 tttt -145.17 152.67 40.38 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.868 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 1.083 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -158.25 150.87 22.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 1.056 ' N ' HD22 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -121.38 161.59 21.86 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.093 -1.005 . . . . 0.0 109.231 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.639 HD11 ' C8 ' ' A' ' 130' ' ' APC . 0.3 OUTLIER -124.4 114.94 43.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.253 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.984 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -84.07 64.46 8.2 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -79.21 -79.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.081 -1.048 . . . . 0.0 109.206 -179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.724 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 73.97 85.76 0.26 Allowed Glycine 0 C--N 1.298 -1.571 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.554 HD13 ' HE1' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -49.43 169.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.03 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.922 HG22 HG13 ' A' ' 87' ' ' VAL . 7.1 pt -137.92 78.1 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.271 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.633 ' HB3' HG23 ' A' ' 18' ' ' ILE . 5.7 ptm180 -82.19 137.87 34.82 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.62 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -158.58 0.23 0.09 Allowed 'General case' 0 C--O 1.187 -2.22 0 C-N-CA 116.748 -1.981 . . . . 0.0 114.805 -177.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.537 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 22.0 tt0 -92.85 -32.52 14.59 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 118.246 -2.784 . . . . 0.0 106.923 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.402 ' C ' ' OD1' ' A' ' 15' ' ' ASN . 16.4 t-20 -163.79 -48.49 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 101.844 -3.391 . . . . 0.0 101.844 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.728 HD21 HD12 ' A' ' 110' ' ' LEU . 56.1 t30 -161.74 37.4 0.13 Allowed 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 175.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.537 ' CG ' ' HB3' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -90.17 101.45 14.17 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.013 -177.166 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.633 HG23 ' HB3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -89.34 149.78 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 122.003 0.906 . . . . 0.0 110.518 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.779 ' HB3' HD11 ' A' ' 11' ' ' ILE . 44.7 t80 -82.98 41.94 0.77 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.703 HD11 ' C ' ' A' ' 34' ' ' GLU . 6.3 tp -81.07 156.23 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 122.193 0.996 . . . . 0.0 111.58 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.487 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -64.39 95.05 0.12 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.835 ' HD3' HD21 ' A' ' 33' ' ' LEU . 32.4 tpt180 -104.82 78.95 1.47 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.211 -0.931 . . . . 0.0 111.055 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.87 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 25.33 76.44 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 120.97 0.415 . . . . 0.0 110.706 179.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.69 -48.53 5.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.43 -0.794 . . . . 0.0 109.07 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.65 154.15 27.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.409 -0.807 . . . . 0.0 108.858 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.71 110.93 1.89 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.047 -1.033 . . . . 0.0 109.16 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.87 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -100.0 149.96 22.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 110.003 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.09 -20.54 52.07 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.424 ' SD ' ' N ' ' A' ' 29' ' ' MET . 2.7 mpp? -97.53 -166.78 1.43 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . -156.78 18.65 0.32 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.014 -1.054 . . . . 0.0 110.217 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.0 m-20 -99.67 17.28 20.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.072 -1.017 . . . . 0.0 108.879 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.512 ' HD2' ' CA ' ' A' ' 23' ' ' ARG . 1.1 tttp -81.52 39.5 0.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.386 -0.821 . . . . 0.0 111.124 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.853 HD13 ' CE1' ' A' ' 115' ' ' PHE . 19.9 mt -107.33 91.91 3.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.826 -1.171 . . . . 0.0 109.351 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.703 ' C ' HD11 ' A' ' 20' ' ' ILE . 37.9 tt0 -91.16 -128.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.314 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 17.9 m-85 -157.11 131.91 5.31 Favored Pre-proline 0 N--CA 1.485 1.324 0 O-C-N 120.81 -1.181 . . . . 0.0 109.758 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.7 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.4 Cg_endo -61.01 88.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.51 2.14 . . . . 0.0 110.435 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -54.65 -160.16 0.01 OUTLIER Glycine 0 N--CA 1.494 2.518 0 O-C-N 121.314 -0.866 . . . . 0.0 111.061 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 163.87 -28.85 0.23 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.641 ' CD ' HD23 ' A' ' 4' ' ' LEU . 0.1 OUTLIER 69.91 102.32 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.973 -0.722 . . . . 0.0 111.058 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.984 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -81.54 132.32 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.199 -0.938 . . . . 0.0 108.928 178.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -171.64 -32.55 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.41 -0.806 . . . . 0.0 109.739 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.409 ' HB2' ' HA ' ' A' ' 49' ' ' ALA . 8.7 mmt -53.02 161.61 0.78 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 109.744 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.04 -121.13 12.52 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -168.99 25.03 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.496 -1.002 . . . . 0.0 108.925 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.685 HG23 ' HD2' ' A' ' 46' ' ' PRO . 63.4 m -154.24 144.37 15.64 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.685 ' HD2' HG23 ' A' ' 45' ' ' THR . 10.8 Cg_exo -48.37 -16.43 0.68 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.894 1.73 . . . . 0.0 111.443 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.586 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.5 mt-10 -78.6 -72.71 0.36 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.744 -1.222 . . . . 0.0 109.124 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.554 ' HA ' HG12 ' A' ' 51' ' ' VAL . 3.8 mt-30 -56.48 -30.87 63.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.399 -1.438 . . . . 0.0 109.321 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.675 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -67.14 -63.24 1.1 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.475 -0.766 . . . . 0.0 109.816 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.845 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.3 p -67.91 -48.19 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.051 -1.031 . . . . 0.0 110.463 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 47' ' ' GLU . 1.6 p -55.73 -42.57 70.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 121.188 0.518 . . . . 0.0 110.334 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 2.4 mmm180 -77.65 -29.79 51.81 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.631 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 21.1 mm-40 -75.75 -11.88 60.08 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.73 HD12 ' CE2' ' A' ' 95' ' ' TRP . 0.7 OUTLIER -80.17 -57.19 3.74 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.755 0.788 . . . . 0.0 108.989 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.507 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -65.38 -42.0 93.14 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.896 -0.502 . . . . 0.0 110.946 -179.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.595 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -57.57 -24.43 56.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.094 -1.004 . . . . 0.0 111.556 -177.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.57 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -80.21 -83.03 0.11 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.409 -1.432 . . . . 0.0 110.572 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.571 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 74.6 t -80.27 -80.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.037 -1.039 . . . . 0.0 110.007 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.21 32.8 0.1 OUTLIER Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.325 -1.417 . . . . 0.0 110.837 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.053 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.8 pp -94.27 -159.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.809 -1.407 . . . . 0.0 108.419 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.63 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.8 m -135.45 -70.87 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.773 -1.205 . . . . 0.0 110.637 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 2.6 Cg_endo -59.3 -171.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.084 0 C-N-CA 121.487 1.458 . . . . 0.0 110.402 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.584 ' HB2' HG21 ' A' ' 87' ' ' VAL . 2.6 pt20 144.03 -22.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.581 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.3 OUTLIER 43.82 72.12 0.21 Allowed 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -69.54 149.17 48.49 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.836 0.826 . . . . 0.0 110.898 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -143.66 144.91 32.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.84 HD13 ' N ' ' A' ' 69' ' ' GLU . 1.9 tm? -66.29 -68.72 0.35 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.774 -1.204 . . . . 0.0 110.25 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.825 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 81.35 -51.72 0.28 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 -178.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.84 ' N ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER 167.74 179.12 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 109.242 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -159.72 158.01 30.53 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.045 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.781 HD21 HD22 ' A' ' 119' ' ' ASN . 1.1 pp -117.93 -177.26 3.22 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.026 -1.047 . . . . 0.0 110.192 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.677 ' HG3' HG23 ' A' ' 81' ' ' THR . 6.8 tt0 -154.84 89.69 1.25 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.524 ' CE2' ' O ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -79.55 127.12 31.76 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.157 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -100.98 133.84 44.87 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.06 -1.025 . . . . 0.0 109.482 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.538 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -116.9 171.09 5.16 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 108.843 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 6.9 Cg_exo -48.23 -47.24 20.28 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.992 1.794 . . . . 0.0 110.196 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.451 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 5.4 p-10 -141.26 33.05 1.7 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.484 ' O ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -140.15 93.14 2.6 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.554 -0.716 . . . . 0.0 110.32 -179.048 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -82.7 92.94 7.28 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.62 HG21 ' C6 ' ' A' ' 130' ' ' APC . 0.3 OUTLIER -97.68 163.42 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -0.963 . . . . 0.0 111.26 -177.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.677 HG23 ' HG3' ' A' ' 72' ' ' GLU . 1.3 m -140.46 168.71 19.17 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.716 ' HB2' HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -157.31 85.23 0.93 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.539 -1.351 . . . . 0.0 110.595 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.64 ' CD1' HG21 ' A' ' 40' ' ' ILE . 70.6 m95 -58.49 126.56 28.1 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.303 -0.873 . . . . 0.0 109.418 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.775 ' CE2' HG11 ' A' ' 122' ' ' VAL . 19.1 m-85 -101.57 70.73 1.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 0.0 109.878 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.717 ' CE2' HD23 ' A' ' 67' ' ' LEU . 93.6 m95 -74.26 91.25 2.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.943 -1.098 . . . . 0.0 108.983 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.825 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.5 mm? -73.48 126.58 30.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.208 -0.932 . . . . 0.0 110.489 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.922 HG13 HG22 ' A' ' 11' ' ' ILE . 1.5 m -112.02 169.18 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 78.0 mt-10 -149.55 17.37 0.91 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.487 -1.383 . . . . 0.0 112.954 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.605 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.26 67.51 0.36 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.089 -1.632 . . . . 0.0 110.56 178.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.62 ' CH2' ' ND2' ' A' ' 13' ' ' ASN . 1.8 p90 -80.74 164.79 22.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.329 -1.482 . . . . 0.0 109.656 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.667 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.9 OUTLIER -80.86 141.97 34.09 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.477 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 27.92 -80.33 0.0 OUTLIER Glycine 0 N--CA 1.502 3.046 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 1.053 ' O ' HG21 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -100.55 151.7 37.64 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.335 -1.097 . . . . 0.0 109.63 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.636 ' HG2' ' CD1' ' A' ' 19' ' ' PHE . 9.9 Cg_endo -73.94 -158.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.724 2.282 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.904 ' CE2' HD11 ' A' ' 60' ' ' ILE . 0.2 OUTLIER 177.53 112.53 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.644 -0.66 . . . . 0.0 109.784 179.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . 174.47 -40.83 0.13 Allowed Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.405 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.548 ' HB2' ' CG ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -44.4 124.24 3.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.101 -1.235 . . . . 0.0 109.489 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.51 ' OE1' ' O2G' ' A' ' 130' ' ' APC . 8.2 tp10 -74.7 -111.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.713 -1.242 . . . . 0.0 107.687 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.76 12.25 64.14 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.548 ' CG ' ' HB2' ' A' ' 97' ' ' LYS . 6.4 pt20 -92.97 170.13 9.33 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.696 -0.885 . . . . 0.0 109.495 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -68.69 -48.67 0.95 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.022 1.814 . . . . 0.0 110.281 -179.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.594 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.62 118.52 0.01 OUTLIER Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.605 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 4.5 pt-20 -157.18 145.19 19.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.932 -1.334 . . . . 0.0 110.44 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.4 ' HE1' ' HG3' ' A' ' 94' ' ' PRO . 1.3 m0 -48.58 135.16 14.87 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.499 ' HG2' ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -129.88 112.95 14.05 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.081 -1.012 . . . . 0.0 109.492 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.9 t -78.22 73.33 4.78 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.825 HD13 ' HG ' ' A' ' 110' ' ' LEU . 8.0 tt -80.7 -66.51 0.87 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.433 -0.792 . . . . 0.0 109.792 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.635 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 99.3 t 103.75 98.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 41.98 82.57 0.02 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.825 ' HG ' HD13 ' A' ' 107' ' ' LEU . 2.1 mp -29.96 153.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.962 0.887 . . . . 0.0 111.612 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.638 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -132.38 -6.26 3.35 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.692 -0.63 . . . . 0.0 110.618 -178.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 73.88 -3.26 2.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.217 -0.927 . . . . 0.0 108.806 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.82 -22.31 40.11 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.696 ' HB3' HD12 ' A' ' 33' ' ' LEU . 14.9 m-20 -104.92 -10.42 17.3 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.853 ' CE1' HD13 ' A' ' 33' ' ' LEU . 27.7 m-85 -102.7 144.99 29.72 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.395 -0.815 . . . . 0.0 109.557 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.537 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 2.3 Cg_endo -65.6 151.19 85.41 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.547 2.165 . . . . 0.0 110.94 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.518 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . 1.6 Cg_endo -65.33 -23.75 58.54 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.239 1.959 . . . . 0.0 109.824 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.524 ' O ' ' CE2' ' A' ' 73' ' ' TYR . . . -46.14 -58.49 3.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.384 -0.822 . . . . 0.0 109.686 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.781 HD22 HD21 ' A' ' 71' ' ' LEU . 12.7 m120 -85.82 45.3 1.19 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 108.892 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.651 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 2.6 mt-10 -59.56 -43.66 96.19 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 121.378 -0.826 . . . . 0.0 112.137 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 7.7 Cg_exo -53.18 -36.44 77.3 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.058 1.839 . . . . 0.0 112.537 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.775 HG11 ' CE2' ' A' ' 84' ' ' PHE . 2.0 t -100.42 -38.0 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.611 -1.305 . . . . 0.0 109.707 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.731 ' HA ' HD22 ' A' ' 126' ' ' LEU . 6.8 mt -56.94 -27.54 26.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.49 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -60.7 -39.0 86.9 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 125' ' ' LYS . 13.7 mmtp -76.11 -40.13 53.59 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.212 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.731 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.2 OUTLIER -55.45 -43.23 75.26 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.546 ' HD3' ' CB ' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -39.58 -41.81 1.08 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.997 0.903 . . . . 0.0 108.652 178.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 129' ' ' LEU . 1.0 OUTLIER -79.21 -50.99 10.09 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.687 HD13 ' HA ' ' A' ' 126' ' ' LEU . 1.8 tp . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.608 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' APC . . . . . 0.639 ' C8 ' HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.512 ' HD3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -159.05 -131.05 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.175 -0.953 . . . . 0.0 109.033 179.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.541 ' CG ' ' O ' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -148.99 158.69 44.38 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.234 -1.541 . . . . 0.0 110.339 -178.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 5' ' ' GLN . 0.7 OUTLIER -136.1 -171.92 3.0 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.087 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.761 ' HB2' HG23 ' A' ' 40' ' ' ILE . 7.8 mp0 -144.05 177.96 8.2 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.586 HG13 ' N7 ' ' A' ' 130' ' ' APC . 0.2 OUTLIER -145.65 109.87 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.72 -178.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.034 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -83.0 67.26 9.01 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.753 HG21 ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -78.83 -73.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.177 -0.952 . . . . 0.0 109.385 -179.514 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.721 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 62.61 81.7 0.09 OUTLIER Glycine 0 C--N 1.295 -1.747 0 N-CA-C 107.958 -2.057 . . . . 0.0 107.958 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.48 ' HB ' HD11 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -48.04 172.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.056 HG22 HG22 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -136.73 81.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.121 -178.551 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.949 ' HB3' HG23 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -91.61 134.96 34.23 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.059 -1.026 . . . . 0.0 108.344 179.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.542 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 5.2 p-10 -161.66 62.2 0.26 Allowed 'General case' 0 C--O 1.189 -2.119 0 C-N-CA 117.596 -1.641 . . . . 0.0 113.158 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.589 ' CB ' ' HG3' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -148.7 -49.55 0.15 Allowed 'General case' 0 C--N 1.269 -2.92 0 CA-C-O 124.499 2.095 . . . . 0.0 105.616 176.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -161.17 -48.54 0.04 OUTLIER 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 100.885 -3.746 . . . . 0.0 100.885 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.489 ' ND2' ' HD2' ' A' ' 12' ' ' ARG . 1.7 t-20 -162.34 42.52 0.13 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.31 -1.768 . . . . 0.0 106.684 175.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.589 ' HG3' ' CB ' ' A' ' 14' ' ' GLU . 9.4 mm-40 -93.46 95.93 9.58 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.962 -1.495 . . . . 0.0 110.901 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.949 HG23 ' HB3' ' A' ' 12' ' ' ARG . 2.7 pt -89.01 153.83 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.637 -0.664 . . . . 0.0 110.362 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.656 ' CZ ' ' O ' ' A' ' 102' ' ' GLY . 3.7 t80 -83.15 47.73 1.28 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.692 ' HB ' HD12 ' A' ' 18' ' ' ILE . 5.2 tt -82.36 155.42 3.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.986 0.898 . . . . 0.0 111.299 -177.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.54 HG23 ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -70.07 98.14 1.27 Allowed 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.554 HH22 ' HB1' ' A' ' 30' ' ' ALA . 28.9 tpt180 -104.46 97.3 7.25 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 110.662 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.939 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 24.49 76.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.211 0.529 . . . . 0.0 110.93 179.186 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -44.61 -52.62 7.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.111 -0.993 . . . . 0.0 109.555 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.27 -178.18 6.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.167 -0.958 . . . . 0.0 109.412 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.71 107.06 8.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.24 -0.913 . . . . 0.0 108.934 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.939 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -101.02 171.96 7.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 110.119 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -127.73 16.08 6.94 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.755 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 4.3 mtm -121.29 -106.33 0.37 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.442 -0.786 . . . . 0.0 109.69 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 148.85 -4.32 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.696 -0.627 . . . . 0.0 110.503 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 31' ' ' ASN . 50.3 t-20 -76.27 6.65 5.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.616 -1.302 . . . . 0.0 109.425 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' HD23 ' A' ' 33' ' ' LEU . 4.1 tmtm? -81.29 62.85 5.38 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.535 -0.728 . . . . 0.0 110.857 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.706 HD13 ' CE1' ' A' ' 115' ' ' PHE . 10.6 mt -124.22 90.29 3.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.052 -1.03 . . . . 0.0 109.045 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.54 ' H ' HG23 ' A' ' 21' ' ' THR . 1.2 tt0 -90.23 -144.97 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.903 -1.123 . . . . 0.0 108.794 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.753 ' HB3' HG21 ' A' ' 8' ' ' VAL . 66.7 m-85 -145.93 124.27 6.41 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 120.901 -1.124 . . . . 0.0 110.019 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.685 ' O ' HG23 ' A' ' 8' ' ' VAL . 9.5 Cg_endo -65.79 90.48 0.24 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.194 1.929 . . . . 0.0 110.219 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.665 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -131.0 127.65 5.22 Favored Glycine 0 N--CA 1.494 2.562 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.368 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.557 ' HA2' ' CG ' ' A' ' 98' ' ' GLU . . . -106.65 38.26 3.41 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 120.05 -1.072 . . . . 0.0 111.163 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.59 ' HB2' H3A2 ' A' ' 130' ' ' APC . 10.5 tptm 60.24 120.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.777 -0.837 . . . . 0.0 111.433 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.034 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -82.59 133.51 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 42' ' ' MET . 1.8 pt-20 -171.83 -25.64 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.548 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.449 ' HE3' ' HG2' ' A' ' 56' ' ' GLU . 3.3 tpp -54.57 129.65 37.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.856 -1.153 . . . . 0.0 109.27 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.12 -120.78 12.54 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -168.27 22.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.402 -1.058 . . . . 0.0 109.716 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.794 HG22 ' H ' ' A' ' 47' ' ' GLU . 20.6 m -140.9 138.91 18.65 Favored Pre-proline 0 C--O 1.201 -1.486 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.608 ' O ' HG12 ' A' ' 50' ' ' VAL . 8.6 Cg_exo -48.57 -16.52 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.829 1.686 . . . . 0.0 111.344 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.794 ' H ' HG22 ' A' ' 45' ' ' THR . 2.7 mt-10 -80.42 -78.7 0.16 Allowed 'General case' 0 C--O 1.201 -1.491 0 O-C-N 120.587 -1.321 . . . . 0.0 108.61 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.548 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 24.7 mt-30 -50.14 -30.75 11.87 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.389 -1.444 . . . . 0.0 109.364 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.776 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -68.6 -60.36 2.47 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.113 -0.992 . . . . 0.0 110.504 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.766 HG23 ' HB1' ' A' ' 7' ' ' ALA . 4.3 p -70.09 -45.83 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.718 -1.239 . . . . 0.0 110.227 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.583 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 1.4 p -58.12 -47.77 86.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.302 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.583 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -73.48 -36.13 65.78 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.643 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 21.7 mm-40 -65.22 -19.83 66.15 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.133 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -78.31 -63.39 1.41 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.885 -178.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.559 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -58.94 -44.5 91.4 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.356 -0.84 . . . . 0.0 110.092 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.588 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -54.92 -20.71 9.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.108 -0.995 . . . . 0.0 110.193 -179.239 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.429 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mt-10 -80.26 -92.82 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.065 -1.022 . . . . 0.0 109.837 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.593 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 47.9 t -80.21 -78.98 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.346 -0.846 . . . . 0.0 110.045 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.88 27.51 0.13 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 118.599 -1.762 . . . . 0.0 112.723 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.102 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.3 pp -81.49 -144.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 120.181 -1.776 . . . . 0.0 107.582 178.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.619 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.3 m -143.07 -71.26 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.206 -1.559 . . . . 0.0 110.24 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 9.4 Cg_endo -67.01 -170.01 0.21 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.249 1.3 . . . . 0.0 110.127 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.592 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 136.28 -26.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.535 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.2 OUTLIER 56.64 -163.31 0.17 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.444 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 7.2 p90 177.11 143.75 0.09 Allowed 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.533 -1.267 . . . . 0.0 110.585 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.591 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -144.13 157.06 44.53 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.619 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -74.29 -69.92 0.42 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.251 -0.906 . . . . 0.0 110.856 -178.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.839 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 83.99 -51.85 0.13 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 3.2 mt-10 157.3 175.05 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HA ' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -161.42 -168.6 2.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.953 -1.092 . . . . 0.0 110.115 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.844 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -147.36 161.41 41.07 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.49 -0.756 . . . . 0.0 109.947 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 80' ' ' ILE . 2.6 tt0 -137.42 90.09 2.48 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.03 119.88 25.47 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.439 -0.788 . . . . 0.0 109.119 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.522 ' HG3' ' HA ' ' A' ' 79' ' ' HIS . 11.1 tt0 -112.2 155.78 23.41 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.318 -0.864 . . . . 0.0 109.824 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.751 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 67.4 m-85 -136.76 -115.22 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.641 0 CA-C-O 117.341 -1.314 . . . . 0.0 109.3 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.751 ' CD ' ' CB ' ' A' ' 75' ' ' PHE . 1.9 Cg_endo -62.44 -43.81 20.9 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 CA-C-N 122.077 1.777 . . . . 0.0 109.895 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -171.4 29.9 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.413 ' HD2' HD11 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -106.91 88.73 2.81 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.488 -0.757 . . . . 0.0 109.933 -179.221 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.541 ' O ' ' CG ' ' A' ' 3' ' ' LYS . 0.3 OUTLIER -79.66 79.84 6.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 108.797 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.134 HG21 ' C5 ' ' A' ' 130' ' ' APC . 2.7 mm -85.0 145.3 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.036 -1.04 . . . . 0.0 110.725 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -120.98 139.43 53.29 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.757 HD13 HN61 ' A' ' 130' ' ' APC . 0.2 OUTLIER -124.44 74.07 1.29 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.949 -1.094 . . . . 0.0 109.658 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.451 ' HD1' HG21 ' A' ' 40' ' ' ILE . 80.1 m95 -53.53 114.02 1.37 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.033 -1.042 . . . . 0.0 109.48 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.725 ' CZ ' HG11 ' A' ' 122' ' ' VAL . 32.4 m-85 -89.53 78.11 7.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.138 -0.976 . . . . 0.0 108.379 179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.665 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 97.7 m95 -74.37 85.77 1.98 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.014 -1.054 . . . . 0.0 109.228 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.839 HD23 ' CD2' ' A' ' 68' ' ' PHE . 2.5 mm? -68.88 124.91 24.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.397 -1.439 . . . . 0.0 110.061 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.056 HG22 HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -113.01 178.87 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.537 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 13.8 mt-10 -160.16 33.46 0.17 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 118.103 -1.439 . . . . 0.0 112.881 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.565 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -161.02 47.08 0.21 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 119.803 -1.811 . . . . 0.0 112.404 179.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.609 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 1.4 p90 -70.57 160.69 32.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 119.863 -1.773 . . . . 0.0 108.991 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -90.29 146.5 24.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.189 -0.944 . . . . 0.0 108.614 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.453 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . 35.94 -82.33 0.0 OUTLIER Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 1.102 ' O ' HG21 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -112.25 157.77 39.0 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.334 -1.097 . . . . 0.0 110.009 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.624 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 9.0 Cg_endo -76.21 -159.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.993 2.462 . . . . 0.0 110.614 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 1.133 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -177.87 39.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.862 -1.149 . . . . 0.0 111.189 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -124.81 -7.57 6.05 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.021 -1.562 . . . . 0.0 111.497 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.556 ' HD2' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -63.44 103.72 0.55 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.717 -1.461 . . . . 0.0 110.998 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.557 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 9.6 tp10 -70.14 92.43 0.75 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -0.99 . . . . 0.0 108.509 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.22 14.99 42.67 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.505 ' HG2' ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -96.69 146.56 31.52 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.6 -0.941 . . . . 0.0 109.027 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.567 ' O ' ' O ' ' A' ' 102' ' ' GLY . 4.9 Cg_exo -58.63 -21.38 55.12 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 N-CA-C 108.385 -1.429 . . . . 0.0 108.385 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.656 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 37.13 105.03 0.01 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -141.43 131.39 24.52 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.382 -1.658 . . . . 0.0 110.483 179.309 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.434 ' C ' ' O ' ' A' ' 103' ' ' GLU . 1.6 m0 -46.17 129.26 10.05 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.541 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -123.4 117.07 24.35 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.623 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.33 63.31 5.6 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.811 HD13 ' HG ' ' A' ' 110' ' ' LEU . 6.9 tt -69.06 -54.06 17.09 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.59 -0.693 . . . . 0.0 110.118 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.678 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 66.6 t 85.32 108.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 129' ' ' LEU . . . 46.87 82.51 0.03 OUTLIER Glycine 0 N--CA 1.486 1.968 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 -178.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.811 ' HG ' HD13 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -34.48 160.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.981 0.896 . . . . 0.0 111.738 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -156.59 141.42 17.04 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.65 ' HB2' ' HD3' ' A' ' 127' ' ' LYS . . . -65.93 -22.34 66.49 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.92 -25.19 4.29 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.604 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -108.17 -18.77 13.69 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.706 ' CE1' HD13 ' A' ' 33' ' ' LEU . 44.5 m-85 -100.54 149.64 36.29 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.291 -0.881 . . . . 0.0 110.605 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.439 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -66.95 144.77 71.67 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.518 2.145 . . . . 0.0 109.941 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 1.6 Cg_endo -64.35 -28.22 63.27 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 121.997 1.798 . . . . 0.0 110.15 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -43.05 -41.08 3.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 109.892 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.415 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 9.3 m120 -108.71 55.72 0.63 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.246 -0.909 . . . . 0.0 109.357 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.681 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -71.76 -35.96 4.05 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.555 -0.715 . . . . 0.0 112.585 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.9 Cg_exo -59.07 -31.37 95.45 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.653 1.569 . . . . 0.0 113.174 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.725 HG11 ' CZ ' ' A' ' 84' ' ' PHE . 1.8 t -99.97 -38.58 6.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.376 -1.452 . . . . 0.0 109.342 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.785 HD13 HD23 ' A' ' 126' ' ' LEU . 2.0 mm -58.86 -37.31 66.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.515 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . . . -39.74 -37.3 0.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.144 0.973 . . . . 0.0 108.946 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.485 ' HE2' ' OE2' ' A' ' 69' ' ' GLU . 7.2 mmtm -81.65 -47.33 13.14 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.802 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.785 HD23 HD13 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -64.62 -10.33 25.77 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.378 -1.451 . . . . 0.0 109.093 179.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.65 ' HD3' ' HB2' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -68.75 -37.71 79.58 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -12.29 59.81 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.333 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.59 HD21 ' CZ ' ' A' ' 12' ' ' ARG . 3.0 tp . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.79 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' APC . . . . . 1.134 ' C5 ' HG21 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' CON . . . . . 0.621 ' N3 ' ' O2A' ' A' ' 130' ' ' APC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.418 ' C ' ' HG3' ' A' ' 2' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.515 0.674 . . . . 0.0 109.386 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.454 ' HD2' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -178.19 -165.2 0.09 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.363 -0.835 . . . . 0.0 109.019 -179.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.522 ' HG2' ' N ' ' A' ' 4' ' ' LEU . 6.1 ttpt -143.63 153.24 42.31 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.061 -1.025 . . . . 0.0 109.991 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 1.095 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -154.11 156.06 36.54 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.069 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.912 ' N ' HD22 ' A' ' 4' ' ' LEU . 14.1 mp0 -124.94 173.66 8.49 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.027 -1.046 . . . . 0.0 108.531 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.713 HG22 HG12 ' A' ' 8' ' ' VAL . 1.1 mm -136.47 110.14 9.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.704 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.881 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -84.63 62.17 7.17 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 36' ' ' PRO . 1.1 p -78.29 -70.0 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.363 -0.835 . . . . 0.0 109.902 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.734 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 59.82 80.82 0.09 OUTLIER Glycine 0 C--N 1.297 -1.615 0 N-CA-C 107.055 -2.418 . . . . 0.0 107.055 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -48.4 170.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -178.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.688 HD11 ' CB ' ' A' ' 19' ' ' PHE . 7.7 pt -137.67 99.84 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 C-N-CA 119.406 -0.918 . . . . 0.0 108.768 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.77 ' HG2' HG22 ' A' ' 18' ' ' ILE . 13.3 mtm180 -76.68 -176.54 3.85 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.613 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -157.17 -61.42 0.09 Allowed 'General case' 0 C--O 1.191 -2.01 0 C-N-CA 116.957 -1.897 . . . . 0.0 114.527 -177.457 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.621 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 1.9 tt0 -93.3 -30.12 15.31 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 119.038 -2.289 . . . . 0.0 111.435 -175.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -160.85 -43.52 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.804 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.57 ' OD1' HD23 ' A' ' 129' ' ' LEU . 14.1 t30 -158.32 34.99 0.24 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 177.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.621 ' HG3' ' HB3' ' A' ' 14' ' ' GLU . 2.4 mt-10 -78.74 83.77 4.87 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 117.965 -1.494 . . . . 0.0 108.764 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.77 HG22 ' HG2' ' A' ' 12' ' ' ARG . 4.7 pt -80.08 142.54 13.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 119.684 -0.807 . . . . 0.0 109.425 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.713 ' CZ ' ' HG2' ' A' ' 94' ' ' PRO . 10.2 t80 -80.19 42.9 0.59 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.699 -0.626 . . . . 0.0 109.544 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.79 HG21 HD22 ' A' ' 33' ' ' LEU . 6.8 tp -82.11 155.62 4.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 122.012 0.91 . . . . 0.0 111.579 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.769 HG23 ' O ' ' A' ' 21' ' ' THR . 7.6 t -64.92 96.48 0.19 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.739 ' HD3' HD21 ' A' ' 33' ' ' LEU . 27.1 tpt180 -98.16 87.44 3.93 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.423 -0.798 . . . . 0.0 110.257 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.75 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 36.79 84.43 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.896 -0.503 . . . . 0.0 109.969 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.59 -51.78 5.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.377 -0.827 . . . . 0.0 109.092 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.89 -160.48 0.16 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -76.17 -43.66 41.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.019 -1.051 . . . . 0.0 109.307 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.75 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . 52.89 110.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.35 -0.844 . . . . 0.0 110.24 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -78.96 -6.13 55.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.981 -1.074 . . . . 0.0 108.981 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.728 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 3.1 mpp? -86.81 -124.64 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.188 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 161.49 -2.33 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.833 -1.167 . . . . 0.0 111.647 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 3.8 p-10 -81.96 13.11 3.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.239 -1.538 . . . . 0.0 109.115 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.599 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -81.41 58.99 3.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.599 -0.688 . . . . 0.0 110.322 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.79 HD22 HG21 ' A' ' 20' ' ' ILE . 14.4 mt -130.61 85.46 2.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.945 -1.097 . . . . 0.0 109.097 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.584 ' C ' HD11 ' A' ' 20' ' ' ILE . 3.2 tt0 -92.94 -127.63 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -0.975 . . . . 0.0 108.879 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.673 ' HB2' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -151.9 134.54 8.81 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.942 -1.099 . . . . 0.0 108.46 178.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.736 ' O ' HG23 ' A' ' 8' ' ' VAL . 4.5 Cg_endo -62.09 92.91 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.924 1.749 . . . . 0.0 109.541 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.528 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -54.56 -152.86 0.01 OUTLIER Glycine 0 N--CA 1.493 2.455 0 CA-C-O 122.051 0.806 . . . . 0.0 111.378 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.593 ' N ' ' CG ' ' A' ' 98' ' ' GLU . . . 162.07 -26.35 0.25 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' HD3' " O5'" ' A' ' 130' ' ' APC . 15.7 tptm 64.09 96.94 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.933 -0.745 . . . . 0.0 110.183 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.881 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -80.4 133.17 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.206 -0.933 . . . . 0.0 108.574 178.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.495 ' HG2' ' N ' ' A' ' 42' ' ' MET . 2.9 pt-20 -170.6 -32.88 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.464 -0.773 . . . . 0.0 109.721 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.495 ' N ' ' HG2' ' A' ' 41' ' ' GLU . 8.0 mtt -59.17 166.43 2.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.203 -0.936 . . . . 0.0 109.696 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 51.66 -125.77 27.12 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -169.38 26.66 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.448 -1.03 . . . . 0.0 109.2 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.783 HG22 ' H ' ' A' ' 47' ' ' GLU . 18.5 m -155.32 141.63 13.11 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.697 ' O ' HG12 ' A' ' 50' ' ' VAL . 15.0 Cg_exo -45.66 -18.44 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.072 1.848 . . . . 0.0 111.176 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.783 ' H ' HG22 ' A' ' 45' ' ' THR . 3.4 mt-10 -77.49 -80.64 0.1 Allowed 'General case' 0 C--O 1.2 -1.541 0 O-C-N 120.827 -1.171 . . . . 0.0 108.773 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.542 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 38.0 mt-30 -48.65 -32.84 8.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.307 -1.496 . . . . 0.0 109.287 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.801 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -65.81 -62.75 1.33 Allowed 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.367 -0.833 . . . . 0.0 110.437 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.881 HG23 ' HB1' ' A' ' 7' ' ' ALA . 4.3 p -70.23 -44.24 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.724 -1.235 . . . . 0.0 110.641 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.4 p -59.4 -43.49 90.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 121.769 -0.582 . . . . 0.0 110.326 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.1 OUTLIER -73.58 -48.19 34.69 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.624 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 7.7 mm-40 -59.95 -18.63 46.82 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.8 HD23 ' O ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -78.8 -65.36 1.0 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.582 0.706 . . . . 0.0 109.479 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -52.45 -55.53 21.25 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.48 -0.762 . . . . 0.0 109.052 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.624 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -43.44 -32.8 0.94 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 109.325 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -76.32 -90.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.452 -0.78 . . . . 0.0 109.656 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.661 HG21 ' HA ' ' A' ' 95' ' ' TRP . 4.9 t -80.03 -78.17 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 121.016 -1.053 . . . . 0.0 109.372 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.65 56.1 0.14 Allowed Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.205 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.873 HG21 ' O ' ' A' ' 93' ' ' GLU . 2.5 pp -107.73 -140.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 120.757 -1.437 . . . . 0.0 109.024 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.634 ' N ' HD12 ' A' ' 60' ' ' ILE . 2.5 m -159.84 -67.19 0.02 OUTLIER Pre-proline 0 N--CA 1.505 2.276 0 O-C-N 119.754 -1.841 . . . . 0.0 112.535 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.656 ' HD2' ' HB3' ' A' ' 91' ' ' GLU . 11.5 Cg_exo -43.17 -67.12 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 122.265 1.977 . . . . 0.0 110.704 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.765 ' HB2' ' CE2' ' A' ' 95' ' ' TRP . 0.8 OUTLIER 29.65 27.71 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 114.603 -1.181 . . . . 0.0 113.638 178.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.631 ' C ' ' O ' ' A' ' 63' ' ' GLN . 20.2 t-160 -14.03 82.28 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.738 0 CA-C-N 120.181 1.355 . . . . 0.0 110.119 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.611 ' N ' ' O ' ' A' ' 63' ' ' GLN . 3.3 p90 -75.71 146.97 39.74 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.92 0.867 . . . . 0.0 112.377 -175.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 86' ' ' LEU . 4.6 m -148.59 151.47 35.1 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.688 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -80.24 -66.96 0.81 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.769 -1.207 . . . . 0.0 109.836 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.886 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 86.32 -56.81 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER 159.71 142.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.602 ' HE3' ' CD2' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -124.45 172.43 9.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.549 -0.719 . . . . 0.0 110.833 -178.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.658 ' HB3' HG23 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -121.11 176.72 5.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.819 . . . . 0.0 109.428 178.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.485 ' HG3' HG23 ' A' ' 81' ' ' THR . 7.3 tt0 -152.88 85.89 1.24 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.89 148.33 31.34 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -114.58 171.76 7.44 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.766 -1.174 . . . . 0.0 110.277 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.685 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -142.44 -177.14 0.62 Allowed Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.685 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 3.0 Cg_exo -57.12 -27.83 76.09 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.469 1.446 . . . . 0.0 109.75 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.475 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 56.5 p30 -169.98 36.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.525 ' O ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -136.61 96.52 3.36 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.663 -0.648 . . . . 0.0 109.564 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.575 ' C ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -82.13 116.43 21.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.391 -0.818 . . . . 0.0 109.501 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.788 HG21 ' C6 ' ' A' ' 130' ' ' APC . 0.4 OUTLIER -115.65 144.78 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.001 -1.062 . . . . 0.0 110.586 -179.282 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.547 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 0.9 OUTLIER -129.99 142.3 50.65 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.701 HD21 HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -127.43 80.8 1.98 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.634 -1.291 . . . . 0.0 110.671 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.644 ' CD1' HG21 ' A' ' 40' ' ' ILE . 82.0 m95 -51.62 108.93 0.3 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.172 -0.955 . . . . 0.0 109.161 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.632 ' CE1' HG11 ' A' ' 122' ' ' VAL . 12.1 m-85 -87.46 70.88 9.91 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.215 -0.928 . . . . 0.0 109.684 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.689 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 13.6 m95 -70.51 83.63 0.59 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.91 -1.119 . . . . 0.0 108.791 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.886 HD23 ' CD2' ' A' ' 68' ' ' PHE . 2.9 mm? -71.87 124.91 25.88 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.41 -1.431 . . . . 0.0 110.242 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.638 HG13 HG22 ' A' ' 11' ' ' ILE . 1.5 m -112.31 -178.4 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.638 ' N ' HG23 ' A' ' 87' ' ' VAL . 54.4 mt-10 -155.99 6.24 0.2 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 117.869 -1.533 . . . . 0.0 112.361 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.589 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -153.23 64.51 0.76 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.209 -1.557 . . . . 0.0 110.51 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.613 ' CH2' ' HB2' ' A' ' 13' ' ' ASN . 8.3 p90 -73.93 159.36 32.88 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.796 -1.19 . . . . 0.0 110.039 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.656 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 0.8 OUTLIER -78.02 138.11 38.63 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.407 -0.808 . . . . 0.0 109.347 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 30.42 -82.0 0.0 OUTLIER Glycine 0 N--CA 1.5 2.939 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.873 ' O ' HG21 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -88.37 158.33 49.1 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.188 -1.184 . . . . 0.0 109.874 -179.393 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.713 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 15.5 Cg_endo -71.41 -156.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.864 2.376 . . . . 0.0 110.332 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.765 ' CE2' ' HB2' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -178.67 120.11 0.08 Allowed 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.324 -0.86 . . . . 0.0 110.167 179.508 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.473 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . 145.25 -48.02 0.72 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.431 -1.842 . . . . 0.0 111.487 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.63 ' HA ' ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -39.36 118.18 0.79 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -1.177 . . . . 0.0 110.466 -178.356 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.593 ' CG ' ' N ' ' A' ' 38' ' ' GLY . 3.4 mm-40 -73.31 -143.54 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' H ' ' HB3' ' A' ' 98' ' ' GLU . . . -53.04 -18.57 6.28 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.96 165.62 12.5 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.38 -1.071 . . . . 0.0 110.749 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.498 ' HG2' ' OG1' ' A' ' 21' ' ' THR . 2.1 Cg_endo -69.05 -60.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.666 2.244 . . . . 0.0 110.006 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.603 ' O ' ' CE1' ' A' ' 19' ' ' PHE . . . 76.22 121.61 0.16 Allowed Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.6 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 5.9 pt-20 -156.29 134.18 11.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.391 -1.064 . . . . 0.0 110.048 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.532 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 1.1 m0 -46.53 133.83 9.81 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.618 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 4.9 tpt -117.98 114.35 23.04 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.031 -1.043 . . . . 0.0 109.432 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.6 t -80.39 61.07 4.03 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.827 HD13 ' HG ' ' A' ' 110' ' ' LEU . 4.7 tt -77.61 -49.1 15.27 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.57 ' CB ' ' O ' ' A' ' 107' ' ' LEU . 21.2 t 89.91 101.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 CA-C-O 121.568 0.699 . . . . 0.0 109.267 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 46.77 84.57 0.02 OUTLIER Glycine 0 N--CA 1.484 1.85 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.827 ' HG ' HD13 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -37.58 162.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.918 -0.754 . . . . 0.0 110.475 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.694 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 6.0 t-20 -138.73 -8.13 1.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 111.339 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 81.74 -18.06 0.51 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.183 -0.948 . . . . 0.0 108.614 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.0 -21.17 66.81 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.778 ' HB3' HD12 ' A' ' 33' ' ' LEU . 13.0 m-20 -104.96 -15.47 15.12 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.824 ' CE1' HD21 ' A' ' 110' ' ' LEU . 3.2 m-85 -91.42 133.44 31.37 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.151 -0.968 . . . . 0.0 109.121 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.1 131.56 43.5 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 121.398 1.399 . . . . 0.0 108.617 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 3.3 Cg_exo -52.99 -22.04 17.46 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.365 2.043 . . . . 0.0 112.181 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.08 -39.07 68.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.723 -1.235 . . . . 0.0 109.552 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.562 ' O ' HD13 ' A' ' 123' ' ' ILE . 25.8 p30 -96.26 45.12 1.07 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.444 -0.785 . . . . 0.0 109.69 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.66 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.2 mt-10 -70.25 -33.15 3.15 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 113.191 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.2 Cg_exo -55.96 -47.83 22.9 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.218 1.279 . . . . 0.0 112.801 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.658 HG23 ' HB3' ' A' ' 71' ' ' LEU . 1.9 t -92.91 -33.93 5.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 120.531 -1.355 . . . . 0.0 109.489 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 1.009 ' HA ' HD22 ' A' ' 126' ' ' LEU . 1.7 mp -66.56 -20.84 27.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -58.55 -29.47 66.38 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 125' ' ' LYS . 0.4 OUTLIER -80.38 -37.96 31.29 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.915 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 1.009 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.83 -24.78 66.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.461 -1.399 . . . . 0.0 107.336 178.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.54 ' HD3' ' CB ' ' A' ' 112' ' ' ALA . 1.5 mtmp? -55.17 -35.73 65.09 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.459 ' O ' ' C ' ' A' ' 129' ' ' LEU . 1.9 mtp180 -83.93 -24.6 30.65 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.524 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 2.1 tp . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.069 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' APC . . . . . 0.788 ' C6 ' HG21 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.408 ' HB2' ' OD1' ' A' ' 77' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.44 ' HD3' ' C ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -159.82 179.07 9.14 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.366 -0.834 . . . . 0.0 109.292 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.434 ' HG3' ' HB3' ' A' ' 79' ' ' HIS . 4.9 ttpt -156.02 145.14 20.6 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.195 -0.941 . . . . 0.0 109.312 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.697 HD22 " O4'" ' A' ' 130' ' ' APC . 0.5 OUTLIER -140.95 177.26 8.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.244 -0.91 . . . . 0.0 109.535 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.63 ' HB2' HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -141.55 174.27 10.72 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.701 HG22 HG12 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -141.81 124.69 14.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 O-C-N 121.019 -1.051 . . . . 0.0 109.821 -178.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.951 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -87.0 60.12 6.03 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.973 HG23 ' O ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -78.63 -87.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.79 -178.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.749 ' N ' HG22 ' A' ' 8' ' ' VAL . . . 75.63 88.85 0.25 Allowed Glycine 0 C--N 1.297 -1.625 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.573 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -49.33 175.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.031 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.038 HG22 HG22 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -143.9 92.09 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.577 -1.249 . . . . 0.0 110.349 -178.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.748 ' HG2' HG22 ' A' ' 18' ' ' ILE . 8.8 mtm180 -75.62 174.09 10.19 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.562 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -161.14 -46.19 0.04 OUTLIER 'General case' 0 C--O 1.191 -2.017 0 C-N-CA 115.744 -2.382 . . . . 0.0 115.142 -177.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.514 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 1.5 tp10 -92.4 -27.97 17.17 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 118.64 -2.537 . . . . 0.0 110.369 -176.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -163.22 -45.21 0.03 OUTLIER 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.576 ' ND2' ' HD2' ' A' ' 12' ' ' ARG . 0.7 OUTLIER -160.04 35.42 0.18 Allowed 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 177.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 105' ' ' MET . 17.4 mt-10 -84.54 94.08 8.49 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.098 -1.441 . . . . 0.0 110.046 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.748 HG22 ' HG2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -83.03 142.75 13.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.579 -0.701 . . . . 0.0 109.374 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.639 ' CD1' ' CG ' ' A' ' 94' ' ' PRO . 70.1 t80 -82.2 46.36 1.02 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.681 HD11 ' C ' ' A' ' 34' ' ' GLU . 6.7 tp -81.9 151.83 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-O 122.256 1.027 . . . . 0.0 112.016 -177.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.508 ' OG1' ' HG2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -63.88 90.45 0.06 Allowed 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.616 ' HD3' HD21 ' A' ' 33' ' ' LEU . 28.7 tpt180 -89.49 106.04 18.19 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.135 -0.978 . . . . 0.0 109.73 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.6 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 3.22 76.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 121.317 0.58 . . . . 0.0 110.865 -179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -39.35 -53.85 1.93 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.25 0.547 . . . . 0.0 109.965 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.54 -177.1 5.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.015 -1.053 . . . . 0.0 109.243 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -80.05 77.35 6.75 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.222 -0.924 . . . . 0.0 109.668 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.415 ' HB3' ' CD ' ' A' ' 23' ' ' ARG . . . -56.79 -31.23 64.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.92 . . . . 0.0 109.357 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.412 ' C ' ' SD ' ' A' ' 29' ' ' MET . 3.5 t60 67.97 8.12 6.26 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.343 -0.848 . . . . 0.0 109.104 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.751 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -120.03 -101.0 0.43 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.276 -0.89 . . . . 0.0 109.096 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 152.31 -10.49 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.703 -0.623 . . . . 0.0 110.329 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 12.2 m120 -78.35 6.03 9.25 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.893 -1.129 . . . . 0.0 109.646 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.514 ' O ' ' HD2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -81.91 47.21 1.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.393 -0.817 . . . . 0.0 110.415 -179.578 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.698 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 13.2 mt -117.84 91.03 3.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.851 -1.156 . . . . 0.0 109.125 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.681 ' C ' HD11 ' A' ' 20' ' ' ILE . 11.9 tt0 -90.31 -127.56 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.496 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.533 ' CG ' ' C ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -155.75 128.89 4.34 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.882 -1.136 . . . . 0.0 109.382 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.973 ' O ' HG23 ' A' ' 8' ' ' VAL . 9.6 Cg_endo -69.79 97.85 0.66 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.055 1.837 . . . . 0.0 109.462 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.571 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -109.28 -173.55 21.03 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.308 -1.425 . . . . 0.0 111.455 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.542 ' HA2' ' OE1' ' A' ' 98' ' ' GLU . . . -163.74 20.35 0.15 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.612 ' HD3' " C5'" ' A' ' 130' ' ' APC . 1.9 tptm 58.83 108.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.528 -0.984 . . . . 0.0 110.106 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.951 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.5 OUTLIER -82.02 130.63 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.825 -1.172 . . . . 0.0 109.227 178.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -173.66 -26.07 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.088 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.67 153.48 0.8 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.977 -1.077 . . . . 0.0 109.272 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 46.87 -117.04 2.76 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -170.95 23.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.471 -1.017 . . . . 0.0 109.621 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 47' ' ' GLU . 84.5 m -140.41 139.67 21.15 Favored Pre-proline 0 C--O 1.203 -1.385 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.585 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 6.3 Cg_exo -50.26 -19.07 4.01 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 121.1 1.2 . . . . 0.0 110.128 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.695 ' H ' HG22 ' A' ' 45' ' ' THR . 1.6 mt-10 -79.71 -86.83 0.07 Allowed 'General case' 0 C--O 1.201 -1.481 0 O-C-N 121.108 -0.995 . . . . 0.0 108.536 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.589 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 15.7 mt-30 -43.09 -29.48 0.36 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.704 -1.247 . . . . 0.0 110.081 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.619 ' HB1' HG13 ' A' ' 40' ' ' ILE . . . -72.04 -60.99 1.95 Allowed 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.418 -0.801 . . . . 0.0 109.83 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.937 ' O ' HD23 ' A' ' 54' ' ' LEU . 3.8 p -66.84 -45.94 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.008 -1.058 . . . . 0.0 110.184 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.574 ' CG1' ' N ' ' A' ' 52' ' ' ARG . 2.2 p -60.15 -46.89 93.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-O 121.239 0.542 . . . . 0.0 109.662 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.589 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 8.0 mmm180 -74.1 -21.61 59.83 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.599 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 26.5 mm-40 -78.3 -19.7 53.03 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.075 HD12 ' CD1' ' A' ' 95' ' ' TRP . 2.1 mm? -79.87 -42.03 25.06 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.166 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.635 ' HG2' ' CZ3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -79.91 -42.78 23.43 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.599 -0.688 . . . . 0.0 109.467 -179.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.559 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 1.1 pp20? -57.68 -23.27 50.68 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.545 -0.722 . . . . 0.0 110.01 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.5 ' OE2' ' HA3' ' A' ' 38' ' ' GLY . 9.1 mt-10 -80.24 -92.08 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.982 -1.074 . . . . 0.0 110.456 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.631 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 22.2 t -80.07 -78.93 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.486 -0.759 . . . . 0.0 110.745 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.36 35.57 0.14 Allowed Glycine 0 N--CA 1.496 2.698 0 C-N-CA 118.572 -1.775 . . . . 0.0 112.783 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.114 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.1 pp -91.13 -145.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 120.276 -1.72 . . . . 0.0 107.127 177.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.629 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.5 m -141.26 -73.45 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.256 -1.528 . . . . 0.0 110.496 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 6.2 Cg_endo -64.54 -171.5 0.16 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 121.105 1.203 . . . . 0.0 110.781 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.555 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 149.41 -23.14 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.564 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 13.5 t-160 43.91 80.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.51 ' CZ ' ' HG2' ' A' ' 47' ' ' GLU . 49.6 p90 -76.32 145.02 39.85 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.621 0.724 . . . . 0.0 110.373 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -141.58 142.54 33.48 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.638 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -67.18 -69.73 0.29 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.812 -1.18 . . . . 0.0 110.475 -179.146 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.745 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 83.99 -51.66 0.13 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.2 mt-10 170.31 177.27 0.05 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.592 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -161.16 173.18 15.5 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 109.675 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.684 HD21 ' OD1' ' A' ' 119' ' ' ASN . 0.3 OUTLIER -141.15 178.41 7.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.145 -0.972 . . . . 0.0 110.596 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -151.41 93.94 1.95 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -79.5 129.68 34.7 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.539 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 4.8 tt0 -101.25 106.05 17.21 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.146 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.539 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -81.22 171.07 13.11 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.219 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 9.5 Cg_exo -47.33 -29.62 9.97 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.972 1.781 . . . . 0.0 109.999 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -162.53 28.28 0.1 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.472 ' HD3' ' O ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -134.36 90.95 2.73 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.791 -0.568 . . . . 0.0 109.961 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.662 ' C ' HD12 ' A' ' 80' ' ' ILE . 1.9 t-160 -86.3 110.17 19.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.101 -1.0 . . . . 0.0 108.513 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.662 HD12 ' C ' ' A' ' 79' ' ' HIS . 0.8 OUTLIER -112.56 152.31 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.137 -0.977 . . . . 0.0 110.426 -178.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.577 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 4.1 m -125.98 137.23 53.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.892 ' CD2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -128.62 79.64 1.92 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.594 -1.317 . . . . 0.0 110.775 -179.287 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.592 ' CE3' ' HD2' ' A' ' 70' ' ' LYS . 94.3 m95 -51.16 108.82 0.28 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.994 -1.066 . . . . 0.0 108.838 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.783 ' CD2' HG11 ' A' ' 122' ' ' VAL . 12.4 m-85 -82.36 69.32 9.08 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.053 -1.03 . . . . 0.0 109.947 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.652 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 97.5 m95 -71.95 82.8 0.94 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.06 -1.025 . . . . 0.0 109.692 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.745 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.0 mm? -67.05 124.17 22.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.459 -1.4 . . . . 0.0 109.631 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.038 HG22 HG22 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -109.14 177.32 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 70.0 mt-10 -154.59 18.85 0.47 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 117.69 -1.604 . . . . 0.0 113.504 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.564 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -161.08 62.11 0.29 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 119.618 -1.926 . . . . 0.0 112.155 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.705 ' HB2' HD13 ' A' ' 60' ' ' ILE . 6.6 p90 -81.09 158.52 25.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.331 -1.481 . . . . 0.0 108.79 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.574 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -91.63 145.39 24.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.953 -1.092 . . . . 0.0 110.235 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 45.64 -87.44 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 1.114 ' O ' HG21 ' A' ' 60' ' ' ILE . 8.1 pt-20 -111.37 161.44 25.26 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.316 -1.108 . . . . 0.0 109.647 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.639 ' CG ' ' CD1' ' A' ' 19' ' ' PHE . 7.0 Cg_endo -74.68 -161.06 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.554 2.169 . . . . 0.0 109.594 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 1.075 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER 179.02 33.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.111 -0.993 . . . . 0.0 110.793 178.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -117.65 6.14 16.31 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.269 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.624 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 8.0 pttt -79.99 147.59 31.49 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.113 -1.227 . . . . 0.0 110.046 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.542 ' OE1' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -82.18 37.26 0.49 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.53 -0.731 . . . . 0.0 109.658 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.81 -10.54 73.4 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.594 ' CB ' ' CD ' ' A' ' 101' ' ' PRO . 11.8 pt20 -64.49 -172.14 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.451 -1.029 . . . . 0.0 108.677 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 100' ' ' GLN . 4.2 Cg_exo -65.65 -55.88 0.39 Allowed 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.122 1.215 . . . . 0.0 109.351 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.61 ' O ' ' CE1' ' A' ' 19' ' ' PHE . . . 57.26 115.38 0.01 OUTLIER Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 2.9 pt-20 -153.26 133.47 13.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.836 -1.391 . . . . 0.0 110.303 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.455 ' C ' ' O ' ' A' ' 103' ' ' GLU . 3.7 m0 -44.43 136.54 4.11 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -130.26 113.88 14.96 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.267 -179.378 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.65 51.11 1.62 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.486 0.66 . . . . 0.0 109.507 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.844 HD21 ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -65.42 -41.56 93.43 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.801 ' N ' HD23 ' A' ' 107' ' ' LEU . 48.9 t 79.61 116.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.984 -0.447 . . . . 0.0 110.332 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . 39.3 83.55 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.106 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -38.65 160.57 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.766 -0.843 . . . . 0.0 110.755 -178.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.672 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 11.4 t30 -136.34 -4.81 2.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.483 -0.761 . . . . 0.0 110.932 -178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 74.91 -4.09 2.45 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.09 -1.006 . . . . 0.0 108.768 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.54 -32.93 36.6 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.584 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -93.19 -11.21 33.27 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 1.106 ' CE1' HD21 ' A' ' 110' ' ' LEU . 5.0 m-85 -98.41 152.62 38.03 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.488 -0.758 . . . . 0.0 109.937 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.508 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 2.8 Cg_endo -68.79 135.44 32.85 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.198 1.932 . . . . 0.0 109.348 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 118' ' ' ALA . 6.3 Cg_exo -59.85 -27.7 85.53 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 121.89 1.727 . . . . 0.0 110.852 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -43.1 -51.18 5.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.107 -0.996 . . . . 0.0 109.572 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.684 ' OD1' HD21 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -88.25 48.46 1.64 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.457 -0.777 . . . . 0.0 109.23 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.676 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -63.33 -41.85 70.82 Favored Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.787 -0.571 . . . . 0.0 112.013 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 8.0 Cg_exo -51.86 -39.18 68.72 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 121.889 1.726 . . . . 0.0 113.088 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.783 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.7 t -100.51 -37.91 6.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 120.446 -1.409 . . . . 0.0 110.037 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.85 ' HA ' HD22 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -60.94 -21.96 25.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.493 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -62.75 -34.52 77.39 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.483 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 9.4 mmtm -79.71 -38.51 33.27 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.982 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.85 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.2 OUTLIER -59.24 -40.51 86.13 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -38.84 -37.16 0.32 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.09 0.947 . . . . 0.0 108.767 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.514 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -80.03 -51.81 8.58 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.287 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.603 ' CD2' ' NH1' ' A' ' 12' ' ' ARG . 2.5 tp . . . . . 0 N--CA 1.505 2.294 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.66 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' APC . . . . . 0.697 " O4'" HD22 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.481 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 1.1 tpp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.596 ' N ' ' HD3' ' A' ' 2' ' ' LYS . 0.2 OUTLIER 176.76 -152.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.474 -0.766 . . . . 0.0 109.243 -179.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.564 ' N ' ' HG2' ' A' ' 2' ' ' LYS . 2.7 tttt -102.1 151.82 21.72 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.698 HD22 " O4'" ' A' ' 130' ' ' APC . 0.2 OUTLIER -149.56 168.4 23.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.238 -0.914 . . . . 0.0 109.112 178.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.859 ' HB2' HG23 ' A' ' 40' ' ' ILE . 1.6 mp0 -142.52 171.35 14.17 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.652 HG22 HG12 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -138.36 115.62 11.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 C-N-CA 118.969 -1.092 . . . . 0.0 109.624 -179.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.956 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -84.39 63.68 7.94 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.714 HG13 ' H ' ' A' ' 9' ' ' GLY . 0.7 OUTLIER -79.06 -77.44 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.381 -0.825 . . . . 0.0 110.345 -178.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.714 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 67.59 88.26 0.07 OUTLIER Glycine 0 C--N 1.296 -1.68 0 N-CA-C 107.038 -2.425 . . . . 0.0 107.038 -177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.573 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -50.19 176.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.846 HG22 HG22 ' A' ' 87' ' ' VAL . 2.5 pt -142.54 77.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 C-N-CA 117.856 -1.537 . . . . 0.0 111.087 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.634 ' HB3' HG23 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -78.89 158.68 28.03 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 177.17 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.514 ' CG ' ' CZ3' ' A' ' 90' ' ' TRP . 12.1 p-10 -160.61 -24.33 0.06 Allowed 'General case' 0 C--O 1.188 -2.143 0 C-N-CA 115.608 -2.437 . . . . 0.0 115.5 -177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.541 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 20.6 tt0 -93.51 -27.0 16.91 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 118.05 -2.906 . . . . 0.0 108.911 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.44 -48.74 0.04 OUTLIER 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.491 ' ND2' HD23 ' A' ' 107' ' ' LEU . 60.9 t-20 -162.95 38.09 0.1 Allowed 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.618 ' HA ' ' O ' ' A' ' 105' ' ' MET . 19.8 mt-10 -84.06 88.5 7.18 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 117.92 -1.512 . . . . 0.0 109.973 -177.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.634 HG23 ' HB3' ' A' ' 12' ' ' ARG . 1.5 pt -82.5 147.24 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.964 0.888 . . . . 0.0 111.167 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.62 ' CE1' ' HG2' ' A' ' 94' ' ' PRO . 12.7 t80 -82.58 45.28 0.96 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.622 HD11 ' N ' ' A' ' 34' ' ' GLU . 4.3 tp -80.42 151.35 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.85 0.833 . . . . 0.0 110.645 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.505 ' N ' HG13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -71.11 88.43 0.8 Allowed 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.591 ' O ' ' C ' ' A' ' 23' ' ' ARG . 28.2 tpt180 -86.2 94.56 9.33 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.53 -0.731 . . . . 0.0 110.373 -178.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.591 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 17.89 75.97 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.142 0.496 . . . . 0.0 110.346 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -39.36 -55.72 1.69 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.608 -0.683 . . . . 0.0 110.168 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.46 -147.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.158 -0.964 . . . . 0.0 108.988 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.712 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 77.4 m-20 -79.88 -60.77 2.21 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.026 -1.046 . . . . 0.0 109.128 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 26' ' ' ASP . . . 81.78 -28.33 0.12 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.435 -0.791 . . . . 0.0 110.715 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER 49.15 25.3 1.13 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.413 ' N ' ' C ' ' A' ' 27' ' ' ALA . 5.6 mtt -145.08 -164.16 1.87 Allowed 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.463 ' O ' ' OD1' ' A' ' 114' ' ' ASP . . . -164.25 23.13 0.07 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.804 -1.185 . . . . 0.0 110.326 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 114' ' ' ASP . 1.3 m-20 -101.9 15.94 27.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.058 -1.026 . . . . 0.0 108.259 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HB3' ' H ' ' A' ' 23' ' ' ARG . 1.4 mmtm -81.81 50.72 1.57 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.767 -0.583 . . . . 0.0 111.006 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.904 HD13 HD21 ' A' ' 110' ' ' LEU . 17.0 mt -109.57 86.77 2.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.763 -1.211 . . . . 0.0 108.875 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.622 ' N ' HD11 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -91.5 -135.87 0.14 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.123 -0.986 . . . . 0.0 110.191 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.584 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -150.45 119.44 3.64 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 120.758 -1.214 . . . . 0.0 109.626 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.587 ' O ' HG23 ' A' ' 8' ' ' VAL . 11.5 Cg_endo -71.29 94.39 0.66 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.323 2.015 . . . . 0.0 110.772 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.708 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -127.2 -135.73 4.19 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 118.767 -1.682 . . . . 0.0 111.04 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.537 ' CA ' ' OE1' ' A' ' 98' ' ' GLU . . . 167.65 35.53 0.02 OUTLIER Glycine 0 N--CA 1.487 2.071 0 O-C-N 121.383 -1.069 . . . . 0.0 110.53 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.617 ' HD3' H5'1 ' A' ' 130' ' ' APC . 14.1 tptm 56.5 110.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.979 -0.718 . . . . 0.0 111.891 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.956 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -81.9 142.13 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.217 -0.927 . . . . 0.0 108.662 177.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.401 ' N ' HG12 ' A' ' 40' ' ' ILE . 10.9 pt-20 -172.21 -30.45 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.417 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.3 mmm -55.33 149.0 13.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.148 -0.97 . . . . 0.0 110.011 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.48 -127.44 33.66 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -164.66 18.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.493 -1.004 . . . . 0.0 109.842 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.794 HG22 ' H ' ' A' ' 47' ' ' GLU . 45.4 m -133.39 137.23 28.64 Favored Pre-proline 0 C--O 1.204 -1.332 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.615 ' HG3' ' CH2' ' A' ' 83' ' ' TRP . 3.0 Cg_exo -48.98 -16.37 0.83 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 121.57 1.513 . . . . 0.0 110.281 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.794 ' H ' HG22 ' A' ' 45' ' ' THR . 2.8 mt-10 -75.5 -85.47 0.05 OUTLIER 'General case' 0 C--O 1.203 -1.386 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.557 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 18.6 mt-30 -45.22 -34.75 2.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.66 -1.275 . . . . 0.0 109.778 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.86 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -63.77 -64.03 1.01 Allowed 'General case' 0 C--N 1.292 -1.927 0 O-C-N 121.339 -0.85 . . . . 0.0 109.666 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.905 ' O ' HD23 ' A' ' 54' ' ' LEU . 2.0 p -66.69 -51.89 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.049 -1.032 . . . . 0.0 110.55 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.57 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 3.7 p -51.97 -44.76 39.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.352 -0.843 . . . . 0.0 110.731 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.56 ' N ' HG13 ' A' ' 51' ' ' VAL . 5.8 mmt180 -74.76 -37.79 62.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 108.875 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.594 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 6.5 mm-40 -70.37 -13.08 61.99 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.174 HD12 ' CD1' ' A' ' 95' ' ' TRP . 1.6 mm? -80.06 -63.82 1.33 Allowed 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.653 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.41 -52.71 64.28 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.833 -0.542 . . . . 0.0 110.176 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.579 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -47.28 -22.35 0.4 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.017 -1.052 . . . . 0.0 109.875 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.441 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 3.4 mt-10 -80.03 -96.79 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.046 -1.034 . . . . 0.0 109.31 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.665 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 57.4 t -80.01 -79.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.215 -0.928 . . . . 0.0 109.322 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 133.66 46.33 0.11 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.247 -1.454 . . . . 0.0 111.777 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.086 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -87.59 -127.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.604 -1.527 . . . . 0.0 108.44 178.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.706 ' H ' HD12 ' A' ' 60' ' ' ILE . 1.3 m -159.64 -68.6 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.006 -1.684 . . . . 0.0 112.146 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 2.2 Cg_endo -54.19 -80.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.028 1.819 . . . . 0.0 112.061 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 1.012 ' NE2' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 39.81 61.62 1.41 Allowed 'General case' 0 C--N 1.289 -2.039 0 CA-C-O 121.781 0.8 . . . . 0.0 109.608 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.687 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -53.24 102.22 0.05 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -95.46 144.28 26.09 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 122.177 0.989 . . . . 0.0 111.362 -177.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -143.25 145.0 32.37 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.149 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.856 HD13 ' N ' ' A' ' 69' ' ' GLU . 1.4 tm? -67.95 -64.45 0.86 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.068 -1.02 . . . . 0.0 110.808 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.882 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 83.6 -54.2 0.15 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.357 -0.84 . . . . 0.0 108.796 -179.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.856 ' N ' HD13 ' A' ' 67' ' ' LEU . 6.0 tp10 164.86 128.9 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.558 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -118.97 -171.71 2.15 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.443 -0.786 . . . . 0.0 109.868 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.643 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -142.06 -172.04 3.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 110.315 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -159.75 94.26 1.13 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.45 151.3 22.08 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.275 -0.891 . . . . 0.0 108.87 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.437 ' OE2' ' CE1' ' A' ' 79' ' ' HIS . 2.0 tt0 -119.71 137.5 53.88 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.144 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.563 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 1.1 m-30 -106.55 172.92 3.48 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 6.5 Cg_exo -46.24 -39.95 21.48 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.706 1.604 . . . . 0.0 110.31 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.437 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 3.1 m-20 -156.24 40.1 0.36 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.57 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -147.33 101.75 3.41 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.991 ' C ' HD12 ' A' ' 80' ' ' ILE . 5.5 m170 -77.81 137.26 38.32 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.991 HD12 ' C ' ' A' ' 79' ' ' HIS . 1.9 mp -132.82 153.74 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.767 -1.208 . . . . 0.0 110.653 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.574 ' HB ' ' CB ' ' A' ' 5' ' ' GLN . 1.6 m -141.67 150.45 41.92 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.65 HD21 HG11 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -138.94 77.73 1.64 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.812 -1.18 . . . . 0.0 109.985 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.615 ' CH2' ' HG3' ' A' ' 46' ' ' PRO . 93.4 m95 -50.68 113.65 0.95 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 108.993 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.599 ' O ' ' O ' ' A' ' 67' ' ' LEU . 13.6 m-85 -90.76 70.56 6.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.254 -0.904 . . . . 0.0 110.208 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.656 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 61.5 m95 -77.46 87.6 3.82 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.705 -1.247 . . . . 0.0 109.751 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.882 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.0 mm? -68.2 129.55 40.25 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.524 -1.36 . . . . 0.0 109.974 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.012 HG11 ' NE2' ' A' ' 63' ' ' GLN . 0.8 OUTLIER -116.42 154.74 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.284 -0.885 . . . . 0.0 108.729 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 1.2 mt-10 -143.02 35.38 1.37 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.738 -1.226 . . . . 0.0 113.219 -178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.687 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -161.32 40.49 0.15 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 119.79 -1.819 . . . . 0.0 111.729 178.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.635 ' CH2' ' CD1' ' A' ' 104' ' ' TRP . 1.3 p90 -67.19 157.09 34.61 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.02 -1.675 . . . . 0.0 109.37 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.574 ' O ' ' CD1' ' A' ' 90' ' ' TRP . 10.4 pt-20 -77.8 -125.77 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.234 -0.916 . . . . 0.0 110.439 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.495 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -53.09 -55.22 25.14 Favored Glycine 0 N--CA 1.494 2.51 0 O-C-N 120.658 -1.277 . . . . 0.0 110.735 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 1.086 ' O ' HG21 ' A' ' 60' ' ' ILE . 6.9 pt-20 -132.94 166.91 25.79 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.161 -1.199 . . . . 0.0 109.577 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.76 ' HB3' HD12 ' A' ' 11' ' ' ILE . 9.9 Cg_endo -77.28 -168.14 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.36 2.04 . . . . 0.0 110.123 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 1.174 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -171.0 28.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 0.0 110.086 178.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.613 ' HA2' HD13 ' A' ' 54' ' ' LEU . . . -116.1 3.38 20.72 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.983 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.567 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 11.5 pttt -76.57 136.46 39.26 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.922 -1.34 . . . . 0.0 109.212 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.602 ' HG3' ' PG ' ' A' ' 130' ' ' APC . 2.6 tp10 -75.61 -117.63 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.64 22.33 36.2 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 107.47 -2.252 . . . . 0.0 107.47 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.483 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 1.5 pt20 -94.97 165.11 17.71 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.731 -0.864 . . . . 0.0 110.136 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 1.4 Cg_endo -66.99 -42.55 8.0 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.994 1.796 . . . . 0.0 109.851 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.589 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 57.69 110.38 0.01 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 7.1 pt-20 -142.96 134.07 25.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.768 -1.43 . . . . 0.0 110.672 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.635 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 1.6 m0 -50.19 127.59 17.34 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.618 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -118.88 116.37 26.36 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.77 45.59 0.71 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.262 -0.899 . . . . 0.0 110.161 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.592 ' HG ' ' N ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -81.41 158.09 24.74 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.051 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.592 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 33.4 t -114.66 134.07 58.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.061 -1.024 . . . . 0.0 109.541 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.484 ' HA2' ' HB3' ' A' ' 129' ' ' LEU . . . 39.52 79.87 0.04 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.904 HD21 HD13 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -41.62 166.13 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.573 -0.957 . . . . 0.0 110.694 -178.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.791 ' H ' HD23 ' A' ' 110' ' ' LEU . 4.5 t30 -159.71 151.17 19.92 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.511 ' HA ' HG21 ' A' ' 123' ' ' ILE . . . -55.98 -22.07 24.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 108.563 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -42.72 -36.9 1.57 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.522 -0.736 . . . . 0.0 109.082 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.536 ' CB ' ' CD1' ' A' ' 33' ' ' LEU . 73.8 m-20 -115.29 -8.5 12.29 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.685 -0.634 . . . . 0.0 109.556 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.828 ' HD2' HD22 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -100.93 123.53 45.01 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.339 -0.851 . . . . 0.0 109.709 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.547 ' O ' ' CD1' ' A' ' 123' ' ' ILE . 7.2 Cg_exo -52.62 148.2 28.3 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.415 2.077 . . . . 0.0 111.373 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.475 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . 2.1 Cg_endo -62.61 -26.18 75.69 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.309 2.006 . . . . 0.0 110.699 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.6 -48.57 5.43 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.123 -0.986 . . . . 0.0 109.656 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.868 ' O ' HD12 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -100.15 55.65 0.92 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.631 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 4.6 mt-10 -67.32 -43.19 42.64 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.602 -0.686 . . . . 0.0 112.366 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 6.3 Cg_exo -55.52 -31.78 79.93 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.764 1.643 . . . . 0.0 112.125 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.571 HG11 ' CZ ' ' A' ' 84' ' ' PHE . 2.4 t -101.05 -38.93 6.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.76 -1.212 . . . . 0.0 109.569 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.868 HD12 ' O ' ' A' ' 119' ' ' ASN . 15.2 mt -55.77 -34.55 36.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.27 -38.5 58.45 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.949 0.881 . . . . 0.0 109.137 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -79.81 -37.37 35.31 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.242 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.927 ' HA ' HD13 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -59.3 -39.67 83.76 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.179 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -39.8 -37.66 0.57 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.949 0.88 . . . . 0.0 108.927 178.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.481 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -87.57 -49.9 6.87 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.927 HD13 ' HA ' ' A' ' 126' ' ' LEU . 1.9 tp . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.322 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' APC . . . . . 0.698 " O4'" HD22 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' CON . . . . . 0.575 ' N3 ' ' O2A' ' A' ' 130' ' ' APC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.406 ' C ' ' HG3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.539 ' HE3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 178.79 -166.77 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.224 -0.923 . . . . 0.0 109.359 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.539 ' N ' ' HE3' ' A' ' 2' ' ' LYS . 17.0 tttt -140.83 140.28 34.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.084 -1.01 . . . . 0.0 109.343 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.949 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -146.67 131.98 18.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.388 -0.82 . . . . 0.0 109.385 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.544 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 2.1 mp0 -98.51 162.06 13.35 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.565 HG13 ' N7 ' ' A' ' 130' ' ' APC . 0.9 OUTLIER -126.0 112.83 31.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.057 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -84.56 65.78 9.17 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.722 HG13 ' H ' ' A' ' 9' ' ' GLY . 1.1 p -78.94 -70.37 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.023 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.722 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 57.5 83.43 0.05 OUTLIER Glycine 0 C--N 1.292 -1.915 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 -178.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.59 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -47.7 168.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -179.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.811 HG22 ' CG2' ' A' ' 87' ' ' VAL . 2.7 pt -133.24 95.14 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.344 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.91 ' HG2' HG22 ' A' ' 18' ' ' ILE . 15.8 mtm180 -76.78 179.83 5.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.619 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -158.69 -60.81 0.08 Allowed 'General case' 0 C--O 1.194 -1.856 0 C-N-CA 116.458 -2.097 . . . . 0.0 115.068 -177.119 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.576 ' CB ' ' HG3' ' A' ' 17' ' ' GLU . 6.9 tp10 -92.72 -26.04 17.94 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 119.254 -2.154 . . . . 0.0 111.745 -175.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -161.96 -45.17 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.479 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 14.7 t30 -160.41 35.81 0.17 Allowed 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 177.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 105' ' ' MET . 4.9 mm-40 -78.36 85.86 4.46 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 118.007 -1.477 . . . . 0.0 109.105 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.91 HG22 ' HG2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -79.15 142.49 13.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.714 ' HB3' HD11 ' A' ' 11' ' ' ILE . 11.9 t80 -81.94 46.0 0.96 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.708 HD12 ' CZ ' ' A' ' 115' ' ' PHE . 12.9 tt -79.1 153.0 4.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-O 121.858 0.837 . . . . 0.0 110.463 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.534 ' HB ' ' HD2' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -66.5 89.91 0.15 Allowed 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.509 ' O ' ' C ' ' A' ' 23' ' ' ARG . 28.5 tpt180 -87.37 81.77 7.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.184 -0.948 . . . . 0.0 110.416 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.715 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 1.1 ptt180 32.53 72.79 0.07 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.917 -0.489 . . . . 0.0 110.269 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.23 -53.31 4.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -0.853 . . . . 0.0 109.302 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.28 -171.54 3.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.232 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -79.92 80.68 6.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.473 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.715 ' HB2' ' HB3' ' A' ' 23' ' ' ARG . . . -61.31 -31.77 71.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.819 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 55.41 21.13 4.05 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.746 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 6.1 mmm -127.36 -112.53 0.28 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 160.01 -14.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.064 -1.022 . . . . 0.0 111.065 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -81.53 12.53 3.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.906 -1.122 . . . . 0.0 109.779 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.72 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -81.99 54.79 2.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.476 -0.765 . . . . 0.0 110.642 -179.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.72 HD23 ' O ' ' A' ' 32' ' ' LYS . 6.4 mt -120.83 83.75 2.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.644 -1.285 . . . . 0.0 109.75 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.46 -146.98 0.19 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.389 -0.82 . . . . 0.0 109.358 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.65 ' CZ ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -140.16 125.61 11.5 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.864 -1.147 . . . . 0.0 110.157 -178.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.682 ' O ' HG23 ' A' ' 8' ' ' VAL . 13.8 Cg_endo -73.78 100.11 1.23 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.364 2.043 . . . . 0.0 110.118 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.671 ' HA2' ' HA ' ' A' ' 8' ' ' VAL . . . -136.36 135.08 7.53 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.175 -1.488 . . . . 0.0 110.961 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.533 ' CA ' ' OE1' ' A' ' 98' ' ' GLU . . . -108.14 36.53 4.32 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.632 ' HD2' HD23 ' A' ' 4' ' ' LEU . 7.0 tptm 59.26 119.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.54 -0.976 . . . . 0.0 112.083 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.021 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -83.24 135.96 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -171.31 -31.51 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.906 -1.121 . . . . 0.0 110.266 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.55 142.98 25.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.133 -0.979 . . . . 0.0 109.316 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.22 -115.96 8.71 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -169.23 -15.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.775 -0.838 . . . . 0.0 110.737 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.779 HG22 ' H ' ' A' ' 47' ' ' GLU . 24.9 m -103.82 141.09 21.78 Favored Pre-proline 0 C--O 1.205 -1.28 0 O-C-N 120.876 -1.14 . . . . 0.0 108.353 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.582 ' HD2' HG23 ' A' ' 45' ' ' THR . 7.9 Cg_exo -47.32 -18.06 0.68 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.082 1.855 . . . . 0.0 110.938 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.779 ' H ' HG22 ' A' ' 45' ' ' THR . 0.7 OUTLIER -77.87 -81.89 0.09 Allowed 'General case' 0 C--O 1.202 -1.424 0 O-C-N 120.857 -1.152 . . . . 0.0 108.594 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.544 ' O ' ' CG ' ' A' ' 52' ' ' ARG . 53.0 mt-30 -48.73 -25.56 1.88 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.384 -1.448 . . . . 0.0 109.948 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.827 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -73.51 -59.65 2.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.875 -1.14 . . . . 0.0 109.874 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.057 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.5 p -70.01 -48.94 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.053 -1.029 . . . . 0.0 109.843 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.571 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 2.1 p -56.33 -42.91 75.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 O-C-N 121.797 -0.564 . . . . 0.0 110.4 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 48' ' ' GLN . 21.2 mmt180 -74.86 -35.7 62.33 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.612 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 15.7 mm-40 -68.07 -15.47 63.61 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.802 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -79.09 -62.79 1.59 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.493 ' NE2' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -57.37 -53.84 53.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.345 -0.847 . . . . 0.0 109.828 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.547 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -50.13 -21.7 1.4 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.334 -0.854 . . . . 0.0 110.496 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.4 mt-10 -80.04 -91.02 0.05 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.059 -1.026 . . . . 0.0 109.967 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.684 HG21 ' HA ' ' A' ' 95' ' ' TRP . 47.3 t -80.06 -78.98 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.448 -0.782 . . . . 0.0 110.302 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.18 22.21 0.1 OUTLIER Glycine 0 N--CA 1.494 2.563 0 C-N-CA 118.77 -1.681 . . . . 0.0 112.472 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.059 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.2 pt -81.19 -136.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.187 -1.772 . . . . 0.0 108.102 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.622 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.2 m -159.08 -68.6 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.465 -1.397 . . . . 0.0 109.967 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 5.7 Cg_endo -62.51 -173.74 0.15 Allowed 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.686 1.591 . . . . 0.0 110.741 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.56 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 1.1 pt20 145.19 -24.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.603 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.2 OUTLIER 43.32 48.96 5.92 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -42.84 160.44 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.745 0.783 . . . . 0.0 110.584 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -156.89 136.91 12.63 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.167 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.637 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -59.64 -71.92 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.824 -1.172 . . . . 0.0 110.321 -178.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.747 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 85.08 -56.55 0.09 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.026 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.619 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 30.9 tp10 165.97 123.38 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.604 0.716 . . . . 0.0 109.753 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.571 ' HD2' ' CD2' ' A' ' 83' ' ' TRP . 5.7 ptmt -110.11 170.54 8.01 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.706 -0.621 . . . . 0.0 109.615 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.799 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -122.8 169.8 10.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.097 -1.002 . . . . 0.0 110.14 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.681 ' HG3' HG23 ' A' ' 81' ' ' THR . 15.6 tt0 -147.07 85.78 1.62 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.21 123.77 28.74 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.429 ' CG ' ' NE2' ' A' ' 79' ' ' HIS . 2.6 tt0 -91.85 108.43 19.92 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.281 -0.968 . . . . 0.0 109.017 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.531 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 1.9 m-85 -78.32 170.35 16.65 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.398 -0.814 . . . . 0.0 109.468 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 7.5 Cg_exo -49.65 -38.15 45.13 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.112 1.874 . . . . 0.0 109.714 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.63 43.46 0.44 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.513 ' O ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -148.07 97.54 2.8 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.459 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -79.82 94.91 5.89 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.607 HG22 ' N ' ' A' ' 81' ' ' THR . 0.4 OUTLIER -102.17 164.52 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.183 -0.948 . . . . 0.0 110.559 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.681 HG23 ' HG3' ' A' ' 72' ' ' GLU . 1.2 m -148.3 151.62 35.7 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.815 HD13 HN61 ' A' ' 130' ' ' APC . 0.2 OUTLIER -142.63 79.56 1.66 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.696 -1.253 . . . . 0.0 110.682 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.571 ' CD2' ' HD2' ' A' ' 70' ' ' LYS . 87.5 m95 -53.96 111.37 0.74 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 109.296 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.776 ' CE1' HG11 ' A' ' 122' ' ' VAL . 8.7 m-85 -87.01 71.31 10.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.157 -0.964 . . . . 0.0 109.546 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.688 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 67.5 m95 -75.44 86.6 2.58 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.94 -1.1 . . . . 0.0 109.554 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.747 HD23 ' CD2' ' A' ' 68' ' ' PHE . 1.7 mm? -67.89 130.75 43.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.626 -1.296 . . . . 0.0 109.711 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.811 ' CG2' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -111.37 179.45 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.19 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.512 ' N ' HG23 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -160.93 17.6 0.12 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.341 -1.475 . . . . 0.0 112.57 -179.349 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.603 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -160.52 50.63 0.28 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.048 -1.657 . . . . 0.0 111.139 179.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.734 ' HB2' HD13 ' A' ' 60' ' ' ILE . 4.0 p90 -67.4 164.61 18.27 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.687 -1.258 . . . . 0.0 109.351 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.613 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 6.6 tt0 -87.95 140.18 29.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.152 -0.967 . . . . 0.0 109.363 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 36.29 -85.17 0.01 OUTLIER Glycine 0 N--CA 1.497 2.731 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 1.059 ' O ' HG21 ' A' ' 60' ' ' ILE . 10.4 pt-20 -101.61 159.61 28.93 Favored Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.242 -1.152 . . . . 0.0 109.706 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.653 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 15.0 Cg_endo -75.52 -159.94 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.364 2.043 . . . . 0.0 109.669 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.802 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER 175.18 27.21 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.72 -0.612 . . . . 0.0 110.667 178.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.416 ' HA2' ' CD1' ' A' ' 54' ' ' LEU . . . -103.28 -6.15 45.3 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.59 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -81.15 128.54 33.87 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.347 -1.09 . . . . 0.0 110.854 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.533 ' OE1' ' CA ' ' A' ' 38' ' ' GLY . 22.7 tp10 -81.69 -96.14 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.522 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . -89.7 -19.5 47.88 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 107.634 -2.187 . . . . 0.0 107.634 177.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.569 ' HG3' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -61.55 149.29 84.53 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.865 -0.786 . . . . 0.0 109.219 179.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.569 ' HD2' ' HG3' ' A' ' 100' ' ' GLN . 1.2 Cg_endo -67.6 -37.35 16.93 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.737 1.625 . . . . 0.0 108.79 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.61 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.12 123.2 0.01 OUTLIER Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.558 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 1.4 pp20? -151.79 125.65 9.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.957 -1.319 . . . . 0.0 109.795 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.592 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 1.2 m-90 -45.08 132.62 7.0 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.633 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 7.7 tpt -124.31 120.73 33.02 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.288 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.31 47.51 1.16 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 1.069 HD13 ' HG ' ' A' ' 110' ' ' LEU . 6.8 tt -59.47 -48.0 83.32 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.74 -0.6 . . . . 0.0 109.427 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.634 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 49.3 t 82.79 112.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 40.89 82.79 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.069 ' HG ' HD13 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -42.08 164.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.377 -1.073 . . . . 0.0 109.869 -179.211 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.71 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 3.6 t-20 -138.43 -6.97 1.53 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.001 -1.062 . . . . 0.0 111.924 -177.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 82.34 -26.43 0.14 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.219 -0.926 . . . . 0.0 108.87 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.27 -24.42 59.35 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.679 ' OD1' ' HB1' ' A' ' 30' ' ' ALA . 4.4 m-20 -103.07 -13.64 16.75 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.708 ' CZ ' HD12 ' A' ' 20' ' ' ILE . 2.0 m-85 -95.3 143.25 25.79 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.287 -0.883 . . . . 0.0 109.945 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -60.15 132.97 47.14 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.032 1.822 . . . . 0.0 109.575 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.55 -16.29 23.42 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.144 1.896 . . . . 0.0 110.988 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.05 -57.28 9.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.939 -1.1 . . . . 0.0 109.104 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.72 ' O ' HD12 ' A' ' 123' ' ' ILE . 9.8 m-20 -86.67 48.55 1.65 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.806 0.812 . . . . 0.0 109.043 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -56.61 -44.12 99.62 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.778 -0.576 . . . . 0.0 112.427 -179.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 11.5 Cg_exo -53.3 -57.55 1.93 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.048 1.832 . . . . 0.0 112.962 -177.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.776 HG11 ' CE1' ' A' ' 84' ' ' PHE . 2.0 t -78.93 -32.99 15.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 120.788 -1.195 . . . . 0.0 109.532 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.72 HD12 ' O ' ' A' ' 119' ' ' ASN . 5.7 mt -64.16 -23.97 34.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.565 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -61.49 -28.45 69.31 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.899 0.857 . . . . 0.0 108.92 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -80.35 -40.09 27.3 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.752 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.778 ' N ' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -66.3 -22.02 66.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.623 -1.298 . . . . 0.0 107.845 179.148 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 12.6 mtmt -58.35 -33.54 69.66 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -87.19 -21.42 25.9 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.602 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 1.6 tp . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.736 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' APC . . . . . 0.815 HN61 HD13 ' A' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 2' ' ' LYS . 2.9 ptt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.509 ' HE2' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -47.43 176.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 0.0 109.467 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.509 ' N ' ' HE2' ' A' ' 2' ' ' LYS . 26.8 tttt -158.72 149.15 19.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.976 . . . . 0.0 109.89 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 1.069 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -157.24 144.33 18.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.979 179.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.632 ' N ' HD22 ' A' ' 4' ' ' LEU . 9.7 mp0 -108.71 166.08 11.06 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.689 HG22 HG12 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -128.81 114.73 34.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 O-C-N 120.992 -1.067 . . . . 0.0 109.334 -178.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.042 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -85.2 62.61 7.6 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 36' ' ' PRO . 1.2 p -79.01 -70.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.353 -0.842 . . . . 0.0 109.972 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.738 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 59.08 84.48 0.04 OUTLIER Glycine 0 N--CA 1.481 1.649 0 N-CA-C 107.569 -2.212 . . . . 0.0 107.569 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.625 HG22 ' HB ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -48.63 166.76 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.8 HG22 ' CG2' ' A' ' 87' ' ' VAL . 1.8 pt -130.65 78.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.687 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.677 ' HB3' HG23 ' A' ' 18' ' ' ILE . 2.9 ptm180 -83.25 144.92 29.42 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.598 ' OD1' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -161.3 -5.6 0.05 OUTLIER 'General case' 0 C--O 1.185 -2.291 0 C-N-CA 116.769 -1.972 . . . . 0.0 114.203 -179.072 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.612 ' HB2' ' CG ' ' A' ' 17' ' ' GLU . 19.7 mm-40 -94.02 -32.2 13.92 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 118.182 -2.824 . . . . 0.0 107.471 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.605 ' CG ' HG22 ' A' ' 108' ' ' VAL . 24.6 t-20 -162.82 -48.62 0.04 OUTLIER 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 102.382 -3.192 . . . . 0.0 102.382 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.478 ' OD1' HD23 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -161.74 35.78 0.13 Allowed 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 175.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 105' ' ' MET . 0.3 OUTLIER -86.1 92.86 8.85 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.069 -1.452 . . . . 0.0 110.8 -176.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.677 HG23 ' HB3' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -84.95 156.66 3.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.536 0.684 . . . . 0.0 109.872 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.615 ' CE1' ' HG2' ' A' ' 94' ' ' PRO . 6.4 t80 -82.97 44.1 0.9 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.58 ' CG2' HG13 ' A' ' 18' ' ' ILE . 7.0 tp -82.05 155.69 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.148 -0.97 . . . . 0.0 110.55 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 21' ' ' THR . 5.0 t -73.08 89.23 1.46 Allowed 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.562 ' HD3' HD21 ' A' ' 33' ' ' LEU . 29.1 tpt180 -90.21 76.06 6.9 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.501 -0.75 . . . . 0.0 110.555 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.872 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 35.26 76.97 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.762 -0.586 . . . . 0.0 110.093 179.167 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.55 -52.98 9.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.928 . . . . 0.0 109.875 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.28 -170.23 2.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.119 -0.988 . . . . 0.0 109.489 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -79.5 128.51 33.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.194 -0.941 . . . . 0.0 109.141 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.872 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -124.46 -44.85 1.97 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.132 -0.98 . . . . 0.0 110.184 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.6 t60 56.41 20.44 4.75 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.71 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 6.3 mtp -115.28 -40.99 3.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.654 -0.654 . . . . 0.0 109.372 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 29' ' ' MET . . . 76.18 -177.49 0.13 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.304 -0.872 . . . . 0.0 109.003 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 1.3 t30 78.1 -5.95 2.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 109.403 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.49 ' O ' ' O ' ' A' ' 21' ' ' THR . 3.8 tmtm? -82.59 48.29 1.29 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.433 -0.792 . . . . 0.0 109.871 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.643 ' HB3' ' CE1' ' A' ' 115' ' ' PHE . 9.5 mt -117.91 79.93 1.44 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.846 -1.158 . . . . 0.0 109.304 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.607 ' HG2' ' CE1' ' A' ' 35' ' ' PHE . 13.2 tt0 -81.3 -134.18 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.345 -0.847 . . . . 0.0 109.132 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.607 ' CE1' ' HG2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -149.37 124.75 4.94 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.544 -1.348 . . . . 0.0 110.261 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.792 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.7 Cg_endo -57.99 94.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.14 1.893 . . . . 0.0 109.515 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -55.34 -148.14 0.01 OUTLIER Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.287 -0.883 . . . . 0.0 111.757 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.602 ' N ' ' CG ' ' A' ' 98' ' ' GLU . . . 157.41 -31.96 0.53 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 107.538 -2.225 . . . . 0.0 107.538 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.464 ' O ' ' OE2' ' A' ' 53' ' ' GLU . 2.5 tptm 67.18 100.43 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 122.237 -0.567 . . . . 0.0 110.744 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.82 HD13 ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -80.74 134.5 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.721 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 42' ' ' MET . 4.0 pt-20 -171.39 -31.94 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.784 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.443 ' O ' ' C ' ' A' ' 43' ' ' GLY . 4.4 mmt -54.69 162.92 1.05 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.113 -0.992 . . . . 0.0 109.252 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 42' ' ' MET . . . 43.93 -125.81 5.68 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -164.6 23.21 0.06 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.474 -1.015 . . . . 0.0 108.948 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.471 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 24.1 m -138.24 140.04 27.34 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.52 ' O ' HG12 ' A' ' 50' ' ' VAL . 10.0 Cg_exo -51.05 -17.84 3.95 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 121.748 1.632 . . . . 0.0 110.136 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.512 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -77.95 -85.14 0.07 Allowed 'General case' 0 C--O 1.202 -1.401 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.519 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.546 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 14.3 mt-30 -43.83 -33.17 1.24 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.569 -1.332 . . . . 0.0 109.715 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.693 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -65.76 -62.63 1.4 Allowed 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.511 -0.743 . . . . 0.0 110.021 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.042 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.6 p -68.99 -49.58 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.216 -0.928 . . . . 0.0 110.316 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.561 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 3.4 p -54.95 -45.48 76.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 121.684 -0.635 . . . . 0.0 110.186 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.552 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 5.4 mmt180 -71.06 -37.35 72.49 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.616 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 17.6 mm-40 -68.9 -14.59 63.13 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.763 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -80.0 -59.94 2.53 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -54.04 46.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.447 -0.783 . . . . 0.0 110.007 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.563 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 1.1 pp20? -47.57 -21.74 0.39 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.039 -1.038 . . . . 0.0 110.075 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.433 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 3.3 mt-10 -80.04 -92.92 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.075 -1.016 . . . . 0.0 109.632 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.776 HG21 ' HA ' ' A' ' 95' ' ' TRP . 36.2 t -79.97 -78.34 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 110.117 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.94 18.89 0.1 OUTLIER Glycine 0 N--CA 1.493 2.496 0 C-N-CA 118.43 -1.843 . . . . 0.0 112.643 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.947 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.6 pp -80.05 -156.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.123 -1.81 . . . . 0.0 107.628 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.624 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.5 m -137.36 -72.25 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.421 -1.424 . . . . 0.0 110.947 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 1.6 Cg_endo -61.43 -169.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 121.029 1.153 . . . . 0.0 110.712 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.584 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER 143.27 -23.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -179.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.609 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 1.6 t-80 44.84 53.21 7.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.455 -0.778 . . . . 0.0 109.484 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -45.97 156.05 0.16 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.036 0.922 . . . . 0.0 110.372 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -149.36 140.62 23.14 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.608 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -63.49 -68.1 0.37 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.731 -1.23 . . . . 0.0 109.78 -179.112 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.641 ' CZ ' HD11 ' A' ' 126' ' ' LEU . 0.0 OUTLIER 83.73 -50.53 0.14 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.599 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.5 mt-10 162.16 174.02 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.36 -172.38 3.36 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.824 -1.172 . . . . 0.0 109.891 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.979 HD21 ' OD1' ' A' ' 119' ' ' ASN . 0.7 OUTLIER -140.18 -177.7 5.13 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.795 0.807 . . . . 0.0 109.891 179.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.637 ' HG3' HG23 ' A' ' 81' ' ' THR . 11.3 tt0 -160.18 88.7 0.82 Allowed 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.03 105.48 9.27 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.512 ' HG3' ' NE2' ' A' ' 79' ' ' HIS . 2.8 tt0 -96.72 118.29 32.86 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.119 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -105.69 174.3 2.72 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 2.9 Cg_exo -49.03 -60.51 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 121.418 1.412 . . . . 0.0 109.558 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.5 50.39 1.71 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.434 ' HD2' ' CD1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -150.36 87.97 1.48 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.457 -0.777 . . . . 0.0 109.743 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.554 ' O ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -90.28 98.72 11.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.89 . . . . 0.0 109.386 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.641 HG21 ' C6 ' ' A' ' 130' ' ' APC . 0.5 OUTLIER -113.14 163.55 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.0 110.253 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.637 HG23 ' HG3' ' A' ' 72' ' ' GLU . 0.7 OUTLIER -151.34 147.1 26.52 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.336 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.641 ' CD2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -134.49 73.83 1.51 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.918 -1.114 . . . . 0.0 110.816 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.652 ' CD1' HG21 ' A' ' 40' ' ' ILE . 78.8 m95 -46.35 117.15 1.47 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.06 -1.025 . . . . 0.0 108.563 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.695 ' CE2' HG11 ' A' ' 122' ' ' VAL . 33.9 m-85 -94.03 76.78 4.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.966 -1.084 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.663 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 24.6 m95 -76.89 84.21 3.45 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.902 -1.124 . . . . 0.0 109.372 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.623 HD11 ' CG1' ' A' ' 10' ' ' ILE . 2.4 mm? -69.24 128.04 35.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.671 -1.268 . . . . 0.0 109.212 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.8 ' CG2' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -112.0 175.78 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 87.2 mt-10 -157.14 19.41 0.3 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.48 -1.388 . . . . 0.0 112.786 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.609 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -160.67 64.16 0.31 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.105 -1.622 . . . . 0.0 111.087 178.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.61 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 1.5 p90 -80.74 164.6 22.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.747 -1.22 . . . . 0.0 109.156 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.6 OUTLIER -88.27 142.94 27.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.854 -1.154 . . . . 0.0 109.386 178.314 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 38.25 -83.37 0.0 OUTLIER Glycine 0 N--CA 1.498 2.814 0 O-C-N 121.585 -0.697 . . . . 0.0 112.073 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.947 ' O ' HG21 ' A' ' 60' ' ' ILE . 10.6 pt-20 -106.98 164.86 13.93 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.149 -1.206 . . . . 0.0 111.254 -177.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.615 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 11.2 Cg_endo -75.86 -160.91 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 122.717 2.278 . . . . 0.0 109.934 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.776 ' HA ' HG21 ' A' ' 58' ' ' VAL . 0.2 OUTLIER 176.51 54.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.196 -0.94 . . . . 0.0 110.865 178.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . -139.98 0.6 2.12 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 118.334 -1.888 . . . . 0.0 111.814 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.651 ' HE3' HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -78.03 106.94 10.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.403 -1.646 . . . . 0.0 110.772 -179.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.602 ' CG ' ' N ' ' A' ' 38' ' ' GLY . 1.2 mm-40 -60.27 -91.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.735 -1.228 . . . . 0.0 107.73 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.74 22.17 34.55 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 106.692 -2.563 . . . . 0.0 106.692 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.506 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -100.11 143.38 26.39 Favored Pre-proline 0 N--CA 1.485 1.289 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 21' ' ' THR . 4.4 Cg_exo -57.31 -30.67 88.5 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 N-CA-C 108.127 -1.528 . . . . 0.0 108.127 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.605 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 53.63 110.97 0.01 OUTLIER Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 4.6 pt-20 -147.8 133.73 19.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.758 -1.437 . . . . 0.0 110.557 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.53 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 7.8 m0 -46.06 123.62 4.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 108.495 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.639 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -115.55 111.07 20.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.08 -1.012 . . . . 0.0 109.764 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.522 ' HA ' ' OE1' ' A' ' 17' ' ' GLU . 19.3 t -79.58 63.07 4.06 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.368 -0.832 . . . . 0.0 110.634 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.842 HD12 ' N ' ' A' ' 108' ' ' VAL . 4.2 pp -82.37 -40.38 21.41 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.3 -0.875 . . . . 0.0 109.883 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.842 ' N ' HD12 ' A' ' 107' ' ' LEU . 2.0 t 70.64 118.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 42.53 84.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.621 -1.791 . . . . 0.0 108.621 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.824 HD21 ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -45.74 174.34 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.587 -0.949 . . . . 0.0 110.147 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.669 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 4.4 t-20 -152.77 0.54 0.28 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.979 -1.075 . . . . 0.0 112.069 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 79.78 -32.3 0.13 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.889 -1.132 . . . . 0.0 109.008 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -49.8 -26.51 3.99 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.571 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 9.2 m-20 -108.3 -17.62 13.96 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.809 -0.557 . . . . 0.0 109.872 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.824 ' CD1' HD21 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -91.77 144.32 29.21 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.134 -0.979 . . . . 0.0 109.853 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.531 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.8 Cg_endo -65.2 134.13 38.05 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.269 1.979 . . . . 0.0 109.962 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 118' ' ' ALA . 5.5 Cg_exo -60.65 -25.52 81.04 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.083 1.856 . . . . 0.0 110.731 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.91 -46.58 5.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.215 -0.928 . . . . 0.0 109.231 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.979 ' OD1' HD21 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -95.33 51.78 1.35 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.326 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.644 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -59.97 -44.15 96.1 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.621 -0.674 . . . . 0.0 112.358 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 6.2 Cg_exo -54.34 -32.89 74.13 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.013 1.809 . . . . 0.0 112.872 -177.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.695 HG11 ' CE2' ' A' ' 84' ' ' PHE . 2.4 t -101.41 -36.8 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.522 -1.361 . . . . 0.0 110.153 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.951 ' HA ' HD22 ' A' ' 126' ' ' LEU . 1.1 mp -61.93 -27.85 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.53 ' HA ' ' CE ' ' A' ' 127' ' ' LYS . . . -55.06 -35.08 64.14 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.462 ' HD3' ' HA ' ' A' ' 125' ' ' LYS . 26.0 mmtp -80.11 -41.62 25.16 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.946 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.951 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -60.3 -22.0 62.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.335 -1.478 . . . . 0.0 107.448 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.537 ' HD3' ' CB ' ' A' ' 112' ' ' ALA . 6.3 mttt -57.36 -42.02 81.23 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -79.07 -18.98 52.45 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.634 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 2.5 tp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.984 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' APC . . . . . 0.641 ' C6 ' HG21 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.412 0.625 . . . . 0.0 109.452 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.538 ' HE3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -156.49 -173.91 4.7 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.408 -0.808 . . . . 0.0 109.2 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.538 ' N ' ' HE3' ' A' ' 2' ' ' LYS . 3.6 ttpm? -121.88 153.81 37.92 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.194 -0.941 . . . . 0.0 109.443 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 1.044 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -148.22 122.11 9.37 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.97 ' N ' HD22 ' A' ' 4' ' ' LEU . 2.9 mp0 -110.65 154.65 23.52 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.114 -0.991 . . . . 0.0 108.339 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.639 HG22 HG12 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -122.5 118.21 54.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.396 -178.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.124 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -85.52 60.76 6.44 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.709 HG13 ' H ' ' A' ' 9' ' ' GLY . 1.0 OUTLIER -79.16 -71.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.096 -179.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.709 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 59.84 82.23 0.07 OUTLIER Glycine 0 C--N 1.298 -1.57 0 N-CA-C 106.304 -2.719 . . . . 0.0 106.304 -177.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.575 ' O ' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -48.15 154.69 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -178.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.931 HG22 ' CG1' ' A' ' 87' ' ' VAL . 4.0 pt -116.48 102.27 13.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.886 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.769 ' HG2' HG23 ' A' ' 18' ' ' ILE . 8.6 mtm180 -76.65 -173.12 2.46 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.619 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -155.43 -66.32 0.12 Allowed 'General case' 0 C--O 1.188 -2.161 0 C-N-CA 116.826 -1.95 . . . . 0.0 114.267 -177.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.61 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 29.1 tp10 -91.51 -33.82 15.03 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 118.953 -2.342 . . . . 0.0 111.496 -175.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.483 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 41.8 t-20 -161.73 -42.08 0.04 OUTLIER 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.529 ' OD1' ' NH1' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -155.96 32.8 0.35 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 177.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 105' ' ' MET . 1.9 mm-40 -90.1 109.45 20.5 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 118.038 -1.465 . . . . 0.0 108.49 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.78 HD12 ' HB3' ' A' ' 105' ' ' MET . 0.2 OUTLIER -102.92 148.44 8.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.793 -177.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.627 ' CE2' ' HG2' ' A' ' 94' ' ' PRO . 20.4 t80 -81.54 38.34 0.49 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.733 HG21 HD22 ' A' ' 33' ' ' LEU . 6.1 tp -78.47 152.55 5.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.259 -0.901 . . . . 0.0 110.442 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.493 ' HB ' ' HD2' ' A' ' 101' ' ' PRO . 1.4 t -65.49 85.5 0.07 Allowed 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.511 ' O ' ' C ' ' A' ' 23' ' ' ARG . 21.2 tpt180 -87.38 93.59 9.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.688 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.939 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 28.55 76.63 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 120.986 0.422 . . . . 0.0 110.385 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.25 -47.52 4.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.363 -0.836 . . . . 0.0 109.105 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.25 155.1 26.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.869 . . . . 0.0 108.992 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -59.6 92.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.07 -1.018 . . . . 0.0 109.649 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.939 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -97.54 96.84 8.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -0.947 . . . . 0.0 109.947 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -48.95 -25.61 2.04 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.41 ' N ' ' C ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -72.06 -167.29 0.29 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.54 0.686 . . . . 0.0 109.477 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.528 ' O ' ' CB ' ' A' ' 31' ' ' ASN . . . -154.58 -157.98 0.81 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 0.7 OUTLIER 75.26 -2.7 2.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.059 -1.025 . . . . 0.0 109.074 -179.164 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -82.39 59.66 4.69 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.563 -0.71 . . . . 0.0 110.279 -179.534 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.733 HD22 HG21 ' A' ' 20' ' ' ILE . 12.0 mt -122.41 85.09 2.36 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.704 ' C ' HD11 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -80.8 -138.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.15 -1.593 . . . . 0.0 109.443 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.639 ' HB3' HG21 ' A' ' 8' ' ' VAL . 23.6 m-85 -154.22 123.98 3.26 Favored Pre-proline 0 N--CA 1.485 1.317 0 O-C-N 121.066 -1.021 . . . . 0.0 109.464 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.579 ' O ' HG23 ' A' ' 8' ' ' VAL . 2.1 Cg_endo -58.63 88.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.889 1.726 . . . . 0.0 109.464 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.544 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -57.12 -141.41 0.01 OUTLIER Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.569 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . 162.48 -55.35 0.3 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HB2' ' PB ' ' A' ' 130' ' ' APC . 0.0 OUTLIER 99.04 69.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 123.11 0.564 . . . . 0.0 110.352 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.741 HD13 ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -53.79 123.45 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.963 -1.086 . . . . 0.0 108.684 179.353 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 42' ' ' MET . 8.1 pt-20 -173.16 -22.52 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.647 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.438 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -38.82 -81.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.133 -0.979 . . . . 0.0 110.153 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.41 -122.95 2.25 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.69 9.07 1.97 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.531 -0.982 . . . . 0.0 109.124 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.553 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 60.4 m -126.01 142.41 42.38 Favored Pre-proline 0 N--CA 1.486 1.335 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.609 ' HG3' ' CZ3' ' A' ' 83' ' ' TRP . 3.6 Cg_exo -52.41 -15.7 4.25 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.545 1.497 . . . . 0.0 110.317 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.696 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.4 tt0 -75.97 -81.25 0.08 Allowed 'General case' 0 C--O 1.201 -1.486 0 O-C-N 120.983 -1.073 . . . . 0.0 108.638 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.544 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 1.3 mt-30 -47.75 -36.02 10.8 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.265 -1.522 . . . . 0.0 109.455 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.702 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -62.17 -64.17 1.01 Allowed 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.198 -0.939 . . . . 0.0 110.136 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.124 HG23 ' HB1' ' A' ' 7' ' ' ALA . 1.3 p -69.47 -49.81 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.305 -0.872 . . . . 0.0 110.657 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.696 HG12 ' O ' ' A' ' 47' ' ' GLU . 3.1 p -55.89 -37.12 46.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.745 -0.597 . . . . 0.0 110.421 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -78.96 -37.16 40.22 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 2.2 mm-40 -69.83 -14.23 62.65 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.006 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -80.08 -65.5 1.0 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.519 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.06 -49.8 74.74 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.697 -0.627 . . . . 0.0 110.479 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.611 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -46.64 -24.76 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.881 -1.137 . . . . 0.0 109.915 -178.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 8.0 mm-40 -80.13 -95.04 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.091 -1.005 . . . . 0.0 109.563 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.632 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 66.3 t -79.96 -79.36 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.098 -1.001 . . . . 0.0 109.911 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.99 37.58 0.09 OUTLIER Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.241 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.086 HG21 ' O ' ' A' ' 93' ' ' GLU . 2.9 pp -93.36 -152.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 120.793 -1.416 . . . . 0.0 108.542 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.829 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.3 m -161.7 -64.96 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 120.327 -1.483 . . . . 0.0 112.511 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 3.8 Cg_exo -51.59 -2.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.827 2.351 . . . . 0.0 114.267 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.508 ' N ' ' HA ' ' A' ' 90' ' ' TRP . 1.3 pt20 -34.89 -29.15 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 119.575 1.079 . . . . 0.0 110.791 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.578 ' N ' ' O ' ' A' ' 62' ' ' PRO . 2.2 t60 55.32 73.37 0.42 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.676 -1.265 . . . . 0.0 108.053 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 15.5 p90 -72.99 146.4 46.01 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.791 0.805 . . . . 0.0 111.179 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -144.4 135.37 25.13 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.629 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -61.46 -70.16 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.752 -1.217 . . . . 0.0 109.985 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.913 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 84.1 -52.51 0.13 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -178.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.9 mm-40 172.69 177.54 0.09 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.262 -0.899 . . . . 0.0 108.885 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HE2' HG22 ' A' ' 81' ' ' THR . 0.0 OUTLIER -161.37 -174.59 4.36 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.195 -0.941 . . . . 0.0 109.38 -179.389 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.714 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -149.02 175.79 11.0 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.135 -0.978 . . . . 0.0 109.986 179.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -144.06 89.16 2.01 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.15 123.16 27.11 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.24 156.3 17.3 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.294 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.585 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -133.22 174.13 5.07 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.585 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 5.4 Cg_exo -47.68 -33.35 18.44 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.696 1.597 . . . . 0.0 109.74 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 1' ' ' MET . 0.5 OUTLIER -164.18 51.59 0.14 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.534 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -155.64 94.0 1.53 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.652 -0.655 . . . . 0.0 109.778 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.75 ' C ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -78.72 120.7 23.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.047 -1.033 . . . . 0.0 108.707 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.75 HD12 ' C ' ' A' ' 79' ' ' HIS . 1.3 mp -117.89 165.25 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 122.135 0.969 . . . . 0.0 110.592 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.598 ' N ' ' CG2' ' A' ' 80' ' ' ILE . 1.5 m -153.6 155.98 37.13 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.575 ' CD2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -148.49 77.04 1.38 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.912 -1.118 . . . . 0.0 110.301 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.609 ' CZ3' ' HG3' ' A' ' 46' ' ' PRO . 75.9 m95 -49.0 108.59 0.19 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.809 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.878 ' CG ' HG11 ' A' ' 122' ' ' VAL . 19.1 m-85 -85.06 69.81 10.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.134 -0.979 . . . . 0.0 109.593 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.684 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 71.0 m95 -74.23 87.53 1.96 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.905 -1.122 . . . . 0.0 109.361 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.913 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.3 mm? -70.07 126.98 31.26 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 120.67 -1.269 . . . . 0.0 109.573 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.931 ' CG1' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -101.52 179.98 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.01 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.494 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 42.8 mt-10 -153.28 1.69 0.27 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 117.735 -1.586 . . . . 0.0 113.219 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.593 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.32 71.27 0.44 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.002 -1.686 . . . . 0.0 110.95 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.619 ' CH2' ' HB2' ' A' ' 13' ' ' ASN . 2.8 p90 -78.87 165.64 23.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.418 -1.426 . . . . 0.0 110.036 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.573 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 1.5 pt-20 -86.98 137.6 32.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.206 -0.934 . . . . 0.0 109.824 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 41.1 -89.49 0.01 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 1.086 ' O ' HG21 ' A' ' 60' ' ' ILE . 12.6 pt-20 -103.9 162.54 19.64 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.199 -1.177 . . . . 0.0 109.745 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.835 ' HB3' HD12 ' A' ' 11' ' ' ILE . 10.1 Cg_endo -76.64 -155.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.58 2.187 . . . . 0.0 110.067 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 1.006 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER 179.48 49.64 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.336 -0.852 . . . . 0.0 110.56 179.115 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . -130.63 -2.92 4.75 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.078 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.499 ' N ' ' CD ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -56.92 99.47 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.242 -1.152 . . . . 0.0 110.29 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.474 ' HB2' ' C ' ' A' ' 37' ' ' GLY . 5.7 tp10 -82.1 84.43 7.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.114 -0.991 . . . . 0.0 108.821 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.07 16.95 65.05 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.507 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 2.8 pt20 -121.54 164.62 23.5 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.556 -0.967 . . . . 0.0 109.003 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 3.2 Cg_exo -65.65 -49.35 2.4 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 121.742 1.628 . . . . 0.0 109.79 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.622 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.94 119.27 0.01 OUTLIER Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.567 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 2.4 pt-20 -151.96 134.7 15.52 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.037 -1.273 . . . . 0.0 110.846 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.611 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 2.1 m0 -48.85 127.88 14.7 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.78 ' HB3' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -108.23 133.41 52.51 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -178.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.521 ' HA ' ' OE2' ' A' ' 17' ' ' GLU . 1.6 t -84.65 41.12 0.83 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.411 -1.431 . . . . 0.0 109.531 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.608 HD21 ' CA ' ' A' ' 110' ' ' LEU . 1.6 tt -82.54 150.96 26.64 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.483 ' N ' ' HG ' ' A' ' 107' ' ' LEU . 48.4 t -119.52 132.32 69.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 109.293 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 129' ' ' LEU . . . 39.96 80.8 0.03 OUTLIER Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.083 HD22 ' CD2' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -41.87 163.71 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.479 -1.013 . . . . 0.0 110.072 -178.177 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.697 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 3.8 t30 -138.79 0.4 2.0 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 111.322 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 82.59 -33.62 0.09 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.221 -0.924 . . . . 0.0 108.632 -178.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -50.87 -28.91 10.55 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.512 -0.742 . . . . 0.0 109.044 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.562 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 8.5 m-20 -101.33 -19.41 15.64 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.538 -0.726 . . . . 0.0 109.406 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 1.083 ' CD2' HD22 ' A' ' 110' ' ' LEU . 1.3 m-85 -86.26 142.46 35.72 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.332 -0.855 . . . . 0.0 108.723 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.57 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.2 Cg_endo -62.94 146.28 94.78 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.276 1.984 . . . . 0.0 110.249 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.508 ' HA ' ' CD ' ' A' ' 120' ' ' GLU . 1.3 Cg_endo -64.4 -18.9 64.68 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.182 1.921 . . . . 0.0 110.994 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.66 -56.48 20.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.949 -1.094 . . . . 0.0 110.09 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.877 ' O ' HD12 ' A' ' 123' ' ' ILE . 9.0 m-80 -91.62 44.96 1.2 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.094 -1.004 . . . . 0.0 109.852 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.709 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 1.3 tp10 -60.71 -47.07 96.94 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.442 -0.786 . . . . 0.0 112.156 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.709 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 24.6 Cg_exo -43.85 -48.14 9.33 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.115 1.877 . . . . 0.0 112.452 -177.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.878 HG11 ' CG ' ' A' ' 84' ' ' PHE . 2.5 t -91.67 -25.75 5.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 O-C-N 120.619 -1.301 . . . . 0.0 107.874 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.879 ' HA ' HD22 ' A' ' 126' ' ' LEU . 1.5 mt -69.42 -11.55 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.539 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -71.36 -27.68 63.53 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -80.24 -38.83 30.24 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.752 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.879 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -67.03 -22.87 65.86 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.525 -1.359 . . . . 0.0 107.719 179.299 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 2.7 mtmm -56.77 -31.46 64.65 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -89.82 -21.78 22.42 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.327 -0.852 . . . . 0.0 108.711 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 1.4 tp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.77 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' APC . . . . . 0.675 ' C6 ' HG21 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' CON . . . . . 0.584 ' N3 ' ' O2A' ' A' ' 130' ' ' APC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.558 ' O ' ' O ' ' A' ' 2' ' ' LYS . 1.8 tpt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.558 ' O ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 45.04 167.36 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 122.065 0.936 . . . . 0.0 111.962 179.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.446 ' CG ' ' N ' ' A' ' 4' ' ' LEU . 2.1 ttpt -162.5 159.07 24.49 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.058 -1.026 . . . . 0.0 109.77 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.761 HD22 " O4'" ' A' ' 130' ' ' APC . 0.2 OUTLIER -160.48 160.0 31.5 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.133 -0.979 . . . . 0.0 109.161 178.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.794 ' HB2' HG23 ' A' ' 40' ' ' ILE . 15.3 mp0 -131.09 173.22 11.24 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.179 -0.951 . . . . 0.0 108.657 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.633 HG13 ' N7 ' ' A' ' 130' ' ' APC . 0.1 OUTLIER -140.85 116.75 7.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 121.131 -0.98 . . . . 0.0 109.084 -179.388 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.096 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -82.29 67.63 8.39 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.845 HG11 ' CD2' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -79.15 -76.27 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.273 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.697 ' HA2' ' N ' ' A' ' 85' ' ' TRP . . . 65.3 78.48 0.22 Allowed Glycine 0 C--N 1.295 -1.697 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 -178.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.835 HD12 ' NH2' ' A' ' 12' ' ' ARG . 0.3 OUTLIER -47.15 168.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -178.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.942 HG22 HG22 ' A' ' 87' ' ' VAL . 3.7 pt -140.38 93.85 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 O-C-N 120.859 -1.15 . . . . 0.0 110.083 -177.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.872 ' NH1' HD13 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -95.56 152.08 18.75 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.621 ' ND2' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -161.08 -10.39 0.04 OUTLIER 'General case' 0 C--O 1.188 -2.182 0 C-N-CA 116.663 -2.015 . . . . 0.0 115.444 -177.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.452 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -94.47 -31.16 14.07 Favored 'General case' 0 N--CA 1.51 2.548 0 O-C-N 118.047 -2.908 . . . . 0.0 108.458 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.8 -48.75 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 102.174 -3.269 . . . . 0.0 102.174 177.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.43 ' C ' ' OE1' ' A' ' 17' ' ' GLU . 16.9 t30 -162.03 38.31 0.12 Allowed 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 175.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -85.35 93.14 8.65 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.432 -1.307 . . . . 0.0 110.697 -177.056 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 2.0 pt -79.12 146.83 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.63 0.729 . . . . 0.0 111.063 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.687 ' HB3' HD11 ' A' ' 11' ' ' ILE . 6.3 t80 -82.75 43.68 0.86 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.837 HD11 ' O ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -80.67 151.11 4.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.07 0.938 . . . . 0.0 110.49 -178.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.695 HG23 ' O ' ' A' ' 21' ' ' THR . 5.3 t -66.56 91.34 0.18 Allowed 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.713 ' HD2' HD21 ' A' ' 33' ' ' LEU . 21.4 tpt180 -94.47 140.5 29.75 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.281 -0.887 . . . . 0.0 108.712 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.841 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -32.21 91.19 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . -42.82 -54.44 4.13 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.493 -0.754 . . . . 0.0 109.149 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.69 -163.09 0.53 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.712 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 73.2 m-20 -70.09 -49.96 45.72 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.908 -1.12 . . . . 0.0 109.805 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.841 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . 81.98 -24.16 0.19 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.346 -0.846 . . . . 0.0 110.212 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.498 ' O ' ' HG2' ' A' ' 29' ' ' MET . 0.1 OUTLIER 47.77 25.43 0.71 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.79 -1.193 . . . . 0.0 108.047 -178.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 28' ' ' HIS . 20.7 mmt -154.94 -167.68 2.65 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.545 ' HB1' ' OD1' ' A' ' 114' ' ' ASP . . . -153.09 -162.47 1.49 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 108.929 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 1.0 OUTLIER 77.18 -2.71 2.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.443 -0.786 . . . . 0.0 109.327 -179.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.656 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -82.09 55.34 2.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.47 -0.769 . . . . 0.0 110.097 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.713 HD21 ' HD2' ' A' ' 22' ' ' ARG . 6.6 mt -124.06 86.53 2.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.805 -1.184 . . . . 0.0 108.544 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.837 ' O ' HD11 ' A' ' 20' ' ' ILE . 4.6 tt0 -82.38 -123.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.078 -1.014 . . . . 0.0 110.32 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -161.38 123.68 1.75 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 120.646 -1.284 . . . . 0.0 109.277 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.777 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.9 Cg_endo -65.03 99.09 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.884 1.723 . . . . 0.0 109.725 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.546 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . -95.02 -130.77 6.19 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.994 -1.098 . . . . 0.0 111.663 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.505 ' HA2' ' OE1' ' A' ' 98' ' ' GLU . . . 150.06 -8.65 0.81 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.614 ' HD3' " C5'" ' A' ' 130' ' ' APC . 15.2 tptm 72.78 106.13 0.07 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.39 0.614 . . . . 0.0 111.056 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.87 HG12 ' HB1' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -81.63 134.7 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.414 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 42' ' ' MET . 2.4 pt-20 -172.33 -29.37 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.216 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.428 ' O ' ' C ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -55.17 160.63 2.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.923 -1.111 . . . . 0.0 108.914 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.454 ' C ' ' HG2' ' A' ' 44' ' ' GLU . . . 46.35 -127.14 9.69 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.454 ' HG2' ' C ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -166.57 23.46 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.35 -1.088 . . . . 0.0 109.046 179.061 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.565 HG23 ' HD2' ' A' ' 46' ' ' PRO . 87.4 m -142.73 142.67 23.3 Favored Pre-proline 0 C--N 1.304 -1.412 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.573 ' O ' HG12 ' A' ' 50' ' ' VAL . 9.0 Cg_exo -48.94 -16.8 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.899 1.732 . . . . 0.0 111.107 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.528 ' O ' HG12 ' A' ' 51' ' ' VAL . 4.8 mt-10 -78.5 -80.4 0.11 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.747 -1.221 . . . . 0.0 108.63 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.595 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 30.6 mt-30 -51.69 -23.94 5.07 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.396 -1.44 . . . . 0.0 109.164 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.87 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -72.1 -64.08 1.01 Allowed 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.484 -0.76 . . . . 0.0 109.737 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.096 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.6 p -70.06 -49.14 58.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.251 -0.906 . . . . 0.0 110.192 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.566 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 1.4 p -52.96 -44.62 50.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 O-C-N 121.749 -0.594 . . . . 0.0 110.292 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 7.8 mmt180 -73.57 -39.66 64.51 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.604 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 6.3 mm-40 -66.67 -15.12 63.27 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.792 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -80.19 -61.08 2.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -54.55 43.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.799 . . . . 0.0 109.906 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.568 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -46.0 -24.22 0.39 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -0.963 . . . . 0.0 109.658 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.44 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.2 mt-10 -79.99 -95.67 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.169 -0.957 . . . . 0.0 109.525 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.607 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 46.9 t -80.0 -78.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 110.109 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.12 24.19 0.12 Allowed Glycine 0 N--CA 1.494 2.507 0 C-N-CA 118.922 -1.609 . . . . 0.0 112.361 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.047 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.1 pp -84.38 -146.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.325 -1.691 . . . . 0.0 107.827 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.708 ' H ' HD12 ' A' ' 60' ' ' ILE . 1.2 m -161.03 -66.92 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 120.174 -1.579 . . . . 0.0 112.329 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.599 ' O ' ' CG ' ' A' ' 63' ' ' GLN . 10.2 Cg_exo -43.54 -94.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.169 1.912 . . . . 0.0 112.426 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.778 ' OE1' HG11 ' A' ' 87' ' ' VAL . 3.2 pt20 54.05 6.21 0.09 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.197 -0.939 . . . . 0.0 111.382 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.598 ' C ' ' O ' ' A' ' 63' ' ' GLN . 5.3 t-160 22.32 50.69 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.58 0 O-C-N 120.962 -1.086 . . . . 0.0 110.444 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 63' ' ' GLN . 1.7 p90 -35.52 141.34 0.08 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.091 0.948 . . . . 0.0 112.127 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -145.2 147.58 32.59 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.609 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -77.85 -65.28 0.99 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.79 -1.194 . . . . 0.0 110.13 -179.004 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.824 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 82.71 -51.33 0.18 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.302 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER 163.42 178.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 0.0 109.496 179.144 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.602 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 15.1 ptmt -160.96 170.3 20.86 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.301 -0.874 . . . . 0.0 109.727 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.74 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -136.16 171.58 14.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.098 179.582 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -150.09 94.15 2.11 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.01 122.23 26.48 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.483 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 15.0 tt0 -96.67 127.64 42.85 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.108 -0.995 . . . . 0.0 109.468 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.563 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 7.1 m-85 -106.7 168.34 8.24 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.362 -0.836 . . . . 0.0 109.17 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 7.5 Cg_exo -48.7 -28.48 12.68 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.943 1.762 . . . . 0.0 109.77 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.495 ' O ' ' HD2' ' A' ' 78' ' ' ARG . 8.0 m-20 -162.25 31.08 0.11 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.546 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.66 89.98 2.36 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.71 -0.619 . . . . 0.0 109.961 -178.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.859 ' C ' HD12 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -89.86 113.3 24.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.911 -1.118 . . . . 0.0 109.126 179.58 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.859 HD12 ' C ' ' A' ' 79' ' ' HIS . 1.6 mp -118.54 155.71 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.974 -1.079 . . . . 0.0 110.446 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.551 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 1.9 m -136.14 137.84 41.39 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.845 ' CD2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -127.22 75.89 1.62 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.815 -1.178 . . . . 0.0 110.101 -179.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.602 ' CE3' ' HD2' ' A' ' 70' ' ' LYS . 92.2 m95 -51.79 111.24 0.57 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.265 -0.897 . . . . 0.0 109.45 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.548 ' O ' ' O ' ' A' ' 67' ' ' LEU . 45.5 m-85 -86.92 73.04 10.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.9 . . . . 0.0 110.178 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.697 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 12.7 m95 -71.94 85.76 0.99 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.819 -1.176 . . . . 0.0 108.328 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.824 HD23 ' CD2' ' A' ' 68' ' ' PHE . 2.8 mm? -67.78 125.78 27.33 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.478 -1.389 . . . . 0.0 110.024 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.942 HG22 HG22 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -112.29 169.81 4.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 38.8 mt-10 -160.54 29.59 0.16 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 117.972 -1.491 . . . . 0.0 112.552 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.581 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.85 30.19 0.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.329 -1.482 . . . . 0.0 109.943 179.235 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.67 ' HB2' HD13 ' A' ' 60' ' ' ILE . 1.6 p90 -48.96 148.78 2.12 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.951 -1.093 . . . . 0.0 109.967 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.574 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 1.6 tt0 -81.26 133.11 35.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.387 -0.821 . . . . 0.0 109.722 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 45.75 -86.89 0.01 OUTLIER Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 1.047 ' O ' HG21 ' A' ' 60' ' ' ILE . 17.1 pt-20 -100.6 161.89 22.51 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.301 -1.117 . . . . 0.0 110.051 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.621 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 13.9 Cg_endo -79.05 -162.6 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.772 2.315 . . . . 0.0 109.908 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.792 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER 177.8 26.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.218 -0.927 . . . . 0.0 111.011 178.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.407 ' HA2' ' CD1' ' A' ' 54' ' ' LEU . . . -93.88 -48.67 2.64 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.521 -1.323 . . . . 0.0 110.24 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.687 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -42.47 146.07 0.37 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -1.117 . . . . 0.0 111.243 -179.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.505 ' OE1' ' HA2' ' A' ' 38' ' ' GLY . 6.2 tp10 -81.08 -97.32 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.449 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . -108.64 3.95 32.51 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.547 ' HG2' ' HB2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -74.85 174.85 4.62 Favored Pre-proline 0 N--CA 1.482 1.166 0 O-C-N 121.826 -0.808 . . . . 0.0 109.199 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 102' ' ' GLY . 2.1 Cg_endo -69.63 -50.86 0.44 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.95 1.767 . . . . 0.0 109.591 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.604 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 61.78 114.38 0.01 OUTLIER Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.064 -2.015 . . . . 0.0 108.064 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.574 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 7.1 pt-20 -148.61 135.85 20.23 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.113 -1.228 . . . . 0.0 110.441 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.622 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 5.0 m0 -48.18 129.29 15.1 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -119.79 119.2 32.92 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.85 -1.157 . . . . 0.0 110.032 -178.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.35 68.12 5.26 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.884 HD13 ' HG ' ' A' ' 110' ' ' LEU . 7.4 tt -81.86 -54.36 5.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 109.188 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.633 ' HB ' ' O ' ' A' ' 107' ' ' LEU . 48.6 t 86.29 112.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 40.3 83.79 0.01 OUTLIER Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.099 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -40.22 165.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.725 -0.868 . . . . 0.0 110.596 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.601 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 14.6 t30 -144.15 1.75 1.12 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.126 -0.984 . . . . 0.0 111.234 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.628 ' HB2' HG23 ' A' ' 123' ' ' ILE . . . 70.24 -3.42 1.82 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.914 -1.116 . . . . 0.0 109.282 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -80.95 -24.68 37.95 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.545 ' OD1' ' HB1' ' A' ' 30' ' ' ALA . 3.3 m-20 -102.11 -13.11 17.62 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 1.099 ' CE1' HD21 ' A' ' 110' ' ' LEU . 4.0 m-85 -95.08 150.98 38.49 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.293 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.54 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.3 Cg_endo -66.63 139.75 54.21 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.498 2.132 . . . . 0.0 109.63 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 118' ' ' ALA . 2.4 Cg_endo -61.93 -31.15 84.46 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.224 1.949 . . . . 0.0 111.179 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.64 -44.83 4.42 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.004 -1.06 . . . . 0.0 110.187 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.585 ' OD1' HD21 ' A' ' 71' ' ' LEU . 3.5 m-80 -99.16 51.61 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 109.273 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.672 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.4 mt-10 -69.36 -36.57 7.31 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.558 -0.714 . . . . 0.0 112.437 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 6.3 Cg_exo -56.35 -34.89 95.3 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.511 1.474 . . . . 0.0 112.047 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.542 HG11 ' CE1' ' A' ' 84' ' ' PHE . 1.7 t -99.77 -36.48 5.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.583 -1.323 . . . . 0.0 108.829 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.628 HG23 ' HB2' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -66.64 -15.56 19.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.565 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.52 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -62.83 -29.9 71.09 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.485 ' HE2' ' OE2' ' A' ' 69' ' ' GLU . 12.8 mmtm -81.53 -39.43 24.69 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.094 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.78 HD12 HD13 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -66.62 -22.05 66.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.733 -1.229 . . . . 0.0 108.195 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.612 ' HD2' ' HB3' ' A' ' 112' ' ' ALA . 1.7 mtmt -53.23 -31.13 41.75 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.03 -27.85 22.95 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.361 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.78 HD13 HD12 ' A' ' 126' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.681 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' APC . . . . . 0.761 " O4'" HD22 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.499 ' HG2' ' HA ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.542 ' HD3' ' O ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -111.94 165.88 11.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.107 -0.996 . . . . 0.0 109.373 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 79' ' ' HIS . 9.1 tttt -162.1 150.96 15.33 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.804 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 1.059 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -158.67 147.36 18.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.478 -0.764 . . . . 0.0 109.007 178.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.708 ' HB2' HG23 ' A' ' 40' ' ' ILE . 1.6 mp0 -111.7 170.13 8.35 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 109.094 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.699 HD11 ' H8 ' ' A' ' 130' ' ' APC . 0.2 OUTLIER -135.04 108.15 9.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.202 -179.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.034 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -82.81 72.68 9.88 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.541 -0.725 . . . . 0.0 109.327 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.786 HG22 ' N ' ' A' ' 9' ' ' GLY . 0.2 OUTLIER -83.81 -84.33 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.415 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.786 ' N ' HG22 ' A' ' 8' ' ' VAL . . . 81.33 78.37 0.97 Allowed Glycine 0 C--N 1.299 -1.475 0 N-CA-C 106.947 -2.461 . . . . 0.0 106.947 -178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.697 ' O ' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -48.21 150.5 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -178.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.815 HG22 ' CG1' ' A' ' 87' ' ' VAL . 10.0 pt -120.48 75.87 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.394 -177.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 1.012 ' NH1' HD21 ' A' ' 129' ' ' LEU . 0.5 OUTLIER -79.69 153.95 28.94 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.46 ' OD1' ' CH2' ' A' ' 90' ' ' TRP . 2.6 p-10 -154.14 -20.98 0.13 Allowed 'General case' 0 C--O 1.187 -2.225 0 C-N-CA 117.218 -1.793 . . . . 0.0 114.901 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.577 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 3.4 tt0 -93.41 -32.31 14.29 Favored 'General case' 0 N--CA 1.511 2.605 0 O-C-N 118.076 -2.89 . . . . 0.0 109.486 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.466 HD22 HG13 ' A' ' 108' ' ' VAL . 61.9 t30 -161.68 -47.44 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 102.971 -2.974 . . . . 0.0 102.971 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.793 ' ND2' HD23 ' A' ' 129' ' ' LEU . 1.5 m120 -161.87 38.07 0.13 Allowed 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.644 ' HA ' ' O ' ' A' ' 105' ' ' MET . 84.0 mt-10 -85.1 84.51 7.68 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.143 -1.423 . . . . 0.0 110.43 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.865 HG23 ' HB3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -78.97 153.85 4.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.434 0.635 . . . . 0.0 109.942 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.737 ' CB ' HD11 ' A' ' 11' ' ' ILE . 6.8 t80 -83.16 42.77 0.83 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.732 HD11 ' C ' ' A' ' 34' ' ' GLU . 5.5 tp -80.69 148.81 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-O 122.585 1.183 . . . . 0.0 111.734 -176.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.614 ' H ' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -58.43 89.41 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.593 ' O ' ' C ' ' A' ' 23' ' ' ARG . 32.0 tpt180 -97.24 91.89 5.75 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.724 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.836 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 13.68 79.4 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 121.356 0.598 . . . . 0.0 110.971 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -41.56 -56.05 2.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.424 -0.798 . . . . 0.0 110.287 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.75 -179.04 3.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.069 -1.019 . . . . 0.0 109.476 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.96 84.44 4.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.214 -0.929 . . . . 0.0 109.534 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.836 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -72.54 -36.92 68.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.243 -0.911 . . . . 0.0 109.324 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 49.92 23.57 1.1 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.583 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -117.12 -33.96 4.53 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.563 -0.711 . . . . 0.0 109.1 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.616 ' HB1' ' OD1' ' A' ' 114' ' ' ASP . . . 69.19 -177.65 0.21 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.437 -0.789 . . . . 0.0 109.822 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 1.1 t30 78.96 -8.63 1.62 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.523 -0.736 . . . . 0.0 109.523 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.567 ' HD2' ' CA ' ' A' ' 23' ' ' ARG . 4.8 tttp -83.29 51.47 1.98 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.385 -0.822 . . . . 0.0 110.227 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.944 HD13 HD21 ' A' ' 110' ' ' LEU . 17.4 mt -107.73 85.84 2.19 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.732 ' C ' HD11 ' A' ' 20' ' ' ILE . 1.5 tt0 -87.4 -137.28 0.09 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.388 -1.445 . . . . 0.0 109.614 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.679 ' CE2' ' CE1' ' A' ' 115' ' ' PHE . 10.9 m-85 -153.31 126.61 4.2 Favored Pre-proline 0 N--CA 1.486 1.364 0 O-C-N 121.048 -1.032 . . . . 0.0 109.586 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.726 ' O ' HG23 ' A' ' 8' ' ' VAL . 5.4 Cg_endo -65.64 89.17 0.22 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.011 1.807 . . . . 0.0 108.483 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.607 ' HA3' HG23 ' A' ' 6' ' ' ILE . . . -115.34 107.18 1.7 Allowed Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.714 -1.231 . . . . 0.0 111.525 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.513 ' HA2' ' CD ' ' A' ' 98' ' ' GLU . . . -82.14 16.81 20.61 Favored Glycine 0 N--CA 1.489 2.181 0 O-C-N 121.576 -0.955 . . . . 0.0 111.168 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.594 ' CD ' HD23 ' A' ' 4' ' ' LEU . 3.1 tptm 63.9 108.25 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 118.244 1.022 . . . . 0.0 110.984 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.034 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -80.37 138.67 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.924 -1.11 . . . . 0.0 109.017 178.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -172.28 -32.81 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.89 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.437 ' SD ' ' HB3' ' A' ' 52' ' ' ARG . 38.5 mtt -55.74 159.34 3.1 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.128 -0.982 . . . . 0.0 109.511 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.56 -130.5 9.39 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.16 24.44 0.11 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.435 -1.038 . . . . 0.0 108.749 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.54 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 27.4 m -136.82 140.86 33.03 Favored Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.574 ' HG3' ' CH2' ' A' ' 83' ' ' TRP . 7.1 Cg_exo -50.09 -20.35 5.2 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.815 1.677 . . . . 0.0 109.897 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 51' ' ' VAL . 3.2 mt-10 -75.72 -87.35 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.346 -0.846 . . . . 0.0 108.763 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.536 ' O ' ' CG ' ' A' ' 52' ' ' ARG . 42.3 mt-30 -41.72 -33.01 0.43 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.845 -1.159 . . . . 0.0 110.147 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.797 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -67.19 -63.26 1.1 Allowed 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.024 -1.047 . . . . 0.0 109.674 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.887 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.2 p -66.72 -49.38 75.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.645 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.573 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 4.1 p -57.31 -44.65 84.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.547 -0.721 . . . . 0.0 110.34 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.536 ' CG ' ' O ' ' A' ' 48' ' ' GLN . 14.9 mmt180 -72.05 -32.25 66.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.009 -1.057 . . . . 0.0 108.665 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.616 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 12.4 mm-40 -75.22 -15.96 60.51 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.949 HD12 ' CG ' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -79.97 -62.62 1.63 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.749 0.785 . . . . 0.0 108.997 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.49 ' N ' ' CZ3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.45 -51.74 68.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.784 -0.572 . . . . 0.0 109.691 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.598 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -47.15 -26.22 1.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.888 -1.133 . . . . 0.0 108.868 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 54' ' ' LEU . 3.6 mt-10 -80.05 -95.3 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.355 -0.841 . . . . 0.0 109.377 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.725 HG21 ' HA ' ' A' ' 95' ' ' TRP . 28.2 t -80.21 -78.91 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.304 -0.873 . . . . 0.0 110.321 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 138.2 32.5 0.21 Allowed Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.374 -1.394 . . . . 0.0 111.275 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.001 HD13 ' HB2' ' A' ' 90' ' ' TRP . 1.1 pp -90.75 -152.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.589 -1.536 . . . . 0.0 108.278 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.72 ' H ' HD12 ' A' ' 60' ' ' ILE . 1.6 m -162.23 -63.16 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.349 -1.469 . . . . 0.0 112.73 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.639 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 6.3 Cg_exo -55.9 0.62 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.537 2.158 . . . . 0.0 114.373 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.778 ' HB3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -39.18 -27.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.623 -1.298 . . . . 0.0 110.289 -179.07 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 62' ' ' PRO . 1.9 t60 51.84 88.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.495 ' HB3' ' NE2' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -88.87 159.31 17.76 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.377 1.084 . . . . 0.0 111.901 -177.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -153.64 141.15 19.81 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.242 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.614 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -63.31 -67.22 0.44 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.878 -1.139 . . . . 0.0 110.272 -178.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.666 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 84.05 -51.75 0.13 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.264 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.578 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 4.9 tp10 159.54 135.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.563 ' HE3' ' CD2' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -125.6 -177.76 4.02 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.467 -0.771 . . . . 0.0 109.515 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -136.51 -177.41 4.71 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.341 -0.85 . . . . 0.0 109.938 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -151.71 86.16 1.32 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.15 104.01 9.48 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -95.18 154.41 17.2 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 119.416 -0.914 . . . . 0.0 108.587 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.577 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -141.73 173.09 5.1 Favored Pre-proline 0 C--N 1.297 -1.677 0 O-C-N 121.214 -0.929 . . . . 0.0 109.104 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 7.3 Cg_exo -48.23 -39.39 34.54 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 121.776 1.651 . . . . 0.0 109.703 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.499 ' HA ' ' HG2' ' A' ' 1' ' ' MET . 4.7 p-10 -148.21 35.14 0.81 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.476 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -142.73 78.95 1.63 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.549 -0.719 . . . . 0.0 110.077 -178.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.953 ' C ' HD12 ' A' ' 80' ' ' ILE . 24.5 m170 -82.35 119.58 24.33 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.953 HD12 ' C ' ' A' ' 79' ' ' HIS . 2.3 mp -129.69 162.75 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 118.793 -1.163 . . . . 0.0 111.433 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.602 ' N ' HG22 ' A' ' 80' ' ' ILE . 2.0 m -147.32 148.84 31.8 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.504 ' CD1' HN61 ' A' ' 130' ' ' APC . 0.2 OUTLIER -141.32 82.96 1.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.716 -1.24 . . . . 0.0 110.348 -179.395 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.694 ' CD1' HG21 ' A' ' 40' ' ' ILE . 89.8 m95 -54.05 111.76 0.82 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.267 -0.896 . . . . 0.0 109.034 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.653 ' CE2' HG11 ' A' ' 122' ' ' VAL . 11.6 m-85 -88.6 68.05 8.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.247 -0.908 . . . . 0.0 109.793 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.641 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 75.3 m95 -72.36 84.29 1.08 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.794 -1.191 . . . . 0.0 109.747 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.697 HD13 ' O ' ' A' ' 10' ' ' ILE . 3.2 mm? -68.07 129.44 39.91 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.566 -1.334 . . . . 0.0 109.942 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.815 ' CG1' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -111.2 -175.08 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.653 ' N ' HG23 ' A' ' 87' ' ' VAL . 1.2 mt-10 -159.89 8.13 0.1 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 117.612 -1.635 . . . . 0.0 113.54 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.572 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.73 71.96 0.44 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 119.855 -1.778 . . . . 0.0 110.651 178.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 1.001 ' HB2' HD13 ' A' ' 60' ' ' ILE . 17.4 p90 -80.69 163.0 23.9 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.718 -1.239 . . . . 0.0 110.191 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.648 ' O ' ' N ' ' A' ' 93' ' ' GLU . 5.0 pt-20 -81.81 135.53 35.45 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.179 -0.951 . . . . 0.0 109.762 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 35.02 -80.34 0.0 OUTLIER Glycine 0 N--CA 1.502 3.088 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.966 ' O ' HG21 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -98.82 153.32 37.92 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.333 -1.098 . . . . 0.0 109.219 -179.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.64 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 20.2 Cg_endo -80.85 -159.07 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.787 2.325 . . . . 0.0 110.025 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.949 ' CG ' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER 178.58 132.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.771 0.796 . . . . 0.0 110.017 178.184 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . 152.93 -40.04 0.72 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.509 ' N ' ' CD ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -41.09 107.51 0.07 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.517 -0.99 . . . . 0.0 109.526 -179.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 5.5 tp10 -77.38 87.28 3.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.273 -0.892 . . . . 0.0 108.712 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.35 30.71 65.04 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.497 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 7.4 pt20 -125.96 168.08 15.05 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.475 -1.015 . . . . 0.0 109.299 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 9.8 Cg_endo -78.21 42.6 1.24 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.562 2.175 . . . . 0.0 110.842 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.57 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . -44.78 123.82 5.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.615 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -146.79 144.38 29.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -1.118 . . . . 0.0 109.8 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.48 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 1.2 m-90 -52.35 139.84 23.47 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.968 -1.083 . . . . 0.0 108.225 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.644 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -139.06 108.85 6.26 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.286 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.524 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -81.33 46.79 0.97 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.597 -0.689 . . . . 0.0 109.351 179.462 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 1.066 HD22 ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -64.72 -12.7 49.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 108.859 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.879 ' N ' HD13 ' A' ' 107' ' ' LEU . 1.4 t 59.63 121.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.452 -0.78 . . . . 0.0 110.189 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.634 ' HA2' ' HB3' ' A' ' 129' ' ' LEU . . . 38.12 74.06 0.13 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.188 HD22 ' CD2' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -38.19 158.24 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.914 -0.756 . . . . 0.0 109.905 -178.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.88 ' H ' HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -154.76 143.77 20.98 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.139 -0.976 . . . . 0.0 110.182 -178.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . . . -44.07 -27.84 0.42 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -42.07 -53.93 3.76 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.317 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.616 ' OD1' ' HB1' ' A' ' 30' ' ' ALA . 14.3 m-20 -97.94 -9.75 25.7 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 1.188 ' CD2' HD22 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -91.96 136.92 25.55 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.543 -0.723 . . . . 0.0 109.754 -179.26 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' A' ' 123' ' ' ILE . 2.5 Cg_endo -68.24 153.6 74.14 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.373 2.049 . . . . 0.0 110.22 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 118' ' ' ALA . 1.7 Cg_endo -65.12 -36.37 37.53 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.212 1.941 . . . . 0.0 110.817 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -39.37 -47.79 1.81 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.408 -0.807 . . . . 0.0 110.123 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.596 ' O ' HD12 ' A' ' 123' ' ' ILE . 0.7 OUTLIER -98.64 55.83 1.09 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.372 -0.83 . . . . 0.0 109.034 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.651 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -69.13 -47.17 29.53 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.722 -0.611 . . . . 0.0 111.688 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 8.2 Cg_exo -52.25 -40.12 70.55 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.194 1.929 . . . . 0.0 112.846 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.653 HG11 ' CE2' ' A' ' 84' ' ' PHE . 2.2 t -98.21 -34.05 4.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 O-C-N 120.642 -1.286 . . . . 0.0 109.5 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.855 HD13 ' HB3' ' A' ' 115' ' ' PHE . 31.4 mt -59.0 -29.18 40.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.539 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -59.44 -35.08 73.35 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.928 0.871 . . . . 0.0 109.129 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.0 mmmt -77.68 -35.58 52.11 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.567 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 1.099 HD23 ' CE2' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -66.71 -34.62 78.26 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.158 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 123' ' ' ILE . 7.1 mtpt -45.4 -29.01 0.97 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.568 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -91.2 -34.65 14.91 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.297 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 1.012 HD21 ' NH1' ' A' ' 12' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.508 2.426 0 CA-C-O 118.035 -0.983 . . . . 0.0 111.635 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' APC . . . . . 0.699 ' H8 ' HD11 ' A' ' 6' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' CON . . . . . 0.443 ' N3 ' ' O2A' ' A' ' 130' ' ' APC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.405 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.488 ' HD3' ' O ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -51.95 164.14 0.29 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.021 -1.049 . . . . 0.0 109.552 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.458 ' N ' ' HE3' ' A' ' 2' ' ' LYS . 15.1 tttt -160.57 157.31 27.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 0.0 109.542 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 1.07 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -158.38 143.84 16.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.808 . . . . 0.0 109.278 179.105 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.653 ' HB2' HG23 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -113.53 166.74 11.21 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.86 -1.15 . . . . 0.0 108.394 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.563 HD11 ' C8 ' ' A' ' 130' ' ' APC . 0.3 OUTLIER -127.23 110.95 23.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.957 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -81.85 68.55 8.27 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.745 HG22 ' N ' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -79.47 -83.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.465 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.745 ' N ' HG22 ' A' ' 8' ' ' VAL . . . 75.61 82.3 0.48 Allowed Glycine 0 N--CA 1.479 1.517 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 -178.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.607 ' O ' HD13 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -49.13 157.2 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.939 HG22 HG22 ' A' ' 87' ' ' VAL . 1.6 pt -124.54 85.27 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.866 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -77.51 167.75 21.12 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.2 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.487 ' OD1' ' HB2' ' A' ' 17' ' ' GLU . 2.0 p-10 -161.94 -26.11 0.05 OUTLIER 'General case' 0 C--O 1.185 -2.31 0 C-N-CA 115.966 -2.294 . . . . 0.0 114.889 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HB3' ' OE2' ' A' ' 17' ' ' GLU . 4.9 tt0 -95.01 -34.22 12.43 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 118.36 -2.712 . . . . 0.0 109.132 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -162.35 -45.95 0.04 OUTLIER 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 103.211 -2.885 . . . . 0.0 103.211 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.67 ' OD1' HD23 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -160.37 36.2 0.17 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 176.511 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -88.14 98.95 11.84 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.088 -1.445 . . . . 0.0 109.234 -178.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.604 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -92.34 150.09 3.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.927 0.87 . . . . 0.0 111.265 -178.414 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.657 ' CE1' ' HA ' ' A' ' 103' ' ' GLU . 14.3 t80 -82.2 43.71 0.81 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.721 HD11 ' C ' ' A' ' 34' ' ' GLU . 5.1 tp -81.02 154.96 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-O 122.053 0.93 . . . . 0.0 111.269 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.52 ' H ' HD12 ' A' ' 20' ' ' ILE . 1.4 t -66.14 93.72 0.22 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.739 ' HD3' HD21 ' A' ' 33' ' ' LEU . 23.7 tpt180 -102.05 149.01 24.69 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.668 -0.645 . . . . 0.0 109.601 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.866 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -34.34 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 22' ' ' ARG . . . -46.55 -54.34 9.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.382 -0.823 . . . . 0.0 110.393 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.49 -151.1 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.006 -1.058 . . . . 0.0 109.204 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.35 -51.39 10.92 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.292 -0.88 . . . . 0.0 109.066 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.866 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . 57.7 -168.45 0.12 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.639 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -162.34 -35.07 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.648 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 1.5 mpt? -49.61 -46.44 49.31 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.337 -0.852 . . . . 0.0 109.398 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 29' ' ' MET . . . 72.34 5.63 5.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.288 -0.883 . . . . 0.0 109.456 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -98.65 11.64 37.85 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.24 -0.912 . . . . 0.0 108.853 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -81.8 54.78 2.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.602 -0.686 . . . . 0.0 110.402 -179.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.739 HD21 ' HD3' ' A' ' 22' ' ' ARG . 15.0 mt -122.49 84.55 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.64 -1.287 . . . . 0.0 109.666 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.721 ' C ' HD11 ' A' ' 20' ' ' ILE . 1.4 tt0 -82.84 -136.86 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.987 -1.071 . . . . 0.0 109.983 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.711 ' HE2' HD11 ' A' ' 123' ' ' ILE . 77.7 m-85 -152.0 125.37 4.22 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.124 -0.985 . . . . 0.0 109.338 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.648 ' O ' HG23 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -58.09 90.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.616 1.544 . . . . 0.0 109.127 178.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.532 ' HA2' ' CG2' ' A' ' 6' ' ' ILE . . . -56.27 -142.46 0.01 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 154.56 -33.3 0.69 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.61 ' HD3' " C5'" ' A' ' 130' ' ' APC . 0.0 OUTLIER 69.89 97.02 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 122.185 -0.597 . . . . 0.0 109.397 -179.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.957 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -80.23 132.62 31.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.794 179.346 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.504 ' HB3' ' NZ ' ' A' ' 39' ' ' LYS . 6.6 pt-20 -170.67 -34.14 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.47 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -47.85 147.16 2.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.337 -0.852 . . . . 0.0 109.54 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 53.03 -120.92 13.76 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.06 23.07 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.647 -0.914 . . . . 0.0 109.125 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.458 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 56.1 m -138.68 139.13 23.34 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.609 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 14.2 Cg_exo -49.3 -17.25 1.45 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.004 1.803 . . . . 0.0 110.606 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.49 ' O ' HG12 ' A' ' 51' ' ' VAL . 2.4 mt-10 -77.89 -83.14 0.08 Allowed 'General case' 0 C--O 1.203 -1.352 0 O-C-N 120.934 -1.104 . . . . 0.0 108.557 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.527 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 36.9 mt-30 -45.67 -33.62 3.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.502 -1.374 . . . . 0.0 109.54 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.732 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -65.2 -63.34 1.13 Allowed 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.452 -0.78 . . . . 0.0 110.24 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.814 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.4 p -68.82 -48.99 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.912 -1.118 . . . . 0.0 110.607 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.575 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 2.3 p -54.63 -44.06 68.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 121.371 0.605 . . . . 0.0 110.295 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.551 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 18.7 mmt180 -74.87 -34.49 62.26 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.642 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 20.8 mm-40 -71.21 -13.39 61.9 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.006 HD12 ' NE1' ' A' ' 95' ' ' TRP . 1.1 mm? -79.34 -64.31 1.22 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.519 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -57.12 -51.49 69.1 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.54 -0.725 . . . . 0.0 110.187 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.59 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 1.3 pp20? -50.18 -21.08 1.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.052 -1.03 . . . . 0.0 110.479 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -80.14 -92.22 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.918 -1.114 . . . . 0.0 110.038 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.789 HG21 ' HA ' ' A' ' 95' ' ' TRP . 21.0 t -79.98 -79.17 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.426 -0.796 . . . . 0.0 109.678 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.54 22.72 0.1 Allowed Glycine 0 N--CA 1.495 2.605 0 C-N-CA 118.485 -1.817 . . . . 0.0 112.554 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.094 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.6 pp -82.93 -166.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.283 -1.716 . . . . 0.0 108.031 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.67 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 2.0 m -123.36 -71.73 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.434 -1.416 . . . . 0.0 110.844 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.67 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 5.7 Cg_endo -64.19 -170.82 0.13 Allowed 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.078 1.185 . . . . 0.0 109.707 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.601 ' HG2' ' CZ2' ' A' ' 95' ' ' TRP . 0.7 OUTLIER 139.54 -23.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -179.204 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.537 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 1.9 t60 57.23 -167.41 0.13 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' A' ' 64' ' ' HIS . 28.3 p90 -179.38 150.83 0.45 Allowed 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.414 -1.314 . . . . 0.0 110.676 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -159.35 141.89 13.9 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.61 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -65.95 -66.71 0.52 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.04 -1.037 . . . . 0.0 109.313 -179.507 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.871 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 85.38 -55.07 0.09 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.562 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 9.5 tp10 169.62 151.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.613 ' HA ' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -143.67 -164.53 1.89 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.847 -1.158 . . . . 0.0 109.295 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.675 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -150.96 -177.13 5.83 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.208 -0.933 . . . . 0.0 110.419 -179.643 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -149.51 90.78 1.75 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -78.21 108.35 11.46 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.433 ' HG3' ' NE2' ' A' ' 79' ' ' HIS . 25.0 tt0 -92.62 99.57 12.25 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.488 -0.758 . . . . 0.0 110.158 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.52 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -79.26 170.97 13.75 Favored Pre-proline 0 C--N 1.301 -1.503 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.338 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.52 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 5.5 Cg_exo -51.89 -55.02 4.31 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.872 1.715 . . . . 0.0 109.606 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.04 35.88 4.08 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.513 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -144.31 91.52 2.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.521 -0.737 . . . . 0.0 109.682 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.498 ' C ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -82.15 90.99 6.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.752 -1.218 . . . . 0.0 109.087 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.761 HG13 HD11 ' A' ' 4' ' ' LEU . 1.0 OUTLIER -98.84 157.28 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.005 -1.059 . . . . 0.0 110.272 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.608 ' N ' HG22 ' A' ' 80' ' ' ILE . 2.2 m -136.34 170.6 15.77 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.651 HD22 ' OD1' ' A' ' 119' ' ' ASN . 0.2 OUTLIER -159.5 85.8 0.79 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.601 -1.312 . . . . 0.0 110.035 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.604 ' CD1' HG21 ' A' ' 40' ' ' ILE . 97.3 m95 -65.43 115.12 5.35 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.786 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.873 ' CD2' HG11 ' A' ' 122' ' ' VAL . 10.1 m-85 -89.56 71.32 7.91 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.938 -1.101 . . . . 0.0 109.606 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.693 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 88.4 m95 -72.28 87.81 1.14 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.015 -1.053 . . . . 0.0 109.149 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.871 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.0 mm? -68.39 130.16 42.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.755 -1.216 . . . . 0.0 110.121 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.939 HG22 HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -117.61 176.89 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.551 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 23.4 mt-10 -159.76 28.88 0.19 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.386 -1.446 . . . . 0.0 112.944 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.595 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -159.62 57.98 0.38 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 119.878 -1.764 . . . . 0.0 111.721 178.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.588 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 2.4 p90 -79.15 162.37 25.83 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.222 -1.549 . . . . 0.0 109.267 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.629 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -92.94 145.86 24.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.999 -1.063 . . . . 0.0 109.583 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 39.29 -87.51 0.01 OUTLIER Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 1.094 ' O ' HG21 ' A' ' 60' ' ' ILE . 2.8 pt-20 -105.34 157.04 35.3 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.235 -1.156 . . . . 0.0 109.868 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.61 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 10.6 Cg_endo -75.59 -159.07 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.93 2.42 . . . . 0.0 110.263 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 1.006 ' NE1' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -179.56 66.16 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.291 -0.881 . . . . 0.0 110.36 178.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . -139.07 -33.71 0.17 Allowed Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.367 -1.397 . . . . 0.0 110.688 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.588 ' HG3' ' CE2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -39.62 106.79 0.06 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.129 -1.218 . . . . 0.0 110.496 -179.063 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.504 ' HB2' ' C ' ' A' ' 37' ' ' GLY . 8.0 tp10 -80.43 100.59 8.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.265 -0.897 . . . . 0.0 109.139 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 54.12 21.96 19.66 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.587 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 7.8 pt20 -122.75 170.82 7.41 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.497 -1.002 . . . . 0.0 108.868 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.587 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 4.2 Cg_exo -63.14 -46.14 10.87 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.0 1.8 . . . . 0.0 110.785 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.58 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 59.69 112.81 0.01 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.657 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 5.2 pt-20 -152.76 137.25 16.76 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.136 -1.214 . . . . 0.0 110.493 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.499 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 1.7 m-90 -48.64 135.7 14.32 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.602 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -125.85 115.65 20.32 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.197 -0.939 . . . . 0.0 109.521 -179.055 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.469 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -82.54 57.81 3.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 110.015 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.854 HD21 ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -80.69 -41.28 23.95 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.168 -0.958 . . . . 0.0 108.417 179.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.794 ' N ' HD23 ' A' ' 107' ' ' LEU . 86.4 t 70.13 126.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.854 -0.529 . . . . 0.0 109.938 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 41.18 81.43 0.03 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.158 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -42.79 166.7 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.487 -1.008 . . . . 0.0 110.545 -178.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.685 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -143.9 -7.34 0.74 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.325 -0.859 . . . . 0.0 111.846 -178.463 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 81.02 -31.53 0.11 Allowed 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.91 -1.119 . . . . 0.0 109.024 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.3 -16.83 15.74 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.453 -0.779 . . . . 0.0 109.099 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.582 ' HB3' HD12 ' A' ' 33' ' ' LEU . 2.0 m-20 -111.67 -12.86 13.84 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.599 -0.688 . . . . 0.0 109.919 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 1.158 ' CE1' HD21 ' A' ' 110' ' ' LEU . 7.5 m-85 -100.7 148.77 35.47 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.905 . . . . 0.0 109.808 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.58 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 3.5 Cg_exo -64.04 142.1 79.73 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.642 2.228 . . . . 0.0 110.547 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 2.3 Cg_endo -62.9 -19.97 70.2 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.04 1.826 . . . . 0.0 110.08 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -45.92 -51.02 13.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 109.25 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.754 ' O ' HD12 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -94.85 54.68 1.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.629 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 2.4 mt-10 -64.8 -45.71 75.2 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 2.8 Cg_exo -54.84 -35.38 88.46 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.907 1.738 . . . . 0.0 112.92 -177.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.873 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.1 t -100.34 -31.94 3.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.579 -1.325 . . . . 0.0 109.243 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.928 ' HA ' HD22 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -61.7 -26.99 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.526 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -55.77 -37.63 68.8 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 29.1 mmtm -78.09 -35.86 48.79 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.861 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.928 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -66.6 -21.71 66.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.45 -1.406 . . . . 0.0 107.334 178.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 7.2 mtmt -57.69 -35.21 70.3 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 177.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 125' ' ' LYS . 4.2 mtp180 -82.34 -22.97 35.32 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.429 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.67 HD23 ' OD1' ' A' ' 16' ' ' ASN . 1.3 tp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.473 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' APC . . . . . 0.629 ' C6 ' HG21 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ptp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.485 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -136.99 -163.52 1.43 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.383 -0.823 . . . . 0.0 109.109 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.541 ' HG2' ' N ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -109.72 154.11 23.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.011 . . . . 0.0 109.938 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.967 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -138.25 125.94 22.25 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.773 ' N ' HD22 ' A' ' 4' ' ' LEU . 0.9 OUTLIER -96.25 164.52 12.63 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.313 -1.492 . . . . 0.0 110.091 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.726 HG22 HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -131.2 117.82 38.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.495 -0.753 . . . . 0.0 109.046 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.048 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -86.61 63.17 7.83 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 36' ' ' PRO . 1.3 p -78.42 -72.43 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 109.735 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.768 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 57.38 87.65 0.02 OUTLIER Glycine 0 N--CA 1.479 1.528 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.602 ' CG1' HD11 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -47.77 168.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.238 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.062 HG22 ' CG2' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -131.04 94.62 2.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 O-C-N 121.181 -0.949 . . . . 0.0 109.33 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.61 ' HG2' HG22 ' A' ' 18' ' ' ILE . 13.9 mtm180 -75.82 177.36 6.99 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.598 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -151.44 -60.98 0.17 Allowed 'General case' 0 C--O 1.191 -1.977 0 C-N-CA 116.783 -1.967 . . . . 0.0 114.367 -176.296 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.506 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -92.32 -29.65 16.25 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 119.204 -2.185 . . . . 0.0 111.091 -176.124 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -162.16 -43.04 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.635 ' O ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -157.43 34.02 0.28 Allowed 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.359 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 105' ' ' MET . 17.1 mt-10 -82.01 87.36 6.45 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 118.005 -1.478 . . . . 0.0 108.88 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -80.0 147.96 6.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.395 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.667 ' CZ ' ' HG2' ' A' ' 94' ' ' PRO . 7.8 t80 -81.68 45.05 0.86 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.693 HD11 ' N ' ' A' ' 34' ' ' GLU . 6.6 tp -79.0 151.78 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-O 122.437 1.113 . . . . 0.0 111.575 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.565 ' CG2' ' NE2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -68.86 84.47 0.31 Allowed 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.438 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.695 ' HD2' HD21 ' A' ' 33' ' ' LEU . 18.2 tpt180 -79.24 84.98 5.13 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.016 -1.053 . . . . 0.0 109.822 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.753 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 1.5 ptt180 31.94 62.9 0.27 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.275 0.56 . . . . 0.0 110.319 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -41.92 -41.8 2.57 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.691 -0.631 . . . . 0.0 109.354 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' A' ' 23' ' ' ARG . . . -80.57 -179.96 7.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 109.195 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 3.6 p30 -78.79 112.86 16.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 109.328 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.753 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -112.27 -30.18 7.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 109.841 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 49.65 28.38 2.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.011 -1.055 . . . . 0.0 108.448 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.712 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 30.8 mmm -140.03 -100.01 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.392 -0.818 . . . . 0.0 109.976 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 152.13 -169.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER 78.84 -8.78 1.6 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.158 -0.964 . . . . 0.0 109.03 -179.312 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.613 ' O ' HD23 ' A' ' 33' ' ' LEU . 5.2 tptt -83.4 55.93 3.37 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.671 -0.643 . . . . 0.0 109.857 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.695 HD21 ' HD2' ' A' ' 22' ' ' ARG . 7.1 mt -120.04 93.09 3.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.288 -0.882 . . . . 0.0 108.779 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.693 ' N ' HD11 ' A' ' 20' ' ' ILE . 3.0 tt0 -88.56 -126.76 0.06 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.876 -1.14 . . . . 0.0 110.786 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.734 ' HB3' HG21 ' A' ' 8' ' ' VAL . 98.9 m-85 -160.07 128.72 3.01 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.756 -1.215 . . . . 0.0 110.247 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.898 ' O ' HG23 ' A' ' 8' ' ' VAL . 3.7 Cg_endo -64.79 97.28 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.113 1.875 . . . . 0.0 109.727 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.562 ' CA ' ' HB2' ' A' ' 98' ' ' GLU . . . -55.51 -153.15 0.01 OUTLIER Glycine 0 N--CA 1.492 2.405 0 O-C-N 121.298 -0.876 . . . . 0.0 111.013 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 163.86 -33.67 0.28 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.709 ' CD ' HD21 ' A' ' 4' ' ' LEU . 10.4 tptm 65.85 101.28 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.95 -0.735 . . . . 0.0 110.253 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.838 HD13 ' O ' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -80.42 135.44 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.039 -1.038 . . . . 0.0 108.693 178.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.544 ' HG3' ' N ' ' A' ' 42' ' ' MET . 6.9 pt-20 -171.12 -31.99 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.422 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.544 ' N ' ' HG3' ' A' ' 41' ' ' GLU . 1.7 mtt -62.08 151.89 34.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.065 -1.022 . . . . 0.0 109.842 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.98 -127.54 43.14 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.35 21.05 0.1 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.443 -1.034 . . . . 0.0 109.209 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.919 HG22 ' H ' ' A' ' 47' ' ' GLU . 1.8 m -147.01 140.78 15.27 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.613 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 11.0 Cg_exo -45.24 -18.6 0.28 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.067 1.845 . . . . 0.0 111.268 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.919 ' H ' HG22 ' A' ' 45' ' ' THR . 0.5 OUTLIER -76.87 -80.18 0.1 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.507 -1.37 . . . . 0.0 108.879 178.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.58 ' O ' ' CG ' ' A' ' 52' ' ' ARG . 60.0 mt-30 -48.58 -33.45 9.75 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.087 -1.633 . . . . 0.0 109.207 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.736 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -64.31 -63.6 1.1 Allowed 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.193 -0.942 . . . . 0.0 110.29 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.048 HG23 ' HB1' ' A' ' 7' ' ' ALA . 1.7 p -68.7 -48.87 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.142 -0.974 . . . . 0.0 110.57 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 47' ' ' GLU . 2.9 p -56.03 -39.0 55.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-O 121.189 0.519 . . . . 0.0 110.357 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.58 ' CG ' ' O ' ' A' ' 48' ' ' GLN . 18.3 mmt180 -78.65 -32.99 47.47 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.606 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 24.3 mm-40 -71.89 -12.84 61.46 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.831 HD12 ' CE2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -80.09 -55.34 5.01 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.645 0.736 . . . . 0.0 109.331 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.453 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -69.38 -33.92 73.76 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.691 -0.631 . . . . 0.0 111.173 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.606 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -64.26 -25.8 68.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.821 -1.175 . . . . 0.0 111.385 -177.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.539 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -80.34 -80.8 0.13 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.499 -1.375 . . . . 0.0 109.887 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.582 ' HB ' ' HB3' ' A' ' 95' ' ' TRP . 69.9 t -80.17 -82.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.145 -0.972 . . . . 0.0 109.463 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.95 21.66 0.12 Allowed Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.632 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.957 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.1 pt -80.17 -144.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.496 -1.591 . . . . 0.0 108.395 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.665 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 2.1 m -151.36 -71.46 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 120.474 -1.392 . . . . 0.0 110.965 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.665 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 1.0 OUTLIER -60.4 -173.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.934 0 C-N-CA 121.082 1.188 . . . . 0.0 109.918 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 1.5 pt20 152.04 -23.55 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.648 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER 47.35 61.64 2.8 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.43 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 5.1 p90 -60.78 155.43 19.4 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.886 0.851 . . . . 0.0 110.735 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -152.51 139.24 18.85 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.169 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.588 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -66.31 -67.15 0.47 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.854 -1.154 . . . . 0.0 109.814 -179.048 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.774 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 81.75 -48.94 0.23 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.281 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER 164.42 176.54 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.093 -1.004 . . . . 0.0 108.412 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.562 ' HE3' ' CE3' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -161.58 175.04 12.51 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.948 -1.095 . . . . 0.0 110.161 -179.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.801 HD21 ' OD1' ' A' ' 119' ' ' ASN . 0.3 OUTLIER -136.73 -179.12 5.5 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.387 -0.821 . . . . 0.0 109.758 179.402 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.596 ' HG3' HG23 ' A' ' 81' ' ' THR . 7.6 tt0 -154.75 90.23 1.29 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.09 162.77 22.41 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.473 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 4.0 mt-10 -118.0 161.08 20.39 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.551 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.652 ' CG ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -128.98 179.48 1.28 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.652 ' HD2' ' CG ' ' A' ' 75' ' ' PHE . 6.9 Cg_exo -52.69 -24.05 21.97 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.522 1.481 . . . . 0.0 109.787 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.441 ' O ' ' HD3' ' A' ' 78' ' ' ARG . 2.2 p30 -171.13 32.55 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.493 ' NH2' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -141.28 93.74 2.61 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.705 -0.622 . . . . 0.0 110.151 -178.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.473 ' CD2' ' HG3' ' A' ' 74' ' ' GLU . 8.9 t-160 -79.1 93.08 5.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.037 -1.039 . . . . 0.0 108.384 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.901 HG21 ' C5 ' ' A' ' 130' ' ' APC . 13.3 mm -83.95 157.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.263 1.03 . . . . 0.0 111.486 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.596 HG23 ' HG3' ' A' ' 72' ' ' GLU . 2.4 m -131.0 155.27 47.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.561 HD12 ' HB ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -141.83 83.92 1.87 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.495 -1.378 . . . . 0.0 110.72 -179.106 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.604 ' CD1' HG21 ' A' ' 40' ' ' ILE . 72.5 m95 -55.74 109.54 0.58 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.939 -1.101 . . . . 0.0 109.162 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.797 ' CD2' HG11 ' A' ' 122' ' ' VAL . 35.7 m-85 -86.79 75.04 9.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.02 -1.05 . . . . 0.0 109.72 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.667 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 83.9 m95 -79.41 89.39 5.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.051 -1.031 . . . . 0.0 109.456 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.774 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.3 mm? -68.78 132.38 46.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.843 -1.161 . . . . 0.0 109.831 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.062 ' CG2' HG22 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -120.54 170.4 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.603 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 87' ' ' VAL . 37.4 mt-10 -154.33 23.11 0.48 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.201 -1.562 . . . . 0.0 113.453 -178.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.648 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -160.24 55.76 0.34 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 119.832 -1.793 . . . . 0.0 111.138 178.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.84 ' HB2' HD13 ' A' ' 60' ' ' ILE . 4.8 p90 -73.99 157.89 35.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.929 -1.107 . . . . 0.0 109.456 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.618 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -79.88 142.54 35.11 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.136 -0.977 . . . . 0.0 109.559 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 29.89 -82.38 0.0 OUTLIER Glycine 0 N--CA 1.5 2.907 0 O-C-N 121.985 -0.447 . . . . 0.0 112.1 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.957 ' O ' HG21 ' A' ' 60' ' ' ILE . 2.9 mm-40 -93.74 157.12 38.75 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.216 -1.167 . . . . 0.0 110.74 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.667 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 29.4 Cg_endo -82.52 -157.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.622 2.215 . . . . 0.0 109.805 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.831 ' CE2' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER 172.63 114.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.454 0.645 . . . . 0.0 109.881 178.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . 165.2 -36.37 0.27 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.55 ' HD3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -39.5 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.667 -0.902 . . . . 0.0 110.789 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.562 ' HB2' ' CA ' ' A' ' 37' ' ' GLY . 3.1 tp10 -68.22 96.3 0.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.014 -1.054 . . . . 0.0 108.423 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.26 46.39 57.14 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.565 ' NE2' ' CG2' ' A' ' 21' ' ' THR . 0.0 OUTLIER -144.5 163.58 33.3 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.559 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 1.2 Cg_endo -64.1 -51.91 1.92 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 121.402 1.402 . . . . 0.0 109.796 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.639 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 59.25 113.35 0.01 OUTLIER Glycine 0 N--CA 1.479 1.519 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.596 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 12.4 pt-20 -150.33 131.78 14.73 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.211 -1.17 . . . . 0.0 109.858 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.629 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -47.25 133.69 11.89 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -124.75 121.84 35.75 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 109.614 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.2 t -81.13 63.2 5.39 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.87 HD21 ' HA ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -80.24 -47.75 14.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.346 -0.847 . . . . 0.0 108.971 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.821 ' N ' HD23 ' A' ' 107' ' ' LEU . 40.7 t 82.2 119.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.841 -0.537 . . . . 0.0 110.081 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 108' ' ' VAL . . . 36.51 82.67 0.01 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.151 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -40.98 164.84 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.625 -0.927 . . . . 0.0 110.67 -178.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.675 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 1.7 t-20 -142.88 -5.19 0.91 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 111.621 -178.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 77.37 -6.38 2.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.998 -1.064 . . . . 0.0 108.51 -177.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 -18.18 50.94 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.552 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -109.61 -11.15 14.8 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.329 0.585 . . . . 0.0 109.562 -179.454 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 1.151 ' CE1' HD21 ' A' ' 110' ' ' LEU . 15.7 m-85 -103.76 149.77 37.48 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.905 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.565 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 2.1 Cg_endo -63.8 145.48 90.76 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.718 2.278 . . . . 0.0 110.651 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.518 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . 1.3 Cg_endo -66.14 -27.5 49.14 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.27 1.98 . . . . 0.0 110.399 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -43.21 -54.25 4.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.049 -1.032 . . . . 0.0 109.621 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.801 ' OD1' HD21 ' A' ' 71' ' ' LEU . 7.5 m-80 -90.08 50.46 1.87 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.655 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 5.4 mt-10 -67.54 -37.85 13.71 Favored Pre-proline 0 C--N 1.3 -1.576 0 O-C-N 121.682 -0.636 . . . . 0.0 112.268 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.655 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 3.2 Cg_exo -55.36 -37.22 94.82 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.392 1.395 . . . . 0.0 112.035 -178.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.797 HG11 ' CD2' ' A' ' 84' ' ' PHE . 2.2 t -99.76 -34.41 4.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.69 -1.257 . . . . 0.0 109.046 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.866 ' HA ' HD22 ' A' ' 126' ' ' LEU . 0.5 OUTLIER -60.68 -22.7 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.567 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -60.7 -36.85 79.82 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.079 0.943 . . . . 0.0 108.501 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.55 -38.92 47.59 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.737 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.866 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -64.17 -23.07 67.18 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.567 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 12.7 mtmt -54.96 -38.65 68.02 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.438 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -80.24 -24.43 40.16 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.686 179.233 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.624 ' HB2' ' O ' ' A' ' 126' ' ' LEU . 2.0 tp . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.936 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' APC . . . . . 0.901 ' C5 ' HG21 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' CON . . . . . 0.603 ' N3 ' ' O2A' ' A' ' 130' ' ' APC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.464 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.31 0.576 . . . . 0.0 109.657 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.576 ' HD3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 168.56 -164.38 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.227 -179.27 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.576 ' N ' ' HD3' ' A' ' 2' ' ' LYS . 4.0 tmmm? -157.55 149.97 22.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.369 -0.832 . . . . 0.0 108.952 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.991 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -148.66 132.74 17.26 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.163 -0.961 . . . . 0.0 108.901 178.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.555 ' HB2' HG23 ' A' ' 40' ' ' ILE . 5.8 mp0 -99.44 155.88 17.32 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.379 -1.451 . . . . 0.0 109.069 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.59 HG13 ' N7 ' ' A' ' 130' ' ' APC . 0.5 OUTLIER -116.97 117.16 54.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.348 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.01 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -84.41 66.19 9.3 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -79.44 -77.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.168 -0.958 . . . . 0.0 110.123 -179.375 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.702 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 63.15 93.24 0.02 OUTLIER Glycine 0 N--CA 1.484 1.852 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.578 ' HB ' ' CD1' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -52.95 162.32 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.98 HG22 ' CG2' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -128.79 92.42 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.328 -179.177 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.959 ' HG2' HG22 ' A' ' 18' ' ' ILE . 8.9 mtm180 -75.71 177.23 7.01 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.646 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.0 OUTLIER -156.76 -61.5 0.1 Allowed 'General case' 0 C--O 1.191 -2.005 0 C-N-CA 116.069 -2.252 . . . . 0.0 114.716 -176.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.524 ' CB ' ' OE2' ' A' ' 17' ' ' GLU . 5.9 tp10 -91.7 -25.94 18.86 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 119.335 -2.103 . . . . 0.0 111.594 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -161.75 -45.53 0.04 OUTLIER 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.454 ' HA ' HH21 ' A' ' 12' ' ' ARG . 53.7 t-20 -160.92 35.6 0.15 Allowed 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.524 ' OE2' ' CB ' ' A' ' 14' ' ' GLU . 12.6 mt-10 -79.83 83.82 5.71 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 118.403 -1.319 . . . . 0.0 109.161 -178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.959 HG22 ' HG2' ' A' ' 12' ' ' ARG . 18.1 pt -79.19 141.36 15.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.22 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.624 ' HB3' HD11 ' A' ' 11' ' ' ILE . 13.5 t80 -81.71 45.09 0.86 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.713 HG22 HG13 ' A' ' 18' ' ' ILE . 4.4 tt -80.13 152.29 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-O 121.93 0.872 . . . . 0.0 110.863 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.472 ' HB ' ' HD2' ' A' ' 101' ' ' PRO . 0.6 OUTLIER -69.88 95.34 0.91 Allowed 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.673 ' HD3' HD21 ' A' ' 33' ' ' LEU . 13.2 tpt180 -99.09 90.37 4.58 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.641 -0.662 . . . . 0.0 111.072 -178.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.994 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 32.41 83.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.898 -0.501 . . . . 0.0 110.177 178.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -42.44 -46.53 4.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.224 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.84 176.43 9.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.432 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -77.47 105.28 8.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.121 -0.987 . . . . 0.0 109.427 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.994 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . -104.14 133.8 48.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.12 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -82.25 4.23 24.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 0.0 109.059 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.738 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -102.55 -126.69 0.21 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.603 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 29' ' ' MET . . . 163.62 -4.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.978 -1.076 . . . . 0.0 111.729 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 114' ' ' ASP . 2.9 p-10 -79.24 8.68 5.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.27 -1.519 . . . . 0.0 109.136 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.629 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -81.5 61.34 4.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.588 -0.695 . . . . 0.0 110.105 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.673 HD21 ' HD3' ' A' ' 22' ' ' ARG . 7.6 mt -123.66 93.11 3.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.868 -1.145 . . . . 0.0 109.291 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.594 ' O ' HD11 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.72 -145.97 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.465 -0.772 . . . . 0.0 109.003 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.497 ' CZ ' ' CG ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -142.53 128.35 10.52 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.745 -1.222 . . . . 0.0 109.49 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.703 ' O ' HG23 ' A' ' 8' ' ' VAL . 3.0 Cg_endo -60.05 97.09 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.004 1.803 . . . . 0.0 109.53 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.552 ' HA2' ' CG2' ' A' ' 6' ' ' ILE . . . -54.13 -141.95 0.0 OUTLIER Glycine 0 N--CA 1.496 2.677 0 O-C-N 121.531 -0.73 . . . . 0.0 111.589 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 153.59 -34.78 0.75 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.599 ' HD3' " C5'" ' A' ' 130' ' ' APC . 5.0 tptm 69.15 95.53 0.07 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.039 -0.683 . . . . 0.0 110.465 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.749 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -80.66 135.71 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.204 -0.935 . . . . 0.0 108.833 178.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -170.28 -34.23 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.353 -0.842 . . . . 0.0 109.756 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.415 ' O ' ' C ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -49.35 156.47 0.6 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.243 -0.911 . . . . 0.0 109.514 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' MET . . . 44.23 -122.44 4.46 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.78 21.27 0.09 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.406 -1.055 . . . . 0.0 109.484 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.699 HG22 ' H ' ' A' ' 47' ' ' GLU . 98.0 m -135.18 141.9 39.72 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.22 -0.925 . . . . 0.0 108.907 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.565 ' HD2' HG23 ' A' ' 45' ' ' THR . 11.2 Cg_exo -50.37 -16.9 2.29 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.573 1.516 . . . . 0.0 110.205 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.699 ' H ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -76.99 -84.08 0.07 Allowed 'General case' 0 C--O 1.202 -1.43 0 O-C-N 121.181 -0.949 . . . . 0.0 108.768 178.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.564 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -45.14 -35.91 3.43 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.484 -1.385 . . . . 0.0 109.747 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.635 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -64.23 -60.67 2.92 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.299 -0.875 . . . . 0.0 110.387 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.01 HG23 ' HB1' ' A' ' 7' ' ' ALA . 1.8 p -70.32 -48.82 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.897 -1.127 . . . . 0.0 110.548 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 47' ' ' GLU . 4.1 p -56.7 -37.41 52.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.823 -0.548 . . . . 0.0 110.575 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.564 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 2.9 mmt180 -79.17 -39.73 32.69 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.65 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 19.9 mm-40 -65.98 -15.66 63.2 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.054 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -80.26 -39.29 29.23 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.752 0.787 . . . . 0.0 109.961 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.63 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 1.8 mt-30 -79.2 -52.55 8.0 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.624 0.726 . . . . 0.0 109.192 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.65 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -44.65 -23.9 0.16 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.644 -0.66 . . . . 0.0 110.097 -179.58 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 3.9 mm-40 -80.16 -95.84 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.864 -1.148 . . . . 0.0 109.516 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.668 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 57.6 t -80.38 -78.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.07 -1.019 . . . . 0.0 109.809 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.64 37.54 0.11 Allowed Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.434 -1.365 . . . . 0.0 111.653 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.103 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -91.56 -147.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.506 -1.585 . . . . 0.0 108.689 178.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.608 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.5 m -162.73 -64.03 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 120.439 -1.413 . . . . 0.0 112.985 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.608 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 1.8 Cg_endo -56.66 -2.63 0.47 Allowed 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 122.53 2.153 . . . . 0.0 113.963 -177.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.849 ' HB3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -40.24 -26.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.789 -1.194 . . . . 0.0 109.917 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.577 ' N ' ' HG3' ' A' ' 63' ' ' GLN . 0.4 OUTLIER 57.4 -170.16 0.1 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -178.255 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -179.34 158.85 0.89 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.521 -1.362 . . . . 0.0 111.683 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -156.84 147.84 21.91 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.749 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.619 HD23 ' CE2' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -70.07 -67.44 0.49 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.888 -1.133 . . . . 0.0 109.655 -179.202 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.861 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 82.31 -52.4 0.22 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.586 ' CB ' ' O ' ' A' ' 68' ' ' PHE . 2.2 mm-40 150.56 133.36 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.798 -0.564 . . . . 0.0 109.819 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.526 ' HA ' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -122.64 -162.74 1.03 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.148 -0.97 . . . . 0.0 109.336 179.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.71 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -145.62 175.79 10.1 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.372 -0.83 . . . . 0.0 109.871 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -148.27 83.26 1.49 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.32 126.23 34.18 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.61 160.69 14.67 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 3.1 m-85 -128.75 170.02 11.62 Favored Pre-proline 0 C--N 1.296 -1.747 0 O-C-N 121.182 -0.948 . . . . 0.0 109.29 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 6.2 Cg_exo -48.83 -23.23 5.54 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.083 1.855 . . . . 0.0 109.694 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.0 42.29 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.56 ' HD3' HD11 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -153.39 90.0 1.39 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.787 -0.571 . . . . 0.0 109.563 -178.37 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.992 ' C ' HD13 ' A' ' 80' ' ' ILE . 7.0 t-160 -80.31 100.28 8.31 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.111 HG21 ' C5 ' ' A' ' 130' ' ' APC . 1.2 mm -115.89 144.41 23.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 118.809 -1.156 . . . . 0.0 112.138 -178.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.534 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 1.6 m -119.3 166.24 13.26 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.692 ' CD2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -151.73 76.24 1.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.761 -1.212 . . . . 0.0 110.069 179.81 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.668 ' CD1' HG21 ' A' ' 40' ' ' ILE . 75.6 m95 -51.68 128.37 23.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.123 -0.986 . . . . 0.0 109.142 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.843 ' CE2' HG11 ' A' ' 122' ' ' VAL . 23.5 m-85 -103.62 76.35 1.39 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.039 -1.038 . . . . 0.0 109.782 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.619 ' CE2' HD23 ' A' ' 67' ' ' LEU . 40.8 m95 -78.39 91.66 4.5 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.997 -1.064 . . . . 0.0 109.209 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.861 HD23 ' CD2' ' A' ' 68' ' ' PHE . 1.6 mm? -71.8 131.76 43.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.955 -1.091 . . . . 0.0 109.882 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.98 ' CG2' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -117.67 -178.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.533 ' N ' HG23 ' A' ' 87' ' ' VAL . 43.5 mt-10 -158.07 2.45 0.11 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.139 -1.601 . . . . 0.0 113.397 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.596 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -151.45 68.61 0.92 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 119.623 -1.923 . . . . 0.0 111.723 -179.62 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 1.03 ' HB2' HD13 ' A' ' 60' ' ' ILE . 9.6 p90 -80.57 167.91 19.53 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.467 -1.395 . . . . 0.0 109.38 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.569 ' CB ' ' HG2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -92.41 144.15 25.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.137 -0.977 . . . . 0.0 109.435 179.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 40.08 -91.03 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 1.103 ' O ' HG21 ' A' ' 60' ' ' ILE . 13.6 pt-20 -107.07 161.65 22.23 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.214 -1.168 . . . . 0.0 109.77 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.61 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 9.8 Cg_endo -75.77 -155.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.563 2.175 . . . . 0.0 109.93 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 1.054 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER 178.96 46.59 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.425 -0.797 . . . . 0.0 109.83 179.277 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -128.1 -20.86 1.58 Allowed Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.751 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -49.92 104.04 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.871 -1.37 . . . . 0.0 109.618 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.509 ' HB2' ' C ' ' A' ' 37' ' ' GLY . 9.0 tp10 -82.81 94.29 7.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.9 -1.125 . . . . 0.0 109.244 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.98 13.54 34.38 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.496 ' CG ' ' HB2' ' A' ' 97' ' ' LYS . 1.8 pt20 -114.92 162.74 22.32 Favored Pre-proline 0 N--CA 1.487 1.383 0 O-C-N 121.345 -1.091 . . . . 0.0 108.683 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 102' ' ' GLY . 6.0 Cg_exo -60.32 -44.11 30.27 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.815 1.677 . . . . 0.0 109.728 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.587 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 56.27 112.75 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 3.7 pt-20 -147.24 132.31 18.26 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.8 -1.412 . . . . 0.0 111.068 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.692 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 2.4 m0 -47.8 126.02 9.66 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.503 ' HE3' ' HB2' ' A' ' 22' ' ' ARG . 7.7 tpp -123.31 105.57 9.96 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.347 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.29 81.39 0.74 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.647 ' O ' ' CB ' ' A' ' 108' ' ' VAL . 6.2 tt -80.99 -80.04 0.15 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.471 -0.768 . . . . 0.0 110.614 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.647 ' CB ' ' O ' ' A' ' 107' ' ' LEU . 54.5 t 115.49 103.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.504 ' CA ' ' OXT' ' A' ' 129' ' ' LEU . . . 41.94 78.77 0.06 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.594 -1.803 . . . . 0.0 108.594 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 1.107 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -39.54 163.66 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.617 -0.931 . . . . 0.0 110.989 -178.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.697 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 1.5 t-20 -139.68 -8.28 1.25 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.406 -0.809 . . . . 0.0 111.412 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 83.66 -25.38 0.14 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.301 -0.875 . . . . 0.0 108.713 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.12 -29.69 61.05 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.658 ' HB3' HD12 ' A' ' 33' ' ' LEU . 9.7 m-20 -94.22 -19.22 20.94 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 1.107 ' CE1' HD21 ' A' ' 110' ' ' LEU . 6.5 m-85 -95.82 148.05 33.95 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.325 -0.859 . . . . 0.0 109.908 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.488 ' CD ' ' O ' ' A' ' 33' ' ' LEU . 1.4 Cg_endo -68.0 142.52 56.9 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.409 2.073 . . . . 0.0 110.061 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 118' ' ' ALA . 2.4 Cg_endo -63.04 -27.97 74.25 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.157 1.905 . . . . 0.0 110.476 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -41.43 -48.56 3.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.414 -0.804 . . . . 0.0 109.383 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.648 ' HB3' HD13 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -96.33 55.17 1.46 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.641 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -62.75 -42.33 77.8 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.764 -0.585 . . . . 0.0 112.027 -179.59 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 11.6 Cg_exo -54.02 -47.94 24.33 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 121.846 1.698 . . . . 0.0 112.615 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.843 HG11 ' CE2' ' A' ' 84' ' ' PHE . 1.5 t -88.64 -38.02 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.704 -1.248 . . . . 0.0 109.62 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.862 ' HA ' HD22 ' A' ' 126' ' ' LEU . 1.1 mp -63.1 -21.0 27.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.544 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -63.64 -31.06 72.12 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -80.32 -40.34 26.92 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.519 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.862 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.09 -21.09 66.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.682 -1.261 . . . . 0.0 107.755 179.366 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 1.9 mtmt -58.1 -36.5 72.98 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -83.23 -20.53 34.4 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.503 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.558 HD13 HD12 ' A' ' 126' ' ' LEU . 1.2 tp . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.627 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' APC . . . . . 1.111 ' C5 ' HG21 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.457 0.646 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.485 ' HD3' ' C ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -160.82 -163.54 1.07 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.474 ' CG ' ' N ' ' A' ' 4' ' ' LEU . 8.6 ttpt -151.82 161.18 43.08 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.035 -1.041 . . . . 0.0 109.26 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.784 HD21 H5'2 ' A' ' 130' ' ' APC . 0.2 OUTLIER -159.0 110.0 2.07 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.548 ' N ' HD13 ' A' ' 4' ' ' LEU . 2.5 mp0 -104.7 169.53 8.4 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.015 -1.053 . . . . 0.0 109.427 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.714 HG22 HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -135.23 122.87 37.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.437 -0.79 . . . . 0.0 108.984 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.975 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -86.2 62.16 7.27 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 36' ' ' PRO . 0.6 OUTLIER -79.15 -77.35 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.717 -179.514 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.717 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 62.99 89.07 0.03 OUTLIER Glycine 0 N--CA 1.48 1.567 0 N-CA-C 106.956 -2.458 . . . . 0.0 106.956 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.112 HG22 ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -55.13 163.93 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.04 HG22 ' CG2' ' A' ' 87' ' ' VAL . 2.0 pt -127.42 71.46 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.301 -177.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.909 ' HB3' HG22 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -77.99 159.78 28.58 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.266 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.07 -18.61 0.04 OUTLIER 'General case' 0 C--O 1.187 -2.19 0 C-N-CA 115.81 -2.356 . . . . 0.0 115.479 -177.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.52 ' HB3' ' CG ' ' A' ' 17' ' ' GLU . 1.4 tm-20 -93.48 -31.67 14.49 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 118.165 -2.834 . . . . 0.0 108.646 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -163.13 -46.51 0.03 OUTLIER 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.483 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 1.1 t-20 -162.05 37.87 0.12 Allowed 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 176.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 105' ' ' MET . 92.3 mt-10 -91.6 94.29 9.34 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 118.003 -1.479 . . . . 0.0 110.831 -177.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.112 ' CD1' HG22 ' A' ' 10' ' ' ILE . 0.6 OUTLIER -96.99 152.36 3.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.544 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.667 ' N ' HD12 ' A' ' 18' ' ' ILE . 13.6 t80 -80.39 45.38 0.76 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.654 HD11 ' C ' ' A' ' 34' ' ' GLU . 5.7 tp -81.09 154.78 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.231 -0.918 . . . . 0.0 111.382 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.535 ' O ' ' O ' ' A' ' 32' ' ' LYS . 1.4 t -67.67 92.98 0.35 Allowed 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.841 ' HD3' HD21 ' A' ' 33' ' ' LEU . 30.3 tpt180 -100.78 83.92 2.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.46 -0.775 . . . . 0.0 110.534 -178.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.765 ' HD2' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 31.69 86.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.826 -0.546 . . . . 0.0 110.129 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -44.7 -52.32 8.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.089 -1.007 . . . . 0.0 109.532 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.62 -161.04 0.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 0.0 109.11 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.76 -27.56 40.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.205 -0.934 . . . . 0.0 109.231 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.765 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . . . 50.76 -175.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 109.787 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.53 25.78 0.23 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.717 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 0.7 OUTLIER -126.45 -41.69 1.86 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.367 -0.833 . . . . 0.0 110.318 -179.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 29' ' ' MET . . . 78.93 0.86 2.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 110.124 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 25.4 p-10 -92.98 9.86 33.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.829 -1.169 . . . . 0.0 108.565 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.535 ' O ' ' O ' ' A' ' 21' ' ' THR . 0.9 OUTLIER -81.22 36.43 0.41 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.565 -0.709 . . . . 0.0 110.653 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.069 HD13 ' CE1' ' A' ' 115' ' ' PHE . 22.3 mt -110.82 88.05 2.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.553 -1.342 . . . . 0.0 109.564 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.654 ' C ' HD11 ' A' ' 20' ' ' ILE . 1.1 tt0 -91.79 -137.38 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.457 -0.777 . . . . 0.0 109.534 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.669 ' HB3' HG21 ' A' ' 8' ' ' VAL . 90.6 m-85 -149.66 130.8 7.23 Favored Pre-proline 0 C--N 1.306 -1.299 0 O-C-N 121.072 -1.017 . . . . 0.0 109.745 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.744 ' O ' HG23 ' A' ' 8' ' ' VAL . 2.1 Cg_endo -56.6 95.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.303 2.002 . . . . 0.0 109.894 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -55.69 -147.04 0.01 OUTLIER Glycine 0 N--CA 1.494 2.528 0 O-C-N 121.319 -0.863 . . . . 0.0 111.205 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . 158.97 -40.29 0.5 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.574 ' HB2' H3A2 ' A' ' 130' ' ' APC . 13.4 tptp 73.75 94.49 0.07 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.146 -0.62 . . . . 0.0 110.596 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.783 HD13 ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -80.92 131.8 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.18 -0.95 . . . . 0.0 108.805 178.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.417 ' HG2' ' N ' ' A' ' 42' ' ' MET . 4.6 pt-20 -171.76 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.963 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.417 ' N ' ' HG2' ' A' ' 41' ' ' GLU . 4.9 mmt -58.7 163.84 3.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -0.913 . . . . 0.0 109.857 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 47.61 -121.73 6.99 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -167.07 24.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.528 -0.984 . . . . 0.0 108.739 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.554 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 30.4 m -146.71 142.87 17.72 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.597 ' HB2' ' CZ2' ' A' ' 85' ' ' TRP . 11.1 Cg_exo -50.58 -17.22 2.75 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 121.412 1.408 . . . . 0.0 109.957 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -75.33 -83.36 0.06 Allowed 'General case' 0 C--O 1.201 -1.483 0 O-C-N 121.081 -1.012 . . . . 0.0 108.938 178.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.529 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 32.9 mt-30 -45.52 -36.66 4.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.37 -1.456 . . . . 0.0 109.776 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.617 ' CB ' HG12 ' A' ' 40' ' ' ILE . . . -62.84 -64.99 0.75 Allowed 'General case' 0 C--N 1.289 -2.056 0 O-C-N 120.964 -1.085 . . . . 0.0 110.26 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.975 HG23 ' HB1' ' A' ' 7' ' ' ALA . 1.9 p -65.05 -48.93 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.048 -1.033 . . . . 0.0 111.018 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.577 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 2.9 p -55.66 -46.48 79.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-O 121.384 0.612 . . . . 0.0 110.109 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.565 ' N ' ' CG1' ' A' ' 51' ' ' VAL . 8.0 mmt180 -72.46 -27.61 62.41 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.591 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 29.9 mm-40 -77.81 -14.18 59.66 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.752 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.8 OUTLIER -80.18 -58.52 3.11 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.493 ' HA ' ' CZ3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -63.16 -50.14 71.56 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.738 -0.601 . . . . 0.0 109.722 179.428 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.585 ' CG ' ' HA ' ' A' ' 53' ' ' GLU . 1.4 pp20? -53.25 -20.12 3.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.994 -1.066 . . . . 0.0 109.746 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.483 ' OE1' ' HA2' ' A' ' 96' ' ' GLY . 1.6 mt-10 -80.2 -91.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 0.0 109.861 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.866 HG21 ' HA ' ' A' ' 95' ' ' TRP . 41.7 t -79.96 -79.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.436 -0.79 . . . . 0.0 110.016 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.02 27.04 0.17 Allowed Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.212 -1.47 . . . . 0.0 111.448 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.031 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -81.75 -145.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.607 -1.525 . . . . 0.0 107.948 178.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.635 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.3 m -145.23 -70.43 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 120.512 -1.367 . . . . 0.0 109.943 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.635 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 8.8 Cg_endo -66.71 -169.42 0.18 Allowed 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 121.137 1.225 . . . . 0.0 109.636 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.628 ' HB2' HG21 ' A' ' 87' ' ' VAL . 0.8 OUTLIER 134.09 -20.27 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 -179.112 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.551 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.1 OUTLIER 52.12 -164.59 0.07 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -179.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -177.22 144.63 0.43 Allowed 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 117.636 -1.626 . . . . 0.0 111.046 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -145.07 143.48 30.46 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.624 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -74.61 -65.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.856 -1.152 . . . . 0.0 110.216 -178.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.624 ' HB3' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER 81.89 -50.74 0.24 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.538 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER 164.15 179.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.135 -0.978 . . . . 0.0 109.595 179.306 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.18 142.82 13.37 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.313 -0.867 . . . . 0.0 109.109 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.839 HD21 HD22 ' A' ' 119' ' ' ASN . 0.5 OUTLIER -96.93 -171.71 2.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.997 -1.064 . . . . 0.0 109.789 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HG3' HG23 ' A' ' 81' ' ' THR . 5.3 tt0 -160.24 95.48 1.14 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.5 123.15 27.29 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.434 ' HG3' ' CD2' ' A' ' 79' ' ' HIS . 2.1 tt0 -96.87 143.23 27.96 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.537 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.556 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 5.5 m-85 -119.39 169.76 7.74 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 7.6 Cg_exo -49.26 -31.86 23.58 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.441 1.427 . . . . 0.0 109.307 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -160.72 41.04 0.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.212 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.546 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -146.16 95.76 2.67 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.597 -0.689 . . . . 0.0 109.956 -178.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.753 ' C ' HD12 ' A' ' 80' ' ' ILE . 14.6 m80 -82.64 113.02 20.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.015 -1.053 . . . . 0.0 108.781 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.753 HD12 ' C ' ' A' ' 79' ' ' HIS . 1.3 mp -110.87 165.09 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -0.987 . . . . 0.0 110.161 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.559 ' N ' ' CG2' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -153.52 149.37 27.62 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.726 HD23 HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -137.0 77.47 1.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.903 -1.123 . . . . 0.0 109.909 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.645 ' CD1' HG21 ' A' ' 40' ' ' ILE . 81.8 m95 -46.71 116.34 1.3 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.183 -0.948 . . . . 0.0 109.658 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.812 ' CE2' HG11 ' A' ' 122' ' ' VAL . 26.0 m-85 -92.37 71.21 5.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.155 -0.966 . . . . 0.0 109.931 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.663 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 30.9 m95 -75.14 91.8 2.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.843 -1.161 . . . . 0.0 109.06 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.56 HD11 ' CG1' ' A' ' 10' ' ' ILE . 3.3 mm? -73.02 127.29 32.14 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.774 -1.204 . . . . 0.0 110.281 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.04 ' CG2' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -115.7 172.79 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 43.8 mt-10 -157.48 32.68 0.27 Allowed 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 117.835 -1.546 . . . . 0.0 113.392 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.593 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -160.21 55.94 0.35 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 119.872 -1.767 . . . . 0.0 111.154 178.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.539 ' C ' ' CD1' ' A' ' 90' ' ' TRP . 5.1 p90 -78.94 159.09 27.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.19 -1.569 . . . . 0.0 109.488 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -88.43 138.21 31.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 91' ' ' GLU . . . 32.79 -79.72 0.0 OUTLIER Glycine 0 N--CA 1.501 3.025 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 1.031 ' O ' HG21 ' A' ' 60' ' ' ILE . 2.8 mm-40 -94.49 144.79 28.53 Favored Pre-proline 0 C--N 1.303 -1.424 0 O-C-N 121.164 -1.198 . . . . 0.0 109.645 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.582 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 14.0 Cg_endo -79.58 -161.62 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.18 1.92 . . . . 0.0 109.651 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.866 ' HA ' HG21 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -176.21 116.72 0.13 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.016 0.912 . . . . 0.0 109.946 177.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.483 ' HA2' ' OE1' ' A' ' 57' ' ' GLU . . . 167.61 -34.59 0.21 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.581 ' CA ' ' HG2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -39.57 100.51 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.539 -0.977 . . . . 0.0 109.849 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.564 ' CG ' ' O2G' ' A' ' 130' ' ' APC . 18.2 tp10 -80.15 105.48 11.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.311 -0.868 . . . . 0.0 108.822 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 50.53 30.77 20.46 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.581 ' HG2' ' CA ' ' A' ' 97' ' ' LYS . 1.7 pt20 -134.26 165.26 38.05 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.544 -0.974 . . . . 0.0 109.337 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 100' ' ' GLN . 3.5 Cg_exo -63.47 -45.61 11.28 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.206 1.938 . . . . 0.0 110.484 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.608 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 60.59 114.42 0.01 OUTLIER Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.625 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 1.8 pt-20 -152.25 134.16 14.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.086 -1.243 . . . . 0.0 110.079 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.522 ' CD1' ' CZ2' ' A' ' 90' ' ' TRP . 1.7 m-90 -46.15 134.45 8.45 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.624 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -125.97 116.15 21.03 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.135 -0.978 . . . . 0.0 109.031 -179.04 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.563 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -79.52 43.69 0.57 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.428 -0.795 . . . . 0.0 110.858 -178.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.765 HD21 ' HA ' ' A' ' 110' ' ' LEU . 9.4 tt -67.01 161.9 23.29 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.723 ' N ' HD23 ' A' ' 107' ' ' LEU . 24.5 t -118.78 114.69 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.048 -1.033 . . . . 0.0 108.935 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 43.18 84.45 0.01 OUTLIER Glycine 0 N--CA 1.493 2.436 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.983 HD21 ' CE1' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -35.55 157.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.764 0.793 . . . . 0.0 111.33 -178.137 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.737 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 3.2 t-20 -138.45 -5.04 1.61 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.687 -0.633 . . . . 0.0 111.346 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.737 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 81.99 -34.93 0.1 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.99 -26.59 4.42 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.452 -0.78 . . . . 0.0 109.266 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 1.013 ' HB3' HD12 ' A' ' 33' ' ' LEU . 62.9 m-20 -104.25 -20.01 13.92 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.753 -0.592 . . . . 0.0 109.503 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 1.069 ' CE1' HD13 ' A' ' 33' ' ' LEU . 9.4 m-85 -98.8 148.36 34.46 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.226 -0.921 . . . . 0.0 109.101 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.566 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 6.1 Cg_exo -62.03 132.27 38.59 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.459 2.106 . . . . 0.0 110.448 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.93 -18.5 42.84 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.948 1.765 . . . . 0.0 110.201 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -46.52 -52.48 13.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.235 -0.916 . . . . 0.0 108.879 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.839 HD22 HD21 ' A' ' 71' ' ' LEU . 10.9 m120 -86.56 46.68 1.38 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.647 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 2.2 mt-10 -57.66 -44.31 99.4 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.667 -0.646 . . . . 0.0 112.485 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 7.1 Cg_exo -53.35 -42.7 63.39 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.877 1.718 . . . . 0.0 113.15 -177.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.812 HG11 ' CE2' ' A' ' 84' ' ' PHE . 1.8 t -96.98 -32.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.458 -1.401 . . . . 0.0 110.06 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.76 ' HA ' HD22 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -62.92 -25.85 39.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.571 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -57.59 -33.36 68.12 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.165 0.983 . . . . 0.0 108.419 178.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 128' ' ' ARG . 68.1 mmtt -80.18 -40.55 27.03 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.704 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.8 ' N ' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -66.95 -16.31 64.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.647 -1.283 . . . . 0.0 107.884 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 12.0 mtmt -61.68 -35.08 76.96 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 177.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 125' ' ' LYS . 1.2 mtp180 -81.91 -19.92 39.82 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.281 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.757 HD23 ' NH1' ' A' ' 12' ' ' ARG . 1.2 tp . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 118.111 -0.947 . . . . 0.0 109.447 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' APC . . . . . 0.784 H5'2 HD21 ' A' ' 4' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' CON . . . . . 0.549 ' N3 ' ' O2A' ' A' ' 130' ' ' APC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.481 ' O ' ' O ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.581 ' HD3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -51.93 -172.2 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.543 -0.723 . . . . 0.0 109.456 -179.436 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.581 ' N ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -150.68 154.05 36.72 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.373 -0.83 . . . . 0.0 108.951 179.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 1.095 HD13 ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -142.88 119.42 11.02 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.043 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.861 ' N ' HD22 ' A' ' 4' ' ' LEU . 8.4 mp0 -101.57 160.92 14.03 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.727 -1.233 . . . . 0.0 107.844 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.892 HG22 HG12 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -123.1 117.76 52.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 C-N-CA 119.351 -0.939 . . . . 0.0 109.288 -179.136 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.912 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -87.44 58.56 5.03 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.892 HG12 HG22 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -78.02 -73.72 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.506 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.756 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 60.01 82.24 0.07 OUTLIER Glycine 0 N--CA 1.48 1.603 0 N-CA-C 107.584 -2.207 . . . . 0.0 107.584 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.639 HD12 HD11 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -45.97 160.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.052 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.089 HG22 ' CG2' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -120.26 95.32 3.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 C-N-CA 119.57 -0.852 . . . . 0.0 108.915 -179.234 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 1.096 ' HG2' HG22 ' A' ' 18' ' ' ILE . 20.3 mtm180 -74.35 173.19 10.59 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.62 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -150.98 -64.41 0.19 Allowed 'General case' 0 C--O 1.188 -2.142 0 C-N-CA 117.18 -1.808 . . . . 0.0 114.222 -176.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 7.7 tp10 -91.81 -32.73 15.25 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 118.957 -2.34 . . . . 0.0 112.014 -175.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.476 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 5.7 t-20 -161.15 -43.96 0.04 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.584 ' HB3' ' CD2' ' A' ' 107' ' ' LEU . 7.5 m120 -157.07 35.35 0.29 Allowed 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.549 ' HG2' ' CB ' ' A' ' 106' ' ' SER . 31.5 mt-10 -88.52 83.92 6.79 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 117.778 -1.569 . . . . 0.0 109.629 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.096 HG22 ' HG2' ' A' ' 12' ' ' ARG . 3.0 pt -79.82 149.09 5.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.645 ' CE2' ' HG2' ' A' ' 94' ' ' PRO . 7.0 t80 -81.57 43.68 0.76 Allowed 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.636 HG21 HD22 ' A' ' 33' ' ' LEU . 6.7 tp -83.33 159.9 3.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.93 0.871 . . . . 0.0 110.806 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.754 HG23 ' O ' ' A' ' 21' ' ' THR . 7.4 t -70.32 98.6 1.42 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 176.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.676 ' HD3' HD21 ' A' ' 33' ' ' LEU . 31.6 tpt180 -99.61 80.39 2.36 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 110.976 -177.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.539 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 32.68 83.63 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.304 0.573 . . . . 0.0 110.137 178.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -43.51 -49.46 7.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.193 -0.942 . . . . 0.0 110.087 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -80.35 178.65 8.15 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.179 -0.951 . . . . 0.0 108.763 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.444 ' O ' ' O ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -57.96 -30.81 66.3 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.171 -1.012 . . . . 0.0 108.894 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.539 ' CB ' ' HD2' ' A' ' 23' ' ' ARG . . . 58.07 159.12 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.325 -0.86 . . . . 0.0 109.537 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -131.57 25.73 4.75 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.67 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 11.2 mtm -129.08 -95.2 0.41 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.497 -0.752 . . . . 0.0 109.242 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.67 ' CB ' ' O ' ' A' ' 29' ' ' MET . . . 137.71 -4.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.61 14.41 5.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.125 -0.984 . . . . 0.0 108.834 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.9 tmtt? -80.98 28.77 0.35 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.468 -0.77 . . . . 0.0 110.708 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.71 HD12 ' HB3' ' A' ' 114' ' ' ASP . 16.6 mt -107.02 83.36 1.82 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.453 -1.405 . . . . 0.0 110.057 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.61 ' C ' HD11 ' A' ' 20' ' ' ILE . 1.7 tt0 -85.46 -143.04 0.09 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.64 ' HB3' HG21 ' A' ' 8' ' ' VAL . 22.2 m-85 -142.66 127.55 10.05 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.693 -1.255 . . . . 0.0 109.701 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.834 ' O ' HG23 ' A' ' 8' ' ' VAL . 5.0 Cg_endo -60.81 95.47 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.813 1.676 . . . . 0.0 109.225 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . -54.26 -149.28 0.01 OUTLIER Glycine 0 N--CA 1.493 2.5 0 CA-C-O 122.039 0.799 . . . . 0.0 111.548 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.533 ' N ' ' CG ' ' A' ' 98' ' ' GLU . . . 159.9 -37.1 0.46 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.643 ' HE2' HD23 ' A' ' 4' ' ' LEU . 20.9 tptp 72.52 98.3 0.07 Allowed 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.172 0.51 . . . . 0.0 110.875 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.982 HD13 ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -81.59 130.21 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.306 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -170.51 -32.3 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.428 -0.795 . . . . 0.0 109.76 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.419 ' HB2' ' HA ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -53.73 164.26 0.58 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.907 . . . . 0.0 109.378 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' MET . . . 45.08 -122.05 4.9 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -165.89 24.05 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.43 -1.041 . . . . 0.0 108.997 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.654 HG22 ' H ' ' A' ' 47' ' ' GLU . 88.4 m -144.19 141.93 19.07 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.356 -0.84 . . . . 0.0 108.845 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 45' ' ' THR . 7.5 Cg_exo -48.89 -18.58 1.74 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.705 1.603 . . . . 0.0 109.804 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.654 ' H ' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -76.0 -87.57 0.04 OUTLIER 'General case' 0 C--O 1.201 -1.449 0 O-C-N 121.214 -0.929 . . . . 0.0 108.799 178.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.55 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 22.7 mt-30 -42.72 -34.81 0.97 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.744 -1.223 . . . . 0.0 109.977 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.599 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . -65.06 -63.87 1.0 Allowed 'General case' 0 C--N 1.29 -1.98 0 O-C-N 121.299 -0.875 . . . . 0.0 109.83 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.806 HG23 ' HB1' ' A' ' 7' ' ' ALA . 1.9 p -65.59 -49.37 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.962 -1.086 . . . . 0.0 110.864 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.568 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 3.8 p -56.55 -43.9 79.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.641 -0.662 . . . . 0.0 110.283 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 27.4 mmm180 -73.83 -28.46 61.62 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.599 ' CG ' ' O ' ' A' ' 49' ' ' ALA . 25.0 mm-40 -76.69 -15.2 59.86 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.018 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -79.85 -55.51 4.93 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.68 0.752 . . . . 0.0 109.297 -179.732 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.635 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -68.71 -41.21 79.39 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.819 -0.551 . . . . 0.0 110.657 -179.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.575 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.9 OUTLIER -59.12 -20.81 56.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.006 -1.059 . . . . 0.0 110.73 -178.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 9.9 mm-40 -80.1 -91.07 0.05 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.812 -1.18 . . . . 0.0 110.445 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.611 ' HB ' ' CB ' ' A' ' 95' ' ' TRP . 94.7 t -77.49 -80.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.37 -0.832 . . . . 0.0 110.203 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.76 32.76 0.1 Allowed Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.178 -1.487 . . . . 0.0 111.678 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.063 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.3 pt -89.44 -137.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.552 -1.558 . . . . 0.0 108.305 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.662 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.8 m -154.32 -71.57 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.333 -1.479 . . . . 0.0 111.166 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.662 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 3.6 Cg_endo -64.09 -175.34 0.3 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 120.965 1.11 . . . . 0.0 110.315 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.705 ' HB2' HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 151.79 -22.04 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.748 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.593 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 1.0 OUTLIER 48.61 50.53 16.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.479 -0.763 . . . . 0.0 109.748 179.026 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.587 ' HB3' ' NE2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -48.64 149.56 1.67 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.808 0.813 . . . . 0.0 110.68 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 86' ' ' LEU . 3.1 m -153.63 133.58 13.19 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.627 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -56.76 -71.4 0.1 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.856 -1.152 . . . . 0.0 110.482 -179.044 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.818 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 84.78 -52.19 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.58 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 0.8 OUTLIER 154.88 138.77 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.151 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.546 ' HA ' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -128.76 -175.17 3.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.972 . . . . 0.0 109.893 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.82 HD11 ' HB2' ' A' ' 82' ' ' LEU . 0.9 OUTLIER -125.16 -169.53 2.01 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.669 0.747 . . . . 0.0 109.647 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.604 ' HG3' HG23 ' A' ' 81' ' ' THR . 4.9 tt0 -156.37 83.12 0.98 Allowed 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.78 106.56 10.87 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.51 -170.17 2.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.348 -0.845 . . . . 0.0 109.471 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.592 ' HB2' ' CB ' ' A' ' 78' ' ' ARG . 5.6 m-85 -160.33 169.46 10.13 Favored Pre-proline 0 C--N 1.297 -1.681 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.351 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 75' ' ' PHE . 6.4 Cg_exo -50.73 -28.85 24.04 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.974 1.783 . . . . 0.0 109.607 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.64 42.07 0.14 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.592 ' CB ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -151.52 92.88 1.81 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.841 -0.537 . . . . 0.0 109.725 -178.383 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.667 ' C ' HD12 ' A' ' 80' ' ' ILE . 24.2 m170 -82.95 104.82 13.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.966 -1.084 . . . . 0.0 109.067 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.083 HG21 ' C6 ' ' A' ' 130' ' ' APC . 0.6 OUTLIER -115.04 138.08 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.005 -1.059 . . . . 0.0 110.284 -179.276 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.604 HG23 ' HG3' ' A' ' 72' ' ' GLU . 1.0 OUTLIER -112.9 179.54 3.94 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.34 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.984 HD23 ' CE1' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -160.32 72.53 0.48 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.658 -1.276 . . . . 0.0 110.394 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.629 ' CD1' HG21 ' A' ' 40' ' ' ILE . 79.3 m95 -51.74 131.12 30.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 108.956 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.984 ' CE1' HD23 ' A' ' 82' ' ' LEU . 16.0 m-85 -110.12 71.92 0.77 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.054 -1.029 . . . . 0.0 109.132 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.638 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 38.2 m95 -70.75 85.11 0.65 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.315 -0.865 . . . . 0.0 109.588 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.818 HD23 ' CD2' ' A' ' 68' ' ' PHE . 3.6 mm? -70.77 124.22 23.79 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.749 -1.181 . . . . 0.0 109.059 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.089 ' CG2' HG22 ' A' ' 11' ' ' ILE . 1.1 m -113.72 159.86 13.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 87' ' ' VAL . 17.1 mp0 -148.44 36.56 0.81 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 118.095 -1.442 . . . . 0.0 112.924 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.593 ' HG2' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -161.06 31.98 0.14 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 119.881 -1.762 . . . . 0.0 111.532 178.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.767 ' HB2' HD13 ' A' ' 60' ' ' ILE . 2.8 p90 -54.79 165.5 0.61 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.16 -1.587 . . . . 0.0 108.274 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.567 ' HG2' ' HB ' ' A' ' 60' ' ' ILE . 8.1 pt-20 -77.35 -123.85 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.994 -1.066 . . . . 0.0 110.408 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.454 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -64.83 -50.46 58.24 Favored Glycine 0 N--CA 1.489 2.217 0 O-C-N 120.738 -1.226 . . . . 0.0 110.075 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 1.063 ' O ' HG21 ' A' ' 60' ' ' ILE . 3.1 mt-10 -123.29 156.56 63.35 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.018 -1.283 . . . . 0.0 110.278 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.691 ' HB3' HD12 ' A' ' 11' ' ' ILE . 8.4 Cg_endo -73.86 -160.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.731 2.288 . . . . 0.0 110.086 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 1.018 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER 176.7 48.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 111.049 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . -132.69 2.89 4.95 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.169 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -80.08 94.91 6.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.383 -1.069 . . . . 0.0 111.239 -179.251 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.533 ' CG ' ' N ' ' A' ' 38' ' ' GLY . 2.8 mm-40 -42.02 -88.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.913 . . . . 0.0 108.729 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.97 1.68 27.15 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.564 ' HG3' ' HD2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER -73.89 146.98 85.92 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.725 -0.868 . . . . 0.0 109.366 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.564 ' HD2' ' HG3' ' A' ' 100' ' ' GLN . 3.0 Cg_exo -56.39 -29.46 77.46 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 N-CA-C 107.897 -1.616 . . . . 0.0 107.897 178.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.627 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 54.76 110.73 0.01 OUTLIER Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.585 ' HA ' ' CE1' ' A' ' 19' ' ' PHE . 2.9 pt-20 -151.83 127.95 10.45 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.07 -1.253 . . . . 0.0 109.19 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.449 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -41.65 141.34 0.8 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.513 ' HG3' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -139.15 96.05 3.04 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.363 -0.836 . . . . 0.0 108.961 -179.455 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.549 ' CB ' ' HG2' ' A' ' 17' ' ' GLU . 10.4 t -78.51 72.17 5.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.46 -0.775 . . . . 0.0 109.399 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.782 HD23 ' N ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -80.03 -10.92 59.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.916 -1.115 . . . . 0.0 109.903 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.782 ' N ' HD23 ' A' ' 107' ' ' LEU . 2.5 t 64.93 122.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.523 ' C ' ' O ' ' A' ' 108' ' ' VAL . . . 33.26 83.03 0.01 OUTLIER Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.966 HD21 ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -41.09 165.07 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.772 -0.84 . . . . 0.0 109.866 -178.068 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.713 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 2.0 t-20 -144.3 -4.94 0.78 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.804 -1.185 . . . . 0.0 111.87 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 81.23 -26.29 0.15 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.961 -1.087 . . . . 0.0 108.56 -177.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -57.24 -40.47 77.64 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.71 ' HB3' HD12 ' A' ' 33' ' ' LEU . 59.8 m-20 -86.67 -13.12 46.44 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.966 ' CD1' HD21 ' A' ' 110' ' ' LEU . 5.1 m-85 -101.3 146.26 31.87 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 110.317 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 5.9 Cg_exo -60.92 141.66 95.24 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.44 2.094 . . . . 0.0 110.31 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.478 ' O ' ' OE1' ' A' ' 120' ' ' GLU . 1.6 Cg_endo -64.36 -8.1 15.94 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.098 1.866 . . . . 0.0 110.626 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.27 -53.45 52.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.09 -1.006 . . . . 0.0 110.174 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.715 ' OD1' HD21 ' A' ' 71' ' ' LEU . 6.7 m-80 -87.85 42.87 1.08 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 109.764 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.691 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -57.66 -44.3 99.39 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 120.981 -1.074 . . . . 0.0 111.734 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.691 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 20.8 Cg_exo -47.15 -44.92 22.84 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.825 1.683 . . . . 0.0 113.043 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.691 HG21 ' CD1' ' A' ' 84' ' ' PHE . 1.7 t -96.37 -35.94 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.306 -1.496 . . . . 0.0 109.215 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.859 ' HA ' HD22 ' A' ' 126' ' ' LEU . 2.1 mt -62.54 -17.95 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.592 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . . . -63.27 -35.87 81.79 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.0 mmtm -74.21 -42.21 60.14 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.668 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.859 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -65.46 -20.61 66.43 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.783 -1.198 . . . . 0.0 108.224 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.592 ' HG3' ' HA ' ' A' ' 124' ' ' ALA . 11.3 mtmt -57.98 -36.75 73.05 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -23.66 41.35 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.584 HD13 HD12 ' A' ' 126' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.539 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' APC . . . . . 1.083 ' C6 ' HG21 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' CON . . . . . 0.606 ' N3 ' ' O2A' ' A' ' 130' ' ' APC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.565 ' HD3' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -54.86 -176.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.571 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.569 ' HG3' ' N ' ' A' ' 4' ' ' LEU . 1.7 tttt -160.22 143.06 13.48 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.406 -0.809 . . . . 0.0 109.352 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 1.087 ' CD1' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -139.54 110.0 6.62 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.785 ' N ' HD22 ' A' ' 4' ' ' LEU . 4.2 mp0 -96.93 162.47 13.38 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.109 -0.994 . . . . 0.0 109.804 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.639 HD11 ' H8 ' ' A' ' 130' ' ' APC . 0.1 OUTLIER -128.92 108.99 18.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.04 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -84.74 64.71 8.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.471 -0.768 . . . . 0.0 109.113 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.741 HG13 ' H ' ' A' ' 9' ' ' GLY . 1.3 p -79.52 -71.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 110.405 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.741 ' H ' HG13 ' A' ' 8' ' ' VAL . . . 60.04 74.04 0.41 Allowed Glycine 0 C--N 1.298 -1.554 0 N-CA-C 106.788 -2.525 . . . . 0.0 106.788 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.679 ' CG1' HD11 ' A' ' 86' ' ' LEU . 0.6 OUTLIER -42.27 142.75 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -178.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.647 HD11 ' CB ' ' A' ' 19' ' ' PHE . 2.7 pt -98.14 97.59 6.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.169 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.956 ' HG2' HG23 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -77.44 171.47 14.83 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.608 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 6.1 t30 -148.92 -64.5 0.23 Allowed 'General case' 0 C--O 1.188 -2.134 0 C-N-CA 116.86 -1.936 . . . . 0.0 114.74 -177.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.549 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 3.0 tp10 -91.86 -28.91 17.01 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 118.775 -2.453 . . . . 0.0 111.592 -175.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -162.79 -43.03 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.735 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -160.06 31.31 0.18 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 177.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 105' ' ' MET . 36.4 mt-10 -83.01 89.31 6.88 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 117.517 -1.673 . . . . 0.0 108.025 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.956 HG23 ' HG2' ' A' ' 12' ' ' ARG . 1.0 OUTLIER -85.01 150.13 4.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-O 121.644 0.735 . . . . 0.0 110.812 -178.235 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.647 ' CB ' HD11 ' A' ' 11' ' ' ILE . 14.0 t80 -82.66 43.72 0.85 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.639 HD11 ' N ' ' A' ' 34' ' ' GLU . 6.6 tp -80.78 157.39 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 121.37 -0.831 . . . . 0.0 110.386 -178.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 21' ' ' THR . 2.0 t -74.01 86.0 1.8 Allowed 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.609 ' HD2' HD21 ' A' ' 33' ' ' LEU . 15.6 tpt180 -82.55 84.28 7.29 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.205 -0.934 . . . . 0.0 109.922 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.532 ' CB ' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 30.21 64.69 0.15 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.37 0.605 . . . . 0.0 110.359 -179.625 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' ARG . . . -45.81 -54.32 8.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.359 -0.838 . . . . 0.0 109.233 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.73 -177.33 3.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -0.892 . . . . 0.0 108.872 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -76.15 86.58 3.01 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.013 -1.054 . . . . 0.0 109.337 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.532 ' HB2' ' CB ' ' A' ' 23' ' ' ARG . . . -68.19 -27.97 66.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.861 . . . . 0.0 109.805 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.592 ' O ' ' CG ' ' A' ' 28' ' ' HIS . 72.7 t60 49.02 24.71 0.93 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -177.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -152.19 -166.65 2.54 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.523 ' O ' ' OD1' ' A' ' 31' ' ' ASN . . . -137.44 -153.09 0.47 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.523 ' OD1' ' O ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER 63.8 2.79 1.41 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.218 -0.926 . . . . 0.0 109.504 -179.033 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.59 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -83.47 50.43 1.78 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.196 -0.94 . . . . 0.0 110.316 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.728 HD12 ' HB3' ' A' ' 114' ' ' ASP . 12.7 mt -128.74 85.77 2.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.975 -1.078 . . . . 0.0 108.197 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.639 ' N ' HD11 ' A' ' 20' ' ' ILE . 21.8 mt-10 -91.2 -123.52 0.07 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.176 -0.952 . . . . 0.0 110.842 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.707 ' CB ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -160.49 124.0 1.95 Allowed Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 120.579 -1.325 . . . . 0.0 109.832 -178.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.62 ' CB ' ' HA ' ' A' ' 97' ' ' LYS . 19.7 Cg_endo -76.7 95.81 1.07 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.415 2.077 . . . . 0.0 110.575 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' CA ' ' HA ' ' A' ' 8' ' ' VAL . . . -145.62 123.4 1.87 Allowed Glycine 0 N--CA 1.499 2.843 0 O-C-N 120.654 -1.279 . . . . 0.0 110.166 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.588 ' HA3' ' OE1' ' A' ' 98' ' ' GLU . . . -103.77 74.22 0.27 Allowed Glycine 0 N--CA 1.491 2.339 0 O-C-N 121.172 -1.193 . . . . 0.0 111.942 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.695 ' CD ' HD23 ' A' ' 4' ' ' LEU . 5.4 tptt 42.07 121.02 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 176.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.04 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -81.65 129.96 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.495 ' OE1' ' HG2' ' A' ' 39' ' ' LYS . 3.1 pt-20 -171.71 -20.9 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 118.534 -1.267 . . . . 0.0 111.43 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.446 ' HG3' ' HG2' ' A' ' 53' ' ' GLU . 2.5 mmt -39.42 -74.28 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.096 -1.003 . . . . 0.0 109.655 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.57 -132.71 7.38 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -134.34 3.1 3.33 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.625 -0.926 . . . . 0.0 109.101 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.544 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 22.5 m -118.64 142.53 31.78 Favored Pre-proline 0 N--CA 1.486 1.338 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 8.2 Cg_exo -52.76 -17.49 7.35 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.395 1.397 . . . . 0.0 109.653 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.498 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -79.48 -87.97 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.209 -0.932 . . . . 0.0 108.821 178.556 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.571 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 10.6 mt-30 -42.66 -34.29 0.86 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.815 -1.178 . . . . 0.0 109.327 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.643 ' HB1' HG12 ' A' ' 40' ' ' ILE . . . -63.88 -62.46 1.63 Allowed 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.069 -1.019 . . . . 0.0 110.119 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.808 HG23 ' HB1' ' A' ' 7' ' ' ALA . 2.1 p -69.3 -49.17 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.186 -0.946 . . . . 0.0 110.763 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.558 ' N ' ' CG1' ' A' ' 50' ' ' VAL . 4.2 p -55.32 -44.22 74.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.551 -0.718 . . . . 0.0 110.264 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.571 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -72.35 -36.88 68.9 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 179.375 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.598 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 11.6 mm-40 -69.0 -13.74 62.63 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.847 HD12 ' CD1' ' A' ' 95' ' ' TRP . 0.8 OUTLIER -80.37 -61.39 1.99 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.563 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -58.13 -50.26 74.1 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.747 -0.596 . . . . 0.0 109.891 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.598 ' HG2' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -49.45 -21.57 0.96 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.062 -1.024 . . . . 0.0 110.04 -178.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' CD ' ' O ' ' A' ' 53' ' ' GLU . 2.8 mt-10 -79.98 -95.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.928 -1.107 . . . . 0.0 109.622 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.612 ' CG2' ' HA ' ' A' ' 95' ' ' TRP . 45.4 t -80.12 -78.48 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 110.184 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.06 31.84 0.13 Allowed Glycine 0 N--CA 1.493 2.434 0 C-N-CA 118.626 -1.75 . . . . 0.0 112.476 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.137 HG21 ' O ' ' A' ' 93' ' ' GLU . 1.2 pp -87.13 -153.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 120.372 -1.664 . . . . 0.0 107.639 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.653 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 1.8 m -135.95 -70.93 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.389 -1.444 . . . . 0.0 110.584 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.653 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 5.8 Cg_endo -63.04 -170.61 0.1 Allowed 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 121.433 1.422 . . . . 0.0 110.719 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.577 ' NE2' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 143.0 -24.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.555 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 0.3 OUTLIER 44.54 71.03 0.28 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.423 -0.798 . . . . 0.0 109.312 178.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.447 ' HB3' ' NE2' ' A' ' 63' ' ' GLN . 8.0 p90 -67.26 141.98 57.06 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.342 -0.849 . . . . 0.0 109.833 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -132.42 135.85 46.36 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.562 ' O ' ' O ' ' A' ' 84' ' ' PHE . 1.3 tm? -57.53 -64.94 0.72 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.977 -1.077 . . . . 0.0 109.36 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.825 ' CD2' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER 80.66 -50.01 0.31 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.589 ' CB ' ' O ' ' A' ' 68' ' ' PHE . 27.1 tt0 150.16 142.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HD2' ' CE3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -131.35 178.07 7.0 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 110.541 -178.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.839 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -127.47 166.34 18.13 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.725 0.774 . . . . 0.0 109.887 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -141.0 91.4 2.4 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.83 113.4 16.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.426 ' CG ' ' CD2' ' A' ' 79' ' ' HIS . 2.8 tt0 -91.72 146.79 23.49 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.576 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -133.51 173.02 6.35 Favored Pre-proline 0 C--N 1.296 -1.722 0 O-C-N 121.272 -0.893 . . . . 0.0 108.731 -179.585 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.576 ' HD2' ' CB ' ' A' ' 75' ' ' PHE . 7.3 Cg_exo -47.93 -40.5 32.84 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.818 1.678 . . . . 0.0 109.742 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -151.63 45.75 0.78 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HB2' ' CB ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -148.77 93.06 2.07 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.714 -0.616 . . . . 0.0 109.565 -178.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.426 ' CD2' ' CG ' ' A' ' 74' ' ' GLU . 22.7 m80 -91.87 73.36 5.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.137 -0.977 . . . . 0.0 108.74 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.087 HG23 ' CD1' ' A' ' 4' ' ' LEU . 3.1 mm -84.52 154.32 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.995 -1.066 . . . . 0.0 110.486 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.468 ' HB ' ' CG ' ' A' ' 5' ' ' GLN . 3.2 m -136.51 154.45 50.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.619 HD22 ' ND2' ' A' ' 119' ' ' ASN . 0.2 OUTLIER -139.77 75.53 1.52 Allowed 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.74 -1.225 . . . . 0.0 110.021 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.593 ' CD1' HG21 ' A' ' 40' ' ' ILE . 89.4 m95 -48.46 124.1 7.6 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 118.6 -1.24 . . . . 0.0 108.611 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.617 ' CD1' ' O ' ' A' ' 82' ' ' LEU . 40.3 m-85 -102.28 71.77 1.25 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.996 -1.065 . . . . 0.0 110.32 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.676 ' N ' ' HA2' ' A' ' 9' ' ' GLY . 76.7 m95 -75.88 85.52 2.83 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.757 -1.214 . . . . 0.0 108.994 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.825 HD23 ' CD2' ' A' ' 68' ' ' PHE . 2.1 mm? -72.58 123.11 22.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.509 -1.369 . . . . 0.0 108.779 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.577 HG11 ' NE2' ' A' ' 63' ' ' GLN . 0.9 OUTLIER -102.76 176.7 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.542 ' CG ' ' O ' ' A' ' 87' ' ' VAL . 41.3 mt-10 -157.1 16.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.654 -1.218 . . . . 0.0 112.113 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.612 ' O ' ' CG ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -159.75 64.39 0.36 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.146 -1.596 . . . . 0.0 111.451 179.131 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.656 ' CH2' ' CD1' ' A' ' 104' ' ' TRP . 2.0 p90 -80.25 168.56 18.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 119.951 -1.718 . . . . 0.0 108.382 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.634 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -89.7 113.95 25.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.077 -1.014 . . . . 0.0 109.05 179.188 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 44.21 -80.87 0.0 OUTLIER Glycine 0 N--CA 1.501 2.984 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 1.137 ' O ' HG21 ' A' ' 60' ' ' ILE . 4.8 mt-10 -82.52 145.7 51.91 Favored Pre-proline 0 C--N 1.298 -1.638 0 O-C-N 120.881 -1.364 . . . . 0.0 109.941 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.627 ' HG2' ' CZ ' ' A' ' 19' ' ' PHE . 11.7 Cg_endo -79.17 -167.25 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.451 2.101 . . . . 0.0 108.511 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.847 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -179.12 34.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.728 -1.233 . . . . 0.0 112.009 178.235 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . -121.36 1.7 11.41 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 178.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.62 ' HA ' ' CB ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -80.83 127.22 32.28 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.446 -1.032 . . . . 0.0 111.863 -179.014 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.588 ' OE1' ' HA3' ' A' ' 38' ' ' GLY . 32.8 mm-40 -81.84 -135.29 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.13 -19.85 47.38 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.444 ' HG2' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -55.21 148.96 28.23 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.866 -0.785 . . . . 0.0 109.84 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 21' ' ' THR . 2.2 Cg_endo -65.28 -37.73 30.05 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.89 1.727 . . . . 0.0 108.418 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.634 ' O ' ' CZ ' ' A' ' 19' ' ' PHE . . . 58.09 115.91 0.01 OUTLIER Glycine 0 N--CA 1.481 1.653 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 20' ' ' ILE . 18.9 pt-20 -150.4 130.0 13.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.038 -1.272 . . . . 0.0 110.174 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.656 ' CD1' ' CH2' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -46.65 131.96 11.18 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.563 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -120.95 123.42 42.42 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.14 -0.975 . . . . 0.0 109.338 -178.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.99 46.87 1.15 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.334 -0.854 . . . . 0.0 108.873 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.997 HD22 ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -75.07 -28.95 60.54 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.916 ' N ' HD13 ' A' ' 107' ' ' LEU . 49.0 t 55.91 123.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.713 -0.617 . . . . 0.0 110.495 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.54 ' O ' ' O ' ' A' ' 110' ' ' LEU . . . 42.83 82.77 0.02 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.814 HD22 ' HD2' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -45.45 175.01 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.562 -0.964 . . . . 0.0 109.433 -177.338 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.729 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 1.5 t30 -143.8 -5.64 0.8 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.266 -1.521 . . . . 0.0 112.762 -177.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . 82.35 -35.75 0.09 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.039 -1.038 . . . . 0.0 108.405 -177.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -54.76 -24.9 24.56 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.728 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -105.38 -17.41 14.45 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.439 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.814 ' HD2' HD22 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -91.61 122.43 65.73 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.397 -0.814 . . . . 0.0 109.14 179.09 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.516 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 14.1 Cg_exo -48.49 147.52 9.08 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.836 1.69 . . . . 0.0 110.446 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.455 ' HA ' ' CG ' ' A' ' 120' ' ' GLU . 3.5 Cg_exo -60.27 -30.58 91.46 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.496 2.13 . . . . 0.0 110.99 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 117' ' ' PRO . . . -42.89 -61.59 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 109.57 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.634 ' ND2' ' CE2' ' A' ' 35' ' ' PHE . 4.6 m-20 -88.71 51.6 2.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.353 -0.842 . . . . 0.0 109.134 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.627 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -70.29 -40.68 12.34 Favored Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -179.079 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 120' ' ' GLU . 5.7 Cg_exo -54.36 -47.21 28.12 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 121.928 1.752 . . . . 0.0 113.12 -177.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 71' ' ' LEU . 2.1 t -87.62 -28.19 5.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 120.581 -1.325 . . . . 0.0 109.118 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.877 ' HA ' HD22 ' A' ' 126' ' ' LEU . 1.1 mp -67.48 -23.16 29.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.511 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . . . -58.61 -28.14 65.33 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -81.01 -41.1 23.24 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.265 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.877 HD22 ' HA ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -64.59 -26.45 68.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.507 -1.371 . . . . 0.0 107.476 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 111' ' ' ASN . 14.8 mtmt -50.75 -37.37 41.53 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -83.53 -27.54 29.28 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.869 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 126' ' ' LEU . 1.1 tp . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.838 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' APC . . . . . 0.883 ' C6 ' HG21 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' CON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_